%0 Journal Article %J Acta Paediatr %D 2019 %T Administering analgesia sublingually is a suitable option for children with acute abdominal pain in the emergency department. %A Cozzi, Giorgio %A Zanchi, Chiara %A Chiaretti, Antonio %A Tipo, Vincenzo %A Cernich, Marta %A D'Anna, Carolina %A Fantacci, Claudia %A Conversano, Ester %A Zanon, Davide %A Ronfani, Luca %A Barbi, Egidio %X

AIM: Acute abdominal pain is a frequent complaint in children attending emergency departments. The aim of this study was to investigate the pain score reductions when children with acute abdominal pain received medication sublingually.

METHODS: We carried out a multicentre randomised controlled trial in three children's hospitals in Italy between March 2015 and June 2017. Children from four to 18 years of age with acute abdominal pain were recruited if their self-reported pain was at least six on a scale from 0-10. The children were randomised to receive ketorolac 0.5 mg/kg (n = 70) or tramadol 2 mg/kg (n = 70) sublingually or a melt in the mouth powder of 20 mg/kg paracetamol (n = 70). The main study outcome was the pain scores for the three drugs after two hours.

RESULTS: The 210 children (58.6% girls) had a median age of 12 years with an interquartile range of 9-14.3. The median pain scores at two hours were not significantly different between ketorolac 2.0 (interquartile ranges, IQR 0.0-4.3) and tramadol 3.0 (IQR 1.0-5.0) vs paracetamol 3.0 (IQR 0.8-5.0). The median pain reductions were all 5.0 points.

CONCLUSION: Delivering analgesia sublingually was a suitable option for pain relief in children with acute abdominal pain in the emergency department.

%B Acta Paediatr %V 108 %P 143-148 %8 2019 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30043434?dopt=Abstract %R 10.1111/apa.14514 %0 Journal Article %J Arch Dis Child Educ Pract Ed %D 2019 %T Adolescent with painful vesicular otitis and vertigo. %A Conversano, Ester %A Cozzi, Giorgio %A Poropat, Federico %A Di Mascio, Alberto %A Salis, Simona %A Grasso, Domenico Leonardo %A Barbi, Egidio %B Arch Dis Child Educ Pract Ed %V 104 %P 103-105 %8 2019 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/29440126?dopt=Abstract %R 10.1136/archdischild-2017-313883 %0 Journal Article %J J Cell Physiol %D 2019 %T Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. %A Mazzoni, Elisa %A Frontini, Francesca %A Rotondo, John Charles %A Zanotta, Nunzia %A Fioravanti, Arianna %A Minelli, Francesca %A Torreggiani, Elena %A Campisciano, Giuseppina %A Marcuzzi, Annalisa %A Guerra, Giovanni %A Tommasini, Alberto %A Touzé, Antoine %A Martini, Fernanda %A Tognon, Mauro %A Comar, Manola %X

Recent data indicate that the Simian virus 40 (SV40) infection appears to be transmitted in humans independently from early SV40-contaminated antipolio vaccines. Serum antibodies against SV40 large T antigen (Tag) were analyzed in children/adolescents and young adults. To investigate antibodies reacting to SV40 Tag antigens, serum samples ( n = 812) from children and young adults were analyzed by indirect ELISAs using specific SV40 Tag mimotopes. Mimotopes were synthetic peptides corresponding to SV40 Tag epitopes. In sera ( n = 412) from healthy children up to 17 years old, IgG antibodies against SV40 Tag mimotopes reached an overall prevalence of 15%. IgM antibodies against SV40 Tag were detected in sera of children 6-8 months old confirming and extending the knowledge that SV40 seroconversion occurs early in life. In children/adolescents affected by different diseases ( n = 180) SV40 Tag had a prevalence of 18%, being the difference no significant compared to healthy subjects ( n = 220; 16%) of the same age. Our immunological data indicate that SV40 circulates in children and young adults, both in healthy conditions and affected by distinct diseases. The IgM detection in sera from healthy children suggests that the SV40 infection/seroconversion occurs early in life (>6 months). Our immunological data support the hypothesis that SV40, or a closely related still unknown polyomavirus, infects humans. The SV40 seroprevalence is lower than common polyomaviruses, such as BKPyV and JCPyV, and other new human polyomaviruses. In addition, our immunological surveillance indicates a lack of association between different diseases, considered herein, and SV40.

%B J Cell Physiol %V 234 %P 3170-3179 %8 2019 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/30362540?dopt=Abstract %R 10.1002/jcp.27490 %0 Journal Article %J J Pediatr Gastroenterol Nutr %D 2019 %T Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study. %A Naviglio, Samuele %A Lacorte, Doriana %A Lucafò, Marianna %A Cifù, Adriana %A Favretto, Diego %A Cuzzoni, Eva %A Silvestri, Tania %A Pozzi Mucelli, Martina %A Radillo, Oriano %A Decorti, Giuliana %A Fabris, Martina %A Bramuzzo, Matteo %A Taddio, Andrea %A Stocco, Gabriele %A Alvisi, Patrizia %A Ventura, Alessandro %A Martelossi, Stefano %X

OBJECTIVES: Anti-tumor necrosis factor antibodies have led to a revolution in the treatment of inflammatory bowel diseases (IBD); however, a sizable proportion of patients does not respond to therapy. There is increasing evidence suggesting that treatment failure may be classified as mechanistic (pharmacodynamic), pharmacokinetic, or immune-mediated. Data regarding the contribution of these factors in children with IBD treated with infliximab (IFX) are still incomplete. The aim was to assess the causes of treatment failure in a prospective cohort of pediatric patients treated with IFX.

METHODS: This observational study considered 49 pediatric (median age 14.4) IBD patients (34 Crohn disease, 15 ulcerative colitis) treated with IFX. Serum samples were collected at 6, 14, 22 and 54 weeks, before IFX infusions. IFX and anti-infliximab antibodies (AIA) were measured using enzyme linked immunosorbent assays. Disease activity was determined by Pediatric Crohn's Disease Activity Index or Pediatric Ulcerative Colitis Activity Index.

RESULTS: Clinical remission, defined as a clinical score <10, was obtained by 76.3% of patients at week 14 and by 73.9% at week 54. Median trough IFX concentration was higher at all time points in patients achieving sustained clinical remission. IFX levels during maintenance correlated also with C-reactive protein, albumin, and fecal calprotectin. After multivariate analysis, IFX concentration at week 14 >3.11 μg/mL emerged as the strongest predictor of sustained clinical remission. AIA concentrations were correlated inversely with IFX concentrations and directly with adverse reactions.

CONCLUSIONS: Most cases of therapeutic failure were associated with low serum drug levels. IFX trough levels at the end of induction are associated with sustained long-term response.

%B J Pediatr Gastroenterol Nutr %V 68 %P 37-44 %8 2019 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30211845?dopt=Abstract %R 10.1097/MPG.0000000000002112 %0 Journal Article %J Am J Reprod Immunol %D 2019 %T Cervico-vaginal secretion cytokine profile: A non-invasive approach to study the endometrial receptivity in IVF cycles. %A Zanotta, Nunzia %A Monasta, Lorenzo %A Skerk, Kristina %A Luppi, Stefania %A Martinelli, Monica %A Ricci, Giuseppe %A Comar, Manola %X

PROBLEM: Cytokines have a significant role in the process of embryo implantation, trophoblast growth, and differentiation by modulating the immune and endocrine system. The aim of this study was to investigate the profile of a large set of cytokines in the cervico-vaginal washing of women undergoing IVF, to explore the association of these proteins with a good receptive endometrium.

METHOD OF STUDY: A cohort of 155 women scheduled for IVF cycle was recruited. All patients were asymptomatic for genitourinary infections and had been screened for chlamydia, mycoplasma, and other bacterial infections. All IVF subjects were treated according to standard clinical and laboratory protocols. A panel of 48 immune factors was analyzed on cervico-vaginal washing, using magnetic bead-based multiplex immunoassays (Bio-Plex, BIO-RAD Laboratories, Milano, Italy).

RESULTS: A total of 99 patients reached embryo transfer, of which 31 had a clinical pregnancy. A pattern of four pro-inflammatory immune molecules, IL-12p40, IFN-a, MIF, and MCP3 (P < 0.001), was found significantly up-regulated in the cervico-vaginal fluid of women with clinical pregnancy. A significantly increased expression of IL-9, Gro , and SDF-1 (P < 0.05) was observed in the presence of endometriosis, while high levels of IL-13 and L-15 were associated with ovulatory infertility factor (P < 0.05).

CONCLUSION: In this pilot study, we demonstrated that the expression of specific cytokines in the cervico-vaginal washing on the day of oocyte retrieval might have a positive correlation with the potential clinical pregnancy. Therefore, cervico-vaginal secretion cytokine profiling might be a new, non-invasive approach to study the endometrial receptivity in IVF management.

%B Am J Reprod Immunol %V 81 %P e13064 %8 2019 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30475413?dopt=Abstract %R 10.1111/aji.13064 %0 Journal Article %J Res Dev Disabil %D 2019 %T An evaluation of the Movement ABC-2 Test for use in Italy: A comparison of data from Italy and the UK. %A Zoia, Stefania %A Biancotto, Marina %A Guicciardi, Marco %A Lecis, Romina %A Lucidi, Fabio %A Pelamatti, Giovanna M %A Carrozzi, Marco %A Skabar, Aldo %A Sugden, David A %A Barnett, Anna L %A Henderson, Sheila E %X

BACKGROUND: The standardized test within the Movement Assessment Battery for Children-2nd edition (MABC-2) is used worldwide to assess motor problems in children. Ideally, any country using a test developed in another country should produce national norms to ensure that it functions effectively in the new context.

AIM: The first objective of this study was to explore the differences in motor performance between Italian and British children. The second was to examine the structural validity of the test for the Italian sample.

METHOD: A total of 718 Italian (IT) and 765 British (UK) children, aged 3-10 years, were individually tested on the age-appropriate items of the MABC-2 Test.

RESULTS: Developmental trends emerged on every task and differences between IT and UK children were obtained on 11 of 27 task comparisons. Interactions between age and country indicated that differences were not consistently in favor of one culture. Confirmatory factor analysis generally supported the proposed structure of the MABC-2 Test.

CONCLUSION: Although the differences between the IT and the UK children were relatively few, those that did emerge emphasize the need for population specific norms and suggest that cultural diversity in motor experiences should be considered when evaluating motor abilities in children.

%B Res Dev Disabil %V 84 %P 43-56 %8 2019 Jan %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29716782?dopt=Abstract %R 10.1016/j.ridd.2018.04.013 %0 Journal Article %J J Paediatr Child Health %D 2019 %T Facing somatic symptom disorder in the emergency department. %A Cozzi, Giorgio %A Barbi, Egidio %X

Somatic symptom disorder is a condition in which a patient's subjective report of physical symptoms is associated with distress; disruption of day-to-day functioning; or disproportionate thoughts, feelings and behaviours regarding the symptoms, whether or not they are associated with an identified medical condition. While somatic symptom disorder affects a considerable proportion of children and adolescents presenting to the emergency department (ED), it has not been well investigated in the ED literature, nor is there much formal training in, or guidelines for, how to care for affected patients in the ED. The aim of this paper is to highlight the historical clues commonly reported by these patients in order to try to help the emergency physicians recognise patients affected by a somatic symptom disorder. Adolescent age, the presence of daily subjective symptoms presenting daily for weeks or months, a long medical history record, an extensive diagnostic workup and, most of all, disproportionate functional impairment related to the symptoms are all features strongly suggestive of this disorder. Emergency physicians should become used to taking advantage of these clues to formulate a positive diagnosis of somatic symptom disorder according to the most recent diagnostic criteria. Emergency physicians have the unique opportunity to contribute to the correct diagnosis and treatment of these patients and to have a positive impact on their prognosis.

%B J Paediatr Child Health %V 55 %P 7-9 %8 2019 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30288831?dopt=Abstract %R 10.1111/jpc.14246 %0 Journal Article %J Acta Paediatr %D 2019 %T First urinary tract infections in children: the role of the risk factors proposed by the Italian recommendations. %A Alberici, I %A La Manna, A %A Pennesi, M %A Starc, M %A Scozzola, F %A Nicolini, G %A Toffolo, A %A Marra, G %A Chimenz, R %A Sica, F %A Maringhini, S %A Monasta, L %A Montini, G %X

AIM: In 2009, the Italian society for paediatric nephrology suggested the need for cystography, following a first febrile urinary tract infection (UTI), only in children at high risk for dilating vesicoureteral reflux or in the event of a second infection. The aim of this study was to evaluate the adequacy of the risk factors proposed by the Italian guidelines.

METHODS: Children aged 2-36 months, managed by 10 Italian hospitals between 2009 and 2013, with a first febrile UTI were retrospectively evaluated.

RESULTS: Four hundred and fourteen children were included: 51% female, mean age eight months. Escherichia coli was responsible of 84% UTIs. 269 children (65%) presented at least one risk factor, thus were further investigated: 44% had a reflux. The presence of a pathogen other than E. coli significantly predicted high-grade reflux, both in the univariate (Odd Ratio 2.52, 95% Confidence Interval 1.32-4.81, p < 0.005) and multivariate analysis (OR 2.74, 95% CI: 1.39-5.41, p: 0.003). 26/145 children (18%) with no risk factors experienced a second UTI, which prompted the execution of cystography, showing a dilating reflux in 11.

CONCLUSION: Among the risk factors proposed by the Italian guidelines, only the presence of a pathogen other than E. coli significantly predicted reflux. Cystography can be postponed in children with no risk factors.

%B Acta Paediatr %V 108 %P 544-550 %8 2019 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/30028535?dopt=Abstract %R 10.1111/apa.14506 %0 Journal Article %J Cancer Epidemiol Biomarkers Prev %D 2019 %T Four-miRNA Signature to Identify Asbestos-Related Lung Malignancies. %A Santarelli, Lory %A Gaetani, Simona %A Monaco, Federica %A Bracci, Massimo %A Valentino, Matteo %A Amati, Monica %A Rubini, Corrado %A Sabbatini, Armando %A Pasquini, Ernesto %A Zanotta, Nunzia %A Comar, Manola %A Neuzil, Jiri %A Tomasetti, Marco %A Bovenzi, Massimo %X

BACKGROUND: Altered miRNA expression is an early event upon exposure to occupational/environmental carcinogens; thus, identification of a novel asbestos-related profile of miRNAs able to distinguish asbestos-induced cancer from cancer with different etiology can be useful for diagnosis. We therefore performed a study to identify miRNAs associated with asbestos-induced malignancies.

METHODS: Four groups of patients were included in the study, including patients with asbestos-related (NSCLC) and asbestos-unrelated non-small cell lung cancer (NSCLC) or with malignant pleural mesothelioma (MPM), and disease-free subjects (CTRL). The selected miRNAs were evaluated in asbestos-exposed population.

RESULTS: Four serum miRNAs, that is miR-126, miR-205, miR-222, and miR-520g, were found to be implicated in asbestos-related malignant diseases. Notably, increased expression of miR-126 and miR-222 were found in asbestos-exposed subjects, and both miRNAs are involved in major pathways linked to cancer development. Epigenetic changes and cancer-stroma cross-talk could induce repression of miR-126 to facilitate tumor formation, angiogenesis, and invasion.

CONCLUSIONS: This study indicates that miRNAs are potentially involved in asbestos-related malignancies, and their expression outlines mechanism(s) whereby miRNAs may be involved in an asbestos-induced pathogenesis.

IMPACT: The discovery of a miRNA panel for asbestos-related malignancies would impact on occupational compensation and may be utilized for screening asbestos-exposed populations.

%B Cancer Epidemiol Biomarkers Prev %V 28 %P 119-126 %8 2019 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30257964?dopt=Abstract %R 10.1158/1055-9965.EPI-18-0453 %0 Journal Article %J Toxicol Lett %D 2019 %T Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents. %A Delfino, Riccarda %A Biasotto, Matteo %A Candido, Riccardo %A Altissimo, Matteo %A Stebel, Marco %A Salomè, Murielle %A van Elteren, Johannes T %A Vogel Mikuš, Katarina %A Zennaro, Cristina %A Šala, Martin %A Addobbati, Riccardo %A Tromba, Giuliana %A Pascolo, Lorella %K Animals %K Contrast Media %K Disease Models, Animal %K Dose-Response Relationship, Drug %K Female %K Gadolinium %K Gadolinium DTPA %K Magnetic Resonance Imaging %K Mice %K Nephrogenic Fibrosing Dermopathy %K Periodontal Ligament %K Renal Insufficiency %K Tissue Distribution %X

Gadolinium deposition in tissue is linked to nephrogenic systemic fibrosis (NSF): a rare disorder occurring in patients with severe chronic kidney disease and associated with administration of Gd-based contrast agents (GBCAs) for Magnetic Resonance Imaging (MRI). It is suggested that the GBCAs prolonged permanence in blood in these patients may result in a Gd precipitation in peripheral or central organs, where it initiates a fibrotic process. In this study we investigated new sites of retention/precipitation of Gd in a mouse model of renal disease (5/6 nephrectomy) receiving two doses (closely after each other) of a linear GBCA. Two commercial GBCAs (Omniscan® and Magnevist®) were administered at doses slightly higher than those used in clinical practice (0.7 mmol/kg body weight, each). The animals were sacrificed one month after the last administration and the explanted organs (kidney, liver, femur, dorsal skin, teeth) were analysed by X-ray fluorescence (XRF) at two synchrotron facilities. The XRF analysis with a millimetre-sized beam at the SYRMEP beamline (Elettra, Italy) produced no detectable levels of Gd in the examined tissues, with the notable exception of the incisors of the nephrectomised mice. The XRF analyses at sub-micron resolution performed at ID21 (ESRF, France) allowed to clearly localize Gd in the periodontal ligaments of teeth both from Omniscan® and Magnevist® treated nephrectomised mice. The latter results were further confirmed by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). The study prompts that prolonged permanence of GBCAs in blood may result in Gd retention in this particular muscular tissue, opening possibilities for diagnostic applications at this level when investigating Gd-related toxicities.

%B Toxicol Lett %V 301 %P 157-167 %8 2019 Feb %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30476537?dopt=Abstract %R 10.1016/j.toxlet.2018.11.014 %0 Journal Article %J Arch Gynecol Obstet %D 2019 %T Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition. %A Vitale, Salvatore Giovanni %A Capriglione, Stella %A Zito, Gabriella %A Lopez, Salvatore %A Gulino, Ferdinando Antonio %A Di Guardo, Federica %A Vitagliano, Amerigo %A Noventa, Marco %A La Rosa, Valentina Lucia %A Sapia, Fabrizio %A Valenti, Gaetano %A Rapisarda, Agnese Maria Chiara %A Peterlunger, Isabel %A Rossetti, Diego %A Laganà, Antonio Simone %X

PURPOSE: Gynaecological cancer management in older people represents a current challenge. Therefore, in the present paper, we aimed to gather all the evidence reported in the literature concerning gynecological cancers in the elderly, illustrating the state of art and the future perspectives.

METHODS: We searched MEDLINE (PubMed), EMBASE, Cochrane Central Register of Controlled Trials, IBECS, BIOSIS, Web of Science, SCOPUS and Grey literature (Google Scholar; British Library) from January 1952 to May 2017, using the terms "ovarian cancer", "endometrial cancer", "cervical cancer", "gynecological cancers" combined with 'elderly', 'cancer', 'clinical trial' and 'geriatric assessment'.

RESULTS: The search identified 81 citations, of which 65 were potentially relevant after initial evaluation and met the criteria for inclusion and were analyzed. We divided all included studies into three different issue: "Endometrial cancer", "Ovarian cancer" and "Cervical cancer".

CONCLUSIONS: The present literature review shows that, in spite of the higher burden of comorbidities, elderly patients can also benefit from standard treatment to manage their gynecological cancers. It is important to overcome the common habit of undertreating the elderly patients because they are more fragile and with a lower life expectancy than their younger counterpart. Further trials with elderly women are warranted.

%B Arch Gynecol Obstet %V 299 %P 299-315 %8 2019 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/30542793?dopt=Abstract %R 10.1007/s00404-018-5006-z %0 Journal Article %J Gynecol Endocrinol %D 2019 %T Menstruation-related disseminated intravascular coagulation in an adenomyosis patient: case report and review of the literature. %A Cernogoraz, Alice %A Schiraldi, Luigi %A Bonazza, Deborah %A Ricci, Giuseppe %X

Disseminated intravascular coagulation (DIC) is a high mortality coagulopathy that leads to simultaneous thrombotic and bleeding problems. It occurs as a complication in different disease as malignancies, obstetrical catastrophes, bacterial sepsis and traumas. We report on an extremely rare case of acute DIC in a patient with misdiagnosed adenomyosis and massive methrorragia which led to acute kidney failure. The patient was successfully treated with hysterectomy and blood product transfusions; however, a slight reduction of renal function persisted. We were able to confirm the cause-consequence link between adenomyosis and consumptive DIC since we saw the thrombi in the adenomyotic uterus from early hysterectomy specimen. Moreover, this is the first case, for the best of our knowledge, in which systemic consequences persist in an adenomyosis patient who developed a DIC. Early diagnose and treatment of acute DIC is essential for patient's survival and to prevent severe complications: adenomyosis should be kept in mind as a possible cause of DIC when a patient shows up with massive bleeding.

%B Gynecol Endocrinol %V 35 %P 32-35 %8 2019 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30044152?dopt=Abstract %R 10.1080/09513590.2018.1488956 %0 Journal Article %J Eur J Hum Genet %D 2019 %T Next-generation sequencing identified SPATC1L as a possible candidate gene for both early-onset and age-related hearing loss. %A Morgan, Anna %A Vuckovic, Dragana %A Krishnamoorthy, Navaneethakrishnan %A Rubinato, Elisa %A Ambrosetti, Umberto %A Castorina, Pierangela %A Franzè, Annamaria %A Vozzi, Diego %A La Bianca, Martina %A Cappellani, Stefania %A Di Stazio, Mariateresa %A Gasparini, Paolo %A Girotto, Giorgia %X

Hereditary hearing loss (HHL) and age-related hearing loss (ARHL) are two major sensory diseases affecting millions of people worldwide. Despite many efforts, additional HHL-genes and ARHL genetic risk factors still need to be identified. To fill this gap a large genomic screening based on next-generation sequencing technologies was performed. Whole exome sequencing in a 3-generation Italian HHL family and targeted re-sequencing in 464 ARHL patients were performed. We detected three variants in SPATC1L: a nonsense allele in an HHL family and a frameshift insertion and a missense variation in two unrelated ARHL patients. In silico molecular modelling of all variants suggested a significant impact on the structural stability of the protein itself, likely leading to deleterious effects and resulting in truncated isoforms. After demonstrating Spatc1l expression in mice inner ear, in vitro functional experiments were performed confirming the results of the molecular modelling studies. Finally, a candidate-gene population-based statistical study in cohorts from Caucasus and Central Asia revealed a statistically significant association of SPATC1L with normal hearing function at low and medium hearing frequencies. Overall, the amount of different genetic data presented here (variants with early-onset and late-onset hearing loss in addition to genetic association with normal hearing function), together with relevant functional evidence, likely suggest a role of SPATC1L in hearing function and loss.

%B Eur J Hum Genet %V 27 %P 70-79 %8 2019 01 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30177775?dopt=Abstract %R 10.1038/s41431-018-0229-9 %0 Journal Article %J Eur J Neurol %D 2019 %T Prevalence and phenotype of the c.1529C>T SPG7 variant in adult-onset cerebellar ataxia in Italy. %A Mancini, C %A Giorgio, E %A Rubegni, A %A Pradotto, L %A Bagnoli, S %A Rubino, E %A Prontera, P %A Cavalieri, S %A Di Gregorio, E %A Ferrero, M %A Pozzi, E %A Riberi, E %A Ferrero, P %A Nigro, P %A Mauro, A %A Zibetti, M %A Tessa, A %A Barghigiani, M %A Antenora, A %A Sirchia, F %A Piacentini, S %A Silvestri, G %A De Michele, G %A Filla, A %A Orsi, L %A Santorelli, F M %A Brusco, A %X

BACKGROUND AND PURPOSE: Hereditary ataxias are heterogeneous groups of neurodegenerative disorders, characterized by cerebellar syndromes associated with dysarthria, oculomotor and corticospinal signs, neuropathy and cognitive impairment. Recent reports have suggested mutations in the SPG7 gene, causing the most common form of autosomal recessive spastic paraplegia (MIM#607259), as a main cause of ataxias. The majority of described patients were homozygotes or compound heterozygotes for the c.1529C>T (p.Ala510Val) change. We screened a cohort of 895 Italian patients with ataxia for p.Ala510Val in order to define the prevalence and genotype-phenotype correlation of this variant.

METHODS: We set up a rapid assay for c.1529C>T using restriction enzyme analysis after polymerase chain reaction amplification. We confirmed the diagnosis with Sanger sequencing.

RESULTS: We identified eight homozygotes and 13 compound heterozygotes, including two novel variants affecting splicing. Mutated patients showed a pure cerebellar ataxia at onset, evolving in mild spastic ataxia (alternatively) associated with dysarthria (~80% of patients), urinary urgency (~30%) and pyramidal signs (~70%). Comparing homozygotes and compound heterozygotes, we noted a difference in age at onset and Scale for the Assessment and Rating of Ataxia score between the two groups, supporting an earlier and more severe phenotype in compound heterozygotes versus homozygotes.

CONCLUSIONS: The SPG7 c.1529C>T (p.Ala510Val) mutants accounted for 2.3% of cerebellar ataxia cases in Italy, suggesting that this variant should be considered as a priority test in the presence of late-onset pure ataxia. Moreover, the heterozygous/homozygous genotype appeared to predict the onset of clinical manifestation and disease progression.

%B Eur J Neurol %V 26 %P 80-86 %8 2019 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30098094?dopt=Abstract %R 10.1111/ene.13768 %0 Journal Article %J Br J Haematol %D 2018 %T ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia. %A Faleschini, Michela %A Melazzini, Federica %A Marconi, Caterina %A Giangregorio, Tania %A Pippucci, Tommaso %A Cigalini, Elena %A Pecci, Alessandro %A Bottega, Roberta %A Ramenghi, Ugo %A Siitonen, Timo %A Seri, Marco %A Pastore, Annalisa %A Savoia, Anna %A Noris, Patrizia %X

The inherited thrombocytopenias (IT) are a heterogeneous group of diseases resulting from mutations in more than 30 different genes. Among them, ACTN1-related thrombocytopenia (ACTN1-RT; Online Mendelian Inheritance in Man: 615193) is one of the most recently identified forms. It has been described as a mild autosomal dominant macrothrombocytopenia caused by mutations in ACTN1, a gene encoding for one of the two non-muscle isoforms of α-actinin. We recently identified seven new unrelated families with ACTN1-RT caused by different mutations. Two of them are novel missense variants (p.Trp128Cys and p.Pro233Leu), whose pathogenic role has been confirmed by in vitro studies. Together with the 10 families we have previously described, our cohort of ACTN1-RT now consists of 49 individuals carrying ACTN1 mutations. This is the largest case series ever collected and enabled a critical evaluation of the clinical aspects of the disease. We concluded that ACTN1-RT is the fourth most frequent form of IT worldwide and it is characterized by platelet macrocytosis in all affected subjects and mild thrombocytopenia in less than 80% of cases. The risk of bleeding, either spontaneous or upon haemostatic challenge, is negligible and there are no other associated defects, either congenital or acquired. Therefore, ACTN1-RT is a benign form of IT, whose diagnosis provides affected individuals and their families with a good prognosis.

%B Br J Haematol %V 183 %P 276-288 %8 2018 Oct %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/30351444?dopt=Abstract %R 10.1111/bjh.15531 %0 Journal Article %J J Pediatr %D 2018 %T Adenomyomatosis of the Gallbladder as a Cause of Recurrent Abdominal Pain. %A Agrusti, Anna %A Gregori, Massimo %A Salviato, Tiziana %A Codrich, Daniela %A Barbi, Egidio %K Abdominal Pain %K Adenomyoma %K Adolescent %K Biopsy, Needle %K Cholecystectomy %K Diagnosis, Differential %K Female %K Gallbladder %K Gallbladder Neoplasms %K Humans %K Immunohistochemistry %K Recurrence %K Risk Assessment %K Severity of Illness Index %K Ultrasonography, Doppler %B J Pediatr %V 202 %P 328-328.e1 %8 2018 11 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29903530?dopt=Abstract %R 10.1016/j.jpeds.2018.05.020 %0 Journal Article %J J Paediatr Child Health %D 2018 %T Afebrile seizures in infants: Never forget magnesium! %A Minute, Marta %A Ventura, Giovanna %A Giorgi, Rita %A Faletra, Flavio %A Costa, Paola %A Cozzi, Giorgio %B J Paediatr Child Health %V 54 %P 446-448 %8 2018 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/29411453?dopt=Abstract %R 10.1111/jpc.13854 %0 Journal Article %J Inflammopharmacology %D 2018 %T Alendronate treatment induces IL-1B expression and apoptosis in glioblastoma cell line. %A Tricarico, Paola Maura %A Epate, Angeladine %A Celsi, Fulvio %A Crovella, Sergio %K Alendronate %K Apoptosis %K Brain %K Cell Line, Tumor %K Diphosphonates %K Glioblastoma %K Humans %K Interleukin-1beta %K Neuroglia %X

Alendronate (ALD), one among the nitrogen-containing bisphosphonates (NBPs), is currently used for the treatment of many pathological conditions. Unfortunately, although generally tolerated, NBPs treatment has been associated with central nervous system (CNS) adverse outcomes, such as amnesia, hallucinations and visual disturbances. So, we analyzed the effect of ALD treatment in glial cells, the main sources of cholesterol for neurons and principal cells involved in the immunological defense of the brain. We treated a glial cell line (U87-MG) with increasing doses of ALD (0.1, 1, 10, 25, 50 μM) for 48 h, aimed at evaluating the influence of this drug treatment on IL-1B expression, NLRP3 and CASP1 expression, mitochondrial activity and apoptotic cell death. We observed that ALD treatment, at the higher concentrations, induced a significant increase of IL-1B, NLRP3, CASP1 expression, provoked apoptosis and also mitochondrial damage in U87-MG. Considering the reported CNS adverse outcomes of NBPs treatment, our results confirm ALD side-effects on glial cell model.

%B Inflammopharmacology %V 26 %P 285-290 %8 2018 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28646347?dopt=Abstract %R 10.1007/s10787-017-0369-5 %0 Journal Article %J J Neurovirol %D 2018 %T Antibody response to polyomavirus primary infection: high seroprevalence of Merkel cell polyomavirus and lymphoid tissue involvement. %A Cason, Carolina %A Monasta, Lorenzo %A Zanotta, Nunzia %A Campisciano, Giuseppina %A Maestri, Iva %A Tommasino, Massimo %A Pawlita, Michael %A Villani, Sonia %A Comar, Manola %A Delbue, Serena %X

Human polyomaviruses (HPyVs) asymptomatically infect the human population establishing latency in the host, and their seroprevalence can reach 90% in healthy adults. Few studies have focused on the pediatric population, and there are no reports regarding the seroprevalence of all the newly isolated HPyVs among Italian children. Therefore, we investigated the frequency of serum antibodies against 12 PyVs in 182 immunocompetent children from Northeast Italy, by means of a multiplex antibody detection system. Additionally, secondary lymphoid tissues were collected to analyze the presence of HPyV DNA sequences using a specific real-time PCRs or PCRs. Almost 100% of subjects were seropositive for at least one PyV. Seropositivity ranged from 3% for antibodies against simian virus 40 (SV40) in children from 0 to 3 years, to 91% for antibodies against WU polyomavirus (WUPyV) and HPyV10 in children from 8 to 17 years. The mean number of PyV for which children were seropositive increased with the increasing of age: 4 standard deviations (SD) 1.8 in the 0-3-year group, 5 (SD 1.9) in the 4-7-year group, and 6 (SD 2.2) in the 8-17-year group. JC polyomavirus (JCPyV) DNA was detected in 1% of the adenoids, WUPyV in 12% of the tonsils, and 28% of the adenoids, and Merkel cell polyomavirus (MCPyV) was present in 6 and 2% of the tonsils and adenoids, respectively. Our study gives new insights on the serological evidence of exposure to PyVs during childhood, and on their possible respiratory route of transmission.

%B J Neurovirol %V 24 %P 314-322 %8 2018 Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29330826?dopt=Abstract %R 10.1007/s13365-017-0612-2 %0 Journal Article %J J Pediatr Gastroenterol Nutr %D 2018 %T Anti-transglutaminase 6 Antibody Development in Children With Celiac Disease Correlates With Duration of Gluten Exposure. %A De Leo, Luigina %A Aeschlimann, Daniel %A Hadjivassiliou, Marios %A Aeschlimann, Pascale %A Salce, Nicola %A Vatta, Serena %A Ziberna, Fabiana %A Cozzi, Giorgio %A Martelossi, Stefano %A Ventura, Alessandro %A Not, Tarcisio %X

OBJECTIVES: Antibodies against transglutaminase 6 (anti-TG6) have been implicated in neurological manifestations in adult patients with genetic gluten intolerance, and it is unclear whether autoimmunity to TG6 develops following prolonged gluten exposure. We measured the anti-TG6 in children with celiac disease (CD) at the diagnosis time to establish a correlation between these autoantibodies and the duration of gluten exposure. We investigated a correlation between anti-TG6 and the presence of neurological disorders.

METHODS: Anti-TG6 (IgA/IgG) were measured by ELISA in sera of children with biopsy-proven CD and of children experiencing gastrointestinal disorders. CD patients positive for anti-TG6 were retested after 2 years of gluten-free diet (GFD).

RESULTS: We analyzed the sera of 274 CD children and of 121 controls. Anti-TG6 were detected in 68/274 (25%) CD patients and in 19/121 (16%) controls, with significant difference between the 2 groups (P = 0.04). None of the CD patients and of the controls testing positive for anti-TG6 were experiencing neurological disorders. Eleven of 18 (61%) CD patients with other autoimmune diseases were positive for anti-TG6. In CD patients, a significant correlation between the gluten exposure before the CD diagnosis and anti-TG6 concentration was found (P = 0.006 for IgA; P < 0.0001 for IgG). After GFD anti-TG6 concentrations were significantly reduced (P < 0.001). No significant correlation was observed between anti-TG6 and anti-TG2 serum concentrations.

CONCLUSIONS: Anti-TG6 are more prevalent in children with untreated CD in the absence of overt neurological disorders. The synthesis of the anti-TG6 is related to a longer exposure to gluten before the CD diagnosis, and the autoimmunity against TG6 is gluten dependent and disappeared during GFD.

%B J Pediatr Gastroenterol Nutr %V 66 %P 64-68 %8 2018 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28542044?dopt=Abstract %R 10.1097/MPG.0000000000001642 %0 Journal Article %J Cardiovasc Ultrasound %D 2018 %T Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study. %A Faganello, Giorgio %A Cioffi, Giovanni %A Rossini, Maurizio %A Ognibeni, Federica %A Giollo, Alessandro %A Fisicaro, Maurizio %A Russo, Giulia %A Di Nora, Concetta %A Doimo, Sara %A Tarantini, Luigi %A Mazzone, Carmine %A Cherubini, Antonella %A D'Agata Mottolesi, Biancamaria %A Pandullo, Claudio %A Di Lenarda, Andrea %A Sinagra, Gianfranco %A Viapiana, Ombretta %K Aorta %K Aortic Coarctation %K Arthritis, Rheumatoid %K Humans %K Prognosis %K Vascular Stiffness %X

BACKGROUND: Patients who underwent a successful repair of the aortic coarctation (CoA) show high risk for cardiovascular (CV) events. Mechanical and structural abnormalities in the ascending aorta (Ao) might have a role in the prognosis of CoA patients. We analyzed the elastic properties of Ao measured as aortic stiffness index (AoSI) in CoA patients in the long-term period and we compared AoSI with a cohort of 38 patients with rheumatoid arthritis (RA) and 38 non-RA matched controls.

METHODS: Data from 19 CoA patients were analyzed 28 ± 13 years after surgery. Abnormally high AoSI was diagnosed if AoSI > 6.07% (95th percentile of the AoSI detected in our reference healthy population). AoSI was assessed at the level of the aortic root by two-dimensional guided M-mode evaluation.

RESULTS: CoA patients showed more than two-fold higher AoSI compared to RA and controls (9.8 ± 12.6 vs 4.8 ± 2.5% and 3.1 ± 2.0%, respectively; all p < 0.05 and in 5 of 19 patients with CoA (26%) AoSI was exceptionally high. The 5 patients with abnormally high AoSI were older with higher BP, LV mass and prevalence of LV diastolic dysfunction. Multiple linear regression analysis revealed that AoSI was independently related to the presence of LV hypertrophy and higher LV relative wall thickness.

CONCLUSIONS: CoA patients have higher AoSI levels than RA patients and non-RA matched controls. AoSI levels are abnormally high in a small sub-group of CoA patients who show a very high-risk clinical profile for adverse CV events.

%B Cardiovasc Ultrasound %V 16 %P 9 %8 2018 Jun 26 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/29940971?dopt=Abstract %R 10.1186/s12947-018-0126-y %0 Journal Article %J Front Biosci (Elite Ed) %D 2018 %T Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. %A Campisciano, Giuseppina %A Cason, Carolina %A Palmisano, Silvia %A Giuricin, Michela %A Rizzardi, Alessia %A Croce, Lory Saveria %A De Manzini, Nicolo %A Comar, Manola %K Biofilms %K Case-Control Studies %K Gastric Bypass %K Gastrointestinal Microbiome %K Humans %K Intestinal Mucosa %K Obesity %K Prospective Studies %X

The intestinal microbiota disequilibrium has been associated with obesity, while the role of the gut mucosal biofilms in this pathology is still unknown. We analysed the changes in the intestinal microbiota of obese patients after bariatric surgery with the aim of disclosing the rearrangement of the biofilm configuration. Although the bariatric surgery drives major rearrangements of the gut microbiota, obese patients maintain the enterotype before and after surgery, as shown by normal weight patients, with an increase of and . The enterotype guarantees the strong ability to form a biofilm which allows a more efficient digestion of polysaccharides than planktonic communities and leads to the production of acetate which is a key player to inhibit enteropathogens. Additionally, the laparoscopic gastric bypass induces an increase of , a facultative anaerobic bacterium involved in intestinal and inflammatory disorders. Bariatric surgery influences the microbial composition of gut biofilm. Further studies are needed to elucidate the impact of this variation on recovery after surgery and on weight loss.

%B Front Biosci (Elite Ed) %V 10 %P 495-505 %8 2018 06 01 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29772522?dopt=Abstract %0 Journal Article %J Eur J Med Genet %D 2018 %T Benign hereditary chorea and deletions outside NKX2-1: What's the role of MBIP? %A Invernizzi, Federica %A Zorzi, Giovanna %A Legati, Andrea %A Coppola, Giovanni %A d'Adamo, Pio %A Nardocci, Nardo %A Garavaglia, Barbara %A Ghezzi, Daniele %K Cells, Cultured %K Chorea %K Haploinsufficiency %K Humans %K Intracellular Signaling Peptides and Proteins %K Pedigree %K Sequence Deletion %K Thyroid Nuclear Factor 1 %X

Heterozygous point mutations or deletions of the NKX2-1 gene cause benign hereditary chorea (BHC) or a various combinations of primary hypothyroidism, respiratory distress and neurological disorders. Deletions proximal to, but not encompassing, NKX2-1 have been described in few subjects with brain-lung-thyroid syndrome. We report on a three-generation Italian family, with 6 subjects presenting BHC and harboring a genomic deletion adjacent to NKX2-1 and including the gene MBIP, recently proposed to be relevant for the pathogenesis of brain-lung-thyroid syndrome. We observed a clear reduction of NKX2-1 transcript levels in fibroblasts from our patients compared to controls; this finding suggests that MBIP deletion affects NKX2-1 expression, mimicking haploinsufficiency caused by classical NKX2-1 related mutations.

%B Eur J Med Genet %V 61 %P 581-584 %8 2018 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/29621620?dopt=Abstract %R 10.1016/j.ejmg.2018.03.011 %0 Journal Article %J Arch Dis Child %D 2018 %T Boy with fish-mouth meatus. %A Cortellazzo Wiel, Luisa %A Pederiva, Federica %A Castagnetti, Marco %A Barbi, Egidio %A Pennesi, Marco %B Arch Dis Child %8 2018 Jun 14 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29903890?dopt=Abstract %R 10.1136/archdischild-2018-315360 %0 Journal Article %J Cell Death Differ %D 2018 %T Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells. %A Bellazzo, Arianna %A Di Minin, Giulio %A Valentino, Elena %A Sicari, Daria %A Torre, Denis %A Marchionni, Luigi %A Serpi, Federica %A Stadler, Michael B %A Taverna, Daniela %A Zuccolotto, Gaia %A Montagner, Isabella Monia %A Rosato, Antonio %A Tonon, Federica %A Zennaro, Cristina %A Agostinis, Chiara %A Bulla, Roberta %A Mano, Miguel %A Del Sal, Giannino %A Collavin, Licio %X

The tumor suppressor DAB2IP contributes to modulate the network of information established between cancer cells and tumor microenvironment. Epigenetic and post-transcriptional inactivation of this protein is commonly observed in multiple human malignancies, and can potentially favor progression of tumors driven by a variety of genetic mutations. Performing a high-throughput screening of a large collection of human microRNA mimics, we identified miR-149-3p as a negative post-transcriptional modulator of DAB2IP. By efficiently downregulating DAB2IP, this miRNA enhances cancer cell motility and invasiveness, facilitating activation of NF-kB signaling and promoting expression of pro-inflammatory and pro-angiogenic factors. In addition, we found that miR-149-3p secreted by prostate cancer cells induces DAB2IP downregulation in recipient vascular endothelial cells, stimulating their proliferation and motility, thus potentially remodeling the tumor microenvironment. Finally, we found that inhibition of endogenous miR-149-3p restores DAB2IP activity and efficiently reduces tumor growth and dissemination of malignant cells. These observations suggest that miR-149-3p can promote cancer progression via coordinated inhibition of DAB2IP in tumor cells and in stromal cells.

%B Cell Death Differ %V 25 %P 1224-1238 %8 2018 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/29568059?dopt=Abstract %R 10.1038/s41418-018-0088-5 %0 Journal Article %J Immunol Invest %D 2018 %T Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy. %A Bonin, Serena %A Zanotta, Nunzia %A Sartori, Arianna %A Bratina, Alessio %A Manganotti, Paolo %A Trevisan, Giusto %A Comar, Manola %K Adult %K Aged %K Biomarkers %K Central Nervous System %K Diagnosis, Differential %K Female %K Hematopoietic Cell Growth Factors %K Humans %K Interleukin-12 %K Lectins, C-Type %K Male %K Middle Aged %K Multiple Sclerosis %K Peripheral Nervous System %K Polyradiculoneuropathy, Chronic Inflammatory Demyelinating %K Proteins %X

BACKGROUND: Cerebrospinal fluid (CSF) analysis in patients with particular neurologic disorders is a powerful tool to evaluate specific central nervous system inflammatory markers for diagnostic needs, because CSF represents the specific immune micro-environment to the central nervous system.

METHODS: CSF samples from 49 patients with multiple sclerosis (MS), chronic inflammatory demyelinating polyneuropathy (CIDP), and non-inflammatory neurologic disorders (NIND) as controls were submitted to protein expression profiles of 47 inflammatory biomarkers by multiplex Luminex bead assay to investigate possible differences in the inflammatory process for MS and CIDP.

RESULTS: Our results showed differences in CSF cytokine levels in MS and CIDP; in particular, IL12 (p40) was significantly highly expressed in MS in comparison with CIDP and NIND, while SDF-1α and SCGF-β were significantly highly expressed in CIDP cohort when compared to MS and NIND. IL-9, IL-13, and IL-17 had higher expression levels in NIND if compared with the other groups.

CONCLUSIONS: Our study showed that, despite some common pathogenic mechanisms, central and peripheral nervous system demyelinating diseases, such as MS and CIDP, differ in some specific inflammatory soluble proteins in CSF, underlining differences in the immune response involved in those autoimmune diseases.

%B Immunol Invest %V 47 %P 135-145 %8 2018 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/29182448?dopt=Abstract %R 10.1080/08820139.2017.1405978 %0 Journal Article %J Ultrasound Obstet Gynecol %D 2018 %T Cervical-length measurement in mid-gestation to predict spontaneous preterm birth in asymptomatic triplet pregnancy. %A Fichera, A %A Pagani, G %A Stagnati, V %A Cascella, S %A Faiola, S %A Gaini, C %A Lanna, M %A Pasquini, L %A Raffaelli, R %A Stampalija, T %A Tommasini, A %A Prefumo, F %K Adult %K Cervical Length Measurement %K Female %K Gestational Age %K Humans %K Infant, Newborn %K Logistic Models %K Predictive Value of Tests %K Pregnancy %K Pregnancy, Triplet %K Premature Birth %K Retrospective Studies %X

OBJECTIVE: To assess the predictive value of sonographic cervical-length (CL) measurement in mid-gestation for spontaneous preterm birth (PTB) in asymptomatic triplet pregnancy.

METHODS: This was a retrospective study of asymptomatic triplet pregnancies followed at five Italian tertiary referral centers, between 2002 and 2015. CL was measured transvaginally between 18 and 24 weeks' gestation. Pregnancies with medically indicated PTB were excluded. Demographic and pregnancy characteristics of pregnancies complicated by PTB were analyzed and the distributions of CL measurements in these patients were calculated. Logistic regression analysis was performed to assess the association between CL and PTB, adjusted for confounders. Performance of CL measurement in prediction of PTB < 28, < 30 and < 32 weeks of gestation was assessed.

RESULTS: A total of 120 triplet pregnancies were included in the final analysis. Median CL was 35 (interquartile range (IQR), 29-40) mm measured at a median gestational age of 20 + 2 (IQR, 20 + 0 to 23 + 4) weeks. Overall, 23 (19.2%), 17 (14.2%) and eight (6.7%) patients had a CL < 25, < 20 and < 15 mm, respectively. Spontaneous PTB < 32 weeks occurred in 41 (34.2%) cases, < 30 weeks in 23 (19.2%) and < 28 weeks in 12 (10%) cases. CL < 15 mm was significantly more frequent in the group of patients who delivered < 28 (P = 0.03) and < 30 (P = 0.01) weeks' gestation, compared with those who delivered after 28 and after 30 weeks, respectively, while CL < 20 mm was more common in triplet pregnancies with delivery < 32 weeks compared with those delivered ≥ 32 weeks (P = 0.03). Logistic regression analysis was possible only for PTB < 32 weeks due to the small number of cases that delivered < 30 and < 28 weeks. After adjustment for confounders, CL was not significantly associated with PTB < 32 weeks (adjusted odds ratio, 0.97; 95% CI, 0.94-1.01). CL measurement had an area under the receiver-operating characteristics curve of 0.41 (95% CI, 0.20-0.62), 0.41 (95% CI, 0.26-0.56) and 0.42 (95% CI, 0.31-0.54) for the prediction of spontaneous PTB < 28, < 30 and < 32 weeks, respectively.

CONCLUSION: CL assessed in mid-gestation is a poor predictor of PTB < 28, < 30 and < 32 weeks' gestation in asymptomatic triplet pregnancy. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

%B Ultrasound Obstet Gynecol %V 51 %P 614-620 %8 2018 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/28295801?dopt=Abstract %R 10.1002/uog.17464 %0 Journal Article %J Epigenetics %D 2018 %T Characterization of multi-locus imprinting disturbances and underlying genetic defects in patients with chromosome 11p15.5 related imprinting disorders. %A Fontana, L %A Bedeschi, M F %A Maitz, S %A Cereda, A %A Faré, C %A Motta, S %A Seresini, A %A D'Ursi, P %A Orro, A %A Pecile, V %A Calvello, M %A Selicorni, A %A Lalatta, F %A Milani, D %A Sirchia, S M %A Miozzo, M %A Tabano, S %K Adaptor Proteins, Signal Transducing %K Adolescent %K Beckwith-Wiedemann Syndrome %K Child %K Child, Preschool %K Chromosomes, Human, Pair 15 %K DNA Methylation %K Female %K Genomic Imprinting %K Humans %K Infant %K Kruppel-Like Transcription Factors %K Male %K Mutation, Missense %K Silver-Russell Syndrome %K Young Adult %X

The identification of multilocus imprinting disturbances (MLID) appears fundamental to uncover molecular pathways underlying imprinting disorders (IDs) and to complete clinical diagnosis of patients. However, MLID genetic associated mechanisms remain largely unknown. To characterize MLID in Beckwith-Wiedemann (BWS) and Silver-Russell (SRS) syndromes, we profiled by MassARRAY the methylation of 12 imprinted differentially methylated regions (iDMRs) in 21 BWS and 7 SRS patients with chromosome 11p15.5 epimutations. MLID was identified in 50% of BWS and 29% of SRS patients as a maternal hypomethylation syndrome. By next-generation sequencing, we searched for putative MLID-causative mutations in genes involved in methylation establishment/maintenance and found two novel missense mutations possibly causative of MLID: one in NLRP2, affecting ADP binding and protein activity, and one in ZFP42, likely leading to loss of DNA binding specificity. Both variants were paternally inherited. In silico protein modelling allowed to define the functional effect of these mutations. We found that MLID is very frequent in BWS/SRS. In addition, since MLID-BWS patients in our cohort show a peculiar pattern of BWS-associated clinical signs, MLID test could be important for a comprehensive clinical assessment. Finally, we highlighted the possible involvement of ZFP42 variants in MLID development and confirmed NLRP2 as causative locus in BWS-MLID.

%B Epigenetics %V 13 %P 897-909 %8 2018 %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/30221575?dopt=Abstract %R 10.1080/15592294.2018.1514230 %0 Journal Article %J J Pediatr %D 2018 %T A Child with Diminished Linear Growth and Waddling Gait. %A Tamaro, Gianluca %A Pederiva, Federica %A Dibello, Daniela %A Gregori, Massimo %A Carbone, Marco %A Pantaleoni, Francesca %A Dentici, Maria Lisa %A Niceta, Marcello %A Barbi, Egidio %K Abnormalities, Multiple %K Child %K Dwarfism %K Female %K Gait %K Humans %K Osteochondrodysplasias %K Radiography %B J Pediatr %V 201 %P 297-297.e1 %8 2018 10 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29752176?dopt=Abstract %R 10.1016/j.jpeds.2018.04.007 %0 Journal Article %J Allergol Immunopathol (Madr) %D 2018 %T Cooking influence in tolerance acquisition in egg-induced acute food protein enterocolitis syndrome. %A Miceli Sopo, S %A Romano, A %A Bersani, G %A Fantacci, C %A Badina, L %A Longo, G %A Monti, G %A Viola, S %A Tripodi, S %A Barilaro, G %A Iacono, I D %A Caffarelli, C %A Mastrorilli, C %A Barni, S %A Mori, F %A Liotti, L %A Cuomo, B %A Franceschini, F %A Viggiano, D %A Monaco, S %X

BACKGROUND: Few studies on the age of resolution of Food Protein Induced Enterocolitis Syndrome (FPIES) induced by solid foods are available. In particular, for FPIES induced by egg, the mean age of tolerance acquisition reported in the literature ranges from 42 to 63 months.

OBJECTIVE: We have assessed whether the age of tolerance acquisition in acute egg FPIES varies depending on whether the egg is cooked or raw.

METHODS: We conducted a retrospective and multicentric study of children with diagnosis of acute egg FPIES seen in 10 Italian allergy units between July 2003 and October 2017. The collected data regarded sex, presence of other allergic diseases, age of onset of symptoms, kind and severity of symptoms, cooking technique of the ingested egg, outcome of the allergy test, age of tolerance acquisition.

RESULTS: Sixty-one children with acute egg FPIES were enrolled, 34 (56%) males and 27 (44%) females. Tolerance to cooked egg has been demonstrated by 47/61 (77%) children at a mean age of 30.2 months. For 32 of them, tolerance to raw egg has been demonstrated at a mean age of 43.9 months. No episodes of severe adverse reaction after baked egg ingestion have been recorded.

CONCLUSIONS: It is possible to perform an OFC with baked egg, to verify the possible acquisition of tolerance, at about 30 months of life in children with acute egg FPIES.

%B Allergol Immunopathol (Madr) %8 2018 Oct 10 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30316559?dopt=Abstract %R 10.1016/j.aller.2018.07.006 %0 Journal Article %J Redox Biol %D 2018 %T Cx26 partial loss causes accelerated presbycusis by redox imbalance and dysregulation of Nfr2 pathway. %A Fetoni, Anna Rita %A Zorzi, Veronica %A Paciello, Fabiola %A Ziraldo, Gaia %A Peres, Chiara %A Raspa, Marcello %A Scavizzi, Ferdinando %A Salvatore, Anna Maria %A Crispino, Giulia %A Tognola, Gabriella %A Gentile, Giulia %A Spampinato, Antonio Gianmaria %A Cuccaro, Denis %A Guarnaccia, Maria %A Morello, Giovanna %A Van Camp, Guy %A Fransen, Erik %A Brumat, Marco %A Girotto, Giorgia %A Paludetti, Gaetano %A Gasparini, Paolo %A Cavallaro, Sebastiano %A Mammano, Fabio %K Animals %K Apoptosis %K Connexin 26 %K Female %K Gene Deletion %K Male %K Mice %K Mice, Inbred C57BL %K NF-E2-Related Factor 2 %K Oxidation-Reduction %K Presbycusis %K Signal Transduction %X

Mutations in GJB2, the gene that encodes connexin 26 (Cx26), are the most common cause of sensorineural hearing impairment. The truncating variant 35delG, which determines a complete loss of Cx26 protein function, is the prevalent GJB2 mutation in several populations. Here, we generated and analyzed Gjb2 mice as a model of heterozygous human carriers of 35delG. Compared to control mice, auditory brainstem responses (ABRs) and distortion product otoacoustic emissions (DPOAEs) worsened over time more rapidly in Gjb2 mice, indicating they were affected by accelerated age-related hearing loss (ARHL), or presbycusis. We linked causally the auditory phenotype of Gjb2 mice to apoptosis and oxidative damage in the cochlear duct, reduced release of glutathione from connexin hemichannels, decreased nutrient delivery to the sensory epithelium via cochlear gap junctions and deregulated expression of genes that are under transcriptional control of the nuclear factor erythroid 2-related factor 2 (Nrf2), a pivotal regulator of tolerance to redox stress. Moreover, a statistically significant genome-wide association with two genes (PRKCE and TGFB1) related to the Nrf2 pathway (p-value < 4 × 10) was detected in a very large cohort of 4091 individuals, originating from Europe, Caucasus and Central Asia, with hearing phenotype (including 1076 presbycusis patients and 1290 healthy matched controls). We conclude that (i) elements of the Nrf2 pathway are essential for hearing maintenance and (ii) their dysfunction may play an important role in the etiopathogenesis of human presbycusis.

%B Redox Biol %V 19 %P 301-317 %8 2018 10 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30199819?dopt=Abstract %R 10.1016/j.redox.2018.08.002 %0 Journal Article %J Eur J Obstet Gynecol Reprod Biol %D 2018 %T Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets. %A Zanotta, Nunzia %A Campisciano, Giuseppina %A Scrimin, Federica %A Blendi, Ura %A Marcuzzi, Annalisa %A Vincenti, Ezio %A Crovella, Sergio %A Comar, Manola %K Adult %K Aged %K Cytokines %K Female %K Humans %K Inflammation %K Middle Aged %K Vaginal Smears %K Vulva %K Vulvodynia %K Women's Health %X

OBJECTIVE: The vulvar pain syndrome (VPS) is a multifactorial disease severely influencing the lifestyle of affected women. Among possible etiological factors, local injury, peripheral and/or central sensitization of the nervous system, and a chronic inflammatory status have been positively associated with the development of VPS. The identification of a constitutive altered local inflammatory profile in VPS women may represent an important point in the characterization of patients' phenotype as a useful marker influencing the vulvar micro-environment. The aim of this study was to investigative the possible role of the local cytokines production in women with VPS in comparison to healthy women.

STUDY DESIGN: In this study were collected vaginal swabs from 57 healthy women (HC) who never suffered from VPS and from 30 patients diagnosed with vulvodynia (VPS) by at least 3 years and currently symptomatic. All patients included in this study showed the absence of Sexually Transmitted (STD) diseases and Reproductive Tract Infection. Real-time PCR was performed to assess the genomic sequences of ST pathogens. The Luminex Bio-Plex platform was used for the analysis of a panel of 48 immune factors.

RESULTS: Eleven molecules, specifically involved in the pro-inflammatory pathway were significantly modulated in VPS patients in comparison to healthy women, suggesting a persistent inflammatory process.

CONCLUSIONS: Therefore, these inflammatory factors could be possible biological markers involved in this disease. Nevertheless, other studies are needed to consider this specific immune profile as a valid marker of the vulvodynia.

%B Eur J Obstet Gynecol Reprod Biol %V 226 %P 66-70 %8 2018 Jul %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29852336?dopt=Abstract %R 10.1016/j.ejogrb.2018.05.035 %0 Journal Article %J J Matern Fetal Neonatal Med %D 2018 %T DEFB1 polymorphisms and HIV-1 mother-to-child transmission in Zambian population. %A Zupin, Luisa %A Polesello, Vania %A Segat, Ludovica %A Kamada, Anselmo Jiro %A Kuhn, Louise %A Crovella, Sergio %X

INTRODUCTION: Human Beta Defensin-1 (hBD-1) is a component of the innate immune system, the first line of defence against pathogens, already reported as involved in the susceptibility to HIV-1 infection and HIV-1 mother-to-child transmission (MTCT) in different populations. We investigated the role of DEFB1 gene (encoding for hBD-1) functional polymorphisms in the susceptibility to HIV-1 MTCT in a population from Zambia.

METHODS: Four selected polymorphisms within DEFB1 gene, three at the 5' untranslated region (UTR), namely -52G > A (rs1799946), -44C > G (rs1800972) and -20G > A (rs11362) and one in the 3'UTR, c.*87A > G (rs1800972), were genotyped in 101 HIV-1 positive mothers (26 transmitters -27% and 75 not transmitters -73%) and 331 infants born to HIV-1 infected mothers (85 HIV-1 positive -26% and 246 exposed but not infected -74%).

RESULTS: DEFB1 c.*87-A allele was more frequent among HIV- children with respect to HIV+ (with intrauterine MTCT). Concerning DEFB1 haplotypes, GCGA haplotype resulted more represented in HIV- than HIV+ infants and DEFB1 ACGG haplotype presented increased frequency in HIV- children respect to HIV+ (with intra-partum MTCT) (p = .02, p = .002 and p = .006, respectively).

CONCLUSIONS: DEFB1 polymorphisms were significantly associated with decreased risk of HIV-1 infection acquisition in the studied Zambian population suggesting that they may play a role in HIV-1 MTCT.

%B J Matern Fetal Neonatal Med %P 1-7 %8 2018 Mar 20 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29506422?dopt=Abstract %R 10.1080/14767058.2018.1449206 %0 Journal Article %J Pediatr Emerg Care %D 2018 %T Does the Application of Heat Gel Pack After Eutectic Mixture of Local Anesthetic Cream Improve Venipuncture or Intravenous Cannulation Success Rate in Children? A Randomized Control Trial. %A Schreiber, Silvana %A Cozzi, Giorgio %A Patti, Giuseppa %A Taddio, Andrea %A Montico, Marcella %A Pierobon, Chiara %A Barbi, Egidio %K Anesthetics, Local %K Child %K Child, Preschool %K Female %K Hot Temperature %K Humans %K Lidocaine %K Lidocaine, Prilocaine Drug Combination %K Male %K Pain %K Pain Management %K Phlebotomy %K Prilocaine %K Prospective Studies %X

OBJECTIVE: Needle-related procedures are the most common sources of pain for children in the hospital setting. The most used topical anesthetic, eutectic mixture of local anesthetic (EMLA) cream, may cause transient vasoconstriction. It has been postulated that this vasoconstriction may decrease vein visualization. The application of heat gel pack after removal of EMLA cream in the site of venipuncture counteracts the vasoconstriction, improving vein visualization. We assessed using a prospective randomized controlled trial whether the application of heat gel pack increases the needle procedure success rate. The primary study outcome was procedural success rate at the first attempt.

METHODS: The study enrolled 400 children, 200 of whom applied heat gel pack after removing EMLA (treatment group) and 200 did not (control group). Procedural success rate at the first attempt, vein perception before procedure, procedural pain, and adverse events were recorded in both groups.

RESULTS: Eighty-eight percent of the procedures were successful at the first attempt in the treatment group and 89% in the control group (P = 0.876). Vein perception was not significantly different in the 2 groups (P = 0.081). Pain score after the procedure was similar in the 2 groups.

CONCLUSIONS: This study shows that the application of heat gel pack after removal of EMLA cream does not improve venipuncture or intravenous cannulation success rate.

%B Pediatr Emerg Care %V 34 %P e24-e27 %8 2018 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/28719485?dopt=Abstract %R 10.1097/PEC.0000000000001248 %0 Journal Article %J BMJ Open %D 2018 %T Effectiveness of the facility-based maternal near-miss case reviews in improving maternal and newborn quality of care in low-income and middle-income countries: a systematic review. %A Lazzerini, Marzia %A Richardson, Sonia %A Ciardelli, Valentina %A Erenbourg, Anna %K Developing Countries %K Female %K Humans %K Infant, Newborn %K Maternal Mortality %K Near Miss, Healthcare %K Parturition %K Patient Satisfaction %K Perinatal Mortality %K Postpartum Hemorrhage %K Poverty %K Pregnancy %K Quality of Health Care %K Uterine Rupture %X

OBJECTIVES: The maternal near-miss case review (NMCR) has been promoted by WHO as an approach to improve quality of care (QoC) at facility level. This systematic review synthesises evidence on the effectiveness of the NMCR on QoC and maternal and perinatal health outcomes in low-income and middle-income countries (LMICs).

METHODS: Studies were searched for in six electronic databases (MEDLINE, Index Medicus, Web of Science, the Cochrane library, Embase, LILACS), with no language restrictions. Two authors independently screened papers and selected them for inclusion and independently extracted data. Maternal mortality was the primary outcome. Secondary outcomes included any outcome informing on any of the six dimensions of QoC: efficacy, safety, efficiency, equity, accessibility and timely care, acceptability and patient-centred care.

RESULTS: Out of 24 822 papers retrieved, 17 studies from 11 countries were included. Maternal mortality measured before and after the implementation of the NMCR cycle significantly decreased (OR 0.77, 95% CI 0.61 to 0.98, eight studies, 55 573 043 women; I=39%). A statistically significant reduction in the incidence of uterine rupture, postpartum haemorrhage and maternal sepsis was observed in three out of six studies. Ten studies reporting on maternal care process all showed some significant improvement when measured against predefined standards. All studies reported that the NMCR resulted in some amelioration of the facility structure (physical structure, staffing, equipment, training, organisation of care). Newborn outcomes were overall poorly reported; four studies showed no significant difference in perinatal mortality. Patient satisfaction and equity were also poorly reported.

CONCLUSIONS: Policy makers may consider implementing the maternal NMCR cycle approach among strategies aiming at improving QoC and reducing maternal mortality and morbidity in LMIC. Future studies should better document the effectiveness of the NMCR cycle particularly on outcomes reflecting patient-centred care and cost-effectiveness.

%B BMJ Open %V 8 %P e019787 %8 2018 04 19 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/29674368?dopt=Abstract %R 10.1136/bmjopen-2017-019787 %0 Journal Article %J J Pediatr Gastroenterol Nutr %D 2018 %T Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry. %A Aloi, Marina %A Bramuzzo, Matteo %A Arrigo, Serena %A Romano, Claudio %A D'Arcangelo, Giulia %A Lacorte, Doriana %A Gatti, Simona %A Illiceto, Maria T %A Zucconi, Francesca %A Dilillo, Dario %A Zuin, Giovanna %A Knafelz, Daniela %A Ravelli, Alberto %A Cucchiara, Salvatore %A Alvisi, Patrizia %X

OBJECTIVES: The aim of this study was to evaluate the effectiveness and safety of adalimumab (ADA) in children with ulcerative colitis (UC) previously treated with infliximab (IFX).

METHODS: Retrospective study including children with UC from a national registry who received ADA therapy. The primary endpoint was the rate of corticosteroid-free remission at week 52. Secondary outcomes were the rate of sustained clinical remission, primary nonresponse, and loss of response at weeks 12, 30, and 52 and rate of mucosal healing and side effects at week 52.

RESULTS: Thirty-two children received ADA (median age 10 ± 4 years). Median disease duration before ADA therapy was 27 months. All patients received previous IFX (43% intolerant, 50% nonresponders [37.5% primary, 42.5% secondary nonresponders], 6.7% positive anti-IFX antibodies). Fifty-two weeks after ADA initiation, 13 patients (41%) were in corticosteroid-free remission. Mucosal healing occurred in 9 patients (28%) at 52 weeks. The cumulative probability of a clinical relapse-free course was 69%, 59%, and 53% at 12, 30, and 52 weeks, respectively. Ten patients (31%) had a primary failure and 5 (15%) a loss of response to ADA. No significant differences in efficacy were reported between not-responders and intolerant to IFX (P = 1.0). Overall, 19 patient (59%) maintained ADA during 52-week follow-up. Seven patients (22%) experienced an adverse event, no serious side effects were observed and none resulted in ADA discontinuation.

CONCLUSIONS: Based on our data, ADA seems to be effective in children with UC, allowing to recover a significant percentage of patients intolerant or not-responding to IFX. The safety profile was good.

%B J Pediatr Gastroenterol Nutr %V 66 %P 920-925 %8 2018 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/29315163?dopt=Abstract %R 10.1097/MPG.0000000000001883 %0 Journal Article %J Andrology %D 2018 %T Endocrine and psychological aspects of sexual dysfunction in Klinefelter patients. %A Ferlin, A %A Selice, R %A Angelini, S %A Di Grazia, M %A Caretta, N %A Cavalieri, F %A Di Mambro, A %A Foresta, C %X

Klinefelter syndrome is a frequent cause of hypogonadism, but despite hundreds of publications on different aspects of Klinefelter syndrome, only a few studies dealt with sexual dysfunction. In particular, testosterone is critical for various aspects of sexual response, but its role on sexuality in Klinefelter syndrome patients is debatable and no studies have evaluated the efficacy of testosterone treatment on sexual dysfunction in these subjects. Furthermore, the impact of psychological and relational aspects on sexual function of Klinefelter syndrome subjects is poorly defined. In this study, we aimed to determine the presence and type of sexual dysfunctions in Klinefelter syndrome subjects; to correlate them with testosterone levels and psychosexological and relational domains; and to evaluate the effects of testosterone therapy. We studied 62 non-mosaic naïve Klinefelter syndrome patients and 60 age-matched controls by means of medical history, psychosexological history, 15-item International Index of Erectile Function questionnaire, endocrine assessment, and dynamic penile color Doppler ultrasound. Twenty-five hypogonadal Klinefelter syndrome patients were studied after 6 months of testosterone replacement therapy. Klinefelter syndrome subjects have reduced 15-item International Index of Erectile Function scores regarding sexual desire, intercourse satisfaction, and overall satisfaction with respect to controls, and these aspects were significantly associated with testosterone levels. Klinefelter syndrome subjects had also higher prevalence of erectile dysfunction, but no relation with testosterone levels was evident. A high prevalence of a range of psychological disturbances was present in Klinefelter syndrome subjects with erectile dysfunction with respect to those without erectile dysfunction. No statistical difference in the prevalence of premature and delayed ejaculation was observed between Klinefelter syndrome and control subjects. Testosterone replacement therapy improved sexual desire, intercourse satisfaction, and overall satisfaction scores, but had no effect on erectile function. Penile color Doppler ultrasound was normal in all subjects. This study shows that sexual dysfunction in Klinefelter syndrome is multifactorial and related only in part to hypogonadism and largely to psychological disturbances. Evaluation and therapy of sexual dysfunction should include a combined andrological and psychosexological approach.

%B Andrology %V 6 %P 414-419 %8 2018 05 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29453817?dopt=Abstract %R 10.1111/andr.12474 %0 Journal Article %J Genome Biol %D 2018 %T Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6. %A Prins, Bram P %A Mead, Timothy J %A Brody, Jennifer A %A Sveinbjornsson, Gardar %A Ntalla, Ioanna %A Bihlmeyer, Nathan A %A van den Berg, Marten %A Bork-Jensen, Jette %A Cappellani, Stefania %A Van Duijvenboden, Stefan %A Klena, Nikolai T %A Gabriel, George C %A Liu, Xiaoqin %A Gulec, Cagri %A Grarup, Niels %A Haessler, Jeffrey %A Hall, Leanne M %A Iorio, Annamaria %A Isaacs, Aaron %A Li-Gao, Ruifang %A Lin, Honghuang %A Liu, Ching-Ti %A Lyytikäinen, Leo-Pekka %A Marten, Jonathan %A Mei, Hao %A Müller-Nurasyid, Martina %A Orini, Michele %A Padmanabhan, Sandosh %A Radmanesh, Farid %A Ramirez, Julia %A Robino, Antonietta %A Schwartz, Molly %A van Setten, Jessica %A Smith, Albert V %A Verweij, Niek %A Warren, Helen R %A Weiss, Stefan %A Alonso, Alvaro %A Arnar, David O %A Bots, Michiel L %A de Boer, Rudolf A %A Dominiczak, Anna F %A Eijgelsheim, Mark %A Ellinor, Patrick T %A Guo, Xiuqing %A Felix, Stephan B %A Harris, Tamara B %A Hayward, Caroline %A Heckbert, Susan R %A Huang, Paul L %A Jukema, J W %A Kähönen, Mika %A Kors, Jan A %A Lambiase, Pier D %A Launer, Lenore J %A Li, Man %A Linneberg, Allan %A Nelson, Christopher P %A Pedersen, Oluf %A Perez, Marco %A Peters, Annette %A Polasek, Ozren %A Psaty, Bruce M %A Raitakari, Olli T %A Rice, Kenneth M %A Rotter, Jerome I %A Sinner, Moritz F %A Soliman, Elsayed Z %A Spector, Tim D %A Strauch, Konstantin %A Thorsteinsdottir, Unnur %A Tinker, Andrew %A Trompet, Stella %A Uitterlinden, André %A Vaartjes, Ilonca %A van der Meer, Peter %A Völker, Uwe %A Völzke, Henry %A Waldenberger, Melanie %A Wilson, James G %A Xie, Zhijun %A Asselbergs, Folkert W %A Dörr, Marcus %A van Duijn, Cornelia M %A Gasparini, Paolo %A Gudbjartsson, Daniel F %A Gudnason, Vilmundur %A Hansen, Torben %A Kääb, Stefan %A Kanters, Jørgen K %A Kooperberg, Charles %A Lehtimäki, Terho %A Lin, Henry J %A Lubitz, Steven A %A Mook-Kanamori, Dennis O %A Conti, Francesco J %A Newton-Cheh, Christopher H %A Rosand, Jonathan %A Rudan, Igor %A Samani, Nilesh J %A Sinagra, Gianfranco %A Smith, Blair H %A Holm, Hilma %A Stricker, Bruno H %A Ulivi, Sheila %A Sotoodehnia, Nona %A Apte, Suneel S %A van der Harst, Pim %A Stefansson, Kari %A Munroe, Patricia B %A Arking, Dan E %A Lo, Cecilia W %A Jamshidi, Yalda %K ADAMTS Proteins %K African Continental Ancestry Group %K Animals %K Connexin 43 %K Electrocardiography %K European Continental Ancestry Group %K Exome %K Female %K Gene Expression %K Gene Expression Profiling %K Genetic Loci %K Genome-Wide Association Study %K Heart Conduction System %K Humans %K Male %K Mice %K Middle Aged %K Myocardium %K Open Reading Frames %K Polymorphism, Single Nucleotide %K Whole Exome Sequencing %X

BACKGROUND: Genome-wide association studies conducted on QRS duration, an electrocardiographic measurement associated with heart failure and sudden cardiac death, have led to novel biological insights into cardiac function. However, the variants identified fall predominantly in non-coding regions and their underlying mechanisms remain unclear.

RESULTS: Here, we identify putative functional coding variation associated with changes in the QRS interval duration by combining Illumina HumanExome BeadChip genotype data from 77,898 participants of European ancestry and 7695 of African descent in our discovery cohort, followed by replication in 111,874 individuals of European ancestry from the UK Biobank and deCODE cohorts. We identify ten novel loci, seven within coding regions, including ADAMTS6, significantly associated with QRS duration in gene-based analyses. ADAMTS6 encodes a secreted metalloprotease of currently unknown function. In vitro validation analysis shows that the QRS-associated variants lead to impaired ADAMTS6 secretion and loss-of function analysis in mice demonstrates a previously unappreciated role for ADAMTS6 in connexin 43 gap junction expression, which is essential for myocardial conduction.

CONCLUSIONS: Our approach identifies novel coding and non-coding variants underlying ventricular depolarization and provides a possible mechanism for the ADAMTS6-associated conduction changes.

%B Genome Biol %V 19 %P 87 %8 2018 07 17 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30012220?dopt=Abstract %R 10.1186/s13059-018-1457-6 %0 Journal Article %J BMJ Open %D 2018 %T Facilitators and barriers to the effective implementation of the individual maternal near-miss case reviews in low/middle-income countries: a systematic review of qualitative studies. %A Lazzerini, Marzia %A Ciuch, Margherita %A Rusconi, Silvia %A Covi, Benedetta %X

BACKGROUND: The maternal near-miss cases review (NMCR), a type of clinical audit, proved to be effective in improving quality of care and decreasing maternal mortality in low/middle-income countries (LMICs). However, challenges in its implementation have been described.

OBJECTIVES: Synthesising the evidence on facilitators and barriers to the effective implementation of NMCR in LMICs.

DESIGN: Systematic review of qualitative studies.

DATA SOURCES: MEDLINE, LILACS, Global Health Library, SCI-EXPANDED, SSCI, Cochrane library and Embase were searched in December 2017.

ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Qualitative studies exploring facilitators and/or barriers of implementing NMCR in LMIC were included.

DATA EXTRACTION AND SYNTHESIS: Two independent reviewers extracted data, performed thematic analysis and assessed risk of bias.

RESULTS: Out of 25 361 papers retrieved, 9 studies from Benin, Brazil, Burkina Faso, Cote D'Ivoire, Ghana, Malawi, Morocco, Tanzania, Uganda could be included in the review. The most frequently reported barriers to NMCR implementation were the following: absence of national guidelines and local protocols; insufficient training on how to perform the audit; lack of leadership, coordination, monitoring and supervision; lack of resources and work overload; fear of blame and punishment; poor knowledge of evidenced-based medicine; hierarchical differences among staff and poor understating of the benefits of the NMCR. Major facilitators to NMCR implementation included: good leadership and coordination; training of all key staff; a good cultural environment; clear staff's perception on the benefits of conducting audit; patient empowerment and the availability of external support.

CONCLUSIONS: In planning the NMCR implementation in LMICs, policy-makers should consider actions to prevent and mitigate common challenges to successful NMCR implementation. Future studies should aim at documenting facilitators and barriers to NMCR outside the African Region.

%B BMJ Open %V 8 %P e021281 %8 2018 Jun 30 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/29961025?dopt=Abstract %R 10.1136/bmjopen-2017-021281 %0 Journal Article %J Environ Sci Pollut Res Int %D 2018 %T Ferruginous bodies resolved by synchrotron XRF in a dog with peritoneal malignant mesothelioma. %A Pascotto, Ernesto %A Gianoncelli, Alessandra %A Calligaro, Carla %A Marcuzzo, Thomas %A Melato, Mauro %A Rizzardi, Clara %A Pascolo, Lorella %K Animals %K Asbestos %K Dogs %K Environmental Exposure %K Immunohistochemistry %K Iron %K Lung %K Lung Neoplasms %K Male %K Mesothelioma %K Peritoneal Neoplasms %K Silicon %K Spectrometry, X-Ray Emission %K Synchrotrons %X

Mesothelioma is a malignant tumor mainly correlated to occupational asbestos exposure. Rare reports describe its occurrence also in animals, mainly linked to asbestos in the environment. Asbestos exposure is demonstrated by the appearance of characteristic histological hallmarks: asbestos containing ferruginous bodies that are iron-based structures forming around fibers and also other dust particles. Here we present a clinical case of a suspect of mesothelioma in the peritoneum of a dog with parallel histological observation of ferruginous bodies. To possibly correlate the dog tumor to environmental exposure, we performed X-ray fluorescence (XRF) analyses at two different synchrotrons to resolve the ferruginous bodies' composition. While the histological examination diagnoses a tubulo-papillary mesothelioma, the XRF analyses show that ferruginous bodies contain Si particles, resembling formations of exogenous origin; however, the morphology is unlikely that of asbestos fibers. We speculate that the peritoneal mesothelioma of this dog could be related to environmental exposure to non-asbestos material.

%B Environ Sci Pollut Res Int %V 25 %P 35707-35714 %8 2018 Dec %G eng %N 35 %1 http://www.ncbi.nlm.nih.gov/pubmed/30357666?dopt=Abstract %R 10.1007/s11356-018-3521-x %0 Journal Article %J Arthritis Care Res (Hoboken) %D 2018 %T Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration. %A Simonini, Gabriele %A Ferrara, Giovanna %A Pontikaki, Irene %A Scoccimarro, Erika %A Giani, Teresa %A Taddio, Andrea %A Meroni, Pier Luigi %A Cimaz, Rolando %X

OBJECTIVE: To assess the time in remission after discontinuing biologic therapy in patients with juvenile idiopathic arthritis (JIA).

METHODS: We enrolled 135 patients followed in 3 tertiary-care centers. The primary outcome was to assess, once remission was achieved, the time in remission up to the first flare after discontinuing treatment. Mann-Whitney U test, Wilcoxon's signed rank test for paired samples, chi-square tests, and Fisher's exact test were used to compare data. Pearson's and Spearman's correlation tests were used to determine correlation coefficients for different variables. To identify predictors of outcome, Cox regression model and Kaplan-Meier curves were constructed, each one at the mean of entered covariates.

RESULTS: The majority of enrolled patients flared after stopping treatment with biologics (102 of 135, 75.6%) after a median followup time in remission off therapy of 6 months (range 3-109 months). A higher probability of maintaining remission after discontinuing treatment was present in systemic-onset disease compared to the rest of the JIA patients (Mantel-Cox χ = 8.31, P < 0.004). In analysis limited to children with JIA with polyarticular and oligoarticular disease, patients who received biologics >2 years after achieving remission had a higher probability of maintaining such remission off therapy (mean ± SD 18.64 ± 3.3 months versus 11.51 ± 2.7 months [P < 0.009]; Mantel-Cox χ = 9.06, P < 0.002). No other clinical variable was significantly associated with a long-lasting remission.

CONCLUSION: Children with oligoarticular and polyarticular JIA who stop treatment before 2 years from remission have a higher chance of relapsing after biologic withdrawal.

%B Arthritis Care Res (Hoboken) %V 70 %P 1046-1051 %8 2018 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/28973842?dopt=Abstract %R 10.1002/acr.23435 %0 Journal Article %J Lasers Med Sci %D 2018 %T Fractional CO laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects. %A Becorpi, Angelamaria %A Campisciano, Giuseppina %A Zanotta, Nunzia %A Tredici, Zelinda %A Guaschino, Secondo %A Petraglia, Felice %A Pieralli, Annalisa %A Sisti, Giovanni %A De Seta, Francesco %A Comar, Manola %K Breast Neoplasms %K Cancer Survivors %K Cytokines %K Dyspareunia %K Female %K Humans %K Lasers, Gas %K Menopause %K Microbiota %K Middle Aged %K Prospective Studies %K Syndrome %K Vagina %K Vaginal Diseases %X

The composition of vaginal microbiome in menopause and cancer survivor women changes dramatically leading to genitourinary syndrome of menopause (GSM) in up to 70% of patients. Recent reports suggest that laser therapy may be valuable as a not hormonal therapeutic modality. The aim of the present study was to evaluate the effects of fractional CO laser treatment on the vaginal secretory pathway of a large panel of immune mediators, usually implicated in tissue remodeling and inflammation, and on microbiome composition in postmenopausal breast cancer survivors. The Ion Torrent PGM platform and the Luminex Bio-Plex platform were used for microbiome and immune factor analysis. The significant reduction of clinical symptoms and the non-significant changes in vaginal microbiome support the efficacy and safety of laser treatment. Moreover, the high remodeling status in vaginal epithelium is demonstrated by the significant changes in inflammatory and modulatory cytokine patterns. Laser therapy can be used for the treatment of GSM symptoms and does not show any adverse effects. However, further studies will be needed to clarify its long-term efficacy and other effects.

%B Lasers Med Sci %V 33 %P 1047-1054 %8 2018 Jul %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/29492713?dopt=Abstract %R 10.1007/s10103-018-2471-3 %0 Journal Article %J Nat Genet %D 2018 %T Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. %A Lee, James J %A Wedow, Robbee %A Okbay, Aysu %A Kong, Edward %A Maghzian, Omeed %A Zacher, Meghan %A Nguyen-Viet, Tuan Anh %A Bowers, Peter %A Sidorenko, Julia %A Karlsson Linnér, Richard %A Fontana, Mark Alan %A Kundu, Tushar %A Lee, Chanwook %A Li, Hui %A Li, Ruoxi %A Royer, Rebecca %A Timshel, Pascal N %A Walters, Raymond K %A Willoughby, Emily A %A Yengo, Loic %A Alver, Maris %A Bao, Yanchun %A Clark, David W %A Day, Felix R %A Furlotte, Nicholas A %A Joshi, Peter K %A Kemper, Kathryn E %A Kleinman, Aaron %A Langenberg, Claudia %A Mägi, Reedik %A Trampush, Joey W %A Verma, Shefali Setia %A Wu, Yang %A Lam, Max %A Zhao, Jing Hua %A Zheng, Zhili %A Boardman, Jason D %A Campbell, Harry %A Freese, Jeremy %A Harris, Kathleen Mullan %A Hayward, Caroline %A Herd, Pamela %A Kumari, Meena %A Lencz, Todd %A Luan, Jian'an %A Malhotra, Anil K %A Metspalu, Andres %A Milani, Lili %A Ong, Ken K %A Perry, John R B %A Porteous, David J %A Ritchie, Marylyn D %A Smart, Melissa C %A Smith, Blair H %A Tung, Joyce Y %A Wareham, Nicholas J %A Wilson, James F %A Beauchamp, Jonathan P %A Conley, Dalton C %A Esko, Tõnu %A Lehrer, Steven F %A Magnusson, Patrik K E %A Oskarsson, Sven %A Pers, Tune H %A Robinson, Matthew R %A Thom, Kevin %A Watson, Chelsea %A Chabris, Christopher F %A Meyer, Michelle N %A Laibson, David I %A Yang, Jian %A Johannesson, Magnus %A Koellinger, Philipp D %A Turley, Patrick %A Visscher, Peter M %A Benjamin, Daniel J %A Cesarini, David %X

Here we conducted a large-scale genetic association analysis of educational attainment in a sample of approximately 1.1 million individuals and identify 1,271 independent genome-wide-significant SNPs. For the SNPs taken together, we found evidence of heterogeneous effects across environments. The SNPs implicate genes involved in brain-development processes and neuron-to-neuron communication. In a separate analysis of the X chromosome, we identify 10 independent genome-wide-significant SNPs and estimate a SNP heritability of around 0.3% in both men and women, consistent with partial dosage compensation. A joint (multi-phenotype) analysis of educational attainment and three related cognitive phenotypes generates polygenic scores that explain 11-13% of the variance in educational attainment and 7-10% of the variance in cognitive performance. This prediction accuracy substantially increases the utility of polygenic scores as tools in research.

%B Nat Genet %V 50 %P 1112-1121 %8 2018 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/30038396?dopt=Abstract %R 10.1038/s41588-018-0147-3 %0 Journal Article %J Nat Genet %D 2018 %T Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. %A Evangelou, Evangelos %A Warren, Helen R %A Mosen-Ansorena, David %A Mifsud, Borbala %A Pazoki, Raha %A Gao, He %A Ntritsos, Georgios %A Dimou, Niki %A Cabrera, Claudia P %A Karaman, Ibrahim %A Ng, Fu Liang %A Evangelou, Marina %A Witkowska, Katarzyna %A Tzanis, Evan %A Hellwege, Jacklyn N %A Giri, Ayush %A Velez Edwards, Digna R %A Sun, Yan V %A Cho, Kelly %A Gaziano, J Michael %A Wilson, Peter W F %A Tsao, Philip S %A Kovesdy, Csaba P %A Esko, Tõnu %A Mägi, Reedik %A Milani, Lili %A Almgren, Peter %A Boutin, Thibaud %A Debette, Stéphanie %A Ding, Jun %A Giulianini, Franco %A Holliday, Elizabeth G %A Jackson, Anne U %A Li-Gao, Ruifang %A Lin, Wei-Yu %A Luan, Jian'an %A Mangino, Massimo %A Oldmeadow, Christopher %A Prins, Bram Peter %A Qian, Yong %A Sargurupremraj, Muralidharan %A Shah, Nabi %A Surendran, Praveen %A Thériault, Sébastien %A Verweij, Niek %A Willems, Sara M %A Zhao, Jing-Hua %A Amouyel, Philippe %A Connell, John %A de Mutsert, Renée %A Doney, Alex S F %A Farrall, Martin %A Menni, Cristina %A Morris, Andrew D %A Noordam, Raymond %A Paré, Guillaume %A Poulter, Neil R %A Shields, Denis C %A Stanton, Alice %A Thom, Simon %A Abecasis, Goncalo %A Amin, Najaf %A Arking, Dan E %A Ayers, Kristin L %A Barbieri, Caterina M %A Batini, Chiara %A Bis, Joshua C %A Blake, Tineka %A Bochud, Murielle %A Boehnke, Michael %A Boerwinkle, Eric %A Boomsma, Dorret I %A Bottinger, Erwin P %A Braund, Peter S %A Brumat, Marco %A Campbell, Archie %A Campbell, Harry %A Chakravarti, Aravinda %A Chambers, John C %A Chauhan, Ganesh %A Ciullo, Marina %A Cocca, Massimiliano %A Collins, Francis %A Cordell, Heather J %A Davies, Gail %A de Borst, Martin H %A de Geus, Eco J %A Deary, Ian J %A Deelen, Joris %A del Greco M, Fabiola %A Demirkale, Cumhur Yusuf %A Dörr, Marcus %A Ehret, Georg B %A Elosua, Roberto %A Enroth, Stefan %A Erzurumluoglu, A Mesut %A Ferreira, Teresa %A Frånberg, Mattias %A Franco, Oscar H %A Gandin, Ilaria %A Gasparini, Paolo %A Giedraitis, Vilmantas %A Gieger, Christian %A Girotto, Giorgia %A Goel, Anuj %A Gow, Alan J %A Gudnason, Vilmundur %A Guo, Xiuqing %A Gyllensten, Ulf %A Hamsten, Anders %A Harris, Tamara B %A Harris, Sarah E %A Hartman, Catharina A %A Havulinna, Aki S %A Hicks, Andrew A %A Hofer, Edith %A Hofman, Albert %A Hottenga, Jouke-Jan %A Huffman, Jennifer E %A Hwang, Shih-Jen %A Ingelsson, Erik %A James, Alan %A Jansen, Rick %A Järvelin, Marjo-Riitta %A Joehanes, Roby %A Johansson, Åsa %A Johnson, Andrew D %A Joshi, Peter K %A Jousilahti, Pekka %A Jukema, J Wouter %A Jula, Antti %A Kähönen, Mika %A Kathiresan, Sekar %A Keavney, Bernard D %A Khaw, Kay-Tee %A Knekt, Paul %A Knight, Joanne %A Kolcic, Ivana %A Kooner, Jaspal S %A Koskinen, Seppo %A Kristiansson, Kati %A Kutalik, Zoltán %A Laan, Maris %A Larson, Marty %A Launer, Lenore J %A Lehne, Benjamin %A Lehtimäki, Terho %A Liewald, David C M %A Lin, Li %A Lind, Lars %A Lindgren, Cecilia M %A Liu, Yongmei %A Loos, Ruth J F %A Lopez, Lorna M %A Lu, Yingchang %A Lyytikäinen, Leo-Pekka %A Mahajan, Anubha %A Mamasoula, Chrysovalanto %A Marrugat, Jaume %A Marten, Jonathan %A Milaneschi, Yuri %A Morgan, Anna %A Morris, Andrew P %A Morrison, Alanna C %A Munson, Peter J %A Nalls, Mike A %A Nandakumar, Priyanka %A Nelson, Christopher P %A Niiranen, Teemu %A Nolte, Ilja M %A Nutile, Teresa %A Oldehinkel, Albertine J %A Oostra, Ben A %A O'Reilly, Paul F %A Org, Elin %A Padmanabhan, Sandosh %A Palmas, Walter %A Palotie, Aarno %A Pattie, Alison %A Penninx, Brenda W J H %A Perola, Markus %A Peters, Annette %A Polasek, Ozren %A Pramstaller, Peter P %A Nguyen, Quang Tri %A Raitakari, Olli T %A Ren, Meixia %A Rettig, Rainer %A Rice, Kenneth %A Ridker, Paul M %A Ried, Janina S %A Riese, Harriëtte %A Ripatti, Samuli %A Robino, Antonietta %A Rose, Lynda M %A Rotter, Jerome I %A Rudan, Igor %A Ruggiero, Daniela %A Saba, Yasaman %A Sala, Cinzia F %A Salomaa, Veikko %A Samani, Nilesh J %A Sarin, Antti-Pekka %A Schmidt, Reinhold %A Schmidt, Helena %A Shrine, Nick %A Siscovick, David %A Smith, Albert V %A Snieder, Harold %A Sõber, Siim %A Sorice, Rossella %A Starr, John M %A Stott, David J %A Strachan, David P %A Strawbridge, Rona J %A Sundström, Johan %A Swertz, Morris A %A Taylor, Kent D %A Teumer, Alexander %A Tobin, Martin D %A Tomaszewski, Maciej %A Toniolo, Daniela %A Traglia, Michela %A Trompet, Stella %A Tuomilehto, Jaakko %A Tzourio, Christophe %A Uitterlinden, André G %A Vaez, Ahmad %A van der Most, Peter J %A van Duijn, Cornelia M %A Vergnaud, Anne-Claire %A Verwoert, Germaine C %A Vitart, Veronique %A Völker, Uwe %A Vollenweider, Peter %A Vuckovic, Dragana %A Watkins, Hugh %A Wild, Sarah H %A Willemsen, Gonneke %A Wilson, James F %A Wright, Alan F %A Yao, Jie %A Zemunik, Tatijana %A Zhang, Weihua %A Attia, John R %A Butterworth, Adam S %A Chasman, Daniel I %A Conen, David %A Cucca, Francesco %A Danesh, John %A Hayward, Caroline %A Howson, Joanna M M %A Laakso, Markku %A Lakatta, Edward G %A Langenberg, Claudia %A Melander, Olle %A Mook-Kanamori, Dennis O %A Palmer, Colin N A %A Risch, Lorenz %A Scott, Robert A %A Scott, Rodney J %A Sever, Peter %A Spector, Tim D %A van der Harst, Pim %A Wareham, Nicholas J %A Zeggini, Eleftheria %A Levy, Daniel %A Munroe, Patricia B %A Newton-Cheh, Christopher %A Brown, Morris J %A Metspalu, Andres %A Hung, Adriana M %A O'Donnell, Christopher J %A Edwards, Todd L %A Psaty, Bruce M %A Tzoulaki, Ioanna %A Barnes, Michael R %A Wain, Louise V %A Elliott, Paul %A Caulfield, Mark J %X

High blood pressure is a highly heritable and modifiable risk factor for cardiovascular disease. We report the largest genetic association study of blood pressure traits (systolic, diastolic and pulse pressure) to date in over 1 million people of European ancestry. We identify 535 novel blood pressure loci that not only offer new biological insights into blood pressure regulation but also highlight shared genetic architecture between blood pressure and lifestyle exposures. Our findings identify new biological pathways for blood pressure regulation with potential for improved cardiovascular disease prevention in the future.

%B Nat Genet %V 50 %P 1412-1425 %8 2018 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/30224653?dopt=Abstract %R 10.1038/s41588-018-0205-x %0 Journal Article %J Gene %D 2018 %T Genetic profile of patients with early onset inflammatory bowel disease. %A Girardelli, Martina %A Basaldella, Federica %A Paolera, Sara Della %A Vuch, Josef %A Tommasini, Alberto %A Martelossi, Stefano %A Crovella, Sergio %A Bianco, Anna Monica %K Age of Onset %K Autophagy-Related Proteins %K Child %K Child, Preschool %K Computer Simulation %K Female %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Humans %K Infant %K Inflammatory Bowel Diseases %K Interleukin-10 %K Male %K Nod2 Signaling Adaptor Protein %K Polymorphism, Single Nucleotide %K Receptors, Interleukin %K Receptors, Interleukin-10 %K Sequence Analysis, DNA %K X-Linked Inhibitor of Apoptosis Protein %X

Inflammatory Bowel disease (IBD) is a widespread pathological condition with clinical heterogeneity and with different levels of severity. Although IBD usually occurs in young adults, onset in childhood and infancy are described in patients within the 10th and second year of age. By genome-wide association studies and meta-analysis, several genetic loci have been identified associated with an increased risk of developing IBD in Western populations with variants that may alter the normal mucosal immunity in the gastrointestinal tract. The clinical complexity and the heterogeneity of the IBD phenotype probably reflect the presence of genetic heterogeneity where different genes or combinations of them may be involved, together with environmental factors. We hypothesized that patients with early onset IBD could have either more severe genetic variants in genes associated with IBD or multiple variants in different genes. Under the multifactorial diseases is crucial to consider the small contribution of a single variant in all not only to other small variations in the same gene but also in different genes belonging to the same pathway. We performed direct gene sequencing looking for 94 variations in NOD2, ATG16L1, IL23R, IL10R, IL10 and XIAP genes previously shown as correlated with IBD both in multifactorial and in Mendelian models. All variants identified are known in literature as being associated with IBD except for three variants in the genes NOD2, IL10 and IL10RB that even though present in online databases have never been involved in association studies on IBD patients. Moreover, we coupled genetic variants identification with an accurate "in silico" analysis to verify their predictive impact on the protein structure and function. The in-silico prediction of these variants results as benign therefore even if they exhibit a very low frequency in control population being benign, they cannot be considered pathogenic as monogenic disease but fall within the multifactorial range. The variants identified in our study partially reflect the association data described in the literature but there are no significant differences with the onset of disease (VEO vs EO-IBD).

%B Gene %V 645 %P 18-29 %8 2018 Mar 01 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29248579?dopt=Abstract %R 10.1016/j.gene.2017.12.029 %0 Journal Article %J J Toxicol Environ Health A %D 2018 %T A genetic variant of NLRP1 gene is associated with asbestos body burden in patients with malignant pleural mesothelioma. %A Crovella, S %A Moura, R R %A Cappellani, S %A Celsi, F %A Trevisan, E %A Schneider, M %A Brollo, A %A Nicastro, E M %A Vita, F %A Finotto, L %A Zabucchi, G %A Borelli, V %X

The presence of asbestos bodies (ABs) in lung parenchyma is considered a histopathologic hallmark of past exposure to asbestos fibers, of which there was a population of longer fibers. The mechanisms underlying AB formation are complex, involving inflammatory responses and iron (Fe) metabolism. Thus, the responsiveness to AB formation is variable, with some individuals appearing to be poor AB formers. The aim of this study was to disclose the possible role of genetic variants of genes encoding inflammasome and iron metabolism proteins in the ability to form ABs in a population of 81 individuals from North East Italy, who died after having developed malignant pleural mesothelioma (MPM). This study included 86 genetic variants distributed in 10 genes involved in Fe metabolism and 7 genetic variants in two genes encoding for inflammasome molecules. Genotypes/haplotypes were compared according to the number of lung ABs. Data showed that the NLRP1 rs12150220 missense variant (H155L) was significantly correlated with numbers of ABs in MPM patients. Specifically, a low number of ABs was detected in individuals carrying the NLRP1 rs12150220 A/T genotype. Our findings suggest that the NLRP1 inflammasome might contribute in the development of lung ABs. It is postulated that the NLRP1 missense variant may be considered as one of the possible host genetic factors contributing to individual variability in coating efficiency, which needs to be taken when assessing occupational exposure to asbestos.

%B J Toxicol Environ Health A %V 81 %P 98-105 %8 2018 %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/29265930?dopt=Abstract %R 10.1080/15287394.2017.1416911 %0 Journal Article %J Am J Hum Genet %D 2018 %T Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. %A Ligthart, Symen %A Vaez, Ahmad %A Võsa, Urmo %A Stathopoulou, Maria G %A de Vries, Paul S %A Prins, Bram P %A van der Most, Peter J %A Tanaka, Toshiko %A Naderi, Elnaz %A Rose, Lynda M %A Wu, Ying %A Karlsson, Robert %A Barbalic, Maja %A Lin, Honghuang %A Pool, René %A Zhu, Gu %A Macé, Aurélien %A Sidore, Carlo %A Trompet, Stella %A Mangino, Massimo %A Sabater-Lleal, Maria %A Kemp, John P %A Abbasi, Ali %A Kacprowski, Tim %A Verweij, Niek %A Smith, Albert V %A Huang, Tao %A Marzi, Carola %A Feitosa, Mary F %A Lohman, Kurt K %A Kleber, Marcus E %A Milaneschi, Yuri %A Mueller, Christian %A Huq, Mahmudul %A Vlachopoulou, Efthymia %A Lyytikäinen, Leo-Pekka %A Oldmeadow, Christopher %A Deelen, Joris %A Perola, Markus %A Zhao, Jing Hua %A Feenstra, Bjarke %A Amini, Marzyeh %A Lahti, Jari %A Schraut, Katharina E %A Fornage, Myriam %A Suktitipat, Bhoom %A Chen, Wei-Min %A Li, Xiaohui %A Nutile, Teresa %A Malerba, Giovanni %A Luan, Jian'an %A Bak, Tom %A Schork, Nicholas %A del Greco M, Fabiola %A Thiering, Elisabeth %A Mahajan, Anubha %A Marioni, Riccardo E %A Mihailov, Evelin %A Eriksson, Joel %A Ozel, Ayse Bilge %A Zhang, Weihua %A Nethander, Maria %A Cheng, Yu-Ching %A Aslibekyan, Stella %A Ang, Wei %A Gandin, Ilaria %A Yengo, Loic %A Portas, Laura %A Kooperberg, Charles %A Hofer, Edith %A Rajan, Kumar B %A Schurmann, Claudia %A den Hollander, Wouter %A Ahluwalia, Tarunveer S %A Zhao, Jing %A Draisma, Harmen H M %A Ford, Ian %A Timpson, Nicholas %A Teumer, Alexander %A Huang, Hongyan %A Wahl, Simone %A Liu, Yongmei %A Huang, Jie %A Uh, Hae-Won %A Geller, Frank %A Joshi, Peter K %A Yanek, Lisa R %A Trabetti, Elisabetta %A Lehne, Benjamin %A Vozzi, Diego %A Verbanck, Marie %A Biino, Ginevra %A Saba, Yasaman %A Meulenbelt, Ingrid %A O'Connell, Jeff R %A Laakso, Markku %A Giulianini, Franco %A Magnusson, Patrik K E %A Ballantyne, Christie M %A Hottenga, Jouke Jan %A Montgomery, Grant W %A Rivadineira, Fernando %A Rueedi, Rico %A Steri, Maristella %A Herzig, Karl-Heinz %A Stott, David J %A Menni, Cristina %A Frånberg, Mattias %A St Pourcain, Beate %A Felix, Stephan B %A Pers, Tune H %A Bakker, Stephan J L %A Kraft, Peter %A Peters, Annette %A Vaidya, Dhananjay %A Delgado, Graciela %A Smit, Johannes H %A Großmann, Vera %A Sinisalo, Juha %A Seppälä, Ilkka %A Williams, Stephen R %A Holliday, Elizabeth G %A Moed, Matthijs %A Langenberg, Claudia %A Räikkönen, Katri %A Ding, Jingzhong %A Campbell, Harry %A Sale, Michele M %A Chen, Yii-Der I %A James, Alan L %A Ruggiero, Daniela %A Soranzo, Nicole %A Hartman, Catharina A %A Smith, Erin N %A Berenson, Gerald S %A Fuchsberger, Christian %A Hernandez, Dena %A Tiesler, Carla M T %A Giedraitis, Vilmantas %A Liewald, David %A Fischer, Krista %A Mellström, Dan %A Larsson, Anders %A Wang, Yunmei %A Scott, William R %A Lorentzon, Matthias %A Beilby, John %A Ryan, Kathleen A %A Pennell, Craig E %A Vuckovic, Dragana %A Balkau, Beverly %A Concas, Maria Pina %A Schmidt, Reinhold %A Mendes de Leon, Carlos F %A Bottinger, Erwin P %A Kloppenburg, Margreet %A Paternoster, Lavinia %A Boehnke, Michael %A Musk, A W %A Willemsen, Gonneke %A Evans, David M %A Madden, Pamela A F %A Kähönen, Mika %A Kutalik, Zoltán %A Zoledziewska, Magdalena %A Karhunen, Ville %A Kritchevsky, Stephen B %A Sattar, Naveed %A LaChance, Genevieve %A Clarke, Robert %A Harris, Tamara B %A Raitakari, Olli T %A Attia, John R %A van Heemst, Diana %A Kajantie, Eero %A Sorice, Rossella %A Gambaro, Giovanni %A Scott, Robert A %A Hicks, Andrew A %A Ferrucci, Luigi %A Standl, Marie %A Lindgren, Cecilia M %A Starr, John M %A Karlsson, Magnus %A Lind, Lars %A Li, Jun Z %A Chambers, John C %A Mori, Trevor A %A de Geus, Eco J C N %A Heath, Andrew C %A Martin, Nicholas G %A Auvinen, Juha %A Buckley, Brendan M %A de Craen, Anton J M %A Waldenberger, Melanie %A Strauch, Konstantin %A Meitinger, Thomas %A Scott, Rodney J %A McEvoy, Mark %A Beekman, Marian %A Bombieri, Cristina %A Ridker, Paul M %A Mohlke, Karen L %A Pedersen, Nancy L %A Morrison, Alanna C %A Boomsma, Dorret I %A Whitfield, John B %A Strachan, David P %A Hofman, Albert %A Vollenweider, Peter %A Cucca, Francesco %A Järvelin, Marjo-Riitta %A Jukema, J Wouter %A Spector, Tim D %A Hamsten, Anders %A Zeller, Tanja %A Uitterlinden, André G %A Nauck, Matthias %A Gudnason, Vilmundur %A Qi, Lu %A Grallert, Harald %A Borecki, Ingrid B %A Rotter, Jerome I %A März, Winfried %A Wild, Philipp S %A Lokki, Marja-Liisa %A Boyle, Michael %A Salomaa, Veikko %A Melbye, Mads %A Eriksson, Johan G %A Wilson, James F %A Penninx, Brenda W J H %A Becker, Diane M %A Worrall, Bradford B %A Gibson, Greg %A Krauss, Ronald M %A Ciullo, Marina %A Zaza, Gianluigi %A Wareham, Nicholas J %A Oldehinkel, Albertine J %A Palmer, Lyle J %A Murray, Sarah S %A Pramstaller, Peter P %A Bandinelli, Stefania %A Heinrich, Joachim %A Ingelsson, Erik %A Deary, Ian J %A Mägi, Reedik %A Vandenput, Liesbeth %A van der Harst, Pim %A Desch, Karl C %A Kooner, Jaspal S %A Ohlsson, Claes %A Hayward, Caroline %A Lehtimäki, Terho %A Shuldiner, Alan R %A Arnett, Donna K %A Beilin, Lawrence J %A Robino, Antonietta %A Froguel, Philippe %A Pirastu, Mario %A Jess, Tine %A Koenig, Wolfgang %A Loos, Ruth J F %A Evans, Denis A %A Schmidt, Helena %A Smith, George Davey %A Slagboom, P Eline %A Eiriksdottir, Gudny %A Morris, Andrew P %A Psaty, Bruce M %A Tracy, Russell P %A Nolte, Ilja M %A Boerwinkle, Eric %A Visvikis-Siest, Sophie %A Reiner, Alex P %A Gross, Myron %A Bis, Joshua C %A Franke, Lude %A Franco, Oscar H %A Benjamin, Emelia J %A Chasman, Daniel I %A Dupuis, Josée %A Snieder, Harold %A Dehghan, Abbas %A Alizadeh, Behrooz Z %X

C-reactive protein (CRP) is a sensitive biomarker of chronic low-grade inflammation and is associated with multiple complex diseases. The genetic determinants of chronic inflammation remain largely unknown, and the causal role of CRP in several clinical outcomes is debated. We performed two genome-wide association studies (GWASs), on HapMap and 1000 Genomes imputed data, of circulating amounts of CRP by using data from 88 studies comprising 204,402 European individuals. Additionally, we performed in silico functional analyses and Mendelian randomization analyses with several clinical outcomes. The GWAS meta-analyses of CRP revealed 58 distinct genetic loci (p < 5 × 10). After adjustment for body mass index in the regression analysis, the associations at all except three loci remained. The lead variants at the distinct loci explained up to 7.0% of the variance in circulating amounts of CRP. We identified 66 gene sets that were organized in two substantially correlated clusters, one mainly composed of immune pathways and the other characterized by metabolic pathways in the liver. Mendelian randomization analyses revealed a causal protective effect of CRP on schizophrenia and a risk-increasing effect on bipolar disorder. Our findings provide further insights into the biology of inflammation and could lead to interventions for treating inflammation and its clinical consequences.

%B Am J Hum Genet %V 103 %P 691-706 %8 2018 Nov 01 %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/30388399?dopt=Abstract %R 10.1016/j.ajhg.2018.09.009 %0 Journal Article %J Nat Genet %D 2018 %T Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error. %A Tedja, Milly S %A Wojciechowski, Robert %A Hysi, Pirro G %A Eriksson, Nicholas %A Furlotte, Nicholas A %A Verhoeven, Virginie J M %A Iglesias, Adriana I %A Meester-Smoor, Magda A %A Tompson, Stuart W %A Fan, Qiao %A Khawaja, Anthony P %A Cheng, Ching-Yu %A Höhn, René %A Yamashiro, Kenji %A Wenocur, Adam %A Grazal, Clare %A Haller, Toomas %A Metspalu, Andres %A Wedenoja, Juho %A Jonas, Jost B %A Wang, Ya Xing %A Xie, Jing %A Mitchell, Paul %A Foster, Paul J %A Klein, Barbara E K %A Klein, Ronald %A Paterson, Andrew D %A Hosseini, S Mohsen %A Shah, Rupal L %A Williams, Cathy %A Teo, Yik Ying %A Tham, Yih Chung %A Gupta, Preeti %A Zhao, Wanting %A Shi, Yuan %A Saw, Woei-Yuh %A Tai, E-Shyong %A Sim, Xue Ling %A Huffman, Jennifer E %A Polasek, Ozren %A Hayward, Caroline %A Bencic, Goran %A Rudan, Igor %A Wilson, James F %A Joshi, Peter K %A Tsujikawa, Akitaka %A Matsuda, Fumihiko %A Whisenhunt, Kristina N %A Zeller, Tanja %A van der Spek, Peter J %A Haak, Roxanna %A Meijers-Heijboer, Hanne %A van Leeuwen, Elisabeth M %A Iyengar, Sudha K %A Lass, Jonathan H %A Hofman, Albert %A Rivadeneira, Fernando %A Uitterlinden, André G %A Vingerling, Johannes R %A Lehtimäki, Terho %A Raitakari, Olli T %A Biino, Ginevra %A Concas, Maria Pina %A Schwantes-An, Tae-Hwi %A Igo, Robert P %A Cuellar-Partida, Gabriel %A Martin, Nicholas G %A Craig, Jamie E %A Gharahkhani, Puya %A Williams, Katie M %A Nag, Abhishek %A Rahi, Jugnoo S %A Cumberland, Phillippa M %A Delcourt, Cécile %A Bellenguez, Céline %A Ried, Janina S %A Bergen, Arthur A %A Meitinger, Thomas %A Gieger, Christian %A Wong, Tien Yin %A Hewitt, Alex W %A Mackey, David A %A Simpson, Claire L %A Pfeiffer, Norbert %A Pärssinen, Olavi %A Baird, Paul N %A Vitart, Veronique %A Amin, Najaf %A van Duijn, Cornelia M %A Bailey-Wilson, Joan E %A Young, Terri L %A Saw, Seang-Mei %A Stambolian, Dwight %A MacGregor, Stuart %A Guggenheim, Jeremy A %A Tung, Joyce Y %A Hammond, Christopher J %A Klaver, Caroline C W %X

Refractive errors, including myopia, are the most frequent eye disorders worldwide and an increasingly common cause of blindness. This genome-wide association meta-analysis in 160,420 participants and replication in 95,505 participants increased the number of established independent signals from 37 to 161 and showed high genetic correlation between Europeans and Asians (>0.78). Expression experiments and comprehensive in silico analyses identified retinal cell physiology and light processing as prominent mechanisms, and also identified functional contributions to refractive-error development in all cell types of the neurosensory retina, retinal pigment epithelium, vascular endothelium and extracellular matrix. Newly identified genes implicate novel mechanisms such as rod-and-cone bipolar synaptic neurotransmission, anterior-segment morphology and angiogenesis. Thirty-one loci resided in or near regions transcribing small RNAs, thus suggesting a role for post-transcriptional regulation. Our results support the notion that refractive errors are caused by a light-dependent retina-to-sclera signaling cascade and delineate potential pathobiological molecular drivers.

%B Nat Genet %V 50 %P 834-848 %8 2018 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/29808027?dopt=Abstract %R 10.1038/s41588-018-0127-7 %0 Journal Article %J Nat Genet %D 2018 %T Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability. %A Hysi, Pirro G %A Valdes, Ana M %A Liu, Fan %A Furlotte, Nicholas A %A Evans, David M %A Bataille, Veronique %A Visconti, Alessia %A Hemani, Gibran %A McMahon, George %A Ring, Susan M %A Smith, George Davey %A Duffy, David L %A Zhu, Gu %A Gordon, Scott D %A Medland, Sarah E %A Lin, Bochao D %A Willemsen, Gonneke %A Jan Hottenga, Jouke %A Vuckovic, Dragana %A Girotto, Giorgia %A Gandin, Ilaria %A Sala, Cinzia %A Concas, Maria Pina %A Brumat, Marco %A Gasparini, Paolo %A Toniolo, Daniela %A Cocca, Massimiliano %A Robino, Antonietta %A Yazar, Seyhan %A Hewitt, Alex W %A Chen, Yan %A Zeng, Changqing %A Uitterlinden, André G %A Ikram, M Arfan %A Hamer, Merel A %A van Duijn, Cornelia M %A Nijsten, Tamar %A Mackey, David A %A Falchi, Mario %A Boomsma, Dorret I %A Martin, Nicholas G %A Hinds, David A %A Kayser, Manfred %A Spector, Timothy D %X

Hair color is one of the most recognizable visual traits in European populations and is under strong genetic control. Here we report the results of a genome-wide association study meta-analysis of almost 300,000 participants of European descent. We identified 123 autosomal and one X-chromosome loci significantly associated with hair color; all but 13 are novel. Collectively, single-nucleotide polymorphisms associated with hair color within these loci explain 34.6% of red hair, 24.8% of blond hair, and 26.1% of black hair heritability in the study populations. These results confirm the polygenic nature of complex phenotypes and improve our understanding of melanin pigment metabolism in humans.

%B Nat Genet %V 50 %P 652-656 %8 2018 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/29662168?dopt=Abstract %R 10.1038/s41588-018-0100-5 %0 Journal Article %J Mol Vis %D 2018 %T A genome-wide association study of corneal astigmatism: The CREAM Consortium. %A Shah, Rupal L %A Li, Qing %A Zhao, Wanting %A Tedja, Milly S %A Tideman, J Willem L %A Khawaja, Anthony P %A Fan, Qiao %A Yazar, Seyhan %A Williams, Katie M %A Verhoeven, Virginie J M %A Xie, Jing %A Wang, Ya Xing %A Hess, Moritz %A Nickels, Stefan %A Lackner, Karl J %A Pärssinen, Olavi %A Wedenoja, Juho %A Biino, Ginevra %A Concas, Maria Pina %A Uitterlinden, André %A Rivadeneira, Fernando %A Jaddoe, Vincent W V %A Hysi, Pirro G %A Sim, Xueling %A Tan, Nicholas %A Tham, Yih-Chung %A Sensaki, Sonoko %A Hofman, Albert %A Vingerling, Johannes R %A Jonas, Jost B %A Mitchell, Paul %A Hammond, Christopher J %A Höhn, René %A Baird, Paul N %A Wong, Tien-Yin %A Cheng, Chinfsg-Yu %A Teo, Yik Ying %A Mackey, David A %A Williams, Cathy %A Saw, Seang-Mei %A Klaver, Caroline C W %A Guggenheim, Jeremy A %A Bailey-Wilson, Joan E %K Acid Phosphatase %K Asian Continental Ancestry Group %K Astigmatism %K Claudins %K Cohort Studies %K Cornea %K Corneal Diseases %K European Continental Ancestry Group %K Gene Expression %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Humans %K Intracellular Signaling Peptides and Proteins %K Odds Ratio %K Polymorphism, Single Nucleotide %K Receptor, Platelet-Derived Growth Factor alpha %K Software %X

Purpose: To identify genes and genetic markers associated with corneal astigmatism.

Methods: A meta-analysis of genome-wide association studies (GWASs) of corneal astigmatism undertaken for 14 European ancestry (n=22,250) and 8 Asian ancestry (n=9,120) cohorts was performed by the Consortium for Refractive Error and Myopia. Cases were defined as having >0.75 diopters of corneal astigmatism. Subsequent gene-based and gene-set analyses of the meta-analyzed results of European ancestry cohorts were performed using VEGAS2 and MAGMA software. Additionally, estimates of single nucleotide polymorphism (SNP)-based heritability for corneal and refractive astigmatism and the spherical equivalent were calculated for Europeans using LD score regression.

Results: The meta-analysis of all cohorts identified a genome-wide significant locus near the platelet-derived growth factor receptor alpha () gene: top SNP: rs7673984, odds ratio=1.12 (95% CI:1.08-1.16), p=5.55×10. No other genome-wide significant loci were identified in the combined analysis or European/Asian ancestry-specific analyses. Gene-based analysis identified three novel candidate genes for corneal astigmatism in Europeans-claudin-7 (), acid phosphatase 2, lysosomal (), and TNF alpha-induced protein 8 like 3 ().

Conclusions: In addition to replicating a previously identified genome-wide significant locus for corneal astigmatism near the gene, gene-based analysis identified three novel candidate genes, , , and , that warrant further investigation to understand their role in the pathogenesis of corneal astigmatism. The much lower number of genetic variants and genes demonstrating an association with corneal astigmatism compared to published spherical equivalent GWAS analyses suggest a greater influence of rare genetic variants, non-additive genetic effects, or environmental factors in the development of astigmatism.

%B Mol Vis %V 24 %P 127-142 %8 2018 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29422769?dopt=Abstract %0 Journal Article %J J Pediatr %D 2018 %T A Giant Ovarian Cyst in an Adolescent. %A Corrias, Francesca %A Pederiva, Federica %A Cozzi, Giorgio %A Ammar, Lydie %A Cattaruzzi, Elisabetta %A Lembo, Maria Antonietta %A Barbi, Egidio %K Child %K Cystadenoma, Serous %K Female %K Humans %K Ovarian Neoplasms %B J Pediatr %V 199 %P 279 %8 2018 08 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29731358?dopt=Abstract %R 10.1016/j.jpeds.2018.03.015 %0 Journal Article %J Ann Emerg Med %D 2018 %T Girl With Chest Pain. %A Scarpa, Maria-Grazia %A Rabach, Ingrid %A Canuto, Arianna %A Sanabor, Daniela %A Barbi, Egidio %A Schleef, Jurgen %B Ann Emerg Med %V 72 %P e17-e18 %8 2018 Aug %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/30031519?dopt=Abstract %R 10.1016/j.annemergmed.2018.03.010 %0 Journal Article %J Benef Microbes %D 2018 %T Gut microbiota characterisation in obese patients before and after bariatric surgery. %A Campisciano, G %A Palmisano, S %A Cason, C %A Giuricin, M %A Silvestri, M %A Guerra, M %A Macor, D %A De Manzini, N %A Crocé, L S %A Comar, M %K Adult %K Bariatric Surgery %K Gastrointestinal Microbiome %K Humans %K Laparoscopy %K Microbiota %K Middle Aged %K Obesity %K Young Adult %X

Intestinal microbiota analysis of obese patients after bariatric surgery showed that Proteobacteria decreased after laparoscopic sleeve gastrectomy (SG), while it increased after laparoscopic gastric bypass (LGB). Comparing to normal weight (NW) patients, obese patients that were selected for SG showed an almost equal amount of Firmicutes and Bacteroidetes and the ratio was not affected by the surgery. Obese patients before LGB showed a predominance of Bacteroidetes, whose amount regained a relative abundance similar to NW patients after surgery. Obese patients before LGB showed the predominance of Bacteroides, which decreased after surgery in favour of Prevotella, a bacterium associated with a healthy diet. The bacteria detected at the highest percentages belonged to biofilm forming species. In conclusion, in this study, we found that the characterization of the gut microbial communities and the modality of mucosal colonisation have a central role as markers for the clinical management of obesity and promote the maintenance of good health and the weight loss.

%B Benef Microbes %V 9 %P 367-373 %8 2018 Apr 25 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29482339?dopt=Abstract %R 10.3920/BM2017.0152 %0 Journal Article %J Expert Rev Gastroenterol Hepatol %D 2018 %T How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease. %A Naviglio, Samuele %A Giuffrida, Paolo %A Stocco, Gabriele %A Lenti, Marco Vincenzo %A Ventura, Alessandro %A Corazza, Gino Roberto %A Di Sabatino, Antonio %K Antibodies, Monoclonal %K Biological Therapy %K Gastrointestinal Agents %K Humans %K Inflammatory Bowel Diseases %K Patient Selection %K Prognosis %K Treatment Outcome %K Tumor Necrosis Factor-alpha %X

INTRODUCTION: Anti-tumor necrosis factor (TNF) agents have changed the therapeutic approach to inflammatory bowel disease (IBD). However, a considerable proportion of patients either do not primarily respond or lose response to treatment. Despite the long-standing experience in the use of these drugs, still there is the need of identifying the possible predictors of efficacy. Areas covered: We critically review the current knowledge on predictors of response to anti-TNF therapy - both those available in clinical practice and those still under investigation. Multiple factors are involved in treatment success, including disease phenotype and severity, adherence to medications, and pharmacogenomic, pharmacokinetic, and immunologic factors. Literature search was conducted in PubMed using keywords 'inflammatory bowel disease,' 'Crohn's disease,' and 'ulcerative colitis,' matched with 'antitumor necrosis factor,' 'biologic therapy,' 'clinical response,' 'predictors,' and 'efficacy,' Relevant articles were selected for review. Expert commentary: While the role of several factors in clinical practice is clearly established, other investigational markers have been proposed, mostly in small studies, yet for many of them little external validation exists. Therapeutic drug monitoring is emerging as a pivotal strategy to guide decisions in clinical practice. In the near future, novel markers could improve our ability to direct treatment and personalize therapy.

%B Expert Rev Gastroenterol Hepatol %V 12 %P 797-810 %8 2018 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/29957083?dopt=Abstract %R 10.1080/17474124.2018.1494573 %0 Journal Article %J Int J Pediatr Otorhinolaryngol %D 2018 %T Human beta defensin-1 is involved in the susceptibility to adeno-tonsillar hypertrophy. %A Zupin, Luisa %A Celsi, Fulvio %A Bresciani, Martina %A Orzan, Eva %A Grasso, Domenico Leonardo %A Crovella, Sergio %K Adenoidectomy %K Adenoids %K Adolescent %K beta-Defensins %K Child %K Child, Preschool %K Female %K Genetic Predisposition to Disease %K Genotype %K Haplotypes %K Humans %K Hypertrophy %K Immunity, Innate %K Immunohistochemistry %K Italy %K Male %K Palatine Tonsil %K Tonsillectomy %X

INTRODUCTION: Innate immunity molecules are known to play a pivotal role in the homeostasis of the oral mucosa, permitting the presence of commensal microflora and, at the same time, providing a first line of defense against pathogens attempting to invade the oral cavity. Tonsils represent the local immune tissue in oral cavity, being able to provide a non-specific response to pathogens; however, in the presence of microbes or foreign materials present in the mouth tonsils could became infected and develop chronic inflammation, thus leading to hypertrophy. The etiology of the disease is multifactorial depending upon environmental and host factors, the latter including molecules of mucosal innate immunity.

METHODS: Ninety-five children with adeno-tonsillar hypertrophy subjected to adeno-tonsillectomy were recruited at the pediatric otorhinolaryngology service of the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste (Italy). The specimen discarded from the surgery were used for genomic DNA extraction and genotyping, for mRNA extraction and gene expression analysis, finally the samples were cut and used to prepare slides to perform immunohistochemistry.

RESULTS: Functional polymorphisms within DEFB1 gene, encoding the human beta defensin-1 (hBD-1), were analyzed finding association between DEFB1 rare haplotypes and susceptibility to adeno-tonsillar hypertrophy. DEFB1 mRNA expression was detected in the tonsils and the hBD-1 protein was localized at the epithelia of tonsils mainly in the proximity of the basal lamina.

CONCLUSION: Our findings lead us to hypothesize an involvement of hBD-1 mediated innate immunity in the modulation of the susceptibility towards adeno-tonsillar hypertrophy development.

%B Int J Pediatr Otorhinolaryngol %V 107 %P 135-139 %8 2018 Apr %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29501294?dopt=Abstract %R 10.1016/j.ijporl.2018.01.041 %0 Journal Article %J Haematologica %D 2018 %T Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia. %A Bottega, Roberta %A Nicchia, Elena %A Cappelli, Enrico %A Ravera, Silvia %A De Rocco, Daniela %A Faleschini, Michela %A Corsolini, Fabio %A Pierri, Filomena %A Calvillo, Michaela %A Russo, Giovanna %A Casazza, Gabriella %A Ramenghi, Ugo %A Farruggia, Piero %A Dufour, Carlo %A Savoia, Anna %X

Fanconi anemia is a rare disease characterized by congenital malformations, aplastic anemia, and predisposition to cancer. Despite the consolidated role of the Fanconi anemia proteins in DNA repair, their involvement in mitochondrial function is emerging. The purpose of this work was to assess whether the mitochondrial phenotype, independent of genomic integrity, could correlate with patient phenotype. We evaluated mitochondrial and clinical features of 11 affected individuals homozygous or compound heterozygous for p.His913Pro and p.Arg951Gln/Trp, the two residues of FANCA that are more frequently affected in our cohort of patients. Although p.His913Pro and p.Arg951Gln proteins are stably expressed in cytoplasm, they are unable to migrate in the nucleus, preventing cells from repairing DNA. In these cells, the electron transfer between respiring complex I-III is reduced and the ATP/AMP ratio is impaired with defective ATP production and AMP accumulation. These activities are intermediate between those observed in wild-type and FANCA-/- cells, suggesting that the variants at residues His913 and Arg951 are hypomorphic mutations. Consistent with these findings, the clinical phenotype of most of the patients carrying these mutations is mild. These data further support the recent finding that the Fanconi anemia proteins play a role in mitochondria, and open up possibilities for genotype/phenotype studies based on novel mitochondrial criteria.

%B Haematologica %V 103 %P 417-426 %8 2018 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29269525?dopt=Abstract %R 10.3324/haematol.2017.176131 %0 Journal Article %J Ital J Pediatr %D 2018 %T Impact of near infrared light in pediatric blood drawing Centre on rate of first attempt success and time of procedure. %A Conversano, Ester %A Cozzi, Giorgio %A Pavan, Matteo %A Minute, Marta %A Gortan, Elena %A Montico, Marcella %A Vecchi Brumatti, Liza %A Ronfani, Luca %A Barbi, Egidio %K Adolescent %K Age Factors %K Child %K Child, Preschool %K Female %K Humans %K Infant %K Infant, Newborn %K Infrared Rays %K Lighting %K Male %K Phlebotomy %K Time Factors %X

BACKGROUND: Peripheral blood access and venipuncture are a stressful and painful experience in pediatric patients; moreover, it is estimated that more than one attempt is required to achieve the procedure in about one third of children. For this reason, we investigated if Near-infrared light technology routinely used, could give an advantage to venipuncture in a pediatric blood center setting.

METHODS: We conducted an open, pseudo-randomized controlled trial with two parallel arms, in the blood-drawing center, with enrolment of 115 patients between 0 and 18 years, in 14 consecutive working days. Fifty-three subjects were enrolled in group 1 (VeinViewer®) and 62 in group 2 (control group). We divided patients into three subgroups considering their age (< 5 years, 6-10 years, > 10 years). The primary study outcome was to assess if the use of VeinViewer® was associated with a reduction of time to perform blood sampling. The secondary outcome was to analyze VienViewer®'s impact on first attempt success rate in blood sampling.

RESULTS: No difference was found regarding the duration of blood sampling between the two groups, even after stratifying the patients into the three age subgroups. There was no difference between the two groups in the success at the first attempt in blood sampling.

CONCLUSIONS: Routine use of VeinViewer® is not useful to reduce time of the procedure during venipuncture.

TRIAL REGISTRATION: The study was registered with ClinicalTrials.gov, with number NCT03277092 , on September 8, 2017.

%B Ital J Pediatr %V 44 %P 60 %8 2018 May 25 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/29801519?dopt=Abstract %R 10.1186/s13052-018-0501-1 %0 Journal Article %J Sci Rep %D 2018 %T In vivo microbiome and associated immune markers: New insights into the pathogenesis of vaginal dysbiosis. %A Campisciano, Giuseppina %A Zanotta, Nunzia %A Licastro, Danilo %A De Seta, Francesco %A Comar, Manola %K Adult %K Biomarkers %K Cytokines %K Dysbiosis %K Female %K Humans %K Microbiota %K Th2 Cells %K Vagina %X

The microbiota fulfils a key role in the training and function of the immune system, which contributes to the symbiosis between the host and complex microbial communities. In this study, we characterized the interplay between vaginal bacteria and local immune mediators during dysbiosis in selected women of reproductive age who were grouped according to Nugent's criteria. The abundance of Gardnerella vaginalis and Bifidobacterium breve was increased in the intermediate dysbiotic status, while the presence of a plethora of non-resident bacteria characterized the group with overt vaginosis. In response to these increases, the anti-inflammatory IL1ra and pro-inflammatory IL2 increased, while the embryo trophic factors FGFβ and GMCSF decreased compared to the healthy milieu. A specific pattern, including IL1α, IL1β, IL8, MIG, MIP1α and RANTES, distinguished the intermediate group from the vaginosis group, while IL5 and IL13, which are secreted by Th2 cells, were significantly associated with the perturbation of the commensals Lactobacilli, Gardnerella and Ureaplasma. Summarizing, we postulate that although the dysbiotic condition triggers a pro-inflammatory process, the presence of a steady state level of Th2 may influence clinical manifestations. These results raise clinically relevant questions regarding the use of vaginal immunological markers as efficacious tools to monitor microbial alterations.

%B Sci Rep %V 8 %P 2307 %8 2018 02 02 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/29396486?dopt=Abstract %R 10.1038/s41598-018-20649-x %0 Journal Article %J Arch Dis Child %D 2018 %T Inclusion cyst of anterior fontanelle. %A Udina, Chiara %A Calligaris, Lorenzo %A Berti, Irene %A Cattaruzzi, Elisabetta %A Barbi, Egidio %B Arch Dis Child %8 2018 Aug 21 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30131348?dopt=Abstract %R 10.1136/archdischild-2018-315727 %0 Journal Article %J Pediatrics %D 2018 %T Infant Analgesia With a Combination of Breast Milk, Glucose, or Maternal Holding. %A Bembich, Stefano %A Cont, Gabriele %A Causin, Enrica %A Paviotti, Giulia %A Marzari, Patrizia %A Demarini, Sergio %X

OBJECTIVES: We studied neonatal cortical brain response to 4 types of nonpharmacological analgesia (oral glucose, expressed breast milk, maternal holding plus oral glucose, breastfeeding). We aimed to assess the differential effect of oral solutions (glucose, breast milk) given alone or combined with the maternal-infant relationship (holding, breastfeeding).

METHODS: Eighty healthy term newborns undergoing a heel stick were randomly assigned to 4 parallel groups of 20 infants each: group 1, infants received a glucose solution on a changing table; group 2, infants received expressed breast milk on a changing table; group 3, infants received a glucose solution in their mothers' arms; and group 4, infants were breastfed by their mothers. Cortical activation in parietal, temporal, and frontal cortices was assessed by multichannel near-infrared spectroscopy. Pain expression was also evaluated.

RESULTS: Oral glucose alone or combined with maternal holding was associated with no cortical activation during heel stick. Expressed breast milk was associated with localized bilateral activation of somatosensory and motor cortices ( < .01). Breastfeeding was associated with extensive bilateral activation of somatomotor, somatosensory, and right parietal cortices ( < .01). Pain expression was lower with the maternal-infant relationship ( = .007).

CONCLUSIONS: Oral glucose, either alone or combined with maternal holding, appears to block or weaken cortical pain processing. Breast milk alone is associated with localized cortical activation. Breastfeeding is associated with extensive activation and may act by extending cortical processing. Maternal relationship, both combined with oral glucose and in breastfeeding, shows the greatest analgesic effect, although the neural patterns involved are distributed differently.

%B Pediatrics %V 142 %8 2018 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/30166366?dopt=Abstract %R 10.1542/peds.2017-3416 %0 Journal Article %J J Prosthodont Res %D 2018 %T Influence of polymerization time on properties of dual-curing cements in combination with high translucency monolithic zirconia. %A Alovisi, Mario %A Scotti, Nicola %A Comba, Allegra %A Manzon, Elena %A Farina, Elena %A Pasqualini, Damiano %A Michelotto Tempesta, Riccardo %A Breschi, Lorenzo %A Cadenaro, Milena %K Composite Resins %K Dental Bonding %K Dental Cements %K Hardness %K Lansoprazole %K Materials Testing %K Polymerization %K Resins, Synthetic %K Spectrophotometry %K Time Factors %K Zirconium %X

PURPOSE: The aim of this in vitro study was to assess conversion degree (DC), micro-hardness (MH) and bond strength of two dual-curing resin cements employed under translucent monolithic zirconia irradiated with different time protocols.

METHODS: 84 square shaped samples of 1mm thickness were prepared from high translucency zirconia blocks and divided into two groups (n=24) according to the cement employed: (1) Rely-X Ultimate; (2) Panavia SA. Each group was further divided into 3 subgroups (n=8) according to the irradiation time: (a) no light; (b) 20s; (c) 120s. Light curing was performed 60s after the sample was placed on the diamond support of a FT-IR spectrophotometer with a high power multiLED lamp. Final DC% were calculated after 10min. After 24h, Vickers Test on the cement layer was performed. The same protocol was used to lute composite cylinders in order to evaluate microshear bond-strength test. ANOVA and Bonferroni tests were performed to find differences between MH and bond-strength to zirconia, while for DC% the Scheirer-Ray-Hare two-way test was used.

RESULTS: The two cements reached higher DC% in subgroup (b) and (c). As concern MH, statistics showed an increase in curing time was able to improve MH significantly. Bond-strength was not affected by irradiation time only for Panavia SA.

CONCLUSIONS: The first null hypothesis has to be rejected since DC% and MH of the dual-cements tested were influenced by the curing time. The second null hypothesis is partially rejected since the bond strength was influenced by the curing time only for Rely-X Ultimate.

%B J Prosthodont Res %V 62 %P 468-472 %8 2018 Oct %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/29983378?dopt=Abstract %R 10.1016/j.jpor.2018.06.003 %0 Journal Article %J Paediatr Anaesth %D 2018 %T Intranasal dexmedetomidine, as midazolam-sparing drug, for MRI in preterm neonates. %A Bua, Jenny %A Massaro, Marta %A Cossovel, Francesca %A Monasta, Lorenzo %A Brovedani, Pierpaolo %A Cozzi, Giorgio %A Barbi, Egidio %A Demarini, Sergio %A Travan, Laura %B Paediatr Anaesth %V 28 %P 747-748 %8 2018 08 %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/30144232?dopt=Abstract %R 10.1111/pan.13454 %0 Journal Article %J Int J Food Sci Nutr %D 2018 %T Investigation of the link between PROP taste perception and vegetables consumption using FAOSTAT data. %A Mezzavilla, Massimo %A Notarangelo, Michela %A Concas, Maria Pina %A Catamo, Eulalia %A Gasparini, Paolo %A Grillotti, Maria Gemma %A Robino, Antonietta %X

In this work we investigated, in populations located in Central Asia, the relationship between PROP taste perception and vegetables liking and consumption using FAOSTAT dataset. Collected data were analysed using distance matrices, Mantel test and Pearson correlation. Populations showing similar ability in tasting PROP bitterness are more similar as respect to vegetable consumption (r = 0.63, p-value = .05). Moreover, a significant negative correlation was found between the percentage of Non Taster (NT) in different countries and the percentage of vegetable consumption (r = -0.87, p-value = .02), while a significant positive correlation emerged between the percentage of Super Taster (ST) and the percentage of vegetable liking (r = 0.87, p-value = .02). In our work we showed that differences in bitter perception among populations contributes to differences in vegetable liking and vegetable consumption. More in detail, populations with higher percentage of ST consume more vegetables than population where the majority of individuals are NT.

%B Int J Food Sci Nutr %P 1-7 %8 2018 Oct 10 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30304964?dopt=Abstract %R 10.1080/09637486.2018.1519527 %0 Journal Article %J Sci Rep %D 2018 %T Iron-related toxicity of single-walled carbon nanotubes and crocidolite fibres in human mesothelial cells investigated by Synchrotron XRF microscopy. %A Cammisuli, Francesca %A Giordani, Silvia %A Gianoncelli, Alessandra %A Rizzardi, Clara %A Radillo, Lucia %A Zweyer, Marina %A Da Ros, Tatiana %A Salomè, Murielle %A Melato, Mauro %A Pascolo, Lorella %K Asbestos, Crocidolite %K Cell Line %K Epithelial Cells %K Humans %K Iron %K Microscopy, Fluorescence %K Nanotubes, Carbon %X

Carbon nanotubes (CNTs) are promising products in industry and medicine, but there are several human health concerns since their fibrous structure resembles asbestos. The presence of transition metals, mainly iron, in the fibres seems also implicated in the pathogenetic mechanisms. To unravel the role of iron at mesothelial level, we compared the chemical changes induced in MeT-5A cells by the exposure to asbestos (crocidolite) or CNTs at different content of iron impurities (raw-SWCNTs, purified- and highly purified-SWCNTs). We applied synchrotron-based X-Ray Fluorescence (XRF) microscopy and soft X-ray imaging (absorption and phase contrast images) to monitor chemical and morphological changes of the exposed cells. In parallel, we performed a ferritin assay. X-ray microscopy imaging and XRF well localize the crocidolite fibres interacting with cells, as well as the damage-related morphological changes. Differently, CNTs presence could be only partially evinced by low energy XRF through carbon distribution and sometimes iron co-localisation. Compared to controls, the cells treated with raw-SWCNTs and crocidolite fibres showed a severe alteration of iron distribution and content, with concomitant stimulation of ferritin production. Interestingly, highly purified nanotubes did not altered iron metabolism. The data provide new insights for possible CNTs effects at mesothelial/pleural level in humans.

%B Sci Rep %V 8 %P 706 %8 2018 01 15 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/29335462?dopt=Abstract %R 10.1038/s41598-017-19076-1 %0 Journal Article %J J Nutr %D 2018 %T Joint Data Analysis in Nutritional Epidemiology: Identification of Observational Studies and Minimal Requirements. %A Pinart, Mariona %A Nimptsch, Katharina %A Bouwman, Jildau %A Dragsted, Lars O %A Yang, Chen %A De Cock, Nathalie %A Lachat, Carl %A Perozzi, Giuditta %A Canali, Raffaella %A Lombardo, Rosario %A D'Archivio, Massimo %A Guillaume, Michèle %A Donneau, Anne-Françoise %A Jeran, Stephanie %A Linseisen, Jakob %A Kleiser, Christina %A Nöthlings, Ute %A Barbaresko, Janett %A Boeing, Heiner %A Stelmach-Mardas, Marta %A Heuer, Thorsten %A Laird, Eamon %A Walton, Janette %A Gasparini, Paolo %A Robino, Antonietta %A Castaño, Luis %A Rojo-Martínez, Gemma %A Merino, Jordi %A Masana, Luis %A Standl, Marie %A Schulz, Holger %A Biagi, Elena %A Nurk, Eha %A Matthys, Christophe %A Gobbetti, Marco %A de Angelis, Maria %A Windler, Eberhard %A Zyriax, Birgit-Christiane %A Tafforeau, Jean %A Pischon, Tobias %K Adult %K Biomarkers %K Blood Glucose %K Case-Control Studies %K Child %K Chronic Disease %K Cohort Studies %K Cross-Sectional Studies %K Diet %K Epidemiology %K Europe %K Genomics %K Health Status %K Humans %K Inflammation %K Insulin %K Life Style %K Lipoproteins %K Longitudinal Studies %K Metabolomics %K Nutritional Status %K Observational Studies as Topic %K Statistics as Topic %X

Background: Joint data analysis from multiple nutrition studies may improve the ability to answer complex questions regarding the role of nutritional status and diet in health and disease.

Objective: The objective was to identify nutritional observational studies from partners participating in the European Nutritional Phenotype Assessment and Data Sharing Initiative (ENPADASI) Consortium, as well as minimal requirements for joint data analysis.

Methods: A predefined template containing information on study design, exposure measurements (dietary intake, alcohol and tobacco consumption, physical activity, sedentary behavior, anthropometric measures, and sociodemographic and health status), main health-related outcomes, and laboratory measurements (traditional and omics biomarkers) was developed and circulated to those European research groups participating in the ENPADASI under the strategic research area of "diet-related chronic diseases." Information about raw data disposition and metadata sharing was requested. A set of minimal requirements was abstracted from the gathered information.

Results: Studies (12 cohort, 12 cross-sectional, and 2 case-control) were identified. Two studies recruited children only and the rest recruited adults. All studies included dietary intake data. Twenty studies collected blood samples. Data on traditional biomarkers were available for 20 studies, of which 17 measured lipoproteins, glucose, and insulin and 13 measured inflammatory biomarkers. Metabolomics, proteomics, and genomics or transcriptomics data were available in 5, 3, and 12 studies, respectively. Although the study authors were willing to share metadata, most refused, were hesitant, or had legal or ethical issues related to sharing raw data. Forty-one descriptors of minimal requirements for the study data were identified to facilitate data integration.

Conclusions: Combining study data sets will enable sufficiently powered, refined investigations to increase the knowledge and understanding of the relation between food, nutrition, and human health. Furthermore, the minimal requirements for study data may encourage more efficient secondary usage of existing data and provide sufficient information for researchers to draft future multicenter research proposals in nutrition.

%B J Nutr %V 148 %P 285-297 %8 2018 02 01 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/29490094?dopt=Abstract %R 10.1093/jn/nxx037 %0 Journal Article %J Am J Hum Genet %D 2018 %T A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure. %A Sung, Yun J %A Winkler, Thomas W %A de Las Fuentes, Lisa %A Bentley, Amy R %A Brown, Michael R %A Kraja, Aldi T %A Schwander, Karen %A Ntalla, Ioanna %A Guo, Xiuqing %A Franceschini, Nora %A Lu, Yingchang %A Cheng, Ching-Yu %A Sim, Xueling %A Vojinovic, Dina %A Marten, Jonathan %A Musani, Solomon K %A Li, Changwei %A Feitosa, Mary F %A Kilpeläinen, Tuomas O %A Richard, Melissa A %A Noordam, Raymond %A Aslibekyan, Stella %A Aschard, Hugues %A Bartz, Traci M %A Dorajoo, Rajkumar %A Liu, Yongmei %A Manning, Alisa K %A Rankinen, Tuomo %A Smith, Albert Vernon %A Tajuddin, Salman M %A Tayo, Bamidele O %A Warren, Helen R %A Zhao, Wei %A Zhou, Yanhua %A Matoba, Nana %A Sofer, Tamar %A Alver, Maris %A Amini, Marzyeh %A Boissel, Mathilde %A Chai, Jin Fang %A Chen, Xu %A Divers, Jasmin %A Gandin, Ilaria %A Gao, Chuan %A Giulianini, Franco %A Goel, Anuj %A Harris, Sarah E %A Hartwig, Fernando Pires %A Horimoto, Andrea R V R %A Hsu, Fang-Chi %A Jackson, Anne U %A Kähönen, Mika %A Kasturiratne, Anuradhani %A Kuhnel, Brigitte %A Leander, Karin %A Lee, Wen-Jane %A Lin, Keng-Hung %A 'an Luan, Jian %A McKenzie, Colin A %A Meian, He %A Nelson, Christopher P %A Rauramaa, Rainer %A Schupf, Nicole %A Scott, Robert A %A Sheu, Wayne H H %A Stančáková, Alena %A Takeuchi, Fumihiko %A van der Most, Peter J %A Varga, Tibor V %A Wang, Heming %A Wang, Yajuan %A Ware, Erin B %A Weiss, Stefan %A Wen, Wanqing %A Yanek, Lisa R %A Zhang, Weihua %A Zhao, Jing Hua %A Afaq, Saima %A Alfred, Tamuno %A Amin, Najaf %A Arking, Dan %A Aung, Tin %A Barr, R Graham %A Bielak, Lawrence F %A Boerwinkle, Eric %A Bottinger, Erwin P %A Braund, Peter S %A Brody, Jennifer A %A Broeckel, Ulrich %A Cabrera, Claudia P %A Cade, Brian %A Caizheng, Yu %A Campbell, Archie %A Canouil, Mickaël %A Chakravarti, Aravinda %A Chauhan, Ganesh %A Christensen, Kaare %A Cocca, Massimiliano %A Collins, Francis S %A Connell, John M %A de Mutsert, Renée %A de Silva, H Janaka %A Debette, Stéphanie %A Dörr, Marcus %A Duan, Qing %A Eaton, Charles B %A Ehret, Georg %A Evangelou, Evangelos %A Faul, Jessica D %A Fisher, Virginia A %A Forouhi, Nita G %A Franco, Oscar H %A Friedlander, Yechiel %A Gao, He %A Gigante, Bruna %A Graff, Misa %A Gu, C Charles %A Gu, Dongfeng %A Gupta, Preeti %A Hagenaars, Saskia P %A Harris, Tamara B %A He, Jiang %A Heikkinen, Sami %A Heng, Chew-Kiat %A Hirata, Makoto %A Hofman, Albert %A Howard, Barbara V %A Hunt, Steven %A Irvin, Marguerite R %A Jia, Yucheng %A Joehanes, Roby %A Justice, Anne E %A Katsuya, Tomohiro %A Kaufman, Joel %A Kerrison, Nicola D %A Khor, Chiea Chuen %A Koh, Woon-Puay %A Koistinen, Heikki A %A Komulainen, Pirjo %A Kooperberg, Charles %A Krieger, Jose E %A Kubo, Michiaki %A Kuusisto, Johanna %A Langefeld, Carl D %A Langenberg, Claudia %A Launer, Lenore J %A Lehne, Benjamin %A Lewis, Cora E %A Li, Yize %A Lim, Sing Hui %A Lin, Shiow %A Liu, Ching-Ti %A Liu, Jianjun %A Liu, Jingmin %A Liu, Kiang %A Liu, Yeheng %A Loh, Marie %A Lohman, Kurt K %A Long, Jirong %A Louie, Tin %A Mägi, Reedik %A Mahajan, Anubha %A Meitinger, Thomas %A Metspalu, Andres %A Milani, Lili %A Momozawa, Yukihide %A Morris, Andrew P %A Mosley, Thomas H %A Munson, Peter %A Murray, Alison D %A Nalls, Mike A %A Nasri, Ubaydah %A Norris, Jill M %A North, Kari %A Ogunniyi, Adesola %A Padmanabhan, Sandosh %A Palmas, Walter R %A Palmer, Nicholette D %A Pankow, James S %A Pedersen, Nancy L %A Peters, Annette %A Peyser, Patricia A %A Polasek, Ozren %A Raitakari, Olli T %A Renstrom, Frida %A Rice, Treva K %A Ridker, Paul M %A Robino, Antonietta %A Robinson, Jennifer G %A Rose, Lynda M %A Rudan, Igor %A Sabanayagam, Charumathi %A Salako, Babatunde L %A Sandow, Kevin %A Schmidt, Carsten O %A Schreiner, Pamela J %A Scott, William R %A Seshadri, Sudha %A Sever, Peter %A Sitlani, Colleen M %A Smith, Jennifer A %A Snieder, Harold %A Starr, John M %A Strauch, Konstantin %A Tang, Hua %A Taylor, Kent D %A Teo, Yik Ying %A Tham, Yih Chung %A Uitterlinden, André G %A Waldenberger, Melanie %A Wang, Lihua %A Wang, Ya X %A Wei, Wen Bin %A Williams, Christine %A Wilson, Gregory %A Wojczynski, Mary K %A Yao, Jie %A Yuan, Jian-Min %A Zonderman, Alan B %A Becker, Diane M %A Boehnke, Michael %A Bowden, Donald W %A Chambers, John C %A Chen, Yii-Der Ida %A de Faire, Ulf %A Deary, Ian J %A Esko, Tõnu %A Farrall, Martin %A Forrester, Terrence %A Franks, Paul W %A Freedman, Barry I %A Froguel, Philippe %A Gasparini, Paolo %A Gieger, Christian %A Horta, Bernardo Lessa %A Hung, Yi-Jen %A Jonas, Jost B %A Kato, Norihiro %A Kooner, Jaspal S %A Laakso, Markku %A Lehtimäki, Terho %A Liang, Kae-Woei %A Magnusson, Patrik K E %A Newman, Anne B %A Oldehinkel, Albertine J %A Pereira, Alexandre C %A Redline, Susan %A Rettig, Rainer %A Samani, Nilesh J %A Scott, James %A Shu, Xiao-Ou %A van der Harst, Pim %A Wagenknecht, Lynne E %A Wareham, Nicholas J %A Watkins, Hugh %A Weir, David R %A Wickremasinghe, Ananda R %A Wu, Tangchun %A Zheng, Wei %A Kamatani, Yoichiro %A Laurie, Cathy C %A Bouchard, Claude %A Cooper, Richard S %A Evans, Michele K %A Gudnason, Vilmundur %A Kardia, Sharon L R %A Kritchevsky, Stephen B %A Levy, Daniel %A O'Connell, Jeff R %A Psaty, Bruce M %A van Dam, Rob M %A Sims, Mario %A Arnett, Donna K %A Mook-Kanamori, Dennis O %A Kelly, Tanika N %A Fox, Ervin R %A Hayward, Caroline %A Fornage, Myriam %A Rotimi, Charles N %A Province, Michael A %A van Duijn, Cornelia M %A Tai, E Shyong %A Wong, Tien Yin %A Loos, Ruth J F %A Reiner, Alex P %A Rotter, Jerome I %A Zhu, Xiaofeng %A Bierut, Laura J %A Gauderman, W James %A Caulfield, Mark J %A Elliott, Paul %A Rice, Kenneth %A Munroe, Patricia B %A Morrison, Alanna C %A Cupples, L Adrienne %A Rao, Dabeeru C %A Chasman, Daniel I %K Blood Pressure %K Cohort Studies %K Continental Population Groups %K Diastole %K Epistasis, Genetic %K Female %K Genetic Loci %K Genome-Wide Association Study %K Humans %K Male %K Polymorphism, Single Nucleotide %K Quantitative Trait Loci %K Reproducibility of Results %K Smoking %K Systole %X

Genome-wide association analysis advanced understanding of blood pressure (BP), a major risk factor for vascular conditions such as coronary heart disease and stroke. Accounting for smoking behavior may help identify BP loci and extend our knowledge of its genetic architecture. We performed genome-wide association meta-analyses of systolic and diastolic BP incorporating gene-smoking interactions in 610,091 individuals. Stage 1 analysis examined ∼18.8 million SNPs and small insertion/deletion variants in 129,913 individuals from four ancestries (European, African, Asian, and Hispanic) with follow-up analysis of promising variants in 480,178 additional individuals from five ancestries. We identified 15 loci that were genome-wide significant (p < 5 × 10) in stage 1 and formally replicated in stage 2. A combined stage 1 and 2 meta-analysis identified 66 additional genome-wide significant loci (13, 35, and 18 loci in European, African, and trans-ancestry, respectively). A total of 56 known BP loci were also identified by our results (p < 5 × 10). Of the newly identified loci, ten showed significant interaction with smoking status, but none of them were replicated in stage 2. Several loci were identified in African ancestry, highlighting the importance of genetic studies in diverse populations. The identified loci show strong evidence for regulatory features and support shared pathophysiology with cardiometabolic and addiction traits. They also highlight a role in BP regulation for biological candidates such as modulators of vascular structure and function (CDKN1B, BCAR1-CFDP1, PXDN, EEA1), ciliopathies (SDCCAG8, RPGRIP1L), telomere maintenance (TNKS, PINX1, AKTIP), and central dopaminergic signaling (MSRA, EBF2).

%B Am J Hum Genet %V 102 %P 375-400 %8 2018 03 01 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29455858?dopt=Abstract %R 10.1016/j.ajhg.2018.01.015 %0 Journal Article %J Ultrasound Obstet Gynecol %D 2018 %T Learning curve for the ultrasonographic diagnosis of deep endometriosis using a structured off-line training program. %A Guerriero, Stefano %A Pascual, M Angela %A Ajossa, Silvia %A Rodriguez, Ignacio %A Zajicek, Michal %A Rolla, Martino %A Rams, Noelia Llop %A Yulzari, Vered %A Bardin, Ron %A Buonomo, Francesca %A Comparetto, Ornella %A Perniciano, Maura %A Saba, Luca %A Mais, Valerio %A Alcazar, Juan Luis %X

OBJECTIVE: The aim of the present study was to assess the learning curves of trainees during a structured off-line/hands-on training program on the diagnosis of deep infiltrating endometriosis (DIE).

METHODS: A two-week training program was conducted. One day was devoted to theoretical issues and guided off-line analysis of 10 volumes of three-dimensional (3D) ultrasound. During the following days, five sessions of real-time sonographic examinations were performed in a DIE referral center Ultrasound unit. In between sessions, the trainees analyzed four off-line sets, containing twenty-five 3D volumes each. At the end of each set, misinterpreted volumes were assessed with the trainer. One trainer and 4 trainees (all post-graduated Ob/Gyn with at least 5 years of experience in ultrasonography in Obstetrics and Gynecology but with no experience in DIE sonographic examinations) participated in the study. Presence or absence of DIE at surgery was considered as gold standard for the trainees. Trainee's results were evaluated by learning curve cumulative summation (LC-CUSUM) and the deviations of the level of trainees' performance at the control stage by CUSUM (standard CUSUM) for different locations of DIE.

RESULTS: The trainees reached competence on average after 17 evaluations (range 21-14) for bladder locations, after 39 evaluations (range 60-30) for rectosigmoid locations, after 25 evaluations (range 34-14) for forniceal locations, after 44 evaluations (range 66-25) for utero-sacral locations (USL), after 21 evaluations (range 43-14) for rectovaginal septum (RVS) locations respectively, and kept the process under control with error levels of less than 4.5% until the end of the test. The overall accuracy for each trainee at the different locations ranged from 0.91 to 0.96 for bladder DIE, from 0.80 to 0.94 for recto-sigmoid DIE, from 0.90 to 0.94% for forniceal DIE, from 0.79 to 0.82 for utero-sacral ligaments DIE and from 0.89 to 0.97 for recto-vaginal septum DIE.

CONCLUSIONS: The suggested two-weeks learning program based on a mix of off-line and live sessions is feasible and suggests a good performance in training for the diagnosis of DIE. This article is protected by copyright. All rights reserved.

%B Ultrasound Obstet Gynecol %8 2018 Nov 13 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30426587?dopt=Abstract %R 10.1002/uog.20176 %0 Journal Article %J Curr HIV Res %D 2018 %T Lopinavir/Ritonavir Treatment Induces Oxidative Stress and Caspaseindependent Apoptosis in Human Glioblastoma U-87 MG Cell Line. %A Gratton, Rossella %A Tricarico, Paola Maura %A Guimarães, Rafael Lima %A Celsi, Fulvio %A Crovella, Sergio %X

BACKGROUND: Lopinavir and Ritonavir (LPV/r) treatment is widely used to prevent HIV mother-to-child transmission. Nevertheless, studies related to the impact of these compounds on patients, in particular in the foetus and newborns, are strictly required due to the controversial findings reported in the literature concerning possible neurologic side effects following the administration of these drugs.

OBJECTIVES: In our study, we evaluated the impact of LPV/r treatment on the human glioblastoma U- 87 MG cell line.

METHODS: In order to evaluate the influence of Lopinavir and Ritonavir in terms of oxidative stress (ROS production), mitochondrial morphology and apoptotic cell death, the latter either in the presence or in the absence of caspase-3 and -9 inhibitors, we treated U-87 MG with increasing doses (0.1-1-10-25-50 µM) of Lopinavir and Ritonavir for 24h, either in single formulation or in combination. ROS production was measured by flow cytometry using H2DCFDA dye, mitochondrial morphology was evaluated using MitoRed dye and apoptotic cell death was monitored by flow cytometry using Annexin V-FITC and Propidium Iodide.

RESULTS: We observed that co-treatment with Lopinavir and Ritonavir (25 and 50 µM) promoted a significant increase in ROS production, caused mitochondrial network damage and induced apoptosis in a caspase-independent manner.

CONCLUSION: Based on our findings, concordant with others reported in the literature, we hypothesize that LPV/r treatment could not be entirely free from side effects, being aware of the need of validation in in vivo models, necessary to confirm our results.

%B Curr HIV Res %V 16 %P 106-112 %8 2018 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/29804534?dopt=Abstract %R 10.2174/1570162X16666180528100922 %0 Journal Article %J Endocrine %D 2018 %T MKRN3 levels in girls with central precocious puberty and correlation with sexual hormone levels: a pilot study. %A Grandone, Anna %A Cirillo, Grazia %A Sasso, Marcella %A Capristo, Carlo %A Tornese, Gianluca %A Marzuillo, Pierluigi %A Luongo, Caterina %A Rosaria Umano, Giuseppina %A Festa, Adalgisa %A Coppola, Ruggero %A Miraglia Del Giudice, Emanuele %A Perrone, Laura %K Adolescent %K Adolescent Nutritional Physiological Phenomena %K Anti-Mullerian Hormone %K Case-Control Studies %K Child %K Child Nutritional Physiological Phenomena %K Child, Preschool %K Cross-Sectional Studies %K Female %K Follicle Stimulating Hormone %K Gonadotropin-Releasing Hormone %K Humans %K Luteinizing Hormone %K Pilot Projects %K Puberty, Precocious %K Ribonucleoproteins %K Sexual Maturation %X

PURPOSE: Recently, mutations of makorin RING-finger protein 3 (MKRN3) have been described in familial central precocious puberty. Serum levels of this protein decline before the pubertal onset in healthy girls and boys. The aim of the study is to investigate MKRN3 circulating levels in patients with central precocious puberty.

METHODS: We performed an observational cross-sectional study. We enrolled 17 patients with central precocious puberty aged 7 years (range: 2-8 years) and breast development onset <8 years; 17 prepubertal control age-matched patients aged 6.3 years (2-8.2); and 10 pubertal stage-matched control patients aged 11.4 years (9-14). Serum values of MKRN3, gonadotropins, (17)estradiol and Anti-Müllerian Hormone were evaluated and the MKRN3 genotyped in central precocious puberty patients.

RESULTS: No MKRN3 mutation was found among central precocious puberty patients. MKRN3 levels were lower in patients with central precocious puberty compared to prepubertal age-matched ones (p: 0.0004) and comparable to those matched for pubertal stage. MKRN3 levels were inversely correlated to Body Mass Index Standard Deviations (r:-0.35; p:0.02), Luteinizing Hormone (r:-0.35; p:0.03), FSH (r:-0.37; p:0.02), and (17)estradiol (r: -0.36; p:0.02).

CONCLUSIONS: We showed that girls with central precocious puberty had lower peripheral levels of MKRN3 compared to age-matched pairs and that they negatively correlated to gonadotropins, estrogen, and BMI. Our findings support the MKRN3 involvement in central precocious puberty also in absence of deleterious mutations, although our sample size is small. In addition our data suggest the role of MKRN3 in the complex mechanism controlling puberty onset and its interaction with other factors affecting puberty such as nutrition.

%B Endocrine %V 59 %P 203-208 %8 2018 01 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28299573?dopt=Abstract %R 10.1007/s12020-017-1281-x %0 Journal Article %J Horm Res Paediatr %D 2018 %T MKRN3 Levels in Girls with Central Precocious Puberty during GnRHa Treatment: A Longitudinal Study. %A Grandone, Anna %A Cirillo, Grazia %A Sasso, Marcella %A Tornese, Gianluca %A Luongo, Caterina %A Festa, Adalgisa %A Marzuillo, Pierluigi %A Miraglia Del Giudice, Emanuele %K Brain Diseases %K Case-Control Studies %K Child %K Child, Preschool %K Female %K Follicle Stimulating Hormone %K Genotype %K Gonadotropin-Releasing Hormone %K Humans %K Longitudinal Studies %K Luteinizing Hormone %K Male %K Puberty, Precocious %K Ribonucleoproteins %X

BACKGROUND: Recently, mutations of makorin RING finger protein 3 (MKRN3) have been identified in familial central precocious puberty (CPP). Serum levels of this protein decline before the pubertal onset in healthy girls and boys and are lower in patients with CPP compared to prepubertal matched pairs. The aim of our study was to investigate longitudinal changes in circulating MKRN3 levels in patients with CPP before and during GnRH analogs (GnRHa) treatment.

METHODS: We performed a longitudinal prospective study. We enrolled 15 patients with CPP aged 7.2 years (range: 2-8) with age at breast development onset < 8 years and 12 control girls matched for the time from puberty onset (mean age 11.8 ± 1.2 years). Serum values of MKRN3, gonadotropins, and 17β-estradiol were evaluated before and during treatment with GnRHa (at 6 and 12 months). The MKRN3 gene was genotyped in CPP patients. In the girls from the control group, only basal levels were analyzed.

RESULTS: No MKRN3 mutations were found among CPP patients. MKRN3 levels declined significantly from baseline to 6 months of GnRHa treatment (p = 0.0007) and from 6 to 12 months of treatment (p = 0.003); MKRN3 levels at 6 months were significantly lower than in the control girls (p < 0.0001).

CONCLUSIONS: We showed that girls with CPP had a decline in peripheral levels of MKRN3 during GnRHa treatment. Our data suggest a suppression of MKRN3 by continuous pharmacological administration of GnRHa.

%B Horm Res Paediatr %V 90 %P 190-195 %8 2018 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/30269125?dopt=Abstract %R 10.1159/000493134 %0 Journal Article %J Acta Paediatr %D 2018 %T Multicentre emergency department study found that paracetamol and ibuprofen were inappropriately used in 83% and 63% of paediatric cases. %A Benini, Franca %A Castagno, Emanuele %A Barbi, Egidio %A Congedi, Sabrina %A Urbino, Antonio %A Biban, Paolo %A Calistri, Lucia %A Mancusi, Rossella Letizia %X

AIM: The Pain Practice in Italian Paediatric Emergency Departments assessed how appropriately analgesic drugs were being used by Italian clinicians, based on national paediatric pain guidelines.

METHODS: This was a retrospective study that involved 17 Italian members of the Pain In Pediatric Emergency Rooms group. It comprised patients up to the age of 14 years who came to hospital emergency departments with pain and were treated with paracetamol, ibuprofen or opioids, such as codeine, tramadol and morphine.

RESULTS: We studied 1471 patients who were given 1593 doses of analgesics. The median time to administration of analgesia was 25 minutes. Opioids were used in 13.5% of the children, and usage increased with age and with more severe clinical conditions, such as trauma: 1.6% of children under two years, 5.9% aged 3-10 and 8.0% aged 11-14. Inappropriate doses of paracetamol, ibuprofen and opioids were used in 83%, 63% and 33% of cases, respectively. The patient's age was a critical determinant of the correct analgesic dosage; for every one-year increase in the patient's age, the probability of appropriate prescriptions rose 14.8%.

CONCLUSION: The appropriate use of paracetamol and ibuprofen for paediatric pain in Italian emergency departments was very poor, but improved with age.

%B Acta Paediatr %V 107 %P 1766-1774 %8 2018 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/29505669?dopt=Abstract %R 10.1111/apa.14306 %0 Journal Article %J Eur J Pediatr %D 2018 %T Needle-related pain and distress management during needle-related procedures in children with and without intellectual disability. %A Pascolo, Paola %A Peri, Francesca %A Montico, Marcella %A Funaro, Mishelle %A Parrino, Roberta %A Vanadia, Francesca %A Rusalen, Francesca %A Vecchiato, Luca %A Benini, Franca %A Congedi, Sabrina %A Barbi, Egidio %A Cozzi, Giorgio %K Adolescent %K Anxiety %K Child %K Child, Preschool %K Cohort Studies %K Female %K Humans %K Intellectual Disability %K Italy %K Male %K Pain Management %K Pain Measurement %K Pain, Procedural %K Phlebotomy %X

Children with intellectual disability frequently undergo needle-related procedures for diagnosis or treatment. Nevertheless, only a few studies deal with pain and distress management during the procedure in this population of children. This study aimed to investigate the number of anxiety and pain management techniques performed during needle procedure in children with intellectual disability (cases) compared to a population of children without intellectual disability (controls). This multicenter cohort study was performed from July 2016 to January 2018 in the pediatric ward of four urban hospitals in Italy. Eligible subjects were children with and without intellectual disability, from 4 to 17 years old, who needed venipuncture or intravenous cannulation for diagnosis or treatment. Use of topical anesthesia, distraction techniques, and physical or verbal comfort during procedures were recorded. Pain and anxiety scores were also recorded. Forty-seven cases and 94 controls were recruited. Three pain- and anxiety-relieving techniques were performed during the procedure in 12 (25%) cases and in 10 controls (11%); two techniques were performed in 23 (50%) cases and in 26 (28%) controls; 12 (25%) cases and 52 (55%) controls received only one.Conclusion: In this series, children with intellectual disability received significantly more relieving techniques, but experienced more pain and anxiety when compared to children without intellectual disability. What is Known: • Children with intellectual disability experience more episodes of pain than cognitively healthy ones, and almost 10% of these episodes are due to medical procedures. What is New: • Children with intellectual disability despite receiving more relieving techniques during a needle-related procedure experienced more pain and anxiety when compared to healthy children.

%B Eur J Pediatr %V 177 %P 1753-1760 %8 2018 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/30203192?dopt=Abstract %R 10.1007/s00431-018-3237-4 %0 Journal Article %J Int J Mol Sci %D 2018 %T Neuronal Dysfunction Associated with Cholesterol Deregulation. %A Marcuzzi, Annalisa %A Loganes, Claudia %A Valencic, Erica %A Piscianz, Elisa %A Monasta, Lorenzo %A Bilel, Sabrine %A Bortul, Roberta %A Celeghini, Claudio %A Zweyer, Marina %A Tommasini, Alberto %K Anticholesteremic Agents %K Cell Line, Tumor %K Cholesterol %K Electron Transport %K Humans %K Lovastatin %K Mitochondria %K Neurons %K Neuroprotective Agents %K Organophosphorus Compounds %K Ubiquinone %X

Cholesterol metabolism is crucial for cells and, in particular, its biosynthesis in the central nervous system occurs in situ, and its deregulation involves morphological changes that cause functional variations and trigger programmed cell death. The pathogenesis of rare diseases, such as Mevalonate Kinase Deficiency or Smith⁻Lemli⁻Opitz Syndrome, arises due to enzymatic defects in the cholesterol metabolic pathways, resulting in a shortage of downstream products. The most severe clinical manifestations of these diseases appear as neurological defects. Expanding the knowledge of this biological mechanism will be useful for identifying potential targets and preventing neuronal damage. Several studies have demonstrated that deregulation of the cholesterol pathway induces mitochondrial dysfunction as the result of respiratory chain damage. We set out to determine whether mitochondrial damage may be prevented by using protective mitochondria-targeted compounds, such as MitoQ, in a neuronal cell line treated with a statin to induce a biochemical block of the cholesterol pathway. Evidence from the literature suggests that mitochondria play a crucial role in the apoptotic mechanism secondary to blocking the cholesterol pathway. Our study shows that MitoQ, administered as a preventive agent, could counteract the cell damage induced by statins in the early stages, but its protective role fades over time.

%B Int J Mol Sci %V 19 %8 2018 May 19 %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/29783748?dopt=Abstract %R 10.3390/ijms19051523 %0 Journal Article %J PLoS One %D 2018 %T Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries. %A Feitosa, Mary F %A Kraja, Aldi T %A Chasman, Daniel I %A Sung, Yun J %A Winkler, Thomas W %A Ntalla, Ioanna %A Guo, Xiuqing %A Franceschini, Nora %A Cheng, Ching-Yu %A Sim, Xueling %A Vojinovic, Dina %A Marten, Jonathan %A Musani, Solomon K %A Li, Changwei %A Bentley, Amy R %A Brown, Michael R %A Schwander, Karen %A Richard, Melissa A %A Noordam, Raymond %A Aschard, Hugues %A Bartz, Traci M %A Bielak, Lawrence F %A Dorajoo, Rajkumar %A Fisher, Virginia %A Hartwig, Fernando P %A Horimoto, Andrea R V R %A Lohman, Kurt K %A Manning, Alisa K %A Rankinen, Tuomo %A Smith, Albert V %A Tajuddin, Salman M %A Wojczynski, Mary K %A Alver, Maris %A Boissel, Mathilde %A Cai, Qiuyin %A Campbell, Archie %A Chai, Jin Fang %A Chen, Xu %A Divers, Jasmin %A Gao, Chuan %A Goel, Anuj %A Hagemeijer, Yanick %A Harris, Sarah E %A He, Meian %A Hsu, Fang-Chi %A Jackson, Anne U %A Kähönen, Mika %A Kasturiratne, Anuradhani %A Komulainen, Pirjo %A Kuhnel, Brigitte %A Laguzzi, Federica %A Luan, Jian'an %A Matoba, Nana %A Nolte, Ilja M %A Padmanabhan, Sandosh %A Riaz, Muhammad %A Rueedi, Rico %A Robino, Antonietta %A Said, M Abdullah %A Scott, Robert A %A Sofer, Tamar %A Stančáková, Alena %A Takeuchi, Fumihiko %A Tayo, Bamidele O %A van der Most, Peter J %A Varga, Tibor V %A Vitart, Veronique %A Wang, Yajuan %A Ware, Erin B %A Warren, Helen R %A Weiss, Stefan %A Wen, Wanqing %A Yanek, Lisa R %A Zhang, Weihua %A Zhao, Jing Hua %A Afaq, Saima %A Amin, Najaf %A Amini, Marzyeh %A Arking, Dan E %A Aung, Tin %A Boerwinkle, Eric %A Borecki, Ingrid %A Broeckel, Ulrich %A Brown, Morris %A Brumat, Marco %A Burke, Gregory L %A Canouil, Mickaël %A Chakravarti, Aravinda %A Charumathi, Sabanayagam %A Ida Chen, Yii-Der %A Connell, John M %A Correa, Adolfo %A de Las Fuentes, Lisa %A de Mutsert, Renée %A de Silva, H Janaka %A Deng, Xuan %A Ding, Jingzhong %A Duan, Qing %A Eaton, Charles B %A Ehret, Georg %A Eppinga, Ruben N %A Evangelou, Evangelos %A Faul, Jessica D %A Felix, Stephan B %A Forouhi, Nita G %A Forrester, Terrence %A Franco, Oscar H %A Friedlander, Yechiel %A Gandin, Ilaria %A Gao, He %A Ghanbari, Mohsen %A Gigante, Bruna %A Gu, C Charles %A Gu, Dongfeng %A Hagenaars, Saskia P %A Hallmans, Goran %A Harris, Tamara B %A He, Jiang %A Heikkinen, Sami %A Heng, Chew-Kiat %A Hirata, Makoto %A Howard, Barbara V %A Ikram, M Arfan %A John, Ulrich %A Katsuya, Tomohiro %A Khor, Chiea Chuen %A Kilpeläinen, Tuomas O %A Koh, Woon-Puay %A Krieger, Jose E %A Kritchevsky, Stephen B %A Kubo, Michiaki %A Kuusisto, Johanna %A Lakka, Timo A %A Langefeld, Carl D %A Langenberg, Claudia %A Launer, Lenore J %A Lehne, Benjamin %A Lewis, Cora E %A Li, Yize %A Lin, Shiow %A Liu, Jianjun %A Liu, Jingmin %A Loh, Marie %A Louie, Tin %A Mägi, Reedik %A McKenzie, Colin A %A Meitinger, Thomas %A Metspalu, Andres %A Milaneschi, Yuri %A Milani, Lili %A Mohlke, Karen L %A Momozawa, Yukihide %A Nalls, Mike A %A Nelson, Christopher P %A Sotoodehnia, Nona %A Norris, Jill M %A O'Connell, Jeff R %A Palmer, Nicholette D %A Perls, Thomas %A Pedersen, Nancy L %A Peters, Annette %A Peyser, Patricia A %A Poulter, Neil %A Raffel, Leslie J %A Raitakari, Olli T %A Roll, Kathryn %A Rose, Lynda M %A Rosendaal, Frits R %A Rotter, Jerome I %A Schmidt, Carsten O %A Schreiner, Pamela J %A Schupf, Nicole %A Scott, William R %A Sever, Peter S %A Shi, Yuan %A Sidney, Stephen %A Sims, Mario %A Sitlani, Colleen M %A Smith, Jennifer A %A Snieder, Harold %A Starr, John M %A Strauch, Konstantin %A Stringham, Heather M %A Tan, Nicholas Y Q %A Tang, Hua %A Taylor, Kent D %A Teo, Yik Ying %A Tham, Yih Chung %A Turner, Stephen T %A Uitterlinden, André G %A Vollenweider, Peter %A Waldenberger, Melanie %A Wang, Lihua %A Wang, Ya Xing %A Wei, Wen Bin %A Williams, Christine %A Yao, Jie %A Yu, Caizheng %A Yuan, Jian-Min %A Zhao, Wei %A Zonderman, Alan B %A Becker, Diane M %A Boehnke, Michael %A Bowden, Donald W %A Chambers, John C %A Deary, Ian J %A Esko, Tõnu %A Farrall, Martin %A Franks, Paul W %A Freedman, Barry I %A Froguel, Philippe %A Gasparini, Paolo %A Gieger, Christian %A Jonas, Jost Bruno %A Kamatani, Yoichiro %A Kato, Norihiro %A Kooner, Jaspal S %A Kutalik, Zoltán %A Laakso, Markku %A Laurie, Cathy C %A Leander, Karin %A Lehtimäki, Terho %A Study, Lifelines Cohort %A Magnusson, Patrik K E %A Oldehinkel, Albertine J %A Penninx, Brenda W J H %A Polasek, Ozren %A Porteous, David J %A Rauramaa, Rainer %A Samani, Nilesh J %A Scott, James %A Shu, Xiao-Ou %A van der Harst, Pim %A Wagenknecht, Lynne E %A Wareham, Nicholas J %A Watkins, Hugh %A Weir, David R %A Wickremasinghe, Ananda R %A Wu, Tangchun %A Zheng, Wei %A Bouchard, Claude %A Christensen, Kaare %A Evans, Michele K %A Gudnason, Vilmundur %A Horta, Bernardo L %A Kardia, Sharon L R %A Liu, Yongmei %A Pereira, Alexandre C %A Psaty, Bruce M %A Ridker, Paul M %A van Dam, Rob M %A Gauderman, W James %A Zhu, Xiaofeng %A Mook-Kanamori, Dennis O %A Fornage, Myriam %A Rotimi, Charles N %A Cupples, L Adrienne %A Kelly, Tanika N %A Fox, Ervin R %A Hayward, Caroline %A van Duijn, Cornelia M %A Tai, E Shyong %A Wong, Tien Yin %A Kooperberg, Charles %A Palmas, Walter %A Rice, Kenneth %A Morrison, Alanna C %A Elliott, Paul %A Caulfield, Mark J %A Munroe, Patricia B %A Rao, Dabeeru C %A Province, Michael A %A Levy, Daniel %K Adolescent %K Adult %K Aged %K Aged, 80 and over %K Alcohol Drinking %K Blood Pressure %K Cohort Studies %K Continental Population Groups %K Female %K Gene-Environment Interaction %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Humans %K Hypertension %K Male %K Middle Aged %K Pedigree %K Polymorphism, Single Nucleotide %K Young Adult %X

Heavy alcohol consumption is an established risk factor for hypertension; the mechanism by which alcohol consumption impact blood pressure (BP) regulation remains unknown. We hypothesized that a genome-wide association study accounting for gene-alcohol consumption interaction for BP might identify additional BP loci and contribute to the understanding of alcohol-related BP regulation. We conducted a large two-stage investigation incorporating joint testing of main genetic effects and single nucleotide variant (SNV)-alcohol consumption interactions. In Stage 1, genome-wide discovery meta-analyses in ≈131K individuals across several ancestry groups yielded 3,514 SNVs (245 loci) with suggestive evidence of association (P < 1.0 x 10-5). In Stage 2, these SNVs were tested for independent external replication in ≈440K individuals across multiple ancestries. We identified and replicated (at Bonferroni correction threshold) five novel BP loci (380 SNVs in 21 genes) and 49 previously reported BP loci (2,159 SNVs in 109 genes) in European ancestry, and in multi-ancestry meta-analyses (P < 5.0 x 10-8). For African ancestry samples, we detected 18 potentially novel BP loci (P < 5.0 x 10-8) in Stage 1 that warrant further replication. Additionally, correlated meta-analysis identified eight novel BP loci (11 genes). Several genes in these loci (e.g., PINX1, GATA4, BLK, FTO and GABBR2) have been previously reported to be associated with alcohol consumption. These findings provide insights into the role of alcohol consumption in the genetic architecture of hypertension.

%B PLoS One %V 13 %P e0198166 %8 2018 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/29912962?dopt=Abstract %R 10.1371/journal.pone.0198166 %0 Journal Article %J Public Health Nutr %D 2018 %T Nutrient intakes in an Italian population of infants during the complementary feeding period. %A Concina, Federica %A Pani, Paola %A Bravo, Giulia %A Barbone, Fabio %A Carletti, Claudia V %A Knowles, Alessandra %A Ronfani, Luca %A Parpinel, Maria %X

OBJECTIVE: To describe the nutrient intakes of an Italian cohort of infants at 6, 9 and 12 months of age.

DESIGN: Dietary data were collected using a food diary at three follow-ups (6, 9 and 12 months of age of infants). The infants' dietary data were used to estimate nutrient intakes using the Italian food composition database integrated with data from nutritional labels and the literature. The mean and standard deviation, median and interquartile range, minimum and maximum, and 5th, 25th, 75th and 95th percentiles were calculated for the daily intake of twenty-eight nutrients, with sex differences evaluated using parametric/non-parametric statistical methods.

SETTING: A prospective population-based birth cohort.SubjectInfants (n 400) living in the urban area of Trieste (Italy).

RESULTS: The sex distribution was fairly balanced at each follow-up. The mean daily intakes of energy and the other twenty-seven nutrients considered were greater in males at all follow-ups. In particular, a significant statistical difference was observed in higher male consumption of cholesterol at 9 months and in energy and carbohydrate intakes at 12 months (P < 0·05). The mean daily intake of proteins was greater than that recommended by the Italian Dietary Reference Values at all follow-ups.

CONCLUSIONS: These preliminary results provide a useful basis for understanding the nutrient intake patterns of infants in this area of Italy during the first year of life.

%B Public Health Nutr %V 21 %P 3018-3026 %8 2018 Nov %G eng %N 16 %1 http://www.ncbi.nlm.nih.gov/pubmed/30157987?dopt=Abstract %R 10.1017/S136898001800201X %0 Journal Article %J Ital J Pediatr %D 2018 %T Orthopaedic challenges for mucopolysaccharidoses. %A Borgo, Andrea %A Cossio, Andrea %A Gallone, Denise %A Vittoria, Francesca %A Carbone, Marco %K Bone Diseases %K Humans %K Mucopolysaccharidoses %K Orthopedic Procedures %X

Mucopolysaccharidoses (MPS) are a group of diseases characterized by abnormal accumulation of glycosaminoglycans (GAGs). Although there are differences among the various disease types, the osteoarticular system is always involved. The aim of the present study was to establish a framework for MPS-related orthopaedic manifestations and for their treatment. The authors, affiliated to three different Italian Orthopaedic Centres, report data taken from the literature reviewed in light of their accumulated professional experience. Bone alterations make up what is known as dysostosis multiplex, involving the trunk and limbs and with typical radiological findings. Joints are affected by pathological tissue infiltrations. The cervical spinal cord is involved, with stenosis and cervical and occipitocervical instability. In MPS there is a much higher incidence of scoliosis compared with healthy subjects without any particular distinctive feature. Kyphosis of the spine is more frequent and also more severe because of its possible neurological complications, and it is localized at the thoracolumbar level with a malformed vertebra at the top of the deformity. Evolving forms, and those associated with neurological damage, require anteroposterior spine fusion. The hip is invariably involved, with dysplasia affecting the femoral neck (coxa valga), the femoral epiphysis (loss of sphericity, osteonecrosis), and the femoral acetabulum which is flared. All these features explain the tendency to progressive hip migration. Genu valgum is often found (a deviation of the physiological axis with an obtuse angle opening laterally). This deformity is often localized at the proximal tibial metaphysis; it causes functional limitations and leads to an irregular erosion of the articular cartilage. In young patients who still have the growth plate, it is possible to execute a medial hemiepiphysiodesis, a temporary inhibition of cartilage growth, with progressive axis correction. In this paper, the characterisation of clinical features and the review of treatments are divided into separate sections based on the part of the body involved. The conclusions of each section are presented as a summary. One section discusses the high risk of anaesthesia-related complications requiring the collaboration of specifically trained personnel.

%B Ital J Pediatr %V 44 %P 123 %8 2018 Nov 16 %G eng %N Suppl 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/30442173?dopt=Abstract %R 10.1186/s13052-018-0557-y %0 Journal Article %J Nutrients %D 2018 %T Paediatric Home Artificial Nutrition in Italy: Report from 2016 Survey on Behalf of Artificial Nutrition Network of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP). %A Lezo, Antonella %A Capriati, Teresa %A Spagnuolo, Maria Immacolata %A Lacitignola, Laura %A Goreva, Irina %A Di Leo, Grazia %A Cecchi, Nicola %A Gandullia, Paolo %A Amarri, Sergio %A Forchielli, Maria Luisa %A Dipasquale, Valeria %A Parma, Barbara %A Gatti, Simona %A Ravaioli, Elisa %A Salvatore, Silvia %A Mainetti, Martina %A Norsa, Lorenzo %A Pellegrino, Maristella %A Fornaro, Martina %A Fiorito, Valentina %A Lanari, Marcello %A Giaquinto, Ester %A Verduci, Elvira %A Baldassarre, Maria Elisabetta %A Diamanti, Antonella %K Adolescent %K Age Factors %K Child %K Child Nutritional Physiological Phenomena %K Child, Preschool %K Enteral Nutrition %K Female %K Health Care Surveys %K Home Care Services %K Humans %K Infant %K Infant, Newborn %K Italy %K Male %K Nutritional Status %K Parenteral Nutrition, Home %K Pediatrics %K Time Factors %K Young Adult %X

Home Artificial Nutrition (HAN) is a safe and efficacious technique that insures children's reintegration into the family, society and school. Epidemiological data on paediatric HAN in Italy are not available.

AIM: to detect the prevalence and incidence of Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN), either via tube or mouth, in Italy in 2016.

MATERIALS AND METHODS: a specific form was sent to all registered SIGENP members and investigators of local HAN centres, inviting them to provide the requested centre's data and demographics, underlying diseases and HAN characteristics of the patients.

RESULTS: we recorded 3403 Italian patients on HAN aged 0 to 19 years from 22 centres: 2277 HEN, 950 Oral Nutritional Supplements (ONS) and 179 HPN programs. The prevalence of HEN (205 pts/million inhabitants) and HPN (16 pts/million inhabitants) has dramatically increased in Italy in the last 9 years. Neurodisabling conditions were the first indication for HEN by tube or mouth while HPN is mainly requested in digestive disorders.

CONCLUSIONS: HAN is a widespread and rapidly growing treatment in Italy, as well as in other European countries. Awareness of its extent and characteristics helps improving HAN service and patients' quality of life.

%B Nutrients %V 10 %8 2018 Sep 16 %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/30223620?dopt=Abstract %R 10.3390/nu10091311 %0 Journal Article %J Pediatr Emerg Care %D 2018 %T Pain Intensity and Risk of Bone Fracture in Children With Minor Extremity Injuries. %A Zanchi, Chiara %A Giangreco, Manuela %A Ronfani, Luca %A Germani, Claudio %A Giorgi, Rita %A Calligaris, Lorenzo %A Norbedo, Stefania %A Liccari, Giulio %A Cozzi, Giorgio %A Barbi, Egidio %X

OBJECTIVES: Injuries are one of the most common causes of pediatric emergency department (ED) visit. The aim of this study was to investigate the relationship between the intensity of pain at the ED visit of children presenting with an extremity injury and the risk of fracture.

METHODS: We conducted a retrospective study, considering all patients presenting to the ED of a children's hospital in Italy, with an accidental extremity injury, between May and December 2015. We selected all children aged 8 to 17 years who underwent an x-ray. Children with major, multiple, or nonextremity injuries were excluded. Age, sex, spontaneous and palpation pain, local swelling, time between injury, and medical evaluation were recorded. Sensibility and specificity of spontaneous and palpation pain in detecting a fracture were calculated.

RESULTS: We reviewed 994 medical records; of these, 344 (34.6%) reported a fracture. Children's median age was 12 years (interquartile range [IQR], 10-14). Median spontaneous pain at the ED visit was not significantly different between children with and without a fracture: 4.0 (1.0-6.0) and 5 (1.0-6.0), respectively (P = 0.129). Children with mild palpation pain and children without an increase of pain of at least 2 points between spontaneous and palpation pain were fractured in 3.2% and 0.97% of cases, respectively.

CONCLUSIONS: In this series, pain intensity in children with a minor extremity injury was not a good marker of fracture. Nevertheless, children with mild palpation pain or with a mild increase of pain between spontaneous and palpation pain had a low risk of fracture.

%B Pediatr Emerg Care %8 2018 Jan 23 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29369266?dopt=Abstract %R 10.1097/PEC.0000000000001418 %0 Journal Article %J Expert Opin Drug Metab Toxicol %D 2018 %T Pharmacogenetics of treatments for inflammatory bowel disease. %A Lucafò, Marianna %A Franca, Raffaella %A Selvestrel, Davide %A Curci, Debora %A Pugnetti, Letizia %A Decorti, Giuliana %A Stocco, Gabriele %K Dose-Response Relationship, Drug %K Epigenesis, Genetic %K Gastrointestinal Agents %K Genetic Markers %K Genetic Predisposition to Disease %K Humans %K Inflammatory Bowel Diseases %K Pharmacogenetics %X

INTRODUCTION: Inflammatory bowel disease is a chronic inflammation of the gut whose pathogenesis is still unclear. Although no curative therapy is currently available, a number of drugs are used in induction and maintenance therapy; however, for most of these drugs, a high inter-individual variability in response is observed. Among the factors of this variability, genetics plays an important role. Areas covered: This review summarizes the results of pharmacogenetic studies, considering the most important drugs used and in particular aminosalycilates, glucocorticoids, thiopurines, monoclonal antibodies and thalidomide. Most studies used a candidate gene approach, even if significant breakthroughs have been obtained recently from applying genome-wide studies. When available, also investigations considering epigenetics and pharmacogenetic dosing guidelines have been included. Expert opinion: Only for thiopurines, genetic markers identified as predictors of efficacy or adverse events have allowed the development of dosing guidelines. For the other drugs, encouraging results are available and great expectations rely on the study of epigenetics and integration with pharmacokinetic information, especially useful for biologics. However, to improve therapy of IBD patients with these drugs, for implementation in the clinics of pharmacogenetics, informatic clinical decision support systems and training about pharmacogenetics of health providers are needed.

%B Expert Opin Drug Metab Toxicol %V 14 %P 1209-1223 %8 2018 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/30465611?dopt=Abstract %R 10.1080/17425255.2018.1551876 %0 Journal Article %J Oxid Med Cell Longev %D 2018 %T Photobiomodulation at Multiple Wavelengths Differentially Modulates Oxidative Stress and . %A Rupel, Katia %A Zupin, Luisa %A Colliva, Andrea %A Kamada, Anselmo %A Poropat, Augusto %A Ottaviani, Giulia %A Gobbo, Margherita %A Fanfoni, Lidia %A Gratton, Rossella %A Santoro, Massimo %A Di Lenarda, Roberto %A Biasotto, Matteo %A Zacchigna, Serena %K Adult %K Aged %K Aged, 80 and over %K Female %K Humans %K Keratinocytes %K Lasers, Semiconductor %K Low-Level Light Therapy %K Male %K Middle Aged %K Neutrophils %K Oxidation-Reduction %K Oxidative Stress %K Stomatitis %X

Photobiomodulation (PBM) is emerging as an effective strategy for the management of multiple inflammatory conditions, including oral mucositis (OM) in cancer patients who receive chemotherapy or radiotherapy. Still, the poor understanding of the mechanisms by which the light interacts with biological tissues and the heterogeneity of light sources and protocols employed worldwide significantly limits its applicability. Reactive oxygen species (ROS) are massively generated during the early phases of OM and play a major role in the pathogenesis of inflammation in general. Here, we report the results of a clinical and experimental study, aimed at evaluating the effect of laser light at different wavelengths on oxidative stress in oncologic patients suffering from OM and in two cell types abundantly present within the inflamed oral mucosa, neutrophil polymorphonuclear (PMN) granulocytes, and keratinocytes. In addition to standard ROS detection methods, we exploited a roGFP2-Orp1 genetically encoded sensor, allowing specific, quantitative, and dynamic imaging of redox events in living cells in response to oxidative stress and PBM. We found that the various wavelengths differentially modulate ROS production. In particular, the 660 nm laser light increases ROS production when applied either before or after an oxidative stimulus. In contrast, the 970 nm laser light exerted a moderate antioxidant activity both in the saliva of OM patients and in both cell types. The most marked reduction in the levels of ROS was detected in cells exposed either to the 800 nm laser light or to the combination of the three wavelengths. Overall, our study demonstrates that PBM exerts different effects on the redox state of both PMNs and keratinocytes depending on the used wavelength and prompts the validation of a multiwavelength protocol in the clinical settings.

%B Oxid Med Cell Longev %V 2018 %P 6510159 %8 2018 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30534349?dopt=Abstract %R 10.1155/2018/6510159 %0 Journal Article %J Nat Commun %D 2018 %T PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity. %A van Setten, Jessica %A Brody, Jennifer A %A Jamshidi, Yalda %A Swenson, Brenton R %A Butler, Anne M %A Campbell, Harry %A Del Greco, Fabiola M %A Evans, Daniel S %A Gibson, Quince %A Gudbjartsson, Daniel F %A Kerr, Kathleen F %A Krijthe, Bouwe P %A Lyytikäinen, Leo-Pekka %A Müller, Christian %A Müller-Nurasyid, Martina %A Nolte, Ilja M %A Padmanabhan, Sandosh %A Ritchie, Marylyn D %A Robino, Antonietta %A Smith, Albert V %A Steri, Maristella %A Tanaka, Toshiko %A Teumer, Alexander %A Trompet, Stella %A Ulivi, Sheila %A Verweij, Niek %A Yin, Xiaoyan %A Arnar, David O %A Asselbergs, Folkert W %A Bader, Joel S %A Barnard, John %A Bis, Josh %A Blankenberg, Stefan %A Boerwinkle, Eric %A Bradford, Yuki %A Buckley, Brendan M %A Chung, Mina K %A Crawford, Dana %A den Hoed, Marcel %A Denny, Josh C %A Dominiczak, Anna F %A Ehret, Georg B %A Eijgelsheim, Mark %A Ellinor, Patrick T %A Felix, Stephan B %A Franco, Oscar H %A Franke, Lude %A Harris, Tamara B %A Holm, Hilma %A Ilaria, Gandin %A Iorio, Annamaria %A Kähönen, Mika %A Kolcic, Ivana %A Kors, Jan A %A Lakatta, Edward G %A Launer, Lenore J %A Lin, Honghuang %A Lin, Henry J %A Loos, Ruth J F %A Lubitz, Steven A %A Macfarlane, Peter W %A Magnani, Jared W %A Leach, Irene Mateo %A Meitinger, Thomas %A Mitchell, Braxton D %A Munzel, Thomas %A Papanicolaou, George J %A Peters, Annette %A Pfeufer, Arne %A Pramstaller, Peter P %A Raitakari, Olli T %A Rotter, Jerome I %A Rudan, Igor %A Samani, Nilesh J %A Schlessinger, David %A Silva Aldana, Claudia T %A Sinner, Moritz F %A Smith, Jonathan D %A Snieder, Harold %A Soliman, Elsayed Z %A Spector, Timothy D %A Stott, David J %A Strauch, Konstantin %A Tarasov, Kirill V %A Thorsteinsdottir, Unnur %A Uitterlinden, André G %A Van Wagoner, David R %A Völker, Uwe %A Völzke, Henry %A Waldenberger, Melanie %A Jan Westra, Harm %A Wild, Philipp S %A Zeller, Tanja %A Alonso, Alvaro %A Avery, Christy L %A Bandinelli, Stefania %A Benjamin, Emelia J %A Cucca, Francesco %A Dörr, Marcus %A Ferrucci, Luigi %A Gasparini, Paolo %A Gudnason, Vilmundur %A Hayward, Caroline %A Heckbert, Susan R %A Hicks, Andrew A %A Jukema, J Wouter %A Kääb, Stefan %A Lehtimäki, Terho %A Liu, Yongmei %A Munroe, Patricia B %A Parsa, Afshin %A Polasek, Ozren %A Psaty, Bruce M %A Roden, Dan M %A Schnabel, Renate B %A Sinagra, Gianfranco %A Stefansson, Kari %A Stricker, Bruno H %A van der Harst, Pim %A van Duijn, Cornelia M %A Wilson, James F %A Gharib, Sina A %A de Bakker, Paul I W %A Isaacs, Aaron %A Arking, Dan E %A Sotoodehnia, Nona %K Atrial Function %K Atrioventricular Node %K Electrocardiography %K Electrophysiological Phenomena %K Female %K Genome-Wide Association Study %K Humans %K Linkage Disequilibrium %K Male %K Mutation, Missense %K Risk Factors %X

Electrocardiographic PR interval measures atrio-ventricular depolarization and conduction, and abnormal PR interval is a risk factor for atrial fibrillation and heart block. Our genome-wide association study of over 92,000 European-descent individuals identifies 44 PR interval loci (34 novel). Examination of these loci reveals known and previously not-yet-reported biological processes involved in cardiac atrial electrical activity. Genes in these loci are over-represented in cardiac disease processes including heart block and atrial fibrillation. Variants in over half of the 44 loci were associated with atrial or blood transcript expression levels, or were in high linkage disequilibrium with missense variants. Six additional loci were identified either by meta-analysis of ~105,000 African and European-descent individuals and/or by pleiotropic analyses combining PR interval with heart rate, QRS interval, and atrial fibrillation. These findings implicate developmental pathways, and identify transcription factors, ion-channel genes, and cell-junction/cell-signaling proteins in atrio-ventricular conduction, identifying potential targets for drug development.

%B Nat Commun %V 9 %P 2904 %8 2018 07 25 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/30046033?dopt=Abstract %R 10.1038/s41467-018-04766-9 %0 Journal Article %J Allergol Immunopathol (Madr) %D 2018 %T Predictive value of the number of adverse reaction episodes for the IgE-mediated food allergy diagnosis. %A Miceli Sopo, S %A Gurnari, G %A Monaco, S %A Romano, A %A Liotti, L %A Cuomo, B %A Dello Iacono, I %A Badina, L %A Longo, G %A Calvani, M %A Giannone, A %A Calabrò, C %A Scala, G %A Verga, M C %X

INTRODUCTION AND OBJECTIVES: The reproducibility of the adverse reaction increases the suggestiveness of a history of food allergy. However, the positive predictive value (PPV) of multiple adverse reaction episodes for the diagnosis of IgE-mediated food allergy is not known. This evaluation was the objective of our study.

PATIENTS AND METHODS: We retrospectively studied 180 children with a history of non-anaphylactic adverse reactions after the ingestion of a food. All children had the prick test positive for the offending food and performed the oral food challenge (OFC) within 12 months after the last adverse reaction episode (ARE). We have evaluated whether increasing the number of ARE increased the probability that the OFC would be positive (failed).

RESULTS: 93 patients (52%) presented one ARE, 49 (27%) presented two ARE, 24 (13%) presented three ARE, 14 (8%) patients presented≥four ARE. The OFC was positive in 94/180 (52%). The outcome of the OFC was found to be positively correlated with the number of ARE (OR=1.56; 95% CI=1.16-2.09; p=0.003). A PPV=100% was observed with a number of ARE≥five.

CONCLUSIONS: The number of ARE is an important predictor of the diagnosis of food allergy, although less than we would have imagined. The number of ARE could be used to increase the predictability of the diagnostic tests currently in use, to define clinical prediction rules alternative to OFC and easy to use in clinical practice.

%B Allergol Immunopathol (Madr) %8 2018 Dec 17 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30573320?dopt=Abstract %R 10.1016/j.aller.2018.10.006 %0 Journal Article %J Am J Reprod Immunol %D 2018 %T Pre-eclampsia affects procalcitonin production in placental tissue. %A Agostinis, Chiara %A Rami, Damiano %A Zacchi, Paola %A Bossi, Fleur %A Stampalija, Tamara %A Mangogna, Alessandro %A Amadio, Leonardo %A Vidergar, Romana %A Vecchi Brumatti, Liza %A Ricci, Giuseppe %A Celeghini, Claudio %A Radillo, Oriano %A Sargent, Ian %A Bulla, Roberta %K Adult %K Calcitonin %K Cohort Studies %K Female %K Humans %K Macrophages %K Placenta %K Pre-Eclampsia %K Pregnancy %K Trophoblasts %K Tumor Necrosis Factor-alpha %K Up-Regulation %K Young Adult %X

PROBLEM: Procalcitonin (PCT) is the prohormone of calcitonin which is usually released from neuroendocrine cells of the thyroid gland (parafollicular) and the lungs (K cells). PCT is synthesized by almost all cell types and tissues, including monocytes and parenchymal tissue, upon LPS stimulation. To date, there is no evidence for PCT expression in the placenta both in physiological and pathological conditions.

METHOD: Circulating and placental PCT levels were analysed in pre-eclamptic (PE) and control patients. Placental cells and macrophages (PBDM), stimulated with PE sera, were analysed for PCT expression. The effect of anti-TNF-α antibody was analysed.

RESULTS: Higher PCT levels were detected in PE sera and in PE placentae compared to healthy women. PE trophoblasts showed increased PCT expression compared to those isolated from healthy placentae. PE sera induced an upregulation of PCT production in macrophages and placental cells. The treatment of PBDM with PE sera in the presence of anti-TNF-α completely abrogated the effect induced by pathologic sera.

CONCLUSION: Trophoblast cells are the main producer of PCT in PE placentae. TNF-α, in association with other circulating factors present in PE sera, upregulates PCT production in macrophages and normal placental cells, thus contributing to the observed increased in circulating PCT in PE sera.

%B Am J Reprod Immunol %V 79 %P e12823 %8 2018 04 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/29427369?dopt=Abstract %R 10.1111/aji.12823 %0 Journal Article %J BMC Pregnancy Childbirth %D 2018 %T Report on an international workshop on kangaroo mother care: lessons learned and a vision for the future. %A Cattaneo, Adriano %A Amani, Adidja %A Charpak, Nathalie %A De Leon-Mendoza, Socorro %A Moxon, Sarah %A Nimbalkar, Somashekhar %A Tamburlini, Giorgio %A Villegas, Julieta %A Bergh, Anne-Marie %K Education %K Education, Nonprofessional %K Female %K Government Programs %K Health Plan Implementation %K Humans %K Infant %K Infant Mortality %K Infant, Newborn %K Infant, Premature %K Infant, Premature, Diseases %K International Cooperation %K Kangaroo-Mother Care Method %K Male %X

BACKGROUND: Globally, complications of prematurity are the leading cause of death in children under five. Preterm infants who survive their first month of life are at greater risk for various diseases and impairments in infancy, childhood and later life, representing a heavy social and economic burden for families, communities and health and social systems. Kangaroo mother care (KMC) is recommended as a beneficial and effective intervention for improving short- and long-term preterm birth outcomes in low- and high-income settings. Nevertheless, KMC is not as widely used as it should be. The International Network on KMC runs biennial workshops and congresses to help improve the coverage and quality of KMC worldwide. This paper reports the results of the two-day workshop held in November 2016, where 92 participants from 33 countries shared experiences in a series of round tables, group work sessions and plenaries.

FINDINGS: Barriers to and enablers of KMC are discussed with regard to parents, health workers and the health system. Key factors for effective implementation and uptake relate to appropriate training for health staff, adherence to protocols and the creation of a welcoming environment for families. Recommendations for planning for national programmes are made according to a six-stage change model. Resources and the cost of making progress are discussed in terms of investment, maintenance, and acceleration and scaling-up costs. KMC training requirements are presented according to three levels of care. To ensure quality KMC, key requisites are proposed for the different KMC components and for sensitive communication with caregivers. The group attending to the monitoring and evaluation of KMC at a national and subnational level highlight the lack of standard indicator definitions. Key priorities for investment include health services research, harmonisation of indicators, development of a costing tool, programming and scaling up, and the follow-up of preterm infants.

CONCLUSION: It is hoped that this report will help to further scale-up and sustain KMC through a systematic approach that includes raising commitment, identifying key strategies to address the main barriers and using existing facilitators, ensuring training and quality, agreeing on indicators for monitoring and evaluation, and advancing implementation research.

%B BMC Pregnancy Childbirth %V 18 %P 170 %8 2018 May 16 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/29769056?dopt=Abstract %R 10.1186/s12884-018-1819-9 %0 Journal Article %J Curr Med Chem %D 2018 %T Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice. %A Marcuzzi, Annalisa %A Loganes, Claudia %A Celeghini, Claudio %A Kleiner, Giulio %K Acyl Coenzyme A %K Cholesterol %K Drug Repositioning %K Farnesyl-Diphosphate Farnesyltransferase %K Humans %K Hypercholesterolemia %K Mevalonate Kinase Deficiency %K Oxazepines %K Phosphotransferases (Alcohol Group Acceptor) %K Piperidines %X

BACKGROUND: Mevalonate Kinase Deficiency (MKD, OMIM #610377) is a rare autosomal recessive metabolic and inflammatory disease. In MKD, defective function of the enzyme mevalonate kinase, due to a mutation in the MVK gene, leads to the shortage of mevalonate- derived intermediates, which results in unbalanced prenylation of proteins and altered metabolism of sterols. These defects lead to a complex multisystem inflammatory and metabolic syndrome.

OBJECTIVE: Although biologic therapies aimed at blocking the inflammatory cytokine interleukin- 1 can significantly reduce inflammation, they cannot completely control the clinical symptoms that affect the nervous system. For this reason, MKD can still be considered an orphan drug disease. The availability of MKD models reproducing the MKD-systematic inflammation, is crucial to improve the knowledge on its pathogenesis, which is still unknown. New therapies are also required in order to improve pateints' conditions and their quality of life.

METHODS: MKD-cellular models can be obtained by biochemical inhibition of mevalonatederived isoprenoids. Of note, these cells present an exaggerated response to inflammatory stimuli that can be reduced by treatment with zaragozic acid, an inhibitor of squalene synthase, thus increasing the availability of isoprenoids intermediates upstream the enzymatic block.

RESULTS: A similar action might be obtained by lapaquistat acetate (TAK-475, Takeda), a drug that underwent extensive clinical trials as a cholesterol lowering agent 10 years ago, with a good safety profile.

CONCLUSIONS: Here we describe the preclinical evidence supporting the possible repositioning of TAK-475 from its originally intended use to the treatment of MKD and discuss its potential to modulate the mevalonate pathway in inflammatory diseases.

%B Curr Med Chem %V 25 %P 2783-2796 %8 2018 %G eng %N 24 %1 http://www.ncbi.nlm.nih.gov/pubmed/28901277?dopt=Abstract %R 10.2174/0929867324666170911161417 %0 Journal Article %J Oxid Med Cell Longev %D 2018 %T The Role of Oxidative Stress and Membrane Transport Systems during Endometriosis: A Fresh Look at a Busy Corner. %A Vitale, Salvatore Giovanni %A Capriglione, Stella %A Peterlunger, Isabel %A La Rosa, Valentina Lucia %A Vitagliano, Amerigo %A Noventa, Marco %A Valenti, Gaetano %A Sapia, Fabrizio %A Angioli, Roberto %A Lopez, Salvatore %A Sarpietro, Giuseppe %A Rossetti, Diego %A Zito, Gabriella %K Endometriosis %K Female %K Humans %K Oxidative Stress %X

Endometriosis is a condition characterized by the presence of endometrial tissue outside the uterine cavity, leading to a chronic inflammatory reaction. It is one of the most widespread gynecological diseases with a 10-15% prevalence in the general female population, rising up to 30-45% in patients with infertility. Although it was first described in 1860, its etiology and pathogenesis are still unclear. It is now accepted that inflammation plays a central role in the development and progression of endometriosis. In particular, it is marked by an inflammatory process associated with the overproduction of an array of inflammatory mediators such as prostaglandins, metalloproteinases, cytokines, and chemokines. In addition, the growth and adhesion of endometrial cells in the peritoneal cavity due to reactive oxygen species (ROS) and free radicals lead to disease onset, its ensuing symptoms-among which pain and infertility. The aim of our review is to evaluate the role of oxidative stress and ROS in the pathogenesis of endometriosis and the efficacy of antioxidant therapy in the treatment and mitigation of its symptoms.

%B Oxid Med Cell Longev %V 2018 %P 7924021 %8 2018 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29743986?dopt=Abstract %R 10.1155/2018/7924021 %0 Journal Article %J Int J Mol Sci %D 2018 %T Rothmund-Thomson Syndrome: Insights from New Patients on the Genetic Variability Underpinning Clinical Presentation and Cancer Outcome. %A Colombo, Elisa A %A Locatelli, Andrea %A Cubells Sánchez, Laura %A Romeo, Sara %A Elcioglu, Nursel H %A Maystadt, Isabelle %A Esteve Martínez, Altea %A Sironi, Alessandra %A Fontana, Laura %A Finelli, Palma %A Gervasini, Cristina %A Pecile, Vanna %A Larizza, Lidia %K Adolescent %K Adult %K Cell Line, Tumor %K Child %K Female %K Homozygote %K Humans %K Male %K Mutation %K Pedigree %K Phenotype %K RecQ Helicases %K Rothmund-Thomson Syndrome %X

Biallelic mutations in gene, a caretaker of the genome, cause Rothmund-Thomson type-II syndrome (RTS-II) and confer increased cancer risk if they damage the helicase domain. We describe five families exemplifying clinical and allelic heterogeneity of RTS-II, and report the effect of pathogenic variants by predictions and transcripts analyses. Complete phenotype of patients #39 and #42 whose affected siblings developed osteosarcoma correlates with their c.[1048_1049del], c.[1878+32_1878+55del] and c.[1568G>C;1573delT], c.[3021_3022del] variants which damage the helicase domain. Literature survey highlights enrichment of these variants affecting the helicase domain in patients with cancer outcome raising the issue of strict oncological surveillance. Conversely, patients #29 and #19 have a mild phenotype and carry, respectively, the unreported homozygous c.3265G>T and c.3054A>G variants, both sparing the helicase domain. Finally, despite matching several criteria for RTS clinical diagnosis, patient #38 is heterozygous for c.2412_2414del; no pathogenic CNVs out of those evidenced by high-resolution CGH-array, emerged as contributors to her phenotype.

%B Int J Mol Sci %V 19 %8 2018 Apr 06 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/29642415?dopt=Abstract %R 10.3390/ijms19041103 %0 Journal Article %J Biomed Res Int %D 2018 %T Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma. %A Sukowati, Caecilia H C %A Patti, Riccardo %A Pascut, Devis %A Ladju, Rusdina B %A Tarchi, Paola %A Zanotta, Nunzia %A Comar, Manola %A Tiribelli, Claudio %A Crocè, Lory S %K Aged %K Carcinoma, Hepatocellular %K Chemoembolization, Therapeutic %K Female %K Hematopoietic Cell Growth Factors %K Humans %K Liver Neoplasms %K Male %K Middle Aged %K Neoplasm Recurrence, Local %K Retrospective Studies %K Stem Cells %K Treatment Outcome %X

Introduction: Chronic inflammatory response is one of major contributors in the development of hepatocellular carcinoma (HCC). Inflammatory molecules, such as cytokines and growth factors in the circulation, can be useful in the diagnosis and prognosis of the patients. The stem cell growth factor beta (SCGF), a newly found protein, is a secreted sulfated glycoprotein and it functions as a growth factor for primitive hematopoietic progenitor cells. The level of SCGF had been reported to be elevated in several cancer types. However, there is very few or even no information on this protein in the study of HCC, even more in clinical studies.

Methods: A multiplex immunoassay panel of 48 cytokines and growth factors were utilized to screen 68 sera from 29 HCC patients at pretreatment (T0), 1 month (T1), and 6 months (T6) after treatment by either radiofrequency ablation (RF) or transarterial chemoembolization (TACE). Treatment response was evaluated according to mRECIST criteria.

Results: Immunoassay screening showed that the levels of IL-17, CTACK, TNF, IL-2R, IL-8, and SCGF were different in Complete Responders (CR) and Nonresponders (NR) groups. At T0 and T1, the SCGF level was significantly the highest in NR (23.8 and 40.7 ng/mL, respectively), followed by early recurrence (25.4 and 25.0 ng/mL), and CR (6.7 and 5.3 ng/mL), independently from HCV, stages, and treatment type. Low basal SCGF level was associated with longer disease-free survival compared to high SCGF.

Conclusion: In this study, for the first time, we demonstrate that the high level of serum SCGF at pre- and posttreatment is associated with HCC nonresponsiveness.

%B Biomed Res Int %V 2018 %P 6435482 %8 2018 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/30246025?dopt=Abstract %R 10.1155/2018/6435482 %0 Journal Article %J Ital J Pediatr %D 2018 %T Teaching pain recognition through art: the Ramsay-Caravaggio sedation scale. %A Poropat, Federico %A Cozzi, Giorgio %A Magnolato, Andrea %A Monasta, Lorenzo %A Borrometi, Fabio %A Krauss, Baruch %A Ventura, Alessandro %A Barbi, Egidio %K Clinical Competence %K Conscious Sedation %K Deep Sedation %K Education, Medical, Graduate %K Female %K Hospitals, University %K Humans %K Internship and Residency %K Italy %K Male %K Medicine in the Arts %K Monitoring, Physiologic %K Pain Measurement %K Paintings %K Pediatrics %K Video Recording %X

BACKGROUND: Clinical observation is a key component of medical ability, enabling immediate evaluation of the patient's emotional state and contributing to a clinical clue that leads to final decision making. In medical schools, the art of learning to look can be taught using medical humanities and especially visual arts. By presenting a Ramsay sedation score (RSS) integrated with Caravaggio's paintings during a procedural sedation conference for pediatric residents, we want to test the effectiveness of this approach to improve the quality of learning.

METHODS: In this preliminary study, we presented videos showing sedated pediatric patients in the setting of a procedural sedation lesson to two randomized groups of residents, one attending a lesson on RSS explained through the masterpieces of Caravaggio, the other without artistic support. A week later we tested their learning with ten multi-choice questions focused on theoretical questions about sedation monitoring and ten more questions focused on recognizing the appropriate RSS viewing the videos. The primary outcome was the comparison of the total number of RSS layers properly recognized in both groups. We also evaluated the appreciation of the residents of the use of works of art integrated with the lesson.

RESULTS: Eleven students were randomized to each group. Two residents in the standard lesson did not attend the test. The percentage of correct answers on the theoretical part was similar, 82% in the art group and 89% in the other (p > 0.05). No difference was found in the video recognition part of the RSS recognition test. Residents exposed to paintings shown great appreciation for the integration of the lesson with the Caravaggio's masterpieces.

CONCLUSIONS: Adding artwork to a standard medical conference does not improve the performance of student tests, although this approach has been greatly appreciated by residents.

%B Ital J Pediatr %V 44 %P 20 %8 2018 Jan 31 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/29386058?dopt=Abstract %R 10.1186/s13052-018-0453-5 %0 Journal Article %J J Allergy Clin Immunol Pract %D 2018 %T Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency. %A Valencic, Erica %A Grasso, Antonio Giacomo %A Conversano, Ester %A Lucafò, Marianna %A Piscianz, Elisa %A Gregori, Massimo %A Conti, Francesca %A Cancrini, Caterina %A Tommasini, Alberto %B J Allergy Clin Immunol Pract %V 6 %P 2165-2167 %8 2018 Nov - Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/29510232?dopt=Abstract %R 10.1016/j.jaip.2018.02.029 %0 Journal Article %J J Allergy Clin Immunol %D 2018 %T A transcriptomics study of hereditary angioedema attacks. %A Castellano, Giuseppe %A Divella, Chiara %A Sallustio, Fabio %A Montinaro, Vincenzo %A Curci, Claudia %A Zanichelli, Andrea %A Bonanni, Erika %A Suffritti, Chiara %A Caccia, Sonia %A Bossi, Fleur %A Gallone, Anna %A Schena, Francesco Paolo %A Gesualdo, Loreto %A Cicardi, Marco %X

BACKGROUND: Hereditary angioedema (HAE) caused by C1-inhibitor deficiency is a lifelong illness characterized by recurrent acute attacks of localized skin or mucosal edema. Activation of the kallikrein/bradykinin pathway at the endothelial cell level has a relevant pathogenetic role in acute HAE attacks. Moreover, other pathways are involved given the variable clinical expression of the disease in different patients.

OBJECTIVE: We sought to explore the involvement of other putative genes in edema formation.

METHODS: We performed a PBMC microarray gene expression analysis on RNA isolated from patients with HAE during an acute attack and compared them with the transcriptomic profile of the same patients in the remission phase.

RESULTS: Gene expression analysis identified 23 genes significantly modulated during acute attacks that are involved primarily in the natural killer cell signaling and leukocyte extravasation signaling pathways. Gene set enrichment analysis showed a significant activation of relevant biological processes, such as response to external stimuli and protein processing (q < 0.05), suggesting involvement of PBMCs during acute HAE attacks. Upregulation of 2 genes, those encoding adrenomedullin and cellular receptor for urokinase plasminogen activator (uPAR), which occurs during an acute attack, was confirmed in PBMCs of 20 additional patients with HAE by using real-time PCR. Finally, in vitro studies demonstrated the involvement of uPAR in the generation of bradykinin and endothelial leakage.

CONCLUSIONS: Our study demonstrates the increase in levels of adrenomedullin and uPAR in PBMCs during an acute HAE attack. Activation of these genes usually involved in regulation of vascular tone and in inflammatory response might have a pathogenic role by amplifying bradykinin production and edema formation in patients with HAE.

%B J Allergy Clin Immunol %V 142 %P 883-891 %8 2018 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29729940?dopt=Abstract %R 10.1016/j.jaci.2018.03.016 %0 Journal Article %J Front Biosci (Elite Ed) %D 2018 %T Vaginal microbiota dysmicrobism and role of biofilm-forming bacteria. %A Campisciano, Giuseppina %A Zanotta, Nunzia %A Petix, Vincenzo %A Corich, Lucia %A De Seta, Francesco %A Comar, Manola %K Adult %K Biofilms %K Female %K Humans %K Microbiota %K Vagina %K Vaginosis, Bacterial %X

Bacterial vaginosis involves the presence of a polymicrobial biofilm on the vaginal epithelium, guaranteeing immune escape and spread of antibiotic resistance. To spot known biofilm-forming bacteria, we profiled the vaginal microbiome of sixty-four symptomatic women suffering from a different grade of vaginal disorders and sixty asymptomatic healthy women. Specific microbial profiles distinguished symptomatic from asymptomatic women and characterized the grade of dysmicrobism within the symptomatic group. Lactobacillus crispatus and iners predominated on the healthy vaginal mucosa, while Lactobacillus gasseri predominated in the intermediate dysmicrobism. Furthermore, the intermediate grade of dysmicrobism was characterized by other lactic acid-producers species than Lactobacilli, able to rescue the microbial imbalance, and Ureaplasma parvum-serovar 3. The vaginosis group exhibited the overgrowth of Prevotella bivia, which is known to enhance the biofilm formation by Gardnerella vaginalis, and the presence of Streptococcus anginosus, which is emerging as a new cooperating player of the vaginal biofilm. Identifying specific microorganisms promoting or preventing the biofilm formation could increase the accuracy for a better definition of the vaginal dysmicrobism concept and therapeutic intervention.

%B Front Biosci (Elite Ed) %V 10 %P 528-536 %8 2018 06 01 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29772525?dopt=Abstract %0 Journal Article %J Ann Emerg Med %D 2018 %T Young Child in Respiratory Distress. %A Cozzi, Giorgio %A Conversano, Ester %A Cattaruzzi, Elisabetta %A Barbi, Egidio %K Acute Disease %K Child, Preschool %K Female %K Humans %K Pulmonary Atelectasis %K Radiography, Thoracic %K Respiratory Insufficiency %B Ann Emerg Med %V 71 %P 17-53 %8 2018 01 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/29268996?dopt=Abstract %R 10.1016/j.annemergmed.2017.07.004 %0 Journal Article %J Sci Rep %D 2017 %T 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function. %A Gorski, Mathias %A van der Most, Peter J %A Teumer, Alexander %A Chu, Audrey Y %A Li, Man %A Mijatovic, Vladan %A Nolte, Ilja M %A Cocca, Massimiliano %A Taliun, Daniel %A Gomez, Felicia %A Li, Yong %A Tayo, Bamidele %A Tin, Adrienne %A Feitosa, Mary F %A Aspelund, Thor %A Attia, John %A Biffar, Reiner %A Bochud, Murielle %A Boerwinkle, Eric %A Borecki, Ingrid %A Bottinger, Erwin P %A Chen, Ming-Huei %A Chouraki, Vincent %A Ciullo, Marina %A Coresh, Josef %A Cornelis, Marilyn C %A Curhan, Gary C %A d'Adamo, Adamo Pio %A Dehghan, Abbas %A Dengler, Laura %A Ding, Jingzhong %A Eiriksdottir, Gudny %A Endlich, Karlhans %A Enroth, Stefan %A Esko, Tõnu %A Franco, Oscar H %A Gasparini, Paolo %A Gieger, Christian %A Girotto, Giorgia %A Gottesman, Omri %A Gudnason, Vilmundur %A Gyllensten, Ulf %A Hancock, Stephen J %A Harris, Tamara B %A Helmer, Catherine %A Höllerer, Simon %A Hofer, Edith %A Hofman, Albert %A Holliday, Elizabeth G %A Homuth, Georg %A Hu, Frank B %A Huth, Cornelia %A Hutri-Kähönen, Nina %A Hwang, Shih-Jen %A Imboden, Medea %A Johansson, Åsa %A Kähönen, Mika %A König, Wolfgang %A Kramer, Holly %A Krämer, Bernhard K %A Kumar, Ashish %A Kutalik, Zoltán %A Lambert, Jean-Charles %A Launer, Lenore J %A Lehtimäki, Terho %A de Borst, Martin %A Navis, Gerjan %A Swertz, Morris %A Liu, Yongmei %A Lohman, Kurt %A Loos, Ruth J F %A Lu, Yingchang %A Lyytikäinen, Leo-Pekka %A McEvoy, Mark A %A Meisinger, Christa %A Meitinger, Thomas %A Metspalu, Andres %A Metzger, Marie %A Mihailov, Evelin %A Mitchell, Paul %A Nauck, Matthias %A Oldehinkel, Albertine J %A Olden, Matthias %A Wjh Penninx, Brenda %A Pistis, Giorgio %A Pramstaller, Peter P %A Probst-Hensch, Nicole %A Raitakari, Olli T %A Rettig, Rainer %A Ridker, Paul M %A Rivadeneira, Fernando %A Robino, Antonietta %A Rosas, Sylvia E %A Ruderfer, Douglas %A Ruggiero, Daniela %A Saba, Yasaman %A Sala, Cinzia %A Schmidt, Helena %A Schmidt, Reinhold %A Scott, Rodney J %A Sedaghat, Sanaz %A Smith, Albert V %A Sorice, Rossella %A Stengel, Bénédicte %A Stracke, Sylvia %A Strauch, Konstantin %A Toniolo, Daniela %A Uitterlinden, André G %A Ulivi, Sheila %A Viikari, Jorma S %A Völker, Uwe %A Vollenweider, Peter %A Völzke, Henry %A Vuckovic, Dragana %A Waldenberger, Melanie %A Jin Wang, Jie %A Yang, Qiong %A Chasman, Daniel I %A Tromp, Gerard %A Snieder, Harold %A Heid, Iris M %A Fox, Caroline S %A Köttgen, Anna %A Pattaro, Cristian %A Böger, Carsten A %A Fuchsberger, Christian %K Computational Biology %K Gene Frequency %K Genetic Loci %K Genome, Human %K Genome-Wide Association Study %K Genotyping Techniques %K Humans %K Kidney %K Polymorphism, Single Nucleotide %X

HapMap imputed genome-wide association studies (GWAS) have revealed >50 loci at which common variants with minor allele frequency >5% are associated with kidney function. GWAS using more complete reference sets for imputation, such as those from The 1000 Genomes project, promise to identify novel loci that have been missed by previous efforts. To investigate the value of such a more complete variant catalog, we conducted a GWAS meta-analysis of kidney function based on the estimated glomerular filtration rate (eGFR) in 110,517 European ancestry participants using 1000 Genomes imputed data. We identified 10 novel loci with p-value < 5 × 10 previously missed by HapMap-based GWAS. Six of these loci (HOXD8, ARL15, PIK3R1, EYA4, ASTN2, and EPB41L3) are tagged by common SNPs unique to the 1000 Genomes reference panel. Using pathway analysis, we identified 39 significant (FDR < 0.05) genes and 127 significantly (FDR < 0.05) enriched gene sets, which were missed by our previous analyses. Among those, the 10 identified novel genes are part of pathways of kidney development, carbohydrate metabolism, cardiac septum development and glucose metabolism. These results highlight the utility of re-imputing from denser reference panels, until whole-genome sequencing becomes feasible in large samples.

%B Sci Rep %V 7 %P 45040 %8 2017 04 28 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28452372?dopt=Abstract %R 10.1038/srep45040 %0 Journal Article %J Ann Rheum Dis %D 2017 %T ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. %A Caorsi, Roberta %A Penco, Federica %A Grossi, Alice %A Insalaco, Antonella %A Omenetti, Alessia %A Alessio, Maria %A Conti, Giovanni %A Marchetti, Federico %A Picco, Paolo %A Tommasini, Alberto %A Martino, Silvana %A Malattia, Clara %A Gallizi, Romina %A Podda, Rosa Anna %A Salis, Annalisa %A Falcini, Fernanda %A Schena, Francesca %A Garbarino, Francesca %A Morreale, Alessia %A Pardeo, Manuela %A Ventrici, Claudia %A Passarelli, Chiara %A Zhou, Qing %A Severino, Mariasavina %A Gandolfo, Carlo %A Damonte, Gianluca %A Martini, Alberto %A Ravelli, Angelo %A Aksentijevich, Ivona %A Ceccherini, Isabella %A Gattorno, Marco %K Adenosine Deaminase %K Adolescent %K Age of Onset %K Case-Control Studies %K Child %K Child, Preschool %K DNA Mutational Analysis %K Female %K Heterozygote %K Homozygote %K Humans %K Immunoglobulins %K Immunosuppressive Agents %K Infant %K Intercellular Signaling Peptides and Proteins %K Italy %K Livedo Reticularis %K Male %K Pedigree %K Polyarteritis Nodosa %K Stroke %K Thalidomide %K Tumor Necrosis Factor-alpha %K Young Adult %X

OBJECTIVES: To analyse the prevalence of mutations in patients diagnosed with early onset livedo reticularis and/or haemorrhagic/ischaemic strokes in the context of inflammation or polyarteritis nodosa (PAN). Forty-eight patients from 43 families were included in the study.

METHODS: Direct sequencing of was performed by Sanger analysis. Adenosine deaminase 2 (ADA2) enzymatic activity was analysed in monocyte isolated from patients and healthy controls incubated with adenosine and with or without an ADA1 inhibitor.

RESULTS: Biallelic homozygous or compound heterozygous mutations were detected in 15/48 patients. A heterozygous disease-associated mutation (p.G47V) was observed in two affected brothers. The mean age of onset of the genetically positive patients was 24 months (6 months to 7 years). Ten patients displayed one or more cerebral strokes during their disease course. Low immunoglobulin levels were detected in six patients. Thalidomide and anti-TNF (tumour necrosis factor) blockers were the most effective drugs. Patients without mutations had a later age at disease onset, a lower prevalence of neurological and skin manifestations; one of these patients displayed all the clinical features of adenosine deaminase 2deficiency (DADA2) and a defective enzymatic activity suggesting the presence of a missed mutation or a synthesis defect.

CONCLUSIONS: DADA2 accounts for paediatric patients diagnosed with PAN-like disease and strokes and might explain an unrecognised condition in patients followed by adult rheumatologist. Timely diagnosis and treatment with anti-TNF agents are crucial for the prevention of severe complications of the disease. Functional assay to measure ADA2 activity should complement genetic testing in patients with non-confirming genotypes.

%B Ann Rheum Dis %V 76 %P 1648-1656 %8 2017 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/28522451?dopt=Abstract %R 10.1136/annrheumdis-2016-210802 %0 Journal Article %J PLoS One %D 2017 %T Adolescent Admissions to Emergency Departments for Self-Injurious Thoughts and Behaviors. %A Zanus, Caterina %A Battistutta, Sara %A Aliverti, Renata %A Montico, Marcella %A Cremaschi, Silvana %A Ronfani, Luca %A Monasta, Lorenzo %A Carrozzi, Marco %K Adolescent %K Child %K Female %K Humans %K Incidence %K Italy %K Male %K Medical Records %K Patient Admission %K Retrospective Studies %K Self-Injurious Behavior %K Sex Factors %K Suicidal Ideation %K Suicide, Attempted %X

The objective of the present study was to describe the incidence and the characteristics of Self-Injurious Thoughts and Behaviors (SITBs), among adolescents aged 11-18 admitted, over a two year period, to all the Emergency Departments of a Region of North-eastern Italy through a comprehensive analysis of medical records. A two-step search was performed in the regional ED electronic database. First, we identified the cases that had been clearly diagnosed as SITBs by an Emergency Department physician. Secondly, suspect cases were detected through a keyword search of the database, and the medical records of these cases were hand screened to identify SITBs. The mean annual incidence rate of SITBs was 90 per 100,000 adolescents aged 11-18 years. Events were more frequent in females. Drug poisoning was the most frequently adopted method (54%). In 42% of cases a diagnosis of SITB was not explicitly reported by the physician. In 65% of cases adolescents were discharged within hours of admission. Only 9% of patients started a psychiatric assessment and treatment program during hospital stay. This research confirms the high incidence of SITBs among adolescents and highlights the difficulty in their proper diagnosis and management. Such difficulty is confirmed by the fact that only a few patients, even among those with a clear diagnosis, were sent for psychiatric assessment. Correct identification and management of SITB patients needs to be improved, since SITBs are an important public health problem in adolescence and one of the main risk factors for suicide.

%B PLoS One %V 12 %P e0170979 %8 2017 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28125701?dopt=Abstract %R 10.1371/journal.pone.0170979 %0 Journal Article %J BJOG %D 2017 %T Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series. %A Floridia, M %A Masuelli, G %A Meloni, A %A Cetin, I %A Tamburrini, E %A Cavaliere, A F %A Dalzero, S %A Sansone, M %A Alberico, S %A Guerra, B %A Spinillo, A %A Chiadò Fiorio Tin, M %A Ravizza, M %K Adult %K Amniocentesis %K Analysis of Variance %K Anti-Retroviral Agents %K Chi-Square Distribution %K Chorionic Villi Sampling %K Female %K Fetal Death %K HIV Infections %K Humans %K Infectious Disease Transmission, Vertical %K Odds Ratio %K Pregnancy %K Pregnancy Complications, Infectious %X

OBJECTIVES: To assess in pregnant women with HIV the rates of amniocentesis and chorionic villus sampling (CVS), and the outcomes associated with such procedures.

DESIGN: Observational study. Data from the Italian National Program on Surveillance on Antiretroviral Treatment in Pregnancy were used.

SETTING: University and hospital clinics.

POPULATION: Pregnant women with HIV.

METHODS: Temporal trends were analysed by analysis of variance and by the Chi-square test for trend. Quantitative variables were compared by Student's t-test and categorical data by the Chi-square test, with odds ratios and 95% confidence intervals calculated.

MAIN OUTCOME MEASURES: Rate of invasive testing, intrauterine death, HIV transmission.

RESULTS: Between 2001 and 2015, among 2065 pregnancies in women with HIV, 113 (5.5%) had invasive tests performed. The procedures were conducted under antiretroviral treatment in 99 cases (87.6%), with a significant increase over time in the proportion of tests performed under highly active antiretroviral therapy (HAART) (100% in 2011-2015). Three intrauterine deaths were observed (2.6%), and 14 pregnancies were terminated because of fetal anomalies. Among 96 live newborns, eight had no information available on HIV status. Among the remaining 88 cases with either amniocentesis (n = 75), CVS (n = 12), or both (n = 1), two HIV transmissions occurred (2.3%). No HIV transmission occurred among the women who were on HAART at the time of invasive testing, and none after 2005.

CONCLUSIONS: The findings reinforce the assumption that invasive prenatal testing does not increase the risk of HIV vertical transmission among pregnant women under suppressive antiretroviral treatment.

TWEETABLE ABSTRACT: No HIV transmission occurred among women who underwent amniocentesis or CVS under effective anti-HIV regimens.

%B BJOG %V 124 %P 1218-1223 %8 2017 Jul %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/27319948?dopt=Abstract %R 10.1111/1471-0528.14183 %0 Journal Article %J Ital J Pediatr %D 2017 %T ANCA-associated vasculitis in childhood: recent advances. %A Calatroni, Marta %A Oliva, Elena %A Gianfreda, Davide %A Gregorini, Gina %A Allinovi, Marco %A Ramirez, Giuseppe A %A Bozzolo, Enrica P %A Monti, Sara %A Bracaglia, Claudia %A Marucci, Giulia %A Bodria, Monica %A Sinico, Renato A %A Pieruzzi, Federico %A Moroni, Gabriella %A Pastore, Serena %A Emmi, Giacomo %A Esposito, Pasquale %A Catanoso, Mariagrazia %A Barbano, Giancarlo %A Bonanni, Alice %A Vaglio, Augusto %K Age Distribution %K Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis %K Antibodies, Antineutrophil Cytoplasmic %K Child %K Child, Preschool %K Churg-Strauss Syndrome %K Female %K Granulomatosis with Polyangiitis %K Humans %K Incidence %K Male %K Microscopic Polyangiitis %K Rare Diseases %K Risk Assessment %K Severity of Illness Index %K Sex Distribution %K Survival Rate %X

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are rare systemic diseases that usually occur in adulthood. They comprise granulomatosis with polyangiitis (GPA, Wegener's), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome). Their clinical presentation is often heterogeneous, with frequent involvement of the respiratory tract, the kidney, the skin and the joints. ANCA-associated vasculitis is rare in childhood but North-American and European cohort studies performed during the last decade have clarified their phenotype, patterns of renal involvement and their prognostic implications, and outcome. Herein, we review the main clinical and therapeutic aspects of childhood-onset ANCA-associated vasculitis, and provide preliminary data on demographic characteristics and organ manifestations of an Italian multicentre cohort.

%B Ital J Pediatr %V 43 %P 46 %8 2017 May 05 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28476172?dopt=Abstract %R 10.1186/s13052-017-0364-x %0 Journal Article %J J Am Soc Nephrol %D 2017 %T and Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. %A Li, Man %A Li, Yong %A Weeks, Olivia %A Mijatovic, Vladan %A Teumer, Alexander %A Huffman, Jennifer E %A Tromp, Gerard %A Fuchsberger, Christian %A Gorski, Mathias %A Lyytikäinen, Leo-Pekka %A Nutile, Teresa %A Sedaghat, Sanaz %A Sorice, Rossella %A Tin, Adrienne %A Yang, Qiong %A Ahluwalia, Tarunveer S %A Arking, Dan E %A Bihlmeyer, Nathan A %A Böger, Carsten A %A Carroll, Robert J %A Chasman, Daniel I %A Cornelis, Marilyn C %A Dehghan, Abbas %A Faul, Jessica D %A Feitosa, Mary F %A Gambaro, Giovanni %A Gasparini, Paolo %A Giulianini, Franco %A Heid, Iris %A Huang, Jinyan %A Imboden, Medea %A Jackson, Anne U %A Jeff, Janina %A Jhun, Min A %A Katz, Ronit %A Kifley, Annette %A Kilpeläinen, Tuomas O %A Kumar, Ashish %A Laakso, Markku %A Li-Gao, Ruifang %A Lohman, Kurt %A Lu, Yingchang %A Mägi, Reedik %A Malerba, Giovanni %A Mihailov, Evelin %A Mohlke, Karen L %A Mook-Kanamori, Dennis O %A Robino, Antonietta %A Ruderfer, Douglas %A Salvi, Erika %A Schick, Ursula M %A Schulz, Christina-Alexandra %A Smith, Albert V %A Smith, Jennifer A %A Traglia, Michela %A Yerges-Armstrong, Laura M %A Zhao, Wei %A Goodarzi, Mark O %A Kraja, Aldi T %A Liu, Chunyu %A Wessel, Jennifer %A Boerwinkle, Eric %A Borecki, Ingrid B %A Bork-Jensen, Jette %A Bottinger, Erwin P %A Braga, Daniele %A Brandslund, Ivan %A Brody, Jennifer A %A Campbell, Archie %A Carey, David J %A Christensen, Cramer %A Coresh, Josef %A Crook, Errol %A Curhan, Gary C %A Cusi, Daniele %A de Boer, Ian H %A de Vries, Aiko P J %A Denny, Joshua C %A Devuyst, Olivier %A Dreisbach, Albert W %A Endlich, Karlhans %A Esko, Tõnu %A Franco, Oscar H %A Fulop, Tibor %A Gerhard, Glenn S %A Glümer, Charlotte %A Gottesman, Omri %A Grarup, Niels %A Gudnason, Vilmundur %A Hansen, Torben %A Harris, Tamara B %A Hayward, Caroline %A Hocking, Lynne %A Hofman, Albert %A Hu, Frank B %A Husemoen, Lise Lotte N %A Jackson, Rebecca D %A Jørgensen, Torben %A Jørgensen, Marit E %A Kähönen, Mika %A Kardia, Sharon L R %A König, Wolfgang %A Kooperberg, Charles %A Kriebel, Jennifer %A Launer, Lenore J %A Lauritzen, Torsten %A Lehtimäki, Terho %A Levy, Daniel %A Linksted, Pamela %A Linneberg, Allan %A Liu, Yongmei %A Loos, Ruth J F %A Lupo, Antonio %A Meisinger, Christine %A Melander, Olle %A Metspalu, Andres %A Mitchell, Paul %A Nauck, Matthias %A Nürnberg, Peter %A Orho-Melander, Marju %A Parsa, Afshin %A Pedersen, Oluf %A Peters, Annette %A Peters, Ulrike %A Polasek, Ozren %A Porteous, David %A Probst-Hensch, Nicole M %A Psaty, Bruce M %A Qi, Lu %A Raitakari, Olli T %A Reiner, Alex P %A Rettig, Rainer %A Ridker, Paul M %A Rivadeneira, Fernando %A Rossouw, Jacques E %A Schmidt, Frank %A Siscovick, David %A Soranzo, Nicole %A Strauch, Konstantin %A Toniolo, Daniela %A Turner, Stephen T %A Uitterlinden, André G %A Ulivi, Sheila %A Velayutham, Dinesh %A Völker, Uwe %A Völzke, Henry %A Waldenberger, Melanie %A Wang, Jie Jin %A Weir, David R %A Witte, Daniel %A Kuivaniemi, Helena %A Fox, Caroline S %A Franceschini, Nora %A Goessling, Wolfram %A Köttgen, Anna %A Chu, Audrey Y %K Animals %K Exome %K Genetic Loci %K Genome-Wide Association Study %K Glomerular Filtration Rate %K Humans %K Kidney %K Protein Tyrosine Phosphatases %K Proto-Oncogene Proteins %K Son of Sevenless Proteins %K Zebrafish %X

Genome-wide association studies have identified >50 common variants associated with kidney function, but these variants do not fully explain the variation in eGFR. We performed a two-stage meta-analysis of associations between genotypes from the Illumina exome array and eGFR on the basis of serum creatinine (eGFRcrea) among participants of European ancestry from the CKDGen Consortium (: 111,666; : 48,343). In single-variant analyses, we identified single nucleotide polymorphisms at seven new loci associated with eGFRcrea (, , and ; <3.7×10), of which most were common and annotated as nonsynonymous variants. Gene-based analysis identified associations of functional rare variants in three genes with eGFRcrea, including a novel association with the SOS Ras/Rho guanine nucleotide exchange factor 2 gene, (=5.4×10 by sequence kernel association test). Experimental follow-up in zebrafish embryos revealed changes in glomerular gene expression and renal tubule morphology in the embryonic kidney of and -knockdowns. These developmental abnormalities associated with altered blood clearance rate and heightened prevalence of edema. This study expands the number of loci associated with kidney function and identifies novel genes with potential roles in kidney formation.

%B J Am Soc Nephrol %V 28 %P 981-994 %8 2017 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/27920155?dopt=Abstract %R 10.1681/ASN.2016020131 %0 Journal Article %J Int J Mol Sci %D 2017 %T Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children. %A Coelho, Antônio Victor Campos %A Tricarico, Paola Maura %A Celsi, Fulvio %A Crovella, Sergio %K Animals %K Anti-HIV Agents %K Antiretroviral Therapy, Highly Active %K Disease Management %K Disease Models, Animal %K Epigenesis, Genetic %K Female %K HIV Infections %K HIV-1 %K Humans %K Infectious Disease Transmission, Vertical %K Maternal Exposure %K Meta-Analysis as Topic %K Mothers %K Neurodevelopmental Disorders %K Pregnancy %K Prenatal Exposure Delayed Effects %X

Since the worldwide introduction of antiretroviral therapy (ART) in human immunodeficiency virus type 1, HIV-1-positive mothers, together with HIV-1 testing prior to pregnancy, caesarian birth and breastfeeding cessation with replacement feeding, a reduction of HIV-1 mother-to-child transmission (MTCT) has been observed in the last few years. As such, an increasing number of children are being exposed in utero to ART. Several questions have arisen concerning the neurological effects of ART exposure in utero, considering the potential effect of antiretroviral drugs on the central nervous system, a structure which is in continuous development in the fetus and characterized by great plasticity. This review aims at discussing the possible neurological impairment of children exposed to ART in utero, focusing attention on the drugs commonly used for HIV-1 MTCT prevention, clinical reports of ART neurotoxicity in children born to HIV-1-positive mothers, and neurologic effects of protease inhibitors (PIs), especially ritonavir-"boosted" lopinavir (LPV/r) in cell and animal central nervous system models evaluating the potential neurotoxic effect of ART. Finally, we present the findings of a meta-analysis to assess the effects on the neurodevelopment of children exposed to ART in utero.

%B Int J Mol Sci %V 18 %8 2017 Feb 15 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/28212307?dopt=Abstract %R 10.3390/ijms18020423 %0 Journal Article %J Clin Biochem %D 2017 %T Association between thyroid hormones and TRAIL. %A Bernardi, Stella %A Bossi, Fleur %A Toffoli, Barbara %A Giudici, Fabiola %A Bramante, Alessandra %A Furlanis, Giulia %A Stenner, Elisabetta %A Secchiero, Paola %A Zauli, Giorgio %A Carretta, Renzo %A Fabris, Bruno %K Aged %K Female %K Gene Expression Regulation %K Humans %K Hyperthyroidism %K Hypothyroidism %K Leukocytes, Mononuclear %K Male %K Middle Aged %K Thyroxine %K TNF-Related Apoptosis-Inducing Ligand %K Triiodothyronine %X

INTRODUCTION: Recent studies suggest that a circulating protein called TRAIL (TNF-related apoptosis-inducing ligand) might have a role in the regulation of body weight and metabolism. Interestingly, thyroid hormones seem to increase TRAIL tissue expression. This study aimed at evaluating whether overt thyroid disorders affected circulating TRAIL levels.

METHODS: TRAIL circulating levels were measured in euthyroid, hyperthyroid, and hypothyroid patients before and after thyroid function normalization. Univariate and multivariate analyses were performed to evaluate the correlation between thyroid hormones and TRAIL. Then, the stimulatory effect of both triiodothyronine (T3) and thyroxine (T4) on TRAIL was evaluated in vitro on peripheral blood mononuclear cells.

RESULTS: Circulating levels of TRAIL significantly increased in hyperthyroid and decreased in hypothyroid patients as compared to controls. Once thyroid function was restored, TRAIL levels normalized. There was an independent association between TRAIL and both fT3 and fT4. Consistent with these findings, T3 and T4 stimulated TRAIL release in vitro.

CONCLUSION: Here we show that thyroid hormones are associated with TRAIL expression in vivo and stimulate TRAIL expression in vitro. Given the overlap between the metabolic effects of thyroid hormones and TRAIL, this work sheds light on the possibility that TRAIL might be one of the molecules mediating thyroid hormones peripheral effects.

%B Clin Biochem %V 50 %P 972-976 %8 2017 Nov %G eng %N 16-17 %1 http://www.ncbi.nlm.nih.gov/pubmed/28551332?dopt=Abstract %R 10.1016/j.clinbiochem.2017.05.011 %0 Journal Article %J Paediatr Drugs %D 2017 %T Authors' Reply to M.S. Raghuraman: "Intranasal Dexmedetomidine for Procedural Sedation in Children, a Suitable Alternative to Chloral Hydrate". %A Cozzi, Giorgio %A Norbedo, Stefania %A Barbi, Egidio %K Administration, Intranasal %K Child %K Chloral Hydrate %K Dexmedetomidine %K Humans %K Hypnotics and Sedatives %K Infant %B Paediatr Drugs %V 19 %P 377 %8 2017 08 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/28660554?dopt=Abstract %R 10.1007/s40272-017-0246-0 %0 Journal Article %J Appl Spectrosc %D 2017 %T Avoiding Ethanol Presence in DNA Samples Enhances the Performance of Ultraviolet Resonance Raman Spectroscopy Analysis. %A Cammisuli, Francesca %A Pascolo, Lorella %A Morgutti, Marcello %A Gessini, Alessandro %A Masciovecchio, Claudio %A D'Amico, Francesco %K DNA %K Ethanol %K Female %K Humans %K Placenta %K Pregnancy %K Spectrophotometry, Ultraviolet %K Spectrum Analysis, Raman %X

Ethanol is an essential chemical reagent in DNA preparation as its use increases the yield of extraction. All methodologies for DNA isolation involve the use of ethanol in order to prevent DNA dissolution in water and to optimize the binding of DNA to chromatographic membranes. In this note, we show how the presence of ethanol traces in DNA aqueous solution affects ultraviolet Raman spectra, leading to possible misinterpretations. We report a simple method to remove the ethanol Raman features from the spectra, based on heating the DNA sample at 80 ℃, followed by a slow cooling procedure.

%B Appl Spectrosc %V 71 %P 152-155 %8 2017 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27815433?dopt=Abstract %R 10.1177/0003702816654152 %0 Journal Article %J J Nerv Ment Dis %D 2017 %T Bipolar Disorder With Psychotic Features and Ocular Toxoplasmosis: A Possible Pathogenetic Role of the Parasite? %A Del Grande, Claudia %A Contini, Carlo %A Schiavi, Elisa %A Rutigliano, Grazia %A Maritati, Martina %A Seraceni, Silva %A Pinto, Barbara %A Dell'Osso, Liliana %A Bruschi, Fabrizio %K Adult %K Bipolar Disorder %K Brazil %K Female %K Humans %K Toxoplasmosis, Ocular %K Young Adult %X

Recent evidence suggests the involvement of Toxoplasma gondii infection in the emergence of psychotic and affective disorders. In this report, we describe the case of a young Brazilian woman affected by recurrent ocular toxoplasmosis and presenting with a manic episode with psychotic features in the context of a diagnosis of Bipolar Disorder (BD), type I. We observed a relationship between ocular manifestations and the clinical course of bipolar illness, confirmed by molecular analyses (nested-PCR), as well as by the high level of T. gondii specific IgG. This case report is the first showing the presence of circulating parasite DNA at the time of occurrence of psychiatric symptoms, thus providing further support for a possible role of the parasite in the pathogenesis of some cases of BD.

%B J Nerv Ment Dis %V 205 %P 192-195 %8 2017 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/27741079?dopt=Abstract %R 10.1097/NMD.0000000000000496 %0 Journal Article %J J Matern Fetal Neonatal Med %D 2017 %T Bolus feeding has no effect on cerebral hemodynamics, irrespective of gestational age. %A Bembich, Stefano %A Cont, Gabriele %A Bua, Jenny %A Orlando, Chiara %A Di Benedetto, Donatella %A Demarini, Sergio %K Cerebrovascular Circulation %K Enteral Nutrition %K Female %K Gestational Age %K Heart Rate %K Humans %K Infant, Newborn %K Infant, Premature %K Intensive Care Units, Neonatal %K Male %K Oxygen %K Oxyhemoglobins %K Spectroscopy, Near-Infrared %X

OBJECTIVE: By multichannel near-infrared spectroscopy, we studied if gestational age has any influence on preterm cerebral hemodynamics, during bolus feeding.

METHODS: Oxy-haemoglobin (HbO), as cerebral blood flow estimate, and the ratio between HbO and total haemoglobin (HbO/HbTot), as cerebral oxygenation estimate, were assessed in 40 stable premature infants, during a 10 min bolus feeding.

RESULTS: We found no effect of any of the gestational ages studied (25-34 weeks) either on cerebral blood flow or on oxygenation, during a bolus feeding procedure.

CONCLUSIONS: Bolus feeding appears not to affect cerebral hemodynamics of uncritically preterm infants, irrespective of gestational age.

%B J Matern Fetal Neonatal Med %V 30 %P 1029-1031 %8 2017 May %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/27718771?dopt=Abstract %R 10.1080/14767058.2016.1199672 %0 Journal Article %J Rheumatology (Oxford) %D 2017 %T CCR5Δ32 and the genetic susceptibility to rheumatoid arthritis in admixed populations: a multicentre study. %A Toson, Bruno %A Dos Santos, Eduardo José %A Adelino, José Eduardo %A Sandrin-Garcia, Paula %A Crovella, Sergio %A Louzada-Júnior, Paulo %A Oliveira, Renê Donizete Ribeiro %A Pedroza, Larysse Santa Rosa Aquino %A de Fátima Lobato Cunha Sauma, Maria %A de Lima, Clayton Pereira Silva %A Barbosa, Fabiola Brasil %A Brenol, Claiton Viegas %A Xavier, Ricardo Machado %A Chies, José Artur Bogo %A Veit, Tiago Degani %K Arthritis, Rheumatoid %K Brazil %K Case-Control Studies %K Consanguinity %K Gene Frequency %K Genetic Predisposition to Disease %K Humans %K Polymorphism, Single Nucleotide %K Receptors, CCR5 %B Rheumatology (Oxford) %V 56 %P 495-497 %8 2017 03 01 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/28082621?dopt=Abstract %R 10.1093/rheumatology/kew398 %0 Journal Article %J JAMA Pediatr %D 2017 %T Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study. %A Kassebaum, Nicholas %A Kyu, Hmwe Hmwe %A Zoeckler, Leo %A Olsen, Helen Elizabeth %A Thomas, Katie %A Pinho, Christine %A Bhutta, Zulfiqar A %A Dandona, Lalit %A Ferrari, Alize %A Ghiwot, Tsegaye Tewelde %A Hay, Simon I %A Kinfu, Yohannes %A Liang, Xiaofeng %A Lopez, Alan %A Malta, Deborah Carvalho %A Mokdad, Ali H %A Naghavi, Mohsen %A Patton, George C %A Salomon, Joshua %A Sartorius, Benn %A Topor-Madry, Roman %A Vollset, Stein Emil %A Werdecker, Andrea %A Whiteford, Harvey A %A Abate, Kalkidan Hasen %A Abbas, Kaja %A Damtew, Solomon Abrha %A Ahmed, Muktar Beshir %A Akseer, Nadia %A Al-Raddadi, Rajaa %A Alemayohu, Mulubirhan Assefa %A Altirkawi, Khalid %A Abajobir, Amanuel Alemu %A Amare, Azmeraw T %A Antonio, Carl A T %A Arnlöv, Johan %A Artaman, Al %A Asayesh, Hamid %A Avokpaho, Euripide Frinel G Arthur %A Awasthi, Ashish %A Ayala Quintanilla, Beatriz Paulina %A Bacha, Umar %A Betsu, Balem Demtsu %A Barac, Aleksandra %A Bärnighausen, Till Winfried %A Baye, Estifanos %A Bedi, Neeraj %A Bensenor, Isabela M %A Berhane, Adugnaw %A Bernabe, Eduardo %A Bernal, Oscar Alberto %A Beyene, Addisu Shunu %A Biadgilign, Sibhatu %A Bikbov, Boris %A Boyce, Cheryl Anne %A Brazinova, Alexandra %A Hailu, Gessessew Bugssa %A Carter, Austin %A Castañeda-Orjuela, Carlos A %A Catalá-López, Ferrán %A Charlson, Fiona J %A Chitheer, Abdulaal A %A Choi, Jee-Young Jasmine %A Ciobanu, Liliana G %A Crump, John %A Dandona, Rakhi %A Dellavalle, Robert P %A Deribew, Amare %A deVeber, Gabrielle %A Dicker, Daniel %A Ding, Eric L %A Dubey, Manisha %A Endries, Amanuel Yesuf %A Erskine, Holly E %A Faraon, Emerito Jose Aquino %A Faro, Andre %A Farzadfar, Farshad %A Fernandes, Joao C %A Fijabi, Daniel Obadare %A Fitzmaurice, Christina %A Fleming, Thomas D %A Flor, Luisa Sorio %A Foreman, Kyle J %A Franklin, Richard C %A Fraser, Maya S %A Frostad, Joseph J %A Fullman, Nancy %A Gebregergs, Gebremedhin Berhe %A Gebru, Alemseged Aregay %A Geleijnse, Johanna M %A Gibney, Katherine B %A Gidey Yihdego, Mahari %A Ginawi, Ibrahim Abdelmageem Mohamed %A Gishu, Melkamu Dedefo %A Gizachew, Tessema Assefa %A Glaser, Elizabeth %A Gold, Audra L %A Goldberg, Ellen %A Gona, Philimon %A Goto, Atsushi %A Gugnani, Harish Chander %A Jiang, Guohong %A Gupta, Rajeev %A Tesfay, Fisaha Haile %A Hankey, Graeme J %A Havmoeller, Rasmus %A Hijar, Martha %A Horino, Masako %A Hosgood, H Dean %A Hu, Guoqing %A Jacobsen, Kathryn H %A Jakovljevic, Mihajlo B %A Jayaraman, Sudha P %A Jha, Vivekanand %A Jibat, Tariku %A Johnson, Catherine O %A Jonas, Jost %A Kasaeian, Amir %A Kawakami, Norito %A Keiyoro, Peter N %A Khalil, Ibrahim %A Khang, Young-Ho %A Khubchandani, Jagdish %A Ahmad Kiadaliri, Aliasghar A %A Kieling, Christian %A Kim, Daniel %A Kissoon, Niranjan %A Knibbs, Luke D %A Koyanagi, Ai %A Krohn, Kristopher J %A Kuate Defo, Barthelemy %A Kucuk Bicer, Burcu %A Kulikoff, Rachel %A Kumar, G Anil %A Lal, Dharmesh Kumar %A Lam, Hilton Y %A Larson, Heidi J %A Larsson, Anders %A Laryea, Dennis Odai %A Leung, Janni %A Lim, Stephen S %A Lo, Loon-Tzian %A Lo, Warren D %A Looker, Katharine J %A Lotufo, Paulo A %A Magdy Abd El Razek, Hassan %A Malekzadeh, Reza %A Markos Shifti, Desalegn %A Mazidi, Mohsen %A Meaney, Peter A %A Meles, Kidanu Gebremariam %A Memiah, Peter %A Mendoza, Walter %A Abera Mengistie, Mubarek %A Mengistu, Gebremichael Welday %A Mensah, George A %A Miller, Ted R %A Mock, Charles %A Mohammadi, Alireza %A Mohammed, Shafiu %A Monasta, Lorenzo %A Mueller, Ulrich %A Nagata, Chie %A Naheed, Aliya %A Nguyen, Grant %A Nguyen, Quyen Le %A Nsoesie, Elaine %A Oh, In-Hwan %A Okoro, Anselm %A Olusanya, Jacob Olusegun %A Olusanya, Bolajoko O %A Ortiz, Alberto %A Paudel, Deepak %A Pereira, David M %A Perico, Norberto %A Petzold, Max %A Phillips, Michael Robert %A Polanczyk, Guilherme V %A Pourmalek, Farshad %A Qorbani, Mostafa %A Rafay, Anwar %A Rahimi-Movaghar, Vafa %A Rahman, Mahfuzar %A Rai, Rajesh Kumar %A Ram, Usha %A Rankin, Zane %A Remuzzi, Giuseppe %A Renzaho, Andre M N %A Roba, Hirbo Shore %A Rojas-Rueda, David %A Ronfani, Luca %A Sagar, Rajesh %A Sanabria, Juan Ramon %A Kedir Mohammed, Muktar Sano %A Santos, Itamar S %A Satpathy, Maheswar %A Sawhney, Monika %A Schöttker, Ben %A Schwebel, David C %A Scott, James G %A Sepanlou, Sadaf G %A Shaheen, Amira %A Shaikh, Masood Ali %A She, June %A Shiri, Rahman %A Shiue, Ivy %A Sigfusdottir, Inga Dora %A Singh, Jasvinder %A Silpakit, Naris %A Smith, Alison %A Sreeramareddy, Chandrashekhar %A Stanaway, Jeffrey D %A Stein, Dan J %A Steiner, Caitlyn %A Sufiyan, Muawiyyah Babale %A Swaminathan, Soumya %A Tabarés-Seisdedos, Rafael %A Tabb, Karen M %A Tadese, Fentaw %A Tavakkoli, Mohammad %A Taye, Bineyam %A Teeple, Stephanie %A Tegegne, Teketo Kassaw %A Temam Shifa, Girma %A Terkawi, Abdullah Sulieman %A Thomas, Bernadette %A Thomson, Alan J %A Tobe-Gai, Ruoyan %A Tonelli, Marcello %A Tran, Bach Xuan %A Troeger, Christopher %A Ukwaja, Kingsley N %A Uthman, Olalekan %A Vasankari, Tommi %A Venketasubramanian, Narayanaswamy %A Vlassov, Vasiliy Victorovich %A Weiderpass, Elisabete %A Weintraub, Robert %A Gebrehiwot, Solomon Weldemariam %A Westerman, Ronny %A Williams, Hywel C %A Wolfe, Charles D A %A Woodbrook, Rachel %A Yano, Yuichiro %A Yonemoto, Naohiro %A Yoon, Seok-Jun %A Younis, Mustafa Z %A Yu, Chuanhua %A Zaki, Maysaa El Sayed %A Zegeye, Elias Asfaw %A Zuhlke, Liesl Joanna %A Murray, Christopher J L %A Vos, Theo %K Adolescent %K Adolescent Health %K Age Factors %K Cause of Death %K Child %K Child Health %K Child Mortality %K Disabled Children %K Female %K Global Burden of Disease %K Global Health %K Humans %K Male %K Pregnancy %K Pregnancy Complications %K Risk Factors %K Sex Factors %K Wounds and Injuries %X

Importance: Comprehensive and timely monitoring of disease burden in all age groups, including children and adolescents, is essential for improving population health.

Objective: To quantify and describe levels and trends of mortality and nonfatal health outcomes among children and adolescents from 1990 to 2015 to provide a framework for policy discussion.

Evidence Review: Cause-specific mortality and nonfatal health outcomes were analyzed for 195 countries and territories by age group, sex, and year from 1990 to 2015 using standardized approaches for data processing and statistical modeling, with subsequent analysis of the findings to describe levels and trends across geography and time among children and adolescents 19 years or younger. A composite indicator of income, education, and fertility was developed (Socio-demographic Index [SDI]) for each geographic unit and year, which evaluates the historical association between SDI and health loss.

Findings: Global child and adolescent mortality decreased from 14.18 million (95% uncertainty interval [UI], 14.09 million to 14.28 million) deaths in 1990 to 7.26 million (95% UI, 7.14 million to 7.39 million) deaths in 2015, but progress has been unevenly distributed. Countries with a lower SDI had a larger proportion of mortality burden (75%) in 2015 than was the case in 1990 (61%). Most deaths in 2015 occurred in South Asia and sub-Saharan Africa. Global trends were driven by reductions in mortality owing to infectious, nutritional, and neonatal disorders, which in the aggregate led to a relative increase in the importance of noncommunicable diseases and injuries in explaining global disease burden. The absolute burden of disability in children and adolescents increased 4.3% (95% UI, 3.1%-5.6%) from 1990 to 2015, with much of the increase owing to population growth and improved survival for children and adolescents to older ages. Other than infectious conditions, many top causes of disability are associated with long-term sequelae of conditions present at birth (eg, neonatal disorders, congenital birth defects, and hemoglobinopathies) and complications of a variety of infections and nutritional deficiencies. Anemia, developmental intellectual disability, hearing loss, epilepsy, and vision loss are important contributors to childhood disability that can arise from multiple causes. Maternal and reproductive health remains a key cause of disease burden in adolescent females, especially in lower-SDI countries. In low-SDI countries, mortality is the primary driver of health loss for children and adolescents, whereas disability predominates in higher-SDI locations; the specific pattern of epidemiological transition varies across diseases and injuries.

Conclusions and Relevance: Consistent international attention and investment have led to sustained improvements in causes of health loss among children and adolescents in many countries, although progress has been uneven. The persistence of infectious diseases in some countries, coupled with ongoing epidemiologic transition to injuries and noncommunicable diseases, require all countries to carefully evaluate and implement appropriate strategies to maximize the health of their children and adolescents and for the international community to carefully consider which elements of child and adolescent health should be monitored.

%B JAMA Pediatr %V 171 %P 573-592 %8 2017 Jun 01 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28384795?dopt=Abstract %R 10.1001/jamapediatrics.2017.0250 %0 Journal Article %J Ital J Pediatr %D 2017 %T Children with cancer: a survey on the experience of Italian primary care pediatricians. %A Minute, Marta %A Cozzi, Giorgio %A Plotti, Chiara %A Montanari, Giuseppe %A Pecile, Paolo %A Zanazzo, Giulio Andrea %A Ventura, Alessandro %A Barbi, Egidio %K Child %K Child, Preschool %K Cross-Sectional Studies %K Disease-Free Survival %K Female %K Humans %K Italy %K Male %K Needs Assessment %K Neoplasms %K Outcome Assessment (Health Care) %K Pediatricians %K Practice Patterns, Physicians' %K Prevalence %K Primary Health Care %K Retrospective Studies %K Risk Assessment %K Survival Analysis %X

BACKGROUND: Cancer is the second cause of death in children and its diagnosis can be difficult, due to the presence of vague and non-specific symptoms. The primary care pediatrician is often involved in the diagnostic process, but no longer in child care once the treatment started. Care models involving both primary care pediatricians and oncologic referral centre highlighted a higher family satisfaction when they worked together. We conducted a survey on primary care pediatricians involved in childhood cancer in order to describe the actual situation.

METHODS: We conducted a retrospective survey enrolling primary care pediatricians from a north-eastern area of Italy. They received a questionnaire that consisted in two parts: the first one aimed to assess the physician's seniority and experience and the second one pertained to each case of cancer and explored the relationship between the pediatrician, the family and the referral centre, and pediatricians degree of satisfaction and emotional impact.

RESULTS: We obtained data from 79 pediatricians who described 150 cancer cases. In 99 cases the primary care pediatrician had visited the child at the onset of symptoms and had referred him to the hospital. In 89 cases, he understood the severity of the disease. In 53.3% of cases the pediatrician was informed by the referral centre. The relationship between the pediatrician and child's family improved in 38% of cases and this was related with their participation to the multidisciplinary meetings on child health.

CONCLUSIONS: Primary pediatricians' sharing in the management of their patients with cancer was not satisfactory. Development of specific protocols targeted to an integrated care is needed to increase primary pediatricians' involvement and families' satisfactions.

%B Ital J Pediatr %V 43 %P 48 %8 2017 May 25 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28545557?dopt=Abstract %R 10.1186/s13052-017-0365-9 %0 Journal Article %J BMC Nephrol %D 2017 %T Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients. %A Bernardi, Stella %A Toffoli, Barbara %A Bossi, Fleur %A Candido, Riccardo %A Stenner, Elisabetta %A Carretta, Renzo %A Barbone, Fabio %A Fabris, Bruno %K Aged %K Animals %K Biomarkers %K Case-Control Studies %K Female %K Follow-Up Studies %K Humans %K Hypertension %K Male %K Mice %K Mice, Inbred C57BL %K Middle Aged %K Osteoprotegerin %K Random Allocation %K Renal Insufficiency, Chronic %X

BACKGROUND: Osteoprotegerin (OPG) is a glycoprotein that plays an important regulatory role in the skeletal, vascular, and immune system. It has been shown that OPG predicts chronic kidney disease (CKD) in diabetic patients. We hypothesized that OPG could be a risk marker of CKD development also in non-diabetic hypertensive patients.

METHODS: A case-control study was carried out to measure circulating OPG levels in 42 hypertensive patients with CKD and in 141 hypertensive patients without CKD. A potential relationship between OPG and the presence of CKD was investigated and a receiver-operating characteristic (ROC) curve was designed thereafter to identify a cut-off value of OPG that best explained the presence of CKD. Secondly, to evaluate whether OPG increase could affect the kidney, 18 C57BL/6J mice were randomized to be treated with saline or recombinant OPG every 3 weeks for 12 weeks.

RESULTS: Circulating OPG levels were significantly higher in hypertensive patients with CKD, and there was a significant inverse association between OPG and renal function, that was independent from other variables. ROC analysis showed that OPG levels had a high statistically predictive value on CKD in hypertensive patients, which was greater than that of hypertension. The OPG best cut-off value associated with CKD was 1109.19 ng/L. In the experimental study, OPG delivery significantly increased the gene expression of pro-inflammatory and pro-fibrotic mediators, as well as the glomerular nitrosylation of proteins.

CONCLUSIONS: This study shows that OPG is associated with CKD in hypertensive patients, where it might have a higher predictive value than that of hypertension for CKD development. Secondly, we found that OPG delivery significantly increased the expression of molecular pathways involved in kidney damage. Further longitudinal studies are needed not only to evaluate whether OPG predicts CKD development but also to clarify whether OPG should be considered a risk factor for CKD.

%B BMC Nephrol %V 18 %P 219 %8 2017 Jul 06 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28683789?dopt=Abstract %R 10.1186/s12882-017-0625-3 %0 Journal Article %J J Travel Med %D 2017 %T Climate change, emerging infections and blood donations. %A Cegolon, L %A Heymann, W C %A Lange, J H %K Blood Transfusion %K Climate Change %K Communicable Diseases, Emerging %K Global Health %K Humans %K Travel %B J Travel Med %V 24 %8 2017 05 01 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/28355622?dopt=Abstract %R 10.1093/jtm/taw098 %0 Journal Article %J Arch Argent Pediatr %D 2017 %T [Clinical and molecular study in a family with autosomal dominant hypohidrotic ectodermal dysplasia]. %A Callea, Michele %A Cammarata-Scalisi, Francisco %A Willoughby, Colin E %A Giglio, Sabrina R %A Sani, Ilaria %A Bargiacchi, Sara %A Traficante, Giovanna %A Bellacchio, Emanuele %A Tadini, Gianluca %A Yavuz, Izzet %A Galeotti, Angela %A Clarich, Gabriella %K Child, Preschool %K Ectodermal Dysplasia 1, Anhidrotic %K Edar Receptor %K Humans %K Male %K Mutation %K Pedigree %X

Hypohidrotic ectodermal dysplasia (HED) is a rare disease characterized by deficiency in development of structure derived from the ectoderm and is caused by mutations in the genes EDA, EDAR, or EDARADD. Phenotypes caused by mutations in these three may exhibit similar clinical features, explained by a common signaling pathway. Mutations in EDA gene cause X linked HED, which is the most common form. Mutations in EDAR and EDARADD genes cause autosomal dominant and recessive form of HED. The most striking clinical findings in HED are hypodontia, hypotrichosis and hypohidrosis that can lead to episodes of hyperthermia. We report on clinical findings in a child with HED with autosomal dominant inheritance pattern with a heterozygous mutation c.1072C>T (p.Arg358X) in the EDAR gene. A review of the literature with regard to other cases presenting the same mutation has been carried out and discussed.

%B Arch Argent Pediatr %V 115 %P e34-e38 %8 2017 02 01 %G spa %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28097853?dopt=Abstract %R 10.5546/aap.2017.e34 %0 Journal Article %J Analyst %D 2017 %T Combined use of AFM and soft X-ray microscopy to reveal fibres' internalization in mesothelial cells. %A Gianoncelli, Alessandra %A Kourousias, George %A Cammisuli, Francesca %A Cassese, Damiano %A Rizzardi, Clara %A Radillo, Oriano %A Lazzarino, Marco %A Pascolo, Lorella %K Asbestos %K Cell Line %K Epithelial Cells %K Epithelium %K Humans %K Microscopy, Atomic Force %K X-Rays %X

Nanotoxicology and nanomedicine investigations often require the probing of nano-objects such as fibres and particles in biological samples and cells, whilst internalization and intracellular destiny are the main issues for in vitro cellular studies. Various high resolution microscopy techniques are well suited for providing this highly sought-after information. However, sample preparation, nanomaterial composition and sectioning challenges make it often difficult to establish whether the fibres or particles have been internalized or they are simply overlaying or underlying the biological matter. In this paper we suggest a novel suitable combination of two different microscopic techniques to reveal in intact cells the uptake of asbestos fibres by mesothelial cells. After exposure to asbestos fibres and fixation, cells were first analysed under the AFM instrument and then imaged under the TwinMic soft X-ray microscope at Elettra Sincrotrone. The suggested approach combines standard soft X-ray microscopy imaging and AFM microscopy, with a common non-invasive sample preparation protocol which drastically reduces the experimental uncertainty and provides a quick and definitive answer to the nanoparticle cellular and tissue uptake.

%B Analyst %V 142 %P 1982-1992 %8 2017 May 30 %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/28509933?dopt=Abstract %R 10.1039/c6an02661c %0 Journal Article %J Pflugers Arch %D 2017 %T Common variants in CLDN14 are associated with differential excretion of magnesium over calcium in urine. %A Corre, Tanguy %A Olinger, Eric %A Harris, Sarah E %A Traglia, Michela %A Ulivi, Sheila %A Lenarduzzi, Stefania %A Belge, Hendrica %A Youhanna, Sonia %A Tokonami, Natsuko %A Bonny, Olivier %A Houillier, Pascal %A Polasek, Ozren %A Deary, Ian J %A Starr, John M %A Toniolo, Daniela %A Gasparini, Paolo %A Vollenweider, Peter %A Hayward, Caroline %A Bochud, Murielle %A Devuyst, Olivier %K Animals %K Calcium %K Claudins %K Humans %K Kidney Tubules %K Magnesium %K Polymorphism, Single Nucleotide %K Urine %X

The nature and importance of genetic factors regulating the differential handling of Ca and Mg by the renal tubule in the general population are poorly defined. We conducted a genome-wide meta-analysis of urinary magnesium-to-calcium ratio to identify associated common genetic variants. We included 9320 adults of European descent from four genetic isolates and three urban cohorts. Urinary magnesium and calcium concentrations were measured centrally in spot urine, and each study conducted linear regression analysis of urinary magnesium-to-calcium ratio on ~2.5 million single-nucleotide polymorphisms (SNPs) using an additive model. We investigated, in mouse, the renal expression profile of the top candidate gene and its variation upon changes in dietary magnesium. The genome-wide analysis evidenced a top locus (rs172639, p = 1.7 × 10), encompassing CLDN14, the gene coding for claudin-14, that was genome-wide significant when using urinary magnesium-to-calcium ratio, but not either one taken separately. In mouse, claudin-14 is expressed in the distal nephron segments specifically handling magnesium, and its expression is regulated by chronic changes in dietary magnesium content. A genome-wide approach identified common variants in the CLDN14 gene exerting a robust influence on the differential excretion of Mg over Ca in urine. These data highlight the power of urinary electrolyte ratios to unravel genetic determinants of renal tubular function. Coupled with mouse experiments, these results support a major role for claudin-14, a gene associated with kidney stones, in the differential paracellular handling of divalent cations by the renal tubule.

%B Pflugers Arch %V 469 %P 91-103 %8 2017 01 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27915449?dopt=Abstract %R 10.1007/s00424-016-1913-7 %0 Journal Article %J Front Immunol %D 2017 %T Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth. %A Agostinis, Chiara %A Vidergar, Romana %A Belmonte, Beatrice %A Mangogna, Alessandro %A Amadio, Leonardo %A Geri, Pietro %A Borelli, Violetta %A Zanconati, Fabrizio %A Tedesco, Francesco %A Confalonieri, Marco %A Tripodo, Claudio %A Kishore, Uday %A Bulla, Roberta %X

C1q is the first recognition subcomponent of the complement classical pathway, which acts toward the clearance of pathogens and apoptotic cells. C1q is also known to modulate a range of functions of immune and non-immune cells, and has been shown to be involved in placental development and sensorial synaptic pruning. We have recently shown that C1q can promote tumor by encouraging their adhesion, migration, and proliferation in addition to angiogenesis and metastasis. In this study, we have examined the role of human C1q in the microenvironment of malignant pleural mesothelioma (MPM), a rare form of cancer commonly associated with exposure to asbestos. We found that C1q was highly expressed in all MPM histotypes, particularly in epithelioid rather than in sarcomatoid histotype. C1q avidly bound high and low molecular weight hyaluronic acid (HA) its globular domain. C1q bound to HA was able to induce adhesion and proliferation of mesothelioma cells (MES) enhancement of ERK1/2, SAPK/JNK, and p38 phosphorylation; however, it did not activate the complement cascade. Consistent with the modular organization of the globular domain, we demonstrated that C1q may bind to HA through ghA module, whereas it may interact with human MES through the ghC. In conclusion, C1q highly expressed in MPM binds to HA and enhances the tumor growth promoting cell adhesion and proliferation. These data can help develop novel diagnostic markers and molecular targets for MPM.

%B Front Immunol %V 8 %P 1559 %8 2017 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29209316?dopt=Abstract %R 10.3389/fimmu.2017.01559 %0 Journal Article %J Mol Cytogenet %D 2017 %T A complete duplication of X chromosome resulting in a tricentric isochromosome originated by centromere repositioning. %A Villa, N %A Conconi, D %A Benussi, D Gambel %A Tornese, G %A Crosti, F %A Sala, E %A Dalprà, L %A Pecile, V %X

BACKGROUND: Neocentromeres are rare and considered chromosomal aberrations, because a non-centromeric region evolves in an active centromere by mutation. The literature reported several structural anomalies of X chromosome and they influence the female reproductive capacity or are associated to Turner syndrome in the presence of monosomy X cell line.

CASE PRESENTATION: We report a case of chromosome X complex rearrangement found in a prenatal diagnosis. The fetal karyotype showed a mosaicism with a 45,X cell line and a 46 chromosomes second line with a big marker, instead of a sex chromosome. The marker morphology and fluorescence in situ hybridization (FISH) characterization allowed us to identify a tricentric X chromosome constituted by two complete X chromosome fused at the p arms telomere and an active neocentromere in the middle, at the union of the two Xp arms, where usually are the telomeric regions. FISH also showed the presence of a paracentric inversion of both Xp arms. Furthermore, fragility figures were found in 56% of metaphases from peripheral blood lymphocytes culture at birth: a shorter marker chromosome and an apparently acentric fragment frequently lost.

CONCLUSIONS: At our knowledge, this is the first isochromosome of an entire non-acrocentric chromosome. The neocentromere is constituted by canonical sequences but localized in an unusual position and the original centromeres are inactivated. We speculated that marker chromosome was the result of a double rearrangement: firstly, a paracentric inversion which involved the Xp arm, shifting a part of the centromere at the p end and subsequently a duplication of the entire X chromosome, which gave rise to an isochromosome. It is possible to suppose that the first event could be a result of a non-allelic homologous recombination mediated by inverted low-copy repeats. As expected, our case shows a Turner phenotype with mild facial features and no major skeletal deformity, normal psychomotor development and a spontaneous development of puberty and menarche, although with irregular menses since the last follow-up.

%B Mol Cytogenet %V 10 %P 22 %8 2017 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28630649?dopt=Abstract %R 10.1186/s13039-017-0323-7 %0 Journal Article %J Nanotechnology %D 2017 %T Cubosomes for in vivo fluorescence lifetime imaging. %A Biffi, Stefania %A Andolfi, Laura %A Caltagirone, Claudia %A Garrovo, Chiara %A Falchi, Angela M %A Lippolis, Vito %A Lorenzon, Andrea %A Macor, Paolo %A Meli, Valeria %A Monduzzi, Maura %A Obiols-Rabasa, Marc %A Petrizza, Luca %A Prodi, Luca %A Rosa, Antonella %A Schmidt, Judith %A Talmon, Yeshayahu %A Murgia, Sergio %K Animals %K Carbocyanines %K Cell Survival %K Drug Compounding %K Erythrocytes %K Female %K Fluorescent Dyes %K Glycerides %K Humans %K Injections, Intravenous %K Liposomes %K Liver %K Mice %K Mice, Inbred BALB C %K Nanoparticles %K NIH 3T3 Cells %K Optical Imaging %K Particle Size %K Spectroscopy, Near-Infrared %K Time-Lapse Imaging %X

Herein we provided the first proof of principle for in vivo fluorescence optical imaging application using monoolein-based cubosomes in a healthy mouse animal model. This formulation, administered at a non-cytotoxic concentration, was capable of providing both exogenous contrast for NIR fluorescence imaging with very high efficiency and chemospecific information upon lifetime analysis. Time-resolved measurements of fluorescence after the intravenous injection of cubosomes revealed that the dye rapidly accumulated mainly in the liver, while lifetimes profiles obtained in vivo allowed for discriminating between free dye or dye embedded within the cubosome nanostructure after injection.

%B Nanotechnology %V 28 %P 055102 %8 2017 Feb 03 %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/28032617?dopt=Abstract %R 10.1088/1361-6528/28/5/055102 %0 Journal Article %J Arch Oral Biol %D 2017 %T DEFB1 polymorphisms and salivary hBD-1 concentration in Oral Lichen Planus patients and healthy subjects. %A Polesello, Vania %A Zupin, Luisa %A Di Lenarda, Roberto %A Biasotto, Matteo %A Pozzato, Gabriele %A Ottaviani, Giulia %A Gobbo, Margherita %A Crovella, Sergio %A Segat, Ludovica %K 5' Untranslated Regions %K Adult %K Aged %K Aged, 80 and over %K beta-Defensins %K Female %K Genetic Predisposition to Disease %K Genotype %K Humans %K Lichen Planus, Oral %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Saliva %K Sequence Analysis, DNA %X

OBJECTIVES: The aetiology of Oral Lichen Planus (OLP), a chronic inflammatory disease of oral mucosa, is not yet well understood. Since innate immunity may be hypothesized as involved in the susceptibility to OLP, we studied human beta defensin 1 (hBD-1) an antimicrobial peptide constitutively expressed in the saliva, looking at functional genetic variants possibly able to diminish hBD-1 production an consequently conferring major susceptibility to OLP.

DESIGN: We analysed three DEFB1 polymorphisms at 5' UTR, -52G>A (rs1799946), -44C>G (rs1800972), -20G>A (rs11362) and two DEFB1 polymorphisms at 3'UTR, c*5G>A (rs1047031), c*87A>G (rs1800971), with the aim of correlating these genetic variants and hBD-1 salivary level in a group of OLP patients and in healthy subjects. We also evaluated hBD-1 salivary concentrations, using ELISA, in OLP and healthy controls.

RESULTS: We compared hBD-1 concentrations in OLP and healthy subjects: hBD-1 concentration was significantly higher in OLP patients respect to control. When considering the correlation between DEFB1 polymorphisms genotypes and hBD-1 expression levels, significant results were obtained for SNPs -52G>A (p=0.03 both in OLP patients and healthy individuals) and -44C>G (p=0.02 in OLP patients).

CONCLUSIONS: hBD-1 production was different between OLP and healthy subjects (not age-matched with OLP). DEFB1 gene polymorphisms, -52G>A and -44C>G, correlated with hBD-1 salivary concentrations.

%B Arch Oral Biol %V 73 %P 161-165 %8 2017 Jan %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27770642?dopt=Abstract %R 10.1016/j.archoralbio.2016.10.008 %0 Journal Article %J Biochim Biophys Acta Mol Basis Dis %D 2017 %T Defects in mitochondrial energetic function compels Fanconi Anaemia cells to glycolytic metabolism. %A Cappelli, Enrico %A Cuccarolo, Paola %A Stroppiana, Giorgia %A Miano, Maurizio %A Bottega, Roberta %A Cossu, Vanessa %A Degan, Paolo %A Ravera, Silvia %K Cell Line %K Fanconi Anemia %K Glycolysis %K Humans %K Mitochondria %K Oxidative Phosphorylation %K Oxidative Stress %X

Energetic metabolism plays an essential role in the differentiation of haematopoietic stem cells (HSC). In Fanconi Anaemia (FA), DNA damage is accumulated during HSC differentiation, an event that is likely associated with bone marrow failure (BMF). One of the sources of the DNA damage is altered mitochondrial metabolism and an associated increment of oxidative stress. Recently, altered mitochondrial morphology and a deficit in the energetic activity in FA cells have been reported. Considering that mitochondria are the principal site of aerobic ATP production, we investigated FA metabolism in order to understand what pathways are able to compensate for this energy deficiency. In this work, we report that the impairment in mitochondrial oxidative phosphorylation (OXPHOS) in FA cells is countered by an increase in glycolytic flux. By contrast, glutaminolysis appears lower with respect to controls. Therefore, it is possible to conclude that in FA cells glycolysis represents the main pathway for producing energy, balancing the NADH/NAD ratio by the conversion of pyruvate to lactate. Finally, we show that a forced switch from glycolytic to OXPHOS metabolism increases FA cell oxidative stress. This could be the cause of the impoverishment in bone marrow HSC during exit from the homeostatic quiescent state. This is the first work that systematically explores FA energy metabolism, highlighting its flaws, and discusses the possible relationships between these defects and BMF.

%B Biochim Biophys Acta Mol Basis Dis %V 1863 %P 1214-1221 %8 2017 06 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28315453?dopt=Abstract %R 10.1016/j.bbadis.2017.03.008 %0 Journal Article %J Clin Rheumatol %D 2017 %T Describing Kawasaki shock syndrome: results from a retrospective study and literature review. %A Taddio, Andrea %A Rossi, Eleonora Dei %A Monasta, Lorenzo %A Pastore, Serena %A Tommasini, Alberto %A Lepore, Loredana %A Bronzetti, Gabriele %A Marrani, Edoardo %A Mottolese, Biancamaria D'Agata %A Simonini, Gabriele %A Cimaz, Rolando %A Ventura, Alessandro %K C-Reactive Protein %K Child %K Child, Preschool %K Echocardiography %K Female %K Heart Failure %K Hemoglobins %K Humans %K Immunoglobulins, Intravenous %K Male %K Mucocutaneous Lymph Node Syndrome %K Retrospective Studies %K Shock %K Syndrome %X

Kawasaki shock syndrome (KSS) is a rare manifestation of Kawasaki disease (KD) characterized by systolic hypotension or clinical signs of poor perfusion. The objectives of the study are to describe the main clinical presentation, echocardiographic, and laboratory findings, as well as the treatment options and clinical outcomes of KSS patients when compared with KD patients. This is a retrospective study. All children referred to two pediatric rheumatology units from January 1, 2012, to December 31, 2014, were enrolled. Patients were divided into patients with or without KSS. We compared the two groups according to the following variables: sex, age, type of KD (classic, with less frequent manifestations, or incomplete), clinical manifestations, cardiac involvement, laboratory findings, therapy administered, response to treatment, and outcome. Eighty-four patients with KD were enrolled. Of these, five (6 %) met the criteria for KSS. Patients with KSS had higher values of C-reactive protein (p = 0.005), lower hemoglobin levels (p = 0.003); more frequent hyponatremia (p = 0.004), hypoalbuminemia (p = 0.004), and coagulopathy (p = 0.003); and increase in cardiac troponins (p = 0.000). Among the KSS patients, three had a coronary artery involvement, but none developed a permanent aneurysm. Intravenous immunoglobulin resistance was more frequent in the KSS group, although not significantly so (3/5, 60 % vs. 23/79, 30 %, P = NS). None of the five cases was fatal, and all recovered without sequelae. KSS patients are more likely to have higher rates of cardiac involvement. However, most cardiovascular abnormalities resolved promptly with therapy.

%B Clin Rheumatol %V 36 %P 223-228 %8 2017 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27230223?dopt=Abstract %R 10.1007/s10067-016-3316-8 %0 Journal Article %J Nutr Rev %D 2017 %T Early-life nutritional exposures and lifelong health: immediate and long-lasting impacts of probiotics, vitamin D, and breastfeeding. %A Berti, Cristiana %A Agostoni, Carlo %A Davanzo, Riccardo %A Hyppönen, Elina %A Isolauri, Erika %A Meltzer, Helle M %A Steegers-Theunissen, Régine P M %A Cetin, Irene %K Breast Feeding %K Diet %K Female %K Humans %K Infant %K Infant Nutritional Physiological Phenomena %K Meta-Analysis as Topic %K Nutritional Status %K Pregnancy %K Pregnancy Outcome %K Probiotics %K Vitamin D %X

Pregnancy and infancy comprise the most critical stages for conditioning an individual's health, with a number of implications for subsequent risks of morbidity, mortality, and reproductive health. Nutrition may influence both the overall pregnancy outcome and the growth trajectory and immune system of the fetus and infant, with short- and long-term effects on the health of the offspring. Within this context, leading experts at Expo Milano 2015 in Milan, Italy, discussed up-to-date knowledge while providing suggestions and challenges before, during, and after pregnancy. This narrative review summarizes the key issues raised by the experts concerning the interplay between the nutritional environment from conception to early infancy and the offspring's immediate and lifelong health, with a particular focus on epigenetic mechanisms, probiotics, vitamin D, and breastfeeding. Taken together, the findings strengthen the awareness that nutritional exposures occurring from preconception to the postnatal period may be strong determinants of the offspring's health and may provide supportive evidence for current nutritional recommendations and guidelines for pregnant women and infants. Critical topics to be addressed in future research and translated into recommendations of public health relevance are also highlighted.

%B Nutr Rev %V 75 %P 83-97 %8 2017 02 01 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/28130504?dopt=Abstract %R 10.1093/nutrit/nuw056 %0 Journal Article %J Nat Commun %D 2017 %T Enrichment of low-frequency functional variants revealed by whole-genome sequencing of multiple isolated European populations. %A Xue, Yali %A Mezzavilla, Massimo %A Haber, Marc %A McCarthy, Shane %A Chen, Yuan %A Narasimhan, Vagheesh %A Gilly, Arthur %A Ayub, Qasim %A Colonna, Vincenza %A Southam, Lorraine %A Finan, Christopher %A Massaia, Andrea %A Chheda, Himanshu %A Palta, Priit %A Ritchie, Graham %A Asimit, Jennifer %A Dedoussis, George %A Gasparini, Paolo %A Palotie, Aarno %A Ripatti, Samuli %A Soranzo, Nicole %A Toniolo, Daniela %A Wilson, James F %A Durbin, Richard %A Tyler-Smith, Chris %A Zeggini, Eleftheria %K European Continental Ancestry Group %K Gene Frequency %K Genetic Variation %K Genetics, Population %K Genome, Human %K Humans %K Polymorphism, Single Nucleotide %K Whole Genome Sequencing %X

The genetic features of isolated populations can boost power in complex-trait association studies, and an in-depth understanding of how their genetic variation has been shaped by their demographic history can help leverage these advantageous characteristics. Here, we perform a comprehensive investigation using 3,059 newly generated low-depth whole-genome sequences from eight European isolates and two matched general populations, together with published data from the 1000 Genomes Project and UK10K. Sequencing data give deeper and richer insights into population demography and genetic characteristics than genotype-chip data, distinguishing related populations more effectively and allowing their functional variants to be studied more fully. We demonstrate relaxation of purifying selection in the isolates, leading to enrichment of rare and low-frequency functional variants, using novel statistics, DVxy and SVxy. We also develop an isolation-index (Isx) that predicts the overall level of such key genetic characteristics and can thus help guide population choice in future complex-trait association studies.

%B Nat Commun %V 8 %P 15927 %8 2017 06 23 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28643794?dopt=Abstract %R 10.1038/ncomms15927 %0 Journal Article %J J Minim Invasive Gynecol %D 2017 %T Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey. %A Franchini, Mario %A Zizolfi, Brunella %A Coppola, Carmela %A Bergamini, Valentino %A Bonin, Cecilia %A Borsellino, Giovanni %A Busato, Enrico %A Calabrese, Stefania %A Calzolari, Stefano %A Fantin, Gian Piero %A Giarrè, Giovanna %A Litta, Piero %A Luerti, Massimo %A Mangino, Francesco Paolo %A Marchino, Gian Luigi %A Molinari, Maria Antonietta %A Scatena, Elisa %A Scrimin, Federica %A Telloli, Paolo %A Di Spiezio Sardo, Attilio %K Adult %K Fallopian Tubes %K Female %K Follow-Up Studies %K Humans %K Hypersensitivity %K Hysterosalpingography %K Hysteroscopy %K Italy %K Laparoscopy %K Middle Aged %K Nickel %K Pain %K Pregnancy %K Pregnancy, Unplanned %K Retrospective Studies %K Sterilization, Reproductive %K Sterilization, Tubal %K Surveys and Questionnaires %K Young Adult %X

STUDY OBJECTIVE: To describe safety, tolerability, and effectiveness results through a minimum 2-year follow-up of patients who underwent permanent sterilization with the Essure insert.

DESIGN: A retrospective multicenter study (Canadian Task Force classification II2).

SETTING: Seven general hospitals and 4 clinical teaching centers in Italy.

PATIENTS: A total of 1968 women, mean age 39.5 years (range, 23-48 years) who underwent office hysteroscopic sterilization using the Essure insert between April 1, 2003, and December 30, 2014.

INTERVENTION: The women underwent office hysteroscopic bilateral Essure insert placement, with satisfactory device location and tube occlusion based on hysterosalpingography or hysterosalpingo-contrast sonography (HyCoSy).

MEASUREMENTS AND MAIN RESULTS: Placement rate, successful bilateral tubal occlusion, perioperative adverse events, early postoperative (during the first 3 months of follow-up), and late complications were evaluated. Satisfactory insertion was accomplished in 97.2% of women and, in 4, perforation and 1 expulsion were detected during hysterosalpingography. Three unintended pregnancies occurred before the 3-month confirmation test. Two pregnancies were reported among women relying on the Essure inserts. Postprocedure pain was minimal and brief; in 9 women, pelvic pain became intractable, necessitating removal of the devices via laparoscopy. On telephone interviews, overall satisfaction was rated as "very satisfied" by the majority of women (97.6%), and no long-term adverse events were reported.

CONCLUSION: The findings from this extended Italian survey further support the effectiveness, tolerability, and satisfaction of Essure hysteroscopic sterilization when motivated women are selected and well informed of the potential risks of the device. Moreover, the results do not demonstrate an increased incidence of complications and pregnancies associated with long-term Essure use. Patients with a known hypersensitivity to nickel may be less suitable candidates for the Essure insert.

%B J Minim Invasive Gynecol %V 24 %P 640-645 %8 2017 May - Jun %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/28232037?dopt=Abstract %R 10.1016/j.jmig.2017.02.004 %0 Journal Article %J J Clin Psychiatry %D 2017 %T Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression Analyses. %A Cervesi, Chiara %A Park, Su Young %A Galling, Britta %A Molteni, Silvia %A Masi, Gabriele %A Gerhard, Tobias %A Olfson, Mark %A Correll, Christoph U %K Adolescent %K Antipsychotic Agents %K Bipolar Disorder %K Child %K Cross-Sectional Studies %K Drug Utilization %K Female %K Humans %K Longitudinal Studies %K Male %K Mood Disorders %K Off-Label Use %K Regression Analysis %X

OBJECTIVE: To meta-analytically examine the trends and correlates of antipsychotic use in youth with mood disorders.

METHODS: Systematic literature search without language restriction in PubMed/MEDLINE/PsycINFO from database inception through March 2015 using the following search terms: (antipsychotic* OR neuroleptic* OR "dopamine blocker*" OR antidopaminergic) AND (child* OR adolescen* OR pediatric OR youth) AND (prescription* OR prescrib* OR use OR utilization OR database OR pharmacoepidemiolog* OR frequency OR rate OR rates). Random effects meta-analysis and meta-regression analyses were conducted.

STUDY SELECTION: Included were studies reporting on the frequency of (1) mood disorders in antipsychotic-treated youth (≤ 19 years) and (2) antipsychotic use in youth with mood disorders.

DATA ABSTRACTION: Two independent investigators abstracted data on study, patient, and treatment characteristics.

RESULTS: Forty-one studies were meta-analyzed (N = 518,919, mean ± SD age = 12.8 ± 1.8 years, males = 65.7%). Altogether, 24.2% of antipsychotic-treated youth had a mood disorder diagnosis (studies = 34, depression spectrum disorder = 10.9%, bipolar spectrum disorder = 13.6%). In longitudinal studies, the overall proportion increased significantly from 17.3% in 2000 (range, 1996-2009) to 24.5% in 2006 (range, 2004-2011) (odds ratio [OR] = 1.50; 95% confidence interval [CI], 1.26-1.79; P < .0001). This increase was driven entirely by bipolar spectrum diagnoses (2001 = 11.1%, 2006 = 16.3%, P < .0001), rather than depression spectrum diagnoses (2001 = 9.1%, 2007 = 9.2%, P = .77). Among youth with mood disorders (8 studies), 24.0% received antipsychotics (depression spectrum disorder = 4.6%; bipolar spectrum disorder = 44.0%).

CONCLUSIONS: The proportion of youth with mood disorder diagnoses increased significantly among antipsychotic-treated youth, driven entirely by an increase in youth with bipolar spectrum disorders. Progress in understanding the reasons for these trends and for an evaluation of the appropriateness of the observed antipsychotic prescribing requires more detailed information than is available in traditional pharmacoepidemiologic databases.

%B J Clin Psychiatry %V 78 %P 347-357 %8 2017 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/28068462?dopt=Abstract %R 10.4088/JCP.15r10435 %0 Journal Article %J Acta Paediatr %D 2017 %T First-time success with needle procedures was higher with a warm lidocaine and tetracaine patch than an eutectic mixture of lidocaine and prilocaine cream. %A Cozzi, Giorgio %A Borrometi, Fabio %A Benini, Franca %A Neri, Elena %A Rusalen, Francesca %A Celentano, Loredana %A Zanon, Davide %A Schreiber, Silvana %A Ronfani, Luca %A Barbi, Egidio %K Anesthetics, Local %K Catheterization, Peripheral %K Child %K Child, Preschool %K Female %K Hot Temperature %K Humans %K Lidocaine %K Lidocaine, Prilocaine Drug Combination %K Male %K Pain %K Phlebotomy %K Prilocaine %K Tetracaine %X

AIM: More than 50% of children report apian during venepuncture or intravenous cannulation and using local anaesthetics before needle procedures can lead to different success rates. This study examined how many needle procedures were successful at the first attempt when children received either a warm lidocaine and tetracaine patch or an eutectic mixture of lidocaine and prilocaine (EMLA) cream.

METHODS: We conducted this multicentre randomised controlled trial at three tertiary-level children's hospitals in Italy in 2015. Children aged three to 10 years were enrolled in an emergency department, paediatric day hospital and paediatric ward and randomly allocated to receive a warm lidocaine and tetracaine patch or EMLA cream. The primary outcome was the success rate at the first attempt.

RESULTS: The analysis included 172 children who received a warm lidocaine and tetracaine patch and 167 who received an EMLA cream. The needle procedure was successful at the first attempt in 158 children (92.4%) who received the warm patch and in 142 children (85.0%) who received the cream (p = 0.03). The pain scores were similar in both groups.

CONCLUSION: This study showed that the first-time needle procedure success was 7.4% higher in children receiving a warm lidocaine and tetracaine patch than EMLA cream.

%B Acta Paediatr %V 106 %P 773-778 %8 2017 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/28130888?dopt=Abstract %R 10.1111/apa.13764 %0 Journal Article %J BMC Genomics %D 2017 %T Genetic structure in the Sherpa and neighboring Nepalese populations. %A Cole, Amy M %A Cox, Sean %A Jeong, Choongwon %A Petousi, Nayia %A Aryal, Dhana R %A Droma, Yunden %A Hanaoka, Masayuki %A Ota, Masao %A Kobayashi, Nobumitsu %A Gasparini, Paolo %A Montgomery, Hugh %A Robbins, Peter %A Di Rienzo, Anna %A Cavalleri, Gianpiero L %K Asian Continental Ancestry Group %K Chromosomes, Human, Y %K DNA %K DNA, Mitochondrial %K Ethnic Groups %K Gene Flow %K Genotype %K Humans %K Leukocytes %K Likelihood Functions %K Nepal %K Principal Component Analysis %X

BACKGROUND: We set out to describe the fine-scale population structure across the Eastern region of Nepal. To date there is relatively little known about the genetic structure of the Sherpa residing in Nepal and their genetic relationship with the Nepalese. We assembled dense genotype data from a total of 1245 individuals representing Nepal and a variety of different populations resident across the greater Himalayan region including Tibet, China, India, Pakistan, Kazakhstan, Uzbekistan, Tajikistan and Kirghizstan. We performed analysis of principal components, admixture and homozygosity.

RESULTS: We identified clear substructure across populations resident in the Himalayan arc, with genetic structure broadly mirroring geographical features of the region. Ethnic subgroups within Nepal show distinct genetic structure, on both admixture and principal component analysis. We detected differential proportions of ancestry from northern Himalayan populations across Nepalese subgroups, with the Nepalese Rai, Magar and Tamang carrying the greatest proportions of Tibetan ancestry.

CONCLUSIONS: We show that populations dwelling on the Himalayan plateau have had a clear impact on the Northern Indian gene pool. We illustrate how the Sherpa are a remarkably isolated population, with little gene flow from surrounding Nepalese populations.

%B BMC Genomics %V 18 %P 102 %8 2017 01 19 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28103797?dopt=Abstract %R 10.1186/s12864-016-3469-5 %0 Journal Article %J Nat Genet %D 2017 %T Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. %A Warren, Helen R %A Evangelou, Evangelos %A Cabrera, Claudia P %A Gao, He %A Ren, Meixia %A Mifsud, Borbala %A Ntalla, Ioanna %A Surendran, Praveen %A Liu, Chunyu %A Cook, James P %A Kraja, Aldi T %A Drenos, Fotios %A Loh, Marie %A Verweij, Niek %A Marten, Jonathan %A Karaman, Ibrahim %A Lepe, Marcelo P Segura %A O'Reilly, Paul F %A Knight, Joanne %A Snieder, Harold %A Kato, Norihiro %A He, Jiang %A Tai, E Shyong %A Said, M Abdullah %A Porteous, David %A Alver, Maris %A Poulter, Neil %A Farrall, Martin %A Gansevoort, Ron T %A Padmanabhan, Sandosh %A Mägi, Reedik %A Stanton, Alice %A Connell, John %A Bakker, Stephan J L %A Metspalu, Andres %A Shields, Denis C %A Thom, Simon %A Brown, Morris %A Sever, Peter %A Esko, Tõnu %A Hayward, Caroline %A van der Harst, Pim %A Saleheen, Danish %A Chowdhury, Rajiv %A Chambers, John C %A Chasman, Daniel I %A Chakravarti, Aravinda %A Newton-Cheh, Christopher %A Lindgren, Cecilia M %A Levy, Daniel %A Kooner, Jaspal S %A Keavney, Bernard %A Tomaszewski, Maciej %A Samani, Nilesh J %A Howson, Joanna M M %A Tobin, Martin D %A Munroe, Patricia B %A Ehret, Georg B %A Wain, Louise V %K Adult %K Blood Pressure %K Cardiovascular Diseases %K European Continental Ancestry Group %K Female %K Genetic Loci %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Humans %K Hypertension %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Risk Factors %X

Elevated blood pressure is the leading heritable risk factor for cardiovascular disease worldwide. We report genetic association of blood pressure (systolic, diastolic, pulse pressure) among UK Biobank participants of European ancestry with independent replication in other cohorts, and robust validation of 107 independent loci. We also identify new independent variants at 11 previously reported blood pressure loci. In combination with results from a range of in silico functional analyses and wet bench experiments, our findings highlight new biological pathways for blood pressure regulation enriched for genes expressed in vascular tissues and identify potential therapeutic targets for hypertension. Results from genetic risk score models raise the possibility of a precision medicine approach through early lifestyle intervention to offset the impact of blood pressure-raising genetic variants on future cardiovascular disease risk.

%B Nat Genet %V 49 %P 403-415 %8 2017 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/28135244?dopt=Abstract %R 10.1038/ng.3768 %0 Journal Article %J Nat Genet %D 2017 %T Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. %A Day, Felix R %A Thompson, Deborah J %A Helgason, Hannes %A Chasman, Daniel I %A Finucane, Hilary %A Sulem, Patrick %A Ruth, Katherine S %A Whalen, Sean %A Sarkar, Abhishek K %A Albrecht, Eva %A Altmaier, Elisabeth %A Amini, Marzyeh %A Barbieri, Caterina M %A Boutin, Thibaud %A Campbell, Archie %A Demerath, Ellen %A Giri, Ayush %A He, Chunyan %A Hottenga, Jouke J %A Karlsson, Robert %A Kolcic, Ivana %A Loh, Po-Ru %A Lunetta, Kathryn L %A Mangino, Massimo %A Marco, Brumat %A McMahon, George %A Medland, Sarah E %A Nolte, Ilja M %A Noordam, Raymond %A Nutile, Teresa %A Paternoster, Lavinia %A Perjakova, Natalia %A Porcu, Eleonora %A Rose, Lynda M %A Schraut, Katharina E %A Segrè, Ayellet V %A Smith, Albert V %A Stolk, Lisette %A Teumer, Alexander %A Andrulis, Irene L %A Bandinelli, Stefania %A Beckmann, Matthias W %A Benitez, Javier %A Bergmann, Sven %A Bochud, Murielle %A Boerwinkle, Eric %A Bojesen, Stig E %A Bolla, Manjeet K %A Brand, Judith S %A Brauch, Hiltrud %A Brenner, Hermann %A Broer, Linda %A Brüning, Thomas %A Buring, Julie E %A Campbell, Harry %A Catamo, Eulalia %A Chanock, Stephen %A Chenevix-Trench, Georgia %A Corre, Tanguy %A Couch, Fergus J %A Cousminer, Diana L %A Cox, Angela %A Crisponi, Laura %A Czene, Kamila %A Davey Smith, George %A de Geus, Eco J C N %A de Mutsert, Renée %A De Vivo, Immaculata %A Dennis, Joe %A Devilee, Peter %A Dos-Santos-Silva, Isabel %A Dunning, Alison M %A Eriksson, Johan G %A Fasching, Peter A %A Fernández-Rhodes, Lindsay %A Ferrucci, Luigi %A Flesch-Janys, Dieter %A Franke, Lude %A Gabrielson, Marike %A Gandin, Ilaria %A Giles, Graham G %A Grallert, Harald %A Gudbjartsson, Daniel F %A Guenel, Pascal %A Hall, Per %A Hallberg, Emily %A Hamann, Ute %A Harris, Tamara B %A Hartman, Catharina A %A Heiss, Gerardo %A Hooning, Maartje J %A Hopper, John L %A Hu, Frank %A Hunter, David J %A Ikram, M Arfan %A Im, Hae Kyung %A Järvelin, Marjo-Riitta %A Joshi, Peter K %A Karasik, David %A Kellis, Manolis %A Kutalik, Zoltán %A LaChance, Genevieve %A Lambrechts, Diether %A Langenberg, Claudia %A Launer, Lenore J %A Laven, Joop S E %A Lenarduzzi, Stefania %A Li, Jingmei %A Lind, Penelope A %A Lindström, Sara %A Liu, Yongmei %A Luan, Jian'an %A Mägi, Reedik %A Mannermaa, Arto %A Mbarek, Hamdi %A McCarthy, Mark I %A Meisinger, Christa %A Meitinger, Thomas %A Menni, Cristina %A Metspalu, Andres %A Michailidou, Kyriaki %A Milani, Lili %A Milne, Roger L %A Montgomery, Grant W %A Mulligan, Anna M %A Nalls, Mike A %A Navarro, Pau %A Nevanlinna, Heli %A Nyholt, Dale R %A Oldehinkel, Albertine J %A O'Mara, Tracy A %A Padmanabhan, Sandosh %A Palotie, Aarno %A Pedersen, Nancy %A Peters, Annette %A Peto, Julian %A Pharoah, Paul D P %A Pouta, Anneli %A Radice, Paolo %A Rahman, Iffat %A Ring, Susan M %A Robino, Antonietta %A Rosendaal, Frits R %A Rudan, Igor %A Rueedi, Rico %A Ruggiero, Daniela %A Sala, Cinzia F %A Schmidt, Marjanka K %A Scott, Robert A %A Shah, Mitul %A Sorice, Rossella %A Southey, Melissa C %A Sovio, Ulla %A Stampfer, Meir %A Steri, Maristella %A Strauch, Konstantin %A Tanaka, Toshiko %A Tikkanen, Emmi %A Timpson, Nicholas J %A Traglia, Michela %A Truong, Therese %A Tyrer, Jonathan P %A Uitterlinden, André G %A Edwards, Digna R Velez %A Vitart, Veronique %A Völker, Uwe %A Vollenweider, Peter %A Wang, Qin %A Widen, Elisabeth %A van Dijk, Ko Willems %A Willemsen, Gonneke %A Winqvist, Robert %A Wolffenbuttel, Bruce H R %A Zhao, Jing Hua %A Zoledziewska, Magdalena %A Zygmunt, Marek %A Alizadeh, Behrooz Z %A Boomsma, Dorret I %A Ciullo, Marina %A Cucca, Francesco %A Esko, Tõnu %A Franceschini, Nora %A Gieger, Christian %A Gudnason, Vilmundur %A Hayward, Caroline %A Kraft, Peter %A Lawlor, Debbie A %A Magnusson, Patrik K E %A Martin, Nicholas G %A Mook-Kanamori, Dennis O %A Nohr, Ellen A %A Polasek, Ozren %A Porteous, David %A Price, Alkes L %A Ridker, Paul M %A Snieder, Harold %A Spector, Tim D %A Stöckl, Doris %A Toniolo, Daniela %A Ulivi, Sheila %A Visser, Jenny A %A Völzke, Henry %A Wareham, Nicholas J %A Wilson, James F %A Spurdle, Amanda B %A Thorsteindottir, Unnur %A Pollard, Katherine S %A Easton, Douglas F %A Tung, Joyce Y %A Chang-Claude, Jenny %A Hinds, David %A Murray, Anna %A Murabito, Joanne M %A Stefansson, Kari %A Ong, Ken K %A Perry, John R B %K Adolescent %K Age Factors %K Body Mass Index %K Databases, Genetic %K Female %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Genomic Imprinting %K Humans %K Intercellular Signaling Peptides and Proteins %K Male %K Membrane Proteins %K Menarche %K Neoplasms %K Polymorphism, Single Nucleotide %K Puberty %K Quantitative Trait Loci %K Ribonucleoproteins %K Risk Factors %X

The timing of puberty is a highly polygenic childhood trait that is epidemiologically associated with various adult diseases. Using 1000 Genomes Project-imputed genotype data in up to ∼370,000 women, we identify 389 independent signals (P < 5 × 10) for age at menarche, a milestone in female pubertal development. In Icelandic data, these signals explain ∼7.4% of the population variance in age at menarche, corresponding to ∼25% of the estimated heritability. We implicate ∼250 genes via coding variation or associated expression, demonstrating significant enrichment in neural tissues. Rare variants near the imprinted genes MKRN3 and DLK1 were identified, exhibiting large effects when paternally inherited. Mendelian randomization analyses suggest causal inverse associations, independent of body mass index (BMI), between puberty timing and risks for breast and endometrial cancers in women and prostate cancer in men. In aggregate, our findings highlight the complexity of the genetic regulation of puberty timing and support causal links with cancer susceptibility.

%B Nat Genet %V 49 %P 834-841 %8 2017 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28436984?dopt=Abstract %R 10.1038/ng.3841 %0 Journal Article %J Pediatr Med Chir %D 2017 %T Guidelines of the Italian Society of Videosurgery in Infancy for the minimally invasive treatment of the esophageal atresia. %A Chiarenza, Salvatore Fabio %A Conighi, Maria Luisa %A Conforti, Andrea %A Esposito, Ciro %A Escolino, Maria %A Beretta, Fabio %A Cheli, Maurizio %A Di Benedetto, Vincenzo %A Scuderi, Maria Grazia %A Casadio, Giovanni %A Marzaro, Maurizio %A Fascetti, Leon Francesco %A Vella, Claudio %A Bleve, Cosimo %A Codric, Daniela %A Caione, Paolo %A Bagolan, Pietro %K Esophageal Atresia %K Humans %K Infant %K Minimally Invasive Surgical Procedures %K Video-Assisted Surgery %X

Not available.

%B Pediatr Med Chir %V 39 %P 166 %8 2017 Oct 04 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29034656?dopt=Abstract %R 10.4081/pmc.2017.166 %0 Journal Article %J Pediatr Med Chir %D 2017 %T Guidelines of the Italian Society of Videosurgery in Infancy for the minimally invasive treatment of the ureteropelvic-junction obstruction. %A Chiarenza, Salvatore Fabio %A Bleve, Cosimo %A Esposito, Ciro %A Escolino, Maria %A Beretta, Fabio %A Cheli, Maurizio %A Di Benedetto, Vincenzo %A Scuderi, Maria Grazia %A Casadio, Giovanni %A Marzaro, Maurizio %A Fascetti, Leon Francesco %A Bagolan, Pietro %A Vella, Claudio %A Conighi, Maria Luisa %A Codric, Daniela %A Nappo, Simona %A Caione, Paolo %K Humans %K Infant %K Kidney Pelvis %K Minimally Invasive Surgical Procedures %K Ureteral Obstruction %K Video-Assisted Surgery %X

Not available.

%B Pediatr Med Chir %V 39 %P 174 %8 2017 Oct 04 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29034657?dopt=Abstract %R 10.4081/pmc.2017.174 %0 Journal Article %J Acta Paediatr %D 2017 %T Higher growth, fat and fat-free masses correlate with larger cerebellar volumes in preterm infants at term. %A Paviotti, Giulia %A De Cunto, Angela %A Zennaro, Floriana %A Boz, Giulia %A Travan, Laura %A Cont, Gabriele %A Bua, Jenny %A Demarini, Sergio %K Body Composition %K Cerebellum %K Child Development %K Female %K Humans %K Infant, Newborn %K Infant, Premature %K Infant, Very Low Birth Weight %K Male %K Nutritional Status %K Organ Size %K Prospective Studies %K Regression Analysis %X

AIM: Smaller cerebellar volumes in very low-birthweight (VLBW) infants at term have been related to adverse cognitive outcomes, and this study evaluated whether these volumes were associated with a growth in body composition during hospital stays.

METHODS: We prospectively recruited 42 VLBW infants from an Italian neonatal unit between January 2013 and August 2015. Cerebellar volumes and body composition were measured by magnetic resonance imaging (MRI) and air-displacement plethysmography, respectively, at 40 weeks of gestational age and anthropometric and nutritional data were collected. We also included 20 term-born controls.

RESULTS: The mean gestational age and birthweight of the VLBW infants were 29.4 (±1.9) weeks and 1120 (±290) g. There was a positive correlation between cerebellar volumes and daily weight gain from birth to term (R = 0.26, p = 0.001), weight (R = 0.25, p = 0.001), length (R = 0.16, p = 0.01), fat mass (R = 0.15, p = 0.01) and fat-free mass at term (R = 0.20, p = 0.003). In multiple regression analysis, daily weight gain, mechanical ventilation and postconceptional age at MRI were independently associated with cerebellar volumes. Anthropometric data and cerebellar volumes were similar between VLBW and control infants.

CONCLUSION: Higher growth, higher fat mass and fat-free mass were associated with larger cerebellar volumes in VLBW infants at term.

%B Acta Paediatr %V 106 %P 918-925 %8 2017 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28295577?dopt=Abstract %R 10.1111/apa.13829 %0 Journal Article %J Skin Pharmacol Physiol %D 2017 %T Histoproteomic Characterization of Localized Cutaneous Amyloidosis in X-Linked Reticulate Pigmentary Disorder. %A L'Imperio, Vincenzo %A Bruno, Irene %A Rabach, Ingrid %A Smith, Andrew %A Chinello, Clizia %A Stella, Martina %A Magni, Fulvio %A Pagni, Fabio %K Amyloidosis %K Genetic Diseases, X-Linked %K Humans %K Pigmentation Disorders %K Proteomics %K Skin Diseases %B Skin Pharmacol Physiol %V 30 %P 90-93 %8 2017 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/28376499?dopt=Abstract %R 10.1159/000464336 %0 Journal Article %J HLA %D 2017 %T HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection. %A Catamo, E %A Zupin, L %A Freato, N %A Polesello, V %A Celsi, F %A Crocè, S L %A Masutti, F %A Pozzato, G %A Segat, L %A Crovella, S %K 3' Untranslated Regions %K 5' Untranslated Regions %K Adult %K Aged %K Aged, 80 and over %K Alleles %K Case-Control Studies %K Exons %K Female %K Gene Expression %K Gene Frequency %K Genetic Association Studies %K Genetic Predisposition to Disease %K Haplotypes %K Hepacivirus %K Hepatitis C %K HLA-G Antigens %K Humans %K Italy %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Risk %K Th1 Cells %X

BACKGROUND: Hepatitis C virus (HCV) is able to bypass the immune system modulating innate and adaptive immune response and blocking T helper 1 (Th1) cell production. Because the human leukocyte antigen (HLA)-G molecule has immunomodulatory properties inhibiting the function and production of natural killer and cytotoxic lymphocyte T cells, as well as promoting shift from Th1 toward Th2 response, we hypothesized its involvement in susceptibility to HCV infection.

MATERIALS AND METHODS: Considering that HLA-G mRNA expression has been reported to be under genetic control, an association study was conducted analyzing 800 base pairs upstream the ATG at the 5'upstream regulator region (URR) and 850 base pairs from ATG to exon 3 and the 3'untranslated region (UTR) of HLA-G gene in Italian HCV-positive patients and uninfected controls.

RESULTS: Four 5'URR polymorphisms (-725C>G>T, -509C>G, -400G>A and -398G>A), 7 polymorphisms at coding region (+15G>A, +36G>A, +243G>A, insC506, 531G>C, delA615 and 685G>A), the +644G>T polymorphism, and 1 haplotype (TTGTTCCIGAC) showed different frequency distributions between HCV patients and uninfected controls.

CONCLUSION: The results from our study suggest a possible involvement of HLA-G in the risk modulation toward HCV infection.

%B HLA %V 89 %P 135-142 %8 2017 03 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/28083985?dopt=Abstract %R 10.1111/tan.12959 %0 Journal Article %J PLoS One %D 2017 %T Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study. %A McCollum, Eric D %A Nambiar, Bejoy %A Deula, Rashid %A Zadutsa, Beatiwel %A Bondo, Austin %A King, Carina %A Beard, James %A Liyaya, Harry %A Mankhambo, Limangeni %A Lazzerini, Marzia %A Makwenda, Charles %A Masache, Gibson %A Bar-Zeev, Naor %A Kazembe, Peter N %A Mwansambo, Charles %A Lufesi, Norman %A Costello, Anthony %A Armstrong, Ben %A Colbourn, Tim %K Child %K Child Mortality %K Cost of Illness %K Dose-Response Relationship, Immunologic %K Geography %K Humans %K Hypoxia %K Malawi %K Pneumococcal Vaccines %K Pneumonia, Pneumococcal %K Time Factors %K Vaccines, Conjugate %X

BACKGROUND: The pneumococcal conjugate vaccine's (PCV) impact on childhood pneumonia during programmatic conditions in Africa is poorly understood. Following PCV13 introduction in Malawi in November 2011, we evaluated the case burden and rates of childhood pneumonia.

METHODS AND FINDINGS: Between January 1, 2012-June 30, 2014 we conducted active pneumonia surveillance in children <5 years at seven hospitals, 18 health centres, and with 38 community health workers in two districts, central Malawi. Eligible children had clinical pneumonia per Malawi guidelines, defined as fast breathing only, chest indrawing +/- fast breathing, or, ≥1 clinical danger sign. Since pulse oximetry was not in the Malawi guidelines, oxygenation <90% defined hypoxemic pneumonia, a distinct category from clinical pneumonia. We quantified the pneumonia case burden and rates in two ways. We compared the period immediately following vaccine introduction (early) to the period with >75% three-dose PCV13 coverage (post). We also used multivariable time-series regression, adjusting for autocorrelation and exploring seasonal variation and alternative model specifications in sensitivity analyses. The early versus post analysis showed an increase in cases and rates of total, fast breathing, and indrawing pneumonia and a decrease in danger sign and hypoxemic pneumonia, and pneumonia mortality. At 76% three-dose PCV13 coverage, versus 0%, the time-series model showed a non-significant increase in total cases (+47%, 95% CI: -13%, +149%, p = 0.154); fast breathing cases increased 135% (+39%, +297%, p = 0.001), however, hypoxemia fell 47% (-5%, -70%, p = 0.031) and hospital deaths decreased 36% (-1%, -58%, p = 0.047) in children <5 years. We observed a shift towards disease without danger signs, as the proportion of cases with danger signs decreased by 65% (-46%, -77%, p<0.0001). These results were generally robust to plausible alternative model specifications.

CONCLUSIONS: Thirty months after PCV13 introduction in Malawi, the health system burden and rates of the severest forms of childhood pneumonia, including hypoxemia and death, have markedly decreased.

%B PLoS One %V 12 %P e0168209 %8 2017 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28052071?dopt=Abstract %R 10.1371/journal.pone.0168209 %0 Journal Article %J J Endocrinol Invest %D 2017 %T Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity. %A Di Bonito, P %A Pacifico, L %A Chiesa, C %A Valerio, G %A Miraglia Del Giudice, E %A Maffeis, C %A Morandi, A %A Invitti, C %A Licenziati, M R %A Loche, S %A Tornese, G %A Franco, F %A Manco, M %A Baroni, M G %K Adolescent %K Blood Glucose %K Case-Control Studies %K Child %K Fasting %K Female %K Glucose Intolerance %K Glucose Tolerance Test %K Humans %K Insulin %K Insulin Resistance %K Italy %K Male %K Obesity %K Overweight %K Prediabetic State %K Prevalence %X

OBJECTIVE: To investigate in a large sample of overweight/obese (OW/OB) children and adolescents the prevalence of prediabetic phenotypes such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), and to assess their association with cardiometabolic risk (CMR) factors including hepatic steatosis (HS).

METHODS: Population data were obtained from the CARdiometabolic risk factors in children and adolescents in ITALY study. Between 2003 and 2013, 3088 youths (972 children and 2116 adolescents) received oral glucose tolerance test (OGTT) and were included in the study. In 798 individuals, abdominal ultrasound for identification of HS was available.

RESULTS: The prevalence of IFG (3.2 vs. 3.3%) and IGT (4.6 vs. 5.0%) was similar between children and adolescents. Children with isolated IGT had a 2-11 fold increased risk of high LDL-C, non-HDL-C, Tg/HDL-C ratio, and low insulin sensitivity, when compared to those with normal glucose tolerance (NGT). No significant association of IFG with any CMR factor was found in children. Among adolescents, IGT subjects, and to a lesser extent those with IFG, showed a worse CMR profile compared to NGT subgroup. In the overall sample, IGT phenotype showed a twofold increased risk of HS compared to NGT subgroup.

CONCLUSIONS: Our study shows an unexpected similar prevalence of IFG and IGT between children and adolescents with overweight/obesity. The IGT phenotype was associated with a worse CMR profile in both children and adolescents. Phenotyping prediabetes conditions by OGTT should be done as part of prediction and prevention of cardiometabolic diseases in OW/OB youth since early childhood.

%B J Endocrinol Invest %V 40 %P 409-416 %8 2017 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/27854028?dopt=Abstract %R 10.1007/s40618-016-0576-8 %0 Journal Article %J BMC Infect Dis %D 2017 %T Imported arboviral infections in Italy, July 2014-October 2015: a National Reference Laboratory report. %A Fortuna, Claudia %A Remoli, Maria Elena %A Rizzo, Caterina %A Benedetti, Eleonora %A Fiorentini, Cristiano %A Bella, Antonino %A Argentini, Claudio %A Farchi, Francesca %A Castilletti, Concetta %A Capobianchi, Maria Rosaria %A Zammarchi, Lorenzo %A Bartoloni, Alessandro %A Zanchetta, Nadia %A Gismondo, Maria Rita %A Nelli, Luca Ceccherini %A Vitale, Giustina %A Baldelli, Franco %A D'Agaro, Pierlanfranco %A Sodano, Giuseppe %A Rezza, Giovanni %A Venturi, Giulietta %K Chikungunya Fever %K Chikungunya virus %K Dengue %K Dengue Virus %K Disease Outbreaks %K Female %K Genotype %K Humans %K Italy %K Male %K Molecular Diagnostic Techniques %K Population Surveillance %K Public Health %K Travel %K Young Adult %K Zika Virus %K Zika Virus Infection %X

BACKGROUND: Imported cases of infections due to Dengue (DENV) and Chikungunya (CHIKV) viruses and, more recently, Zika virus (ZIKV) are commonly reported among travelers returning from endemic regions. In areas where potentially competent vectors are present, the risk of autochthonous transmission of these vector-borne pathogens is relatively high. Laboratory surveillance is crucial to rapidly detect imported cases in order to reduce the risk of transmission. This study describes the laboratory activity performed by the National Reference Laboratory for Arboviruses (NRLA) at the Italian National Institute of Health in the period from July 2014 to October 2015.

METHODS: Samples from 180 patients visited/hospitalized with a suspected DENV/CHIKV/ZIKV infection were sent to the NRLA from several Italian Hospitals and from Regional Reference Laboratories for Arboviruses, in agreement with the National Plan on human surveillance of vector-borne diseases. Both serological (ELISA IgM test and Plaque Reduction Neutralization Test-PRNT) and molecular assays (Real Time PCR tests, RT-PCR plus nested PCR and sequencing of positive samples) were performed.

RESULTS: DENV infection was the most frequently diagnosed (80 confirmed/probable cases), and all four genotypes were detected. However, an increase in imported CHIKV cases (41 confirmed/probable cases) was observed, along with the detection of the first ZIKV cases (4 confirmed cases), as a consequence of the recent spread of both CHIKV and ZIKV in the Americas.

CONCLUSIONS: Main diagnostic issues highlighted in our study are sensitivity limitations of molecular tests, and the importance of PRNT to confirm serological results for differential diagnosis of Arboviruses. The continuous evaluation of diagnostic strategy, and the implementation of laboratories networks involved in surveillance activities is essential to ensure correct diagnosis, and to improve the preparedness for a rapid and proper identification of viral threats.

%B BMC Infect Dis %V 17 %P 216 %8 2017 03 16 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28302072?dopt=Abstract %R 10.1186/s12879-017-2320-1 %0 Journal Article %J J Inflamm (Lond) %D 2017 %T Influence of vaginal lactoferrin administration on amniotic fluid cytokines and its role against inflammatory complications of pregnancy. %A Maritati, Martina %A Comar, Manola %A Zanotta, Nunzia %A Seraceni, Silva %A Trentini, Alessandro %A Corazza, Fabrizio %A Vesce, Fortunato %A Contini, Carlo %X

BACKGROUND: An altered amniotic cytokine profile has been reported in inflammatory pregnancy complications with a leading role for IL-6, a marker of the foetal systemic inflammatory response. Up to this date there is no exhaustive information neither on the foetal cytokine balance nor on the best method for its modulation. We aimed to evaluate the influence of vaginal lactoferrin administration on amniotic fluid concentration of 47 cytokines, chemokines and growth factors.

METHODS: Sixty women undergoing genetic amniocentesis were enrolled in an open-label clinical trial. 300 mg of vaginal lactoferrin (Florence, Italy) were randomly administered to obtain 3 groups: A, 20 untreated patients; B and C (20 patients in each) respectively treated 4 and 12 h before amniocentesis. Cytokines, chemokines and growth factors concentrations were quantified by a magnetic bead Luminex multiplex immunoassays panel technology. Data analysis was performed with the software Stata (v. 13.1) and GraphPad Prism (v. 5). Group comparisons were performed using Kruskal-Wallis followed by Mann-Whitney U tests, with Bonferroni correction for multiple comparisons. A  < 0.05 was considered significant.

RESULTS: Among the 47 tested mediators, 24 (51.06%) were influenced by lactoferrin. 11 (23.4%), showed a highly significant difference (p <0.001); among these IL-9, IL-15, IFN-γ, IP-10, TNF-α, IL-1α and MCP-3 underwent a down-regulation, while IL-17 and FGF-basic, G-CSF, GM-CSF an up-regulation. Difference between group C and both B and A was small for IL-15, IP-10, IL-1α, MCP-3, while it was negligible for IL-9, IFN-γ and TNF-α. IL-17 and the 3 growth factors were strongly enhanced in B and C groups. IL-17, FGF-basic and GM-CSF showed increasing concentrations in both B and C groups, while G-CSF resulted up-regulated only in group C. Significance was intermediate ( < 0.01) for the down regulated IL-2RA, IL-12p40 and IFNα2 (6.38%) while it was small for 10 mediators (21.27%) 7 of which (IL-2, IL-4, eotaxin, PDGF-BB, RANTES, IL-18 and MIF) down-regulated and 3 (MCP-1, IL-3, and SDF-1α) up-regulated.

CONCLUSION: Lactoferrin down-regulates 17 pro-inflammatory amniotic mediators while up-regulating 7 anti-inflammatory amniotic mediators, 5 of which definitively belonging to an anti-inflammatory profile. These findings open to clinical investigation on its use against inflammatory complications of pregnancy.

%B J Inflamm (Lond) %V 14 %P 5 %8 2017 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28289333?dopt=Abstract %R 10.1186/s12950-017-0152-9 %0 Journal Article %J Lancet %D 2017 %T Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. %A Ravelli, Angelo %A Davì, Sergio %A Bracciolini, Giulia %A Pistorio, Angela %A Consolaro, Alessandro %A van Dijkhuizen, Evert Hendrik Pieter %A Lattanzi, Bianca %A Filocamo, Giovanni %A Verazza, Sara %A Gerloni, Valeria %A Gattinara, Maurizio %A Pontikaki, Irene %A Insalaco, Antonella %A De Benedetti, Fabrizio %A Civino, Adele %A Presta, Giuseppe %A Breda, Luciana %A Marzetti, Valentina %A Pastore, Serena %A Magni-Manzoni, Silvia %A Maggio, Maria Cristina %A Garofalo, Franco %A Rigante, Donato %A Gattorno, Marco %A Malattia, Clara %A Picco, Paolo %A Viola, Stefania %A Lanni, Stefano %A Ruperto, Nicolino %A Martini, Alberto %K Adrenal Cortex Hormones %K Arthritis, Juvenile %K Humans %K Injections, Intra-Articular %K Italy %K Methotrexate %K Prospective Studies %K Treatment Outcome %X

BACKGROUND: Little evidence-based information is available to guide the treatment of oligoarticular juvenile idiopathic arthritis. We aimed to investigate whether oral methotrexate increases the efficacy of intra-articular corticosteroid therapy.

METHODS: We did this prospective, open-label, randomised trial at ten hospitals in Italy. Using a concealed computer-generated list, children younger than 18 years with oligoarticular-onset disease were randomly assigned (1:1) to intra-articular corticosteroids alone or in combination with oral methotrexate (15 mg/m; maximum 20 mg). Corticosteroids used were triamcinolone hexacetonide (shoulder, elbow, wrist, knee, and tibiotalar joints) or methylprednisolone acetate (ie, subtalar and tarsal joints). We did not mask patients or investigators to treatment assignments. Our primary outcome was the proportion of patients in the intention-to-treat population who had remission of arthritis in all injected joints at 12 months. This trial is registered with European Union Clinical Trials Register, EudraCT number 2008-006741-70.

FINDINGS: Between July 7, 2009, and March 31, 2013, we screened 226 participants and randomly assigned 102 to intra-articular corticosteroids alone and 105 to intra-articular corticosteroids plus methotrexate. 33 (32%) patients assigned to intra-articular corticosteroids alone and 39 (37%) assigned to intra-articular corticosteroids and methotrexate therapy had remission of arthritis in all injected joints (p=0·48). Adverse events were recorded for 20 (17%) patients who received methotrexate, which led to permanent treatment discontinuation in two patients (one due to increased liver transaminases and one due to gastrointestinal discomfort). No patient had a serious adverse event.

INTERPRETATION: Concomitant administration of methotrexate did not augment the effectiveness of intra-articular corticosteroid therapy. Future studies are needed to define the optimal therapeutic strategies for oligoarticular juvenile idiopathic arthritis.

FUNDING: Italian Agency of Drug Evaluation.

%B Lancet %V 389 %P 909-916 %8 2017 03 04 %G eng %N 10072 %1 http://www.ncbi.nlm.nih.gov/pubmed/28162781?dopt=Abstract %R 10.1016/S0140-6736(17)30065-X %0 Journal Article %J Paediatr Drugs %D 2017 %T Intranasal Dexmedetomidine for Procedural Sedation in Children, a Suitable Alternative to Chloral Hydrate. %A Cozzi, Giorgio %A Norbedo, Stefania %A Barbi, Egidio %K Administration, Intranasal %K Child %K Chloral Hydrate %K Dexmedetomidine %K Humans %K Hypnotics and Sedatives %X

Sedation is often required for children undergoing diagnostic procedures. Chloral hydrate has been one of the sedative drugs most used in children over the last 3 decades, with supporting evidence for its efficacy and safety. Recently, chloral hydrate was banned in Italy and France, in consideration of evidence of its carcinogenicity and genotoxicity. Dexmedetomidine is a sedative with unique properties that has been increasingly used for procedural sedation in children. Several studies demonstrated its efficacy and safety for sedation in non-painful diagnostic procedures. Dexmedetomidine's impact on respiratory drive and airway patency and tone is much less when compared to the majority of other sedative agents. Administration via the intranasal route allows satisfactory procedural success rates. Studies that specifically compared intranasal dexmedetomidine and chloral hydrate for children undergoing non-painful procedures showed that dexmedetomidine was as effective as and safer than chloral hydrate. For these reasons, we suggest that intranasal dexmedetomidine could be a suitable alternative to chloral hydrate.

%B Paediatr Drugs %V 19 %P 107-111 %8 2017 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/28275979?dopt=Abstract %R 10.1007/s40272-017-0217-5 %0 Journal Article %J Ann Emerg Med %D 2017 %T Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation. %A Cozzi, Giorgio %A Lega, Sara %A Giorgi, Rita %A Barbi, Egidio %K Acute Disease %K Administration, Intranasal %K Anxiety %K Asthma %K Child, Preschool %K Dexmedetomidine %K Emergency Service, Hospital %K Female %K Humans %K Hypnotics and Sedatives %K Infant %K Psychomotor Agitation %X

We describe 2 patients with acute asthma exacerbation who were admitted to the emergency department (ED) with severe agitation and restlessness as a prominent finding, for which bedside asthma treatment sedation with intranasal dexmedetomidine was performed. In both cases, dexmedetomidine allowed the patients to rest and improved tolerance to treatment. Dexmedetomidine is a unique sedative with an excellent safety profile and minimal effect on respiratory function. These properties render it particularly promising for the management of severe agitation in children admitted to the ED with acute asthma exacerbation.

%B Ann Emerg Med %V 69 %P 125-127 %8 2017 01 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27776827?dopt=Abstract %R 10.1016/j.annemergmed.2016.08.005 %0 Journal Article %J Nutrients %D 2017 %T Introduction of Complementary Foods in a Cohort of Infants in Northeast Italy: Do Parents Comply with WHO Recommendations? %A Carletti, Claudia %A Pani, Paola %A Monasta, Lorenzo %A Knowles, Alessandra %A Cattaneo, Adriano %K Adult %K Cohort Studies %K Dairy Products %K Diet %K Edible Grain %K Female %K Follow-Up Studies %K Fruit %K Humans %K Infant %K Infant Nutritional Physiological Phenomena %K Italy %K Logistic Models %K Male %K Mothers %K Patient Compliance %K Recommended Dietary Allowances %K Socioeconomic Factors %K Vegetables %K World Health Organization %X

Timing and type of complementary food in infancy affect nutritional status and health later in life. The objective of this paper was to assess complementary feeding practices, looking at timing, type, and compliance with World Health Organization (WHO) recommendations. Data were obtained from a birth cohort of 400 infants, enrolled in Trieste (Italy) between July 2007 and July 2008 and followed up for three years, using a "food introduction timing table". Five WHO recommendations standards were used to assess parental compliance and associated factors. Thirty seven percent of mothers returned the completed "timing table" up until the child was three years of age. Eighty six percent of infants were already receiving complementary foods at six months. The first food type to be introduced was fresh fruit (170 days from birth, median). Overall, infants shared a very similar diet, which was different from the family diet and characterized by delayed introduction of certain food types. Five percent of parents complied with either all five or only one of the WHO recommendations, 34% with three, and 35% with four. The parents' partial compliance with WHO recommendations is probably due to conflicting information received from different sources. This advocates for national evidence-based guidelines, supported and promoted by health professionals.

%B Nutrients %V 9 %8 2017 Jan 04 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28054972?dopt=Abstract %R 10.3390/nu9010034 %0 Journal Article %J Sci Rep %D 2017 %T ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract development. %A Zhang, Rong %A Knapp, Michael %A Suzuki, Kentaro %A Kajioka, Daiki %A Schmidt, Johanna M %A Winkler, Jonas %A Yilmaz, Öznur %A Pleschka, Michael %A Cao, Jia %A Kockum, Christina Clementson %A Barker, Gillian %A Holmdahl, Gundela %A Beaman, Glenda %A Keene, David %A Woolf, Adrian S %A Cervellione, Raimondo M %A Cheng, Wei %A Wilkins, Simon %A Gearhart, John P %A Sirchia, Fabio %A Di Grazia, Massimo %A Ebert, Anne-Karolin %A Rösch, Wolfgang %A Ellinger, Jörg %A Jenetzky, Ekkehart %A Zwink, Nadine %A Feitz, Wout F %A Marcelis, Carlo %A Schumacher, Johannes %A Martinón-Torres, Federico %A Hibberd, Martin Lloyd %A Khor, Chiea Chuen %A Heilmann-Heimbach, Stefanie %A Barth, Sandra %A Boyadjiev, Simeon A %A Brusco, Alfredo %A Ludwig, Michael %A Newman, William %A Nordenskjöld, Agneta %A Yamada, Gen %A Odermatt, Benjamin %A Reutter, Heiko %K Animals %K Bladder Exstrophy %K Embryo, Mammalian %K Female %K Gene Expression Regulation, Developmental %K Genetic Predisposition to Disease %K Humans %K Larva %K LIM-Homeodomain Proteins %K Mesoderm %K Mice %K Organogenesis %K Polymorphism, Single Nucleotide %K Pronephros %K Protein Isoforms %K Transcription Factors %K Urinary Tract %K Zebrafish %X

Previously genome-wide association methods in patients with classic bladder exstrophy (CBE) found association with ISL1, a master control gene expressed in pericloacal mesenchyme. This study sought to further explore the genetics in a larger set of patients following-up on the most promising genomic regions previously reported. Genotypes of 12 markers obtained from 268 CBE patients of Australian, British, German Italian, Spanish and Swedish origin and 1,354 ethnically matched controls and from 92 CBE case-parent trios from North America were analysed. Only marker rs6874700 at the ISL1 locus showed association (p = 2.22 × 10). A meta-analysis of rs6874700 of our previous and present study showed a p value of 9.2 × 10. Developmental biology models were used to clarify the location of ISL1 activity in the forming urinary tract. Genetic lineage analysis of Isl1-expressing cells by the lineage tracer mouse model showed Isl1-expressing cells in the urinary tract of mouse embryos at E10.5 and distributed in the bladder at E15.5. Expression of isl1 in zebrafish larvae staged 48 hpf was detected in a small region of the developing pronephros. Our study supports ISL1 as a major susceptibility gene for CBE and as a regulator of urinary tract development.

%B Sci Rep %V 7 %P 42170 %8 2017 02 08 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28176844?dopt=Abstract %R 10.1038/srep42170 %0 Journal Article %J Ital J Pediatr %D 2017 %T The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse. %A Pasini, Andrea %A Benetti, Elisa %A Conti, Giovanni %A Ghio, Luciana %A Lepore, Marta %A Massella, Laura %A Molino, Daniela %A Peruzzi, Licia %A Emma, Francesco %A Fede, Carmelo %A Trivelli, Antonella %A Maringhini, Silvio %A Materassi, Marco %A Messina, Giovanni %A Montini, Giovanni %A Murer, Luisa %A Pecoraro, Carmine %A Pennesi, Marco %K Adrenal Cortex Hormones %K Child %K Child, Preschool %K Consensus %K Dose-Response Relationship, Drug %K Drug Administration Schedule %K Female %K Humans %K Italy %K Male %K Nephrotic Syndrome %K Practice Guidelines as Topic %K Prognosis %K Recurrence %K Retreatment %K Societies, Medical %K Survival Rate %K Treatment Outcome %X

This consensus document is aimed at providing an updated, multidisciplinary overview on the diagnosis and treatment of pediatric nephrotic syndrome (NS) at first presentation. It is the first consensus document of its kind to be produced by all the pediatric nephrology centres in Italy, in line with what is already present in other countries such as France, Germany and the USA. It is based on the current knowledge surrounding the symptomatic and steroid treatment of NS, with a view to providing the basis for a separate consensus document on the treatment of relapses. NS is one of the most common pediatric glomerular diseases, with an incidence of around 2-7 cases per 100000 children per year. Corticosteroids are the mainstay of treatment, but the optimal therapeutic regimen for managing childhood idiopathic NS is still under debate. In Italy, shared treatment guidelines were lacking and, consequently, the choice of steroid regimen was based on the clinical expertise of each individual unit. On the basis of the 2015 Cochrane systematic review, KDIGO Guidelines and more recent data from the literature, this working group, with the contribution of all the pediatric nephrology centres in Italy and on the behalf of the Italian Society of Pediatric Nephrology, has produced a shared steroid protocol that will be useful for National Health System hospitals and pediatricians. Investigations at initial presentation and the principal causes of NS to be screened are suggested. In the early phase of the disease, symptomatic treatment is also important as many severe complications can occur which are either directly related to the pathophysiology of the underlying NS or to the steroid treatment itself. To date, very few studies have been published on the prophylaxis and treatment of these early complications, while recommendations are either lacking or conflicting. This consensus provides indications for the prevention, early recognition and treatment of these complications (management of edema and hypovolemia, therapy and prophylaxis of infections and thromboembolic events). Finally, recommendations about the clinical definition of steroid resistance and its initial diagnostic management, as well as indications for renal biopsy are provided.

%B Ital J Pediatr %V 43 %P 41 %8 2017 Apr 21 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28427453?dopt=Abstract %R 10.1186/s13052-017-0356-x %0 Journal Article %J Cell Physiol Biochem %D 2017 %T Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency. %A Tricarico, Paola Maura %A Romeo, Alessandra %A Gratton, Rossella %A Crovella, Sergio %A Celsi, Fulvio %K Animals %K Apoptosis %K Autophagy %K Cell Line, Tumor %K Macrolides %K Mevalonate Kinase Deficiency %K Microtubule-Associated Proteins %K Models, Biological %K Mutation %K Phosphotransferases (Alcohol Group Acceptor) %K Protein Prenylation %K Rats %X

BACKGROUND/AIMS: Mevalonate Kinase Deficiency (MKD), is a hereditary disease due to mutations in mevalonate kinase gene (MVK). MKD has heterogeneous clinical phenotypes: the correlation between MVK mutations and MKD clinical phenotype is still to be fully elucidated. Deficiency of prenylated proteins has been hypothesized as possible MKD pathogenic mechanism. Based on this hypothesis and considering that neurologic impairment characterizes Mevalonic Aciduria (MA), the most severe form of MKD, we studied the effects of I268T and N301T MVK mutations on protein prenylation, autophagy and programmed cell death in SH-SY5Y neuroblastoma cell lines.

METHODS: SH-SY5Y cells were transiently transfected, with the pCMV-6 plasmid containing MVK wild type and the two mutated sequences. Protein prenylation levels were evaluated using GFP-RhoA-F to assess farnesylation, and GFP-RhoA to evaluate geranylgeranylation; autophagy was measured by evaluating LC3 and p62 protein levels, while Annexin V-FITC and Propidium Iodide staining allowed apoptosis detection.

RESULTS: MVK mutants' over-expression causes decreased levels of farnesylation and geranylgeranylation, and also increased LC3 lipidation in SH-SY5Y, with concomitant p62 accumulation. Treatment with bafilomycin A1 (an inhibitor of vacuolar H+-ATPase, a late autophagy inhibitor) further increase LC3-II and p62 levels, suggesting that degradation of autophagolysosome could be impaired. SH-SY5Y, with both MVK mutants, showed apoptosis increase; the presence of N301T associated with augmented cell death.

CONCLUSIONS: We hypothesize that mevalonate pathway impairment causes alteration of farnesylation and geranylgeranylation proteins and alteration of the autophagic flux; these changes can induce apoptosis, possibly more relevant in the presence of N301T mutation.

%B Cell Physiol Biochem %V 41 %P 1649-1660 %8 2017 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/28359055?dopt=Abstract %R 10.1159/000471235 %0 Journal Article %J Oral Dis %D 2017 %T LTF and DEFB1 polymorphisms are associated with susceptibility toward chronic periodontitis development. %A Zupin, L %A Robino, A %A Navarra, C O %A Pirastu, N %A Di Lenarda, R %A Gasparini, P %A Crovella, S %A Bevilacqua, L %K Adolescent %K Adult %K Aged %K Aged, 80 and over %K beta-Defensins %K Case-Control Studies %K Chronic Periodontitis %K Female %K Genetic Predisposition to Disease %K Humans %K Lactoferrin %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Young Adult %X

OBJECTIVES: Chronic periodontitis is a common pathological condition that affects the supporting tissue of the teeth, leading to progressive alveolar bone destruction and teeth loss. The disease is caused by bacteria and derives from an altered host immune and inflammatory response, also involving different factors such as the oral hygiene, smoking, and genetic background. The innate immune response, the first line of host defense, could also play an important role in the susceptibility to chronic periodontitis. In this study, we evaluated the possible association between periodontal disease and seven genetic variations within DEFB1 and LTF genes, encoding for β-defensins 1 and lactoferrin (two members of oral innate immune system), in an Italian isolated population.

SUBJECTS AND METHODS: DEFB1 5'UTR g. -52G>A (rs1799946), g. -44C>G (rs1800972), g. -20G>A (rs11362), 3'UTR c*5G>A (rs1047031), c*87A>G (rs1800971), LTF p.Ala29Thr (rs1126477), and p.Lys47Arg (rs1126478) single nucleotide polymorphisms (SNPs) were analyzed in 155 healthy individuals and 439 chronic periodontitis patients from North-East Italy.

RESULTS: Significant associations were found between periodontitis and g. -20G>A (rs11362) and g. -44C>G (rs1800972) SNPs in DEFB1 gene as well as p.Ala29Thr (rs1126477) and p.Lys47Arg (rs1126478) SNPs in LTF gene.

DISCUSSION: Our results suggest the involvement of DEFB1 and LTF genetic variations in the susceptibility toward development of periodontitis.

%B Oral Dis %V 23 %P 1001-1008 %8 2017 Oct %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/28485077?dopt=Abstract %R 10.1111/odi.12689 %0 Journal Article %J J Clin Endocrinol Metab %D 2017 %T MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency. %A Desai, Swapna %A Wood-Trageser, Michelle %A Matic, Jelena %A Chipkin, Jaqueline %A Jiang, Huaiyang %A Bachelot, Anne %A Dulon, Jerome %A Sala, Cinzia %A Barbieri, Caterina %A Cocca, Massimiliano %A Toniolo, Daniela %A Touraine, Philippe %A Witchel, Selma %A Rajkovic, Aleksandar %K Adult %K Aging %K DNA Damage %K DNA Repair %K Female %K Humans %K Minichromosome Maintenance Proteins %K Primary Ovarian Insufficiency %K Sequence Analysis, DNA %X

Objective: To assess the frequency of variants, including biallelic pathogenic variants, in minichromosome maintenance 8 (MCM8) and minichromosome maintenance 9 (MCM9), other genes related to MCM8-MCM9, and DNA damage repair (DDR) pathway in participants with primary ovarian insufficiency (POI).

Design: MCM8, MCM9, and genes encoding DDR proteins that have been implicated in reproductive aging were sequenced among POI participants.

Setting: Academic research institution.

Participants: All were diagnosed with POI prior to age 40 years and presented with elevated follicle-stimulating hormone levels.

Interventions: None.

Main Outcome Measures: We identified nucleotide variants in MCM8, MCM9, and genes thought to be involved in the DNA damage response pathway and/or implicated in reproductive aging.

Results: MCM8 was sequenced in 155 POI participants, whereas MCM9 was sequenced in 151 participants. Three of 155 (2%) participants carried possibly damaging heterozygous variants in MCM8, whereas 7 of 151 (5%) individuals carried possibly damaging heterozygous variants in MCM9. One participant carried a novel homozygous variant, c.1651C>T, p.Gln551*, in MCM9, which is predicted to introduce a premature stop codon in exon 9. Biallelic damaging heterozygous variants in both MCM8 and MCM9 were identified in 1 participant. Of a total of 10 participants carrying damaging heterozygous variants in either MCM8 or MCM9, 2 individuals carried heterozygous damaging variants in genes associated with either MCM8 or MCM9 or the DDR pathway.

Conclusions: We identified a significant number of potentially damaging and novel variants in MCM8 and MCM9 among participants with POI and examined multiallelic association with variants in DDR and MCM8-MCM9 interactome genes.

%B J Clin Endocrinol Metab %V 102 %P 576-582 %8 2017 02 01 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/27802094?dopt=Abstract %R 10.1210/jc.2016-2565 %0 Journal Article %J Pediatr Emerg Care %D 2017 %T Mental Health Problems in Children and Adolescents in the Emergency Department: "The Times They Are A-Changin'". %A Cozzi, Giorgio %A Minute, Marta %A Ventura, Giovanna %A Barbi, Egidio %K Adolescent %K Child %K Emergency Service, Hospital %K Humans %K Mental Disorders %K Mental Health Services %K Patient Admission %B Pediatr Emerg Care %V 33 %P e8 %8 2017 07 %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/28590995?dopt=Abstract %R 10.1097/PEC.0000000000001193 %0 Journal Article %J Clin Transl Oncol %D 2017 %T Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials? %A Di Cataldo, A %A Agodi, A %A Balaguer, J %A Garaventa, A %A Barchitta, M %A Segura, V %A Bianchi, M %A Castel, V %A Castellano, A %A Cesaro, S %A Couselo, J M %A Cruz, O %A D'Angelo, P %A De Bernardi, B %A Donat, J %A de Andoin, N G %A Hernandez, M I %A La Spina, M %A Lillo, M %A Lopez-Almaraz, R %A Luksch, R %A Mastrangelo, S %A Mateos, E %A Molina, J %A Moscheo, C %A Mura, R %A Porta, F %A Russo, G %A Tondo, A %A Torrent, M %A Vetrella, S %A Villegas, J A %A Viscardi, E %A Zanazzo, G A %A Cañete, A %K Biomarkers, Tumor %K Child %K Child, Preschool %K Clinical Trials as Topic %K Combined Modality Therapy %K Female %K Follow-Up Studies %K Gene Amplification %K Humans %K Infant %K Infant, Newborn %K Male %K N-Myc Proto-Oncogene Protein %K Neoplasm Staging %K Neuroblastoma %K Prognosis %K Survival Rate %X

INTRODUCTION: SIOPEN INES protocol yielded excellent 5-year survival rates for MYCN-non-amplified metastatic neuroblastoma. Patients deemed ineligible due to lack or delay of MYCN status or late registration were treated, but not included in the study. Our goal was to analyse survival at 10 years among the whole population.

MATERIALS AND METHODS: Italian and Spanish metastatic INES patients' data are reported. SPSS 20.0 was used for statistical analysis.

RESULTS: Among 98 infants, 27 had events and 19 died, while 79 were disease free. Five- and 10-year event-free survival (EFS) were 73 and 70 %, and overall survival (OS) was 81 and 74 %, respectively. MYCN status was significant for EFS, but not for OS in multivariate analysis.

CONCLUSIONS: The survival rates of patients who complied with all the inclusion criteria for INES trials are higher compared to those that included also not registered patients. Five-year EFS and OS for INES 99.2 were 87.8 and 95.7 %, while our stage 4s population obtained 78 and 87 %. Concerning 99.3, 5-year EFS and OS were 86.7 and 95.6 %, while for stage 4 we registered 61 and 68 %. MYCN amplification had a strong impact on prognosis and therefore we consider it unacceptable that many patients were not studied for MYCN and probably inadequately treated. Ten-year survival rates were shown to decrease: EFS from 73 to 70 % and OS from 81 to 74 %, indicating a risk of late events, particularly in stage 4s. Population-based registries like European ENCCA WP 11-task 11 will possibly clarify these data.

%B Clin Transl Oncol %V 19 %P 76-83 %8 2017 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27041689?dopt=Abstract %R 10.1007/s12094-016-1505-1 %0 Journal Article %J Inflamm Bowel Dis %D 2017 %T Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease. %A Stocco, Gabriele %A Martelossi, Stefano %A Arrigo, Serena %A Barabino, Arrigo %A Aloi, Marina %A Martinelli, Massimo %A Miele, Erasmo %A Knafelz, Daniela %A Romano, Claudio %A Naviglio, Samuele %A Favretto, Diego %A Cuzzoni, Eva %A Franca, Raffaella %A Decorti, Giuliana %A Ventura, Alessandro %K Adolescent %K Age of Onset %K Antimetabolites %K Azathioprine %K Case-Control Studies %K Child %K Child, Preschool %K Chromatography, High Pressure Liquid %K Dose-Response Relationship, Drug %K Erythrocytes %K Female %K Guanine Nucleotides %K Humans %K Inflammatory Bowel Diseases %K Male %K Mercaptopurine %K Methyltransferases %K Thioguanine %X

BACKGROUND: Early-onset inflammatory bowel disease (IBD) is generally aggressive, with a high probability of complications and need of surgery. Despite the introduction of highly effective biological drugs, treatment with azathioprine continues to be important even for early-onset IBD; however, in these patients azathioprine response seems to be reduced. This study evaluated azathioprine doses, metabolite concentrations, and their associations with patients' age in children with IBD treated at 6 tertiary pediatric referral centers.

METHODS: Azathioprine doses, metabolites, and clinical effects were assessed after at least 3 months of therapy in 17 early-onset (age < 6 yr, cases) and 51 nonearly-onset (aged > 12 and <18 yrs, controls) patients with IBD. Azathioprine dose was titrated on therapeutic efficacy (response and adverse effects). Azathioprine metabolites and thiopurine methyltransferase activity were determined by high-performance liquid chromatography with ultra violet-vis detection (HPLC-UV) methods.

RESULTS: Frequency of patients in remission was similar among early-onset and control groups, respectively (82% and 84%, P value = 0.72). Early-onset patients required higher doses of azathioprine (median 2.7 versus 2.0 mg·kg·d, P value = 1.1 × 10). Different doses resulted in comparable azathioprine active thioguanine nucleotide metabolite concentrations (median 263 versus 366 pmol/8 × 10 erythrocytes, P value = 0.41) and methylmercaptopurine nucleotide concentrations (median 1455 versus 1532 pmol/8 × 10 erythrocytes, P value = 0.60). Lower ratios between thioguanine nucleotide metabolites and azathioprine doses were found in early-onset patients (median 98 versus 184 pmol/8 × 10 erythrocytes·mg·kg·d, P value = 0.017). Interestingly, early-onset patients presented also higher thiopurine methyltransferase activity (median 476 versus 350 nmol methylmercaptopurine/mg hemoglobin/h, P-value = 0.046).

CONCLUSIONS: This study demonstrated that patients with early-onset IBD present increased inactivating azathioprine metabolism, likely because of elevated activity of the enzyme thiopurine methyltransferase.

%B Inflamm Bowel Dis %V 23 %P 628-634 %8 2017 04 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/28296824?dopt=Abstract %R 10.1097/MIB.0000000000001051 %0 Journal Article %J Am J Hematol %D 2017 %T Mutations of RUNX1 in families with inherited thrombocytopenia. %A De Rocco, Daniela %A Melazzini, Federica %A Marconi, Caterina %A Pecci, Alessandro %A Bottega, Roberta %A Gnan, Chiara %A Palombo, Flavia %A Giordano, Paola %A Coccioli, Maria Susanna %A Glembotsky, Ana C %A Heller, Paula G %A Seri, Marco %A Savoia, Anna %A Noris, Patrizia %K Adult %K Blood Platelets %K Cell Size %K Child %K Child, Preschool %K Core Binding Factor Alpha 2 Subunit %K Female %K Frameshift Mutation %K Genes, Dominant %K Heterozygote %K Humans %K Introns %K Leukemia, Myeloid, Acute %K Male %K Middle Aged %K Mutation, Missense %K Protein Domains %K RNA Splice Sites %K Sequence Deletion %K Thrombocythemia, Essential %K Thrombopoietin %K Transcriptional Activation %K Young Adult %B Am J Hematol %V 92 %P E86-E88 %8 2017 06 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28240786?dopt=Abstract %R 10.1002/ajh.24703 %0 Journal Article %J Immunotherapy %D 2017 %T Natalizumab treatment of multiple sclerosis: new insights. %A Delbue, Serena %A Comar, Manola %A Ferrante, Pasquale %K Animals %K Drug-Related Side Effects and Adverse Reactions %K Humans %K Immunotherapy %K Integrin alpha Chains %K Integrin alpha4 %K Integrin beta Chains %K JC Virus %K Leukoencephalopathy, Progressive Multifocal %K Multiple Sclerosis, Relapsing-Remitting %K Natalizumab %K Risk %K Virus Activation %K Virus Replication %X

Natalizumab is a monoclonal antibody directed against the α4 chain of the very late activating antigen 4 and α4β7 integrins, present on the leukocytes surface, used as monotherapy for the treatment of relapsing-remitting multiple sclerosis. It substantially reduces relapse rate and the accumulation of disability, but its use is associated with a very adverse event, that is the development of progressive multifocal leukoencephalopathy, a fatal demyelinating disease of the CNS, due to the lytic replication of the human polyomavirus JC. The main focus of the review is to describe the newest insights on natalizumab, its current use in the clinical practice, the natalizumab-treated patients' management and the risk stratification related to the progressive multifocal leukoencephalopathy development.

%B Immunotherapy %V 9 %P 157-171 %8 2017 01 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/28004598?dopt=Abstract %R 10.2217/imt-2016-0113 %0 Journal Article %J AJNR Am J Neuroradiol %D 2017 %T Neuroimaging Changes in Menkes Disease, Part 1. %A Manara, R %A D'Agata, L %A Rocco, M C %A Cusmai, R %A Freri, E %A Pinelli, L %A Darra, F %A Procopio, E %A Mardari, R %A Zanus, C %A Di Rosa, G %A Soddu, C %A Severino, M %A Ermani, M %A Longo, D %A Sartori, S %K Brain %K Disease Progression %K Female %K Humans %K Magnetic Resonance Imaging %K Male %K Menkes Kinky Hair Syndrome %K Neuroimaging %K Retrospective Studies %K White Matter %X

Menkes disease is a rare multisystem X-linked disorder of copper metabolism. Despite an early, severe, and progressive neurologic involvement, our knowledge of brain involvement remains unsatisfactory. The first part of this retrospective and review MR imaging study aims to define the frequency rate, timing, imaging features, and evolution of intracranial vascular and white matter changes. According to our analysis, striking but also poorly evolutive vascular abnormalities characterize the very early phases of disease. After the first months, myelination delay becomes evident, often in association with protean focal white matter lesions, some of which reveal an age-specific brain vulnerability. In later phases of the disease, concomitant progressive neurodegeneration might hinder the myelination progression. The currently enriched knowledge of neuroradiologic finding evolution provides valuable clues for early diagnosis, identifies possible MR imaging biomarkers of new treatment efficacy, and improves our comprehension of possible mechanisms of brain injury in Menkes disease.

%B AJNR Am J Neuroradiol %V 38 %P 1850-1857 %8 2017 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/28495946?dopt=Abstract %R 10.3174/ajnr.A5186 %0 Journal Article %J Hypertension %D 2017 %T Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney. %A Wain, Louise V %A Vaez, Ahmad %A Jansen, Rick %A Joehanes, Roby %A van der Most, Peter J %A Erzurumluoglu, A Mesut %A O'Reilly, Paul F %A Cabrera, Claudia P %A Warren, Helen R %A Rose, Lynda M %A Verwoert, Germaine C %A Hottenga, Jouke-Jan %A Strawbridge, Rona J %A Esko, Tõnu %A Arking, Dan E %A Hwang, Shih-Jen %A Guo, Xiuqing %A Kutalik, Zoltán %A Trompet, Stella %A Shrine, Nick %A Teumer, Alexander %A Ried, Janina S %A Bis, Joshua C %A Smith, Albert V %A Amin, Najaf %A Nolte, Ilja M %A Lyytikäinen, Leo-Pekka %A Mahajan, Anubha %A Wareham, Nicholas J %A Hofer, Edith %A Joshi, Peter K %A Kristiansson, Kati %A Traglia, Michela %A Havulinna, Aki S %A Goel, Anuj %A Nalls, Mike A %A Sõber, Siim %A Vuckovic, Dragana %A Luan, Jian'an %A del Greco M, Fabiola %A Ayers, Kristin L %A Marrugat, Jaume %A Ruggiero, Daniela %A Lopez, Lorna M %A Niiranen, Teemu %A Enroth, Stefan %A Jackson, Anne U %A Nelson, Christopher P %A Huffman, Jennifer E %A Zhang, Weihua %A Marten, Jonathan %A Gandin, Ilaria %A Harris, Sarah E %A Zemunik, Tatijana %A Lu, Yingchang %A Evangelou, Evangelos %A Shah, Nabi %A de Borst, Martin H %A Mangino, Massimo %A Prins, Bram P %A Campbell, Archie %A Li-Gao, Ruifang %A Chauhan, Ganesh %A Oldmeadow, Christopher %A Abecasis, Goncalo %A Abedi, Maryam %A Barbieri, Caterina M %A Barnes, Michael R %A Batini, Chiara %A Beilby, John %A Blake, Tineka %A Boehnke, Michael %A Bottinger, Erwin P %A Braund, Peter S %A Brown, Morris %A Brumat, Marco %A Campbell, Harry %A Chambers, John C %A Cocca, Massimiliano %A Collins, Francis %A Connell, John %A Cordell, Heather J %A Damman, Jeffrey J %A Davies, Gail %A de Geus, Eco J %A de Mutsert, Renée %A Deelen, Joris %A Demirkale, Yusuf %A Doney, Alex S F %A Dörr, Marcus %A Farrall, Martin %A Ferreira, Teresa %A Frånberg, Mattias %A Gao, He %A Giedraitis, Vilmantas %A Gieger, Christian %A Giulianini, Franco %A Gow, Alan J %A Hamsten, Anders %A Harris, Tamara B %A Hofman, Albert %A Holliday, Elizabeth G %A Hui, Jennie %A Järvelin, Marjo-Riitta %A Johansson, Åsa %A Johnson, Andrew D %A Jousilahti, Pekka %A Jula, Antti %A Kähönen, Mika %A Kathiresan, Sekar %A Khaw, Kay-Tee %A Kolcic, Ivana %A Koskinen, Seppo %A Langenberg, Claudia %A Larson, Marty %A Launer, Lenore J %A Lehne, Benjamin %A Liewald, David C M %A Lin, Li %A Lind, Lars %A Mach, François %A Mamasoula, Chrysovalanto %A Menni, Cristina %A Mifsud, Borbala %A Milaneschi, Yuri %A Morgan, Anna %A Morris, Andrew D %A Morrison, Alanna C %A Munson, Peter J %A Nandakumar, Priyanka %A Nguyen, Quang Tri %A Nutile, Teresa %A Oldehinkel, Albertine J %A Oostra, Ben A %A Org, Elin %A Padmanabhan, Sandosh %A Palotie, Aarno %A Paré, Guillaume %A Pattie, Alison %A Penninx, Brenda W J H %A Poulter, Neil %A Pramstaller, Peter P %A Raitakari, Olli T %A Ren, Meixia %A Rice, Kenneth %A Ridker, Paul M %A Riese, Harriëtte %A Ripatti, Samuli %A Robino, Antonietta %A Rotter, Jerome I %A Rudan, Igor %A Saba, Yasaman %A Saint Pierre, Aude %A Sala, Cinzia F %A Sarin, Antti-Pekka %A Schmidt, Reinhold %A Scott, Rodney %A Seelen, Marc A %A Shields, Denis C %A Siscovick, David %A Sorice, Rossella %A Stanton, Alice %A Stott, David J %A Sundström, Johan %A Swertz, Morris %A Taylor, Kent D %A Thom, Simon %A Tzoulaki, Ioanna %A Tzourio, Christophe %A Uitterlinden, André G %A Völker, Uwe %A Vollenweider, Peter %A Wild, Sarah %A Willemsen, Gonneke %A Wright, Alan F %A Yao, Jie %A Thériault, Sébastien %A Conen, David %A Attia, John %A Sever, Peter %A Debette, Stéphanie %A Mook-Kanamori, Dennis O %A Zeggini, Eleftheria %A Spector, Tim D %A van der Harst, Pim %A Palmer, Colin N A %A Vergnaud, Anne-Claire %A Loos, Ruth J F %A Polasek, Ozren %A Starr, John M %A Girotto, Giorgia %A Hayward, Caroline %A Kooner, Jaspal S %A Lindgren, Cecila M %A Vitart, Veronique %A Samani, Nilesh J %A Tuomilehto, Jaakko %A Gyllensten, Ulf %A Knekt, Paul %A Deary, Ian J %A Ciullo, Marina %A Elosua, Roberto %A Keavney, Bernard D %A Hicks, Andrew A %A Scott, Robert A %A Gasparini, Paolo %A Laan, Maris %A Liu, Yongmei %A Watkins, Hugh %A Hartman, Catharina A %A Salomaa, Veikko %A Toniolo, Daniela %A Perola, Markus %A Wilson, James F %A Schmidt, Helena %A Zhao, Jing Hua %A Lehtimäki, Terho %A van Duijn, Cornelia M %A Gudnason, Vilmundur %A Psaty, Bruce M %A Peters, Annette %A Rettig, Rainer %A James, Alan %A Jukema, J Wouter %A Strachan, David P %A Palmas, Walter %A Metspalu, Andres %A Ingelsson, Erik %A Boomsma, Dorret I %A Franco, Oscar H %A Bochud, Murielle %A Newton-Cheh, Christopher %A Munroe, Patricia B %A Elliott, Paul %A Chasman, Daniel I %A Chakravarti, Aravinda %A Knight, Joanne %A Morris, Andrew P %A Levy, Daniel %A Tobin, Martin D %A Snieder, Harold %A Caulfield, Mark J %A Ehret, Georg B %X

Elevated blood pressure is a major risk factor for cardiovascular disease and has a substantial genetic contribution. Genetic variation influencing blood pressure has the potential to identify new pharmacological targets for the treatment of hypertension. To discover additional novel blood pressure loci, we used 1000 Genomes Project-based imputation in 150 134 European ancestry individuals and sought significant evidence for independent replication in a further 228 245 individuals. We report 6 new signals of association in or near , , , , , and , and provide new replication evidence for a further 2 signals in and Combining large whole-blood gene expression resources totaling 12 607 individuals, we investigated all novel and previously reported signals and identified 48 genes with evidence for involvement in blood pressure regulation that are significant in multiple resources. Three novel kidney-specific signals were also detected. These robustly implicated genes may provide new leads for therapeutic innovation.

%B Hypertension %8 2017 Jul 24 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28739976?dopt=Abstract %R 10.1161/HYPERTENSIONAHA.117.09438 %0 Journal Article %J Dis Markers %D 2017 %T A Novel Panel of Serum Biomarkers for MPM Diagnosis. %A Bonotti, A %A Foddis, R %A Landi, S %A Melaiu, O %A De Santi, C %A Giusti, L %A Donadio, E %A Ciregia, F %A Mazzoni, M R %A Lucacchini, A %A Bovenzi, M %A Comar, M %A Pantani, E %A Pistelli, A %A Cristaudo, A %K Aged %K Biomarkers, Tumor %K Blood Proteins %K Case-Control Studies %K Female %K Humans %K Lung Neoplasms %K Male %K Mesothelioma %K Middle Aged %K Proteome %X

Exposure to asbestos is the main cause of malignant pleural mesothelioma (MPM), a highly aggressive cancer of the pleura. Since the only tools for early detection are based on radiological tests, some authors focused on serum markers (i.e., mesothelin). The aim of this study was the evaluation of new serum biomarkers to be used individually or in combination, in order to improve the outcome of patients whose disease would be diagnosed at an earlier stage. Serum and plasma were available from 43 subjects previously exposed to asbestos and 27 MPM patients, all being epithelioid type. All the new markers found differentially expressed in MPM and healthy subjects, by proteomic and genomic approaches, have been validated in the serum by the use of specific ELISA. The combined approach, using tools of genomics and proteomics, is found to be highly innovative for this type of disease and led to the identification of new serum markers in the diagnosis of MPM. These results, if confirmed in a larger series, may have a strong impact in this area, because early detection of this cancer in people at high risk could significantly improve the course of the disease and the clinical approach to an individualized therapy.

%B Dis Markers %V 2017 %P 3510984 %8 2017 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28348450?dopt=Abstract %R 10.1155/2017/3510984 %0 Journal Article %J Nephrol Dial Transplant %D 2017 %T Outcome of childhood-onset full-house nephropathy. %A Ruggiero, Barbara %A Vivarelli, Marina %A Gianviti, Alessandra %A Pecoraro, Carmine %A Peruzzi, Licia %A Benetti, Elisa %A Ventura, Giovanna %A Pennesi, Marco %A Murer, Luisa %A Coppo, Rosanna %A Emma, Francesco %K Adolescent %K Age of Onset %K Child %K Disease Progression %K Female %K Glomerular Filtration Rate %K Glomerulonephritis %K Humans %K Kidney Diseases %K Lupus Erythematosus, Systemic %K Lupus Nephritis %K Male %K Proteinuria %K Recurrence %K Remission Induction %K Retrospective Studies %K Risk Factors %K Survival Rate %X

Background: Patients with full-house nephropathy (FHN) present renal lesions that are indistinguishable from those of lupus nephritis (LN) but lack the systemic features necessary to meet diagnostic criteria for systemic lupus erithematosus (SLE). Some have been reported to develop a delayed SLE with time. The clinical outcome of children having FHN without SLE has never been reported.

Methods: Children with biopsy-proven FHN were selected after excluding SLE cases by the absence of America College of Rheumatology criteria. The proportion of patients with complete (proteinuria <0.5 g/day) or partial remission (proteinuria ≤50% from baseline), relapse (estimated glomerular filtration rate <25% and/or proteinuria ≥50% from baseline) and progression to Stage III chronic kidney disease (CKD) was described according to age and gender groups with the Kaplan-Meier curve and compared with the Log-rank test. Entity of treatment was summarized by a score at induction (0-6 months) and maintenance (6-18 months). Cox-regression model was performed to test predictors of remission, relapse and progression to CKD.

Results: Among 42 patients (28 pre-pubertal) who met the inclusion criteria, 39 (92.9%) achieved partial and 32 (76.2%) complete remission of nephropathy over 2.78 and 7.51 months of follow-up. At 10 years, the probability of progressing to CKD was 4.8%. Of those achieving remission, 18% had a renal flare mainly within 4 years after remission. Pre-pubertal males achieved complete remission more frequently than other patients but often relapsed; pre-pubertal females were treated more aggressively. Cox-regression analysis did not find independent predictors of remission or relapse.

Conclusions: The outcome of the patients with FHN we investigated was encouraging. Recurrences are limited to the first 4 years following diagnosis, allowing progressive withdrawal of immunosuppression in patients achieving remission. Evaluation of risk factors for adverse outcome is necessary especially in pre-pubertal children.

%B Nephrol Dial Transplant %V 32 %P 1194-1204 %8 2017 Jul 01 %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/27270291?dopt=Abstract %R 10.1093/ndt/gfw230 %0 Journal Article %J World J Gastroenterol %D 2017 %T Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology. %A Romano, Claudio %A Oliva, Salvatore %A Martellossi, Stefano %A Miele, Erasmo %A Arrigo, Serena %A Graziani, Maria Giovanna %A Cardile, Sabrina %A Gaiani, Federica %A de'Angelis, Gian Luigi %A Torroni, Filippo %K Adolescent %K Child %K Child, Preschool %K Diagnostic Imaging %K Endoscopy %K Gastroenterology %K Gastrointestinal Diseases %K Gastrointestinal Hemorrhage %K Hemodynamics %K Humans %K Infant %K Infant, Newborn %K Italy %K Pediatrics %K Recurrence %K Societies, Medical %X

There are many causes of gastrointestinal bleeding (GIB) in children, and this condition is not rare, having a reported incidence of 6.4%. Causes vary with age, but show considerable overlap; moreover, while many of the causes in the pediatric population are similar to those in adults, some lesions are unique to children. The diagnostic approach for pediatric GIB includes definition of the etiology, localization of the bleeding site and determination of the severity of bleeding; timely and accurate diagnosis is necessary to reduce morbidity and mortality. To assist medical care providers in the evaluation and management of children with GIB, the "Gastro-Ped Bleed Team" of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) carried out a systematic search on MEDLINE PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) to identify all articles published in English from January 1990 to 2016; the following key words were used to conduct the electronic search: "upper GIB" and "pediatric" [all fields]; "lower GIB" and "pediatric" [all fields]; "obscure GIB" and "pediatric" [all fields]; "GIB" and "endoscopy" [all fields]; "GIB" and "therapy" [all fields]. The identified publications included articles describing randomized controlled trials, reviews, case reports, cohort studies, case-control studies and observational studies. References from the pertinent articles were also reviewed. This paper expresses a position statement of SIGENP that can have an immediate impact on clinical practice and for which sufficient evidence is not available in literature. The experts participating in this effort were selected according to their expertise and professional qualifications.

%B World J Gastroenterol %V 23 %P 1328-1337 %8 2017 Feb 28 %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/28293079?dopt=Abstract %R 10.3748/wjg.v23.i8.1328 %0 Journal Article %J J Pediatr Adolesc Gynecol %D 2017 %T Pediatric Ovarian Torsion and its Recurrence: A Multicenter Study. %A Bertozzi, Mirko %A Esposito, Ciro %A Vella, Claudio %A Briganti, Vito %A Zampieri, Nicola %A Codrich, Daniela %A Ubertazzi, Michele %A Trucchi, Alessandro %A Magrini, Elisa %A Battaglia, Sonia %A Bini, Vittorio %A Conighi, Maria Luisa %A Gulia, Caterina %A Farina, Alessandra %A Camoglio, Francesco Saverio %A Rigamonti, Waifro %A Gamba, Piergiorgio %A Riccipetitoni, Giovanna %A Chiarenza, Salvatore Fabio %A Inserra, Alessandro %A Appignani, Antonino %K Adolescent %K Child %K Child, Preschool %K Cohort Studies %K Female %K Humans %K Infant %K Italy %K Laparoscopy %K Laparotomy %K Menarche %K Ovarian Diseases %K Ovariectomy %K Postoperative Complications %K Recurrence %K Retrospective Studies %K Surveys and Questionnaires %K Torsion Abnormality %X

STUDY OBJECTIVE: To report results of a retrospective multicentric Italian survey concerning the management of pediatric ovarian torsion (OT) and its recurrence.

DESIGN: Multicenter retrospective cohort study.

SETTING: Italian Units of Pediatric Surgery.

PARTICIPANTS: Participants were female aged 1-14 years of age with surgically diagnosed OT between 2004 and 2014.

INTERVENTIONS: Adnexal detorsion, adnexectomy, mass excision using laparoscopy or laparotomy. Different kinds of oophoropexy (OPY) for OT or recurrence, respectively.

MAIN OUTCOME MEASURES: A total of 124 questionnaires were returned and analyzed to understand the current management of pediatric OT and its recurrence. The questionnaires concerned patient age, presence of menarche, OT site, presence and type of mass, performed procedure, OPY technique adopted, intra- and postoperative complications, recurrence and site, procedure performed for recurrence, OPY technique for recurrence, and 1 year follow-up of detorsed ovaries.

RESULTS: Mean age at surgery was 9.79 ± 3.54 years. Performed procedures were open adnexectomy (52 of 125; 41.6%), laparoscopic adnexectomy (25 of 125; 20%), open detorsion (10 of 125; 8%), and laparoscopic detorsion (38 of 125; 30.4%). Recurrence occurred in 15 of 125 cases (12%) and resulted as significant (P = .012) if associated with a normal ovary at the first episode of torsion. Recurrence occurred only in 1 of 19 cases after OPY (5.2%). Ultrasonographic results of detorsed ovaries were not significant whether an OPY was performed or not (P = 1.00).

CONCLUSION: Unfortunately, oophorectomy and open technique are still widely adopted even if not advised. Recurrence is not rare and the risk is greater in patients without ovarian masses. OPY does not adversely affect ultrasonographic results at 1 year. When possible OPY should be performed at the first episode of OT.

%B J Pediatr Adolesc Gynecol %V 30 %P 413-417 %8 2017 Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/27894860?dopt=Abstract %R 10.1016/j.jpag.2016.11.008 %0 Journal Article %J Am J Med Genet A %D 2017 %T Phenotypic expression of 19q13.32 microdeletions: Report of a new patient and review of the literature. %A Travan, Laura %A Naviglio, Samuele %A De Cunto, Angela %A Pellegrin, Andrea %A Pecile, Vanna %A Spinelli, Alessandro Mauro %A Cappellani, Stefania %A Faletra, Flavio %X

The phenotypic manifestations of microdeletions in the 19q13.32 region are still poorly known. In this paper we report a patient who presented with hypotonia, developmental delay, facial dysmorphism, micrognathia, kyphoscoliosis, and buried penis. Chromosomal microarray revealed an interstitial 327 kb de novo microdeletion in the 19q13.32 region comprising eight genes (ARGHAP35, NPAS1, TMEM160, ZC3H4, SAE1, BBC3, MIR3190, and MIR3191). Previously reported cases of microdeletions in the 19q13.32 region were reviewed and compared to our patient, highlighting the common features of a possible 19q13.32 microdeletion syndrome.

%B Am J Med Genet A %8 2017 Apr 14 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28411391?dopt=Abstract %R 10.1002/ajmg.a.38256 %0 Journal Article %J Inflammopharmacology %D 2017 %T Polymorphisms in key bone modulator cytokines genes influence bisphosphonates therapy in postmenopausal women. %A Lima, C A D %A Javorski, N R %A Souza, A P O %A Barbosa, A D %A Valença, A P M C %A Crovella, S %A Souza, P R E %A de Azevêdo Silva, J %A Sandrin-Garcia, P %K Aged %K Bone Density %K Bone Remodeling %K Cytokines %K Diphosphonates %K Female %K Humans %K Middle Aged %K Osteoporosis, Postmenopausal %K Polymorphism, Single Nucleotide %K Postmenopause %X

Osteoporosis is a multifactorial and debilitating disease resulting from decreased bone mineral density (BMD) and loss of tissue microarchitecture. Ineffective therapies may lead to bone fractures and subsequent death. Single nucleotide polymorphisms (SNPs) in key immune regulator genes have been associated with therapeutic response to bisphosphonates, which are the first therapeutic line of choice for osteoporosis. However, cytokine pathways and their relation with therapeutic adhesion remain to be fully elucidated. Aimed at better understanding these processes, we investigated the response to bisphosphonate therapy in postmenopausal women and four SNPs in key proinflammatory cytokines genes: IL23R +2284 (C>A) (rs10889677), IL17A +672 (G>A) (rs7747909), IL12B +1188 (T>G) (rs3212227) and INF-γ -1616 (G>A) (rs2069705). A total of 69 patients treated with bisphosphonate were followed for a period of 1 up to 4 years, genotyped and compared according to their changes in bone mineral density (BMD) and level of biochemical markers during their treatment. The INF-γ -1616 G/G associated with increased BMD values in femoral neck (GG/AA, p = 0.016) and decreased BMD values in total hip (GG/GA, p = 0.019; GG/AA, p = 0.011). In relation to biochemical markers, INF-γ -1616 SNP associated with increased alkaline phosphatase (GG/AA; p < 0.0001) and parathyroid hormone levels (AA/GA; p = 0.017). Vitamin D values changes were related to IL17A +672 (GG/GA, p = 0.034) and to IL12B +1188 (TT/TG, p = 0.046) SNPs. Besides, significant differences in changes of calcium levels correlated with IL23R +2284 (CC/CA, p = 0.016) genotypes. Altogether, we suggest that these polymorphisms may play an important role for therapeutic decisions in osteoporosis treatment.

%B Inflammopharmacology %V 25 %P 191-201 %8 2017 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/28220389?dopt=Abstract %R 10.1007/s10787-017-0322-7 %0 Journal Article %J J Rheumatol %D 2017 %T Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis. %A Simonini, Gabriele %A Bracaglia, Claudia %A Cattalini, Marco %A Taddio, Andrea %A Brambilla, Alice %A de Libero, Cinzia %A Pires Marafon, Denise %A Caputo, Roberto %A Cimaz, Rolando %K Adolescent %K Antirheumatic Agents %K Autoimmune Diseases %K Child %K Child, Preschool %K Female %K Humans %K Male %K Predictive Value of Tests %K Recurrence %K Retrospective Studies %K Treatment Outcome %K Uveitis %K Withholding Treatment %X

OBJECTIVE: To identify clinical predictors of relapse in childhood autoimmune chronic uveitis after stopping systemic treatment.

METHODS: A retrospective, multicenter, cohort study.

RESULTS: Ninety-four children in remission, receiving no treatments and with at least a 6-month followup, were enrolled. A higher probability of maintaining remission after discontinuing treatment was shown in idiopathic compared with juvenile idiopathic arthritis uveitis (Mantel-Cox chi-square = 23.21) if inactivity had been obtained within 6 months from starting systemic treatment (Mantel-Cox chi-square = 24.17) and by antitumor necrosis factor-α treatment (Mantel-Cox chi-square = 6.43).

CONCLUSION: Type of disease, time, and type of systemic therapy to achieve inactivity predict different duration of uveitis remission after treatment withdrawal.

%B J Rheumatol %V 44 %P 822-826 %8 2017 06 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28365583?dopt=Abstract %R 10.3899/jrheum.161336 %0 Journal Article %J Epidemiol Infect %D 2017 %T Pregnant with HIV before age 25: data from a large national study in Italy, 2001-2016. %A Floridia, M %A Masuelli, G %A Tamburrini, E %A Cetin, I %A Liuzzi, G %A Martinelli, P %A Guaraldi, G %A Spinillo, A %A Vimercati, A %A Maso, G %A Pinnetti, C %A Frisina, V %A Dalzero, S %A Ravizza, M %K Adolescent %K Cohort Studies %K Female %K HIV Infections %K Humans %K Italy %K Odds Ratio %K Pregnancy %K Young Adult %X

Young pregnant women with HIV may be at significant risk of unplanned pregnancy, lower treatment coverage, and other adverse pregnancy outcomes. In a large cohort of pregnant women with HIV in Italy, among 2979 pregnancies followed in 2001-2016, 9·0% were in women <25 years, with a significant increase over time (2001-2005: 7·0%; 2006-2010: 9·1%; 2011-2016: 12·2%, P < 0·001). Younger women had a lower rate of planned pregnancy (23·2% vs. 37·7%, odds ratio (OR) 0·50, 95% confidence interval (CI) 0·36-0·69), were more frequently diagnosed with HIV in pregnancy (46·5% vs. 20·9%, OR 3·29, 95% CI 2·54-4·25), and, if already diagnosed with HIV before pregnancy, were less frequently on antiretroviral treatment at conception (<25 years: 56·3%; ⩾25 years: 69·0%, OR 0·58, 95% CI 0·41-0·81). During pregnancy, treatment coverage was almost universal in both age groups (98·5% vs. 99·3%), with no differences in rate of HIV viral suppression at third trimester and adverse pregnancy outcomes. The data show that young women represent a growing proportion of pregnant women with HIV, and are significantly more likely to have unplanned pregnancy, undiagnosed HIV infection, and lower treatment coverage at conception. During pregnancy, antiretroviral treatment, HIV suppression, and pregnancy outcomes are similar compared with older women. Earlier intervention strategies may provide additional benefits in the quality of care for women with HIV.

%B Epidemiol Infect %V 145 %P 2360-2365 %8 2017 08 %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/28712385?dopt=Abstract %R 10.1017/S0950268817001340 %0 Journal Article %J Int J Gynecol Cancer %D 2017 %T Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study. %A Fanfani, Francesco %A Restaino, Stefano %A Cicogna, Stefania %A Petrillo, Marco %A Montico, Marcella %A Perrone, Emanuele %A Radillo, Oriano %A De Leo, Rossella %A Ceccarello, Matteo %A Scambia, Giovanni %A Ricci, Giuseppe %K Adult %K Aged %K Aged, 80 and over %K Biomarkers, Tumor %K Endometrial Neoplasms %K Female %K Humans %K Middle Aged %K Neoplasm Staging %K Preoperative Care %K Prognosis %K Prospective Studies %K Proteins %X

OBJECTIVE: The aim of the study was to evaluate the prognostic value of human epididymis protein 4 (HE4) and cancer antigen 125 markers with pathological prognostic factor to complete the preoperative clinical panel and help the treatment planning.

METHODS: This prospective multicenter study was conducted in 2 gynecologic oncology centers between 2012 and 2014 (Institute for Maternal and Child Health IRCCS Burlo Garofolo in Trieste and Catholic University of the Sacred Heart in Rome, Italy). We enrolled 153 patients diagnosed with clinical early (International Federation of Gynecology and Obstetrics stages I-II) type I endometrial cancer.

RESULTS: Human epididymis protein 4 levels seemed to be strictly related to age (P < 0.001) and menopausal status (P < 0.002). Compared with myometrial invasion (MI), the HE4 values were significantly higher in case of invasion of greater than 50% of the thickness: MI of greater than 50%, median of 94.85 pmol/L (38.3-820.8 pmol/L), versus MI of less than 50%, median of 65.65 pmol/L (25.1-360.2 pmol/L), (P < 0.001). The HE4 levels increase significantly with increasing tumor size: diameter of larger than 2 cm, median of 86.9 pmol/L (35.8-820.8 pmol/L), versus diameter of smaller than 2 cm, median of 52.2 pmol/L (33.3-146.8 pmol/L), (P < 0.001). In our population, HE4 did not correlate with the histological grade, endometrial cancer type I versus type II (P = 0.86), the lymphovascular infiltration (P = 0.12), and the cervical invasion (P = 0.6). We established a new variable, considering 3 high-risk tumor features: MI of greater than 50% and/or histological G3 and/or type II. Human epididymis protein 4 levels significantly increase in high-risk tumors (high risk HE4, 93.6 pmol/L vs low-medium risk, 65.5 pmol/L; P < 0.001).

CONCLUSIONS: A preoperative HE4 evaluation could help stratify patients with deep invasion and/or metastatic disease and is correlated with other relevant prognostic factors to be considered to tailor an adequate surgical strategy.

%B Int J Gynecol Cancer %V 27 %P 1200-1205 %8 2017 07 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28557834?dopt=Abstract %R 10.1097/IGC.0000000000001015 %0 Journal Article %J J Pediatr Urol %D 2017 %T Preputial reconstruction in hypospadias repair. %A Castagnetti, Marco %A Bagnara, Vincenzo %A Rigamonti, Waifro %A Cimador, Marcello %A Esposito, Ciro %X

OBJECTIVE: In principle, the prepuce can be reconstructed during hypospadias repair, but the procedure has not gained wide acceptance and preputial reconstruction (PR) is surrounded by several controversies.

MATERIAL AND METHODS: A review is provided of the technique for PR, how PR combines with the other steps of hypospadias repair, the risks of complications related to the urethroplasty and specific to PR, and the results of PR with particular regard to the relevance for the patient and his family.

RESULTS: PR can be important for patients requiring hypospadias repair and their parents. It can be performed in almost all patients with distal hypospadias except perhaps those with the most asymmetrical prepuces or severe ventral skin deficiency. PR does not seem to increase urethroplasty complications, but combination of PR with tubularisation of the urethral plate urethroplasty seems to offer the best chance of success. Specific complications occur in around 8% of patients and include partial or complete dehiscence of the prepuce and secondary phimosis. To prevent the latter, the reconstructed prepuce should be easily retractile at the end of surgery. Technical modifications can help to achieve this goal. Cosmetically, reconstructed prepuces are not fully normal, but the abnormality could be less important for a patient and his parents that the complete absence of the prepuce.

CONCLUSION: On the basis of the evidence summarised above, an algorithm for PR in patients with distal hypospadias is proposed. PR can be offered to the vast majority of distal hypospadias patients, although some modification of the technique for hypospadias repair can be required. Retractility of the reconstructed prepuce at the end of surgery seems paramount for final success.

%B J Pediatr Urol %V 13 %P 102-109 %8 2017 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27773620?dopt=Abstract %R 10.1016/j.jpurol.2016.07.018 %0 Journal Article %J Arch Dis Child Fetal Neonatal Ed %D 2017 %T Presentation of acute suppurative parotitis in a newborn with incessant crying. %A Velkoski, Angelika %A Amoroso, Stefano %A Brovedani, Pierpaolo %A Cont, Gabriele %A Trappan, Antonella %A Travan, Laura %K Acute Disease %K Anti-Bacterial Agents %K Crying %K Female %K Humans %K Infant, Newborn %K Parotitis %K Staphylococcal Infections %K Staphylococcus aureus %B Arch Dis Child Fetal Neonatal Ed %V 102 %P F125 %8 2017 Mar %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/27986789?dopt=Abstract %R 10.1136/archdischild-2016-312070 %0 Journal Article %J Anticancer Res %D 2017 %T Puzzling Results from Germline Mutations Analysis in a Group of Asbestos-Exposed Patients in a High-risk Area of Northeast Italy. %A Rizzardi, Clara %A Athanasakis, Emmanouil %A Cammisuli, Francesca %A Monego, Simeone Dal %A DE Spelorzi, Yeraldin Chiquinquira Castillo %A Costantinides, Fulvio %A Giudici, Fabiola %A Pinamonti, Maurizio %A Canzonieri, Vincenzo %A Melato, Mauro %A Pascolo, Lorella %K Aged %K Aged, 80 and over %K Asbestos %K Environmental Exposure %K Female %K Germ-Line Mutation %K Humans %K Italy %K Lung Neoplasms %K Male %K Mesothelioma %K Middle Aged %K Risk %K Tumor Suppressor Proteins %K Ubiquitin Thiolesterase %X

BACKGROUND: Germline mutations of the oncosuppressor gene breast cancer 1-associated protein 1 (BAP1) were recently related to an autosomal-dominant tumor predisposition syndrome (BAP1-TPDS), characterized by uveal melanoma, malignant mesothelioma (MM), cutaneous melanoma, and other malignancies. The demonstration that BAP1 mutations are strongly associated with MM has provided a real breakthrough in the study of genetic predisposition in MM, that may explain why only a fraction of asbestos-exposed individuals go on to develop MM.

MATERIALS AND METHODS: To evaluate the possible role of BAP1 mutations in the epidemiology of sporadic MM, and their relationship with asbestos exposure, we determined the prevalence of germline BAP1 mutations by the Sanger method in a group of 29 asbestos-exposed patients, 21 of which were diagnosed with MM. They were residents of Trieste, a ship-building town in Northeast Italy with a very high incidence of mesothelioma.

RESULTS: We identified non-obviously pathogenetic germline sequence variants of BAP1 in 3/29 patients and in 2/21 MM cases (10%).

CONCLUSION: Non obviously pathogenic germline sequence variants of BAP1 were found. Nevertheless, limitations of predictive web tools allowed us to comment on some interesting peculiarities of our findings.

%B Anticancer Res %V 37 %P 3073-3083 %8 2017 06 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28551647?dopt=Abstract %R 10.21873/anticanres.11663 %0 Journal Article %J Nature %D 2017 %T Rare and low-frequency coding variants alter human adult height. %A Marouli, Eirini %A Graff, Mariaelisa %A Medina-Gomez, Carolina %A Lo, Ken Sin %A Wood, Andrew R %A Kjaer, Troels R %A Fine, Rebecca S %A Lu, Yingchang %A Schurmann, Claudia %A Highland, Heather M %A Rüeger, Sina %A Thorleifsson, Gudmar %A Justice, Anne E %A Lamparter, David %A Stirrups, Kathleen E %A Turcot, Valérie %A Young, Kristin L %A Winkler, Thomas W %A Esko, Tõnu %A Karaderi, Tugce %A Locke, Adam E %A Masca, Nicholas G D %A Ng, Maggie C Y %A Mudgal, Poorva %A Rivas, Manuel A %A Vedantam, Sailaja %A Mahajan, Anubha %A Guo, Xiuqing %A Abecasis, Goncalo %A Aben, Katja K %A Adair, Linda S %A Alam, Dewan S %A Albrecht, Eva %A Allin, Kristine H %A Allison, Matthew %A Amouyel, Philippe %A Appel, Emil V %A Arveiler, Dominique %A Asselbergs, Folkert W %A Auer, Paul L %A Balkau, Beverley %A Banas, Bernhard %A Bang, Lia E %A Benn, Marianne %A Bergmann, Sven %A Bielak, Lawrence F %A Blüher, Matthias %A Boeing, Heiner %A Boerwinkle, Eric %A Böger, Carsten A %A Bonnycastle, Lori L %A Bork-Jensen, Jette %A Bots, Michiel L %A Bottinger, Erwin P %A Bowden, Donald W %A Brandslund, Ivan %A Breen, Gerome %A Brilliant, Murray H %A Broer, Linda %A Burt, Amber A %A Butterworth, Adam S %A Carey, David J %A Caulfield, Mark J %A Chambers, John C %A Chasman, Daniel I %A Chen, Yii-Der Ida %A Chowdhury, Rajiv %A Christensen, Cramer %A Chu, Audrey Y %A Cocca, Massimiliano %A Collins, Francis S %A Cook, James P %A Corley, Janie %A Galbany, Jordi Corominas %A Cox, Amanda J %A Cuellar-Partida, Gabriel %A Danesh, John %A Davies, Gail %A de Bakker, Paul I W %A de Borst, Gert J %A de Denus, Simon %A de Groot, Mark C H %A de Mutsert, Renée %A Deary, Ian J %A Dedoussis, George %A Demerath, Ellen W %A den Hollander, Anneke I %A Dennis, Joe G %A Di Angelantonio, Emanuele %A Drenos, Fotios %A Du, Mengmeng %A Dunning, Alison M %A Easton, Douglas F %A Ebeling, Tapani %A Edwards, Todd L %A Ellinor, Patrick T %A Elliott, Paul %A Evangelou, Evangelos %A Farmaki, Aliki-Eleni %A Faul, Jessica D %A Feitosa, Mary F %A Feng, Shuang %A Ferrannini, Ele %A Ferrario, Marco M %A Ferrières, Jean %A Florez, Jose C %A Ford, Ian %A Fornage, Myriam %A Franks, Paul W %A Frikke-Schmidt, Ruth %A Galesloot, Tessel E %A Gan, Wei %A Gandin, Ilaria %A Gasparini, Paolo %A Giedraitis, Vilmantas %A Giri, Ayush %A Girotto, Giorgia %A Gordon, Scott D %A Gordon-Larsen, Penny %A Gorski, Mathias %A Grarup, Niels %A Grove, Megan L %A Gudnason, Vilmundur %A Gustafsson, Stefan %A Hansen, Torben %A Harris, Kathleen Mullan %A Harris, Tamara B %A Hattersley, Andrew T %A Hayward, Caroline %A He, Liang %A Heid, Iris M %A Heikkilä, Kauko %A Helgeland, Øyvind %A Hernesniemi, Jussi %A Hewitt, Alex W %A Hocking, Lynne J %A Hollensted, Mette %A Holmen, Oddgeir L %A Hovingh, G Kees %A Howson, Joanna M M %A Hoyng, Carel B %A Huang, Paul L %A Hveem, Kristian %A Ikram, M Arfan %A Ingelsson, Erik %A Jackson, Anne U %A Jansson, Jan-Håkan %A Jarvik, Gail P %A Jensen, Gorm B %A Jhun, Min A %A Jia, Yucheng %A Jiang, Xuejuan %A Johansson, Stefan %A Jørgensen, Marit E %A Jørgensen, Torben %A Jousilahti, Pekka %A Jukema, J Wouter %A Kahali, Bratati %A Kahn, René S %A Kähönen, Mika %A Kamstrup, Pia R %A Kanoni, Stavroula %A Kaprio, Jaakko %A Karaleftheri, Maria %A Kardia, Sharon L R %A Karpe, Fredrik %A Kee, Frank %A Keeman, Renske %A Kiemeney, Lambertus A %A Kitajima, Hidetoshi %A Kluivers, Kirsten B %A Kocher, Thomas %A Komulainen, Pirjo %A Kontto, Jukka %A Kooner, Jaspal S %A Kooperberg, Charles %A Kovacs, Peter %A Kriebel, Jennifer %A Kuivaniemi, Helena %A Küry, Sébastien %A Kuusisto, Johanna %A La Bianca, Martina %A Laakso, Markku %A Lakka, Timo A %A Lange, Ethan M %A Lange, Leslie A %A Langefeld, Carl D %A Langenberg, Claudia %A Larson, Eric B %A Lee, I-Te %A Lehtimäki, Terho %A Lewis, Cora E %A Li, Huaixing %A Li, Jin %A Li-Gao, Ruifang %A Lin, Honghuang %A Lin, Li-An %A Lin, Xu %A Lind, Lars %A Lindström, Jaana %A Linneberg, Allan %A Liu, Yeheng %A Liu, Yongmei %A Lophatananon, Artitaya %A Luan, Jian'an %A Lubitz, Steven A %A Lyytikäinen, Leo-Pekka %A Mackey, David A %A Madden, Pamela A F %A Manning, Alisa K %A Männistö, Satu %A Marenne, Gaëlle %A Marten, Jonathan %A Martin, Nicholas G %A Mazul, Angela L %A Meidtner, Karina %A Metspalu, Andres %A Mitchell, Paul %A Mohlke, Karen L %A Mook-Kanamori, Dennis O %A Morgan, Anna %A Morris, Andrew D %A Morris, Andrew P %A Müller-Nurasyid, Martina %A Munroe, Patricia B %A Nalls, Mike A %A Nauck, Matthias %A Nelson, Christopher P %A Neville, Matt %A Nielsen, Sune F %A Nikus, Kjell %A Njølstad, Pål R %A Nordestgaard, Børge G %A Ntalla, Ioanna %A O'Connel, Jeffrey R %A Oksa, Heikki %A Loohuis, Loes M Olde %A Ophoff, Roel A %A Owen, Katharine R %A Packard, Chris J %A Padmanabhan, Sandosh %A Palmer, Colin N A %A Pasterkamp, Gerard %A Patel, Aniruddh P %A Pattie, Alison %A Pedersen, Oluf %A Peissig, Peggy L %A Peloso, Gina M %A Pennell, Craig E %A Perola, Markus %A Perry, James A %A Perry, John R B %A Person, Thomas N %A Pirie, Ailith %A Polasek, Ozren %A Posthuma, Danielle %A Raitakari, Olli T %A Rasheed, Asif %A Rauramaa, Rainer %A Reilly, Dermot F %A Reiner, Alex P %A Renstrom, Frida %A Ridker, Paul M %A Rioux, John D %A Robertson, Neil %A Robino, Antonietta %A Rolandsson, Olov %A Rudan, Igor %A Ruth, Katherine S %A Saleheen, Danish %A Salomaa, Veikko %A Samani, Nilesh J %A Sandow, Kevin %A Sapkota, Yadav %A Sattar, Naveed %A Schmidt, Marjanka K %A Schreiner, Pamela J %A Schulze, Matthias B %A Scott, Robert A %A Segura-Lepe, Marcelo P %A Shah, Svati %A Sim, Xueling %A Sivapalaratnam, Suthesh %A Small, Kerrin S %A Smith, Albert Vernon %A Smith, Jennifer A %A Southam, Lorraine %A Spector, Timothy D %A Speliotes, Elizabeth K %A Starr, John M %A Steinthorsdottir, Valgerdur %A Stringham, Heather M %A Stumvoll, Michael %A Surendran, Praveen %A 't Hart, Leen M %A Tansey, Katherine E %A Tardif, Jean-Claude %A Taylor, Kent D %A Teumer, Alexander %A Thompson, Deborah J %A Thorsteinsdottir, Unnur %A Thuesen, Betina H %A Tönjes, Anke %A Tromp, Gerard %A Trompet, Stella %A Tsafantakis, Emmanouil %A Tuomilehto, Jaakko %A Tybjaerg-Hansen, Anne %A Tyrer, Jonathan P %A Uher, Rudolf %A Uitterlinden, André G %A Ulivi, Sheila %A van der Laan, Sander W %A Van Der Leij, Andries R %A van Duijn, Cornelia M %A van Schoor, Natasja M %A van Setten, Jessica %A Varbo, Anette %A Varga, Tibor V %A Varma, Rohit %A Edwards, Digna R Velez %A Vermeulen, Sita H %A Vestergaard, Henrik %A Vitart, Veronique %A Vogt, Thomas F %A Vozzi, Diego %A Walker, Mark %A Wang, Feijie %A Wang, Carol A %A Wang, Shuai %A Wang, Yiqin %A Wareham, Nicholas J %A Warren, Helen R %A Wessel, Jennifer %A Willems, Sara M %A Wilson, James G %A Witte, Daniel R %A Woods, Michael O %A Wu, Ying %A Yaghootkar, Hanieh %A Yao, Jie %A Yao, Pang %A Yerges-Armstrong, Laura M %A Young, Robin %A Zeggini, Eleftheria %A Zhan, Xiaowei %A Zhang, Weihua %A Zhao, Jing Hua %A Zhao, Wei %A Zhao, Wei %A Zheng, He %A Zhou, Wei %A Rotter, Jerome I %A Boehnke, Michael %A Kathiresan, Sekar %A McCarthy, Mark I %A Willer, Cristen J %A Stefansson, Kari %A Borecki, Ingrid B %A Liu, Dajiang J %A North, Kari E %A Heard-Costa, Nancy L %A Pers, Tune H %A Lindgren, Cecilia M %A Oxvig, Claus %A Kutalik, Zoltán %A Rivadeneira, Fernando %A Loos, Ruth J F %A Frayling, Timothy M %A Hirschhorn, Joel N %A Deloukas, Panos %A Lettre, Guillaume %K ADAMTS Proteins %K Adult %K Alleles %K Body Height %K Cell Adhesion Molecules %K Female %K Gene Frequency %K Genetic Variation %K Genome, Human %K Glycoproteins %K Glycosaminoglycans %K Hedgehog Proteins %K Humans %K Intercellular Signaling Peptides and Proteins %K Interferon Regulatory Factors %K Interleukin-11 Receptor alpha Subunit %K Male %K Multifactorial Inheritance %K NADPH Oxidase 4 %K NADPH Oxidases %K Phenotype %K Pregnancy-Associated Plasma Protein-A %K Procollagen N-Endopeptidase %K Proteoglycans %K Proteolysis %K Receptors, Androgen %K Somatomedins %X

Height is a highly heritable, classic polygenic trait with approximately 700 common associated variants identified through genome-wide association studies so far. Here, we report 83 height-associated coding variants with lower minor-allele frequencies (in the range of 0.1-4.8%) and effects of up to 2 centimetres per allele (such as those in IHH, STC2, AR and CRISPLD2), greater than ten times the average effect of common variants. In functional follow-up studies, rare height-increasing alleles of STC2 (giving an increase of 1-2 centimetres per allele) compromised proteolytic inhibition of PAPP-A and increased cleavage of IGFBP-4 in vitro, resulting in higher bioavailability of insulin-like growth factors. These 83 height-associated variants overlap genes that are mutated in monogenic growth disorders and highlight new biological candidates (such as ADAMTS3, IL11RA and NOX4) and pathways (such as proteoglycan and glycosaminoglycan synthesis) involved in growth. Our results demonstrate that sufficiently large sample sizes can uncover rare and low-frequency variants of moderate-to-large effect associated with polygenic human phenotypes, and that these variants implicate relevant genes and pathways.

%B Nature %V 542 %P 186-190 %8 2017 02 09 %G eng %N 7640 %1 http://www.ncbi.nlm.nih.gov/pubmed/28146470?dopt=Abstract %R 10.1038/nature21039 %0 Journal Article %J Eur J Haematol %D 2017 %T Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients. %A Cesaro, Simone %A Tridello, Gloria %A Castagnola, Elio %A Calore, Elisabetta %A Carraro, Francesca %A Mariotti, Ilaria %A Colombini, Antonella %A Perruccio, Katia %A Decembrino, Nunzia %A Russo, Giovanna %A Maximova, Natalia %A Baretta, Valentina %A Caselli, Désirée %K Adolescent %K Antifungal Agents %K Antineoplastic Combined Chemotherapy Protocols %K Child %K Child, Preschool %K Drug Therapy, Combination %K Female %K Hematologic Neoplasms %K Hematopoietic Stem Cell Transplantation %K Humans %K Incidence %K Male %K Mycoses %K Patient Outcome Assessment %K Retrospective Studies %K Survival Analysis %K Treatment Outcome %X

BACKGROUND: Invasive fungal infection (IFI) is a cause of morbidity, mortality and increased health costs in children undergoing chemotherapy or hematopoietic stem cell transplant (HSCT).

METHODS: Multicenter, retrospective study to assess the incidence, outcome of proven and probable IFI (PP-IFI) in children treated for acute leukemia, non-Hodgkin lymphoma or who underwent HSCT from 2006 to 2012.

RESULTS: Over the 7-year period, 127 PP-IFI were diagnosed in 123 patients, median age of 9.7 years. The 1-year cumulative incidence was 2.5% (CI 1.8-3.7) after frontline chemotherapy, 9.4% (CI 5.8-15.0) after relapse, and 5.3% (CI 3.9-7.1) after HSCT. Severe neutropenia was present in 98 (77%) patients. Culture-proven agents were Candida spp., mostly non-albicans, 28, mold 23, whereas three proven IFI were identified by histopathology. Favorable response to treatment within 3 months from diagnosis was observed in 77 (89%). The overall ninety-day probability of survival was 68% (CI 59-76).

CONCLUSIONS: About two-thirds of pediatric patients with PP-IFI survived, regardless of whether the infection occurred after frontline chemotherapy, reinduction chemotherapy for disease relapse, or after HSCT. Further prospective studies are needed to define the impact of antifungal prophylaxis and early combination therapy on short-term overall survival.

%B Eur J Haematol %V 99 %P 240-248 %8 2017 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/28556426?dopt=Abstract %R 10.1111/ejh.12910 %0 Journal Article %J Infect Agent Cancer %D 2017 %T Review on the role of the human Polyomavirus JC in the development of tumors. %A Delbue, Serena %A Comar, Manola %A Ferrante, Pasquale %X

Almost one fifth of human cancers worldwide are associated with infectious agents, either bacteria or viruses, and this makes the possible association between infections and tumors a relevant research issue. We focused our attention on the human Polyomavirus JC (JCPyV), that is a small, naked DNA virus, belonging to the family. It is the recognized etiological agent of the Progressive Multifocal Leukoencephalopathy (PML), a fatal demyelinating disease, occurring in immunosuppressed individuals. JCPyV is able to induce cell transformation in vitro when infecting non-permissive cells, that do not support viral replication and JCPyV inoculation into small animal models and non human primates drives to tumor formation. The molecular mechanisms involved in JCPyV oncogenesis have been extensively studied: the main oncogenic viral protein is the large tumor antigen (T-Ag), that is able to bind, among other cellular factors, both Retinoblastoma protein (pRb) and p53 and to dysregulate the cell cycle, but also the early proteins small tumor antigen (t-Ag) and Agnoprotein appear to cooperate in the process of cell transformation. Consequently, it is not surprising that JCPyV genomic sequences and protein expression have been detected in Central Nervous System (CNS) tumors and colon cancer and an association between this virus and several brain and non CNS-tumors has been proposed. However, the significances of these findings are under debate because there is still insufficient evidence of a casual association between JCPyV and solid cancer development. In this paper we summarized and critically analyzed the published literature, in order to describe the current knowledge on the possible role of JCPyV in the development of human tumors.

%B Infect Agent Cancer %V 12 %P 10 %8 2017 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28174598?dopt=Abstract %R 10.1186/s13027-017-0122-0 %0 Journal Article %J J Paediatr Child Health %D 2017 %T Risk of hospitalisation after early-revisit in the emergency department. %A Cozzi, Giorgio %A Ghirardo, Sergio %A Fiorese, Ilaria %A Proietti, Ilaria %A Monasta, Lorenzo %A Minute, Marta %A Barbi, Egidio %A Calligaris, Lorenzo %K Adolescent %K Child %K Child, Preschool %K Emergency Service, Hospital %K Female %K Hospitalization %K Humans %K Infant %K Italy %K Male %K Retrospective Studies %K Risk Assessment %K Tertiary Care Centers %K Time Factors %X

AIM: Early-revisits are frequent in the paediatric emergency department (ED) setting, but few data are available about early-revisited patients. The aim of this study was to investigate the hospitalisation rate of a population of early-revisited patients and to detect if an early-revisited patient was at risk of a more severe disease.

METHODS: Between June 2014 and January 2015, we conducted a retrospective cohort study, considering all patients presented to the ED of a tertiary level children's hospital in Italy. We selected all patients who were revisited within 72 h from the initial visit (study cohort), while all other patients accessed in the same period were considered the control cohort. The two cohorts were compared for age, gender, triage category, hospitalisation rate, diagnosis at admission and hospital length of stay.

RESULTS: In the study period, we reviewed 10 750 visits, of which 430 (4%) were unplanned revisits for the same chief complaint within 72 h from the initial visit. Hospitalisation rate of early-revisited patients was significantly higher compared to control patients (8.4 vs. 2.9%). Hospitalisation rate increases in parallel with the number of revisits, but in many cases, it was not directly related to a worst triage category, neither to a longer hospital length of stay.

CONCLUSION: Early revisited patients in the ED had a significantly higher risk of hospitalisation, but this risk was only partially related to their clinical conditions.

%B J Paediatr Child Health %V 53 %P 850-854 %8 2017 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/28513890?dopt=Abstract %R 10.1111/jpc.13561 %0 Journal Article %J Ital J Pediatr %D 2017 %T Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience. %A El Hachem, Maya %A Gesualdo, Francesco %A Diociaiuti, Andrea %A Berti, Irene %A Vercellino, Nadia %A Boccaletti, Valeria %A Neri, Iria %A Porcedda, Giulio %A Greco, Antonella %A Carnevale, Claudia %A Oranges, Teresa %A Cutrone, Mario %A Dalmonte, Pietro %K Administration, Oral %K Age Factors %K Cohort Studies %K Dose-Response Relationship, Drug %K Drug Administration Schedule %K Female %K Hemangioma %K Humans %K Infant %K Infant, Newborn %K Italy %K Male %K Patient Safety %K Propranolol %K Retrospective Studies %K Skin Neoplasms %K Treatment Outcome %X

BACKGROUND: Despite not being licensed for the treatment of infantile hemangiomas (IH) in infants younger than 5 weeks or older than 5 months, propranolol is often used in these age groups to prevent or to treat potentially severe complications. The objective of the present study was to review the experience of 8 Italian pediatric and dermatologic centers regarding propranolol treatment for IH started before 5 weeks or after 5 months of age.

METHODS: We retrospectively reviewed the records of patients followed up for IH, on propranolol treatment started before 5 weeks or after 5 months of age, and collected information on sociodemographic data, treatment indications, IH involution, IH relapse, and treatment side effects.

RESULTS: A total of 343 patients were enrolled; 15 were started on propranolol before 5 weeks (group 1), 328 were started after 5 months of age (group 2). The most frequent indications were permanent aesthetical disfigurement (91.8%) and function threatening complications (42.6%). In most cases, the treatment was effective. The involution was partial in 67.7% of patients. In 11.8% of cases a relapse was observed. No relapse was observed in group 1. Treatment complications were reported in 15.8% of children, most frequently sleep disorders (6.6%), followed by irritability (5.1%) and diarrhea (2.2%). Only a case of mild constipation was observed in group 1.

CONCLUSION: The safety and effectiveness profile of propranolol in infants younger than 5 weeks or older than 5 months may be acceptable. Taking in account propranolol's potential in preventing severe complications, further studies should assess the acceptability of propranolol treatment, especially in the <5-week age group .

%B Ital J Pediatr %V 43 %P 40 %8 2017 Apr 19 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28424095?dopt=Abstract %R 10.1186/s13052-017-0357-9 %0 Journal Article %J Eur J Dent %D 2017 %T Shifts of subgingival bacterial population after nonsurgical and pharmacological therapy of localized aggressive periodontitis, followed for 1 year by Ion Torrent PGM platform. %A Campisciano, Giuseppina %A Toschetti, Annamaria %A Comar, Manola %A Taranto, Rosanna Di %A Berton, Federico %A Stacchi, Claudio %X

The possibility of targeting the hypervariable region V3 of the 16S rRNA gene using Ion Torrent Personal Genome Machine (PGM) could provide a complete analysis of subgingival plaque samples, potentially able to identify microbiological species missed by culture-based methods. A 16-year-old female smoker patient, affected by localized aggressive periodontitis, underwent a full-mouth disinfection protocol and was inserted in a 3-month recall program. Microbiological samples were collected at baseline and at 30, 100, 365 days follow-up and analyzed by Ion Torrent PGM. , , , and were the most represented pathogens at baseline. Nonsurgical treatment and systemic antibiotics drastically lowered the anaerobic species, and their presence remained limited after 100 days, while a consistent recolonization by anaerobic bacteria was detected at 365 days. The patient showed a general improvement of periodontal conditions. Differently from polymerase chain reaction and other microarray techniques, Ion Torrent performs a quantitative analysis of the microbiota, irrespective of the searched species. An accurate definition of the shifts of the bacterial community might help periodontal researchers for a better understanding of the impact of different treatment approaches or in intercepting nonresponsive conditions.

%B Eur J Dent %V 11 %P 126-129 %8 2017 Jan-Mar %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28435379?dopt=Abstract %R 10.4103/ejd.ejd_309_16 %0 Journal Article %J Acta Paediatr %D 2017 %T Somatic symptom disorder was common in children and adolescents attending an emergency department complaining of pain. %A Cozzi, Giorgio %A Minute, Marta %A Skabar, Aldo %A Pirrone, Angela %A Jaber, Mohamad %A Neri, Elena %A Montico, Marcella %A Ventura, Alessandro %A Barbi, Egidio %K Adolescent %K Child %K Emergency Service, Hospital %K Female %K Humans %K Italy %K Male %K Medically Unexplained Symptoms %K Pain %K Prospective Studies %X

AIM: The aim of this study was to quantify the prevalence of somatic pain in a paediatric emergency department (ED).

METHODS: We conducted a prospective observational study using patients admitted to the ED of an Italian children's hospital between December 2014 and February 2015. We enrolled children aged 7-17 who turned up at the ED complaining of pain. Patients and parents were asked to fill in a questionnaire to allow the analysis of the patients' medical history and provide contact details for follow-up. We divided the enrolled patients into four groups: post-traumatic pain, organic pain, functional pain and somatic pain. The questionnaire was used to define pain characteristics and to generate an impairment score.

RESULTS: Of the 713 patients who met inclusion criteria, 306 (42.9%) were enrolled in the study. Of these, 135 (44.0%) suffered from post-traumatic pain, 104 (34.0%) from organic pain, 41 (13.4%) from functional pain and 26 (8.6%) from somatic pain. Somatic pain patients had endured pain longer, had missed more school days and had suffered severe functional impairment.

CONCLUSION: This study highlighted that somatic pain was a significant contributor to paediatric emergency room visits and should be suspected and diagnosed in children reporting pain.

%B Acta Paediatr %V 106 %P 586-593 %8 2017 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/28052403?dopt=Abstract %R 10.1111/apa.13741 %0 Journal Article %J J Cell Physiol %D 2017 %T Subclinical alteration of the cervical-vaginal microbiome in women with idiopathic infertility. %A Campisciano, Giuseppina %A Florian, Fiorella %A D'Eustacchio, Angela %A Stanković, David %A Ricci, Giuseppe %A De Seta, Francesco %A Comar, Manola %K Adult %K Biodiversity %K Cervix Uteri %K Cohort Studies %K Demography %K Female %K Humans %K Infertility, Female %K Microbiota %K Species Specificity %K Vagina %K Vaginosis, Bacterial %X

Biomarkers have a wide application in research and clinic, they help to choose the correct treatment for diseases. Recent studies, addressing the vaginal microbiome using next generation sequencing (NGS), reported the involvement of bacterial species in infertility. We compared the vaginal microbiome of idiopathic infertile women with that of healthy, including bacterial vaginosis affected women and non-idiopathic infertile women, to identify bacterial species suitable as biomarkers. Information on microorganisms was obtained from the V3-16S rDNA sequencing of cervical-vaginal fluids of 96 women using the Ion Torrent platform. Data were processed with QIIME and classified against the Vaginal 16S rDNA Reference Database. The analysis revealed a significant beta-diversity variation (p < 0.001) between the four groups included in the study. L. iners, L. crispatus, and L. gasseri distinguished idiopathic infertile women from the other groups. In these women, a microbial profile similar to that observed in bacterial vaginosis women has been detected. Our results suggest that the quantitative assessment and identification of specific microorganisms of the cervical-vaginal microflora could increase the accuracy of available tools for the diagnosis of infertility and improve the adoption of therapeutic protocols.

%B J Cell Physiol %V 232 %P 1681-1688 %8 2017 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/28098358?dopt=Abstract %R 10.1002/jcp.25806 %0 Journal Article %J Pediatr Med Chir %D 2017 %T Surgery for distal hypospadias: what about the catheter? %A Scarpa, Maria-Grazia %A Perin, Giordano %A Di Grazia, Massimo %A Codrich, Daniela %A Pederiva, Federica %A Guida, Edoardo %A Lembo, Maria Antonietta %A Giannotta, Antonio %A Schleef, Jurgen %K Child %K Child, Preschool %K Device Removal %K Humans %K Hypospadias %K Infant %K Length of Stay %K Male %K Retrospective Studies %K Stents %K Treatment Outcome %K Urinary Catheterization %X

No agreed recommendations exist for timing of urethral stent removal, after distal hypospadias surgery. We compared our preliminary case series with outcomes from literature: 18/44 patients were treated with catheter and 26/44 without it. The surgical outcome was comparable in the two groups. After hypospadias surgery, the main advantage of the immediate postoperative catheter removal was the shorter hospital stay without negatively affecting the care and home management.

%B Pediatr Med Chir %V 39 %P 145 %8 2017 Sep 28 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29034655?dopt=Abstract %R 10.4081/pmc.2017.145 %0 Journal Article %J J Cell Physiol %D 2017 %T SV40 Infection of Mesenchymal Stromal Cells From Wharton's Jelly Drives the Production of Inflammatory and Tumoral Mediators. %A Cason, Carolina %A Campisciano, Giuseppina %A Zanotta, Nunzia %A Valencic, Erica %A Delbue, Serena %A Bella, Ramona %A Comar, Manola %K Cell Line, Transformed %K Cell Separation %K Cell Transformation, Viral %K Chemokine CCL5 %K Chemokine CXCL9 %K Cytopathogenic Effect, Viral %K DNA, Viral %K Host-Pathogen Interactions %K Humans %K Inflammation Mediators %K Interleukin-12 Subunit p40 %K Interleukin-3 %K JC Virus %K Mesenchymal Stem Cells %K Real-Time Polymerase Chain Reaction %K Simian virus 40 %K Time Factors %K Up-Regulation %K Viral Load %K Virus Replication %K Wharton Jelly %X

The Mesenchymal Stromal Cells from umbilical cord Wharton's jelly (WJSCs) are a source of cells with high potentiality for the treatment of human immunological disorders. Footprints of the oncogenic viruses Simian Virus 40 (SV40) and JC Virus (JCPyV) have been recently detected in human WJSCs specimens. The aim of this study is to evaluate if WJSCs can be efficiently infected by these Polyomaviruses and if they can potentially exert tumoral activity. Cell culture experiments indicated that WJSCs could sustain both SV40 and JCPyV infections. A transient and lytic replication was observed for JCPyV, while SV40 persistently infected WJSCs over a long period of time, releasing a viral progeny at low titer without evident cytopathic effect (CPE). Considering the association between SV40 and human tumors and the reported ability of the oncogenic viruses to drive the host innate immune response to cell transformation, the expression profile of a large panel of immune mediators was evaluated in supernatants by the Bioplex platform. RANTES, IL-3, MIG, and IL-12p40, involved in chronic inflammation, cells differentiation, and transformation, were constantly measured at high concentration comparing to control. These findings represent a new aspect of SV40 biological activity in the humans, highlighting its interaction with specific host cellular pathways. In view of these results, it seems to be increasingly urgent to consider Polyomaviruses in the management of WJSCs for their safely use as promising therapeutic source. J. Cell. Physiol. 232: 3060-3066, 2017. © 2016 Wiley Periodicals, Inc.

%B J Cell Physiol %V 232 %P 3060-3066 %8 2017 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/27925194?dopt=Abstract %R 10.1002/jcp.25723 %0 Journal Article %J J Pediatr %D 2017 %T A Teenager with Sudden Unilateral Breast Enlargement. %A Pellegrin, Maria Chiara %A Naviglio, Samuele %A Cattaruzzi, Elisabetta %A Barbi, Egidio %A Ventura, Alessandro %K Bullying %K Child %K Gynecomastia %K Hematoma %K Humans %K Male %K Wounds, Nonpenetrating %B J Pediatr %V 182 %P 394 %8 2017 03 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27956018?dopt=Abstract %R 10.1016/j.jpeds.2016.11.044 %0 Journal Article %J Acta Haematol %D 2017 %T Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis. %A Simeone, Roberto %A Giacomello, Roberta %A Bruno, Germano %A Parco, Sergio %A Maximova, Natalia %A Martinelli, Monica %A Zito, Gabriella %A Luppi, Stefania %A Cervi, Gina %A Ricci, Giuseppe %K Adult %K Anticoagulants %K Case-Control Studies %K Factor Xa Inhibitors %K Female %K Heparin, Low-Molecular-Weight %K Humans %K Nadroparin %K Partial Thromboplastin Time %K Peptide Fragments %K Pilot Projects %K Pregnancy %K Pregnancy Complications, Hematologic %K Prothrombin %K Thrombophilia %K Thrombosis %X

The aim of this study is to investigate thrombogenesis and the hypercoagulable changes in pregnant women affected by thrombophilia who received low-molecular-weight heparin (LWMH) prophylaxis. We included 21 pregnant women affected by thrombophilia treated with LWMH and 20 nontreated normal pregnant women as the control group. The sample group of thrombophilic pregnant women included different conditions (factor V Leiden mutation, protein C deficiency, protein S deficiency, antiphospholipid antibodies syndrome, and combined defects). Three blood samples were collected during pregnancy (i.e., at 16, 20, and 24 weeks) and tested for activated partial thromboplastin time and prothrombin fragment F1 + 2 (F1 + 2); anti-FXa activity was tested only in treated thrombophilic pregnant women. F1 + 2 levels progressively increased during pregnancy in both study groups. However, the F1 + 2 increase in women exposed to heparin prophylaxis was significantly lower than that in normal pregnant women in all 3 measurements carried out during gestation (p < 0.05); a statistically significant inverse correlation between F1 + 2 levels and anti-Xa activity (R = -0.8575, p < 0.05) was observed in treated women during pregnancy. Our findings suggest that F1 + 2 in addition to anti-Xa measurement could be used to adjust LWMH prophylaxis, at least in high-risk pregnant women.

%B Acta Haematol %V 137 %P 201-206 %8 2017 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/28478442?dopt=Abstract %R 10.1159/000467385 %0 Journal Article %J Virus Res %D 2017 %T Towards measles elimination in Italy: Virological surveillance and genotypes trend (2013-2015). %A Magurano, Fabio %A Baggieri, Melissa %A Filia, Antonietta %A Del Manso, Martina %A Lazzarotto, Tiziana %A Amendola, Antonella %A D'Agaro, Pierlanfranco %A Chironna, Maria %A Ansaldi, Filippo %A Iannazzo, Stefania %A Bucci, Paola %A Marchi, Antonella %A Nicoletti, Loredana %K Adolescent %K Adult %K Aged %K Child %K Child, Preschool %K Disease Outbreaks %K Female %K Genotype %K Humans %K Infant %K Italy %K Male %K Measles %K Measles virus %K Middle Aged %K Molecular Epidemiology %K Phylogeny %K RNA, Viral %K Sentinel Surveillance %K Young Adult %X

In accordance with the goal of the World Health Organization Regional Office for Europe, the Italian National Measles and Rubella Elimination Plan aimed to interrupt indigenous measles transmission in Italy by the end of 2015. However, from 2013 to 2015, Italy experienced high measles burden with 4902 measles cases (49.3% laboratory-confirmed) reported to the enhanced measles surveillance system (cumulative incidence in the triennium reference period: 2.4/100,000 population). The measles elimination goal was not reached. Laboratory surveillance of measles circulating genotypes is performed by the Measles and Rubella National Reference Laboratory (NRL) at the Italian National Institute of Health (Istituto Superiore di Sanità - ISS), in Rome. Samples received from 1 January 2013-31 December 2015 were analysed. Those positive for measles genome by molecular tests were sequenced and phylogenetically analysed. Phylogenetic analysis performed by NRL identified that genotypes D4 and D8 were endemic and co-circulated in 2011-2013: study results show that genotype D4 disappeared during 2013. Sporadic cases were associated to genotype B3 during 2011-2013, which became endemic in Italy during 2014 and co-circulated with D8 until 2015. Sporadic cases were found belonging to genotypes D9 and H1 all over the period in exam. Similar trend has been observed in European WHO Region.

%B Virus Res %V 236 %P 24-29 %8 2017 05 15 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/28522332?dopt=Abstract %R 10.1016/j.virusres.2017.05.009 %0 Journal Article %J Ann Ig %D 2017 %T Training in Occupational Medicine: Jurisprudential Malfunctions in the Italian System and European Perspectives. %A Cegolon, L %A Heymann, W C %A Xodo, C %A Lange, J H %K Certification %K European Union %K Italy %K Occupational Medicine %X

BACKGROUND: To practice occupational health in Europe, a medical doctor must qualify in occupational medicine. This requires a period of postgraduate specialist medical training lasting a minimum of four years, in conformity with European regulations, to obtain a certificate of completion of training which is then mutually recognized within the entire European Union.

DISCUSSION: In 2002 an Italian law allowed doctors specialized in public health medicine and legal/forensic medicine to also practice as consultants in occupational medicine in the country. However a subsequent law in 2008 determined that only physicians specialized in occupational medicine could freely practice as consultants in this discipline. The other two categories (consultants in public health medicine and consultants in legal/forensic medicine) were required to undertake additional training (a Master course) to qualify as consultants in occupational medicine.

CONCLUSIONS: Doctors who entered postgraduate training in public health or legal/forensic medicine before 2008, with the option to practice also as consultants in occupational medicine upon completion of their training, suffered an unprecedented and legally questionable retroactive application of this new law which stripped them of previously acquired rights. Moreover, even after qualifying by undertaking this extra training in occupational medicine, the latter two categories of doctors do not have their training recognized in other member states of the European Union. To disallow the rights of doctors qualified in occupational medicine to work as consultants in the latter medical discipline elsewhere within the European Union seems a clear violation of professional rights and, as such, legal action could be taken to submit this issue to European attention.

%B Ann Ig %V 29 %P 197-205 %8 2017 May-Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/28383611?dopt=Abstract %R 10.7416/ai.2017.2147 %0 Journal Article %J Paediatr Drugs %D 2017 %T An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children. %A Taddio, Andrea %A Zennaro, Floriana %A Pastore, Serena %A Cimaz, Rolando %K Adrenal Cortex Hormones %K Anti-Inflammatory Agents, Non-Steroidal %K Child %K Chronic Disease %K Diagnosis, Differential %K Humans %K Osteomyelitis %K Recurrence %K Tumor Necrosis Factor-alpha %X

Chronic recurrent multifocal osteomyelitis (CRMO), also known as chronic non-bacterial osteomyelitis (CNO), is a rare inflammatory disorder that primarily affects children. It is characterized by pain, local bone expansion, and radiological findings suggestive of osteomyelitis, usually at multiple sites. CRMO predominantly affects the metaphyses of long bones, but involvement of the clavicle or mandible are suggestive of the diagnosis. CRMO is a diagnosis of exclusion, and its pathogenesis remains unknown. Differential diagnosis includes infection, malignancies, benign bone tumors, metabolic disorders, and other autoinflammatory disorders. Biopsy of the bone lesion is not often required but could be necessary in unclear cases, especially for differentiation from bone neoplasia. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first-line treatment. Alternative therapies have been used, including corticosteroids, methotrexate, bisphosphonates, and tumor necrosis factor (TNF)-α inhibitors. No guidelines have been established regarding diagnosis and treatment options. This manuscript gives an overview of the most recent findings on the pathogenesis of CRMO and clinical approaches for patients with the condition.

%B Paediatr Drugs %V 19 %P 165-172 %8 2017 Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/28401420?dopt=Abstract %R 10.1007/s40272-017-0226-4 %0 Journal Article %J Am J Hum Genet %D 2017 %T Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits. %A Tachmazidou, Ioanna %A Süveges, Dániel %A Min, Josine L %A Ritchie, Graham R S %A Steinberg, Julia %A Walter, Klaudia %A Iotchkova, Valentina %A Schwartzentruber, Jeremy %A Huang, Jie %A Memari, Yasin %A McCarthy, Shane %A Crawford, Andrew A %A Bombieri, Cristina %A Cocca, Massimiliano %A Farmaki, Aliki-Eleni %A Gaunt, Tom R %A Jousilahti, Pekka %A Kooijman, Marjolein N %A Lehne, Benjamin %A Malerba, Giovanni %A Männistö, Satu %A Matchan, Angela %A Medina-Gomez, Carolina %A Metrustry, Sarah J %A Nag, Abhishek %A Ntalla, Ioanna %A Paternoster, Lavinia %A Rayner, Nigel W %A Sala, Cinzia %A Scott, William R %A Shihab, Hashem A %A Southam, Lorraine %A St Pourcain, Beate %A Traglia, Michela %A Trajanoska, Katerina %A Zaza, Gialuigi %A Zhang, Weihua %A Artigas, María S %A Bansal, Narinder %A Benn, Marianne %A Chen, Zhongsheng %A Danecek, Petr %A Lin, Wei-Yu %A Locke, Adam %A Luan, Jian'an %A Manning, Alisa K %A Mulas, Antonella %A Sidore, Carlo %A Tybjaerg-Hansen, Anne %A Varbo, Anette %A Zoledziewska, Magdalena %A Finan, Chris %A Hatzikotoulas, Konstantinos %A Hendricks, Audrey E %A Kemp, John P %A Moayyeri, Alireza %A Panoutsopoulou, Kalliope %A Szpak, Michal %A Wilson, Scott G %A Boehnke, Michael %A Cucca, Francesco %A Di Angelantonio, Emanuele %A Langenberg, Claudia %A Lindgren, Cecilia %A McCarthy, Mark I %A Morris, Andrew P %A Nordestgaard, Børge G %A Scott, Robert A %A Tobin, Martin D %A Wareham, Nicholas J %A Burton, Paul %A Chambers, John C %A Smith, George Davey %A Dedoussis, George %A Felix, Janine F %A Franco, Oscar H %A Gambaro, Giovanni %A Gasparini, Paolo %A Hammond, Christopher J %A Hofman, Albert %A Jaddoe, Vincent W V %A Kleber, Marcus %A Kooner, Jaspal S %A Perola, Markus %A Relton, Caroline %A Ring, Susan M %A Rivadeneira, Fernando %A Salomaa, Veikko %A Spector, Timothy D %A Stegle, Oliver %A Toniolo, Daniela %A Uitterlinden, André G %A Barroso, Inês %A Greenwood, Celia M T %A Perry, John R B %A Walker, Brian R %A Butterworth, Adam S %A Xue, Yali %A Durbin, Richard %A Small, Kerrin S %A Soranzo, Nicole %A Timpson, Nicholas J %A Zeggini, Eleftheria %K Anthropometry %K Body Height %K Cohort Studies %K Databases, Genetic %K DNA Methylation %K Female %K Genetic Variation %K Genome, Human %K Genome-Wide Association Study %K Humans %K Lipodystrophy %K Male %K Meta-Analysis as Topic %K Obesity %K Physical Chromosome Mapping %K Quantitative Trait Loci %K Sequence Analysis, DNA %K Sex Characteristics %K Syndrome %K United Kingdom %X

Deep sequence-based imputation can enhance the discovery power of genome-wide association studies by assessing previously unexplored variation across the common- and low-frequency spectra. We applied a hybrid whole-genome sequencing (WGS) and deep imputation approach to examine the broader allelic architecture of 12 anthropometric traits associated with height, body mass, and fat distribution in up to 267,616 individuals. We report 106 genome-wide significant signals that have not been previously identified, including 9 low-frequency variants pointing to functional candidates. Of the 106 signals, 6 are in genomic regions that have not been implicated with related traits before, 28 are independent signals at previously reported regions, and 72 represent previously reported signals for a different anthropometric trait. 71% of signals reside within genes and fine mapping resolves 23 signals to one or two likely causal variants. We confirm genetic overlap between human monogenic and polygenic anthropometric traits and find signal enrichment in cis expression QTLs in relevant tissues. Our results highlight the potential of WGS strategies to enhance biologically relevant discoveries across the frequency spectrum.

%B Am J Hum Genet %V 100 %P 865-884 %8 2017 Jun 01 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28552196?dopt=Abstract %R 10.1016/j.ajhg.2017.04.014 %0 Journal Article %J Pediatr Crit Care Med %D 2017 %T Withdrawal Assessment Tool-1 Monitoring in PICU: A Multicenter Study on Iatrogenic Withdrawal Syndrome. %A Amigoni, Angela %A Mondardini, Maria Cristina %A Vittadello, Ilaria %A Zaglia, Federico %A Rossetti, Emanuele %A Vitale, Francesca %A Ferrario, Stefania %A Savron, Fabio %A Coffaro, Giancarlo %A Brugnaro, Luca %A Amato, Roberta %A Wolfler, Andrea %A Franck, Linda S %K Adolescent %K Analgesics %K Child %K Child, Preschool %K Critical Care %K Female %K Humans %K Hypnotics and Sedatives %K Iatrogenic Disease %K Infant %K Infant, Newborn %K Intensive Care Units, Pediatric %K Italy %K Logistic Models %K Male %K Prospective Studies %K Respiration, Artificial %K Substance Withdrawal Syndrome %X

OBJECTIVES: Withdrawal syndrome is an adverse reaction of analgesic and sedative therapy, with a reported occurrence rate between 17% and 57% in critically ill children. Although some factors related to the development of withdrawal syndrome have been identified, there is weak evidence for the effectiveness of preventive and therapeutic strategies. The main aim of this study was to evaluate the frequency of withdrawal syndrome in Italian PICUs, using a validated instrument. We also analyzed differences in patient characteristics, analgesic and sedative treatment, and patients' outcome between patients with and without withdrawal syndrome.

DESIGN: Observational multicenter prospective study.

SETTING: Eight Italian PICUs belonging to the national PICU network Italian PICU network.

PATIENTS: One hundred thirteen patients, less than 18 years old, mechanically ventilated and treated with analgesic and sedative therapy for five or more days. They were admitted in PICU from November 2012 to May 2014.

INTERVENTIONS: Symptoms of withdrawal syndrome were monitored with Withdrawal Assessment Tool-1 scale.

MEASUREMENTS AND MAIN RESULTS: The occurrence rate of withdrawal syndrome was 64.6%. The following variables were significantly different between the patients who developed withdrawal syndrome and those who did not: type, duration, and cumulative dose of analgesic therapy; duration and cumulative dose of sedative therapy; clinical team judgment about analgesia and sedation's difficulty; and duration of analgesic weaning, mechanical ventilation, and PICU stay. Multivariate logistic regression analysis revealed that patients receiving morphine as their primary analgesic were 83% less likely to develop withdrawal syndrome than those receiving fentanyl or remifentanil.

CONCLUSIONS: Withdrawal syndrome was frequent in PICU patients, and patients with withdrawal syndrome had prolonged hospital treatment. We suggest adopting the lowest effective dose of analgesic and sedative drugs and frequent reevaluation of the need for continued use. Further studies are necessary to define common preventive and therapeutic strategies.

%B Pediatr Crit Care Med %V 18 %P e86-e91 %8 2017 02 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/28157809?dopt=Abstract %R 10.1097/PCC.0000000000001054 %0 Journal Article %J Biochem Biophys Res Commun %D 2017 %T Zika virus induces inflammasome activation in the glial cell line U87-MG. %A Tricarico, Paola Maura %A Caracciolo, Ilaria %A Crovella, Sergio %A D'Agaro, Pierlanfranco %K Apoptosis %K Cell Line %K Cytokines %K Humans %K Immunity, Innate %K Inflammasomes %K Inflammation Mediators %K Neuroglia %K Oxidative Stress %K Virus Replication %K Zika Virus %X

In the last years, neurological complications related to Zika virus (ZIKV) infection have emerged as an important threat to public health worldwide. ZIKV infection has been associated to neurological disorders such as congenital microcephaly in newborns and Guillain-Barré syndrome, myelopathy and encephalitis in adults. ZIKV is characterized by neurotropism and neurovirulence. Several studies have identified microglial nodules, gliosis, neuronal and glial cells degeneration and necrosis in the brain of ZIKV infected infants, suggesting that ZIKV could play a role in these neurological disorders through neuroinflammation and microglial activation. Little information is available about neuroinflammation and ZIKV-related neurological disorders. Therefore, we investigated if ZIKV is able to infect a glial cell line (U87-MG) and how the glial cell line responds to this infection in terms of inflammation (IL-1β, NLRP-3 and CASP-1), oxidative stress (SOD2 and HemeOX) and cell death. We observed a significant increase of ZIKV load in both cells and supernatants after 72 h, compared to 48 h of infection. We found that ZIKV infection induces an increase of IL-1β, NLRP-3 and CASP-1 genes expression. Significant increase of IL-1β and unchanged pro-IL-1β protein levels have also been detected. Moreover, we observed SOD2 and HemeOX increased gene expression mainly after 72 h post ZIKV infection. Subsequently, we found a decrease of U87-MG cell viability, after both 48 h and 72 h of ZIKV infection. Our results show that U87-MG cells are susceptible to ZIKV infection. ZIKV is able to successfully replicate in infected cells causing oxidative stress, NLRP3 inflammasome activation and subsequent release of mature IL-1β; this process culminates in cell death. Thus, considering the central role of neuroinflammation in neurological disorders, it is important to comprehend every aspect of this mechanism in order to better understand the pathogenesis of ZIKV infection and to identify possible strategies to fight the virus by rescuing cell death.

%B Biochem Biophys Res Commun %V 492 %P 597-602 %8 2017 10 28 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/28153732?dopt=Abstract %R 10.1016/j.bbrc.2017.01.158 %0 Journal Article %J Acta Otorhinolaryngol Ital %D 2016 %T Achieving early functional auditory access in paediatric cochlear implantation. %A Orzan, E %A Muzzi, E %A Marchi, R %A Falzone, C %A Battelino, S %A Ciciriello, E %X

Cochlear implantation (CI) is a viable option for providing access to auditory stimulation in severe-to-profound hearing loss/impairment of cochlear origin. It has been demonstrated that CI is safe and effective for deaf children. Younger age at activation after CI is linked with better outcomes. It is important to study variables and issues that can interfere with an early fitting and access to sound after CI. They range from patient characteristics, family compliance and support, to technical, medical or organisational problems. A SWOT analysis and a subsequent TOWS matrix was conducted to discuss issues and propose recommendations to be considered when operating an early switch on of the CI.

%B Acta Otorhinolaryngol Ital %V 36 %P 45-50 %8 2016 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27054390?dopt=Abstract %R 10.14639/0392-100X-1075 %0 Journal Article %J Acta Otorhinolaryngol Ital %D 2016 %T Achieving effective hearing aid fitting within one month after identification of childhood permanent hearing impairment. %A Bastanza, G %A Gallus, R %A De Carlini, M %A Picciotti, P M %A Muzzi, E %A Ciciriello, E %A Orzan, E %A Conti, G %X

Diagnosis of child permanent hearing impairment (PHI) can be made with extreme timeliness compared to the past thanks to improvements in PHI identification through newborn hearing screening programmes. It now becomes essential to provide an effective amplification as quickly as possible in order to restore auditory function and favour speech and language development. The early fitting of hearing aids and possible later cochlear implantation indeed prompts the development of central auditory pathways, connections with secondary sensory brain areas, as well as with motor and articulatory cortex. The aim of this paper is to report the results of a strategic analysis that involves identification of strengths, weaknesses, opportunities and threats regarding the process of achieving early amplification in all cases of significant childhood PHI. The analysis is focused on the Italian situation and is part of the Italian Ministry of Health project CCM 2013 "Preventing Communication Disorders: a Regional Program for Early Identification, Intervention and Care of Hearing Impaired Children".

%B Acta Otorhinolaryngol Ital %V 36 %P 38-44 %8 2016 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27054389?dopt=Abstract %R 10.14639/0392-100X-1077 %0 Journal Article %J Mol Med Rep %D 2016 %T Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes. %A Piscianz, Elisa %A Candilera, Vanessa %A Valencic, Erica %A Loganes, Claudia %A Paron, Greta %A De Iudicibus, Sara %A Decorti, Giuliana %A Tommasini, Alberto %X

Chronic inflammation associated with autoimmune activation is characteristic of rheumatic diseases from childhood to adulthood. In recent decades, significant improvements in the treatment of these types of disease have been achieved using disease modifying anti-rheumatic drugs (DMARDs), such as methotrexate (MTX) and, more recently, using biologic inhibitors. The recent introduction of kinase inhibitors (for example, tofacitinib; Tofa) further increases the available ARDs. However, there are patients that do not respond to any treatment strategies, for whom combination therapies are proposed. The data regarding the combined action of different drugs is lacking and the knowledge of the mechanisms of ARDs and their actions upon pathogenic lymphocytes, which are hypothesized to sustain disease, is poor. An in vitro model of inflammation was developed in the current study, in which stimulated and unstimulated lymphocytes were cultured together, but tracked separately, to investigate the action of MTX and Tofa on the two populations. By analysing lymphocyte proliferation and activation, and cytokine secretion in the culture supernatants, it was established that, due to the presence of activated cells, unstimulated cells underwent a bystander activation that was modulated by the ARDs. Additionally, varying administration schedules were demonstrated to affect lymphocytes differently in vitro, either directly or via bystander activation. Furthermore, MTX and Tofa exerted different effects; while MTX showed an antiproliferative effect, Tofa marginally effected activation, although only a slight antiproliferative action, which could be potentiated by sequential treatment with MTX. Thus, it was hypothesized that these differences may be exploited in sequential therapeutic strategies, to maximize the anti‑rheumatic effect. These findings are notable and must be accounted for, as bystander‑activated cells in vivo could contribute to the spread of autoimmune activation and disease progression.

%B Mol Med Rep %V 14 %P 574-82 %8 2016 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27175898?dopt=Abstract %R 10.3892/mmr.2016.5263 %0 Journal Article %J J Neurovirol %D 2016 %T Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection. %A Cucca, A %A Stragapede, L %A Antonutti, L %A Catalan, M %A Caracciolo, I %A Valentinotti, Romina %A Granato, A %A D'Agaro, P %A Manganotti, P %X

A 21-year-old woman presented with acute-onset spastic paraparesis. The MRI spinal scan revealed a contrast-enhanced T2 hyperintensity between C5-T2. The most common neurotropic pathogens were excluded by first level tests. Under suspicion of an acute immune-mediated myelitis, a corticosteroid therapy was administered. However, a seropositivity for both human immunodeficiency virus (HIV) type 1 and human T-lymphotropic virus (HTLV) subsequently emerged. An antiretroviral therapy was started while steroids discontinued. Patient's clinical conditions remained unchanged. HIV-HTLV-1 co-infection should be included in the differential diagnosis of any acute myelitis, even in patients with a preserved immune status and no risk factors.

%B J Neurovirol %8 2016 May 31 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27245591?dopt=Abstract %R 10.1007/s13365-016-0455-2 %0 Journal Article %J Eur J Clin Invest %D 2016 %T Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes. %A Carbone, Federico %A Satta, Nathalie %A Montecucco, Fabrizio %A Virzi, Julien %A Burger, Fabienne %A Roth, Aline %A Roversi, Gloria %A Tamborino, Carmine %A Casetta, Ilaria %A Seraceni, Silva %A Trentini, Alessandro %A Padroni, Marina %A Dallegri, Franco %A Lalive, Patrice H %A Mach, François %A Fainardi, Enrico %A Vuilleumier, Nicolas %X

BACKGROUND: Autoantibodies to apolipoprotein A-1 (anti-ApoA-1 IgG) were shown to predict major adverse cardiovascular events and promote atherogenesis. However, their potential relationship with clinical disability and ischaemic lesion volume after acute ischaemic stroke (AIS) remains unexplored.

MATERIALS AND METHODS: We included n = 76 patients admitted for AIS and we investigated whether baseline serum anti-ApoA-1 IgG levels could predict (i) AIS-induced clinical disability [assessed by the modified Rankin Scale (mRS)], and (ii) AIS-related ischaemic lesion volume [assessed by Computed Tomography (CT)]. We also evaluated the possible pro-apoptotic and pro-necrotic effects of anti-ApoA-1 IgG on human astrocytoma cell line (U251) using flow cytometry.

RESULTS: High levels of anti-ApoA-1 IgG were retrieved in 15·8% (12/76) of patients. Increased baseline levels of anti-ApoA-1 IgG were independently correlated with worse mRS [β = 0·364; P = 0·002; adjusted odds ratio (OR): 1·05 (95% CI 1·01-1·09); P = 0·017] and CT-assessed ischaemic lesion volume [β = 0·333; P < 0·001; adjusted OR: 1·06 (95% CI 1·01-1·12); P = 0·048] at 3 months. No difference in baseline clinical, biochemical and radiological characteristics was observed between patients with high vs. low levels of anti-ApoA-1 IgG. Incubating human astrocytoma cells with anti-ApoA-1 IgG dose dependently induced necrosis and apoptosis of U251 cells in vitro.

CONCLUSION: Anti-ApoA-1 IgG serum levels at AIS onset are associated with poorer clinical recovery and worse brain lesion volume 3 months after AIS. These observations could be partly explained by the deleterious effect of anti-ApoA-1 IgG on human brain cell survival in vitro and may have clinical implication in the prediction of poor outcome in AIS.

%B Eur J Clin Invest %V 46 %P 805-17 %8 2016 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/27490973?dopt=Abstract %R 10.1111/eci.12664 %0 Journal Article %J J Thorac Oncol %D 2016 %T Association between Congenital Lung Malformations and Lung Tumors in Children and Adults. A Systematic Review. %A Casagrande, Arianna %A Pederiva, Federica %X

INTRODUCTION: The appropriate management of asymptomatic congenital pulmonary malformations (CPMs) remains controversial. Prophylactic surgery is recommended to avoid the risk for development of pulmonary infections and to prevent the highly debated development of malignancy. However, the true risk for development of malignancy remains unknown. A systematic review analyzed all cases in which lung tumors associated with CPMs in both the pediatric and adult populations were described.

METHODS: A comprehensive literature search was carried out; it included all the cases in which an association between CPMs and malignant pulmonary lesions was reported.

RESULTS: In all, 134 publications were eligible for inclusion. In 168 patients CPM was found associated with lung tumor. The diagnosis was made in 76 children at a mean age of 3.68 ± 3.4, whereas in the adult population (n = 92) it was made at a mean age of 44.62 ± 16.09. Cough was the most frequent presenting symptom both in children and in adults. Most of the patients underwent lobectomy. The tumor most often associated with CPM was pleuropulmonary bastoma in children (n = 31) and adenocarcinoma (n = 20) or bronchioloalveolar carcinoma (n = 20) in adults. The CPM most frequenty associated with tumors in children was congenital cystic adenomatoid malformation (n = 37), especially type 1 (n = 21), whereas in adults it was bronchogenic cyst (n = 25), followed by congenital cystic adenomatoid malformation (n = 21).

CONCLUSIONS: CPMs should be followed up and never underestimated because they may conceal a tumor. Apparently, there is no age limit for malignant progression of CPMs and no limit of the interval between first detection of the CPM and appearance of the associated tumor.

%B J Thorac Oncol %8 2016 Jul 15 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27423390?dopt=Abstract %R 10.1016/j.jtho.2016.06.023 %0 Journal Article %J Tumour Biol %D 2016 %T Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV. %A Lima, Géssica %A Santos, Erinaldo %A Angelo, Hildson %A Oliveira, Micheline %A Heráclio, Sandra %A Leite, Fernanda %A de Melo, Celso %A Crovella, Sergio %A Maia, Maria %A Souza, Paulo %X

Infection by high-risk human papillomavirus (HR-HPV) and single nucleotide polymorphism (SNP) in genes involved in cell cycle control, as p21 and p27, are important factors in the development of different types of human cancers. This study aims at investigating whether both the p21 Ser31Arg and p27 V109G polymorphisms are associated with susceptibility to the development of cervical lesions in women HR-HPV positive. We analyzed 132 women HPV positive and with cervical lesions or CC and 154 healthy control (HPV negative and without cervical lesions). p21 Ser31Arg and p27 V109G polymorphisms were analyzed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and sequencing. The p21 31Arg allele was associated with susceptibility for the development of cervical lesions (P* = 0.0009), while p27 V109G polymorphism showed no significant differences for this association (P* = 0.89). However, the combined effect of the polymorphisms showed that the presence of the CC genotype (SNP p21 Ser31Arg) conferred protection for the development of cervical lesions (OR = 0.39). p21 Ser31Arg and p27 V109G polymorphisms were not associated with the grade of cervical lesions (CINI, CINII, and CINIII) or CC (P* > 0.05). The HR-HPV more frequent in this study were of 16 (57.6 %) and 18 (37.1 %) types; however, no association was observed when both polymorphisms and risk factors analyzed were compared (P* > 0.05). Our findings suggest a possible association between p21 Ser31tabArg polymorphism and susceptibility to the development of cervical lesions in women from Pernambuco. Brazil.

%B Tumour Biol %V 37 %P 10935-41 %8 2016 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/26886286?dopt=Abstract %R 10.1007/s13277-016-4979-0 %0 Journal Article %J Int J Immunogenet %D 2016 %T Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight. %A Garziera, M %A Catamo, E %A Crovella, S %A Montico, M %A Cecchin, E %A Lonardi, S %A Mini, E %A Nobili, S %A Romanato, L %A Toffoli, G %X

This study aimed to explore functional and regulatory polymorphisms and haplotypes at the HLA-G 3'UTR region in colorectal cancer development. The presence of nonpolymorphic variants was also evaluated. Three-hundred and eight patients with colorectal cancer and 294 healthy controls were analysed at the germinal level. We found an association with increased risk of colorectal cancer for +2960 14-bp INDEL, +3196 C>G SNPs and UTR-2 haplotype, and a 'protective' role for +3003 T>C, +3010 C>G polymorphisms and UTR-4 haplotype. We detected in 3 distinct patients, a novel nucleotide change (+3037 C>A) and 2 already described rare variants, +3032 G/C (EUR MAF = 0.1%) and +3092 G/T (EUR MAF = 0%). This is the first study showing associations between different polymorphisms in the HLA-G 3'UTR and colorectal cancer susceptibility.

%B Int J Immunogenet %V 43 %P 32-9 %8 2016 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/26752414?dopt=Abstract %R 10.1111/iji.12243 %0 Journal Article %J Acta Paediatr %D 2016 %T Body mass index curves for Italian preterm infants are comparable with American curves for infants born before 34 weeks of gestational age. %A Paviotti, Giulia %A Monasta, Lorenzo %A Ronfani, Luca %A Montico, Marcella %A Copertino, Marco %A De Cunto, Angela %A Demarini, Sergio %X

AIM: Body mass index (BMI)-for-age curves have been developed in the USA, but not compared with other populations. This study created gender-specific intrauterine BMI-for-age curves for Italian preterm infants and compared them with the USA version.

METHODS: Data on 92 262 newborn infants, born at 26-42 weeks of gestational age in the north-eastern Italian region of Friuli Venezia Giulia between 2005 and 2013, were analysed to create gender-specific BMI-for-age curves. Gender-specific and age-specific BMI Z scores for Italian infants were calculated using the parameters of the USA growth curves and the World Health Organization charts.

RESULTS: Gender-specific BMI-for-age at birth curves were developed for premature Italian infants from 26 gestational weeks. The comparison with the USA charts showed no significant difference in BMI percentiles in Italian infants born at ≤33 gestational weeks, but infants born at ≥34 gestational weeks had a significantly higher BMI than the USA population, by 0.2 standard deviations.

CONCLUSION: We developed the first European BMI-for-age at birth curves for premature infants. According to our findings, the Italian curves were comparable to the USA curves for the subgroup of infants born at ≤33 gestational weeks, but not ≥34 gestational weeks.

%B Acta Paediatr %V 105 %P 483-9 %8 2016 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/26871711?dopt=Abstract %R 10.1111/apa.13364 %0 Journal Article %J PLoS One %D 2016 %T Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation. %A Zanotta, Nunzia %A Tornesello, Maria Lina %A Annunziata, Clorinda %A Stellato, Giovanni %A Buonaguro, Franco Maria %A Comar, Manola %K Adult %K Cell Survival %K Cervix Uteri %K Chemokines %K Cohort Studies %K Female %K Humans %K Neovascularization, Pathologic %K Papillomaviridae %K Papillomavirus Infections %X

BACKGROUND: The causal interpretation of cervical immune response to Human Papillomavirus (HPV) infection is complex and poorly characterized mainly due to the delicate balance that exists between viral infection, increase of inflammatory cytokines and host risk factors. This study aims to explore the significance of cervical immune mediators associated to cell survival, angiogenesis and interaction with immune response, in predicting the risk to develop HPV-related intraepithelial lesions.

METHODS: A panel of 48 cytokines and growth factors were explored in a selected cohort of 168 immunocompetent women including 88 diagnosed with low (LSIL) or high (HSIL) squamous intraepithelial lesions of the cervix and 80 with normal cervical cytology (NIL). HPV genotyping was performed by Linear Array HPV test and the soluble concentration of 48 immune molecules was analyzed using the Bio-Plex platform.

RESULTS: The prevalence of single HR-HPV infection was 30% in NIL and 100% in LSIL and HSIL women. The expression of 13 cytokines, including interleukins IL-6, IL-3, IL-12p40, IL-12p70, IL-16, IL-18, LIF, of chemokines CCL7 (MCP-3), CXCL9 (MIG), CXCL12 (SDF-1α) and of the tropic factors VEGF, G-CSF, M-CSF were significantly associated with the presence of infection, with levels being higher in women with precancerous lesions compared to NIL HPV negative women. Only the growth factor GM-CSF was positively associated with the cytological abnormalities.

CONCLUSIONS: The ability of HR-HPV to escape from innate immune recognition and to orchestrate the production of specific inflammatory and growth factors, involved in early inflammatory response and in the cell-proliferating phase of intraepithelial damage, was documented in women before the development of cervical lesions.

%B PLoS One %V 11 %P e0151851 %8 2016 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26990868?dopt=Abstract %R 10.1371/journal.pone.0151851 %0 Journal Article %J Blood Cells Mol Dis %D 2016 %T Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis. %A Abate, Maria Valentina %A Stocco, Gabriele %A Devescovi, Raffaella %A Carrozzi, Marco %A Pierobon, Chiara %A Valencic, Erica %A Lucafò, Marianna %A Di Silvestre, Alessia %A d'Adamo, Pio %A Tommasini, Alberto %A Decorti, Giuliana %A Ventura, Alessandro %B Blood Cells Mol Dis %V 59 %P 97-9 %8 2016 Jul %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27282575?dopt=Abstract %R 10.1016/j.bcmd.2016.05.001 %0 Journal Article %J Mem Inst Oswaldo Cruz %D 2016 %T CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study. %A Santos, Erinaldo Ubirajara Damasceno Dos %A Lima, Géssica Dayane Cordeiro de %A Oliveira, Micheline de Lucena %A Heráclio, Sandra de Andrade %A Silva, Hildson Dornelas Angelo da %A Crovella, Sergio %A Maia, Maria de Mascena Diniz %A Souza, Paulo Roberto Eleutério de %X

Polymorphisms in chemokine receptors play an important role in the progression of cervical intraepithelial neoplasia (CIN) to cervical cancer (CC). Our study examined the association of CCR2-64I (rs1799864) andCCR5-Δ32 (rs333) polymorphisms with susceptibility to develop cervical lesion (CIN and CC) in a Brazilian population. The genotyping of 139 women with cervical lesions and 151 women without cervical lesions for the CCR2-64I and CCR5-Δ32 polymorphisms were performed using polymerase chain reaction-restriction fragment length polymorphism. The individuals carrying heterozygous or homozygous genotypes (GA+AA) for CCR2-64I polymorphisms seem to be at lower risk for cervical lesion [odds ratio (OR) = 0.37, p = 0.0008)]. The same was observed for the A allele (OR = 0.39, p = 0.0002), while no association was detected (p > 0.05) with CCR5-Δ32 polymorphism. Regarding the human papillomavirus (HPV) type, patients carrying the CCR2-64Ipolymorphism were protected against infection by HPV type 16 (OR = 0.35, p = 0.0184). In summary, our study showed a protective effect ofCCR2-64I rs1799864 polymorphism against the development of cervical lesions (CIN and CC) and in the susceptibility of HPV 16 infection.

%B Mem Inst Oswaldo Cruz %V 111 %P 174-80 %8 2016 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26982176?dopt=Abstract %R 10.1590/0074-02760150367 %0 Journal Article %J Mol Immunol %D 2016 %T CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response. %A Zupin, Luisa %A Polesello, Vania %A Alberi, Giulia %A Moratelli, Giulia %A Crocè, Saveria Lory %A Masutti, Flora %A Pozzato, Gabriele %A Crovella, Sergio %A Segat, Ludovica %X

Hepatitis C is a severe liver disease caused by hepatitis C virus that could persist in the host causing progression towards chronic disease in about 80% of the cases. Pegylated-interferon plus ribavirin was the gold standard therapy, however treatment's response was quite variable among individuals and different host/viral factors may play a role in disease outcome. The cluster of differentiation 209 (CD209 antigen) is a component of the innate immune system able to recognize HCV and consequently activating the immune response. We enrolled 203 Italian HCV infected patients and 220 healthy controls investigating if five promoter polymorphisms within CD209 gene (encoding for CD209 antigen) correlated with HCV infection susceptibility, spontaneous viral clearance and interferon treatment response. CD209 -939G>A and -871A>G polymorphisms associated with HCV infection susceptibility, while, CD209 -871A>G and -336A>G polymorphisms associated with response to treatment. In conclusion, CD209 polymorphisms could play a role in the susceptibility to HCV infection as well as interferon treatment response in our study population from North-East of Italy.

%B Mol Immunol %V 76 %P 49-54 %8 2016 Aug %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27348632?dopt=Abstract %R 10.1016/j.molimm.2016.06.009 %0 Journal Article %J Lung Cancer %D 2016 %T Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma. %A Comar, M %A Zanotta, N %A Zanconati, F %A Cortale, M %A Bonotti, A %A Cristaudo, A %A Bovenzi, M %X

OBJECTIVES: Immune mediators are likely to be relevant for the biological response to asbestos exposure. The aim of this study was to investigate the association between immune mediators involved in inflammation, cell survival and angiogenesis, and asbestos-related diseases in workers from a coastal area of North-East Italy with a high incidence of pleural malignant mesothelioma (PMM).

MATERIALS AND METHODS: A selected custom set of 12 soluble mediators was evaluated with a Luminex platform in sera, pleural fluid and mesothelioma biopsies from 123 asbestos-exposed workers (38 free from pleural-pulmonary disorders, 46 with non-malignant asbestos diseases, 39 with PMM) and in sera from 33 healthy controls from the same territorial area.

RESULTS: Increased immune mediator concentrations were observed in the sera of the asbestos-exposed workers compared to controls for human fibroblast growth factor (FGF-b), vascular endothelial growth factor (VEGF), CCL5 (RANTES), CXCL10 (IP-10), CLEC11A (SCGF-b), CCL27 (CTACK), CCL11 (EOTAXIN), IL-5 and IL-6 (p<0.001). The chemokines IP-10 and RANTES were associated with the severity of asbestos-related diseases. In the workers with PMM, the immune proteins secreted by mesothelioma biopsies showed detectable levels of RANTES, VEGF, and IP-10. In the same workers with PMM, a significant relationship between serum and pleural fluid concentrations was found for RANTES alone.

CONCLUSIONS: Occupational exposure to asbestos seems to drive the production of specific growth factors dually involved in the early inflammatory response and in pro-tumoral activity before clinical evidence of related disorders, suggesting that their over-expression may precede the onset of asbestos-related diseases. These findings suggest that some chemokines may have a prognostic role in the progression of asbestos-related diseases and could be used for the health surveillance of either workers with an occupational history of asbestos exposure or patients affected by non-malignant asbestos-related diseases.

%B Lung Cancer %V 94 %P 61-7 %8 2016 Apr %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26973208?dopt=Abstract %R 10.1016/j.lungcan.2016.01.020 %0 Journal Article %J Curr HIV Res %D 2016 %T Chemokines SNPs in HIV-1+ Patients and Healthy Controls from Northeast Brazil: Association with Protection against HIV-1 Infection. %A Celerino da Silva, Ronaldo %A Victor Campos Coelho, Antonio %A Cláudio Arraes, Luiz %A André Cavalcanti Brandão, Lucas %A Lima Guimarães, Rafael %A Crovella, Sergio %X

BACKGROUND: HIV-1 virus is known to infect the host mainly through CD4+ T-lymphocyte cells, by interactions among the viral envelope proteins, CD4 receptor and HIV-1 coreceptors, such as chemokines receptors. Variations in the genes encoding HIV-1 coreceptors and their natural ligands have been shown to modify HIV-1 infection susceptibility and disease progression.

METHODS AND RESULTS: We analysed the distribution of SNPs in chemokines (CCL3, CCL4, CCL5, CXCL12) and chemokine receptor (CXCR6) genes, in 268 HIV-1 infected patients (HIV-1+) and 221 healthy controls from Northeast Brazil, and their possible connection with susceptibility to HIV-1 infection. The genotyping were performed through allele specific fluorogenic probes using real time PCR. We observed that the T alleles and AT genotype of rs1719153 CCL4 SNP were more frequent in healthy controls (19.8% and 35.0%, respectively) than in HIV-1+ patients (T allele: 14.1%; OR=0.67; 95%CI=0.47-0.95; p-value=0.020; and AT genotype: 24.4%; OR=0.61; 95%CI=0.40- 0.93; p-value=0.021) after correcting for age and sex. The rs1719134 (CCL3) and rs1719153 (CCL4) SNPs presented linkage disequilibrium (D'=0.83). The AT haplotype frequency was increased in healthy controls (17.3%) in relation to HIV-1+ patients (11.0%; OR=0.62; 95%CI=0.42-0.93; p-value=0.020).

CONCLUSION: Since our results revealed an increased frequency of alleles and genotypes of CCL3/CCL4 SNPs and haplotype (CCL3-CCL4) among healthy controls, we suggest that these variations might have a potential protective role against HIV-1 infection.

%B Curr HIV Res %V 14 %P 340-5 %8 2016 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26785888?dopt=Abstract %0 Journal Article %J J Pediatr %D 2016 %T A Child with Severe Developmental Delay and Growth Retardation. %A Rossetto, Elena %A Matarazzo, Lorenza %A Maschio, Massimo %A Taddio, Andrea %A Costa, Paola %A Ventura, Alessandro %B J Pediatr %V 175 %P 241-241.e1 %8 2016 Aug %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27266964?dopt=Abstract %R 10.1016/j.jpeds.2016.05.006 %0 Journal Article %J Acta Otorhinolaryngol Ital %D 2016 %T Childhood hearing surveillance activity in Italy: preliminary recommendations. %A Orzan, E %A Ruta, F %A Bolzonello, P %A Marchi, R %A Ceschin, F %A Ciciriello, E %X

Following the positive outcomes of the newborn hearing screening programmes already underway in several Italian regions, it is now necessary to address the identification of childhood hearing impairments that missed the neonatal screening programme or have delayed onset. Within the framework of the Ministry of Health project CCM 2013 "Preventing Communication Disorders: a Regional Program for early Identification, Intervention and Care of Hearing Impaired Children", a group of professionals identified three main recommendations that can be useful to improve hearing surveillance activity within the regional and state Italian Health System. The family paediatrician is recognised as having a key role in ongoing monitoring of hearing capacity and development of the growing child.

%B Acta Otorhinolaryngol Ital %V 36 %P 15-20 %8 2016 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27054386?dopt=Abstract %R 10.14639/0392-100X-1073 %0 Journal Article %J Acta Paediatr %D 2016 %T Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients. %A Pastore, Serena %A Ferrara, Giovanna %A Monasta, Lorenzo %A Meini, Antonella %A Cattalini, Marco %A Martino, Silvana %A Alessio, Maria %A La Torre, Francesco %A Teruzzi, Barbara %A Gerloni, Valeria %A Breda, Luciana %A Taddio, Andrea %A Lepore, Loredana %X

AIM: The aim of this Italian study was to describe the clinical features, treatment options and outcomes of a cohort of patients with chronic nonbacterial osteomyelitis (CNO).

METHODS: This was a retrospective cohort study. Laboratory data, diagnostic imaging, histological features and clinical course are reported.

RESULTS: We enrolled 47 patients diagnosed with CNO. Bone pain was the leading symptom, and multifocal disease was present in 87% of the patients. The majority of the bone lesions were located in the appendicular skeleton (58%). Extraosseous manifestations were present in 34% of the patients, and renal involvement was detected in four patients. Inflammatory indices were increased in 80%, and bone x-rays were negative in 15% of the patients. Nonsteroidal anti-inflammatory drugs (NSAIDs) were the first therapy for all patients, achieving clinical remission in 27%. A good response to NSAIDs was significantly associated with a better prognosis. Bisphosphonates were used in 26 patients, with remission in 73%. Only six patients (13%), all with spine involvement, developed sequelae.

CONCLUSION: We found a possible association between CNO and renal disease. Bisphosphonates were more likely to lead to clinical remission when NSAIDs and corticosteroids had failed. Vertebral localisation was the only risk factor for potential sequelae.

%B Acta Paediatr %V 105 %P e328-33 %8 2016 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/27059298?dopt=Abstract %R 10.1111/apa.13420 %0 Journal Article %J J Rheumatol %D 2016 %T Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study. %A Naselli, Aldo %A Penco, Federica %A Cantarini, Luca %A Insalaco, Antonella %A Alessio, Mariolina %A Tommasini, Alberto %A Maggio, Cristina %A Obici, Laura %A Gallizi, Romina %A Cimmino, Marco %A Signa, Sara %A Lucherini, Orso Maria %A Carta, Sonia %A Caroli, Francesco %A Martini, Alberto %A Rubartelli, Anna %A Ceccherini, Isabella %A Gattorno, Marco %X

OBJECTIVE: The aim of our study was to analyze the clinical and functional effect of the p.Q703K (p. Q705K, c. 2107C>A) variant of the NLRP3 gene in a population of patients screened for suspected cryopyrin-associated periodic syndrome (CAPS).

METHODS: Since 2002, 580 patients underwent molecular analysis for NLRP3. Data on clinical presentation, response to treatment, and longterm followup were collected using a uniform questionnaire. The pattern of cytokine secretion after lipopolysaccharide stimulation from isolated monocytes was analyzed in 3 patients carrying the p.Q703K variant and 1 patient with a chronic infantile neurologic, cutaneous, articular syndrome phenotype carrying both the p.M406I and p.Q703K, and compared with 7 patients with CAPS with sure pathogenic variants and 6 healthy controls.

RESULTS: The p.Q703K variant was found in 57 screened patients with an overall allelic frequency of 5%. The frequency in normal controls was 5.5%. Clinical data at the moment of molecular analysis and at followup were available in 36 patients. Two patients displayed additional mutations of NLRP3. The mean followup was 2.5 years. Thirteen patients (39%) had a final diagnosis different from the original suspicion of CAPS. The remaining 21 patients displayed a mild phenotype mainly characterized by recurrent episodes of urticarial rash and arthralgia. Only 8 patients were treated with anti-interleukin (IL)-1 treatment, with a complete response in 5 patients. The pattern of secretion of IL-1β and other cytokines (IL-6 and IL-1 receptor antagonist) in patients did not display the aberrancies observed in patients with CAPS and was similar to that observed in healthy controls.

CONCLUSION: The present study confirms the weak clinical and functional effect of the p.Q703K variant.

%B J Rheumatol %V 43 %P 1093-100 %8 2016 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/27036377?dopt=Abstract %R 10.3899/jrheum.150962 %0 Journal Article %J Ital J Pediatr %D 2016 %T Consensus Conference on Clinical Management of pediatric Atopic Dermatitis. %A Galli, Elena %A Neri, Iria %A Ricci, Giampaolo %A Baldo, Ermanno %A Barone, Maurizio %A Belloni Fortina, Anna %A Bernardini, Roberto %A Berti, Irene %A Caffarelli, Carlo %A Calamelli, Elisabetta %A Capra, Lucetta %A Carello, Rossella %A Cipriani, Francesca %A Comberiati, Pasquale %A Diociaiuti, Andrea %A El Hachem, Maya %A Fontana, Elena %A Gruber, Michaela %A Haddock, Ellen %A Maiello, Nunzia %A Meglio, Paolo %A Patrizi, Annalisa %A Peroni, Diego %A Scarponi, Dorella %A Wielander, Ingrid %A Eichenfield, Lawrence F %X

The Italian Consensus Conference on clinical management of atopic dermatitis in children reflects the best and most recent scientific evidence, with the aim to provide specialists with a useful tool for managing this common, but complex clinical condition. Thanks to the contribution of experts in the field and members of the Italian Society of Pediatric Allergology and Immunology (SIAIP) and the Italian Society of Pediatric Dermatology (SIDerP), this Consensus statement integrates the basic principles of the most recent guidelines for the management of atopic dermatitis to facilitate a practical approach to the disease. The therapeutical approach should be adapted to the clinical severity and requires a tailored strategy to ensure good compliance by children and their parents. In this Consensus, levels and models of intervention are also enriched by the Italian experience to facilitate a practical approach to the disease.

%B Ital J Pediatr %V 42 %P 26 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26936273?dopt=Abstract %R 10.1186/s13052-016-0229-8 %0 Journal Article %J Pain %D 2016 %T The cortical response to a noxious procedure changes over time in preterm infants. %A Bembich, Stefano %A Marrazzo, Francesca %A Barini, Alice %A Ravalico, Paola %A Cont, Gabriele %A Demarini, Sergio %X

The aim of the study was to investigate whether cortical response to a repeated noxious procedure may change over time in preterm infants. Possible reasons for change are: (1) advancing maturation of central nervous system; and (2) increasing experience with noxious procedures during hospital stay. Sixteen preterm infants were recruited, with a postmenstrual age (PMA) ranging between 29 and 36 weeks. Newborns were assessed during a heel-prick procedure, once a week for at least 3 consecutive times. Multichannel near-infrared spectroscopy was used to detect cortical activation, by measuring increase in cortical oxy-haemoglobin (HbO2). Parietal, temporal, and posterior frontal areas were monitored bilaterally. By regression analysis, we studied the effect of (1) increasing PMA and (2) increasing number of heel pricks, on the magnitude of cortical activation. We observed a bilateral nociceptive event-related activation of the posterior frontal cortex, mainly contralateral to the side pricked. Additionally, we found a significant positive effect of PMA, as HbO2 progressively increased in the posterior frontal cortex (P < 0.001), bilaterally, over time. Conversely, the degree of cortical activation decreased as the number of noxious events increased (P < 0.002). We conclude the following: (1) Preterm newborns showed a significant activation of the posterior frontal cortex in association with noxious stimuli; (2) Cortical activation was progressively greater with increasing PMA; (3) There was an inverse relationship between cortical activation and the number of heel pricks. We speculate that such findings may be due to both endogenous cortical maturation and experience-dependent neuroplasticity of the developing brain (eg, synaptogenesis, synaptic pruning).

%B Pain %V 157 %P 1979-87 %8 2016 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/27152689?dopt=Abstract %R 10.1097/j.pain.0000000000000605 %0 Journal Article %J Lancet %D 2016 %T Current concepts in management of pain in children in the emergency department. %A Krauss, Baruch S %A Calligaris, Lorenzo %A Green, Steven M %A Barbi, Egidio %K Acute Pain %K Analgesics, Opioid %K Anesthetics, Local %K Anti-Inflammatory Agents, Non-Steroidal %K Anxiety %K Child %K Emergency Medicine %K Emergency Service, Hospital %K Humans %K Pain Management %K Pediatrics %K Stress, Psychological %X

Pain is common in children presenting to emergency departments with episodic illnesses, acute injuries, and exacerbation of chronic disorders. We review recognition and assessment of pain in infants and children and discuss the manifestations of pain in children with chronic illness, recurrent pain syndromes, and cognitive impairment, including the difficulties of pain management in these patients. Non-pharmacological interventions, as adjuncts to pharmacological management for acute anxiety and pain, are described by age and development. We discuss the pharmacological management of acute pain and anxiety, reviewing invasive and non-invasive routes of administration, pharmacology, and adverse effects.

%B Lancet %V 387 %P 83-92 %8 2016 Jan 2 %G eng %N 10013 %1 http://www.ncbi.nlm.nih.gov/pubmed/26095580?dopt=Abstract %R 10.1016/S0140-6736(14)61686-X %0 Journal Article %J Braz J Microbiol %D 2016 %T DEFB1 gene polymorphisms and tuberculosis in a Northeastern Brazilian population. %A Celerino da Silva, Ronaldo %A da Cruz, Heidi Lacerda Alves %A Brandão, Lucas André Cavalcanti %A Guimarães, Rafael Lima %A Montenegro, Lilian Maria Lapa %A Schindler, Haiana Charifker %A Segat, Ludovica %A Crovella, Sergio %X

β-Defensin-1, an antimicrobial peptide encoded by the DEFB1 gene, is known to play an important role in lung mucosal immunity. In our association study we analyzed three DEFB1 functional polymorphisms -52G>A (rs1799946), -44C>G (rs1800972) and -20G>A (rs11362) in 92 tuberculosis patients and 286 healthy controls, both from Northeast Brazil: no association was found between the studied DEFB1 polymorphisms and the disease. However we cannot exclude that this lack of association could be due to the low number of subjects analyzed, as suggested by the low statistical power achieved for the three analyzed SNPs (values between 0.16 and 0.50).

%B Braz J Microbiol %V 47 %P 389-93 %8 2016 Apr-Jun %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/26991287?dopt=Abstract %R 10.1016/j.bjm.2015.09.001 %0 Journal Article %J Int J Pediatr Otorhinolaryngol %D 2016 %T DEFB1 polymorphisms and susceptibility to recurrent tonsillitis in Italian children. %A Zupin, Luisa %A Polesello, Vania %A Grasso, Domenico Leonardo %A Crovella, Sergio %A Segat, Ludovica %X

INTRODUCTION: The tonsils are secondary lymphoid organs fundamental for immune system response against pathogens within the oral cavity. Tonsillitis refers to inflammation of the pharyngeal tonsils that may include the adenoids and the lingual tonsils and that can be acute, recurrent, and chronic. Viral or bacterial infections, as well as immunologic factors are the main trigger to tonsillitis and disease's chronicity: the host immune responses, especially the innate one, could play an important role in susceptibility to the disease.

OBJECTIVES: The current study aims at investigating the role of functional polymorphisms in the 5'UTR (c.-52G>A, c.-44G>C and c.-20G>A) of DEFB1 gene, encoding for the antimicrobial peptide human beta-defensin 1, in the predisposition to recurrent tonsillitis in children from North Eastern Italy.

RESULTS: No significant correlation was found between DEFB1 allele, genotype and haplotype frequencies and recurrent tonsillitis susceptibility with the exception of an increased risk to disease development in patients carrying DEFB1 rare haplotypes.

CONCLUSION: Our results may suggest that DEFB1 polymorphisms alone may not influence pathology susceptibility, however they could possibly concur, together with other factors involved in the genetic control of innate immune system, in the predisposition towards recurrent tonsillitis.

%B Int J Pediatr Otorhinolaryngol %V 83 %P 12-5 %8 2016 Apr %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26968045?dopt=Abstract %R 10.1016/j.ijporl.2016.01.025 %0 Journal Article %J Virol J %D 2016 %T Detection of Malawi polyomavirus sequences in secondary lymphoid tissues from Italian healthy children: a transient site of infection. %A Papa, N %A Zanotta, N %A Knowles, A %A Orzan, E %A Comar, M %X

BACKGROUND: The novel Malawi polyomavirus (MWPyV) was initially detected in stool specimens from healthy children and children with gastrointestinal symptoms, mostly diarrhea, indicating that MWPyV might play a role in human gastroenteric diseases. Recently, MWPyV sequences were additionally identified in respiratory secretions from both healthy and acutely ill children suggesting that MWPyV may have a tropism for different human tissues. This study was designed to investigate the possible sites of latency/persistence for MWPyV in a cohort of healthy Italian children.

METHODS: Specimens (n° 500) of tonsils, adenoids, blood, urines and feces, from 200 healthy and immunocompetent children (age range: 1-15 years) were tested for the amplification of the MWPyV LT antigen sequence by quantitative real-time PCR. Samples (n° 80) of blood and urines from 40 age-matched children with autoimmune diseases, were screened for comparison. Polyomaviruses JC/BK and Epstein-Barr Virus (EBV) were also tested as markers of infection in all samples using the same molecular technique.

RESULTS: In our series of healthy children, MWPyV was detected only in the lymphoid tissues showing a prevalence of 6 % in tonsils and 1 % in adenoids, although with a low viral load. No JCPyV or BKPyV co-infection was found in MWPyV positive samples, while EBV showed a similar percentage of both in tonsils and adenoids (38 and 37 %). Conversely, no MWPyV DNA was detected in stool from babies with gastroenteric syndrome. With regards to autoimmune children, neither MWPyV nor BKPyV were detected in blood, while JCPyV viremia was observed in 15 % (6/40) of children treated with Infliximab. Urinary BKPyV shedding was observed in 12.5 % (5/40) while JCPyV in 100 % of the samples.

CONCLUSIONS: The detection of MWPyV sequences in tonsils and adenoids of healthy children suggests that secondary lymphoid tissues can harbour MWPyV probably as transient sites of persistence rather than actual sites of latency.

%B Virol J %V 13 %P 97 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27287743?dopt=Abstract %R 10.1186/s12985-016-0553-z %0 Journal Article %J Front Pediatr %D 2016 %T Does Preputial Reconstruction Increase Complication Rate of Hypospadias Repair? 20-Year Systematic Review and Meta-Analysis. %A Castagnetti, Marco %A Gnech, Michele %A Angelini, Lorenzo %A Rigamonti, Waifro %A Bagnara, Vincenzo %A Esposito, Ciro %X

INTRODUCTION: We performed a systematic review of the literature on preputial reconstruction (PR) during hypospadias repair to determine the cumulative risk of preputial skin complications and the influence of PR on urethroplasty complications, namely, fistula formation and overall reoperation rate of the repair.

MATERIALS AND METHODS: A systematic search of the literature published after 06/1995 was performed in 06/2015 using the keyword "hypospadias." Only studies on the outcome of PR in children, defined as dehiscence of the reconstructed prepuce or secondary phimosis needing circumcision, were selected. A meta-analysis of studies comparing PR vs. circumcision was performed for the outcomes "hypospadias fistula formation" and "reoperation rate."

RESULTS: Twenty studies were identified. Nineteen reported the outcome of PR in 2115 patients. Overall, 95% (2016/2115) of patients undergoing PR had distal hypospadias. The cumulative rate of PR complications was 7.7% (163/2115 patients), including 5.7% (121/2115 patients) preputial dehiscences and 1.5% (35/2117 reported patients) secondary phimoses needing circumcision. A meta-analysis of seven studies comparing patients undergoing PR vs. circumcision showed no increased risk of urethral fistula formation associated with PR, odds ratio (OR) (Mantel-Haenszel, Fixed effect, 95% CI), 1.25 (0.80-1.97). Likewise, two studies comparing the overall reoperation rate did not show an increased risk of reoperation associated with PR, OR (Mantel-Haenszel, Random effect, 95% CI), 1.27 (0.45-3.58).

CONCLUSION: PR carries an 8% risk of specific complications (dehiscence of reconstructed prepuce or secondary phimosis needing circumcision), but does not seem to increase the risk of urethroplasty complications, and the overall reoperation rate of hypospadias repair.

%B Front Pediatr %V 4 %P 41 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27200322?dopt=Abstract %R 10.3389/fped.2016.00041 %0 Journal Article %J Pediatr Infect Dis J %D 2016 %T Dyslipidemia, Diet, and Physical Exercise in Children on Treatment with Anti-Retroviral Medication in El Salvador: A Cross-Sectional Study. %A Sonego, Michela %A Sagrado, Maria José %A Escobar, Gustavo %A Lazzerini, Marzia %A Rivas, Estefanie %A Martín-Cañavate, Rocio %A de López, Elsy Pérez %A Ayala, Sandra %A Castaneda, Luis %A Aparicio, Pilar %A Custodio, Estefanía %X

BACKGROUND: Dyslipidemias are common in HIV-infected children, especially if treated with protease-inhibitors, but there are few data on how to treat dyslipidemias in this population. We estimated the dislypidemia prevalence and its association with treatment, diet, and physical exercise in children on anti-retroviral treatment at the El Salvador reference center for pediatric HIV care (CENID).

METHODS: Information was gathered regarding socio-demographic characteristics, treatment, diet, and physical activity of 173 children aged 5-18 years and receiving anti-retroviral therapy.Triglycerides, total cholesterol, low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), viral load, and CD4 T-lymphocytes were measured. Abnormal concentrations were defined as triglycerides ≥130 mg/dl in 10- to 18-year-olds and ≥100 mg/dl in <10 year-olds; total cholesterol ≥200 mg/dl; LDL-C ≥130 mg/dl; and HDL-C ≤35 mg/dl.We adjusted four different multivariate models to assess the independent association of each type of dyslipidemia with protease-inhibitors, diet, and physical exercise.

RESULTS: Of the 173 children, 83 (48%) had hypertriglyceridemia and 25 (14.5%) hypercholesterolemia. High LDL-C concentrations were observed in 17 children (9.8%) and low HDL-C in 38 (22%). Treatment with protease-inhibitors was significantly associated with hypertriglyceridemia (Prevalence Ratio (PR) 2.8; 95%CI 2.0-3.8) and hypercholesterolemia (PR 9.0; 95%CI 3.6-22.2).Higher adherence to a "high fat/sugar diet" was associated with hypercholesterolemia (PR 1.6; 95%CI 1.1-2.3) and high LDL-C (PR 1.7; 95%CI 1.0-2.9).Compared with those exercising <3 times/week, children exercising ≥7 times were less likely to have low HDL-C (PR=0.4; 95%CI 0.2-0.7).

CONCLUSIONS: These results suggest that a healthy diet and exercise habits can contribute to controlling some aspects of the lipid profile in this population.

%B Pediatr Infect Dis J %8 2016 May 31 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27254031?dopt=Abstract %R 10.1097/INF.0000000000001244 %0 Journal Article %J Neuropsychiatr Dis Treat %D 2016 %T Early diagnosis and Early Start Denver Model intervention in autism spectrum disorders delivered in an Italian Public Health System service. %A Devescovi, Raffaella %A Monasta, Lorenzo %A Mancini, Alice %A Bin, Maura %A Vellante, Valerio %A Carrozzi, Marco %A Colombi, Costanza %X

BACKGROUND: Early diagnosis combined with an early intervention program, such as the Early Start Denver Model (ESDM), can positively influence the early natural history of autism spectrum disorders. This study evaluated the effectiveness of an early ESDM-inspired intervention, in a small group of toddlers, delivered at low intensity by the Italian Public Health System.

METHODS: Twenty-one toddlers at risk for autism spectrum disorders, aged 20-36 months, received 3 hours/wk of one-to-one ESDM-inspired intervention by trained therapists, combined with parents' and teachers' active engagement in ecological implementation of treatment. The mean duration of treatment was 15 months. Cognitive and communication skills, as well as severity of autism symptoms, were assessed by using standardized measures at pre-intervention (Time 0 [T0]; mean age =27 months) and post-intervention (Time 1 [T1]; mean age =42 months).

RESULTS: Children made statistically significant improvements in the language and cognitive domains, as demonstrated by a series of nonparametric Wilcoxon tests for paired data. Regarding severity of autism symptoms, younger age at diagnosis was positively associated with greater improvement at post-assessment.

CONCLUSION: Our results are consistent with the literature that underlines the importance of early diagnosis and early intervention, since prompt diagnosis can reduce the severity of autism symptoms and improve cognitive and language skills in younger children. Particularly in toddlers, it seems that an intervention model based on the ESDM principles, involving the active engagement of parents and nursery school teachers, may be effective even when the individual treatment is delivered at low intensity. Furthermore, our study supports the adaptation and the positive impact of the ESDM entirely sustained by the Italian Public Health System.

%B Neuropsychiatr Dis Treat %V 12 %P 1379-84 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27366069?dopt=Abstract %R 10.2147/NDT.S106850 %0 Journal Article %J Inflamm Bowel Dis %D 2016 %T Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis. %A Aloi, Marina %A DʼArcangelo, Giulia %A Bramuzzo, Matteo %A Gasparetto, Marco %A Martinelli, Massimo %A Alvisi, Patrizia %A Illiceto, Maria Teresa %A Valenti, Simona %A Distante, Manuela %A Pellegrino, Salvatore %A Gatti, Simona %A Arrigo, Serena %A Civitelli, Fortunata %A Martelossi, Stefano %X

BACKGROUND: We aimed at describing the efficacy of azathioprine (AZA) in pediatric ulcerative colitis, comparing the outcomes of early (0-6 months) versus late (6-24 months) initiation of therapy.

METHODS: Children with ulcerative colitis treated with AZA within 24 months of diagnosis were included. Corticosteroid (CS)-free remission and mucosal healing (MH), assessed by endoscopy or fecal calprotectin, at 12 months were the primary outcomes. Patients were also compared for CS-free remission and MH, need for treatment escalation or surgery, number of hospitalizations, and adverse events during a 24-month follow-up.

RESULTS: A total of 121 children entered the study (median age 10.5 ± 4.0 years, 59% girls). Seventy-six (63%) started AZA between 0 and 6 months (early group) and 45 (37%) started between 6 and 24 months (late group). Seventy-five percent and 53% of patients in the early and late group, respectively, received CS at the diagnosis (P = 0.01). CS-free remission at 1 year was achieved by 30 (50%) of the early and 23 (57%) of the late patients (P = 0.54). MH occurred in 37 (37%) patients at 1 year, with no difference between the 2 groups (33% early, 42% late; P = 0.56). No difference was found for the other outcomes.

CONCLUSIONS: Introduction of AZA within 6 months of diagnosis seems not more effective than later treatment to achieve CS-free remission in pediatric ulcerative colitis. MH does not depend on the timing of AZA initiation; however, because of the incomplete comparability of the 2 groups at the diagnosis and the use of fecal calprotectin as a surrogate marker of MH, our results should be further confirmed by prospective studies.

%B Inflamm Bowel Dis %V 22 %P 1647-54 %8 2016 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/27271489?dopt=Abstract %R 10.1097/MIB.0000000000000828 %0 Journal Article %J BMJ Open %D 2016 %T Effectiveness of the Baby Friendly Community Initiative in Italy: a non-randomised controlled study. %A Cattaneo, Adriano %A Bettinelli, Maria Enrica %A Chapin, Elise %A Macaluso, Anna %A Córdova do Espírito Santo, Lílian %A Murante, Anna Maria %A Montico, Marcella %X

OBJECTIVE: To assess the effectiveness of the Baby Friendly Community Initiative (BFCI) on exclusive breast feeding at 6 months.

DESIGN: Controlled, non-randomised trial.

SETTING: 18 Local Health Authorities in 9 regions of Italy.

PARTICIPANTS: 5094 mother/infant dyads in 3 cohorts were followed up to 12 months after birth in 3 rounds of data collection: at baseline, after implementation of the intervention in the early intervention group and after implementation in the late intervention group. 689 (14%) dyads did not complete the study.

INTERVENTION: Implementation of the 7 steps of the BFCI.

MAIN OUTCOME MEASURES: The rate of exclusive breast feeding at 6 months was the primary outcome; breast feeding at discharge, 3 and 12 months was also measured.

RESULTS: The crude rates of exclusive breast feeding at discharge, 3 and 6 months, and of any breast feeding at 6 and 12 months increased at each round of data collection after baseline in the early and late intervention groups. At the end of the project, 10% of infants were exclusively breast fed at 6 months and 38% were continuing to breast feed at 12 months. However, the comparison by adjusted rates and logistic regression failed to show statistically significant differences between groups and rounds of data collection in the intention-to-treat analysis, as well as when compliance with the intervention and training coverage was taken into account.

CONCLUSIONS: The study failed to demonstrate an effect of the BFCI on the rates of breast feeding. This may be due, among other factors, to the time needed to observe an effect on breast feeding following this complex intervention.

%B BMJ Open %V 6 %P e010232 %8 2016 %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/27154476?dopt=Abstract %R 10.1136/bmjopen-2015-010232 %0 Journal Article %J BMJ Open %D 2016 %T Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01). %A Rosati, Anna %A Ilvento, Lucrezia %A L'Erario, Manuela %A De Masi, Salvatore %A Biggeri, Annibale %A Fabbro, Giancarlo %A Bianchi, Roberto %A Stoppa, Francesca %A Fusco, Lucia %A Pulitanò, Silvia %A Battaglia, Domenica %A Pettenazzo, Andrea %A Sartori, Stefano %A Biban, Paolo %A Fontana, Elena %A Cesaroni, Elisabetta %A Mora, Donatella %A Costa, Paola %A Meleleo, Rosanna %A Vittorini, Roberta %A Conio, Alessandra %A Wolfler, Andrea %A Mastrangelo, Massimo %A Mondardini, Maria Cristina %A Franzoni, Emilio %A McGreevy, Kathleen S %A Di Simone, Lorena %A Pugi, Alessandra %A Mirabile, Lorenzo %A Vigevano, Federico %A Guerrini, Renzo %X

INTRODUCTION: Status epilepticus (SE) is a life-threatening neurological emergency. SE lasting longer than 120 min and not responding to first-line and second-line antiepileptic drugs is defined as 'refractory' (RCSE) and requires intensive care unit treatment. There is currently neither evidence nor consensus to guide either the optimal choice of therapy or treatment goals for RCSE, which is generally treated with coma induction using conventional anaesthetics (high dose midazolam, thiopental and/or propofol). Increasing evidence indicates that ketamine (KE), a strong N-methyl-d-aspartate glutamate receptor antagonist, may be effective in treating RCSE. We hypothesised that intravenous KE is more efficacious and safer than conventional anaesthetics in treating RCSE.

METHODS AND ANALYSIS: A multicentre, randomised, controlled, open-label, non-profit, sequentially designed study will be conducted to assess the efficacy of KE compared with conventional anaesthetics in the treatment of RCSE in children. 10 Italian centres/hospitals are involved in enrolling 57 patients aged 1 month to 18 years with RCSE. Primary outcome is the resolution of SE up to 24 hours after withdrawal of therapy and is updated for each patient treated according to the sequential method.

ETHICS AND DISSEMINATION: The study received ethical approval from the Tuscan Paediatric Ethics Committee (12/2015). The results of this study will be published in peer-reviewed journals and presented at international conferences.

TRIAL REGISTRATION NUMBER: NCT02431663; Pre-results.

%B BMJ Open %V 6 %P e011565 %8 2016 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/27311915?dopt=Abstract %R 10.1136/bmjopen-2016-011565 %0 Journal Article %J Acta Otorhinolaryngol Ital %D 2016 %T Empowering the family during the first months after identification of permanent hearing impairment in children. %A Ciciriello, E %A Bolzonello, P %A Marchi, R %A Falzone, C %A Muzzi, E %A Orzan, E %X

The latest international guidelines highlight the importance of involving the family in the diagnostic and rehabilitation process of children affected by permanent hearing impairment. This emphasises how meaningful this approach is for the development of the deaf child. So far, there is very little evidence about this approach in Italy, and there are still some barriers to its practical management. The aim of this paper is to report the results of a strategic analysis, which identifies the strengths, weaknesses, opportunities and threats of the family empowerment process during early auditory diagnosis and rehabilitation. The audiology programme should have the goal to offer information and support to families in order to achieve a conscious decision about the use and type of auditory prosthesis and rehabilitation choice within three months after audiologic diagnosis. Within the framework of the Ministry of Health project CCM 2013 "Preventing Communication Disorders: a Regional Program for Early Identification, Intervention and Care of Hearing Impaired Children", a group of professionals identified three main recommendations that can be useful to foster the natural communicative development of the child by strengthening the therapeutic alliance and empowerment of the family. The recommendations obtained with this analysis can help to develop new Italian guidelines with the aim to foster natural communicative development of the child by strengthening the therapeutic alliance and empowerment of the family.

%B Acta Otorhinolaryngol Ital %V 36 %P 64-70 %8 2016 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27054393?dopt=Abstract %R 10.14639/0392-100X-1071 %0 Journal Article %J Brain %D 2016 %T EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy. %A Byrne, Susan %A Jansen, Lara %A U-King-Im, Jean-Marie %A Siddiqui, Ata %A Lidov, Hart G W %A Bodi, Istvan %A Smith, Luke %A Mein, Rachael %A Cullup, Thomas %A Dionisi-Vici, Carlo %A Al-Gazali, Lihadh %A Al-Owain, Mohammed %A Bruwer, Zandre %A Al Thihli, Khalid %A El-Garhy, Rana %A Flanigan, Kevin M %A Manickam, Kandamurugu %A Zmuda, Erik %A Banks, Wesley %A Gershoni-Baruch, Ruth %A Mandel, Hanna %A Dagan, Efrat %A Raas-Rothschild, Annick %A Barash, Hila %A Filloux, Francis %A Creel, Donnell %A Harris, Michael %A Hamosh, Ada %A Kölker, Stefan %A Ebrahimi-Fakhari, Darius %A Hoffmann, Georg F %A Manchester, David %A Boyer, Philip J %A Manzur, Adnan Y %A Lourenco, Charles Marques %A Pilz, Daniela T %A Kamath, Arveen %A Prabhakar, Prab %A Rao, Vamshi K %A Rogers, R Curtis %A Ryan, Monique M %A Brown, Natasha J %A McLean, Catriona A %A Said, Edith %A Schara, Ulrike %A Stein, Anja %A Sewry, Caroline %A Travan, Laura %A Wijburg, Frits A %A Zenker, Martin %A Mohammed, Shehla %A Fanto, Manolis %A Gautel, Mathias %A Jungbluth, Heinz %K Agenesis of Corpus Callosum %K Animals %K Autophagy %K Cataract %K Child, Preschool %K Cross-Sectional Studies %K Drosophila melanogaster %K Female %K Hippocampus %K Humans %K Male %K Mutation %K Neurodevelopmental Disorders %K Proteins %K Retrospective Studies %X

Vici syndrome is a progressive neurodevelopmental multisystem disorder due to recessive mutations in the key autophagy gene EPG5. We report genetic, clinical, neuroradiological, and neuropathological features of 50 children from 30 families, as well as the neuronal phenotype of EPG5 knock-down in Drosophila melanogaster. We identified 39 different EPG5 mutations, most of them truncating and predicted to result in reduced EPG5 protein. Most mutations were private, but three recurrent mutations (p.Met2242Cysfs*5, p.Arg417*, and p.Gln336Arg) indicated possible founder effects. Presentation was mainly neonatal, with marked hypotonia and feeding difficulties. In addition to the five principal features (callosal agenesis, cataracts, hypopigmentation, cardiomyopathy, and immune dysfunction), we identified three equally consistent features (profound developmental delay, progressive microcephaly, and failure to thrive). The manifestation of all eight of these features has a specificity of 97%, and a sensitivity of 89% for the presence of an EPG5 mutation and will allow informed decisions about genetic testing. Clinical progression was relentless and many children died in infancy. Survival analysis demonstrated a median survival time of 24 months (95% confidence interval 0-49 months), with only a 10th of patients surviving to 5 years of age. Survival outcomes were significantly better in patients with compound heterozygous mutations (P = 0.046), as well as in patients with the recurrent p.Gln336Arg mutation. Acquired microcephaly and regression of skills in long-term survivors suggests a neurodegenerative component superimposed on the principal neurodevelopmental defect. Two-thirds of patients had a severe seizure disorder, placing EPG5 within the rapidly expanding group of genes associated with early-onset epileptic encephalopathies. Consistent neuroradiological features comprised structural abnormalities, in particular callosal agenesis and pontine hypoplasia, delayed myelination and, less frequently, thalamic signal intensity changes evolving over time. Typical muscle biopsy features included fibre size variability, central/internal nuclei, abnormal glycogen storage, presence of autophagic vacuoles and secondary mitochondrial abnormalities. Nerve biopsy performed in one case revealed subtotal absence of myelinated axons. Post-mortem examinations in three patients confirmed neurodevelopmental and neurodegenerative features and multisystem involvement. Finally, downregulation of epg5 (CG14299) in Drosophila resulted in autophagic abnormalities and progressive neurodegeneration. We conclude that EPG5-related Vici syndrome defines a novel group of neurodevelopmental disorders that should be considered in patients with suggestive features in whom mitochondrial, glycogen, or lysosomal storage disorders have been excluded. Neurological progression over time indicates an intriguing link between neurodevelopment and neurodegeneration, also supported by neurodegenerative features in epg5-deficient Drosophila, and recent implication of other autophagy regulators in late-onset neurodegenerative disease.

%B Brain %V 139 %P 765-81 %8 2016 Mar %G eng %N Pt 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26917586?dopt=Abstract %R 10.1093/brain/awv393 %0 Journal Article %J Curr Protein Pept Sci %D 2016 %T Epigenetic Signals on Plant Adaptation: A Biotic Stress Perspective. %A Neto, José Ribamar Costa Ferreira %A da Silva, Manassés Daniel %A Pandolfi, Valesca %A Crovella, Sergio %A Benko-Iseppon, Ana Maria %A Kido, Éderson Akio %X

For sessile organisms such as plants, regulatory mechanisms of gene expression are vital, since they remain exposed to climatic and biological threats. Thus, they have to face hazards with instantaneous reorganization of their internal environment. For this purpose, besides the use of transcription factors, the participation of chromatin as an active factor in the regulation of transcription is crucial. Chemical changes in chromatin structure affect the accessibility of the transcriptional machinery and acting in signaling, engaging/inhibiting factors that participate in the transcription processes. Mechanisms in which gene expression undergoes changes without the occurrence of DNA gene mutations in the monomers that make up DNA, are understood as epigenetic phenomena. These include (1) post-translational modifications of histones, which results in stimulation or repression of gene activity and (2) cytosine methylation in the promoter region of individual genes, both preventing access of transcriptional activators as well as signaling the recruitment of repressors. There is evidence that such modifications can pass on to subsequent generations of daughter cells and even generations of individuals. However, reports indicate that they persist only in the presence of a stressor factor (or an inductor of the above-mentioned modifications). In its absence, these modifications weaken or lose heritability, being eliminated in the next few generations. In this review, it is argued how epigenetic signals influence gene regulation, the mechanisms involved and their participation in processes of resistance to biotic stresses, controlling processes of the plant immune system.

%B Curr Protein Pept Sci %8 2016 Jul 24 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27455972?dopt=Abstract %0 Journal Article %J Sci Rep %D 2016 %T Evaluation of energy metabolism and calcium homeostasis in cells affected by Shwachman-Diamond syndrome. %A Ravera, Silvia %A Dufour, Carlo %A Cesaro, Simone %A Bottega, Roberta %A Faleschini, Michela %A Cuccarolo, Paola %A Corsolini, Fabio %A Usai, Cesare %A Columbaro, Marta %A Cipolli, Marco %A Savoia, Anna %A Degan, Paolo %A Cappelli, Enrico %X

Isomorphic mutation of the SBDS gene causes Shwachman-Diamond syndrome (SDS). SDS is a rare genetic bone marrow failure and cancer predisposition syndrome. SDS cells have ribosome biogenesis and their protein synthesis altered, which are two high-energy consuming cellular processes. The reported changes in reactive oxygen species production, endoplasmic reticulum stress response and reduced mitochondrial functionality suggest an energy production defect in SDS cells. In our work, we have demonstrated that SDS cells display a Complex IV activity impairment, which causes an oxidative phosphorylation metabolism defect, with a consequent decrease in ATP production. These data were confirmed by an increased glycolytic rate, which compensated for the energetic stress. Moreover, the signalling pathways involved in glycolysis activation also appeared more activated; i.e. we reported AMP-activated protein kinase hyper-phosphorylation. Notably, we also observed an increase in a mammalian target of rapamycin phosphorylation and high intracellular calcium concentration levels ([Ca(2+)]i), which probably represent new biochemical equilibrium modulation in SDS cells. Finally, the SDS cell response to leucine (Leu) was investigated, suggesting its possible use as a therapeutic adjuvant to be tested in clinical trials.

%B Sci Rep %V 6 %P 25441 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27146429?dopt=Abstract %R 10.1038/srep25441 %0 Journal Article %J Mol Psychiatry %D 2016 %T Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index. %A Hinney, A %A Kesselmeier, M %A Jall, S %A Volckmar, A-L %A Föcker, M %A Antel, J %A Heid, I M %A Winkler, T W %A Grant, S F A %A Guo, Y %A Bergen, A W %A Kaye, W %A Berrettini, W %A Hakonarson, H %A Herpertz-Dahlmann, B %A de Zwaan, M %A Herzog, W %A Ehrlich, S %A Zipfel, S %A Egberts, K M %A Adan, R %A Brandys, M %A van Elburg, A %A Boraska Perica, V %A Franklin, C S %A Tschöp, M H %A Zeggini, E %A Bulik, C M %A Collier, D %A Scherag, A %A Müller, T D %A Hebebrand, J %X

The maintenance of normal body weight is disrupted in patients with anorexia nervosa (AN) for prolonged periods of time. Prior to the onset of AN, premorbid body mass index (BMI) spans the entire range from underweight to obese. After recovery, patients have reduced rates of overweight and obesity. As such, loci involved in body weight regulation may also be relevant for AN and vice versa. Our primary analysis comprised a cross-trait analysis of the 1000 single-nucleotide polymorphisms (SNPs) with the lowest P-values in a genome-wide association meta-analysis (GWAMA) of AN (GCAN) for evidence of association in the largest published GWAMA for BMI (GIANT). Subsequently we performed sex-stratified analyses for these 1000 SNPs. Functional ex vivo studies on four genes ensued. Lastly, a look-up of GWAMA-derived BMI-related loci was performed in the AN GWAMA. We detected significant associations (P-values <5 × 10(-5), Bonferroni-corrected P<0.05) for nine SNP alleles at three independent loci. Interestingly, all AN susceptibility alleles were consistently associated with increased BMI. None of the genes (chr. 10: CTBP2, chr. 19: CCNE1, chr. 2: CARF and NBEAL1; the latter is a region with high linkage disequilibrium) nearest to these SNPs has previously been associated with AN or obesity. Sex-stratified analyses revealed that the strongest BMI signal originated predominantly from females (chr. 10 rs1561589; Poverall: 2.47 × 10(-06)/Pfemales: 3.45 × 10(-07)/Pmales: 0.043). Functional ex vivo studies in mice revealed reduced hypothalamic expression of Ctbp2 and Nbeal1 after fasting. Hypothalamic expression of Ctbp2 was increased in diet-induced obese (DIO) mice as compared with age-matched lean controls. We observed no evidence for associations for the look-up of BMI-related loci in the AN GWAMA. A cross-trait analysis of AN and BMI loci revealed variants at three chromosomal loci with potential joint impact. The chromosome 10 locus is particularly promising given that the association with obesity was primarily driven by females. In addition, the detected altered hypothalamic expression patterns of Ctbp2 and Nbeal1 as a result of fasting and DIO implicate these genes in weight regulation.Molecular Psychiatry advance online publication, 17 May 2016; doi:10.1038/mp.2016.71.

%B Mol Psychiatry %8 2016 May 17 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27184124?dopt=Abstract %R 10.1038/mp.2016.71 %0 Journal Article %J Infect Genet Evol %D 2016 %T Frequency of the CCR5-delta32 allele in Brazilian populations: A systematic literature review and meta-analysis. %A Silva-Carvalho, Wlisses Henrique Veloso %A De Moura, Ronald Rodrigues %A Coelho, Antônio Victor Campos %A Crovella, Sergio %A Guimarães, Rafael Lima %X

The CCR5 is a chemokine receptor widely expressed by several immune cells that are engaged in inflammatory responses. Some populations have individuals exhibiting a 32bp deletion in the CCR5 gene (CCR5-delta32) that produces a truncated non-functional protein not expressed on the cell surface. This polymorphism, known to be associated with susceptibility to infectious and inflammatory diseases, such as osteomyelitis, pre-eclampsia, systemic lupus erythematous, juvenile idiopathic arthritis, rheumatoid arthritis and HIV/AIDS, is more commonly found in European populations with average frequency of 10%. However, it is also possible to observe a significant frequency in other world populations, such as the Brazilian one. We performed a systematic review and meta-analysis of CCR5-delta32 genetic association studies in Brazilian populations throughout the country to estimate the frequency of this polymorphism. We also compared CCR5-delta32 frequencies across Brazilian regions. The systematic literature reviewed studies involving delta32 allele in Brazilian populations published from 1995 to 2015. Among the reviewed literature, 25 studies including 30 Brazilian populations distributed between the North, Northeast, South and Southeast regions were included in our meta-analysis. We observed an overall allelic frequency of 4% (95%-CI, 0.03-0.05), that was considered moderate and, notably, higher than some European populations, such as Cyprus (2.8%), Italy (3%) and Greece (2.4%). Regarding the regional frequency comparisons between North-Northeast (N-NE) and South-Southeast (S-SE) regions, we observed an allelic frequency of 3% (95%-CI, 0.02-0.04) and 4% (95%-CI, 0.03-0.05), respectively. The populations from S-SE regions had a slightly higher CCR5-delta32 frequency than N-NE regions (OR=1.41, p=0.002). Although there are several studies about the CCR5-delta32 polymorphism and its effect on the immune response of some infectious diseases, this report is the first meta-analysis study that provides a descriptive study of the distribution of CCR5-delta32 allele in Brazilian population.

%B Infect Genet Evol %V 43 %P 101-7 %8 2016 Sep %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27208805?dopt=Abstract %R 10.1016/j.meegid.2016.05.024 %0 Journal Article %J Nat Commun %D 2016 %T Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. %A Pattaro, Cristian %A Teumer, Alexander %A Gorski, Mathias %A Chu, Audrey Y %A Li, Man %A Mijatovic, Vladan %A Garnaas, Maija %A Tin, Adrienne %A Sorice, Rossella %A Li, Yong %A Taliun, Daniel %A Olden, Matthias %A Foster, Meredith %A Yang, Qiong %A Chen, Ming-Huei %A Pers, Tune H %A Johnson, Andrew D %A Ko, Yi-An %A Fuchsberger, Christian %A Tayo, Bamidele %A Nalls, Michael %A Feitosa, Mary F %A Isaacs, Aaron %A Dehghan, Abbas %A d'Adamo, Pio %A Adeyemo, Adebowale %A Dieffenbach, Aida Karina %A Zonderman, Alan B %A Nolte, Ilja M %A van der Most, Peter J %A Wright, Alan F %A Shuldiner, Alan R %A Morrison, Alanna C %A Hofman, Albert %A Smith, Albert V %A Dreisbach, Albert W %A Franke, Andre %A Uitterlinden, André G %A Metspalu, Andres %A Tönjes, Anke %A Lupo, Antonio %A Robino, Antonietta %A Johansson, Åsa %A Demirkan, Ayse %A Kollerits, Barbara %A Freedman, Barry I %A Ponte, Belen %A Oostra, Ben A %A Paulweber, Bernhard %A Krämer, Bernhard K %A Mitchell, Braxton D %A Buckley, Brendan M %A Peralta, Carmen A %A Hayward, Caroline %A Helmer, Catherine %A Rotimi, Charles N %A Shaffer, Christian M %A Müller, Christian %A Sala, Cinzia %A van Duijn, Cornelia M %A Saint-Pierre, Aude %A Ackermann, Daniel %A Shriner, Daniel %A Ruggiero, Daniela %A Toniolo, Daniela %A Lu, Yingchang %A Cusi, Daniele %A Czamara, Darina %A Ellinghaus, David %A Siscovick, David S %A Ruderfer, Douglas %A Gieger, Christian %A Grallert, Harald %A Rochtchina, Elena %A Atkinson, Elizabeth J %A Holliday, Elizabeth G %A Boerwinkle, Eric %A Salvi, Erika %A Bottinger, Erwin P %A Murgia, Federico %A Rivadeneira, Fernando %A Ernst, Florian %A Kronenberg, Florian %A Hu, Frank B %A Navis, Gerjan J %A Curhan, Gary C %A Ehret, George B %A Homuth, Georg %A Coassin, Stefan %A Thun, Gian-Andri %A Pistis, Giorgio %A Gambaro, Giovanni %A Malerba, Giovanni %A Montgomery, Grant W %A Eiriksdottir, Gudny %A Jacobs, Gunnar %A Li, Guo %A Wichmann, H-Erich %A Campbell, Harry %A Schmidt, Helena %A Wallaschofski, Henri %A Völzke, Henry %A Brenner, Hermann %A Kroemer, Heyo K %A Kramer, Holly %A Lin, Honghuang %A Leach, I Mateo %A Ford, Ian %A Guessous, Idris %A Rudan, Igor %A Prokopenko, Inga %A Borecki, Ingrid %A Heid, Iris M %A Kolcic, Ivana %A Persico, Ivana %A Jukema, J Wouter %A Wilson, James F %A Felix, Janine F %A Divers, Jasmin %A Lambert, Jean-Charles %A Stafford, Jeanette M %A Gaspoz, Jean-Michel %A Smith, Jennifer A %A Faul, Jessica D %A Wang, Jie Jin %A Ding, Jingzhong %A Hirschhorn, Joel N %A Attia, John %A Whitfield, John B %A Chalmers, John %A Viikari, Jorma %A Coresh, Josef %A Denny, Joshua C %A Karjalainen, Juha %A Fernandes, Jyotika K %A Endlich, Karlhans %A Butterbach, Katja %A Keene, Keith L %A Lohman, Kurt %A Portas, Laura %A Launer, Lenore J %A Lyytikäinen, Leo-Pekka %A Yengo, Loic %A Franke, Lude %A Ferrucci, Luigi %A Rose, Lynda M %A Kedenko, Lyudmyla %A Rao, Madhumathi %A Struchalin, Maksim %A Kleber, Marcus E %A Cavalieri, Margherita %A Haun, Margot %A Cornelis, Marilyn C %A Ciullo, Marina %A Pirastu, Mario %A de Andrade, Mariza %A McEvoy, Mark A %A Woodward, Mark %A Adam, Martin %A Cocca, Massimiliano %A Nauck, Matthias %A Imboden, Medea %A Waldenberger, Melanie %A Pruijm, Menno %A Metzger, Marie %A Stumvoll, Michael %A Evans, Michele K %A Sale, Michele M %A Kähönen, Mika %A Boban, Mladen %A Bochud, Murielle %A Rheinberger, Myriam %A Verweij, Niek %A Bouatia-Naji, Nabila %A Martin, Nicholas G %A Hastie, Nick %A Probst-Hensch, Nicole %A Soranzo, Nicole %A Devuyst, Olivier %A Raitakari, Olli %A Gottesman, Omri %A Franco, Oscar H %A Polasek, Ozren %A Gasparini, Paolo %A Munroe, Patricia B %A Ridker, Paul M %A Mitchell, Paul %A Muntner, Paul %A Meisinger, Christa %A Smit, Johannes H %A Kovacs, Peter %A Wild, Philipp S %A Froguel, Philippe %A Rettig, Rainer %A Mägi, Reedik %A Biffar, Reiner %A Schmidt, Reinhold %A Middelberg, Rita P S %A Carroll, Robert J %A Penninx, Brenda W %A Scott, Rodney J %A Katz, Ronit %A Sedaghat, Sanaz %A Wild, Sarah H %A Kardia, Sharon L R %A Ulivi, Sheila %A Hwang, Shih-Jen %A Enroth, Stefan %A Kloiber, Stefan %A Trompet, Stella %A Stengel, Bénédicte %A Hancock, Stephen J %A Turner, Stephen T %A Rosas, Sylvia E %A Stracke, Sylvia %A Harris, Tamara B %A Zeller, Tanja %A Zemunik, Tatijana %A Lehtimäki, Terho %A Illig, Thomas %A Aspelund, Thor %A Nikopensius, Tiit %A Esko, Tõnu %A Tanaka, Toshiko %A Gyllensten, Ulf %A Völker, Uwe %A Emilsson, Valur %A Vitart, Veronique %A Aalto, Ville %A Gudnason, Vilmundur %A Chouraki, Vincent %A Chen, Wei-Min %A Igl, Wilmar %A März, Winfried %A Koenig, Wolfgang %A Lieb, Wolfgang %A Loos, Ruth J F %A Liu, Yongmei %A Snieder, Harold %A Pramstaller, Peter P %A Parsa, Afshin %A O'Connell, Jeffrey R %A Susztak, Katalin %A Hamet, Pavel %A Tremblay, Johanne %A de Boer, Ian H %A Böger, Carsten A %A Goessling, Wolfram %A Chasman, Daniel I %A Köttgen, Anna %A Kao, W H Linda %A Fox, Caroline S %K Gene Expression Regulation %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Genotype %K Humans %K Renal Insufficiency, Chronic %X

Reduced glomerular filtration rate defines chronic kidney disease and is associated with cardiovascular and all-cause mortality. We conducted a meta-analysis of genome-wide association studies for estimated glomerular filtration rate (eGFR), combining data across 133,413 individuals with replication in up to 42,166 individuals. We identify 24 new and confirm 29 previously identified loci. Of these 53 loci, 19 associate with eGFR among individuals with diabetes. Using bioinformatics, we show that identified genes at eGFR loci are enriched for expression in kidney tissues and in pathways relevant for kidney development and transmembrane transporter activity, kidney structure, and regulation of glucose metabolism. Chromatin state mapping and DNase I hypersensitivity analyses across adult tissues demonstrate preferential mapping of associated variants to regulatory regions in kidney but not extra-renal tissues. These findings suggest that genetic determinants of eGFR are mediated largely through direct effects within the kidney and highlight important cell types and biological pathways.

%B Nat Commun %V 7 %P 10023 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26831199?dopt=Abstract %R 10.1038/ncomms10023 %0 Journal Article %J Nature %D 2016 %T Genome-wide association study identifies 74 loci associated with educational attainment. %A Okbay, Aysu %A Beauchamp, Jonathan P %A Fontana, Mark Alan %A Lee, James J %A Pers, Tune H %A Rietveld, Cornelius A %A Turley, Patrick %A Chen, Guo-Bo %A Emilsson, Valur %A Meddens, S Fleur W %A Oskarsson, Sven %A Pickrell, Joseph K %A Thom, Kevin %A Timshel, Pascal %A de Vlaming, Ronald %A Abdellaoui, Abdel %A Ahluwalia, Tarunveer S %A Bacelis, Jonas %A Baumbach, Clemens %A Bjornsdottir, Gyda %A Brandsma, Johannes H %A Pina Concas, Maria %A Derringer, Jaime %A Furlotte, Nicholas A %A Galesloot, Tessel E %A Girotto, Giorgia %A Gupta, Richa %A Hall, Leanne M %A Harris, Sarah E %A Hofer, Edith %A Horikoshi, Momoko %A Huffman, Jennifer E %A Kaasik, Kadri %A Kalafati, Ioanna P %A Karlsson, Robert %A Kong, Augustine %A Lahti, Jari %A van der Lee, Sven J %A deLeeuw, Christiaan %A Lind, Penelope A %A Lindgren, Karl-Oskar %A Liu, Tian %A Mangino, Massimo %A Marten, Jonathan %A Mihailov, Evelin %A Miller, Michael B %A van der Most, Peter J %A Oldmeadow, Christopher %A Payton, Antony %A Pervjakova, Natalia %A Peyrot, Wouter J %A Qian, Yong %A Raitakari, Olli %A Rueedi, Rico %A Salvi, Erika %A Schmidt, Börge %A Schraut, Katharina E %A Shi, Jianxin %A Smith, Albert V %A Poot, Raymond A %A St Pourcain, Beate %A Teumer, Alexander %A Thorleifsson, Gudmar %A Verweij, Niek %A Vuckovic, Dragana %A Wellmann, Juergen %A Westra, Harm-Jan %A Yang, Jingyun %A Zhao, Wei %A Zhu, Zhihong %A Alizadeh, Behrooz Z %A Amin, Najaf %A Bakshi, Andrew %A Baumeister, Sebastian E %A Biino, Ginevra %A Bønnelykke, Klaus %A Boyle, Patricia A %A Campbell, Harry %A Cappuccio, Francesco P %A Davies, Gail %A De Neve, Jan-Emmanuel %A Deloukas, Panos %A Demuth, Ilja %A Ding, Jun %A Eibich, Peter %A Eisele, Lewin %A Eklund, Niina %A Evans, David M %A Faul, Jessica D %A Feitosa, Mary F %A Forstner, Andreas J %A Gandin, Ilaria %A Gunnarsson, Bjarni %A Halldórsson, Bjarni V %A Harris, Tamara B %A Heath, Andrew C %A Hocking, Lynne J %A Holliday, Elizabeth G %A Homuth, Georg %A Horan, Michael A %A Hottenga, Jouke-Jan %A de Jager, Philip L %A Joshi, Peter K %A Jugessur, Astanand %A Kaakinen, Marika A %A Kähönen, Mika %A Kanoni, Stavroula %A Keltigangas-Järvinen, Liisa %A Kiemeney, Lambertus A L M %A Kolcic, Ivana %A Koskinen, Seppo %A Kraja, Aldi T %A Kroh, Martin %A Kutalik, Zoltán %A Latvala, Antti %A Launer, Lenore J %A Lebreton, Maël P %A Levinson, Douglas F %A Lichtenstein, Paul %A Lichtner, Peter %A Liewald, David C M %A Loukola, Anu %A Madden, Pamela A %A Mägi, Reedik %A Mäki-Opas, Tomi %A Marioni, Riccardo E %A Marques-Vidal, Pedro %A Meddens, Gerardus A %A McMahon, George %A Meisinger, Christa %A Meitinger, Thomas %A Milaneschi, Yusplitri %A Milani, Lili %A Montgomery, Grant W %A Myhre, Ronny %A Nelson, Christopher P %A Nyholt, Dale R %A Ollier, William E R %A Palotie, Aarno %A Paternoster, Lavinia %A Pedersen, Nancy L %A Petrovic, Katja E %A Porteous, David J %A Räikkönen, Katri %A Ring, Susan M %A Robino, Antonietta %A Rostapshova, Olga %A Rudan, Igor %A Rustichini, Aldo %A Salomaa, Veikko %A Sanders, Alan R %A Sarin, Antti-Pekka %A Schmidt, Helena %A Scott, Rodney J %A Smith, Blair H %A Smith, Jennifer A %A Staessen, Jan A %A Steinhagen-Thiessen, Elisabeth %A Strauch, Konstantin %A Terracciano, Antonio %A Tobin, Martin D %A Ulivi, Sheila %A Vaccargiu, Simona %A Quaye, Lydia %A van Rooij, Frank J A %A Venturini, Cristina %A Vinkhuyzen, Anna A E %A Völker, Uwe %A Völzke, Henry %A Vonk, Judith M %A Vozzi, Diego %A Waage, Johannes %A Ware, Erin B %A Willemsen, Gonneke %A Attia, John R %A Bennett, David A %A Berger, Klaus %A Bertram, Lars %A Bisgaard, Hans %A Boomsma, Dorret I %A Borecki, Ingrid B %A Bültmann, Ute %A Chabris, Christopher F %A Cucca, Francesco %A Cusi, Daniele %A Deary, Ian J %A Dedoussis, George V %A van Duijn, Cornelia M %A Eriksson, Johan G %A Franke, Barbara %A Franke, Lude %A Gasparini, Paolo %A Gejman, Pablo V %A Gieger, Christian %A Grabe, Hans-Jörgen %A Gratten, Jacob %A Groenen, Patrick J F %A Gudnason, Vilmundur %A van der Harst, Pim %A Hayward, Caroline %A Hinds, David A %A Hoffmann, Wolfgang %A Hyppönen, Elina %A Iacono, William G %A Jacobsson, Bo %A Järvelin, Marjo-Riitta %A Jöckel, Karl-Heinz %A Kaprio, Jaakko %A Kardia, Sharon L R %A Lehtimäki, Terho %A Lehrer, Steven F %A Magnusson, Patrik K E %A Martin, Nicholas G %A McGue, Matt %A Metspalu, Andres %A Pendleton, Neil %A Penninx, Brenda W J H %A Perola, Markus %A Pirastu, Nicola %A Pirastu, Mario %A Polasek, Ozren %A Posthuma, Danielle %A Power, Christine %A Province, Michael A %A Samani, Nilesh J %A Schlessinger, David %A Schmidt, Reinhold %A Sørensen, Thorkild I A %A Spector, Tim D %A Stefansson, Kari %A Thorsteinsdottir, Unnur %A Thurik, A Roy %A Timpson, Nicholas J %A Tiemeier, Henning %A Tung, Joyce Y %A Uitterlinden, André G %A Vitart, Veronique %A Vollenweider, Peter %A Weir, David R %A Wilson, James F %A Wright, Alan F %A Conley, Dalton C %A Krueger, Robert F %A Davey Smith, George %A Hofman, Albert %A Laibson, David I %A Medland, Sarah E %A Meyer, Michelle N %A Yang, Jian %A Johannesson, Magnus %A Visscher, Peter M %A Esko, Tõnu %A Koellinger, Philipp D %A Cesarini, David %A Benjamin, Daniel J %K Alzheimer Disease %K Bipolar Disorder %K Brain %K Cognition %K Computational Biology %K Educational Status %K Fetus %K Gene Expression Regulation %K Gene-Environment Interaction %K Genome-Wide Association Study %K Great Britain %K Humans %K Molecular Sequence Annotation %K Polymorphism, Single Nucleotide %K Schizophrenia %X

Educational attainment is strongly influenced by social and other environmental factors, but genetic factors are estimated to account for at least 20% of the variation across individuals. Here we report the results of a genome-wide association study (GWAS) for educational attainment that extends our earlier discovery sample of 101,069 individuals to 293,723 individuals, and a replication study in an independent sample of 111,349 individuals from the UK Biobank. We identify 74 genome-wide significant loci associated with the number of years of schooling completed. Single-nucleotide polymorphisms associated with educational attainment are disproportionately found in genomic regions regulating gene expression in the fetal brain. Candidate genes are preferentially expressed in neural tissue, especially during the prenatal period, and enriched for biological pathways involved in neural development. Our findings demonstrate that, even for a behavioural phenotype that is mostly environmentally determined, a well-powered GWAS identifies replicable associated genetic variants that suggest biologically relevant pathways. Because educational attainment is measured in large numbers of individuals, it will continue to be useful as a proxy phenotype in efforts to characterize the genetic influences of related phenotypes, including cognition and neuropsychiatric diseases.

%B Nature %V 533 %P 539-42 %8 2016 May 26 %G eng %N 7604 %1 http://www.ncbi.nlm.nih.gov/pubmed/27225129?dopt=Abstract %R 10.1038/nature17671 %0 Journal Article %J Int J Mol Sci %D 2016 %T Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology. %A Marcuzzi, Annalisa %A Piscianz, Elisa %A Zweyer, Marina %A Bortul, Roberta %A Loganes, Claudia %A Girardelli, Martina %A Baj, Gabriele %A Monasta, Lorenzo %A Celeghini, Claudio %X

Deregulation of the cholesterol pathway is an anomaly observed in human diseases, many of which have in common neurological involvement and unknown pathogenesis. In this study we have used Mevalonate Kinase Deficiency (MKD) as a disease-model in order to investigate the link between the deregulation of the mevalonate pathway and the consequent neurodegeneration. The blocking of the mevalonate pathway in a neuronal cell line (Daoy), using statins or mevalonate, induced an increase in the expression of the inflammasome gene (NLRP3) and programmed cell death related to mitochondrial dysfunction. The morphology of the mitochondria changed, clearly showing the damage induced by oxidative stress and the decreased membrane potential associated with the alterations of the mitochondrial function. The co-administration of geranylgeraniol (GGOH) reduced the inflammatory marker and the damage of the mitochondria, maintaining its shape and components. Our data allow us to speculate about the mechanism by which isoprenoids are able to rescue the inflammatory marker in neuronal cells, independently from the block of the mevalonate pathway, and about the fact that cell death is mitochondria-related.

%B Int J Mol Sci %V 17 %P 365 %8 2016 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26978350?dopt=Abstract %R 10.3390/ijms17030365 %0 Journal Article %J Sci Rep %D 2016 %T Global diversity in the TAS2R38 bitter taste receptor: revisiting a classic evolutionary PROPosal. %A Risso, Davide S %A Mezzavilla, Massimo %A Pagani, Luca %A Robino, Antonietta %A Morini, Gabriella %A Tofanelli, Sergio %A Carrai, Maura %A Campa, Daniele %A Barale, Roberto %A Caradonna, Fabio %A Gasparini, Paolo %A Luiselli, Donata %A Wooding, Stephen %A Drayna, Dennis %X

The ability to taste phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP) is a polymorphic trait mediated by the TAS2R38 bitter taste receptor gene. It has long been hypothesized that global genetic diversity at this locus evolved under pervasive pressures from balancing natural selection. However, recent high-resolution population genetic studies of TAS2Rs suggest that demographic events have played a critical role in the evolution of these genes. We here utilized the largest TAS2R38 database yet analyzed, consisting of 5,589 individuals from 105 populations, to examine natural selection, haplotype frequencies and linkage disequilibrium to estimate the effects of both selection and demography on contemporary patterns of variation at this locus. We found signs of an ancient balancing selection acting on this gene but no post Out-Of-Africa departures from neutrality, implying that the current observed patterns of variation can be predominantly explained by demographic, rather than selective events. In addition, we found signatures of ancient selective forces acting on different African TAS2R38 haplotypes. Collectively our results provide evidence for a relaxation of recent selective forces acting on this gene and a revised hypothesis for the origins of the present-day worldwide distribution of TAS2R38 haplotypes.

%B Sci Rep %V 6 %P 25506 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27138342?dopt=Abstract %R 10.1038/srep25506 %0 Journal Article %J Acta Paediatr %D 2016 %T Hand-held computers can help to distract children undergoing painful venipuncture procedures. %A Crevatin, Franca %A Cozzi, Giorgio %A Braido, Elena %A Bertossa, Gabriella %A Rizzitelli, Patrizia %A Lionetti, Daniela %A Matassi, Daniela %A Calusa, Dorotea %A Ronfani, Luca %A Barbi, Egidio %X

AIM: Needle-related procedures can be painful for children, and distraction provides ideal pain relief in blood-drawing centres. This study assessed the effectiveness of playing a computer game during venipuncture, compared with low-tech distraction by a nurse.

METHODS: We conducted this prospective, randomised controlled trial at the blood-drawing centre of a tertiary-level children's hospital in Italy. Half of the 200 children played Angry Birds on a hand-held computer while the other half were distracted by a second, specifically trained nurse who sang to them, read a book, blew bubbles or played with puppets. Pain was measured using a faces pain scale for children aged 4-7 years and a numeric scale for children aged 8-13 years.

RESULTS: The 200 children had a median age of eight years. Children reported significant pain in 16 cases (16%) in the hand-held computer distraction group and in 15 cases (15%) in the nurse-led low-tech distraction group (p = 0.85). The procedural success rate at the first attempt was not different in the two groups.

CONCLUSION: Playing a game on a hand-held computer meant that only one in six children reported pain during venipuncture, but it was not superior to being distracted by nurses.

%B Acta Paediatr %V 105 %P 930-4 %8 2016 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/27128220?dopt=Abstract %R 10.1111/apa.13454 %0 Journal Article %J Curr Protein Pept Sci %D 2016 %T Heterologous Expression Systems for Plant Defensin Expression: Examples of Success and Pitfalls. %A Gazzaneo, Luis Rs %A Pandolfi, Valesca %A Jesus, André Ls %A Crovella, Sergio %A Benko-Iseppon, Ana M %A Freitas, Antonio Carlos %X

Defensins are a superfamily of antimicrobial peptides, present in vertebrates, invertebrates, fungi and plants, suggesting that they appeared prior to the divergence in eukaryotes. The destitution of toxicity to mammalian cells of plant defensins has led to a new research ground, i.e., their potential medical use against human infectious diseases. Isolating defensins from natural sources, like plant tissues, can be time-consuming, labor intensive and usually present low yields. Strategies for large-scale production of purified active defensins have been employed using heterologous expression systems (HES) for defensin production, usually based in E. coli system. Like any other technology, HES present limitations and drawbacks demanding a careful experimental design prior the system selection. This review is proposed to discuss some of the major concerns when choosing to heterologously express plant defensins, with special attention on bacterial expression system.

%B Curr Protein Pept Sci %8 2016 Jun 24 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27356942?dopt=Abstract %0 Journal Article %J Data Brief %D 2016 %T Histopathological data of iron and calcium in the mouse lung after asbestos exposure. %A Trevisan, Elisa %A Zabucchi, Giuliano %A Pascolo, Lorella %A Pascotto, Ernesto %A Casarsa, Claudia %A Lucattelli, Monica %A Lungarella, Giuseppe %A Cavarra, Eleonora %A Bartalesi, Barbara %A Zweyer, Marina %A Borelli, Violetta %X

This data article contains data related to the research article entitled, "Synchrotron X-ray microscopy reveals early calcium and iron interaction with crocidolite fibers in the lung of exposed mice" [1]. Asbestos fibers disrupt iron homeostasis in the human and mouse lung, leading to the deposition of iron (Fe) onto longer asbestos fibers which forms asbestos bodies (AB) [2]. Similar to Fe, calcium (Ca) is also deposited in the coats of the AB. This article presents data on iron and calcium in the mouse lung after asbestos exposure detected by histochemical evaluation.

%B Data Brief %V 6 %P 769-75 %8 2016 Mar %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26909387?dopt=Abstract %R 10.1016/j.dib.2016.01.026 %0 Journal Article %J J Med Microbiol %D 2016 %T HPV genotypes distribution in Chlamydia trachomatis co-infection in a large cohort of women from north-east Italy. %A Seraceni, Silva %A Campisciano, Giuseppina %A Contini, Carlo %A Comar, Manola %X

Human papillomavirus (HPV) and Chlamydia trachomatis are pathogens with oncogenic potential associated with persistent infections. Epidemiological data on C. trachomatis infection status, C. trachomatis/HPV co-infection and the relationship between HPV genotypes in Italian women are only preliminary. The aim of the present study was to characterize the relationship between HPV genotypes and C. trachomatis in an extending cohort of asymptomatic immunocompetent women from an area of north-east Italy. A retrospective study was conducted using Luminex technology on cervical swabs from asymptomatic immunocompetent women, comprising 921 attending the prevention centre for the Cervical Cancer Program and 6214 who had been referred to the Sexually Transmitted Infections Center, with clinical indications of HPV and C. trachomatis infections. A quantitative real-time PCR was performed to assess chronic C. trachomatis infection by heat-shock protein 60 (Hsp60) gene expression. The overall prevalence of the investigated pathogens was 39 % (359/921) for HPV and 4 % (251/6214) for C. trachomatis. The Hsp60 gene was detected in 57 % of the women infected with C. trachomatis. HPV co-infection was present in 58 % of C. trachomatis-infected women. A high prevalence of co-infection was found in women with chronic C. trachomatis infection (68 %, P = 0.0002), especially in women ≤ 25 years (72 %) where HPV multiple infections were found in 78 % (P = 0.022). HPV genotype distribution showed that uncommon low-risk genotypes were associated with C. trachomatis. These results indicate a high frequency of co-detection of multiple HPV genotypes in chronically infected young women and suggest that the expression of the C. trachomatis Hsp60 gene may favour HPV infection.

%B J Med Microbiol %V 65 %P 406-13 %8 2016 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/26944507?dopt=Abstract %R 10.1099/jmm.0.000245 %0 Journal Article %J Pediatr Crit Care Med %D 2016 %T The Importance of Mortality Risk Assessment: Validation of the Pediatric Index of Mortality 3 Score. %A Wolfler, Andrea %A Osello, Raffaella %A Gualino, Jenny %A Calderini, Edoardo %A Vigna, Gianluca %A Santuz, Pierantonio %A Amigoni, Angela %A Savron, Fabio %A Caramelli, Fabio %A Rossetti, Emanuele %A Cecchetti, Corrado %A Corbari, Maurizio %A Piastra, Marco %A Testa, Raffaele %A Coffaro, Giancarlo %A Stancanelli, Giusi %A Gitto, Eloisa %A Amato, Roberta %A Prinelli, Federica %A Salvo, Ida %X

OBJECTIVE: To evaluate the performance of the newest version of the Pediatric Index of Mortality 3 score and compare it with the Pediatric Index of Mortality 2 in a multicenter national cohort of children admitted to PICU.

DESIGN: Retrospective, prospective cohort study.

SETTING: Seventeen Italian PICUs.

PATIENTS: All children 0 to 15 years old admitted in PICU from January 2010 to October 2014.

INTERVENTIONS: None.

MEASUREMENT AND MAIN RESULTS: Eleven thousand one hundred nine children were enrolled in the study. The mean Pediatric Index of Mortality 2 and 3 values of 4.9 and 3.9, respectively, differed significantly (p < 0.05). Overall mortality rate was 3.9%, and the standardized mortality ratio was 0.80 for Pediatric Index of Mortality 2 and 0.98 for Pediatric Index of Mortality 3 (p < 0.05). The area under the curve of the receiver operating characteristic curves was similar for Pediatric Index of Mortality 2 and Pediatric Index of Mortality 3. The Hosmer-Lemeshow test was not significant for Pediatric Index of Mortality 3 (p = 0.21) but was highly significant for Pediatric Index of Mortality 2 (p < 0.001), which overestimated death mainly in high-risk categories.

CONCLUSIONS: Mortality indices require validation in each country where it is used. The new Pediatric Index of Mortality 3 score performed well in an Italian population. Both calibration and discrimination were appropriate, and the score more accurately predicted the mortality risk than Pediatric Index of Mortality 2.

%B Pediatr Crit Care Med %V 17 %P 251-6 %8 2016 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26825046?dopt=Abstract %R 10.1097/PCC.0000000000000657 %0 Journal Article %J Acta Otorhinolaryngol Ital %D 2016 %T Improving regional universal newborn hearing screening programmes in Italy. %A Molini, E %A Cristi, M C %A Lapenna, R %A Calzolaro, L %A Muzzi, E %A Ciciriello, E %A Della Volpe, A %A Orzan, E %A Ricci, G %X

The Universal Newborn Hearing Screening (UNHS) programme aims at achieving early detection of hearing impairment. Subsequent diagnosis and intervention should follow promptly. Within the framework of the Ministry of Health project CCM 2013 "Preventing Communication Disorders: a Regional Program for early Identification, Intervention and Care of Hearing Impaired Children", the limitations and strengths of current UNHS programs in Italy have been analysed by a group of professionals working in tertiary centres involved in regional UNHS programmes, using SWOT analysis and a subsequent TOWS matrix. Coverage and lost-to-follow up rates are issues related to UNHS programmes. Recommendations to improve the effectiveness of the UNHS programme have been identified. The need for homogeneous policies, high-quality information and dissemination of knowledge for operators and families of hearing-impaired children emerged from the discussion.

%B Acta Otorhinolaryngol Ital %V 36 %P 10-4 %8 2016 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27054385?dopt=Abstract %R 10.14639/0392-100X-1072 %0 Journal Article %J Clin Pharmacol Ther %D 2016 %T In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome. %A Cuzzoni, E %A De Iudicibus, S %A Stocco, G %A Favretto, D %A Pelin, M %A Messina, G %A Ghio, L %A Monti, E %A Pasini, A %A Montini, G %A Decorti, G %X

The aim of this study was to evaluate the in vitro steroid sensitivity as a predictor of clinical response to glucocorticoids in childhood idiopathic nephrotic syndrome (INS). Seventy-four patients (median age 4.33, interquartile range [IQR] 2.82-7.23; 63.5% male) were enrolled in a prospective multicenter study: in vitro steroid inhibition of patients' peripheral blood mononuclear cell proliferation was evaluated by [methyl-(3) H] thymidine incorporation assay at disease onset (T0) and after 4 weeks (T4) of treatment. Steroid dependence was associated with increased in vitro sensitivity at T4 assessed both as drug concentration inducing 50% of inhibition (IC50 ; odds ratio [OR] = 0.48, 95% confidence interval [CI] = 0.24-0.85; P = 0.0094) and maximum inhibition at the highest drug concentration (Imax ; OR = 1.13, 95% CI = 1.02-1.31; P = 0.017). IC50 > 4.4 nM and Imax < 92% at T4 were good predictors for optimal clinical response. These results suggest that this test may be useful for predicting the response to glucocorticoid therapy in pediatric INS.

%B Clin Pharmacol Ther %V 100 %P 268-74 %8 2016 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/27007551?dopt=Abstract %R 10.1002/cpt.372 %0 Journal Article %J Acta Diabetol %D 2016 %T The incidence rate and prevalence of pediatric type 1 diabetes mellitus (age 0-18) in the Italian region Friuli Venezia Giulia: population-based estimates through the analysis of health administrative databases. %A Valent, Francesca %A Candido, Riccardo %A Faleschini, Elena %A Tonutti, Laura %A Tortul, Carla %A Zanatta, Manuela %A Zanette, Giorgio %A Zanier, Loris %X

AIMS: The main objective of this study was to estimate the incidence rate and prevalence of pediatric type 1 diabetes mellitus (T1DM; population 0-18 years of age) in the northeastern Italian region Friuli Venezia Giulia and to characterize the subjects affected by the disease.

METHODS: This was a retrospective population-based study conducted through the individual-level linkage of several health administrative databases of the Friuli Venezia Giulia region. The incidence rate and prevalence were calculated in the population 0-18 years of age. Using the Mid-p exact method, 95 % confidence intervals for rates were calculated.

RESULTS: The incidence rate of pediatric T1DM in the years 2010-2013 was 15.8 new cases/100,000 person-years, peaking in the age class 10-14 years. The rate has increased substantially as compared with the previous regional estimate that dated back to 1993. We observed a seasonal pattern both in the date of birth of the incident cases and in the date of onset of the disease. In the region in 2013, there were 294 prevalent cases (15.1/10,000 inhabitants). Most of them had at least one glycated hemoglobin test in the year. More than 15 % had co-existing autoimmune comorbidities.

CONCLUSIONS: The incidence rate of pediatric T1DM in Friuli Venezia Giulia has increased in the last years, and the disease is a relevant public health issue in the region.

%B Acta Diabetol %V 53 %P 629-35 %8 2016 Aug %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26997510?dopt=Abstract %R 10.1007/s00592-016-0854-0 %0 Journal Article %J Dig Liver Dis %D 2016 %T Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease. %A Di Sabatino, Antonio %A Giuffrida, Paolo %A Fornasa, Giulia %A Salvatore, Chiara %A Vanoli, Alessandro %A Naviglio, Samuele %A De Leo, Luigina %A Pasini, Alessandra %A De Amici, Mara %A Alvisi, Costanza %A Not, Tarcisio %A Rescigno, Maria %A Corazza, Gino Roberto %X

BACKGROUND: Immune mechanisms have been implicated in nonceliac gluten sensitivity (NCGS), a condition characterized by intestinal and/or extraintestinal symptoms caused by the ingestion of gluten in non-celiac/non-wheat allergic individuals.

AIMS: We investigated innate and adaptive immunity in self-reported NCGS versus celiac disease (CD).

METHODS: In the supernatants of ex vivo-cultured duodenal biopsies from 14 self-reported NCGS patients, 9 untreated and 10 treated CD patients, and 12 controls we detected innate cytokines - interleukin (IL)-15, tumor necrosis factor-α, IL-1β, IL-6, IL-12p70, IL-23, IL-27, IL-32α, thymic stromal lymphopoietin (TSLP), IFN-α-, adaptive cytokines - interferon (IFN)-γ, IL-17A, IL-4, IL-5, IL-10, IL-13-, chemokines - IL-8, CCL1, CCL2, CCL3, CCL4, CCL5, CXCL1, CXCL10-, granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF).

RESULTS: Mucosal innate and adaptive cytokines, chemokines and growth factors did not differ between self-reported NCGS, treated CD and controls. On the contrary, IL-6, IL-15, IL-27, IFN-α, IFN-γ, IL-17A, IL-23, G-CSF, GM-CSF, IL-8, CCL1 and CCL4 were significantly higher in untreated CD than in self-reported NCGS, treated CD and controls, while TSLP was significantly lower in untreated CD than in self-reported NCGS, treated CD and controls.

CONCLUSION: In our hands, patients with self-reported NCGS showed no abnormalities of the mucosal immune response.

%B Dig Liver Dis %V 48 %P 745-52 %8 2016 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/27130911?dopt=Abstract %R 10.1016/j.dld.2016.03.024 %0 Journal Article %J J Toxicol Environ Health A %D 2016 %T Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study. %A Crovella, Sergio %A Bianco, Anna Monica %A Vuch, Joseph %A Zupin, Luisa %A Moura, Ronald Rodrigues %A Trevisan, Elisa %A Schneider, Manuela %A Brollo, Alessandro %A Nicastro, Enza Maria %A Cosenzi, Alessandro %A Zabucchi, Giuliano %A Borelli, Violetta %K Adult %K Aged %K Asbestos %K Autopsy %K Case-Control Studies %K Female %K Ferritins %K Gene Frequency %K Genetic Markers %K Humans %K Iron %K Lung Neoplasms %K Male %K Membrane Proteins %K Mesothelioma %K Middle Aged %K Mutation, Missense %K Polymorphism, Single Nucleotide %K Transferrin %K Young Adult %X

Malignant pleural mesothelioma (MPM) is an aggressive cancer with poor prognosis. The development of MPM is frequently linked to inhalation of asbestos fibers. A genetic component of susceptibility to this disease is suggested by the observation that some individuals develop MPM following lower doses of asbestos exposure, whereas others exposed to higher quantities do not seem to be affected. This hypothesis is supported also by frequent reports of MPM familial clustering. Despite the widely recognized role of iron (Fe) in cellular asbestos-induced pulmonary toxicity, the role of the related gene polymorphisms in the etiology of MPM has apparently not been evaluated. Eighty-six single-nucleotide polymorphisms (SNPs) of 10 Fe-metabolism genes were examined by exploiting formalin-fixed paraffin-embedded postmortem samples from 77 patients who died due to MPM (designated AEM) and compared with 48 who were exposed to asbestos but from died in old age of cause other than asbestos (designated AENM). All subjects showed objective signs of asbestos exposure. Three SNPs, localized in the ferritin heavy polypeptide, transferrin, and hephaestin genes, whose frequencies were distributed differently in AEM and AENM populations, were identified. For ferritin and transferrin the C/C and the G/G genotypes, respectively, representing intronic polymorphisms, were significantly associated with protection against MPM and need to be considered as possible genetic markers of protection. Similarly, the C/C hephaestin SNP, a missense variation of this multicopper ferroxidase encoding gene, may be related, also functionally, with protection against MPM. In conclusion, it is proposed that three Fe metabolism-associated genes, significantly associated with protection against development of MPM, may serve as protective markers for this aggressive tumor.

%B J Toxicol Environ Health A %V 79 %P 129-41 %8 2016 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26818092?dopt=Abstract %R 10.1080/15287394.2015.1123452 %0 Journal Article %J Congenit Anom (Kyoto) %D 2016 %T Isolated hypoplasia of abdominal wall muscles associated with fetal ascites. %A Travan, Laura %A Naviglio, Samuele %A Cont, Gabriele %A Brovedani, Pierpaolo %A Davanzo, Riccardo %A Demarini, Sergio %X

We report the case of an infant born after parvovirus B19-induced fetal hydrops, who presented at birth with bilateral abdominal wall laxity, which was more evident on the flanks. Imaging exams revealed congenital hypoplasia of oblique abdominal muscles not associated with other anatomical abnormalities except for small liver calcifications. We review the medical literature and identify similar cases associated with fetal ascites. We propose that isolated hypoplasia of abdominal wall muscles can be associated with fetal ascites from various causes, and represents a separate condition from prune belly syndrome.

%B Congenit Anom (Kyoto) %V 56 %P 184-186 %8 2016 Jul %G ENG %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26762954?dopt=Abstract %R 10.1111/cga.12156 %0 Journal Article %J Andrology %D 2016 %T The Klinefelter syndrome is associated with high recurrence of copy number variations on the X chromosome with a potential role in the clinical phenotype. %A Rocca, M S %A Pecile, V %A Cleva, L %A Speltra, E %A Selice, R %A Di Mambro, A %A Foresta, C %A Ferlin, A %X

The Klinefelter syndrome (KS) is the most frequent sex chromosomal disorder in males, characterized by at least one supernumerary X chromosome (most frequent karyotype 47,XXY). This syndrome presents with a broad range of phenotypes. The common characteristics include small testes and infertility, but KS subjects are at increased risk of hypogonadism, cognitive dysfunction, obesity, diabetes, metabolic syndrome, osteoporosis, and autoimmune disorders, which are present in variable proportion. Although part of the clinical variability might be linked to a different degree of testicular function observed in KS patients, genetic mechanisms of the supernumerary X chromosome might contribute. Gene-dosage effects and parental origin of the supernumerary X chromosome have been suggested to this regard. No study has been performed analyzing the genetic constitution of the X chromosome in terms of copy number variations (CNVs) and their possible involvement in phenotype of KS. To this aim, we performed a SNP arrays analysis on 94 KS and 85 controls. We found that KS subjects have more frequently than controls X-linked CNVs (39/94, [41.5%] with respect to 12/42, [28.6%] of females, and 8/43, [18.6%] of males, p < 0.01). The number of X-linked CNVs in KS patients was 4.58 ± 1.92 CNVs/subject, significantly higher with respect to that found in control females (1.50 ± 1.29 CNVs/subject) and males (1.14 ± 0.37 CNVs/subject). Importantly, 94.4% X-linked CNVs in KS subjects were duplications, higher with respect to control males (50.0%, p < 0.001) and females (83.3%, p = 0.1). Half of the X-linked CNVs fell within regions encompassing genes and most of them (90%) included genes escaping X-inactivation in the regions of X-Y homology, particularly in the pseudoautosomal region 1 (PAR1) and Xq21.31. This study described for the first time the genetic properties of the X chromosome in KS and suggests that X-linked CNVs (especially duplications) might contribute to the clinical phenotype.

%B Andrology %V 4 %P 328-34 %8 2016 Mar %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/26789125?dopt=Abstract %R 10.1111/andr.12146 %0 Journal Article %J Int J Pediatr Otorhinolaryngol %D 2016 %T Lactoferrin gene polymorphisms in Italian patients with recurrent tonsillitis. %A Zupin, Luisa %A Angelelli, Francesco %A Grasso, Domenico Leonardo %A Crovella, Sergio %X

INTRODUCTION: Recurrent tonsillitis is an oral pathology characterized by inflammation of tonsils. The disease susceptibility depends upon environmental and host factors, specifically the innate immune response, the first line of host defence could play an important role. Among innate immunity members, lactoferrin, known for its antimicrobial properties, was previously correlated with the risk of oral pathology as periodontitis and dental caries.

METHODS: 89 Italian children presenting recurrent tonsillitis and 95 healthy children were genotyped for two LTF non-synonymous polymorphisms, called Thr29Ala and Arg47Lys, in order to investigate their potential role in recurrent tonsillitis susceptibility.

RESULTS: no different allele, genotype and haplotype frequency distributions were detected comparing patients and controls.

CONCLUSION: data from the current study indicate that LTF polymorphisms might not be involved in recurrent tonsillitis development in our Italian population. However, since the importance of lactoferrin in oral immunity has been previously assessed, further studies should be necessary to unravel the potential role of LTF genetic variants in oral cavity.

%B Int J Pediatr Otorhinolaryngol %V 88 %P 153-6 %8 2016 Sep %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27497404?dopt=Abstract %R 10.1016/j.ijporl.2016.07.002 %0 Journal Article %J Immunol Res %D 2016 %T MBL2 genetic polymorphisms and HIV-1 mother-to-child transmission in Zambia. %A Zupin, Luisa %A Polesello, Vania %A Segat, Ludovica %A Kuhn, Louise %A Crovella, Sergio %X

Since antiretroviral drugs have been introduced to prevent mother-to-child transmission, the risk of HIV-1 infection in infants has decreased considerably worldwide. Nevertheless, many factors are involved in viral transmission and host susceptibility to infection. The immune system and its components, including mannose binding protein C (encoding by MBL2 gene), are already known to play an important role in this scenario. In the present study, 313 children and 98 of their mothers from Zambia were genotyped for the MBL2 promoter HL (rs11003125) and XY (rs7096206) polymorphisms and exon 1 D (rs5030737, at codon 52) B (rs1800450, at codon 54) and C (rs1800451, at codon 57) polymorphisms in order to investigate the potential role of these genetic variants in HIV-1 mother-to-child transmission. No statistical significant association was observed comparing transmitter and non-transmitter mothers and also confronting HIV-positive and HIV-negative children. The findings of the current study obtained on mother and children from Zambia evidence lack of association between MBL2 functional polymorphisms and HIV-1 mother-to-child transmission.

%B Immunol Res %V 64 %P 775-84 %8 2016 Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26740328?dopt=Abstract %R 10.1007/s12026-015-8779-1 %0 Journal Article %J Scand J Immunol %D 2016 %T MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response. %A Zupin, L %A Polesello, V %A Alberi, G %A Moratelli, G %A Crocè, S L %A Masutti, F %A Pozzato, G %A Crovella, S %A Segat, L %X

Hepatitis C is disease that damages the liver, and it is caused by the hepatitis C virus (HCV). The pathology became chronic in about 80% of the cases due to virus persistence in the host organism. The standard of care consists of pegylated interferon plus ribavirin; however, the treatment response is very variable and different host/viral factors may concur in the disease outcome. The mannose-binding protein C (MBL) is a component of the innate immune system, able to recognize HCV and consecutively activating the immune response. MBL is encoded by MBL2 gene, and polymorphisms, two in the promoter region (H/L and X/Y) and three in exon 1 (at codon 52, 54 and 57), have been described as functionally influencing protein expression. In this work, 203 Italian HCV patients and 61 healthy controls were enrolled and genotyped for the five MBL2 polymorphisms mentioned above to investigate their role in HCV infection susceptibility, spontaneous viral clearance and treatment response. MBL2 polymorphisms were not associated with HCV infection susceptibility and with spontaneous viral clearance, while MBL2 O allele, O/O genotype, HYO haplotype and DP combined genotype (all correlated with low or deficient MBL expression) were associated with sustained virological response. Moreover, a meta-analysis to assess the role of MBL2 polymorphisms in HCV infection susceptibility was also performed: YA haplotype could be associated with protection towards HCV infection.

%B Scand J Immunol %V 84 %P 61-9 %8 2016 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27136459?dopt=Abstract %R 10.1111/sji.12444 %0 Journal Article %J Arch Dis Child %D 2016 %T A minor trauma revealing linear morphoea in a 4-year-old female. %A Pastore, Serena %A Contorno, Sarah %A Caddeo, Giulia %A Calligaris, Lorenzo %A Taddio, Andrea %B Arch Dis Child %8 2016 May 12 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27173895?dopt=Abstract %R 10.1136/archdischild-2016-310670 %0 Journal Article %J Lancet Glob Health %D 2016 %T Mortality and its risk factors in Malawian children admitted to hospital with clinical pneumonia, 2001-12: a retrospective observational study. %A Lazzerini, Marzia %A Seward, Nadine %A Lufesi, Norman %A Banda, Rosina %A Sinyeka, Sophie %A Masache, Gibson %A Nambiar, Bejoy %A Makwenda, Charles %A Costello, Anthony %A McCollum, Eric D %A Colbourn, Tim %X

BACKGROUND: Few studies have reported long-term data on mortality rates for children admitted to hospital with pneumonia in Africa. We examined trends in case fatality rates for all-cause clinical pneumonia and its risk factors in Malawian children between 2001 and 2012.

METHODS: Individual patient data for children (<5 years) with clinical pneumonia who were admitted to hospitals participating in Malawi's Child Lung Health Programme between 2001 and 2012 were recorded prospectively on a standardised medical form. We analysed trends in pneumonia mortality and children's clinical characteristics, and we estimated the association of risk factors with case fatality for children younger than 2 months, 2-11 months of age, and 12-59 months of age using separate multivariable mixed effects logistic regression models.

FINDINGS: Between November, 2012, and May, 2013, we retrospectively collected all available hard copies of yellow forms from 40 of 41 participating hospitals. We examined 113 154 pneumonia cases, 104 932 (92·7%) of whom had mortality data and 6903 of whom died, and calculated an overall case fatality rate of 6·6% (95% CI 6·4-6·7). The case fatality rate significantly decreased between 2001 (15·2% [13·4-17·1]) and 2012 (4·5% [4·1-4·9]; ptrend<0·0001). Univariable analyses indicated that the decrease in case fatality rate was consistent across most subgroups. In multivariable analyses, the risk factors significantly associated with increased odds of mortality were female sex, young age, very severe pneumonia, clinically suspected Pneumocystis jirovecii infection, moderate or severe underweight, severe acute malnutrition, disease duration of more than 21 days, and referral from a health centre. Increasing year between 2001 and 2012 and increasing age (in months) were associated with reduced odds of mortality. Fast breathing was associated with reduced odds of mortality in children 2-11 months of age. However, case fatality rate in 2012 remained high for children with very severe pneumonia (11·8%), severe undernutrition (15·4%), severe acute malnutrition (34·8%), and symptom duration of more than 21 days (9·0%).

INTERPRETATION: Pneumonia mortality and its risk factors have steadily improved in the past decade in Malawi; however, mortality remains high in specific subgroups. Improvements in hospital care may have reduced case fatality rates though a lack of sufficient data on quality of care indicators and the potential of socioeconomic and other improvements outside the hospital precludes adequate assessment of why case-fatality rates fell. Results from this study emphasise the importance of effective national systems for data collection. Further work combining this with data on trends in the incidence of pneumonia in the community are needed to estimate trends in the overall risk of mortality from pneumonia in children in Malawi.

FUNDING: Bill & Melinda Gates Foundation.

%B Lancet Glob Health %V 4 %P e57-68 %8 2016 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/26718810?dopt=Abstract %R 10.1016/S2214-109X(15)00215-6 %0 Journal Article %J Clin Epigenetics %D 2016 %T A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-Russell and Beckwith-Wiedemann syndromes. %A Russo, Silvia %A Calzari, Luciano %A Mussa, Alessandro %A Mainini, Ester %A Cassina, Matteo %A Di Candia, Stefania %A Clementi, Maurizio %A Guzzetti, Sara %A Tabano, Silvia %A Miozzo, Monica %A Sirchia, Silvia %A Finelli, Palma %A Prontera, Paolo %A Maitz, Silvia %A Sorge, Giovanni %A Calcagno, Annalisa %A Maghnie, Mohamad %A Divizia, Maria Teresa %A Melis, Daniela %A Manfredini, Emanuela %A Ferrero, Giovanni Battista %A Pecile, Vanna %A Larizza, Lidia %K Beckwith-Wiedemann Syndrome %K Blotting, Southern %K Child %K Child, Preschool %K Chromosomes, Human, Pair 11 %K CpG Islands %K DNA Methylation %K Epigenesis, Genetic %K Female %K Humans %K Infant %K Male %K Mosaicism %K Multiplex Polymerase Chain Reaction %K Oligonucleotide Array Sequence Analysis %K Silver-Russell Syndrome %X

BACKGROUND: Multiple (epi)genetic defects affecting the expression of the imprinted genes within the 11p15.5 chromosomal region underlie Silver-Russell (SRS) and Beckwith-Wiedemann (BWS) syndromes. The molecular diagnosis of these opposite growth disorders requires a multi-approach flowchart to disclose known primary and secondary (epi)genetic alterations; however, up to 20 and 30 % of clinically diagnosed BWS and SRS cases remain without molecular diagnosis. The complex structure of the 11p15 region with variable CpG methylation and low-rate mosaicism may account for missed diagnoses. Here, we demonstrate the relevance of complementary techniques for the assessment of different CpGs and the importance of testing multiple tissues to increase the SRS and BWS detection rate.

RESULTS: Molecular testing of 147 and 450 clinically diagnosed SRS and BWS cases provided diagnosis in 34 SRS and 185 BWS patients, with 9 SRS and 21 BWS cases remaining undiagnosed and herein referred to as "borderline." A flowchart including complementary techniques and, when applicable, the analysis of buccal swabs, allowed confirmation of the molecular diagnosis in all borderline cases. Comparison of methylation levels by methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) in borderline and control cases defined an interval of H19/IGF2:IG-DMR loss of methylation that was distinct between "easy to diagnose" and "borderline" cases, which were characterized by values ≤mean -3 standard deviations (SDs) compared to controls. Values ≥mean +1 SD at H19/IGF2: IG-DMR were assigned to borderline hypermethylated BWS cases and those ≤mean -2 SD at KCNQ1OT1: TSS-DMR to hypomethylated BWS cases; these were supported by quantitative pyrosequencing or Southern blot analysis. Six BWS cases suspected to carry mosaic paternal uniparental disomy of chromosome 11 were confirmed by SNP array, which detected mosaicism till 10 %. Regarding the clinical presentation, borderline SRS were representative of the syndromic phenotype, with exception of one patient, whereas BWS cases showed low frequency of the most common features except hemihyperplasia.

CONCLUSIONS: A conclusive molecular diagnosis was reached in borderline methylation cases, increasing the detection rate by 6 % for SRS and 5 % for BWS cases. The introduction of complementary techniques and additional tissue analyses into routine diagnostic work-up should facilitate the identification of cases undiagnosed because of mosaicism, a distinctive feature of epigenetic disorders.

%B Clin Epigenetics %V 8 %P 23 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26933465?dopt=Abstract %R 10.1186/s13148-016-0183-8 %0 Journal Article %J Acta Paediatr %D 2016 %T Nationwide study of headache pain in Italy shows that pain assessment is still inadequate in paediatric emergency care. %A Benini, Franca %A Piga, Simone %A Zangardi, Tiziana %A Messi, Gianni %A Tomasello, Caterina %A Pirozzi, Nicola %A Cuttini, Marina %X

AIM: Italian national guidelines on pain management were published in 2010, but there is little information on how effective pain management is in paediatric emergency care, with other countries reporting poor levels. Using headache as an indicator, we described pain assessment in Italian emergency departments and identified predictors of algometric scale use.

METHODS: All Italian paediatric and maternal and child hospitals participated, plus four general hospitals. Data on all children aged 4-14 years admitted during a one-month period with headache as their chief complaint were abstracted from clinical records. Multivariable analyses identified predictors of algometric assessment, taking into account the cluster study design.

RESULTS: We studied 470 admissions. During triage, pain was assessed using a standardised scale (41.5%), informally (15.5%) or was not recorded (42.9%). Only 32.1% of the children received analgesia in the emergency department. The odds ratios for predictors of algometric assessment were non-Italian nationality (3.6), prehospital medication (1.8), admission to a research hospital (7.3) and a more favourable nurses-to-admissions ratio of 10.8 for the highest versus lowest tertile.

CONCLUSION: Despite national guidelines, paediatric pain assessment in Italian emergency care was suboptimal. Hospital variables appeared to be stronger predictors of adequate assessment than patient characteristics.

%B Acta Paediatr %V 105 %P e200-8 %8 2016 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/26792256?dopt=Abstract %R 10.1111/apa.13335 %0 Journal Article %J J Transl Med %D 2016 %T Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations. %A Cocca, Massimiliano %A Bedognetti, Davide %A La Bianca, Martina %A Gasparini, Paolo %A Girotto, Giorgia %X

BACKGROUND: Breast cancer is the most common cancer in women characterized by a high variable clinical outcome among individuals treated with equivalent regimens and novel targeted therapies. In this study, we performed a population based approach intersecting high-throughput genotype data from Friuli Venezia Giulia (FVG) isolated populations with publically available pharmacogenomics information to estimate the frequency of genotypes correlated with responsiveness to breast cancer treatment thus improving the clinical management of this disease in an efficient and cost effective way.

METHODS: A list of 80 variants reported to be related to the efficacy or toxicity of breast cancer drugs was obtained from PharmGKB database. Fourty-one were present in FVG, 1000G European (EUR) and ExAC (Non Finnish European) databases. Their frequency was extracted using PLINK software and the differences tested by Fisher's exact test.

RESULTS: Statistical analyses revealed that 13 out of the 41 (32 %) variants were significantly different in frequency in our sample as compared to the EUR/ExAC cohorts. For nine variants the available level of evidence (LOE) included polymorphisms related to cyclophosphamide, tamoxifen, doxorubicin, fluorpyrimidine and paclitaxel. In particular, for trastuzumab two variants were detected: (1) rs1801274-G within FCGR2A and associated with decreased efficacy (LOE 2B); (2) rs1136201-G located within ERBB2 and associated with increased toxicity (LOE 3). Both these two variants were underrepresented in the FVG population compared to EUR/ExAC population thus suggesting a high therapeutic index of this drug in our population. Moreover, as regards fluoropyrimidines, the frequency of two polymorphisms within the DPYD gene associated with drug toxicity (e.g., rs2297595-C allele and rs3918290-T allele, LOE 2A and 1, respectively) was extremely low in FVG population thus suggesting that a larger number of FVG patients could benefit from full dosage of fluoropyrimidine therapy.

CONCLUSIONS: All these findings increase the overall knowledge on the prevalence of specific variants related with breast cancer treatment responsiveness in FVG population and highlight the importance of assessing gene polymorphisms related with cancer medications in isolated communities.

%B J Transl Med %V 14 %P 22 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26801900?dopt=Abstract %R 10.1186/s12967-016-0778-z %0 Journal Article %J Reprod Toxicol %D 2016 %T Pitfalls and promises in FTIR spectromicroscopy analyses to monitor iron-mediated DNA damage in sperm. %A Pascolo, Lorella %A Bedolla, Diana E %A Vaccari, Lisa %A Venturin, Irene %A Cammisuli, Francesca %A Gianoncelli, Alessandra %A Mitri, Elisa %A Giolo, Elena %A Luppi, Stefania %A Martinelli, Monica %A Zweyer, Marina %A Ricci, Giuseppe %X

Many drugs, chemicals, and environmental factors can impair sperm functionality by inducing DNA damage, one of the important causes of reduced fertility potential. The use of vibrational spectromicroscopy represents a promising approach for monitoring DNA integrity in sperm, although some limitations exist, depending from the experimental conditions. Here, we report that when using FTIR spectromicroscopy to reveal oxidative stress mediated by Fenton's reaction on hydrated sperm samples, DNA damage interpretation is partially compromised by unexpected cell surface precipitates. The precipitates give a broad band in the 1150-1000cm(-1) infrared region, which partially covers one of the signatures of DNA (phosphate stretching bands), and are detected as iron and oxygen containing material when using XRF spectroscopy. On the other hand, the analyses further support the potential of FTIR spectromicroscopy to reveal cellular oxidative damage events such as lipid peroxidation, protein misfolding and aggregations, as well as DNA strain breaks.

%B Reprod Toxicol %V 61 %P 39-46 %8 2016 Jun %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26923261?dopt=Abstract %R 10.1016/j.reprotox.2016.02.011 %0 Journal Article %J Acta Otorhinolaryngol Ital %D 2016 %T Planning early childhood audiologic intervention programs on a regional scale: introduction to an Italian study. %A Orzan, E %A Ciciriello, E %X

Non-uniform, late, or inappropriate care of childhood with permanent hearing impairment (PHI) predisposes many children to develop communicative- behaviour problems and impaired psychosocial adjustment that can persist in adolescence and adulthood.In March 2014, the CCM (Centro Controllo Malattie or Disease Control Centre) of the Italian Ministry of Health funded a project entitled " Preventing Communication Disorders: a Regional Program for Early Identification, Intervention and Care of Hearing Impaired Children". The project involved 5 tertiary centres with UNHS programs formally approved by the Region. The main purpose of the project is to define and launch an integrated regionally-based public health model for identification, diagnosis and intervention of childhood PHI. The first phase of the project investigated the state of art and produced recommendations for positive changes in identification, diagnosis, therapy and care of childhood PHI in Italy, taking into account diagnostic and treatment innovations, family empowerment, treatment alliance and an interdisciplinary approach. Recommendations drawn from this initial phase will represent the basis for a regional system for early intervention that is validated, integrated and shared between the five regions.

%B Acta Otorhinolaryngol Ital %V 36 %P 3-9 %8 2016 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27054384?dopt=Abstract %R 10.14639/0392-100X-1070 %0 Journal Article %J Curr Protein Pept Sci %D 2016 %T Plant Elite Squad: First Defense Line and Resistance Genes - Identification, Diversity and Functional Roles. %A Wanderley-Nogueira, Ana Carolina %A Bezerra-Neto, João Pacífico %A Kido, Éderson Akio %A de Araújo, Flávia Tadeu %A Amorim, Lidiane Lindinalva Barbosa %A Crovella, Sergio %A Benko-Iseppon, Ana Maria %X

Plants exhibit sensitive mechanisms to respond to environmental stresses, presenting some specific and non-specific reactions when attacked by pathogens, including organisms from different classes and complexity, as viroids, viruses, bacteria, fungi and nematodes. A crucial step to define the fate of the plant facing an invading pathogen is the activation of a compatible Resistance (R) gene, the focus of the present review. Different aspects regarding R-genes and their products are discussed, including pathogen recognition mechanisms, signaling and effects on induced and constitutive defense processes, splicing and post transcriptional mechanisms involved. There are still countless challenges to the complete understanding of the mechanisms involving R-genes in plants, in particular those related to the interactions with other genes of the pathogen and of the host itself, their regulation, acting mechanisms at transcriptional and post-transcriptional levels, as well as the influence of other types of stress over their regulation. A magnification of knowledge is expected when considering the novel information from the omics and systems biology.

%B Curr Protein Pept Sci %8 2016 Jul 24 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27455974?dopt=Abstract %0 Journal Article %J Curr Protein Pept Sci %D 2016 %T Plants Defense-related Cyclic Peptides: Diversity, Structure and Applications. %A Maria, Ana Carolina Wanderley-Nogueira %A Bezerra-Neto, João Pacífico %A Kido, Éderson Akio %A de Araújo, Flávia Tadeu %A Amorim, Lidiane Lindinalva Barbosa %A Crovella, Sergio %A Benko-Iseppon, Ana Maria %X

Plant growth is prone to several unfavorable factors that may compromise or impair development and survival, including abiotic or biotic stressors. Aiming at defending themselves, plants have developed several strategies to survive and adapt to such adversities. Cyclotides are a family of plant-derived proteins that exhibit a diverse range of biological activities including antimicrobial and insecticidal activities that actively participate in plant defense processes. Three main categories of peptides have been described: (i) Cyclotides (ii) Sunflower Trypsin Inhibitor (SFTI) and (iii) peptides MCoTI-I and II, from Momordica cochinchinensis. They comprise proteins of approximately 30 amino acids, containing a head-to-tail cyclized backbone, with three disulfide bonds configured in a cystine knot topology, therefore bearing greater peptide stability. Given their features and multifunctionality, cyclotides stand out as promising sources for the discovery of new antimicrobial agents. The present review describes cyclotide occurrence, abundance and action in plants, also their diversity and evolution. Considerations regarding their use in the context of biomedical and agronomical sciences uses are also presented.

%B Curr Protein Pept Sci %8 2016 Jul 24 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27455973?dopt=Abstract %0 Journal Article %J Eur J Cancer %D 2016 %T The prognostic value of biological markers in paediatric Hodgkin lymphoma. %A Farruggia, Piero %A Puccio, Giuseppe %A Sala, Alessandra %A Todesco, Alessandra %A Buffardi, Salvatore %A Garaventa, Alberto %A Bottigliero, Gaetano %A Bianchi, Maurizio %A Zecca, Marco %A Locatelli, Franco %A Pession, Andrea %A Pillon, Marta %A Favre, Claudio %A D'Amico, Salvatore %A Provenzi, Massimo %A Trizzino, Angela %A Zanazzo, Giulio Andrea %A Sau, Antonella %A Santoro, Nicola %A Murgia, Giulio %A Casini, Tommaso %A Mascarin, Maurizio %A Burnelli, Roberta %K Adolescent %K Age Factors %K Antineoplastic Combined Chemotherapy Protocols %K Biomarkers, Tumor %K Blood Platelets %K Child %K Child, Preschool %K Databases, Factual %K Disease Progression %K Disease-Free Survival %K Eosinophils %K Female %K Ferritins %K Hodgkin Disease %K Humans %K Infant %K Infant, Newborn %K Italy %K Kaplan-Meier Estimate %K Leukocyte Count %K Male %K Multivariate Analysis %K Neoplasm Staging %K Platelet Count %K Predictive Value of Tests %K Proportional Hazards Models %K Retrospective Studies %K Risk Factors %K Time Factors %K Treatment Outcome %X

BACKGROUND: Many biological and inflammatory markers have been proposed as having a prognostic value at diagnosis of Hodgkin lymphoma (HL), but very few have been validated in paediatric patients. We explored the significance of these markers in a large population of 769 affected children.

PATIENTS AND METHODS: By using the database of patients enrolled in A.I.E.O.P. (Associazione Italiana di Emato-Oncologia Pediatrica) trial LH2004 for paediatric HL, we identified 769 consecutive patients treated with curative intent from 1st June 2004 to 1st April 2014 with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine), or hybrid COPP/ABV (cyclophosphamide, vincristine, prednisone, procarbazine, doxorubicin, bleomycin and vinblastine) regimens.

RESULTS: On multivariate analysis with categorical forms, the 5-year freedom from progression survival was significantly lower in patients with stage IV or elevated value of platelets, eosinophils and ferritin at diagnosis. Furthermore, stage IV and eosinophils seem to maintain their predictive value independently of interim (after IV cycles of chemotherapy) positron emission tomography.

CONCLUSION: Using the combination of four simple markers such as stage IV and elevated levels of platelets, ferritin and eosinophils, it is possible to classify the patients into subgroups with very different outcomes.

%B Eur J Cancer %V 52 %P 33-40 %8 2016 Jan %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26630532?dopt=Abstract %R 10.1016/j.ejca.2015.09.003 %0 Journal Article %J J Acquir Immune Defic Syndr %D 2016 %T Protective Role of BST2 Polymorphisms in Mother-to-Child Transmission of HIV-1 and Adult AIDS Progression. %A Kamada, Anselmo J %A Bianco, Anna M %A Zupin, Luisa %A Girardelli, Martina %A Matte, Maria C C %A Medeiros, Rúbia Marília de %A Almeida, Sabrina Esteves de Matos %A Rocha, Marineide M %A Segat, Ludovica %A Chies, José A B %A Kuhn, Louise %A Crovella, Sergio %X

Bone marrow stromal cell antigen-2 (BST-2)/Tetherin is a restriction factor that prevents Human immunodeficiency virus type 1 (HIV-1) release from infected cells and mediates pro-inflammatory cytokine production. This study investigated the risk conferred by single nucleotide polymorphisms (rs919266, rs9192677, and rs9576) at BST-2 coding gene (BST2) in HIV-1 mother-to-child transmission and in disease progression. Initially, 101 HIV-1+ pregnant women and 331 neonates exposed to HIV-1 from Zambia were enrolled. Additional BST2 single nucleotide polymorphism analyses were performed in 2 cohorts with acquired immunodeficiency syndrome (AIDS) progression: an adult Brazilian cohort (37 rapid, 30 chronic and 21 long-term non-progressors) and an Italian pediatric cohort (21 rapid and 67 slow progressors). The rs9576A allele was nominally associated with protection during breastfeeding (P = 0.019) and individuals carrying rs919266 GA showed slower progression to AIDS (P = 0.033). Despite the influence of rs919266 and rs9576 on BST2 expression being still undetermined, a preventive role by BST2 polymorphisms was found during HIV-1 infection.

%B J Acquir Immune Defic Syndr %V 72 %P 237-41 %8 2016 Jul 1 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26885809?dopt=Abstract %R 10.1097/QAI.0000000000000949 %0 Journal Article %J Mol Med Rep %D 2016 %T Putative modifier genes in mevalonate kinase deficiency. %A Marcuzzi, Annalisa %A Vozzi, Diego %A Girardelli, Martina %A Tricarico, Paola Maura %A Knowles, Alessandra %A Crovella, Sergio %A Vuch, Josef %A Tommasini, Alberto %A Piscianz, Elisa %A Bianco, Anna Monica %X

Mevalonate kinase deficiency (MKD) is an autosomal recessive auto‑inflammatory disease, caused by impairment of the mevalonate pathway. Although the molecular mechanism remains to be elucidated, there is clinical evidence suggesting that other regulatory genes may be involved in determining the phenotype. The identification of novel target genes may explain non‑homogeneous genotype‑phenotype correlations, and provide evidence in support of the hypothesis that novel regulatory genes predispose or amplify deregulation of the mevalonate pathway in this orphan disease. In the present study, DNA samples were obtained from five patients with MKD, which were then analyzed using whole exome sequencing. A missense variation in the PEX11γ gene was observed in homozygosis in P2, possibly correlating with visual blurring. The UNG rare gene variant was detected in homozygosis in P5, without correlating with a specific clinical phenotype. A number of other variants were found in the five analyzed DNA samples from the MKD patients, however no correlation with the phenotype was established. The results of the presents study suggested that further analysis, using next generation sequencing approaches, is required on a larger sample size of patients with MKD, who share the same MVK mutations and exhibit 'extreme' clinical phenotypes. As MVK mutations may be associated with MKD, the identification of specific modifier genes may assist in providing an earlier diagnosis.

%B Mol Med Rep %V 13 %P 3181-9 %8 2016 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26935981?dopt=Abstract %R 10.3892/mmr.2016.4918 %0 Journal Article %J Expert Rev Clin Immunol %D 2016 %T Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis. %A Taddio, Andrea %A Cattalini, Marco %A Simonini, Gabriele %A Cimaz, Rolando %X

Juvenile Idiopathic Arthritis (JIA) encompasses a group of diseases of unknown etiology having in common arthritis in at least 1 joint that persists for 6 weeks and begins before 16 years of age, with other conditions excluded. With a prevalence of 1 per 1,000 children in the USA, JIA is the most common pediatric rheumatic illness and a major cause of acquired childhood disability. During the last 20 years, the advent of host immune response modifiers known as biologic agents, in particular the anti-TNFα agents (etanercept, infliximab, adalimumab), which directly inhibit the action of pro-inflammatory mediators, has revolutionized the treatment and the expected outcome of JIA. This article highlights treatment indications of anti-TNFα drugs and their more frequent side effects in JIA patients.

%B Expert Rev Clin Immunol %V 12 %P 641-9 %8 2016 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/26809126?dopt=Abstract %R 10.1586/1744666X.2016.1146132 %0 Journal Article %J Nat Genet %D 2016 %T A reference panel of 64,976 haplotypes for genotype imputation. %A McCarthy, Shane %A Das, Sayantan %A Kretzschmar, Warren %A Delaneau, Olivier %A Wood, Andrew R %A Teumer, Alexander %A Kang, Hyun Min %A Fuchsberger, Christian %A Danecek, Petr %A Sharp, Kevin %A Luo, Yang %A Sidore, Carlo %A Kwong, Alan %A Timpson, Nicholas %A Koskinen, Seppo %A Vrieze, Scott %A Scott, Laura J %A Zhang, He %A Mahajan, Anubha %A Veldink, Jan %A Peters, Ulrike %A Pato, Carlos %A van Duijn, Cornelia M %A Gillies, Christopher E %A Gandin, Ilaria %A Mezzavilla, Massimo %A Gilly, Arthur %A Cocca, Massimiliano %A Traglia, Michela %A Angius, Andrea %A Barrett, Jeffrey C %A Boomsma, Dorrett %A Branham, Kari %A Breen, Gerome %A Brummett, Chad M %A Busonero, Fabio %A Campbell, Harry %A Chan, Andrew %A Chen, Sai %A Chew, Emily %A Collins, Francis S %A Corbin, Laura J %A Smith, George Davey %A Dedoussis, George %A Dörr, Marcus %A Farmaki, Aliki-Eleni %A Ferrucci, Luigi %A Forer, Lukas %A Fraser, Ross M %A Gabriel, Stacey %A Levy, Shawn %A Groop, Leif %A Harrison, Tabitha %A Hattersley, Andrew %A Holmen, Oddgeir L %A Hveem, Kristian %A Kretzler, Matthias %A Lee, James C %A McGue, Matt %A Meitinger, Thomas %A Melzer, David %A Min, Josine L %A Mohlke, Karen L %A Vincent, John B %A Nauck, Matthias %A Nickerson, Deborah %A Palotie, Aarno %A Pato, Michele %A Pirastu, Nicola %A McInnis, Melvin %A Richards, J Brent %A Sala, Cinzia %A Salomaa, Veikko %A Schlessinger, David %A Schoenherr, Sebastian %A Slagboom, P Eline %A Small, Kerrin %A Spector, Timothy %A Stambolian, Dwight %A Tuke, Marcus %A Tuomilehto, Jaakko %A Van den Berg, Leonard H %A van Rheenen, Wouter %A Völker, Uwe %A Wijmenga, Cisca %A Toniolo, Daniela %A Zeggini, Eleftheria %A Gasparini, Paolo %A Sampson, Matthew G %A Wilson, James F %A Frayling, Timothy %A de Bakker, Paul I W %A Swertz, Morris A %A McCarroll, Steven %A Kooperberg, Charles %A Dekker, Annelot %A Altshuler, David %A Willer, Cristen %A Iacono, William %A Ripatti, Samuli %A Soranzo, Nicole %A Walter, Klaudia %A Swaroop, Anand %A Cucca, Francesco %A Anderson, Carl A %A Myers, Richard M %A Boehnke, Michael %A McCarthy, Mark I %A Durbin, Richard %X

We describe a reference panel of 64,976 human haplotypes at 39,235,157 SNPs constructed using whole-genome sequence data from 20 studies of predominantly European ancestry. Using this resource leads to accurate genotype imputation at minor allele frequencies as low as 0.1% and a large increase in the number of SNPs tested in association studies, and it can help to discover and refine causal loci. We describe remote server resources that allow researchers to carry out imputation and phasing consistently and efficiently.

%B Nat Genet %8 2016 Aug 22 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27548312?dopt=Abstract %R 10.1038/ng.3643 %0 Journal Article %J Curr Protein Pept Sci %D 2016 %T Resistance (R) Genes: Applications and Prospects for Plant Biotechnology and Breeding. %A Pandolfi, Valesca %A Neto, José Ribamar Costa Ferreira %A Silva, Manassés Daniel %A Amorim, Lidiane Lindinalva Barbosa %A Wanderley-Nogueira, Ana Carolina %A de Oliveira Silva, Roberta Lane %A Kido, Éderson Akio %A Crovella, Sergio %A Iseppon, Ana Maria Benko %X

The discovery of novel plant resistance (R) genes (including their homologs and analogs) opened interesting possibilities for controlling plant diseases caused by several pathogens. However, due to environmental pressure and high selection operated by pathogens, several crop plants have lost specificity, broad-spectrum or durability of resistance. On the other hand, the advances in plant genome sequencing and biotechnological approaches, combined with the increasing knowledge on R-genes have provided new insights on their applications for plant genetic breeding, allowing the identification and implementation of novel and efficient strategies that enhance or optimize their use for efficiently controlling plant diseases. The present review focuses on main perspectives of application of R-genes and its co-players for the acquisition of resistance to pathogens in cultivated plants, with emphasis on biotechnological inferences, including transgenesis, cisgenesis, directed mutagenesis and gene editing, with examples of success and challenges to be faced.

%B Curr Protein Pept Sci %8 2016 Jul 24 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27455971?dopt=Abstract %0 Journal Article %J J Med Virol %D 2016 %T Role of inflammasome genetics in susceptibility to HPV infection and cervical cancer development. %A Pontillo, A %A Bricher, P %A Leal, V N C %A Lima, S %A Souza, P R E %A Crovella, S %X

PROBLEM: Only a small proportion of HPV+ women develop virus-associated lesions and cervical cancer, suggesting that other factors are involved in HPV+ keratinocyte transformation. Immune response plays an important role in clearing HPV infection, and host genetic variants resulting in defective immune response have been associated with virus persistence and/or cervical cancer. Considering that genetic variations in inflammasome genes were previously associated with viral infection and cancer development, the present study investigates selected single nucleotide polymorphisms (SNPs) in inflammasome genes as a possible risk factor for HPV infection susceptibility and/or for progression to cervical cancer.

PATIENTS AND METHODS: 12 SNPs in seven inflammasome-related genes (NLRP1, NLRP3, NLRP6, CARD8, IL1B, IL18, TNFAIP3) were genotyped in a Brazilian HPV+ case/control cohort (n = 246/310). Multivariate analysis was performed in case/control as well as in HPV+ women stratified by the presence or severity of histologic lesion, HPV persistence, and type of virus.

RESULTS: IL1B rs1143643 was associated with protection against HPV infection in case/control analysis. NLRP1 rs11651270 plays a protection role against HPV persistence and/or oncogenesis. NLRP3 rs10754558 and IL18 rs1834481 exert a beneficial role against HPV persistence. NLRP3 rs10754558 variant resulted significantly associated with a lower risk to be infected with a high-risk HPV.

CONCLUSION: Our findings for the first time demonstrated that inflammasome genetics could affect HPV/host interaction in terms of virus susceptibility as well as of virus/persistence and cervical cancer progression. J. Med. Virol. 88:1646-1651, 2016. © 2016 Wiley Periodicals, Inc.

%B J Med Virol %V 88 %P 1646-51 %8 2016 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/26945813?dopt=Abstract %R 10.1002/jmv.24514 %0 Journal Article %J Curr Protein Pept Sci %D 2016 %T Snakin: Structure, Roles and Applications of a Plant Antimicrobial Peptide. %A Oliveira-Lima, Marx %A Benko-Iseppon, Ana Maria %A Neto, José Ribamar Costa Ferreira %A Rodríguez-Decuadro, Susana %A Kido, Éderson Akio %A Crovella, Sergio %A Pandolfi, Valesca %X

Snakins are plant antimicrobial peptides (AMPs) of the Snakin/GASA family, formed by three distinct regions: an N-terminal signal peptide; a variable site; and the GASA domain in the C-terminal region composed by twelve conserved cysteine residues that contribute to the biochemical stability of the molecule. These peptides are known to play different roles in response to a variety of biotic (i.e. induced by bacteria, fungi and nematode pathogens) and abiotic (salinity, drought and ROS) stressors, as well as in crosstalk promoted by plant hormones, with emphasis on abscisic and salicylic acid (ABA and SA, respectively). Such properties make snakin/GASA members promising biotechnological sources for potential therapeutic and agricultural applications. However, information regarding their tertiary structure, mode of action and function are not yet completely elucidated. The present review presents aspects of snakin structure, expression, functional studies and perspectives about the potential applications for agricultural and medical purposes.

%B Curr Protein Pept Sci %8 2016 Jun 19 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27323806?dopt=Abstract %0 Journal Article %J Am J Hematol %D 2016 %T Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Associ %A Svahn, Johanna %A Bagnasco, Francesca %A Cappelli, Enrico %A Onofrillo, Daniela %A Caruso, Silvia %A Corsolini, Fabio %A De Rocco, Daniela %A Savoia, Anna %A Longoni, Daniela %A Pillon, Marta %A Marra, Nicoletta %A Ramenghi, Ugo %A Farruggia, Piero %A Locasciulli, Anna %A Addari, Carmen %A Cerri, Carla %A Mastrodicasa, Elena %A Casazza, Gabriella %A Verzegnassi, Federico %A Riccardi, Francesca %A Haupt, Riccardo %A Barone, Angelica %A Cesaro, Simone %A Cugno, Chiara %A Dufour, Carlo %X

We analyzed 97 Fanconi anemia patients from a clinic/biological database for genotype, somatic, and hematologic phenotype, adverse hematological events, solid tumors, and treatment. Seventy-two patients belonged to complementation group A. Eighty percent of patients presented with mild/moderate somatic phenotype and most with cytopenia. No correlation was seen between somatic/hematologic phenotype and number of missense mutations of FANCA alleles. Over follow-up, 33% of patients improved or maintained mild/moderate cytopenia or normal blood count, whereas remaining worsened cytopenia. Eleven patients developed a hematological adverse event (MDS, AML, pathological cytogenetics) and three developed solid tumors. 10 years cumulative risk of death of the whole cohort was 25.6% with median follow-up 5.8 years. In patients eligible to hematopoietic stem cell transplantation because of moderate cytopenia, mortality was significantly higher in subjects transplanted from matched unrelated donor over nontransplanted subjects, whereas there was no significant difference between matched sibling donor transplants and nontransplanted patients. In patients eligible to transplant because of severe cytopenia and clonal disease, mortality risk was not significantly different in transplanted from matched unrelated versus matched sibling donor versus nontransplanted subjects. The decision to transplant should rely on various elements including, type of donor, HLA matching, patient comorbidities, impairment, and clonal evolution of hematopoiesis. Am. J. Hematol. 91:666-671, 2016. © 2016 Wiley Periodicals, Inc.

%B Am J Hematol %V 91 %P 666-71 %8 2016 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/27013026?dopt=Abstract %R 10.1002/ajh.24373 %0 Journal Article %J Toxicol Lett %D 2016 %T Synchrotron X-ray microscopy reveals early calcium and iron interaction with crocidolite fibers in the lung of exposed mice. %A Pascolo, Lorella %A Zabucchi, Giuliano %A Gianoncelli, Alessandra %A Kourousias, George %A Trevisan, Elisa %A Pascotto, Ernesto %A Casarsa, Claudia %A Ryan, Chris %A Lucattelli, Monica %A Lungarella, Giuseppe %A Cavarra, Eleonora %A Bartalesi, Barbara %A Zweyer, Marina %A Cammisuli, Francesca %A Melato, Mauro %A Borelli, Violetta %X

Human exposure to asbestos can cause a wide variety of lung diseases that are still a current major health concern, even if asbestos has been banned in many countries. It has been shown in many studies that asbestos fibers, ingested by alveolar macrophages, disrupt lung iron homeostasis by sequestering iron. Calcium can also be deposited on the fibers. The pathways along which iron and above all calcium interact with fibers are still unknown. Our aim was that of investigating if the iron accumulation induced by the inhaled asbestos fibers also involves calcium ions accumulation. Lung sections of asbestos-exposed mice were analyzed using an extremely sensitive procedure available at the synchrotron facilities, that provides morphological and chemical information based on X-ray fluorescence microspectroscopy (μ-XRF). In this study we show that (1) where conventional histochemical procedures revealed only weak deposits of iron and calcium, μ-XRF analysis is able to detect significant deposits of both iron and calcium on the inhaled asbestos fibers; (2) the extent of the deposition of these ions is proportionally directly related and (3) iron and calcium deposition on inhaled asbestos fibers is concomitant with the appearance of inflammatory and hyperplastic reactions.

%B Toxicol Lett %V 241 %P 111-20 %8 2016 Jan 22 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26602167?dopt=Abstract %R 10.1016/j.toxlet.2015.11.016 %0 Journal Article %J BJOG %D 2016 %T Time to optimise and enforce training in interpretation of intrapartum cardiotocograph. %A Ugwumadu, A %A Steer, P %A Parer, B %A Carbone, B %A Vayssiere, C %A Maso, G %A Arulkumaran, S %B BJOG %V 123 %P 866-9 %8 2016 May %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/26773808?dopt=Abstract %R 10.1111/1471-0528.13846 %0 Journal Article %J BMC Med Genet %D 2016 %T Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy. %A Cini, Giulia %A Mezzavilla, Massimo %A Della Puppa, Lara %A Cupelli, Elisa %A Fornasin, Alessio %A D'Elia, Angela Valentina %A Dolcetti, Riccardo %A Damante, Giuseppe %A Bertok, Sara %A Miolo, Gianmaria %A Maestro, Roberta %A de Paoli, Paolo %A Amoroso, Antonio %A Viel, Alessandra %K Adult %K Aged %K Alleles %K BRCA1 Protein %K BRCA2 Protein %K Breast Neoplasms %K Case-Control Studies %K DNA Mutational Analysis %K Female %K Founder Effect %K Genetic Testing %K Genome-Wide Association Study %K Genotyping Techniques %K Haplotypes %K Humans %K Italy %K Male %K Microsatellite Repeats %K Middle Aged %K Mutation %K Ovarian Neoplasms %K Young Adult %X

BACKGROUND: About 20 % of hereditary breast cancers are caused by mutations in BRCA1 and BRCA2 genes. Since BRCA1 and BRCA2 mutations may be spread throughout the gene, genetic testing is usually performed by direct sequencing of entire coding regions. In some populations, especially if relatively isolated, a few number of recurrent mutations is reported, sometimes caused by founder effect.

METHODS: BRCA1 and BRCA2 screening for mutations was carried out on 1114 breast and/or ovarian cancer patients complying with the eligibility criteria for BRCA testing. Haplotype analysis was performed on the probands carrying recurrent mutations and their relatives, using two sets of microsatellite markers covering the BRCA1 (D17S588, D17S806, D17S902, D17S1325, D17S855, D17S1328, D17S800, and D17S250) and BRCA2 (D13S220, D13S267, D13S171, D13S1701, D13S1698, D13S260, D13S290, D13S1246) loci. The DMLE + 2.2 software was used to estimate the age of BRCA1 c.676delT and BRCA2 c.7806-2A > G. A multiplex PCR and two different primer extension assays were optimized and used for genotyping the recurrent mutations of the two genes.

RESULTS: In the time frame of almost 20 years of genetic testing, we have found that five BRCA1 and three BRCA2 mutations are recurrent in a substantial subset of carriers from North-East Italy and neighboring Istria, where they represent more than 50 % of all mutations. Microsatellite analyses identified a common haplotype of different length for each mutation. Age estimation of BRCA1 c.676delT and BRCA2 c.7806-2A > G mutations revealed that they arose in the Friuli Venezia Giulia area about 86 and 94 generations ago, respectively. Suggestion of an association between BRCA2 c.7806-2A > G and risk of breast cancer in males has emerged. Finally, we developed a simple and efficient pre-screening test, performing an in-house primer extension SNaPshot® assay for the rapid identification of the eight recurrent mutations.

CONCLUSIONS: Proofs of common ancestry has been obtained for the eight recurrent mutations. The observed genotype-phenotype correlation and the proposed rapid mutation detection strategy could improve the clinical management of breast and ovarian patients in North-East of Italy and neighboring geographic areas.

%B BMC Med Genet %V 17 %P 11 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26852130?dopt=Abstract %R 10.1186/s12881-016-0274-6 %0 Journal Article %J Curr Protein Pept Sci %D 2016 %T Transcription factors involved in plant resistance to pathogens. %A Amorim, Lidiane L B %A da Fonseca-Dos-Santos, Romulo %A Guida-Santos, Mauro %A Crovella, Sergio %A Benko-Iseppon, Ana Maria %X

Phytopathogenic microorganisms have a significant influence on survival and productivity of several crop plants. Transcription factors (TFs) are important players in the response to biotic stresses, as insect attack and pathogen infection. In face of such adversities many TF families have been previously reported as differentially expressed in plants as a reaction to bacterial, fungal and viral infection. This review highlights recent progresses in understanding the structure, function, signal regulation and interaction of transcription factors with other proteins in response to pathogens. Hence, we focus on three families of transcription factors: ERF, bZIP and WRKY, due to their abundance, importance and the availability of functionally well-characterized members in response to pathogen attack. Their roles and the possibilities related to the use of this knowledge for engineering pathogen resistance in crop plants are also discussed.

%B Curr Protein Pept Sci %8 2016 Jun 19 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27323805?dopt=Abstract %0 Journal Article %J Immunol Res %D 2016 %T TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil. %A Celerino da Silva, Ronaldo %A Coelho, Antônio Victor Campos %A Arraes, Luiz Claudio %A Brandão, Lucas André Cavalcanti %A Crovella, Sergio %A Guimarães, Rafael Lima %X

Humans show heterogeneity in vulnerability to HIV-1 infection, partially under control of genes involved in host immunity and virus replication. TRIM5α protein has restriction activity against replication of many retroviruses. Human TRIM5 gene single nucleotide polymorphisms have been reported as involved in susceptibility to HIV-1 infection. We recruited 213 HIV-1-positive patients and 234 healthy uninfected controls from Northeast Brazil; two non-synonymous variants at exon 2, rs3740996 (H43Y) and rs10838525 (R136Q), and one regulatory polymorphism (rs16934386) at 5'UTR region of TRIM5 were analyzed. The R136Q variation presented significant differences between HIV-1-positive patients and healthy controls. The 136Q allele and the 136QQ genotype were more frequent in healthy controls (32.7 and 10.2 %, respectively) than in HIV-1-positive patients (136Q allele: 24.4 %; OR 0.66; CI 95 % 0.49-0.90; p value = 0.008/136QQ genotype: 4.2 %; OR 0.33; CI 95 % 0.13-0.79, p = 0.008) also after adjusting for age and sex. We also stratified our findings according to the presence of CCR5Δ32 variation, but the results remained the same. We observed that rs10838525 (R136Q) and rs3740996 (H43Y) were in linkage disequilibrium (D' = 0.71), forming four possible haplotypes. The H43-136Q haplotype was significantly more frequent in healthy controls (28.2 %) than in HIV-positive patients (21.4 %; OR 0.69; CI 95 % 0.50-0.96; p = 0.022). An increased frequency of allele (136Q) and genotype (136QQ) of the non-synonymous rs10838525 (R136Q) variant and the haplotype (43H-136Q) was observed among healthy controls individuals. Being aware of the limitation of this study (unavailability of exposed but uninfected individuals), we hypothesize a potential role for TRIM5 variations in the protection against HIV-1 infection.

%B Immunol Res %8 2016 Jul 8 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/27388872?dopt=Abstract %R 10.1007/s12026-016-8810-1 %0 Journal Article %J Physiol Behav %D 2016 %T Understanding the role of personality and alexithymia in food preferences and PROP taste perception. %A Robino, Antonietta %A Mezzavilla, Massimo %A Pirastu, Nicola %A La Bianca, Martina %A Gasparini, Paolo %A Carlino, Davide %A Tepper, Beverly J %X

Taste perception and food preferences are influenced by a variety of factors, including personality characteristics. The aims of this study were to examine the role of personality characteristics, such as alexithymia (a personality construct characterized by inability to identify, describe, and work with one's own feelings), in: 1) taste responses to the bitter genetic taste-marker PROP and 2) food liking. We studied 649 healthy subjects residing in six genetically-isolated villages of Northeast Italy. Data on PROP taste responsiveness, food liking, personality characteristics and TAS2R28 genotypes were collected. Results showed that PROP non-tasters had higher alexithymia scores than PROP tasters. Moreover, the presence of alexithymia in heterozygous individuals for the rs1726886 polymorphism of the TAS2R38 gene was associated with a reduction in the perceived intensity of PROP. Finally, higher alexithymia scores were associated with liking of alcohol, sweets and fats/meats whereas lower alexithymia scores were related to liking of vegetables, condiments and strong cheeses, Measures of temperament, character, anxiety and depression were also related to food liking. Our findings suggest that: 1) alexithymia, in addition to the TAS2R38 polymorphism, may play a role in responsiveness to the aversive and bitter taste of PROP; and 2) alexithymia, in combination with other personality traits, may provide important insights for better understanding food liking.

%B Physiol Behav %V 157 %P 72-8 %8 2016 Apr 1 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26805725?dopt=Abstract %R 10.1016/j.physbeh.2016.01.022 %0 Journal Article %J Int J Surg Case Rep %D 2016 %T When a lymphatic malformation determines a bowel volvulus: Are clinical status and images always reliable? %A Guida, Edoardo %A Di Grazia, Massimo %A Cattaruzzi, Elisabetta %A Bussani, Rossana %A Rigamonti, Waifro %A Lembo, Maria Antonietta %X

INTRODUCTION: An acute abdomen in the form of small-bowel volvulus could be a presentation of a lymphatic malformation in childhood.

CASE PRESENTATION: A 5year old male was admitted to our Institute for an acute abdomen. Clinical aspects and radiological images were not specific for a certain diagnosis. Laparotomy revealed a big soft mass, with a milky content, completely involving about 50cm of ileus with a partial volvulus of the intestinal loop. A complete mass excision and also a bowel involved resection were performed. After a histological examination, a lymphatic malformation was diagnosed.

DISCUSSION: The diagnosis of a mesenteric lymphatic malformation could be intraoperative and a complete resection should be the treatment of choice. Sometimes it could be necessary to perform an involved bowel tract resection in the case of volvolus with ischemia.

CONCLUSIONS: Paediatricians and surgeons should bare in mind that an intrabdominal lymphatic malformation may present as a nonspecific an acute abdomen caused by a bowel volvolus and diagnosis may not be so simple preoperatively.

%B Int J Surg Case Rep %V 25 %P 192-5 %8 2016 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27388707?dopt=Abstract %R 10.1016/j.ijscr.2016.06.030 %0 Journal Article %J Blood %D 2015 %T ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. %A Bottega, Roberta %A Marconi, Caterina %A Faleschini, Michela %A Baj, Gabriele %A Cagioni, Claudia %A Pecci, Alessandro %A Pippucci, Tommaso %A Ramenghi, Ugo %A Pardini, Simonetta %A Ngu, Loretta %A Baronci, Carlo %A Kunishima, Shinji %A Balduini, Carlo L %A Seri, Marco %A Savoia, Anna %A Noris, Patrizia %K Actinin %K Adolescent %K Adult %K Aged %K Aged, 80 and over %K Blood Platelets %K Case-Control Studies %K Child %K Child, Preschool %K Female %K Gene Expression %K Genotype %K Heterozygote %K Humans %K Male %K Middle Aged %K Mutation, Missense %K Pedigree %K Phenotype %K Platelet Count %K Severity of Illness Index %K Thrombocytopenia %K Thrombopoiesis %K Thrombopoietin %X

Inherited thrombocytopenias (ITs) are a heterogeneous group of syndromic and nonsyndromic diseases caused by mutations affecting different genes. Alterations of ACTN1, the gene encoding for α-actinin 1, have recently been identified in a few families as being responsible for a mild form of IT (ACTN1-related thrombocytopenia; ACTN1-RT). To better characterize this disease, we screened ACTN1 in 128 probands and found 10 (8 novel) missense heterozygous variants in 11 families. Combining bioinformatics, segregation, and functional studies, we demonstrated that all but 1 amino acid substitution had deleterious effects. The clinical and laboratory findings of 31 affected individuals confirmed that ACTN1-RT is a mild macrothrombocytopenia with low risk for bleeding. Low reticulated platelet counts and only slightly increased serum thrombopoietin levels indicated that the latest phases of megakaryopoiesis were affected. Given its relatively high frequency in our cohort (4.2%), ACTN1-RT has to be taken into consideration in the differential diagnosis of ITs.

%B Blood %V 125 %P 869-72 %8 2015 Jan 29 %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/25361813?dopt=Abstract %R 10.1182/blood-2014-08-594531 %0 Journal Article %J Leuk Lymphoma %D 2015 %T Acute myeloid leukemia in a 3 years old child with cleidocranial dysplasia. %A Callea, Michele %A Bellacchio, Emanuele %A Fattori, Fabiana %A Bertini, Enrico %A Callea, Francesco %A Cammarata-Scalisi, Francisco %B Leuk Lymphoma %P 1-3 %8 2015 Dec 24 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26700323?dopt=Abstract %R 10.3109/10428194.2015.1115030 %0 Journal Article %J J Child Neurol %D 2015 %T Acute pseudotumoral hemicerebellitis in a child: a rare and distinct entity? %A Alberini, Elena %A Vellante, Valerio %A Zennaro, Floriana %A Calligaris, Lorenzo %A Barbi, Egidio %A Carrozzi, Marco %A Devescovi, Raffaella %K Brain %K Cerebellar Diseases %K Child %K Diagnosis, Differential %K Encephalitis %K Humans %K Magnetic Resonance Imaging %K Male %X

A pseudotumoral presentation of acute hemicerebellitis is rare in pediatric age. The authors report a new single case study of a 7-year-old child with pseudotumoral unilateral cerebellitis mimicking an intracranial tumor, which clinically presented itself with signs of intracranial hypertension and mild contralateral hemiparesis, completely recovered after anti-inflammatory therapy. Brain magnetic resonance imaging (MRI) was essential for the differential diagnosis between inflammatory and neoplastic processes. The literature highlighting specific clues about pseudotumoral hemicerebellitis as a distinct clinical and radiological entity is reviewed.

%B J Child Neurol %V 30 %P 496-9 %8 2015 Mar %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25143480?dopt=Abstract %R 10.1177/0883073814545114 %0 Journal Article %J Arch Dis Child %D 2015 %T Advertisements of follow-on formula and their perception by pregnant women and mothers in Italy. %A Cattaneo, Adriano %A Pani, Paola %A Carletti, Claudia %A Guidetti, Margherita %A Mutti, Valentina %A Guidetti, Cecilia %A Knowles, Alessandra %K Adult %K Advertising as Topic %K Attitude to Health %K Cross-Sectional Studies %K Female %K Humans %K Infant %K Infant Formula %K Italy %K Mothers %K Perception %K Periodicals as Topic %K Pregnancy %K Pregnant Women %K Reading %K Surveys and Questionnaires %K Young Adult %X

OBJECTIVE: To assess how follow-on formula milks for infants aged 6-12 months are presented to and understood by mothers.

DESIGN: A quantitative and qualitative cross-sectional study including (1) an analysis of advertisements in three magazines for parents; (2) in-depth semistructured qualitative interviews to pregnant women on their perception of two advertisements for follow-on formula and (3) self-administered questionnaires for mothers to explore their exposure to and perception of formula advertisements.

PARTICIPANTS: Eighty pregnant women 32-36 weeks of gestation with no previous children and 562 mothers of children <3 years old.

SETTING: Maternal and child health centres in eight cities of Italy.

RESULTS: Advertisements of formula (n=89) represented about 7% of all advertisements in the three magazines, the majority (58%) being for follow-on formula. Advertisements were parent-oriented, aimed at helping parents solve health problems of their babies or at eliciting good feelings, or both. The qualitative interviews to pregnant women showed inability to define the advertised products at first glance due to the ambiguity of the numeral 2 and the presumed age of the portrayed baby; this inability did not disappear after carefully viewing the advertisements and reading the text. When asked in the self-administered questionnaires whether they had ever come across advertisements of infant formula, 81% of mothers reported that they had, despite the legal inexistence of such advertisements, and 65% thought that it was for a product to be used from birth.

CONCLUSIONS: Advertisements of follow-on formula are perceived by pregnant women and mothers as promoting infant formula.

%B Arch Dis Child %V 100 %P 323-8 %8 2015 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25512963?dopt=Abstract %R 10.1136/archdischild-2014-306996 %0 Journal Article %J J Hum Lact %D 2015 %T Advising Mothers on the Use of Medications during Breastfeeding: A Need for a Positive Attitude. %A Davanzo, Riccardo %A Bua, Jenny %A De Cunto, Angela %A Farina, Maria Luisa %A De Ponti, Fabrizio %A Clavenna, Antonio %A Mandrella, Stefania %A Sagone, Antonella %A Clementi, Maurizio %X

The use of medications by the nursing mother is a common reason for interrupting breastfeeding. Few drugs have been demonstrated to be absolutely contraindicated during breastfeeding. Excessive caution may lead health professionals to unnecessarily advise to interrupt breastfeeding, without assessing the latest evidence or considering the risk-benefit ratio of taking a medication versus terminating breastfeeding. To foster an appropriate approach toward the use of medications in breastfeeding women, the Italian Society of Perinatal Medicine created the following policy statement.

%B J Hum Lact %8 2015 Jul 14 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26173811?dopt=Abstract %R 10.1177/0890334415595513 %0 Journal Article %J Mol Med Rep %D 2015 %T Alendronate, a double-edged sword acting in the mevalonate pathway. %A Tricarico, Paola Maura %A Girardelli, Martina %A Kleiner, Giulio %A Knowles, Alessandra %A Valencic, Erica %A Crovella, Sergio %A Marcuzzi, Annalisa %X

Aminobisphosphonate aledronate is a compound commonly used clinically for the treatment of osteoporosis and other bone diseases, as a result of it preventing bone resorption. However, in previous years it has also been used to obtain cellular and animal models of a rare genetic disorder termed Mevalonate Kinase Deficiency (MKD). MKD is caused by mutations affecting the mevalonate kinase enzyme, in the cholesterol pathway and alendronate can be used to biochemically mimic the genetic defect as it inhibits farnesyl pyrophosphate synthase in the same pathway. Despite evidence in favor of the inhibition exerted on the mevalonate pathway, there is at least one clinical case of MKD in which alendronate improved not only skeletal and bone fractures, as expected, but also MKD clinical features. Based on this finding, the present study assessed the anti‑inflammatory properties of this aminobisphosphonate in vitro. No anti‑inflammatory effects of alendronate were observed in the in vitro experiments. Since MKD lacks specific treatments, these results may assist scientists and physicians in making the decision as to the most suitable choice of therapeutic compounds for this neglected disease.

%B Mol Med Rep %V 12 %P 4238-42 %8 2015 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26096667?dopt=Abstract %R 10.3892/mmr.2015.3957 %0 Journal Article %J Acta Paediatr %D 2015 %T Analgesia by cooling vibration during venipuncture in children with cognitive impairment. %A Schreiber, Silvana %A Cozzi, Giorgio %A Rutigliano, Rosaria %A Assandro, Paola %A Tubaro, Martina %A Cortellazzo Wiel, Luisa %A Ronfani, Luca %A Barbi, Egidio %X

AIM: Children with cognitive impairment experience pain more frequently than healthy children and are more likely to require venipuncture or intravenous cannulation for various procedures. They are frequently unable to report pain and often receive poor pain assessment and management. This study assessed the effectiveness of physical analgesia during vascular access in children with cognitive impairments.

METHODS: We conducted a prospective randomised controlled study at a tertiary-level children's hospital in Italy from April to May 2015 to assess whether a cooling vibration device called Buzzy decreased pain during venipuncture and intravenous cannulation in children with cognitive impairment. None of the children had verbal skills and the main cognitive impairments were cerebral palsy, epileptic encephalopathy and genetic syndromes.

RESULTS: We tested 70 children with a median age of nine years: 34 in the Buzzy group and 36 in the no-intervention group. Parents were trained in the use of the Noncommunicating Children's Pain Checklist - postoperative version scale, and they reported no or mild procedural pain in 32 cases (91.4%) in the Buzzy group and in 22 cases (61.1%) in the no-intervention group (p = 0.003).

CONCLUSION: Cooling vibration analgesia during vascular access reduced pain in children with cognitive impairment.

%B Acta Paediatr %8 2015 Sep 24 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26401633?dopt=Abstract %R 10.1111/apa.13224 %0 Journal Article %J Psychiatry Res %D 2015 %T Analysis of functional variants reveals new candidate genes associated with alexithymia. %A Mezzavilla, Massimo %A Ulivi, Sheila %A Bianca, Martina La %A Carlino, Davide %A Gasparini, Paolo %A Robino, Antonietta %K Adolescent %K Adult %K Affective Symptoms %K Aged %K Case-Control Studies %K DNA-Binding Proteins %K Emotions %K Female %K Humans %K Male %K Membrane Proteins %K Middle Aged %K P-Glycoproteins %K Personality Inventory %K Phenotype %K Tumor Suppressor Proteins %K Young Adult %X

In this study we explored the possible association between 36,915 functional variants and alexithymia, a personality trait characterized by the inability to identify and describe emotions and feelings. From our analysis, variants in the genes ABCB4, TP53AIP1, ARHGAP32 and TMEM88B were identified linked to the alexithymia phenotype.

%B Psychiatry Res %V 227 %P 363-5 %8 2015 Jun 30 %G eng %N 2-3 %1 http://www.ncbi.nlm.nih.gov/pubmed/25882097?dopt=Abstract %R 10.1016/j.psychres.2015.03.018 %0 Journal Article %J Oncotarget %D 2015 %T The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway. %A Agnoletto, Chiara %A Brunelli, Laura %A Melloni, Elisabetta %A Pastorelli, Roberta %A Casciano, Fabio %A Rimondi, Erika %A Rigolin, Gian Matteo %A Cuneo, Antonio %A Secchiero, Paola %A Zauli, Giorgio %X

B-chronic lymphocytic leukemia (B-CLL) patients harboring p53 mutations are invariably refractory to therapies based on purine analogues and have limited treatment options and poor survival. Having recently demonstrated that the mitochondria-targeting small molecule sodium dichloroacetate (DCA) exhibits anti-leukemic activity in p53wild-type B-CLL cells, the aim of this study was to evaluate the effect of DCA in p53mutated B-CLL cells and in p53mutated/null leukemic cell lines. DCA exhibited comparable cytotoxicity in p53wild-type and p53mutated B-CLL patient cell cultures, as well as in p53mutated B leukemic cell lines (MAVER, MEC-1, MEC-2). At the molecular level, DCA promoted the transcriptional induction of p21 in all leukemic cell types investigated, including p53null HL-60. By using a proteomic approach, we demonstrated that DCA up-regulated the ILF3 transcription factor, which is a known regulator of p21 expression. The role of the ILF3/p21 axis in mediating the DCA anti-leukemic activity was underscored by knocking-down experiments. Indeed, transfection with ILF3 and p21 siRNAs significantly decreased both the DCA-induced p21 expression and the DCA-mediated cytotoxicity. Taken together, our results emphasize that DCA is a small molecule that merits further evaluation as a therapeutic agent also for p53mutated leukemic cells, by acting through the induction of a p53-independent pathway.

%B Oncotarget %V 6 %P 2385-96 %8 2015 Feb 10 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25544776?dopt=Abstract %R 10.18632/oncotarget.2960 %0 Journal Article %J Br J Haematol %D 2015 %T Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort. %A Randi, Maria L %A Geranio, Giulia %A Bertozzi, Irene %A Micalizzi, Concetta %A Ramenghi, Ugo %A Tucci, Fabio %A Notarangelo, Lucia D %A Ladogana, Saverio %A Menna, Giuseppe %A Giordano, Paola %A Consarino, Caterina %A Farruggia, Piero %A Zanazzo, Giulio A %A Fiori, Giovanni M %A Burnelli, Roberta %A Russo, Giovanna %A Jankovich, Momcilo %A Peroni, Edoardo %A Duner, Elena %A Basso, Giuseppe %A Fabris, Fabrizio %A Putti, Maria C %K Adolescent %K Adult %K Amino Acid Substitution %K Child %K Child, Preschool %K Cohort Studies %K Female %K Hematologic Neoplasms %K Humans %K Infant %K Janus Kinase 2 %K Male %K Mutation, Missense %K Neoplasm Proteins %K Thrombocythemia, Essential %X

Sporadic essential thrombocythaemia (ET) is rare in paediatrics, and the diagnostic and clinical approach to paediatric cases cannot be simply copied from experience with adults. Here, we assessed 89 children with a clinical diagnosis of ET and found that 23 patients (25·8%) had a clonal disease. The JAK2 V617F mutation was identified in 14 children, 1 child had the MPL W515L mutation, and 6 had CALR mutations. The monoclonal X-chromosome inactivation pattern was seen in six patients (two with JAK2 V617F and two with CALR mutations). The other 66 patients (74·2%) had persistent thrombocytosis with no clonality. There were no clinical or haematological differences between the clonal and non-clonal patients. The relative proportion of ET-specific mutations in the clonal children was much the same as in adults. The higher prevalence of non-clonal cases suggests that some patients may not have myeloproliferative neoplasms, with significant implications for their treatment.

%B Br J Haematol %V 169 %P 584-9 %8 2015 May %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25716342?dopt=Abstract %R 10.1111/bjh.13329 %0 Journal Article %J PLoS One %D 2015 %T Assessment of the olfactory function in Italian patients with type 3 von Willebrand disease caused by a homozygous 253 Kb deletion involving VWF and TMEM16B/ANO2. %A Cenedese, Valentina %A Mezzavilla, Massimo %A Morgan, Anna %A Marino, Renato %A Ettorre, Cosimo Pietro %A Margaglione, Maurizio %A Gasparini, Paolo %A Menini, Anna %K Adult %K Case-Control Studies %K Female %K Genetic Association Studies %K Homozygote %K Humans %K Italy %K Male %K Membrane Proteins %K Middle Aged %K Olfactory Mucosa %K Olfactory Perception %K Sequence Deletion %K Smell %K von Willebrand Disease, Type 3 %K von Willebrand Factor %K Young Adult %X

Type 3 Von Willebrand disease is an autosomal recessive disease caused by the virtual absence of the von Willebrand factor (VWF). A rare 253 kb gene deletion on chromosome 12, identified only in Italian and German families, involves both the VWF gene and the N-terminus of the neighbouring TMEM16B/ANO2 gene, a member of the family named transmembrane 16 (TMEM16) or anoctamin (ANO). TMEM16B is a calcium-activated chloride channel expressed in the olfactory epithelium. As a patient homozygous for the 253 kb deletion has been reported to have an olfactory impairment possibly related to the partial deletion of TMEM16B, we assessed the olfactory function in other patients using the University of Pennsylvania Smell Identification Test (UPSIT). The average UPSIT score of 4 homozygous patients was significantly lower than that of 5 healthy subjects with similar sex, age and education. However, 4 other members of the same family, 3 heterozygous for the deletion and 1 wild type, had a slightly reduced olfactory function indicating that socio-cultural or other factors were likely to be responsible for the observed difference. These results show that the ability to identify odorants of the homozygous patients for the deletion was not significantly different from that of the other members of the family, showing that the 253 kb deletion does not affect the olfactory performance. As other genes may compensate for the lack of TMEM16B, we identified some predicted functional partners from in silico studies of the protein-protein network of TMEM16B. Calculation of diversity for the corresponding genes for individuals of the 1000 Genomes Project showed that TMEM16B has the highest level of diversity among all genes of the network, indicating that TMEM16B may not be under purifying selection and suggesting that other genes in the network could compensate for its function for olfactory ability.

%B PLoS One %V 10 %P e0116483 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25635880?dopt=Abstract %R 10.1371/journal.pone.0116483 %0 Journal Article %J PLoS One %D 2015 %T Association Study between Cervical Lesions and Single or Multiple Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types in Women from Northeastern Brazil. %A Chagas, Bárbara Simas %A Comar, Manola %A Gurgel, Ana Pavla Almeida Diniz %A Paiva, Sérgio %A Seraceni, Silva %A de Freitas, Antonio Carlos %A Crovella, Sergio %X

We performed an association between high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL) and single or multiple vaccine-target as well as non-vaccine target Human papillomavirus (HPV) types. Using bead-based HPV genotyping, 594 gynecological samples were genotyped. An association between squamous intraepithelial lesion (SIL) and presence of HPV16, 18, 31, 58 and 56 types were calculated. The risk was estimated by using odds ratio (OR) and 95% of confidence intervals (CI). A total of 370 (62.3%) women were HPV positive. Among these, 157 (42.7%) presented a single HPV infection, and 212 (57.3%) were infected by more than one HPV type. HPV31 was the most prevalent genotype, regardless single and multiple HPV infections. Single infection with HPV31 was associated with LSIL (OR=2.32; 95%CI: 1.01 to 5.32; p=0.04); HPV31 was also associated with LSIL (OR=3.28; 95%CI: 1.74 to 6.19; p= 0.0002) and HSIL (OR=3.82; 95%CI: 2.10 to 6.97; p<0.001) in multiple HPV infections. Risk to harbor cervical lesions was observed in multiple HPV infections with regard to the HPV56 (OR=5.39; 95%CI: 2.44 to 11.90; p<0.001for LSIL; OR=5.37; 95%CI: 2.71 to 10.69; p<0.001) and HPV58 (OR=3.29; 95%CI: 1.34 to 8.09; p=0.0091 for LSIL; OR=3.55; 95%CI: 1.56 to 8.11; p=0.0026) genotypes. In addition, women coinfected with HPV16/31/56 types had 6 and 5-fold increased risk of HSIL (OR=6.46; 95%CI: 1.89 to 22.09; p=0.002) and LSIL (OR=5.22; 95%CI: 1.10 to 24.70; p=0.03), respectively. Multiple HPV infections without HPV16/18 has 2-fold increased risk of HSIL (OR=2.57; 95%CI: 1.41 to 4.70; p=0.002) and LSIL OR=2.03; 95%CI: 1.08 to 3.79; p=0.02). The results of this study suggest that single and multiple vaccine target as well as non-vaccine target HPV types are associated with LSIL and HSIL. These finding should be taken into consideration in the design of HPV vaccination strategies.

%B PLoS One %V 10 %P e0132570 %8 2015 %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/26176537?dopt=Abstract %R 10.1371/journal.pone.0132570 %0 Journal Article %J Ultrasound Obstet Gynecol %D 2015 %T Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy. %A Ferrazzi, E %A Zullino, S %A Stampalija, T %A Vener, C %A Cavoretto, P %A Gervasi, M T %A Vergani, P %A Mecacci, F %A Marozio, L %A Oggè, G %A Algeri, P %A Ruffatti, A %A Milani, S %A Todros, T %X

OBJECTIVE: We hypothesized that fetal abdominal circumference (AC) and Uterine Doppler Pulsatility Index (UtA-PI) could select two homogenous subgroups of women affected by hypertensive disorders of pregnancy (HDP), characterized by the coexistence of maternal hypertension with and without IUGR.

METHODS: This is a multicentre study that studied cases affected by HDP in whom fetal AC and UtA-PI had been measured at admission to feto Maternal Medicine Units. Maternal characteristics, pregnancy complications and outcome were recorded. These data allowed us to model the characteristics of fetal growth in cases affected by HDP, and to design a composite index for risk factors of maternal metabolic syndrome (rfMMS) and composite index of severity for maternal organ and/or function damage (OFD).

RESULTS: Measurements of fetal AC and UtA-PI allowed us to define a group of HDP with AGA fetuses (HDP-AGAf) diagnosed by normal fetal AC and a UtA-PI (#205), and a group of HDP with IUGR fetuses (HDP-IUGR) diagnosed by fetal AC <5(th) centile and UtA-PI >95(th) centile (#124). Curves fitted to birth-weight of the two groups were significantly different, and gestational age at admission for HDP, <34 or ≥34, had no effect on their models. When birth-weight was expressed as standard deviation score (SDS) of local reference charts, the average SDS (±standard error) corresponded to the 6(th) and 48(th) centile respectively. The risk of developing HDP-AGAf was significantly associated with risk factors for maternal metabolic syndrome (OR= 2.79;CI 1.57-4.97), independently of gestational age. The same risk factors yielded a non significant ORs of developing late onset HDP. Women with HDP-IUGR proved to be associated with the worst clinical outcomes.

CONCLUSIONS: This study adds genuine new data based on simple prenatal bedside examinations, that might help to differentiate HDP with IUGR, from HDP with AGA fetuses, associated with different fetal growth patterns and different risk factors, not affected by gestational age at onset of the disease.

%B Ultrasound Obstet Gynecol %8 2015 Sep 9 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26350023?dopt=Abstract %R 10.1002/uog.15741 %0 Journal Article %J BJOG %D 2015 %T Brain sparing effect in growth-restricted fetuses is associated with decreased cardiac acceleration and deceleration capacities: a case-control study. %A Stampalija, T %A Casati, D %A Monasta, L %A Sassi, R %A Rivolta, M W %A Muggiasca, M L %A Bauer, A %A Ferrazzi, E %X

OBJECTIVE: Phase rectified signal averaging (PRSA) is a new method of fetal heart rate variability (fHRV) analysis that quantifies the average acceleration (AC) and deceleration capacity (DC) of the heart. The aim of this study was to evaluate AC and DC of fHR [recorded by trans-abdominal fetal electrocardiogram (ta-fECG)] in relation to Doppler velocimetry characteristics of intrauterine growth restriction (IUGR).

DESIGN: Prospective case-control study.

SETTING: Single third referral centre.

POPULATION: IUGR (n = 66) between 25 and 40 gestational weeks and uncomplicated pregnancies (n = 79).

METHODS: In IUGR the nearest ta-fECG monitoring to delivery was used for PRSA analysis and Doppler velocimetry parameters obtained within 48 hours. AC and DC were computed at s = T = 9. The relation was evaluated between either AC or DC and Doppler velocimetry parameters adjusting for gestational age at monitoring, as well as the association between either AC or DC and IUGR with or without brain sparing.

RESULTS: In IUGRs there was a significant association between either AC and DC and middle cerebral artery pulsatility index (PI; P = 0.01; P = 0.005), but the same was not true for uterine or umbilical artery PI (P > 0.05). Both IUGR fetuses with and without brain sparing had lower AC and DC than controls, but this association was stronger for IUGRs with brain sparing.

CONCLUSIONS: Our study observed for the first time that AC and DC at PRSA analysis are associated with middle cerebral artery PI, but not with uterine or umbilical artery PI, and that there is a significant decrease of AC and DC in association with brain sparing in IUGR fetuses from 25 weeks of gestation to term.

TWEETABLE ABSTRACT: Brain sparing in IUGR fetuses is associated with decreased acceleration and deceleration capacities of the heart.

%B BJOG %8 2015 Sep 23 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26395895?dopt=Abstract %R 10.1111/1471-0528.13607 %0 Journal Article %J PeerJ %D 2015 %T Brain-derived neurotrophic factor serum levels in genetically isolated populations: gender-specific association with anxiety disorder subtypes but not with anxiety levels or Val66Met polymorphism. %A Carlino, Davide %A Francavilla, Ruggiero %A Baj, Gabriele %A Kulak, Karolina %A d'Adamo, Pio %A Ulivi, Sheila %A Cappellani, Stefania %A Gasparini, Paolo %A Tongiorgi, Enrico %X

Anxiety disorders (ADs) are disabling chronic disorders with exaggerated behavioral response to threats. This study was aimed at testing the hypothesis that ADs may be associated with reduced neurotrophic activity, particularly of Brain-derived neurotrophic factor (BDNF), and determining possible effects of genetics on serum BDNF concentrations. In 672 adult subjects from six isolated villages in North-Eastern Italy with high inbreeding, we determined serum BDNF levels and identified subjects with different ADs subtypes such as Social and Specific Phobias (PHSOC, PHSP), Generalized Anxiety Disorder (GAD), and Panic Disorder (PAD). Analysis of the population as a whole or individual village showed no significant correlation between serum BDNF levels and Val66Met polymorphism and no association with anxiety levels. Stratification of subjects highlighted a significant decrease in serum BDNF in females with GAD and males with PHSP. This study indicates low heritability and absence of any impact of the Val66Met polymorphism on circulating concentrations of BDNF. Our results show that BDNF is not a general biomarker of anxiety but serum BDNF levels correlate in a gender-specific manner with ADs subtypes.

%B PeerJ %V 3 %P e1252 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26539329?dopt=Abstract %R 10.7717/peerj.1252 %0 Journal Article %J J Vasc Access %D 2015 %T Central venous access devices in pediatric malignancies: a position paper of Italian Association of Pediatric Hematology and Oncology. %A Crocoli, Alessandro %A Tornesello, Assunta %A Pittiruti, Mauro %A Barone, Angelica %A Muggeo, Paola %A Inserra, Alessandro %A Molinari, Angelo Claudio %A Grillenzoni, Valeria %A Durante, Viviana %A Cicalese, Maria Pia %A Zanazzo, Giulio Andrea %A Cesaro, Simone %X

INTRODUCTION: Treatment of pediatric malignancies is becoming progressively more complex, implying the adoption of multimodal therapies. A reliable, long-lasting venous access represents one of the critical requirements for the success of those treatments. Recent technical innovations-such as minimally invasive procedures for placement, new devices and novel materials-have rapidly spread for clinical use in adult patients, but are still not consistently used in the pediatric population.

METHODS: The Supportive Therapy Working Group of Italian Association of Hematology and Oncology (AIEOP) reviewed medical literature focusing on new aspects of central venous access devices (VADs) in pediatric patients affected by oncohematological diseases.

RESULTS: Appropriate recommendations for clinical use in these patients have been discussed and formulated.

CONCLUSIONS: The importance of the correct choice, management and use of VADs in pediatric oncohematological patients is a necessary prerequisite for an adequate standard of care, also considering the increased chances of cure and the longer life expectancy of those patients with modern therapies.

%B J Vasc Access %V 16 %P 130-6 %8 2015 Mar-Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25362978?dopt=Abstract %R 10.5301/jva.5000314 %0 Journal Article %J Arch Dis Child Fetal Neonatal Ed %D 2015 %T Cerebral oxygenation with different nasal continuous positive airway pressure levels in preterm infants. %A Bembich, Stefano %A Travan, Laura %A Cont, Gabriele %A Bua, Jenny %A Strajn, Tamara %A Demarini, Sergio %K Cerebrovascular Circulation %K Continuous Positive Airway Pressure %K Female %K Hemoglobins %K Humans %K Infant, Newborn %K Infant, Premature %K Intensive Care, Neonatal %K Male %K Nasal Cavity %K Oxygen %K Oxygen Consumption %K Oxyhemoglobins %K Spectroscopy, Near-Infrared %X

OBJECTIVES: This study evaluates the effect of varying nasal continuous positive airway pressure (NCPAP) level on cerebral blood flow (CBF) and oxygenation in preterm infants.

METHODS: Oxy-haemoglobin (HbO2) and total haemoglobin (HbTot), as CBF estimates, and the ratio between HbO2 and HbTot (HbO2/HbTot), as cerebral oxygenation estimate, were assessed by near-infrared spectroscopy in 26 stable preterm newborns at a postmenstrual age between 26 and 33 weeks. Baseline HbO2, HbTot and HbO2/HbTot values were initially collected with NCPAP at 5 cm H2O and then compared with values obtained with NCPAP levels at both 3 and 8 cm H2O.

RESULTS: Compared with 5 cm H2O, cerebral HbO2, HbTot and HbO2/HbTot remained unchanged both after increasing (to 8 cm H2O) and decreasing (to 3 cm H2O) the NCPAP level. This result was observed both in regional areas (24 sites) and in the overall monitored area (frontal and parietal cortex). Compared with 8 cm H2O, peripheral oxygen saturation significantly decreased at 3 cm H2O (p=0.021). Heart rate did not change.

CONCLUSIONS: No differences in CBF and cerebral oxygenation were observed with NCPAP levels in the range 3-8 cm H2O despite a decrease in peripheral oxygenation with 3 cm H2O.

%B Arch Dis Child Fetal Neonatal Ed %V 100 %P F165-8 %8 2015 Mar %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25336677?dopt=Abstract %R 10.1136/archdischild-2014-306356 %0 Journal Article %J Hum Genet %D 2015 %T Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire. %A Rusconi, Daniela %A Negri, Gloria %A Colapietro, Patrizia %A Picinelli, Chiara %A Milani, Donatella %A Spena, Silvia %A Magnani, Cinzia %A Silengo, Margherita Cirillo %A Sorasio, Lorena %A Curtisova, Vaclava %A Cavaliere, Maria Luigia %A Prontera, Paolo %A Stangoni, Gabriela %A Ferrero, Giovanni Battista %A Biamino, Elisa %A Fischetto, Rita %A Piccione, Maria %A Gasparini, Paolo %A Salviati, Leonardo %A Selicorni, Angelo %A Finelli, Palma %A Larizza, Lidia %A Gervasini, Cristina %K Adolescent %K Adult %K Base Sequence %K Child %K Child, Preschool %K Cohort Studies %K CREB-Binding Protein %K Female %K Humans %K Infant %K Infant, Newborn %K Male %K Middle Aged %K Point Mutation %K Rubinstein-Taybi Syndrome %K Sequence Deletion %X

Rubinstein-Taybi syndrome (RSTS) is a rare, clinically heterogeneous disorder characterized by cognitive impairment and several multiple congenital anomalies. The syndrome is caused by almost private point mutations in the CREBBP (~55% of cases) and EP300 (~8%) genes. The CREBBP mutational spectrum is variegated and characterized by point mutations (30-50 %) and deletions (~10%). The latter are diverse in size and genomic position and remove either the whole CREBBP gene and its flanking regions or only an intragenic portion. Here, we report 14 novel CREBBP deletions ranging from single exons to the whole gene and flanking regions which were identified by applying complementary cytomolecular techniques: fluorescence in situ hybridization, multiplex ligation-dependent probe amplification and array comparative genome hybridization, to a large cohort of RSTS patients. Deletions involving CREBBP account for 23% of our detected CREBBP mutations, making an important contribution to the mutational spectrum. Genotype-phenotype correlations revealed that patients with CREBBP deletions extending beyond this gene did not always have a more severe phenotype than patients harboring CREBBP point mutations, suggesting that neighboring genes play only a limited role in the etiopathogenesis of CREBBP-centerd contiguous gene syndrome. Accordingly, the extent of the deletion is not predictive of the severity of the clinical phenotype.

%B Hum Genet %V 134 %P 613-26 %8 2015 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/25805166?dopt=Abstract %R 10.1007/s00439-015-1542-9 %0 Journal Article %J Arch Argent Pediatr %D 2015 %T [Clinical and molecular study in a child with X-linked hypohidrotic ectodermal dysplasia]. %A Callea, Michele %A Yavuz, Izzet %A Clarich, Gabriella %A Cammarata-Scalisi, Francisco %X

Ectodermal dysplasia encompasses more than 200 clinically distinct entities, which affect at least two structures derived from the ectoderm, including the skin, hair, nails, teeth, sweat glands, and sebaceous glands. X-linked hypohidrotic ectodermal dysplasia is the most common type and is caused by mutation of the EDA gene that encodes Ectodysplasin-A. It occurs in less than 1 in 100 000 individuals and is clinically characterized by hypodontia, hypohidrosis, hypotrichosis, and eye dis orders. We present a child evaluated in a multidisciplinary manner with clinical and molecular diagnosis of X-linked hypohidrotic ectodermal dysplasia with type missense mutation c.1133C> T; p.T378M in EDA gene.

%B Arch Argent Pediatr %V 113 %P e341-4 %8 2015 Dec 1 %G spa %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/26593813?dopt=Abstract %0 Journal Article %J Birth Defects Res A Clin Mol Teratol %D 2015 %T Clinical aspects of Fanconi anemia individuals with the same mutation of FANCF identified by next generation sequencing. %A Nicchia, Elena %A Benedicenti, Francesco %A Rocco, Daniela De %A Greco, Chiara %A Bottega, Roberta %A Inzana, Francesca %A Faleschini, Michela %A Bonin, Serena %A Cappelli, Enrico %A Mogni, Massimo %A Stanzial, Franco %A Svahn, Johanna %A Dufour, Carlo %A Savoia, Anna %X

BACKGROUND: Fanconi anemia (FA) is a rare genetic disease characterized by congenital malformations, aplastic anemia and increased risk of developing malignancies. FA is genetically heterogeneous as it is caused by at least 17 different genes. Among these, FANCA, FANCC, and FANCG account for approximately 85% of the patients whereas the remaining genes are mutated in only a small percentage of cases. For this reason, the molecular diagnostic process is complex and not always extended to all the FA genes, preventing the characterization of individuals belonging to rare groups.

METHODS: The FA genes were analyzed using a next generation sequencing approach in two unrelated families.

RESULTS: The analysis identified the same, c.484_485del, homozygous mutation of FANCF in both families. A careful examination of three electively aborted fetuses in one family and one affected girl in the other indicated an association of the FANCF loss-of-function mutation with a severe phenotype characterized by multiple malformations.

CONCLUSION: The systematic use of next generation sequencing will allow the recognition of individuals from rare complementation groups, a better definition of their clinical phenotypes, and consequently, an appropriate genetic counseling. Birth Defects Research (Part A) 103:1003-1010, 2015. © 2015 Wiley Periodicals, Inc.

%B Birth Defects Res A Clin Mol Teratol %V 103 %P 1003-1010 %8 2015 Dec %G ENG %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/26033879?dopt=Abstract %R 10.1002/bdra.23388 %0 Journal Article %J Arch Dis Child %D 2015 %T Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study. %A Benelli, Elisa %A Carrato, Valentina %A Martelossi, Stefano %A Ronfani, Luca %A Not, Tarcisio %A Ventura, Alessandro %X

OBJECTIVE: To evaluate the consequences of the last European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) guidelines for the diagnosis of coeliac disease (CD) by means of a prospective study.

DESIGN: Prospective cohort study.

SETTING: Institute for Maternal and Child Health IRCCS Burlo Garofolo (Trieste, Italy).

PATIENTS: Children diagnosed with CD without a duodenal biopsy (group 1), following the last ESPGHAN and BSPGHAN guidelines, and children diagnosed with a duodenal biopsy, matched for sex, age and year of diagnosis (group 2), were prospectively enrolled over a 3-year period. All patients were put on a gluten-free diet (GFD) and were followed up for clinical conditions and laboratory testing at 6 months every year since diagnosis (median follow up: 1.9 years).

OUTCOME MEASURES: Resolution of symptoms, body mass index, laboratory testing (haemoglobin, anti-transglutaminase IgA), adherence to a GFD, quality of life, and supplementary post-diagnosis medical consultations.

RESULTS: 51 out of 468 (11%) patients were diagnosed without a duodenal biopsy (group 1; median age 2.1 years) and matched to 92 patients diagnosed with a biopsy (group 2; median age 2.4 years). At the end of follow-up the two groups were statistically comparable in terms of clinical and nutritional status, anti-transglutaminase IgA antibody titres, quality of life, adherence to a GFD, and number of supplementary medical consultations.

CONCLUSIONS: On the basis of this prospective study, diagnosis of CD can be reliably performed without a duodenal biopsy in approximately 11% of cases. At least during a medium-term follow-up, this approach has no negative consequences relating to clinical remission, adherence to diet, and quality of life of children with CD.

%B Arch Dis Child %8 2015 Nov 17 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26578746?dopt=Abstract %R 10.1136/archdischild-2015-309259 %0 Journal Article %J Lung Cancer %D 2015 %T Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma. %A Santarelli, Lory %A Staffolani, Sara %A Strafella, Elisabetta %A Nocchi, Linda %A Manzella, Nicola %A Grossi, Paola %A Bracci, Massimo %A Pignotti, Elettra %A Alleva, Renata %A Borghi, Battista %A Pompili, Cecilia %A Sabbatini, Armando %A Rubini, Corrado %A Zuccatosta, Lina %A Bichisecchi, Elisabetta %A Valentino, Matteo %A Horwood, Keith %A Comar, Manola %A Bovenzi, Massimo %A Dong, Lan-Feng %A Neuzil, Jiri %A Amati, Monica %A Tomasetti, Marco %X

OBJECTIVES: Malignant mesothelioma (MM) is a highly aggressive tumor with poor prognosis. A major challenge is the development and application of early and highly reliable diagnostic marker(s). Serum biomarkers, such as 'soluble mesothelin-related proteins' (SMRPs), is the most studied and frequently used in MM. However, the low sensitivity of SMRPs for early MM limits its value; therefore, additional biomarkers are required. In this study, two epigenetically regulated markers in MM (microRNA-126, miR-126, and methylated thrombomodulin promoter, Met-TM) were combined with SMRPs and evaluated as a potential strategy to detect MM at an early stage.

MATERIALS AND METHODS: A total of 188 subjects, including 45 MM patients, 99 asbestos-exposed subjects, and 44 healthy controls were prospectively enrolled, serum samples collected, and serum levels of SMRPs, miR-126 and Met-TM evaluated. Logistic regression analysis was performed to evaluate the diagnostic value of the three biomarkers. Using this approach, the performance of the '3-biomarker classifier' was tested by calculating the overall probability score of the MM and control samples, respectively, and the ROC curve was generated.

RESULTS AND CONCLUSION: The combination of the three biomarkers was the best predictor to differentiate MM patients from asbestos-exposed subjects and healthy controls. The accuracy and cancer specificity was confirmed in a second validation cohort and lung cancer population. We propose that the combination of the two epigenetic biomarkers with SMRPs as a diagnosis for early MM overcomes the limitations of using SMRPs alone.

%B Lung Cancer %8 2015 Sep 25 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26431916?dopt=Abstract %R 10.1016/j.lungcan.2015.09.021 %0 Journal Article %J Gene %D 2015 %T Comment to Santos et al., "hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype". %A Santos, Ruda de Luna Almeida %A Crovella, Sergio %A Celsi, Fulvio %K Fever %K Humans %K Immunoglobulin D %K Male %K Mutation, Missense %K Phosphotransferases (Alcohol Group Acceptor) %X

We performed molecular modeling analysis onto a novel mutation in the gene MVK, described by Santos et al., found to be causative of a severe form of Hyper-IgD/Mevalonate Kinase Deficiency. The mutation p.R277G, in our analysis, lowers the binding affinity for some enzyme's substrates. Interestingly, we found that p.R277G mutation inhibits binding of Isopentenyl Pyrophosphate (IPP) (binding free energy=0 kcal/mol), one of isoprenoids responsible for feedback-inhibition of MVK. IPP is known to be an activator of a specific class of T-cells and we can hypothesize that increased levels of this metabolite generate an aberrant immune system response. Indeed other experiments are needed to verify this hypothesis; however, this work demonstrates usefulness of molecular modeling in generating novel pathogenic hypothesis.

%B Gene %V 559 %P 99-101 %8 2015 Mar 15 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25620160?dopt=Abstract %R 10.1016/j.gene.2015.01.029 %0 Journal Article %J Tissue Antigens %D 2015 %T Comprehensive analysis of polymorphisms in the HLA-G 5' upstream regulatory and 3' untranslated regions in Brazilian patients with systemic lupus erythematosus. %A Catamo, E %A Addobbati, C %A Segat, L %A Sotero Fragoso, T %A Tavares Dantas, A %A de Ataíde Mariz, H %A Ferreira da Rocha Junior, L %A Branco PintoDuarte, A L %A Coelho, A V C %A de Moura, R R %A Polesello, V %A Crovella, S %A Sandrin Garcia, P %X

This study aims to comprehensively analyze human leucocyte antigen (HLA)-G polymorphisms association with susceptibility to systemic lupus erythematosus (SLE) development and clinical manifestations. The HLA-G 5' upstream regulatory region (URR), 3' untranslated region (UTR) and a cytosine deletion at exon 3 (ΔC, HLA-G*0105N allele) were analyzed in 114 SLE patients and 128 healthy controls from North East Brazil. The +3003T>C (rs1707) C allele and the HG010101c extended HLA-G allele were significantly more frequent in SLE patients than healthy controls (+3003C allele frequency: 12% in SLE patients vs 6% in controls; odds ratio (OR), 2.10, 95% confidence interval (CI), 1.06-4.28, P = 0.026; HG010101c frequency: 11.8% in SLE patients and 6.3% in controls; OR, 2.14, 95% CI, 1.01-4.51, P = 0.046) and were associated with susceptibility for disease development. Other polymorphisms were associated with different clinical manifestations. Although HLA-G role in SLE disease is far from being elucidated yet, our association study results along with a systematic review and meta-analysis suggest that HLA-G might be able to slightly modulate the complex SLE phenotype (pooled OR, 1.14, 95% CI, 1.02-1.27, P = 0.021).

%B Tissue Antigens %V 85 %P 458-65 %8 2015 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/25762019?dopt=Abstract %R 10.1111/tan.12545 %0 Journal Article %J J Med Chem %D 2015 %T Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity. %A Trapella, Claudio %A Voltan, Rebecca %A Melloni, Elisabetta %A Tisato, Veronica %A Celeghini, Claudio %A Bianco, Sara %A Fantinati, Anna %A Salvadori, Severo %A Guerrini, Remo %A Secchiero, Paola %A Zauli, Giorgio %X

The mitochondrial kinase inhibitor dichloroacetate (DCA) has recently received attention in oncology due to its ability to target glycolysis. However, DCA molecule exhibits poor bioavailability and cellular uptake with limited ability to reach its target mitochondria. To overcome these biases, we have synthesized novel DCA-loaded compounds. The selection of the most promising therapeutic molecule was evaluated by combining in vitro assays, to test the antitumoral potential on leukemic cells, and a preliminary characterization of the molecule stability in vivo, in mice. Among the newly synthesized compounds, we have selected the multiple DCA-loaded compound 10, characterized by a tertiary amine scaffold, because it exhibited enhanced (>30-fold) in vitro antitumor activity with respect to DCA and increased in vivo stability. On the basis of these results, we believe that compound 10 should be considered for further preclinical evaluations for the treatment of cancers and/or other diseases characterized by altered metabolic origin.

%B J Med Chem %8 2015 Dec 23 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26653539?dopt=Abstract %R 10.1021/acs.jmedchem.5b01165 %0 Journal Article %J BMC Pediatr %D 2015 %T The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency. %A Girardelli, Martina %A Arrigo, Serena %A Barabino, Arrigo %A Loganes, Claudia %A Morreale, Giuseppe %A Crovella, Sergio %A Tommasini, Alberto %A Bianco, Anna Monica %X

BACKGROUND: Aggressive course and resistance to treatments usually characterize very early onset inflammatory bowel disease (VEO-IBD). Some VEO-IBD cases are due to monogenic immune defects and can benefit from hematopoietic stem cell transplantation (HSCT).

CASE PRESENTATION: We describe a Caucasian male baby who presented in the first months of life macrophage activation syndrome, followed by intractable colitis, recurrent episodes of fever and mild splenomegaly. After several immunological, genetic and clinical investigations, subsequently a therapeutic attempt with colectomy, analysis of VEO-IBD-associated genes, revealed a causative mutation in XIAP. The genetic diagnosis of a primary immune deficiency allowed curing the boy with hematopoietic stem cell transplantation.

CONCLUSION: Our report, together with novel findings from recent literature, should contribute to increase awareness of monogenic immune defects as a cause of VEO-IBD. Comprehensive genetic analysis can allow a prompt diagnosis, resulting in the choice of effective treatments and sparing useless and damaging procedures.

%B BMC Pediatr %V 15 %P 208 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/26671016?dopt=Abstract %R 10.1186/s12887-015-0522-5 %0 Journal Article %J Seizure %D 2015 %T Diagnostic criteria currently proposed for "ictal epileptic headache": Perspectives on strengths, weaknesses and pitfalls. %A Parisi, Pasquale %A Verrotti, Alberto %A Costa, Paola %A Striano, Pasquale %A Zanus, Caterina %A Carrozzi, Marco %A Raucci, Umberto %A Villa, Maria Pia %A Belcastro, Vincenzo %X

PURPOSE: When we published the diagnostic criteria for "ictal epileptic headache" in 2012, we deliberately and consciously chose to adopt restrictive criteria that probably underestimate the phenomenon, rather than spread panic among patients and physicians who are reluctant to accept this entity.

METHODS: Here we discuss four intriguing clinical cases to highlight why we believe, to this day, that it is necessary to follow these restrictive diagnostic criteria.

CONCLUSIONS: EEG is not recommended as a routine examination for children diagnosed with headache, but it is mandatory and must be carried out promptly in cases of prolonged headache that does not respond to antimigraine drugs, if epilepsy is suspected or has been diagnosed previously. This is not a marginal or irrelevant question because possible isolated, non-motor, ictal manifestations should be taken into account before declaring that an epileptic patient is "seizure free" so as to ensure that any decision taken to suspend anticonvulsant therapy is safe.

%B Seizure %V 31 %P 56-63 %8 2015 Sep %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26362378?dopt=Abstract %R 10.1016/j.seizure.2015.07.005 %0 Journal Article %J Sci Rep %D 2015 %T Differential protein folding and chemical changes in lung tissues exposed to asbestos or particulates. %A Pascolo, Lorella %A Borelli, Violetta %A Canzonieri, Vincenzo %A Gianoncelli, Alessandra %A Birarda, Giovanni %A Bedolla, Diana E %A Salomè, Murielle %A Vaccari, Lisa %A Calligaro, Carla %A Cotte, Marine %A Hesse, Bernhard %A Luisi, Fernando %A Zabucchi, Giuliano %A Melato, Mauro %A Rizzardi, Clara %X

Environmental and occupational inhalants may induce a large number of pulmonary diseases, with asbestos exposure being the most risky. The mechanisms are clearly related to chemical composition and physical and surface properties of materials. A combination of X-ray fluorescence (μXRF) and Fourier Transform InfraRed (μFTIR) microscopy was used to chemically characterize and compare asbestos bodies versus environmental particulates (anthracosis) in lung tissues from asbestos exposed and control patients. μXRF analyses revealed heterogeneously aggregated particles in the anthracotic structures, containing mainly Si, K, Al and Fe. Both asbestos and particulates alter lung iron homeostasis, with a more marked effect in asbestos exposure. μFTIR analyses revealed abundant proteins on asbestos bodies but not on anthracotic particles. Most importantly, the analyses demonstrated that the asbestos coating proteins contain high levels of β-sheet structures. The occurrence of conformational changes in the proteic component of the asbestos coating provides new insights into long-term asbestos effects.

%B Sci Rep %V 5 %P 12129 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26159651?dopt=Abstract %R 10.1038/srep12129 %0 Journal Article %J Nature %D 2015 %T Directional dominance on stature and cognition in diverse human populations. %A Joshi, Peter K %A Esko, Tõnu %A Mattsson, Hannele %A Eklund, Niina %A Gandin, Ilaria %A Nutile, Teresa %A Jackson, Anne U %A Schurmann, Claudia %A Smith, Albert V %A Zhang, Weihua %A Okada, Yukinori %A Stančáková, Alena %A Faul, Jessica D %A Zhao, Wei %A Bartz, Traci M %A Concas, Maria Pina %A Franceschini, Nora %A Enroth, Stefan %A Vitart, Veronique %A Trompet, Stella %A Guo, Xiuqing %A Chasman, Daniel I %A O'Connel, Jeffrey R %A Corre, Tanguy %A Nongmaithem, Suraj S %A Chen, Yuning %A Mangino, Massimo %A Ruggiero, Daniela %A Traglia, Michela %A Farmaki, Aliki-Eleni %A Kacprowski, Tim %A Bjonnes, Andrew %A van der Spek, Ashley %A Wu, Ying %A Giri, Anil K %A Yanek, Lisa R %A Wang, Lihua %A Hofer, Edith %A Rietveld, Cornelius A %A McLeod, Olga %A Cornelis, Marilyn C %A Pattaro, Cristian %A Verweij, Niek %A Baumbach, Clemens %A Abdellaoui, Abdel %A Warren, Helen R %A Vuckovic, Dragana %A Mei, Hao %A Bouchard, Claude %A Perry, John R B %A Cappellani, Stefania %A Mirza, Saira S %A Benton, Miles C %A Broeckel, Ulrich %A Medland, Sarah E %A Lind, Penelope A %A Malerba, Giovanni %A Drong, Alexander %A Yengo, Loic %A Bielak, Lawrence F %A Zhi, Degui %A van der Most, Peter J %A Shriner, Daniel %A Mägi, Reedik %A Hemani, Gibran %A Karaderi, Tugce %A Wang, Zhaoming %A Liu, Tian %A Demuth, Ilja %A Zhao, Jing Hua %A Meng, Weihua %A Lataniotis, Lazaros %A van der Laan, Sander W %A Bradfield, Jonathan P %A Wood, Andrew R %A Bonnefond, Amelie %A Ahluwalia, Tarunveer S %A Hall, Leanne M %A Salvi, Erika %A Yazar, Seyhan %A Carstensen, Lisbeth %A de Haan, Hugoline G %A Abney, Mark %A Afzal, Uzma %A Allison, Matthew A %A Amin, Najaf %A Asselbergs, Folkert W %A Bakker, Stephan J L %A Barr, R Graham %A Baumeister, Sebastian E %A Benjamin, Daniel J %A Bergmann, Sven %A Boerwinkle, Eric %A Bottinger, Erwin P %A Campbell, Archie %A Chakravarti, Aravinda %A Chan, Yingleong %A Chanock, Stephen J %A Chen, Constance %A Chen, Y-D Ida %A Collins, Francis S %A Connell, John %A Correa, Adolfo %A Cupples, L Adrienne %A Smith, George Davey %A Davies, Gail %A Dörr, Marcus %A Ehret, Georg %A Ellis, Stephen B %A Feenstra, Bjarke %A Feitosa, Mary F %A Ford, Ian %A Fox, Caroline S %A Frayling, Timothy M %A Friedrich, Nele %A Geller, Frank %A Scotland, Generation %A Gillham-Nasenya, Irina %A Gottesman, Omri %A Graff, Misa %A Grodstein, Francine %A Gu, Charles %A Haley, Chris %A Hammond, Christopher J %A Harris, Sarah E %A Harris, Tamara B %A Hastie, Nicholas D %A Heard-Costa, Nancy L %A Heikkilä, Kauko %A Hocking, Lynne J %A Homuth, Georg %A Hottenga, Jouke-Jan %A Huang, Jinyan %A Huffman, Jennifer E %A Hysi, Pirro G %A Ikram, M Arfan %A Ingelsson, Erik %A Joensuu, Anni %A Johansson, Åsa %A Jousilahti, Pekka %A Jukema, J Wouter %A Kähönen, Mika %A Kamatani, Yoichiro %A Kanoni, Stavroula %A Kerr, Shona M %A Khan, Nazir M %A Koellinger, Philipp %A Koistinen, Heikki A %A Kooner, Manraj K %A Kubo, Michiaki %A Kuusisto, Johanna %A Lahti, Jari %A Launer, Lenore J %A Lea, Rodney A %A Lehne, Benjamin %A Lehtimäki, Terho %A Liewald, David C M %A Lind, Lars %A Loh, Marie %A Lokki, Marja-Liisa %A London, Stephanie J %A Loomis, Stephanie J %A Loukola, Anu %A Lu, Yingchang %A Lumley, Thomas %A Lundqvist, Annamari %A Männistö, Satu %A Marques-Vidal, Pedro %A Masciullo, Corrado %A Matchan, Angela %A Mathias, Rasika A %A Matsuda, Koichi %A Meigs, James B %A Meisinger, Christa %A Meitinger, Thomas %A Menni, Cristina %A Mentch, Frank D %A Mihailov, Evelin %A Milani, Lili %A Montasser, May E %A Montgomery, Grant W %A Morrison, Alanna %A Myers, Richard H %A Nadukuru, Rajiv %A Navarro, Pau %A Nelis, Mari %A Nieminen, Markku S %A Nolte, Ilja M %A O'Connor, George T %A Ogunniyi, Adesola %A Padmanabhan, Sandosh %A Palmas, Walter R %A Pankow, James S %A Patarcic, Inga %A Pavani, Francesca %A Peyser, Patricia A %A Pietilainen, Kirsi %A Poulter, Neil %A Prokopenko, Inga %A Ralhan, Sarju %A Redmond, Paul %A Rich, Stephen S %A Rissanen, Harri %A Robino, Antonietta %A Rose, Lynda M %A Rose, Richard %A Sala, Cinzia %A Salako, Babatunde %A Salomaa, Veikko %A Sarin, Antti-Pekka %A Saxena, Richa %A Schmidt, Helena %A Scott, Laura J %A Scott, William R %A Sennblad, Bengt %A Seshadri, Sudha %A Sever, Peter %A Shrestha, Smeeta %A Smith, Blair H %A Smith, Jennifer A %A Soranzo, Nicole %A Sotoodehnia, Nona %A Southam, Lorraine %A Stanton, Alice V %A Stathopoulou, Maria G %A Strauch, Konstantin %A Strawbridge, Rona J %A Suderman, Matthew J %A Tandon, Nikhil %A Tang, Sian-Tsun %A Taylor, Kent D %A Tayo, Bamidele O %A Töglhofer, Anna Maria %A Tomaszewski, Maciej %A Tšernikova, Natalia %A Tuomilehto, Jaakko %A Uitterlinden, André G %A Vaidya, Dhananjay %A van Hylckama Vlieg, Astrid %A van Setten, Jessica %A Vasankari, Tuula %A Vedantam, Sailaja %A Vlachopoulou, Efthymia %A Vozzi, Diego %A Vuoksimaa, Eero %A Waldenberger, Melanie %A Ware, Erin B %A Wentworth-Shields, William %A Whitfield, John B %A Wild, Sarah %A Willemsen, Gonneke %A Yajnik, Chittaranjan S %A Yao, Jie %A Zaza, Gianluigi %A Zhu, Xiaofeng %A Salem, Rany M %A Melbye, Mads %A Bisgaard, Hans %A Samani, Nilesh J %A Cusi, Daniele %A Mackey, David A %A Cooper, Richard S %A Froguel, Philippe %A Pasterkamp, Gerard %A Grant, Struan F A %A Hakonarson, Hakon %A Ferrucci, Luigi %A Scott, Robert A %A Morris, Andrew D %A Palmer, Colin N A %A Dedoussis, George %A Deloukas, Panos %A Bertram, Lars %A Lindenberger, Ulman %A Berndt, Sonja I %A Lindgren, Cecilia M %A Timpson, Nicholas J %A Tönjes, Anke %A Munroe, Patricia B %A Sørensen, Thorkild I A %A Rotimi, Charles N %A Arnett, Donna K %A Oldehinkel, Albertine J %A Kardia, Sharon L R %A Balkau, Beverley %A Gambaro, Giovanni %A Morris, Andrew P %A Eriksson, Johan G %A Wright, Margie J %A Martin, Nicholas G %A Hunt, Steven C %A Starr, John M %A Deary, Ian J %A Griffiths, Lyn R %A Tiemeier, Henning %A Pirastu, Nicola %A Kaprio, Jaakko %A Wareham, Nicholas J %A Pérusse, Louis %A Wilson, James G %A Girotto, Giorgia %A Caulfield, Mark J %A Raitakari, Olli %A Boomsma, Dorret I %A Gieger, Christian %A van der Harst, Pim %A Hicks, Andrew A %A Kraft, Peter %A Sinisalo, Juha %A Knekt, Paul %A Johannesson, Magnus %A Magnusson, Patrik K E %A Hamsten, Anders %A Schmidt, Reinhold %A Borecki, Ingrid B %A Vartiainen, Erkki %A Becker, Diane M %A Bharadwaj, Dwaipayan %A Mohlke, Karen L %A Boehnke, Michael %A van Duijn, Cornelia M %A Sanghera, Dharambir K %A Teumer, Alexander %A Zeggini, Eleftheria %A Metspalu, Andres %A Gasparini, Paolo %A Ulivi, Sheila %A Ober, Carole %A Toniolo, Daniela %A Rudan, Igor %A Porteous, David J %A Ciullo, Marina %A Spector, Tim D %A Hayward, Caroline %A Dupuis, Josée %A Loos, Ruth J F %A Wright, Alan F %A Chandak, Giriraj R %A Vollenweider, Peter %A Shuldiner, Alan R %A Ridker, Paul M %A Rotter, Jerome I %A Sattar, Naveed %A Gyllensten, Ulf %A North, Kari E %A Pirastu, Mario %A Psaty, Bruce M %A Weir, David R %A Laakso, Markku %A Gudnason, Vilmundur %A Takahashi, Atsushi %A Chambers, John C %A Kooner, Jaspal S %A Strachan, David P %A Campbell, Harry %A Hirschhorn, Joel N %A Perola, Markus %A Polasek, Ozren %A Wilson, James F %K Biological Evolution %K Blood Pressure %K Body Height %K Cholesterol, LDL %K Cognition %K Cohort Studies %K Educational Status %K Female %K Forced Expiratory Volume %K Genome, Human %K Homozygote %K Humans %K Lung Volume Measurements %K Male %K Phenotype %X

Homozygosity has long been associated with rare, often devastating, Mendelian disorders, and Darwin was one of the first to recognize that inbreeding reduces evolutionary fitness. However, the effect of the more distant parental relatedness that is common in modern human populations is less well understood. Genomic data now allow us to investigate the effects of homozygosity on traits of public health importance by observing contiguous homozygous segments (runs of homozygosity), which are inferred to be homozygous along their complete length. Given the low levels of genome-wide homozygosity prevalent in most human populations, information is required on very large numbers of people to provide sufficient power. Here we use runs of homozygosity to study 16 health-related quantitative traits in 354,224 individuals from 102 cohorts, and find statistically significant associations between summed runs of homozygosity and four complex traits: height, forced expiratory lung volume in one second, general cognitive ability and educational attainment (P < 1 × 10(-300), 2.1 × 10(-6), 2.5 × 10(-10) and 1.8 × 10(-10), respectively). In each case, increased homozygosity was associated with decreased trait value, equivalent to the offspring of first cousins being 1.2 cm shorter and having 10 months' less education. Similar effect sizes were found across four continental groups and populations with different degrees of genome-wide homozygosity, providing evidence that homozygosity, rather than confounding, directly contributes to phenotypic variance. Contrary to earlier reports in substantially smaller samples, no evidence was seen of an influence of genome-wide homozygosity on blood pressure and low density lipoprotein cholesterol, or ten other cardio-metabolic traits. Since directional dominance is predicted for traits under directional evolutionary selection, this study provides evidence that increased stature and cognitive function have been positively selected in human evolution, whereas many important risk factors for late-onset complex diseases may not have been.

%B Nature %V 523 %P 459-62 %8 2015 Jul 23 %G eng %N 7561 %1 http://www.ncbi.nlm.nih.gov/pubmed/26131930?dopt=Abstract %R 10.1038/nature14618 %0 Journal Article %J Genet Mol Res %D 2015 %T Distribution of forensic marker allelic frequencies in Pernambuco, Northestern Brazil. %A Santos, S M %A Souza, C A %A Rabelo, K C N %A Souza, P R E %A Moura, R R %A Oliveira, T C %A Crovella, S %X

Pernambuco is one of the 27 federal units of Brazil, ranking seventh in the number of inhabitants. We examined the allele frequencies of 13 short tandem repeat loci (CFS1PO, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, D21S11, FGA, TH01, vWA, and TPOX), the minimum recommended by the Federal Bureau of Investigation and commonly used in forensic genetics laboratories in Brazil, in a sample of 609 unrelated individuals from all geographic regions of Pernambuco. The allele frequencies ranged from 5 to 47.2%. No significant differences for any loci analyzed were observed compared with other publications in other various regions of Brazil. Most of the markers observed were in Hardy-Weinberg equilibrium. The occurrence of the allele 47.2 (locus FGA) and alleles 35.1 and 39 (locus D21S11), also described in a single study of the Brazilian population, was observed. The other forensic parameters analyzed (matching probability, power of discrimination, polymorphic information content, paternity exclusion, complement factor I, observed heterozygosity, expected heterozygosity) indicated that the studied markers are very informative for human forensic identification purposes in the Pernambuco population.

%B Genet Mol Res %V 14 %P 4303-10 %8 2015 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25966202?dopt=Abstract %R 10.4238/2015.April.30.2 %0 Journal Article %J J Pediatr Hematol Oncol %D 2015 %T Dysplastic bone marrow changes during maintenance therapy for acute leukemia. %A Chinello, Matteo %A Naviglio, Samuele %A Shardlow, Alison %A Severino, Alessandro %A Ventura, Alessandro %A Locasciulli, Anna %K 6-Mercaptopurine %K Antineoplastic Combined Chemotherapy Protocols %K Bone Marrow Diseases %K Child %K Disease Management %K Female %K Follow-Up Studies %K Humans %K Methotrexate %K Precursor B-Cell Lymphoblastic Leukemia-Lymphoma %K Prognosis %X

We describe the case of an 8-year-old girl with common precursor B-cell acute lymphoblastic leukemia who presented with severe pancytopenia during maintenance therapy with methotrexate and 6-mercaptopurine. The bone marrow smear showed moderate hypocellularity and trilinear dysplastic changes consistent with a diagnosis of drug toxicity, with no evidence of lymphoblasts. Flow cytometric immunophenotyping was negative for leukemic cells. Blood cell counts normalized after treatment with folinic acid. Maintenance therapy was gradually restarted and she remained well at follow-up visits. Myelotoxicity from methotrexate and 6-mercaptopurine may represent an unpredictable incident during an otherwise uneventful maintenance therapy, and may occur independently of other organ toxicities.

%B J Pediatr Hematol Oncol %V 37 %P 156-7 %8 2015 Mar %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25493456?dopt=Abstract %R 10.1097/MPH.0000000000000295 %0 Journal Article %J Inflamm Bowel Dis %D 2015 %T Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial. %A Lazzerini, Marzia %A Martelossi, Stefano %A Magazzù, Giuseppe %A Pellegrino, Salvatore %A Lucanto, Maria Cristina %A Barabino, Arrigo %A Calvi, Angela %A Arrigo, Serena %A Lionetti, Paolo %A Lorusso, Monica %A Mangiantini, Francesca %A Fontana, Massimo %A Zuin, Giovanna %A Palla, Gabriella %A Maggiore, Giuseppe %A Bramuzzo, Matteo %A Pellegrin, Maria Chiara %A Maschio, Massimo %A Villanacci, Vincenzo %A Manenti, Stefania %A Decorti, Giuliana %A De Iudicibus, Sara %A Paparazzo, Rossella %A Montico, Marcella %A Ventura, Alessandro %X

BACKGROUND: In a randomized controlled trial, thalidomide has shown to be effective in refractory Crohn's disease in children. This pilot study aimed at evaluating thalidomide in refractory pediatric ulcerative colitis (UC).

METHODS: Double-blind, placebo-controlled randomized clinical trial on thalidomide 1.5 to 2.5 mg/kg/day in children with active UC despite multiple immunosuppressive treatments. In an open-label extension, nonresponders to placebo received thalidomide for an additional 8 weeks; all responders were followed up for a minimum of 52 weeks.

RESULTS: Twenty-six children with refractory UC were randomized to thalidomide or placebo. Clinical remission at week 8 was achieved by significantly more children treated with thalidomide {10/12 (83.3%) versus 2/11 (18.8%); risk ratio, 4.5 (95% confidence interval [CI], 1.2-16.4); P = 0.005; number needed to treat, 1.5}. Of the nonresponders to placebo who were switched to thalidomide, 8 of 11 (72.7%) subsequently reached remission at week 8 (risk ratio, 4.0 [95% CI, 1.1-14.7]; number needed to treat, 2.45; P = 0.01). Clinical remission in the thalidomide group was 135.0 weeks (95% CI, 32-238), compared with 8.0 weeks (95% CI, 2.4-13.6) in the placebo group (P < 0.0001). Cumulative incidence of severe adverse events was 3.1 per 1000 patient-weeks. Peripheral neuropathy and amenorrhea were the most frequent adverse events.

CONCLUSIONS: In this pilot randomized controlled trial on cases of UC refractory to immunosuppressive therapy, thalidomide compared with placebo resulted in improved clinical remission at 8 weeks of treatment and in longer term maintenance of remission. These findings require replication in larger clinical studies evaluating both thalidomide efficacy and safety.

%B Inflamm Bowel Dis %V 21 %P 1739-49 %8 2015 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/26185909?dopt=Abstract %R 10.1097/MIB.0000000000000437 %0 Journal Article %J Clin Res Hepatol Gastroenterol %D 2015 %T Efficacy of intravenous immunoglobulin therapy in giant cell hepatitis with autoimmune hemolytic anemia: A multicenter study. %A Marsalli, Giulia %A Nastasio, Silvia %A Sciveres, Marco %A Calvo, Pier Luigi %A Ramenghi, Ugo %A Gatti, Simona %A Albano, Veronica %A Lega, Sara %A Ventura, Alessandro %A Maggiore, Giuseppe %X

BACKGROUND AND OBJECTIVE: Giant cell hepatitis with autoimmune hemolytic anemia (GCH-AHA) is a rare disease of infancy, of possible autoimmune mechanism with poor prognosis due to its scarce response to immunosuppressive drugs. The aim of this retrospective multicenter study was to evaluate the efficacy and safety of intravenous immunoglobulin (IVIg) treatment in inducing and maintaining remission of the liver disease, in patients with GCH-AHA.

METHODS: Seven children with GCH-AHA, four newly diagnosed, and three in relapse, being treated with different therapies, received one to three IVIg infusions (0.5 to 2g/kg) in association with other immunosuppressive drugs. Subsequently five of them received monthly sequential IVIg infusions (mean 13.4, range 7-24).

RESULTS: IVIg infusions as first-line therapy associated with prednisone and other immunosuppressive drugs significantly (P=0.04) reduced the aminotransferase activity in all patients and normalized prothombin activity in the only patient with severe liver dysfunction. Sequential monthly IVIg infusions determined a steroid-sparing effect and allowed a complete or partial remission in all patients, although with temporary efficacy, since relapse of the hemolytic anemia and/or of liver disease occurred in all patients. IVIg infusions were associated with mild side effects in two patients.

CONCLUSIONS: IVIg infusion can be safely and effectively administered in patients with severe GCH-AHA at diagnosis, or in case of relapse, in association with other immunosuppressive drugs. Repeated IVIg infusions may help maintain remission, however, due to their temporary efficacy, they should not be routinely employed.

%B Clin Res Hepatol Gastroenterol %8 2015 Jun 29 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26138133?dopt=Abstract %R 10.1016/j.clinre.2015.03.009 %0 Journal Article %J World J Gastroenterol %D 2015 %T Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease. %A Taddio, Andrea %A Tommasini, Alberto %A Valencic, Erica %A Biagi, Ettore %A Decorti, Giuliana %A De Iudicibus, Sara %A Cuzzoni, Eva %A Gaipa, Giuseppe %A Badolato, Raffaela %A Prandini, Alberto %A Biondi, Andrea %A Ventura, Alessandro %X

Mesenchymal stem cells (MSC) are cells of stromal origin which exhibit unlimited self-renewal capacity and pluripotency in vitro. It has recently been observed that MSC may also exert a profound immunosuppressive and anti-inflammatory effect both in vitro and in vivo with consequent potential use in autoimmune disorders. We present the case of a patient suffering from childhood-onset, multidrug resistant and steroid-dependent Crohn's disease who underwent systemic infusions of MSC, which led to a temporary reduction in CCR4, CCR7 and CXCR4 expression by T-cells, and a temporary decrease in switched memory B-cells, In addition, following MSC infusion, lower doses of steroids were needed to inhibit proliferation of the patient's peripheral blood mononuclear cells. Despite these changes, no significant clinical benefit was observed, and the patient required rescue therapy with infliximab and subsequent autologous hematopoietic stem cell transplantation. The results of biological and in vitro observations after MSC use and the clinical effects of infusion are discussed, and a brief description is provided of previous data on MSC-based therapy in autoimmune disorders.

%B World J Gastroenterol %V 21 %P 4379-84 %8 2015 Apr 14 %G eng %N 14 %1 http://www.ncbi.nlm.nih.gov/pubmed/25892890?dopt=Abstract %R 10.3748/wjg.v21.i14.4379 %0 Journal Article %J Ann Hum Genet %D 2015 %T Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and Rheumatoid Arthritis. %A Addobbati, Catarina %A De Azevêdo Silva, Jaqueline %A A C Tavares, Nathália %A Monticielo, Odirlei %A M Xavier, Ricardo %A T Brenol, João Carlos %A Crovella, Sergio %A B Chies, José Artur %A Sandrin-Garcia, Paula %X

Systemic lupus erythemathosus (SLE) and rheumatoid arthritis (RA) are complex autoimmune diseases characterized by an immune balance breakdown and by chronic inflammation. Several findings link SLE and RA development with the complement system and ficolin components have emerged as candidates for disease development. Since genetic association studies with ficolin genes in SLE and RA have not yet been conducted in a Brazilian population, the aim of this study was to determine whether polymorphisms of ficolin-1(FCN1) and ficolin-2 (FCN2) genes are associated with SLE and RA susceptibility as well as disease manifestation. Two SNPs within FCN1 (rs2989727 and 1071583) and three in FCN2 (rs17514136, rs3124954, and rs7851696) were studied in 208 SLE and184 RA patients as well as 264 healthy individuals in a Southeast Brazilian population. For SLE patients, the FCN2 rs17514136 SNP was associated with a more severe disease (SLICC) (p = 0.0067). Furthermore, an association between the occurrence of nephritis and the T/T genotype for FCN2 rs3124954 SNP (p = 0.047, OR = 3.17, 95%CI = 1.34-7.5) was observed. No association was observed between the studied polymorphisms and RA development. Thus, our data support involvement of the FCN2 gene in the SLE phenotype.

%B Ann Hum Genet %8 2015 Oct 14 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26464189?dopt=Abstract %R 10.1111/ahg.12129 %0 Journal Article %J World J Pediatr %D 2015 %T Genetic analysis of Italian patients with congenital tufting enteropathy. %A d'Apolito, Maria %A Pisanelli, Daniela %A Faletra, Flavio %A Giardino, Ida %A Gigante, Maddalena %A Pettoello-Mantovani, Massimo %A Goulet, Olivier %A Gasparini, Paolo %A Campanozzi, Angelo %X

BACKGROUND: Congenital tufting enteropathy (CTE), an inherited autosomal recessive rare disease, is a severe diarrhea of infancy which is clinically characterized by absence of inflammation and presence of intestinal villous atrophy. Mutations in the EpCAM gene were identified to cause CTE. Recent cases of syndromic tufting enteropathy harboring the SPINT2 (19q13.2) mutation were described.

METHODS: Four CTE Italian patients were clinically and immunohistochemically characterized. Direct DNA sequencing of EpCAM and SPINT2 genes was performed.

RESULTS: All patients were of Italian origin. Three different mutations were detected (p.Asp219Metfs*15, Tyr186Phefs*6 and p.Ile146Asn) in the EpCAM gene; one of them is novel (p.Ile146Asn). Two patients (P1 and P2) showed compound heterozygosity revealing two mutations in separate alleles. A third patient (P3) was heterozygous for only one novel EpCAM missense mutation (p.Ile146Asn). In a syndromic patient (P4), no deleterious EpCAM mutation was found. Additional SPINT2 mutational analysis was performed. P4 showed a homozygous SPINT2 mutation (p.Y163C). No SPINT2 mutation was found in P3. CLDN7 was also evaluated as a candidate gene by mutational screening in P3 but no mutation was identified.

CONCLUSIONS: This study presented a molecular characterization of CTE Italian patients, and identified three mutations in the EpCAM gene and one in the SPINT2 gene. One of EpCAM mutations was novel, therefore increasing the mutational spectrum of allelic variants of the EpCAM gene. Molecular analysis of the SPINT2 gene also allowed us to identify a SPINT2 substitution mutation (c.488A>G) recently found to be associated with syndromic CTE subjects.

%B World J Pediatr %8 2015 Dec 18 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26684320?dopt=Abstract %R 10.1007/s12519-015-0070-y %0 Journal Article %J Eur J Hum Genet %D 2015 %T Genetic evidence for an origin of the Armenians from Bronze Age mixing of multiple populations. %A Haber, Marc %A Mezzavilla, Massimo %A Xue, Yali %A Comas, David %A Gasparini, Paolo %A Zalloua, Pierre %A Tyler-Smith, Chris %X

The Armenians are a culturally isolated population who historically inhabited a region in the Near East bounded by the Mediterranean and Black seas and the Caucasus, but remain under-represented in genetic studies and have a complex history including a major geographic displacement during World War I. Here, we analyse genome-wide variation in 173 Armenians and compare them with 78 other worldwide populations. We find that Armenians form a distinctive cluster linking the Near East, Europe, and the Caucasus. We show that Armenian diversity can be explained by several mixtures of Eurasian populations that occurred between ~3000 and ~2000 bce, a period characterized by major population migrations after the domestication of the horse, appearance of chariots, and the rise of advanced civilizations in the Near East. However, genetic signals of population mixture cease after ~1200 bce when Bronze Age civilizations in the Eastern Mediterranean world suddenly and violently collapsed. Armenians have since remained isolated and genetic structure within the population developed ~500 years ago when Armenia was divided between the Ottomans and the Safavid Empire in Iran. Finally, we show that Armenians have higher genetic affinity to Neolithic Europeans than other present-day Near Easterners, and that 29% of Armenian ancestry may originate from an ancestral population that is best represented by Neolithic Europeans.European Journal of Human Genetics advance online publication, 21 October 2015; doi:10.1038/ejhg.2015.206.

%B Eur J Hum Genet %8 2015 Oct 21 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26486470?dopt=Abstract %R 10.1038/ejhg.2015.206 %0 Journal Article %J Pediatr Rheumatol Online J %D 2015 %T Genetic profiling of autoinflammatory disorders in patients with periodic fever: a prospective study. %A De Pieri, Carlo %A Vuch, Josef %A De Martino, Eleonora %A Bianco, Anna M %A Ronfani, Luca %A Athanasakis, Emmanouil %A Bortot, Barbara %A Crovella, Sergio %A Taddio, Andrea %A Severini, Giovanni M %A Tommasini, Alberto %K Adolescent %K Carrier Proteins %K Child %K Cryopyrin-Associated Periodic Syndromes %K Cytoskeletal Proteins %K Familial Mediterranean Fever %K Female %K Fever %K Gene Expression Profiling %K Genotype %K Hereditary Autoinflammatory Diseases %K Humans %K Intracellular Signaling Peptides and Proteins %K Logistic Models %K Male %K Mutation %K Phosphotransferases (Alcohol Group Acceptor) %K Prospective Studies %K Receptors, Tumor Necrosis Factor, Type I %K Syndrome %X

BACKGROUND: Periodic fever syndromes (PFS) are an emerging group of autoinflammatory disorders. Clinical overlap exists and multiple genetic analyses may be needed to assist diagnosis. We evaluated the diagnostic value of a 5-gene sequencing panel (5GP) in patients with undiagnosed PFS.

METHODS: Simultaneous double strand Sanger sequencing of MEFV, MVK, TNFRSF1A, NLRP3, NLRP12 genes was performed in 42 patients with unexplained PFS. Clinical features were correlated with genetic results.

RESULTS: None of 42 patients analyzed displayed a causative genotype. However, single or multiple genetic variants of uncertain significance were detected in 24 subjects. Only in 5 subjects a definite diagnosis was made by taking into account both genetic and clinical data (2 TRAPS syndrome; 2 FMF; 1 FCAS). Statistical analysis showed that patients carrying genetic variants in one or more of the five selected genes displayed a significantly lower response to glucocorticoids compared with subjects who had completely negative genetic results.

CONCLUSIONS: The sequencing of multiple genes is of little help in the diagnostics of PFS and can often lead to results of uncertain interpretation, thus the clinically driven sequencing of single genes should remain the recommended approach. However, the presence of single or multiple genetic variants of uncertain significance, even if not allowing any specific diagnosis, correlated with a poorer response to glucocorticoids, possibly indicating a multifactorial subgroup of PFS with differential response to pharmacological treatment.

%B Pediatr Rheumatol Online J %V 13 %P 11 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25866490?dopt=Abstract %R 10.1186/s12969-015-0006-z %0 Journal Article %J Nature %D 2015 %T Genetic studies of body mass index yield new insights for obesity biology. %A Locke, Adam E %A Kahali, Bratati %A Berndt, Sonja I %A Justice, Anne E %A Pers, Tune H %A Day, Felix R %A Powell, Corey %A Vedantam, Sailaja %A Buchkovich, Martin L %A Yang, Jian %A Croteau-Chonka, Damien C %A Esko, Tõnu %A Fall, Tove %A Ferreira, Teresa %A Gustafsson, Stefan %A Kutalik, Zoltán %A Luan, Jian'an %A Mägi, Reedik %A Randall, Joshua C %A Winkler, Thomas W %A Wood, Andrew R %A Workalemahu, Tsegaselassie %A Faul, Jessica D %A Smith, Jennifer A %A Hua Zhao, Jing %A Zhao, Wei %A Chen, Jin %A Fehrmann, Rudolf %A Hedman, Åsa K %A Karjalainen, Juha %A Schmidt, Ellen M %A Absher, Devin %A Amin, Najaf %A Anderson, Denise %A Beekman, Marian %A Bolton, Jennifer L %A Bragg-Gresham, Jennifer L %A Buyske, Steven %A Demirkan, Ayse %A Deng, Guohong %A Ehret, Georg B %A Feenstra, Bjarke %A Feitosa, Mary F %A Fischer, Krista %A Goel, Anuj %A Gong, Jian %A Jackson, Anne U %A Kanoni, Stavroula %A Kleber, Marcus E %A Kristiansson, Kati %A Lim, Unhee %A Lotay, Vaneet %A Mangino, Massimo %A Mateo Leach, Irene %A Medina-Gomez, Carolina %A Medland, Sarah E %A Nalls, Michael A %A Palmer, Cameron D %A Pasko, Dorota %A Pechlivanis, Sonali %A Peters, Marjolein J %A Prokopenko, Inga %A Shungin, Dmitry %A Stančáková, Alena %A Strawbridge, Rona J %A Ju Sung, Yun %A Tanaka, Toshiko %A Teumer, Alexander %A Trompet, Stella %A van der Laan, Sander W %A van Setten, Jessica %A Van Vliet-Ostaptchouk, Jana V %A Wang, Zhaoming %A Yengo, Loic %A Zhang, Weihua %A Isaacs, Aaron %A Albrecht, Eva %A Arnlöv, Johan %A Arscott, Gillian M %A Attwood, Antony P %A Bandinelli, Stefania %A Barrett, Amy %A Bas, Isabelita N %A Bellis, Claire %A Bennett, Amanda J %A Berne, Christian %A Blagieva, Roza %A Blüher, Matthias %A Böhringer, Stefan %A Bonnycastle, Lori L %A Böttcher, Yvonne %A Boyd, Heather A %A Bruinenberg, Marcel %A Caspersen, Ida H %A Ida Chen, Yii-Der %A Clarke, Robert %A Daw, E Warwick %A de Craen, Anton J M %A Delgado, Graciela %A Dimitriou, Maria %A Doney, Alex S F %A Eklund, Niina %A Estrada, Karol %A Eury, Elodie %A Folkersen, Lasse %A Fraser, Ross M %A Garcia, Melissa E %A Geller, Frank %A Giedraitis, Vilmantas %A Gigante, Bruna %A Go, Alan S %A Golay, Alain %A Goodall, Alison H %A Gordon, Scott D %A Gorski, Mathias %A Grabe, Hans-Jörgen %A Grallert, Harald %A Grammer, Tanja B %A Gräßler, Jürgen %A Grönberg, Henrik %A Groves, Christopher J %A Gusto, Gaëlle %A Haessler, Jeffrey %A Hall, Per %A Haller, Toomas %A Hallmans, Goran %A Hartman, Catharina A %A Hassinen, Maija %A Hayward, Caroline %A Heard-Costa, Nancy L %A Helmer, Quinta %A Hengstenberg, Christian %A Holmen, Oddgeir %A Hottenga, Jouke-Jan %A James, Alan L %A Jeff, Janina M %A Johansson, Åsa %A Jolley, Jennifer %A Juliusdottir, Thorhildur %A Kinnunen, Leena %A Koenig, Wolfgang %A Koskenvuo, Markku %A Kratzer, Wolfgang %A Laitinen, Jaana %A Lamina, Claudia %A Leander, Karin %A Lee, Nanette R %A Lichtner, Peter %A Lind, Lars %A Lindström, Jaana %A Sin Lo, Ken %A Lobbens, Stéphane %A Lorbeer, Roberto %A Lu, Yingchang %A Mach, François %A Magnusson, Patrik K E %A Mahajan, Anubha %A McArdle, Wendy L %A McLachlan, Stela %A Menni, Cristina %A Merger, Sigrun %A Mihailov, Evelin %A Milani, Lili %A Moayyeri, Alireza %A Monda, Keri L %A Morken, Mario A %A Mulas, Antonella %A Müller, Gabriele %A Müller-Nurasyid, Martina %A Musk, Arthur W %A Nagaraja, Ramaiah %A Nöthen, Markus M %A Nolte, Ilja M %A Pilz, Stefan %A Rayner, Nigel W %A Renstrom, Frida %A Rettig, Rainer %A Ried, Janina S %A Ripke, Stephan %A Robertson, Neil R %A Rose, Lynda M %A Sanna, Serena %A Scharnagl, Hubert %A Scholtens, Salome %A Schumacher, Fredrick R %A Scott, William R %A Seufferlein, Thomas %A Shi, Jianxin %A Vernon Smith, Albert %A Smolonska, Joanna %A Stanton, Alice V %A Steinthorsdottir, Valgerdur %A Stirrups, Kathleen %A Stringham, Heather M %A Sundström, Johan %A Swertz, Morris A %A Swift, Amy J %A Syvänen, Ann-Christine %A Tan, Sian-Tsung %A Tayo, Bamidele O %A Thorand, Barbara %A Thorleifsson, Gudmar %A Tyrer, Jonathan P %A Uh, Hae-Won %A Vandenput, Liesbeth %A Verhulst, Frank C %A Vermeulen, Sita H %A Verweij, Niek %A Vonk, Judith M %A Waite, Lindsay L %A Warren, Helen R %A Waterworth, Dawn %A Weedon, Michael N %A Wilkens, Lynne R %A Willenborg, Christina %A Wilsgaard, Tom %A Wojczynski, Mary K %A Wong, Andrew %A Wright, Alan F %A Zhang, Qunyuan %A Brennan, Eoin P %A Choi, Murim %A Dastani, Zari %A Drong, Alexander W %A Eriksson, Per %A Franco-Cereceda, Anders %A Gådin, Jesper R %A Gharavi, Ali G %A Goddard, Michael E %A Handsaker, Robert E %A Huang, Jinyan %A Karpe, Fredrik %A Kathiresan, Sekar %A Keildson, Sarah %A Kiryluk, Krzysztof %A Kubo, Michiaki %A Lee, Jong-Young %A Liang, Liming %A Lifton, Richard P %A Ma, Baoshan %A McCarroll, Steven A %A McKnight, Amy J %A Min, Josine L %A Moffatt, Miriam F %A Montgomery, Grant W %A Murabito, Joanne M %A Nicholson, George %A Nyholt, Dale R %A Okada, Yukinori %A Perry, John R B %A Dorajoo, Rajkumar %A Reinmaa, Eva %A Salem, Rany M %A Sandholm, Niina %A Scott, Robert A %A Stolk, Lisette %A Takahashi, Atsushi %A Tanaka, Toshihiro %A Van't Hooft, Ferdinand M %A Vinkhuyzen, Anna A E %A Westra, Harm-Jan %A Zheng, Wei %A Zondervan, Krina T %A Heath, Andrew C %A Arveiler, Dominique %A Bakker, Stephan J L %A Beilby, John %A Bergman, Richard N %A Blangero, John %A Bovet, Pascal %A Campbell, Harry %A Caulfield, Mark J %A Cesana, Giancarlo %A Chakravarti, Aravinda %A Chasman, Daniel I %A Chines, Peter S %A Collins, Francis S %A Crawford, Dana C %A Cupples, L Adrienne %A Cusi, Daniele %A Danesh, John %A de Faire, Ulf %A den Ruijter, Hester M %A Dominiczak, Anna F %A Erbel, Raimund %A Erdmann, Jeanette %A Eriksson, Johan G %A Farrall, Martin %A Felix, Stephan B %A Ferrannini, Ele %A Ferrières, Jean %A Ford, Ian %A Forouhi, Nita G %A Forrester, Terrence %A Franco, Oscar H %A Gansevoort, Ron T %A Gejman, Pablo V %A Gieger, Christian %A Gottesman, Omri %A Gudnason, Vilmundur %A Gyllensten, Ulf %A Hall, Alistair S %A Harris, Tamara B %A Hattersley, Andrew T %A Hicks, Andrew A %A Hindorff, Lucia A %A Hingorani, Aroon D %A Hofman, Albert %A Homuth, Georg %A Hovingh, G Kees %A Humphries, Steve E %A Hunt, Steven C %A Hyppönen, Elina %A Illig, Thomas %A Jacobs, Kevin B %A Järvelin, Marjo-Riitta %A Jöckel, Karl-Heinz %A Johansen, Berit %A Jousilahti, Pekka %A Jukema, J Wouter %A Jula, Antti M %A Kaprio, Jaakko %A Kastelein, John J P %A Keinanen-Kiukaanniemi, Sirkka M %A Kiemeney, Lambertus A %A Knekt, Paul %A Kooner, Jaspal S %A Kooperberg, Charles %A Kovacs, Peter %A Kraja, Aldi T %A Kumari, Meena %A Kuusisto, Johanna %A Lakka, Timo A %A Langenberg, Claudia %A Le Marchand, Loic %A Lehtimäki, Terho %A Lyssenko, Valeriya %A Männistö, Satu %A Marette, André %A Matise, Tara C %A McKenzie, Colin A %A McKnight, Barbara %A Moll, Frans L %A Morris, Andrew D %A Morris, Andrew P %A Murray, Jeffrey C %A Nelis, Mari %A Ohlsson, Claes %A Oldehinkel, Albertine J %A Ong, Ken K %A Madden, Pamela A F %A Pasterkamp, Gerard %A Peden, John F %A Peters, Annette %A Postma, Dirkje S %A Pramstaller, Peter P %A Price, Jackie F %A Qi, Lu %A Raitakari, Olli T %A Rankinen, Tuomo %A Rao, D C %A Rice, Treva K %A Ridker, Paul M %A Rioux, John D %A Ritchie, Marylyn D %A Rudan, Igor %A Salomaa, Veikko %A Samani, Nilesh J %A Saramies, Jouko %A Sarzynski, Mark A %A Schunkert, Heribert %A Schwarz, Peter E H %A Sever, Peter %A Shuldiner, Alan R %A Sinisalo, Juha %A Stolk, Ronald P %A Strauch, Konstantin %A Tönjes, Anke %A Trégouët, David-Alexandre %A Tremblay, Angelo %A Tremoli, Elena %A Virtamo, Jarmo %A Vohl, Marie-Claude %A Völker, Uwe %A Waeber, Gerard %A Willemsen, Gonneke %A Witteman, Jacqueline C %A Zillikens, M Carola %A Adair, Linda S %A Amouyel, Philippe %A Asselbergs, Folkert W %A Assimes, Themistocles L %A Bochud, Murielle %A Boehm, Bernhard O %A Boerwinkle, Eric %A Bornstein, Stefan R %A Bottinger, Erwin P %A Bouchard, Claude %A Cauchi, Stéphane %A Chambers, John C %A Chanock, Stephen J %A Cooper, Richard S %A de Bakker, Paul I W %A Dedoussis, George %A Ferrucci, Luigi %A Franks, Paul W %A Froguel, Philippe %A Groop, Leif C %A Haiman, Christopher A %A Hamsten, Anders %A Hui, Jennie %A Hunter, David J %A Hveem, Kristian %A Kaplan, Robert C %A Kivimaki, Mika %A Kuh, Diana %A Laakso, Markku %A Liu, Yongmei %A Martin, Nicholas G %A März, Winfried %A Melbye, Mads %A Metspalu, Andres %A Moebus, Susanne %A Munroe, Patricia B %A Njølstad, Inger %A Oostra, Ben A %A Palmer, Colin N A %A Pedersen, Nancy L %A Perola, Markus %A Pérusse, Louis %A Peters, Ulrike %A Power, Chris %A Quertermous, Thomas %A Rauramaa, Rainer %A Rivadeneira, Fernando %A Saaristo, Timo E %A Saleheen, Danish %A Sattar, Naveed %A Schadt, Eric E %A Schlessinger, David %A Slagboom, P Eline %A Snieder, Harold %A Spector, Tim D %A Thorsteinsdottir, Unnur %A Stumvoll, Michael %A Tuomilehto, Jaakko %A Uitterlinden, André G %A Uusitupa, Matti %A van der Harst, Pim %A Walker, Mark %A Wallaschofski, Henri %A Wareham, Nicholas J %A Watkins, Hugh %A Weir, David R %A Wichmann, H-Erich %A Wilson, James F %A Zanen, Pieter %A Borecki, Ingrid B %A Deloukas, Panos %A Fox, Caroline S %A Heid, Iris M %A O'Connell, Jeffrey R %A Strachan, David P %A Stefansson, Kari %A van Duijn, Cornelia M %A Abecasis, Goncalo R %A Franke, Lude %A Frayling, Timothy M %A McCarthy, Mark I %A Visscher, Peter M %A Scherag, André %A Willer, Cristen J %A Boehnke, Michael %A Mohlke, Karen L %A Lindgren, Cecilia M %A Beckmann, Jacques S %A Barroso, Inês %A North, Kari E %A Ingelsson, Erik %A Hirschhorn, Joel N %A Loos, Ruth J F %A Speliotes, Elizabeth K %K Adipogenesis %K Adiposity %K Age Factors %K Body Mass Index %K Continental Population Groups %K Energy Metabolism %K Europe %K Female %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Glutamic Acid %K Humans %K Insulin %K Male %K Obesity %K Polymorphism, Single Nucleotide %K Quantitative Trait Loci %K Synapses %X

Obesity is heritable and predisposes to many diseases. To understand the genetic basis of obesity better, here we conduct a genome-wide association study and Metabochip meta-analysis of body mass index (BMI), a measure commonly used to define obesity and assess adiposity, in up to 339,224 individuals. This analysis identifies 97 BMI-associated loci (P < 5 × 10(-8)), 56 of which are novel. Five loci demonstrate clear evidence of several independent association signals, and many loci have significant effects on other metabolic phenotypes. The 97 loci account for ∼2.7% of BMI variation, and genome-wide estimates suggest that common variation accounts for >20% of BMI variation. Pathway analyses provide strong support for a role of the central nervous system in obesity susceptibility and implicate new genes and pathways, including those related to synaptic function, glutamate signalling, insulin secretion/action, energy metabolism, lipid biology and adipogenesis.

%B Nature %V 518 %P 197-206 %8 2015 Feb 12 %G eng %N 7538 %1 http://www.ncbi.nlm.nih.gov/pubmed/25673413?dopt=Abstract %R 10.1038/nature14177 %0 Journal Article %J J Transl Med %D 2015 %T Genetic testing and genomic analysis: a debate on ethical, social and legal issues in the Arab world with a focus on Qatar. %A El Shanti, Hatem %A Chouchane, Lotfi %A Badii, Ramin %A Gallouzi, Imed Eddine %A Gasparini, Paolo %X

In 2013 both Saudi Arabia and Qatar launched genome projects with the aim of providing information for better diagnosis, treatment and prevention of diseases and, ultimately to realize personalized medicine by sequencing hundred thousands samples. These population based genome activities raise a series of relevant ethical, legal and social issues general, related to the specific population structure as well as to the Islamic perspective on genomic analysis and genetic testing. To contribute to the debate, the Authors after reviewing the existing literature and taking advantage of their professional experience in the field and in the geographic area, discuss and provide their opinions. In particular, the Authors focus on the impact of consanguinity on population structure and disease frequency in the Arab world, on genetic testing and genomic analysis (i.e. technical aspects, impact, etc.) and on their regulations. A comparison between the Islamic perspective and the ethical, social and legal issues raised in other population contexts is also carried. In conclusion, this opinion article with an up-to-date contribution to the discussion on the relevance and impact of genomic analysis and genetic testing in the Arab world, might help in producing specific national guidelines on genetic testing and genomic analysis and help accelerate the implementation and roll out of genome projects in Muslim countries and more specifically in Qatar, and other countries of the Gulf.

%B J Transl Med %V 13 %P 358 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/26572608?dopt=Abstract %R 10.1186/s12967-015-0720-9 %0 Journal Article %J Nat Genet %D 2015 %T Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. %A Sidore, Carlo %A Busonero, Fabio %A Maschio, Andrea %A Porcu, Eleonora %A Naitza, Silvia %A Zoledziewska, Magdalena %A Mulas, Antonella %A Pistis, Giorgio %A Steri, Maristella %A Danjou, Fabrice %A Kwong, Alan %A Ortega Del Vecchyo, Vicente Diego %A Chiang, Charleston W K %A Bragg-Gresham, Jennifer %A Pitzalis, Maristella %A Nagaraja, Ramaiah %A Tarrier, Brendan %A Brennan, Christine %A Uzzau, Sergio %A Fuchsberger, Christian %A Atzeni, Rossano %A Reinier, Frederic %A Berutti, Riccardo %A Huang, Jie %A Timpson, Nicholas J %A Toniolo, Daniela %A Gasparini, Paolo %A Malerba, Giovanni %A Dedoussis, George %A Zeggini, Eleftheria %A Soranzo, Nicole %A Jones, Chris %A Lyons, Robert %A Angius, Andrea %A Kang, Hyun M %A Novembre, John %A Sanna, Serena %A Schlessinger, David %A Cucca, Francesco %A Abecasis, Goncalo R %X

We report ∼17.6 million genetic variants from whole-genome sequencing of 2,120 Sardinians; 22% are absent from previous sequencing-based compilations and are enriched for predicted functional consequences. Furthermore, ∼76,000 variants common in our sample (frequency >5%) are rare elsewhere (<0.5% in the 1000 Genomes Project). We assessed the impact of these variants on circulating lipid levels and five inflammatory biomarkers. We observe 14 signals, including 2 major new loci, for lipid levels and 19 signals, including 2 new loci, for inflammatory markers. The new associations would have been missed in analyses based on 1000 Genomes Project data, underlining the advantages of large-scale sequencing in this founder population.

%B Nat Genet %V 47 %P 1272-81 %8 2015 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/26366554?dopt=Abstract %R 10.1038/ng.3368 %0 Journal Article %J Hum Mol Genet %D 2015 %T Genome-wide association analysis on normal hearing function identifies PCDH20 and SLC28A3 as candidates for hearing function and loss. %A Vuckovic, Dragana %A Dawson, Sally %A Scheffer, Deborah I %A Rantanen, Taina %A Morgan, Anna %A Di Stazio, Mariateresa %A Vozzi, Diego %A Nutile, Teresa %A Concas, Maria P %A Biino, Ginevra %A Nolan, Lisa %A Bahl, Aileen %A Loukola, Anu %A Viljanen, Anne %A Davis, Adrian %A Ciullo, Marina %A Corey, David P %A Pirastu, Mario %A Gasparini, Paolo %A Girotto, Giorgia %X

Hearing loss and individual differences in normal hearing both have a substantial genetic basis. Although many new genes contributing to deafness have been identified, very little is known about genes/variants modulating the normal range of hearing ability. To fill this gap, we performed a two-stage meta-analysis on hearing thresholds (tested at 0.25, 0.5, 1, 2, 4, 8 kHz) and on pure-tone averages (low-, medium- and high-frequency thresholds grouped) in several isolated populations from Italy and Central Asia (total N = 2636). Here, we detected two genome-wide significant loci close to PCDH20 and SLC28A3 (top hits: rs78043697, P = 4.71E-10 and rs7032430, P = 2.39E-09, respectively). For both loci, we sought replication in two independent cohorts: B58C from the UK (N = 5892) and FITSA from Finland (N = 270). Both loci were successfully replicated at a nominal level of significance (P < 0.05). In order to confirm our quantitative findings, we carried out RT-PCR and reported RNA-Seq data, which showed that both genes are expressed in mouse inner ear, especially in hair cells, further suggesting them as good candidates for modulatory genes in the auditory system. Sequencing data revealed no functional variants in the coding region of PCDH20 or SLC28A3, suggesting that variation in regulatory sequences may affect expression. Overall, these results contribute to a better understanding of the complex mechanisms underlying human hearing function.

%B Hum Mol Genet %V 24 %P 5655-64 %8 2015 Oct 1 %G eng %N 19 %1 http://www.ncbi.nlm.nih.gov/pubmed/26188009?dopt=Abstract %R 10.1093/hmg/ddv279 %0 Journal Article %J Nat Genet %D 2015 %T Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. %A Noetzli, Leila %A Lo, Richard W %A Lee-Sherick, Alisa B %A Callaghan, Michael %A Noris, Patrizia %A Savoia, Anna %A Rajpurkar, Madhvi %A Jones, Kenneth %A Gowan, Katherine %A Balduini, Carlo L %A Pecci, Alessandro %A Gnan, Chiara %A De Rocco, Daniela %A Doubek, Michael %A Li, Ling %A Lu, Lily %A Leung, Richard %A Landolt-Marticorena, Carolina %A Hunger, Stephen %A Heller, Paula %A Gutierrez-Hartmann, Arthur %A Xiayuan, Liang %A Pluthero, Fred G %A Rowley, Jesse W %A Weyrich, Andrew S %A Kahr, Walter H A %A Porter, Christopher C %A Di Paola, Jorge %K Adult %K Child, Preschool %K DNA Mutational Analysis %K Erythrocytes, Abnormal %K Exome %K Female %K Genetic Association Studies %K Genetic Predisposition to Disease %K Germ-Line Mutation %K HEK293 Cells %K Hematologic Diseases %K Humans %K Male %K Mutation, Missense %K Pedigree %K Precursor Cell Lymphoblastic Leukemia-Lymphoma %K Proto-Oncogene Proteins c-ets %K Repressor Proteins %K Thrombocytopenia %X

Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia. We identified a family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell-precursor acute lymphoblastic leukemia (ALL). Whole-exome sequencing identified a heterozygous single-nucleotide change in ETV6 (ets variant 6), c.641C>T, encoding a p.Pro214Leu substitution in the central domain, segregating with thrombocytopenia and elevated MCV. A screen of 23 families with similar phenotypes identified 2 with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.

%B Nat Genet %V 47 %P 535-8 %8 2015 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/25807284?dopt=Abstract %R 10.1038/ng.3253 %0 Journal Article %J JAMA Oncol %D 2015 %T The Global Burden of Cancer 2013. %A Fitzmaurice, Christina %A Dicker, Daniel %A Pain, Amanda %A Hamavid, Hannah %A Moradi-Lakeh, Maziar %A MacIntyre, Michael F %A Allen, Christine %A Hansen, Gillian %A Woodbrook, Rachel %A Wolfe, Charles %A Hamadeh, Randah R %A Moore, Ami %A Werdecker, Andrea %A Gessner, Bradford D %A Te Ao, Braden %A McMahon, Brian %A Karimkhani, Chante %A Yu, Chuanhua %A Cooke, Graham S %A Schwebel, David C %A Carpenter, David O %A Pereira, David M %A Nash, Denis %A Kazi, Dhruv S %A De Leo, Diego %A Plass, Dietrich %A Ukwaja, Kingsley N %A Thurston, George D %A Yun Jin, Kim %A Simard, Edgar P %A Mills, Edward %A Park, Eun-Kee %A Catalá-López, Ferrán %A deVeber, Gabrielle %A Gotay, Carolyn %A Khan, Gulfaraz %A Hosgood, H Dean %A Santos, Itamar S %A Leasher, Janet L %A Singh, Jasvinder %A Leigh, James %A Jonas, Jost %A Sanabria, Juan %A Beardsley, Justin %A Jacobsen, Kathryn H %A Takahashi, Ken %A Franklin, Richard C %A Ronfani, Luca %A Montico, Marcella %A Naldi, Luigi %A Tonelli, Marcello %A Geleijnse, Johanna %A Petzold, Max %A Shrime, Mark G %A Younis, Mustafa %A Yonemoto, Naohiro %A Breitborde, Nicholas %A Yip, Paul %A Pourmalek, Farshad %A Lotufo, Paulo A %A Esteghamati, Alireza %A Hankey, Graeme J %A Ali, Raghib %A Lunevicius, Raimundas %A Malekzadeh, Reza %A Dellavalle, Robert %A Weintraub, Robert %A Lucas, Robyn %A Hay, Roderick %A Rojas-Rueda, David %A Westerman, Ronny %A Sepanlou, Sadaf G %A Nolte, Sandra %A Patten, Scott %A Weichenthal, Scott %A Abera, Semaw Ferede %A Fereshtehnejad, Seyed-Mohammad %A Shiue, Ivy %A Driscoll, Tim %A Vasankari, Tommi %A Alsharif, Ubai %A Rahimi-Movaghar, Vafa %A Vlassov, Vasiliy V %A Marcenes, W S %A Mekonnen, Wubegzier %A Melaku, Yohannes Adama %A Yano, Yuichiro %A Artaman, Al %A Campos, Ismael %A MacLachlan, Jennifer %A Mueller, Ulrich %A Kim, Daniel %A Trillini, Matias %A Eshrati, Babak %A Williams, Hywel C %A Shibuya, Kenji %A Dandona, Rakhi %A Murthy, Kinnari %A Cowie, Benjamin %A Amare, Azmeraw T %A Antonio, Carl Abelardo %A Castañeda-Orjuela, Carlos %A van Gool, Coen H %A Violante, Francesco %A Oh, In-Hwan %A Deribe, Kedede %A Soreide, Kjetil %A Knibbs, Luke %A Kereselidze, Maia %A Green, Mark %A Cárdenas, Rosario %A Roy, Nobhojit %A Tillman, Taavi %A Li, Yongmei %A Krueger, Hans %A Monasta, Lorenzo %A Dey, Subhojit %A Sheikhbahaei, Sara %A Hafezi-Nejad, Nima %A Kumar, G Anil %A Sreeramareddy, Chandrashekhar T %A Dandona, Lalit %A Wang, Haidong %A Vollset, Stein Emil %A Mokdad, Ali %A Salomon, Joshua A %A Lozano, Rafael %A Vos, Theo %A Forouzanfar, Mohammad %A Lopez, Alan %A Murray, Christopher %A Naghavi, Mohsen %X

IMPORTANCE: Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies.

OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013.

EVIDENCE REVIEW: The general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs.

FINDINGS: In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs. Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million). Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths. For men, TBL cancer was the leading cause of DALYs (24.9 million). For women, breast cancer was the leading cause of DALYs (13.1 million). Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3). Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10% in 113 countries and decreased by more than 10% in 12 of 188 countries.

CONCLUSIONS AND RELEVANCE: Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990. The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments. The annual update on the Global Burden of Cancer will provide all stakeholders with timely estimates to guide policy efforts in cancer prevention, screening, treatment, and palliation.

%B JAMA Oncol %V 1 %P 505-27 %8 2015 Jul %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26181261?dopt=Abstract %R 10.1001/jamaoncol.2015.0735 %0 Journal Article %J Lancet %D 2015 %T Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. %A Forouzanfar, Mohammad H %A Alexander, Lily %A Anderson, H Ross %A Bachman, Victoria F %A Biryukov, Stan %A Brauer, Michael %A Burnett, Richard %A Casey, Daniel %A Coates, Matthew M %A Cohen, Aaron %A Delwiche, Kristen %A Estep, Kara %A Frostad, Joseph J %A Astha, K C %A Kyu, Hmwe H %A Moradi-Lakeh, Maziar %A Ng, Marie %A Slepak, Erica Leigh %A Thomas, Bernadette A %A Wagner, Joseph %A Aasvang, Gunn Marit %A Abbafati, Cristiana %A Abbasoglu Ozgoren, Ayse %A Abd-Allah, Foad %A Abera, Semaw F %A Aboyans, Victor %A Abraham, Biju %A Abraham, Jerry Puthenpurakal %A Abubakar, Ibrahim %A Abu-Rmeileh, Niveen M E %A Aburto, Tania C %A Achoki, Tom %A Adelekan, Ademola %A Adofo, Koranteng %A Adou, Arsène K %A Adsuar, José C %A Afshin, Ashkan %A Agardh, Emilie E %A Al Khabouri, Mazin J %A Al Lami, Faris H %A Alam, Sayed Saidul %A Alasfoor, Deena %A Albittar, Mohammed I %A Alegretti, Miguel A %A Aleman, Alicia V %A Alemu, Zewdie A %A Alfonso-Cristancho, Rafael %A Alhabib, Samia %A Ali, Raghib %A Ali, Mohammed K %A Alla, François %A Allebeck, Peter %A Allen, Peter J %A Alsharif, Ubai %A Alvarez, Elena %A Alvis-Guzmán, Nelson %A Amankwaa, Adansi A %A Amare, Azmeraw T %A Ameh, Emmanuel A %A Ameli, Omid %A Amini, Heresh %A Ammar, Walid %A Anderson, Benjamin O %A Antonio, Carl Abelardo T %A Anwari, Palwasha %A Argeseanu Cunningham, Solveig %A Arnlöv, Johan %A Arsenijevic, Valentina S Arsic %A Artaman, Al %A Asghar, Rana J %A Assadi, Reza %A Atkins, Lydia S %A Atkinson, Charles %A Avila, Marco A %A Awuah, Baffour %A Badawi, Alaa %A Bahit, Maria C %A Bakfalouni, Talal %A Balakrishnan, Kalpana %A Balalla, Shivanthi %A Balu, Ravi Kumar %A Banerjee, Amitava %A Barber, Ryan M %A Barker-Collo, Suzanne L %A Barquera, Simon %A Barregard, Lars %A Barrero, Lope H %A Barrientos-Gutierrez, Tonatiuh %A Basto-Abreu, Ana C %A Basu, Arindam %A Basu, Sanjay %A Basulaiman, Mohammed O %A Batis Ruvalcaba, Carolina %A Beardsley, Justin %A Bedi, Neeraj %A Bekele, Tolesa %A Bell, Michelle L %A Benjet, Corina %A Bennett, Derrick A %A Benzian, Habib %A Bernabe, Eduardo %A Beyene, Tariku J %A Bhala, Neeraj %A Bhalla, Ashish %A Bhutta, Zulfiqar A %A Bikbov, Boris %A Bin Abdulhak, Aref A %A Blore, Jed D %A Blyth, Fiona M %A Bohensky, Megan A %A Bora Başara, Berrak %A Borges, Guilherme %A Bornstein, Natan M %A Bose, Dipan %A Boufous, Soufiane %A Bourne, Rupert R %A Brainin, Michael %A Brazinova, Alexandra %A Breitborde, Nicholas J %A Brenner, Hermann %A Briggs, Adam D M %A Broday, David M %A Brooks, Peter M %A Bruce, Nigel G %A Brugha, Traolach S %A Brunekreef, Bert %A Buchbinder, Rachelle %A Bui, Linh N %A Bukhman, Gene %A Bulloch, Andrew G %A Burch, Michael %A Burney, Peter G J %A Campos-Nonato, Ismael R %A Campuzano, Julio C %A Cantoral, Alejandra J %A Caravanos, Jack %A Cárdenas, Rosario %A Cardis, Elisabeth %A Carpenter, David O %A Caso, Valeria %A Castañeda-Orjuela, Carlos A %A Castro, Ruben E %A Catalá-López, Ferrán %A Cavalleri, Fiorella %A Cavlin, Alanur %A Chadha, Vineet K %A Chang, Jung-Chen %A Charlson, Fiona J %A Chen, Honglei %A Chen, Wanqing %A Chen, Zhengming %A Chiang, Peggy P %A Chimed-Ochir, Odgerel %A Chowdhury, Rajiv %A Christophi, Costas A %A Chuang, Ting-Wu %A Chugh, Sumeet S %A Cirillo, Massimo %A Claßen, Thomas K D %A Colistro, Valentina %A Colomar, Mercedes %A Colquhoun, Samantha M %A Contreras, Alejandra G %A Cooper, Cyrus %A Cooperrider, Kimberly %A Cooper, Leslie T %A Coresh, Josef %A Courville, Karen J %A Criqui, Michael H %A Cuevas-Nasu, Lucia %A Damsere-Derry, James %A Danawi, Hadi %A Dandona, Lalit %A Dandona, Rakhi %A Dargan, Paul I %A Davis, Adrian %A Davitoiu, Dragos V %A Dayama, Anand %A de Castro, E Filipa %A De la Cruz-Góngora, Vanessa %A De Leo, Diego %A de Lima, Graça %A Degenhardt, Louisa %A del Pozo-Cruz, Borja %A Dellavalle, Robert P %A Deribe, Kebede %A Derrett, Sarah %A Des Jarlais, Don C %A Dessalegn, Muluken %A deVeber, Gabrielle A %A Devries, Karen M %A Dharmaratne, Samath D %A Dherani, Mukesh K %A Dicker, Daniel %A Ding, Eric L %A Dokova, Klara %A Dorsey, E Ray %A Driscoll, Tim R %A Duan, Leilei %A Durrani, Adnan M %A Ebel, Beth E %A Ellenbogen, Richard G %A Elshrek, Yousef M %A Endres, Matthias %A Ermakov, Sergey P %A Erskine, Holly E %A Eshrati, Babak %A Esteghamati, Alireza %A Fahimi, Saman %A Faraon, Emerito Jose A %A Farzadfar, Farshad %A Fay, Derek F J %A Feigin, Valery L %A Feigl, Andrea B %A Fereshtehnejad, Seyed-Mohammad %A Ferrari, Alize J %A Ferri, Cleusa P %A Flaxman, Abraham D %A Fleming, Thomas D %A Foigt, Nataliya %A Foreman, Kyle J %A Paleo, Urbano Fra %A Franklin, Richard C %A Gabbe, Belinda %A Gaffikin, Lynne %A Gakidou, Emmanuela %A Gamkrelidze, Amiran %A Gankpé, Fortuné G %A Gansevoort, Ron T %A García-Guerra, Francisco A %A Gasana, Evariste %A Geleijnse, Johanna M %A Gessner, Bradford D %A Gething, Pete %A Gibney, Katherine B %A Gillum, Richard F %A Ginawi, Ibrahim A M %A Giroud, Maurice %A Giussani, Giorgia %A Goenka, Shifalika %A Goginashvili, Ketevan %A Gomez Dantes, Hector %A Gona, Philimon %A Gonzalez de Cosio, Teresita %A González-Castell, Dinorah %A Gotay, Carolyn C %A Goto, Atsushi %A Gouda, Hebe N %A Guerrant, Richard L %A Gugnani, Harish C %A Guillemin, Francis %A Gunnell, David %A Gupta, Rahul %A Gupta, Rajeev %A Gutiérrez, Reyna A %A Hafezi-Nejad, Nima %A Hagan, Holly %A Hagstromer, Maria %A Halasa, Yara A %A Hamadeh, Randah R %A Hammami, Mouhanad %A Hankey, Graeme J %A Hao, Yuantao %A Harb, Hilda L %A Haregu, Tilahun Nigatu %A Haro, Josep Maria %A Havmoeller, Rasmus %A Hay, Simon I %A Hedayati, Mohammad T %A Heredia-Pi, Ileana B %A Hernandez, Lucia %A Heuton, Kyle R %A Heydarpour, Pouria %A Hijar, Martha %A Hoek, Hans W %A Hoffman, Howard J %A Hornberger, John C %A Hosgood, H Dean %A Hoy, Damian G %A Hsairi, Mohamed %A Hu, Guoqing %A Hu, Howard %A Huang, Cheng %A Huang, John J %A Hubbell, Bryan J %A Huiart, Laetitia %A Husseini, Abdullatif %A Iannarone, Marissa L %A Iburg, Kim M %A Idrisov, Bulat T %A Ikeda, Nayu %A Innos, Kaire %A Inoue, Manami %A Islami, Farhad %A Ismayilova, Samaya %A Jacobsen, Kathryn H %A Jansen, Henrica A %A Jarvis, Deborah L %A Jassal, Simerjot K %A Jauregui, Alejandra %A Jayaraman, Sudha %A Jeemon, Panniyammakal %A Jensen, Paul N %A Jha, Vivekanand %A Jiang, Fan %A Jiang, Guohong %A Jiang, Ying %A Jonas, Jost B %A Juel, Knud %A Kan, Haidong %A Kany Roseline, Sidibe S %A Karam, Nadim E %A Karch, André %A Karema, Corine K %A Karthikeyan, Ganesan %A Kaul, Anil %A Kawakami, Norito %A Kazi, Dhruv S %A Kemp, Andrew H %A Kengne, Andre P %A Keren, Andre %A Khader, Yousef S %A Khalifa, Shams Eldin Ali Hassan %A Khan, Ejaz A %A Khang, Young-Ho %A Khatibzadeh, Shahab %A Khonelidze, Irma %A Kieling, Christian %A Kim, Daniel %A Kim, Sungroul %A Kim, Yunjin %A Kimokoti, Ruth W %A Kinfu, Yohannes %A Kinge, Jonas M %A Kissela, Brett M %A Kivipelto, Miia %A Knibbs, Luke D %A Knudsen, Ann Kristin %A Kokubo, Yoshihiro %A Kose, M Rifat %A Kosen, Soewarta %A Kraemer, Alexander %A Kravchenko, Michael %A Krishnaswami, Sanjay %A Kromhout, Hans %A Ku, Tiffany %A Kuate Defo, Barthelemy %A Kucuk Bicer, Burcu %A Kuipers, Ernst J %A Kulkarni, Chanda %A Kulkarni, Veena S %A Kumar, G Anil %A Kwan, Gene F %A Lai, Taavi %A Lakshmana Balaji, Arjun %A Lalloo, Ratilal %A Lallukka, Tea %A Lam, Hilton %A Lan, Qing %A Lansingh, Van C %A Larson, Heidi J %A Larsson, Anders %A Laryea, Dennis O %A Lavados, Pablo M %A Lawrynowicz, Alicia E %A Leasher, Janet L %A Lee, Jong-Tae %A Leigh, James %A Leung, Ricky %A Levi, Miriam %A Li, Yichong %A Li, Yongmei %A Liang, Juan %A Liang, Xiaofeng %A Lim, Stephen S %A Lindsay, M Patrice %A Lipshultz, Steven E %A Liu, Shiwei %A Liu, Yang %A Lloyd, Belinda K %A Logroscino, Giancarlo %A London, Stephanie J %A Lopez, Nancy %A Lortet-Tieulent, Joannie %A Lotufo, Paulo A %A Lozano, Rafael %A Lunevicius, Raimundas %A Ma, Jixiang %A Ma, Stefan %A Machado, Vasco M P %A MacIntyre, Michael F %A Magis-Rodriguez, Carlos %A Mahdi, Abbas A %A Majdan, Marek %A Malekzadeh, Reza %A Mangalam, Srikanth %A Mapoma, Christopher C %A Marape, Marape %A Marcenes, Wagner %A Margolis, David J %A Margono, Christopher %A Marks, Guy B %A Martin, Randall V %A Marzan, Melvin B %A Mashal, Mohammad T %A Masiye, Felix %A Mason-Jones, Amanda J %A Matsushita, Kunihiro %A Matzopoulos, Richard %A Mayosi, Bongani M %A Mazorodze, Tasara T %A McKay, Abigail C %A McKee, Martin %A McLain, Abigail %A Meaney, Peter A %A Medina, Catalina %A Mehndiratta, Man Mohan %A Mejia-Rodriguez, Fabiola %A Mekonnen, Wubegzier %A Melaku, Yohannes A %A Meltzer, Michele %A Memish, Ziad A %A Mendoza, Walter %A Mensah, George A %A Meretoja, Atte %A Mhimbira, Francis Apolinary %A Micha, Renata %A Miller, Ted R %A Mills, Edward J %A Misganaw, Awoke %A Mishra, Santosh %A Mohamed Ibrahim, Norlinah %A Mohammad, Karzan A %A Mokdad, Ali H %A Mola, Glen L %A Monasta, Lorenzo %A Montañez Hernandez, Julio C %A Montico, Marcella %A Moore, Ami R %A Morawska, Lidia %A Mori, Rintaro %A Moschandreas, Joanna %A Moturi, Wilkister N %A Mozaffarian, Dariush %A Mueller, Ulrich O %A Mukaigawara, Mitsuru %A Mullany, Erin C %A Murthy, Kinnari S %A Naghavi, Mohsen %A Nahas, Ziad %A Naheed, Aliya %A Naidoo, Kovin S %A Naldi, Luigi %A Nand, Devina %A Nangia, Vinay %A Narayan, K M Venkat %A Nash, Denis %A Neal, Bruce %A Nejjari, Chakib %A Neupane, Sudan P %A Newton, Charles R %A Ngalesoni, Frida N %A Ngirabega, Jean de Dieu %A Nguyen, Grant %A Nguyen, Nhung T %A Nieuwenhuijsen, Mark J %A Nisar, Muhammad I %A Nogueira, José R %A Nolla, Joan M %A Nolte, Sandra %A Norheim, Ole F %A Norman, Rosana E %A Norrving, Bo %A Nyakarahuka, Luke %A Oh, In-Hwan %A Ohkubo, Takayoshi %A Olusanya, Bolajoko O %A Omer, Saad B %A Opio, John Nelson %A Orozco, Ricardo %A Pagcatipunan, Rodolfo S %A Pain, Amanda W %A Pandian, Jeyaraj D %A Panelo, Carlo Irwin A %A Papachristou, Christina %A Park, Eun-Kee %A Parry, Charles D %A Paternina Caicedo, Angel J %A Patten, Scott B %A Paul, Vinod K %A Pavlin, Boris I %A Pearce, Neil %A Pedraza, Lilia S %A Pedroza, Andrea %A Pejin Stokic, Ljiljana %A Pekericli, Ayfer %A Pereira, David M %A Perez-Padilla, Rogelio %A Perez-Ruiz, Fernando %A Perico, Norberto %A Perry, Samuel A L %A Pervaiz, Aslam %A Pesudovs, Konrad %A Peterson, Carrie B %A Petzold, Max %A Phillips, Michael R %A Phua, Hwee Pin %A Plass, Dietrich %A Poenaru, Dan %A Polanczyk, Guilherme V %A Polinder, Suzanne %A Pond, Constance D %A Pope, C Arden %A Pope, Daniel %A Popova, Svetlana %A Pourmalek, Farshad %A Powles, John %A Prabhakaran, Dorairaj %A Prasad, Noela M %A Qato, Dima M %A Quezada, Amado D %A Quistberg, D Alex A %A Racapé, Lionel %A Rafay, Anwar %A Rahimi, Kazem %A Rahimi-Movaghar, Vafa %A Rahman, Sajjad Ur %A Raju, Murugesan %A Rakovac, Ivo %A Rana, Saleem M %A Rao, Mayuree %A Razavi, Homie %A Reddy, K Srinath %A Refaat, Amany H %A Rehm, Jürgen %A Remuzzi, Giuseppe %A Ribeiro, Antonio L %A Riccio, Patricia M %A Richardson, Lee %A Riederer, Anne %A Robinson, Margaret %A Roca, Anna %A Rodriguez, Alina %A Rojas-Rueda, David %A Romieu, Isabelle %A Ronfani, Luca %A Room, Robin %A Roy, Nobhojit %A Ruhago, George M %A Rushton, Lesley %A Sabin, Nsanzimana %A Sacco, Ralph L %A Saha, Sukanta %A Sahathevan, Ramesh %A Sahraian, Mohammad Ali %A Salomon, Joshua A %A Salvo, Deborah %A Sampson, Uchechukwu K %A Sanabria, Juan R %A Sanchez, Luz Maria %A Sánchez-Pimienta, Tania G %A Sanchez-Riera, Lidia %A Sandar, Logan %A Santos, Itamar S %A Sapkota, Amir %A Satpathy, Maheswar %A Saunders, James E %A Sawhney, Monika %A Saylan, Mete I %A Scarborough, Peter %A Schmidt, Jürgen C %A Schneider, Ione J C %A Schöttker, Ben %A Schwebel, David C %A Scott, James G %A Seedat, Soraya %A Sepanlou, Sadaf G %A Serdar, Berrin %A Servan-Mori, Edson E %A Shaddick, Gavin %A Shahraz, Saeid %A Levy, Teresa Shamah %A Shangguan, Siyi %A She, Jun %A Sheikhbahaei, Sara %A Shibuya, Kenji %A Shin, Hwashin H %A Shinohara, Yukito %A Shiri, Rahman %A Shishani, Kawkab %A Shiue, Ivy %A Sigfusdottir, Inga D %A Silberberg, Donald H %A Simard, Edgar P %A Sindi, Shireen %A Singh, Abhishek %A Singh, Gitanjali M %A Singh, Jasvinder A %A Skirbekk, Vegard %A Sliwa, Karen %A Soljak, Michael %A Soneji, Samir %A Søreide, Kjetil %A Soshnikov, Sergey %A Sposato, Luciano A %A Sreeramareddy, Chandrashekhar T %A Stapelberg, Nicolas J C %A Stathopoulou, Vasiliki %A Steckling, Nadine %A Stein, Dan J %A Stein, Murray B %A Stephens, Natalie %A Stöckl, Heidi %A Straif, Kurt %A Stroumpoulis, Konstantinos %A Sturua, Lela %A Sunguya, Bruno F %A Swaminathan, Soumya %A Swaroop, Mamta %A Sykes, Bryan L %A Tabb, Karen M %A Takahashi, Ken %A Talongwa, Roberto T %A Tandon, Nikhil %A Tanne, David %A Tanner, Marcel %A Tavakkoli, Mohammad %A Te Ao, Braden J %A Teixeira, Carolina M %A Téllez Rojo, Martha M %A Terkawi, Abdullah S %A Texcalac-Sangrador, José Luis %A Thackway, Sarah V %A Thomson, Blake %A Thorne-Lyman, Andrew L %A Thrift, Amanda G %A Thurston, George D %A Tillmann, Taavi %A Tobollik, Myriam %A Tonelli, Marcello %A Topouzis, Fotis %A Towbin, Jeffrey A %A Toyoshima, Hideaki %A Traebert, Jefferson %A Tran, Bach X %A Trasande, Leonardo %A Trillini, Matias %A Trujillo, Ulises %A Dimbuene, Zacharie Tsala %A Tsilimbaris, Miltiadis %A Tuzcu, Emin Murat %A Uchendu, Uche S %A Ukwaja, Kingsley N %A Uzun, Selen B %A van de Vijver, Steven %A Van Dingenen, Rita %A van Gool, Coen H %A van Os, Jim %A Varakin, Yuri Y %A Vasankari, Tommi J %A Vasconcelos, Ana Maria N %A Vavilala, Monica S %A Veerman, Lennert J %A Velasquez-Melendez, Gustavo %A Venketasubramanian, N %A Vijayakumar, Lakshmi %A Villalpando, Salvador %A Violante, Francesco S %A Vlassov, Vasiliy Victorovich %A Vollset, Stein Emil %A Wagner, Gregory R %A Waller, Stephen G %A Wallin, Mitchell T %A Wan, Xia %A Wang, Haidong %A Wang, JianLi %A Wang, Linhong %A Wang, Wenzhi %A Wang, Yanping %A Warouw, Tati S %A Watts, Charlotte H %A Weichenthal, Scott %A Weiderpass, Elisabete %A Weintraub, Robert G %A Werdecker, Andrea %A Wessells, K Ryan %A Westerman, Ronny %A Whiteford, Harvey A %A Wilkinson, James D %A Williams, Hywel C %A Williams, Thomas N %A Woldeyohannes, Solomon M %A Wolfe, Charles D A %A Wong, John Q %A Woolf, Anthony D %A Wright, Jonathan L %A Wurtz, Brittany %A Xu, Gelin %A Yan, Lijing L %A Yang, Gonghuan %A Yano, Yuichiro %A Ye, Pengpeng %A Yenesew, Muluken %A Yentür, Gökalp K %A Yip, Paul %A Yonemoto, Naohiro %A Yoon, Seok-Jun %A Younis, Mustafa Z %A Younoussi, Zourkaleini %A Yu, Chuanhua %A Zaki, Maysaa E %A Zhao, Yong %A Zheng, Yingfeng %A Zhou, Maigeng %A Zhu, Jun %A Zhu, Shankuan %A Zou, Xiaonong %A Zunt, Joseph R %A Lopez, Alan D %A Vos, Theo %A Murray, Christopher J %X

BACKGROUND: The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) is the first of a series of annual updates of the GBD. Risk factor quantification, particularly of modifiable risk factors, can help to identify emerging threats to population health and opportunities for prevention. The GBD 2013 provides a timely opportunity to update the comparative risk assessment with new data for exposure, relative risks, and evidence on the appropriate counterfactual risk distribution.

METHODS: Attributable deaths, years of life lost, years lived with disability, and disability-adjusted life-years (DALYs) have been estimated for 79 risks or clusters of risks using the GBD 2010 methods. Risk-outcome pairs meeting explicit evidence criteria were assessed for 188 countries for the period 1990-2013 by age and sex using three inputs: risk exposure, relative risks, and the theoretical minimum risk exposure level (TMREL). Risks are organised into a hierarchy with blocks of behavioural, environmental and occupational, and metabolic risks at the first level of the hierarchy. The next level in the hierarchy includes nine clusters of related risks and two individual risks, with more detail provided at levels 3 and 4 of the hierarchy. Compared with GBD 2010, six new risk factors have been added: handwashing practices, occupational exposure to trichloroethylene, childhood wasting, childhood stunting, unsafe sex, and low glomerular filtration rate. For most risks, data for exposure were synthesised with a Bayesian meta-regression method, DisMod-MR 2.0, or spatial-temporal Gaussian process regression. Relative risks were based on meta-regressions of published cohort and intervention studies. Attributable burden for clusters of risks and all risks combined took into account evidence on the mediation of some risks such as high body-mass index (BMI) through other risks such as high systolic blood pressure and high cholesterol.

FINDINGS: All risks combined account for 57·2% (95% uncertainty interval [UI] 55·8-58·5) of deaths and 41·6% (40·1-43·0) of DALYs. Risks quantified account for 87·9% (86·5-89·3) of cardiovascular disease DALYs, ranging to a low of 0% for neonatal disorders and neglected tropical diseases and malaria. In terms of global DALYs in 2013, six risks or clusters of risks each caused more than 5% of DALYs: dietary risks accounting for 11·3 million deaths and 241·4 million DALYs, high systolic blood pressure for 10·4 million deaths and 208·1 million DALYs, child and maternal malnutrition for 1·7 million deaths and 176·9 million DALYs, tobacco smoke for 6·1 million deaths and 143·5 million DALYs, air pollution for 5·5 million deaths and 141·5 million DALYs, and high BMI for 4·4 million deaths and 134·0 million DALYs. Risk factor patterns vary across regions and countries and with time. In sub-Saharan Africa, the leading risk factors are child and maternal malnutrition, unsafe sex, and unsafe water, sanitation, and handwashing. In women, in nearly all countries in the Americas, north Africa, and the Middle East, and in many other high-income countries, high BMI is the leading risk factor, with high systolic blood pressure as the leading risk in most of Central and Eastern Europe and south and east Asia. For men, high systolic blood pressure or tobacco use are the leading risks in nearly all high-income countries, in north Africa and the Middle East, Europe, and Asia. For men and women, unsafe sex is the leading risk in a corridor from Kenya to South Africa.

INTERPRETATION: Behavioural, environmental and occupational, and metabolic risks can explain half of global mortality and more than one-third of global DALYs providing many opportunities for prevention. Of the larger risks, the attributable burden of high BMI has increased in the past 23 years. In view of the prominence of behavioural risk factors, behavioural and social science research on interventions for these risks should be strengthened. Many prevention and primary care policy options are available now to act on key risks.

FUNDING: Bill & Melinda Gates Foundation.

%B Lancet %V 386 %P 2287-323 %8 2015 Dec 5 %G eng %N 10010 %1 http://www.ncbi.nlm.nih.gov/pubmed/26364544?dopt=Abstract %R 10.1016/S0140-6736(15)00128-2 %0 Journal Article %J Lancet %D 2015 %T Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. %A Murray, Christopher J L %A Barber, Ryan M %A Foreman, Kyle J %A Abbasoglu Ozgoren, Ayse %A Abd-Allah, Foad %A Abera, Semaw F %A Aboyans, Victor %A Abraham, Jerry P %A Abubakar, Ibrahim %A Abu-Raddad, Laith J %A Abu-Rmeileh, Niveen M %A Achoki, Tom %A Ackerman, Ilana N %A Ademi, Zanfina %A Adou, Arsène K %A Adsuar, José C %A Afshin, Ashkan %A Agardh, Emilie E %A Alam, Sayed Saidul %A Alasfoor, Deena %A Albittar, Mohammed I %A Alegretti, Miguel A %A Alemu, Zewdie A %A Alfonso-Cristancho, Rafael %A Alhabib, Samia %A Ali, Raghib %A Alla, François %A Allebeck, Peter %A AlMazroa, Mohammad A %A Alsharif, Ubai %A Alvarez, Elena %A Alvis-Guzmán, Nelson %A Amare, Azmeraw T %A Ameh, Emmanuel A %A Amini, Heresh %A Ammar, Walid %A Anderson, H Ross %A Anderson, Benjamin O %A Antonio, Carl Abelardo T %A Anwari, Palwasha %A Arnlöv, Johan %A Arsic Arsenijevic, Valentina S %A Artaman, Al %A Asghar, Rana J %A Assadi, Reza %A Atkins, Lydia S %A Avila, Marco A %A Awuah, Baffour %A Bachman, Victoria F %A Badawi, Alaa %A Bahit, Maria C %A Balakrishnan, Kalpana %A Banerjee, Amitava %A Barker-Collo, Suzanne L %A Barquera, Simon %A Barregard, Lars %A Barrero, Lope H %A Basu, Arindam %A Basu, Sanjay %A Basulaiman, Mohammed O %A Beardsley, Justin %A Bedi, Neeraj %A Beghi, Ettore %A Bekele, Tolesa %A Bell, Michelle L %A Benjet, Corina %A Bennett, Derrick A %A Bensenor, Isabela M %A Benzian, Habib %A Bernabe, Eduardo %A Bertozzi-Villa, Amelia %A Beyene, Tariku J %A Bhala, Neeraj %A Bhalla, Ashish %A Bhutta, Zulfiqar A %A Bienhoff, Kelly %A Bikbov, Boris %A Biryukov, Stan %A Blore, Jed D %A Blosser, Christopher D %A Blyth, Fiona M %A Bohensky, Megan A %A Bolliger, Ian W %A Bora Başara, Berrak %A Bornstein, Natan M %A Bose, Dipan %A Boufous, Soufiane %A Bourne, Rupert R A %A Boyers, Lindsay N %A Brainin, Michael %A Brayne, Carol E %A Brazinova, Alexandra %A Breitborde, Nicholas J K %A Brenner, Hermann %A Briggs, Adam D %A Brooks, Peter M %A Brown, Jonathan C %A Brugha, Traolach S %A Buchbinder, Rachelle %A Buckle, Geoffrey C %A Budke, Christine M %A Bulchis, Anne %A Bulloch, Andrew G %A Campos-Nonato, Ismael R %A Carabin, Hélène %A Carapetis, Jonathan R %A Cárdenas, Rosario %A Carpenter, David O %A Caso, Valeria %A Castañeda-Orjuela, Carlos A %A Castro, Ruben E %A Catalá-López, Ferrán %A Cavalleri, Fiorella %A Cavlin, Alanur %A Chadha, Vineet K %A Chang, Jung-Chen %A Charlson, Fiona J %A Chen, Honglei %A Chen, Wanqing %A Chiang, Peggy P %A Chimed-Ochir, Odgerel %A Chowdhury, Rajiv %A Christensen, Hanne %A Christophi, Costas A %A Cirillo, Massimo %A Coates, Matthew M %A Coffeng, Luc E %A Coggeshall, Megan S %A Colistro, Valentina %A Colquhoun, Samantha M %A Cooke, Graham S %A Cooper, Cyrus %A Cooper, Leslie T %A Coppola, Luis M %A Cortinovis, Monica %A Criqui, Michael H %A Crump, John A %A Cuevas-Nasu, Lucia %A Danawi, Hadi %A Dandona, Lalit %A Dandona, Rakhi %A Dansereau, Emily %A Dargan, Paul I %A Davey, Gail %A Davis, Adrian %A Davitoiu, Dragos V %A Dayama, Anand %A De Leo, Diego %A Degenhardt, Louisa %A del Pozo-Cruz, Borja %A Dellavalle, Robert P %A Deribe, Kebede %A Derrett, Sarah %A Des Jarlais, Don C %A Dessalegn, Muluken %A Dharmaratne, Samath D %A Dherani, Mukesh K %A Diaz-Torné, Cesar %A Dicker, Daniel %A Ding, Eric L %A Dokova, Klara %A Dorsey, E Ray %A Driscoll, Tim R %A Duan, Leilei %A Duber, Herbert C %A Ebel, Beth E %A Edmond, Karen M %A Elshrek, Yousef M %A Endres, Matthias %A Ermakov, Sergey P %A Erskine, Holly E %A Eshrati, Babak %A Esteghamati, Alireza %A Estep, Kara %A Faraon, Emerito Jose A %A Farzadfar, Farshad %A Fay, Derek F %A Feigin, Valery L %A Felson, David T %A Fereshtehnejad, Seyed-Mohammad %A Fernandes, Jefferson G %A Ferrari, Alize J %A Fitzmaurice, Christina %A Flaxman, Abraham D %A Fleming, Thomas D %A Foigt, Nataliya %A Forouzanfar, Mohammad H %A Fowkes, F Gerry R %A Paleo, Urbano Fra %A Franklin, Richard C %A Fürst, Thomas %A Gabbe, Belinda %A Gaffikin, Lynne %A Gankpé, Fortuné G %A Geleijnse, Johanna M %A Gessner, Bradford D %A Gething, Peter %A Gibney, Katherine B %A Giroud, Maurice %A Giussani, Giorgia %A Gomez Dantes, Hector %A Gona, Philimon %A Gonzalez-Medina, Diego %A Gosselin, Richard A %A Gotay, Carolyn C %A Goto, Atsushi %A Gouda, Hebe N %A Graetz, Nicholas %A Gugnani, Harish C %A Gupta, Rahul %A Gupta, Rajeev %A Gutiérrez, Reyna A %A Haagsma, Juanita %A Hafezi-Nejad, Nima %A Hagan, Holly %A Halasa, Yara A %A Hamadeh, Randah R %A Hamavid, Hannah %A Hammami, Mouhanad %A Hancock, Jamie %A Hankey, Graeme J %A Hansen, Gillian M %A Hao, Yuantao %A Harb, Hilda L %A Haro, Josep Maria %A Havmoeller, Rasmus %A Hay, Simon I %A Hay, Roderick J %A Heredia-Pi, Ileana B %A Heuton, Kyle R %A Heydarpour, Pouria %A Higashi, Hideki %A Hijar, Martha %A Hoek, Hans W %A Hoffman, Howard J %A Hosgood, H Dean %A Hossain, Mazeda %A Hotez, Peter J %A Hoy, Damian G %A Hsairi, Mohamed %A Hu, Guoqing %A Huang, Cheng %A Huang, John J %A Husseini, Abdullatif %A Huynh, Chantal %A Iannarone, Marissa L %A Iburg, Kim M %A Innos, Kaire %A Inoue, Manami %A Islami, Farhad %A Jacobsen, Kathryn H %A Jarvis, Deborah L %A Jassal, Simerjot K %A Jee, Sun Ha %A Jeemon, Panniyammakal %A Jensen, Paul N %A Jha, Vivekanand %A Jiang, Guohong %A Jiang, Ying %A Jonas, Jost B %A Juel, Knud %A Kan, Haidong %A Karch, André %A Karema, Corine K %A Karimkhani, Chante %A Karthikeyan, Ganesan %A Kassebaum, Nicholas J %A Kaul, Anil %A Kawakami, Norito %A Kazanjan, Konstantin %A Kemp, Andrew H %A Kengne, Andre P %A Keren, Andre %A Khader, Yousef S %A Khalifa, Shams Eldin A %A Khan, Ejaz A %A Khan, Gulfaraz %A Khang, Young-Ho %A Kieling, Christian %A Kim, Daniel %A Kim, Sungroul %A Kim, Yunjin %A Kinfu, Yohannes %A Kinge, Jonas M %A Kivipelto, Miia %A Knibbs, Luke D %A Knudsen, Ann Kristin %A Kokubo, Yoshihiro %A Kosen, Soewarta %A Krishnaswami, Sanjay %A Kuate Defo, Barthelemy %A Kucuk Bicer, Burcu %A Kuipers, Ernst J %A Kulkarni, Chanda %A Kulkarni, Veena S %A Kumar, G Anil %A Kyu, Hmwe H %A Lai, Taavi %A Lalloo, Ratilal %A Lallukka, Tea %A Lam, Hilton %A Lan, Qing %A Lansingh, Van C %A Larsson, Anders %A Lawrynowicz, Alicia E B %A Leasher, Janet L %A Leigh, James %A Leung, Ricky %A Levitz, Carly E %A Li, Bin %A Li, Yichong %A Li, Yongmei %A Lim, Stephen S %A Lind, Maggie %A Lipshultz, Steven E %A Liu, Shiwei %A Liu, Yang %A Lloyd, Belinda K %A Lofgren, Katherine T %A Logroscino, Giancarlo %A Looker, Katharine J %A Lortet-Tieulent, Joannie %A Lotufo, Paulo A %A Lozano, Rafael %A Lucas, Robyn M %A Lunevicius, Raimundas %A Lyons, Ronan A %A Ma, Stefan %A MacIntyre, Michael F %A Mackay, Mark T %A Majdan, Marek %A Malekzadeh, Reza %A Marcenes, Wagner %A Margolis, David J %A Margono, Christopher %A Marzan, Melvin B %A Masci, Joseph R %A Mashal, Mohammad T %A Matzopoulos, Richard %A Mayosi, Bongani M %A Mazorodze, Tasara T %A Mcgill, Neil W %A McGrath, John J %A McKee, Martin %A McLain, Abigail %A Meaney, Peter A %A Medina, Catalina %A Mehndiratta, Man Mohan %A Mekonnen, Wubegzier %A Melaku, Yohannes A %A Meltzer, Michele %A Memish, Ziad A %A Mensah, George A %A Meretoja, Atte %A Mhimbira, Francis A %A Micha, Renata %A Miller, Ted R %A Mills, Edward J %A Mitchell, Philip B %A Mock, Charles N %A Mohamed Ibrahim, Norlinah %A Mohammad, Karzan A %A Mokdad, Ali H %A Mola, Glen L D %A Monasta, Lorenzo %A Montañez Hernandez, Julio C %A Montico, Marcella %A Montine, Thomas J %A Mooney, Meghan D %A Moore, Ami R %A Moradi-Lakeh, Maziar %A Moran, Andrew E %A Mori, Rintaro %A Moschandreas, Joanna %A Moturi, Wilkister N %A Moyer, Madeline L %A Mozaffarian, Dariush %A Msemburi, William T %A Mueller, Ulrich O %A Mukaigawara, Mitsuru %A Mullany, Erin C %A Murdoch, Michele E %A Murray, Joseph %A Murthy, Kinnari S %A Naghavi, Mohsen %A Naheed, Aliya %A Naidoo, Kovin S %A Naldi, Luigi %A Nand, Devina %A Nangia, Vinay %A Narayan, K M Venkat %A Nejjari, Chakib %A Neupane, Sudan P %A Newton, Charles R %A Ng, Marie %A Ngalesoni, Frida N %A Nguyen, Grant %A Nisar, Muhammad I %A Nolte, Sandra %A Norheim, Ole F %A Norman, Rosana E %A Norrving, Bo %A Nyakarahuka, Luke %A Oh, In-Hwan %A Ohkubo, Takayoshi %A Ohno, Summer L %A Olusanya, Bolajoko O %A Opio, John Nelson %A Ortblad, Katrina %A Ortiz, Alberto %A Pain, Amanda W %A Pandian, Jeyaraj D %A Panelo, Carlo Irwin A %A Papachristou, Christina %A Park, Eun-Kee %A Park, Jae-Hyun %A Patten, Scott B %A Patton, George C %A Paul, Vinod K %A Pavlin, Boris I %A Pearce, Neil %A Pereira, David M %A Perez-Padilla, Rogelio %A Perez-Ruiz, Fernando %A Perico, Norberto %A Pervaiz, Aslam %A Pesudovs, Konrad %A Peterson, Carrie B %A Petzold, Max %A Phillips, Michael R %A Phillips, Bryan K %A Phillips, David E %A Piel, Frédéric B %A Plass, Dietrich %A Poenaru, Dan %A Polinder, Suzanne %A Pope, Daniel %A Popova, Svetlana %A Poulton, Richie G %A Pourmalek, Farshad %A Prabhakaran, Dorairaj %A Prasad, Noela M %A Pullan, Rachel L %A Qato, Dima M %A Quistberg, D Alex %A Rafay, Anwar %A Rahimi, Kazem %A Rahman, Sajjad U %A Raju, Murugesan %A Rana, Saleem M %A Razavi, Homie %A Reddy, K Srinath %A Refaat, Amany %A Remuzzi, Giuseppe %A Resnikoff, Serge %A Ribeiro, Antonio L %A Richardson, Lee %A Richardus, Jan Hendrik %A Roberts, D Allen %A Rojas-Rueda, David %A Ronfani, Luca %A Roth, Gregory A %A Rothenbacher, Dietrich %A Rothstein, David H %A Rowley, Jane T %A Roy, Nobhojit %A Ruhago, George M %A Saeedi, Mohammad Y %A Saha, Sukanta %A Sahraian, Mohammad Ali %A Sampson, Uchechukwu K A %A Sanabria, Juan R %A Sandar, Logan %A Santos, Itamar S %A Satpathy, Maheswar %A Sawhney, Monika %A Scarborough, Peter %A Schneider, Ione J %A Schöttker, Ben %A Schumacher, Austin E %A Schwebel, David C %A Scott, James G %A Seedat, Soraya %A Sepanlou, Sadaf G %A Serina, Peter T %A Servan-Mori, Edson E %A Shackelford, Katya A %A Shaheen, Amira %A Shahraz, Saeid %A Shamah Levy, Teresa %A Shangguan, Siyi %A She, Jun %A Sheikhbahaei, Sara %A Shi, Peilin %A Shibuya, Kenji %A Shinohara, Yukito %A Shiri, Rahman %A Shishani, Kawkab %A Shiue, Ivy %A Shrime, Mark G %A Sigfusdottir, Inga D %A Silberberg, Donald H %A Simard, Edgar P %A Sindi, Shireen %A Singh, Abhishek %A Singh, Jasvinder A %A Singh, Lavanya %A Skirbekk, Vegard %A Slepak, Erica Leigh %A Sliwa, Karen %A Soneji, Samir %A Søreide, Kjetil %A Soshnikov, Sergey %A Sposato, Luciano A %A Sreeramareddy, Chandrashekhar T %A Stanaway, Jeffrey D %A Stathopoulou, Vasiliki %A Stein, Dan J %A Stein, Murray B %A Steiner, Caitlyn %A Steiner, Timothy J %A Stevens, Antony %A Stewart, Andrea %A Stovner, Lars J %A Stroumpoulis, Konstantinos %A Sunguya, Bruno F %A Swaminathan, Soumya %A Swaroop, Mamta %A Sykes, Bryan L %A Tabb, Karen M %A Takahashi, Ken %A Tandon, Nikhil %A Tanne, David %A Tanner, Marcel %A Tavakkoli, Mohammad %A Taylor, Hugh R %A Te Ao, Braden J %A Tediosi, Fabrizio %A Temesgen, Awoke M %A Templin, Tara %A Ten Have, Margreet %A Tenkorang, Eric Y %A Terkawi, Abdullah S %A Thomson, Blake %A Thorne-Lyman, Andrew L %A Thrift, Amanda G %A Thurston, George D %A Tillmann, Taavi %A Tonelli, Marcello %A Topouzis, Fotis %A Toyoshima, Hideaki %A Traebert, Jefferson %A Tran, Bach X %A Trillini, Matias %A Truelsen, Thomas %A Tsilimbaris, Miltiadis %A Tuzcu, Emin M %A Uchendu, Uche S %A Ukwaja, Kingsley N %A Undurraga, Eduardo A %A Uzun, Selen B %A Van Brakel, Wim H %A van de Vijver, Steven %A van Gool, Coen H %A van Os, Jim %A Vasankari, Tommi J %A Venketasubramanian, N %A Violante, Francesco S %A Vlassov, Vasiliy V %A Vollset, Stein Emil %A Wagner, Gregory R %A Wagner, Joseph %A Waller, Stephen G %A Wan, Xia %A Wang, Haidong %A Wang, JianLi %A Wang, Linhong %A Warouw, Tati S %A Weichenthal, Scott %A Weiderpass, Elisabete %A Weintraub, Robert G %A Wenzhi, Wang %A Werdecker, Andrea %A Westerman, Ronny %A Whiteford, Harvey A %A Wilkinson, James D %A Williams, Thomas N %A Wolfe, Charles D %A Wolock, Timothy M %A Woolf, Anthony D %A Wulf, Sarah %A Wurtz, Brittany %A Xu, Gelin %A Yan, Lijing L %A Yano, Yuichiro %A Ye, Pengpeng %A Yentür, Gökalp K %A Yip, Paul %A Yonemoto, Naohiro %A Yoon, Seok-Jun %A Younis, Mustafa Z %A Yu, Chuanhua %A Zaki, Maysaa E %A Zhao, Yong %A Zheng, Yingfeng %A Zonies, David %A Zou, Xiaonong %A Salomon, Joshua A %A Lopez, Alan D %A Vos, Theo %K Aged %K Chronic Disease %K Communicable Diseases %K Female %K Global Health %K Health Transition %K Humans %K Life Expectancy %K Male %K Middle Aged %K Mortality, Premature %K Quality-Adjusted Life Years %K Socioeconomic Factors %K Wounds and Injuries %X

BACKGROUND: The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age-sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic development.

METHODS: We used the published GBD 2013 data for age-specific mortality, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) to calculate DALYs and HALE for 1990, 1995, 2000, 2005, 2010, and 2013 for 188 countries. We calculated HALE using the Sullivan method; 95% uncertainty intervals (UIs) represent uncertainty in age-specific death rates and YLDs per person for each country, age, sex, and year. We estimated DALYs for 306 causes for each country as the sum of YLLs and YLDs; 95% UIs represent uncertainty in YLL and YLD rates. We quantified patterns of the epidemiological transition with a composite indicator of sociodemographic status, which we constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population. We applied hierarchical regression to DALY rates by cause across countries to decompose variance related to the sociodemographic status variable, country, and time.

FINDINGS: Worldwide, from 1990 to 2013, life expectancy at birth rose by 6·2 years (95% UI 5·6-6·6), from 65·3 years (65·0-65·6) in 1990 to 71·5 years (71·0-71·9) in 2013, HALE at birth rose by 5·4 years (4·9-5·8), from 56·9 years (54·5-59·1) to 62·3 years (59·7-64·8), total DALYs fell by 3·6% (0·3-7·4), and age-standardised DALY rates per 100 000 people fell by 26·7% (24·6-29·1). For communicable, maternal, neonatal, and nutritional disorders, global DALY numbers, crude rates, and age-standardised rates have all declined between 1990 and 2013, whereas for non-communicable diseases, global DALYs have been increasing, DALY rates have remained nearly constant, and age-standardised DALY rates declined during the same period. From 2005 to 2013, the number of DALYs increased for most specific non-communicable diseases, including cardiovascular diseases and neoplasms, in addition to dengue, food-borne trematodes, and leishmaniasis; DALYs decreased for nearly all other causes. By 2013, the five leading causes of DALYs were ischaemic heart disease, lower respiratory infections, cerebrovascular disease, low back and neck pain, and road injuries. Sociodemographic status explained more than 50% of the variance between countries and over time for diarrhoea, lower respiratory infections, and other common infectious diseases; maternal disorders; neonatal disorders; nutritional deficiencies; other communicable, maternal, neonatal, and nutritional diseases; musculoskeletal disorders; and other non-communicable diseases. However, sociodemographic status explained less than 10% of the variance in DALY rates for cardiovascular diseases; chronic respiratory diseases; cirrhosis; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; and self-harm and interpersonal violence. Predictably, increased sociodemographic status was associated with a shift in burden from YLLs to YLDs, driven by declines in YLLs and increases in YLDs from musculoskeletal disorders, neurological disorders, and mental and substance use disorders. In most country-specific estimates, the increase in life expectancy was greater than that in HALE. Leading causes of DALYs are highly variable across countries.

INTERPRETATION: Global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health does not mean fewer demands on health systems. The notion of an epidemiological transition--in which increasing sociodemographic status brings structured change in disease burden--is useful, but there is tremendous variation in burden of disease that is not associated with sociodemographic status. This further underscores the need for country-specific assessments of DALYs and HALE to appropriately inform health policy decisions and attendant actions.

FUNDING: Bill & Melinda Gates Foundation.

%B Lancet %V 386 %P 2145-91 %8 2015 Nov 28 %G eng %N 10009 %1 http://www.ncbi.nlm.nih.gov/pubmed/26321261?dopt=Abstract %R 10.1016/S0140-6736(15)61340-X %0 Journal Article %J Pharmacogenomics %D 2015 %T Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome. %A Cuzzoni, Eva %A De Iudicibus, Sara %A Franca, Raffaella %A Stocco, Gabriele %A Lucafò, Marianna %A Pelin, Marco %A Favretto, Diego %A Pasini, Andrea %A Montini, Giovanni %A Decorti, Giuliana %X

Idiopathic nephrotic syndrome represents the most common type of primary glomerular disease in children: glucocorticoids (GCs) are the first-line therapy, even if considerable interindividual differences in thepir efficacy and side effects have been reported. Immunosuppressive and anti-inflammatory effects of these drugs are mainly due to the GC-mediated transcription regulation of pro- and anti-inflammatory genes. This mechanism of action is the result of a complex multistep pathway that involves the glucocorticoid receptor and several other proteins, encoded by polymorphic genes. Aim of this review is to highlight the current knowledge on genetic variants that could affect GC response, particularly focusing on children with idiopathic nephrotic syndrome.

%B Pharmacogenomics %V 16 %P 1631-48 %8 2015 Sep %G eng %N 14 %1 http://www.ncbi.nlm.nih.gov/pubmed/26419298?dopt=Abstract %R 10.2217/pgs.15.101 %0 Journal Article %J Rheumatol Int %D 2015 %T GRID2 a novel gene possibly associated with mevalonate kinase deficiency. %A Moura, Ronald %A Tricarico, Paola Maura %A Campos Coelho, Antonio Victor %A Crovella, Sergio %X

Mevalonate kinase deficiency (MKD) is a rare autosomal disease caused by mutations in the mevalonate kinase gene (MVK). The genotype-phenotype correlation is sometimes problematic due to the great genetic and clinical heterogeneity; so we hypothesize that genes other than MVK are able to modulate MKD clinical phenotypes. This hypothesis was tested by analyzing the exome of 22 patients with MKD all carrying MVK gene mutations, and 20 patients with recurrent fevers (RF) not carrying MVK mutations. Our preliminary findings suggest a possible role of GRID2 in the susceptibility to develop MKD. GRID2 gene (4q22.2), encoding for human glutamate receptor delta-2, associated with MKD: The rs1450500 SNP was differently distributed in patients with MKD with respect to those with RF. Being aware of the small number of patients analyzed, we hypothesized a possible role for GRID2 as possible phenotype modifier in MKD patients, especially in those with severe phenotypes.

%B Rheumatol Int %V 35 %P 657-9 %8 2015 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25146332?dopt=Abstract %R 10.1007/s00296-014-3115-y %0 Journal Article %J Surgery %D 2015 %T Handlebar injury in children: The hidden danger. %A Pederiva, Federica %A Guida, Edoardo %A Maschio, Massimo %A Rigamonti, Waifro %A Gregori, Massimo %A Codrich, Daniela %B Surgery %8 2015 Sep 18 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26387787?dopt=Abstract %R 10.1016/j.surg.2015.08.009 %0 Journal Article %J Hum Immunol %D 2015 %T HLA-G and susceptibility to develop celiac disease. %A Catamo, Eulalia %A Zupin, Luisa %A Segat, Ludovica %A Celsi, Fulvio %A Crovella, Sergio %K Adolescent %K Adult %K Alleles %K Case-Control Studies %K Celiac Disease %K Child %K Female %K Gene Frequency %K Genetic Predisposition to Disease %K Haplotypes %K HLA-DQ Antigens %K HLA-G Antigens %K Humans %K Male %K Middle Aged %K Polymorphism, Genetic %K Retrospective Studies %X

The Human Leukocyte Antigen-G has immunomodulatory function and its expression has been associated with several diseases. In our study we analyzed HLA-G polymorphisms in order to evaluate their possible association with susceptibility to celiac disease development. A total of 420 celiac patients and 509 controls were genotyped for HLA-G polymorphisms. We sequenced 800bp upstream the ATG codon (5' upstream regulatory region) and the whole 3' untranslated region of the HLA-G gene, whereas the ΔC deletion at exon 3 was detected by RFLP-PCR. Five polymorphisms (namely -477 C>G, -369 C>A, 14bp del/ins, 3187 A>G, 3196 C>G) and one haplotype (TCGGTACGAAITCCCGAG) were significantly more frequent in celiac patients than controls and associated with increased disease susceptibility. The 14bp I/I, 3187 G/G, 3196 G/G genotypes and TCGGTACGAAITCCCGAG haplotype, were still significantly associated with increased disease susceptibility (and in addition also the 3003 C/C genotype) when the analysis was restricted to patients and controls presenting the DQ2.5 or DQ8 HLA-DQ celiac disease risk haplotypes. Our findings indicate an association between HLA-G gene polymorphisms and susceptibility to celiac disease development, suggesting that HLA-G molecule is possibly involved in the pathogenesis of the disease.

%B Hum Immunol %V 76 %P 36-41 %8 2015 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25500250?dopt=Abstract %R 10.1016/j.humimm.2014.12.006 %0 Journal Article %J Int J Environ Res Public Health %D 2015 %T An IBCLC in the Maternity Ward of a Mother and Child Hospital: A Pre- and Post-Intervention Study. %A Chiurco, Antonella %A Montico, Marcella %A Brovedani, Pierpaolo %A Monasta, Lorenzo %A Davanzo, Riccardo %X

Published evidence on the impact of the integration of International Board Certified Lactation Consultants (IBCLCs) for breastfeeding promotion is growing, but still relatively limited. Our study aims at evaluating the effects of adding an IBCLC for breastfeeding support in a mother and child hospital environment. We conducted a prospective study in the maternity ward of our maternal and child health Institute, recruiting 402 mothers of healthy term newborns soon after birth. The 18-month intervention of the IBCLC (Phase II) was preceded (Phase I) by data collection on breastfeeding rates and factors related to breastfeeding, both at hospital discharge and two weeks later. Data collection was replicated just before the end of the intervention (Phase III). In Phase III, a significantly higher percentage of mothers: (a) received help to breastfeed, and also received correct information on breastfeeding and community support, (b) started breastfeeding within two hours from delivery, (c) reported a good experience with the hospital staff. Moreover, the frequency of sore and/or cracked nipples was significantly lower in Phase III. However, no difference was found in exclusive breastfeeding rates at hospital discharge or at two weeks after birth.

%B Int J Environ Res Public Health %V 12 %P 9938-51 %8 2015 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/26308018?dopt=Abstract %R 10.3390/ijerph120809938 %0 Journal Article %J J Eur Acad Dermatol Venereol %D 2015 %T Identification of a novel frameshift mutation in the EDAR gene causing autosomal dominant hypohidrotic ectodermal dysplasia. %A Callea, M %A Willoughby, C E %A Nieminen, P %A Di Stazio, M %A Bellacchio, E %A Giglio, S %A Sani, I %A Vinciguerra, A %A Maglione, M %A Tadini, G %A Clarich, G %B J Eur Acad Dermatol Venereol %V 29 %P 1032-4 %8 2015 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/24641098?dopt=Abstract %R 10.1111/jdv.12457 %0 Journal Article %J Cancer %D 2015 %T Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40. %A Tognon, Mauro %A Luppi, Mario %A Corallini, Alfredo %A Taronna, Angelo %A Barozzi, Patrizia %A Rotondo, John Charles %A Comar, Manola %A Casali, Maria Vittoria %A Bovenzi, Massimo %A D'Agostino, Antonio %A Vinante, Fabrizio %A Rigo, Antonella %A Ferrarini, Isacco %A Barbanti-Brodano, Giuseppe %A Martini, Fernanda %A Mazzoni, Elisa %K Adult %K Aged %K Antibodies, Viral %K Capsid Proteins %K Enzyme-Linked Immunosorbent Assay %K Female %K Humans %K Lymphoma, Non-Hodgkin %K Male %K Middle Aged %K Polyomavirus Infections %K Seroepidemiologic Studies %K Simian virus 40 %K Tumor Virus Infections %X

BACKGROUND: Non-Hodgkin lymphoma (NHL), the most common cancer of the lymphatic system, is of unknown etiology. The identification of etiologic factors in the onset of NHL is a key event that could facilitate the prevention and cure of this malignancy. Simian virus 40 (SV40) has been considered an oncogenic agent in the onset/progression of NHL.

METHODS: In this study, an indirect enzyme-linked immunosorbent assay with 2 synthetic peptides that mimic SV40 antigens of viral capsid proteins 1 to 3 was employed to detect specific antibodies against SV40. Serum samples were taken from 2 distinct cohorts of NHL-affected patients (NHL1 [n = 89] and NHL2 [n = 61]) along with controls represented by oncologic patients affected by breast cancer (BC; n = 78) and undifferentiated nasopharyngeal carcinoma (UNPC; n = 64) and 3 different cohorts of healthy subjects (HSs; HS1 [n = 130], HS2 [n = 83], and HS3 [n = 87]).

RESULTS: Immunologic data indicated that in serum samples from NHL patients, antibodies against SV40 mimotopes were detectable with a prevalence of 40% in NHL1 patients and with a prevalence of 43% in NHL2 patients. In HSs of the same median age as NHL patients, the prevalence was 16% for the HS1 group (57 years) and 14% for the HS2 group (65 years). The difference was statistically significant (P < .0001 and P < .001). Interestingly, the difference between NHL1/NHL2 patients and BC patients (40%/43% vs 15%, P < .001) and between NHL1/NHL2 patients and UNPC patients (40%/43% vs 25%, P < .05) was significant.

CONCLUSIONS: Our data indicate a strong association between NHL and SV40 and thus a need for innovative therapeutic approaches for this hematologic malignancy.

%B Cancer %V 121 %P 2618-26 %8 2015 Aug 1 %G eng %N 15 %1 http://www.ncbi.nlm.nih.gov/pubmed/25877010?dopt=Abstract %R 10.1002/cncr.29404 %0 Journal Article %J Arch Oral Biol %D 2015 %T Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration. %A Polesello, Vania %A Zupin, Luisa %A Di Lenarda, Roberto %A Biasotto, Matteo %A Ottaviani, Giulia %A Gobbo, Margherita %A Cecco, Luca %A Alberi, Giulia %A Pozzato, Gabriele %A Crovella, Sergio %A Segat, Ludovica %X

OBJECTIVES: Human β-defensin 1 (hBD-1) is an antimicrobial peptide involved in epithelial defence of various tissues, also present in the saliva. Individual genetic variations within the DEFB1 gene, encoding for hBD-1, could influence gene expression and protein production.

DESIGN: Three DEFB1 polymorphisms at 5' untranslated region (UTR), -52G > A (rs1799946), -44C > G (rs1800972) and -20G > A (rs11362), and two polymorphisms at DEFB1 3' UTR, c*5G > A (rs1047031) and c*87A > G (rs1800971), were analysed by direct sequencing and correlated with hDB-1 salivary concentration (tested with enzyme-linked immunosorbent assay (ELISA)) in 40 healthy subjects.

RESULTS: Significant associations were found between individuals presenting different DEFB1 polymorphisms at positions -52 and -44 of the gene and hBD-1 salivary concentrations: -52 G/G carriers had higher levels of protein than G/A and A/A; -44C/G subjects showed a higher protein concentration than homozygous wild-type C/C. For the -20G > A, c*5G > A and c*87A > G polymorphisms, no statistically significant differences were found. Combined haplotype analysis confirmed the results obtained considering the single-nucleotide polymorphisms (SNPs) singularly.

CONCLUSION: Polymorphisms in the DEFB1 gene influence hBD-1 production and, therefore, could modify the innate immune system responses and, consequently, the oral health.

%B Arch Oral Biol %V 60 %P 1054-8 %8 2015 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/25939140?dopt=Abstract %R 10.1016/j.archoralbio.2015.03.009 %0 Journal Article %J J Pediatr %D 2015 %T Impact of Surgery for Neonatal Gastrointestinal Diseases on Weight and Fat Mass. %A De Cunto, Angela %A Paviotti, Giulia %A Travan, Laura %A Bua, Jenny %A Cont, Gabriele %A Demarini, Sergio %X

OBJECTIVE: To compare growth, fat mass (FM), and fat-free mass in surgical infants vs matched controls at similar postconceptional age (PCA).

STUDY DESIGN: Anthropometric and body composition measurements by air-displacement plethysmography (PeaPod-Infant Body Composition System; LMI, Concord, California) were performed at the same PCA in 21 infants who received gastrointestinal surgery and in 21 controls matched for gestational age, birth weight, and sex.

RESULTS: Despite similar anthropometry at birth, postsurgical infants were shorter (50.4 [4.7] cm vs 53.2 [4.1] cm, P = .001), lighter (3516 [743] g vs 3946 [874] g, P < .001), and had lower FM content (%FM 14.8 [4.7]% vs 20.2 [5.8]%, P < .0001) than their peers at similar PCA (43 [4] weeks). All surgical infants but 1 (20/21) received parenteral nutrition (PN). Mean PN duration was 40 (30) days. Five infants in the control group received PN because of prematurity for 15 (9-30) days. Nine infants in the surgical group and 1 in the control group had PN-associated cholestasis.

CONCLUSIONS: Neonates having surgery for gastrointestinal diseases were shorter, had lower weight, and lower FM content than their peers, despite receiving more PN. Body composition evaluation and monitoring may help optimize growth in these newborns.

%B J Pediatr %V 167 %P 568-71 %8 2015 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26148657?dopt=Abstract %R 10.1016/j.jpeds.2015.06.013 %0 Journal Article %J Cytokine %D 2015 %T Impaired immune response to Candida albicans in cells from Fanconi anemia patients. %A Parodi, Alessia %A Kalli, Francesca %A Svahn, Johanna %A Stroppiana, Giorgia %A De Rocco, Daniela %A Terranova, Paola %A Dufour, Carlo %A Fenoglio, Daniela %A Cappelli, Enrico %K Adolescent %K Candida albicans %K CD8-Positive T-Lymphocytes %K Cell Proliferation %K Cells, Cultured %K Child %K Child, Preschool %K Cytokines %K Fanconi Anemia %K Humans %K Immunity %K Infant %K Young Adult %X

Fanconi anemia (FA) is a genetic disorder characterized by bone marrow failure and cancer predisposition. Several studies show alterations of the immunological status of FA patients including defects in peripheral blood lymphocyte subsets, serum immunoglobulin levels, and inflammatory cytokines. However scanty information is available on the response of FA cells to specific infectious antigens. In this work we examined the response of FA cells to different immunological stimuli and found a defective response of IL-1β, TNF-α and IL-17 to Candida albicans stimulation thus pointing to a potentially impaired response to fungal infections of FA patients.

%B Cytokine %V 73 %P 203-7 %8 2015 May %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25769809?dopt=Abstract %R 10.1016/j.cyto.2015.02.016 %0 Journal Article %J Congenit Heart Dis %D 2015 %T Insights from Cardiac Mechanics after Three Decades from Successfully Repaired Aortic Coarctation. %A Faganello, Giorgio %A Fisicaro, Maurizio %A Russo, Giulia %A Iorio, Anita %A Mazzone, Carmine %A Grande, Eliana %A Humar, Franco %A Cherubini, Antonella %A Pandullo, Claudio %A Barbati, Giulia %A Tarantini, Luigi %A Benettoni, Alessandra %A Pozzi, Marco %A Di Lenarda, Andrea %A Cioffi, Giovanni %X

BACKGROUND AND AIMS: Patients who underwent a successful repair of the aortic coarctation show chronic hyperdynamic state and normal left ventricular (LV) geometry; however, there are few data regarding the LV systolic function in the long term. Accordingly, we assessed LV systolic mechanics and factors associated with LV systolic dysfunction (LVSD) in patients with repaired CoA.

METHODS: Clinical and echocardiographic data from 19 repaired CoA were analyzed 28 ± 13 years after surgery. Stress-corrected midwall shortening (sc-MS) and mitral annular peak systolic velocity (S') were analyzed as indexes of LV circumferential and longitudinal systolic function, respectively. Echocardiographic data of CoA patients were compared with 19 patients matched for age and hypertension and 38 healthy controls. Sc-MS was considered impaired if <89%, S' if <8.5 cm/s (10th percentiles of healthy controls, respectively).

RESULTS: There were no statistical differences between study groups in LV volumes, mass and geometry. LV ejection fraction and Sc-MS were similar in all groups, however, CoA group had a significantly lower peak S' in comparison with matched and healthy controls (7.1 ± 1.3, 10.3 ± 1.9, and 11.1 ± 1.5, respectively; all P < 0.001). Prevalence of longitudinal LVSD defined as low S' was 84% in CoA, 13% in matched, and 5% in healthy control group (all P<0.05). Multivariate logistic regression analysis revealed that low peak S' was independently related to higher E/E' ratio and the presence of CoA.

CONCLUSIONS: Patients who underwent a successful repair of CoA commonly show asymptomatic longitudinal LVSD associated with worse LV diastolic function in the long-term follow-up.

%B Congenit Heart Dis %8 2015 Nov 11 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26554640?dopt=Abstract %R 10.1111/chd.12310 %0 Journal Article %J Mol Biol Rep %D 2015 %T Interleukin-18 gene promoter polymorphisms and celiac disease in Italian patients. %A Zupin, Luisa %A Catamo, Eulalia %A Polesello, Vania %A Crovella, Sergio %A Segat, Ludovica %X

Celiac disease (CD) is the most common food-sensitive enteropathy in genetically susceptible individuals. The major genetic risk factors known are specific human leukocyte antigen (HLA)-DQ haplotypes, but other genetic factors are supposed to be involved. Interleukin-18 (IL-18) is a pro-inflammatory cytokine that has an important role in the immune defense and it has the potential to influence inflammatory disorders. IL-18 is able to promote Th1 cell development and it is expressed in the mucosa of the small intestine in celiac patients. Given the IL-18 biological role, and since a few studies have previously suggested its involvement in CD, in order to investigate the role of IL18 gene in the susceptibility to CD we have performed a case-control study, analyzing two IL18 gene promoter polymorphisms, previously reported to impair the transcriptional activity of the gene, (-137G > C and -607C > A, rs187238 and rs1946518 respectively). A total of 556 CD Italian patients and 582 controls, further stratified for HLA class II (DQ) CD risk haplotypes were enrolled. The -607A > C A allele and A/A genotype, as well as the combination of this allele with the -137G allele in the AG haplotype, were associated with an increased risk towards CD development, in particular in HLA-DQ2.2 patients. Although the association was very moderate, our results indicate the possible involvement of IL18 gene in the susceptibility to CD, and for this reason we do think it should deserve further investigation.

%B Mol Biol Rep %V 42 %P 525-33 %8 2015 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25374428?dopt=Abstract %R 10.1007/s11033-014-3796-z %0 Journal Article %J Tissue Antigens %D 2015 %T Interleukin-18, interleukin-12B and interferon-γ gene polymorphisms in Brazilian patients with rheumatoid arthritis: a pilot study. %A Angelo, H D %A Gomes Silva, I I F %A Oliveira, R D R %A Louzada-Júnior, P %A Donadi, E A %A Crovella, S %A Maia, M M D %A de Souza, P R E %A Sandrin-Garcia, P %X

Polymorphisms in interleukin (IL)-18, IL-12 and interferon (IFN)-γ genes are associated with different levels of cytokines expression and have been associated with rheumatoid arthritis (RA). IL-18 +105 A/C, IL-12B +1188 A/C and IFN-γ +874 T/A polymorphisms were analyzed by restriction fragment length polymorphism-polymerase chain reaction (PCR) and amplification refractory mutation system PCR from 90 RA patients and 186 healthy individuals. There were significant differences to IL-18 +105 A/C polymorphism between the RA and control groups (odds ratio = 3.77; P < 0.0001). Individual carriers of the variant allele C had a 3.77-fold increased risk of for RA (P = 0.0032). No association was observed for IL-12B and IFN-γ polymorphisms. Our finds suggest a possible role for IL-18 polymorphism in the RA susceptibility in studied population.

%B Tissue Antigens %V 86 %P 276-8 %8 2015 Oct %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26302971?dopt=Abstract %R 10.1111/tan.12645 %0 Journal Article %J Front Psychol %D 2015 %T Intranasal adminsitration of oxytocin in postnatal depression: implications for psychodynamic psychotherapy from a randomized double-blind pilot study. %A Clarici, Andrea %A Pellizzoni, Sandra %A Guaschino, Secondo %A Alberico, Salvatore %A Bembich, Stefano %A Giuliani, Rosella %A Short, Antonia %A Guarino, Giuseppina %A Panksepp, Jaak %X

Oxytocin is a neuropeptide that is active in the central nervous system and is generally considered to be involved in prosocial behaviors and feelings. In light of its documented positive effect on maternal behavior, we designed a study to ascertain whether oxytocin exerts any therapeutic effects on depressive symptoms in women affected by maternal postnatal depression. A group of 16 mothers were recruited in a randomized double-blind study: the women agreed to take part in a brief course of psychoanalytic psychotherapy (12 sessions, once a week) while also being administered, during the 12-weeks period, a daily dose of intranasal oxytocin (or a placebo). The pre-treatment evaluation also included a personality assessment of the major primary-process emotional command systems described by Panksepp () and a semi-quantitative assessment by the therapist of the mother's depressive symptoms and of her personality. No significant effect on depressive symptomatology was found following the administration of oxytocin (as compared to a placebo) during the period of psychotherapy. Nevertheless, a personality trait evaluation of the mothers, conducted in our overall sample group, showed a decrease in the narcissistic trait only within the group who took oxytocin. The depressive (dysphoric) trait was in fact significantly affected by psychotherapy (this effect was only present in the placebo group so it may reflect a positive placebo effect enhancing the favorable influence of psychotherapy on depressive symptoms) but not in the presence of oxytocin. Therefore, the neuropeptide would appear to play some role in the modulation of cerebral functions involved in the self-centered (narcissistic) dimension of the suffering that can occur with postnatal depression. Based on these results, there was support for our hypothesis that what is generally defined as postnatal depression may include disturbances of narcissistic affective balance, and oxytocin supplementation can counteract that type of affective disturbance. The resulting improvements in well-being, reflected in better self-centering in post-partuent mothers, may in turn facilitate better interpersonal acceptance of (and interactions with) the child and thereby, improved recognition of the child's needs.

%B Front Psychol %V 6 %P 426 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25941501?dopt=Abstract %R 10.3389/fpsyg.2015.00426 %0 Journal Article %J J Inflamm (Lond) %D 2015 %T Knockdown of MVK does not lead to changes in NALP3 expression or activation. %A Celsi, Fulvio %A Piscianz, Elisa %A Romano, Maurizio %A Crovella, Sergio %X

BACKGROUND: Mutations in the Mevalonate Kinase gene (MVK) are causes of a rare autoinflammatory disease: Mevalonate Kinase Deficiency and its more acute manifestation, Mevalonic Aciduria. The latter is characterized, among other features, by neuroinflammation, developmental delay and ataxia, due to failed cerebellar development or neuronal death through chronic inflammation. Pathogenesis of neuroinflammation in Mevalonate Kinase Deficiency and Mevalonic Aciduria has not yet been completely clarified, however different research groups have been suggesting the inflammasome complex as the key factor in the disease development. A strategy to mimic this disease is blocking the mevalonate pathway, using HMG-CoA reductase inhibitors (Statins), while knock-out mice for Mevalonate Kinase are non-vital and their hemyzygous (i.e only one copy of gene preserved) littermate display almost no pathological features.

FINDINGS: We sought to generate a murine cellular model closely resembling the pathogenic conditions found in vivo, by direct silencing of Mevalonate Kinase gene. Knockdown of Mevalonate Kinase in a murine microglial cellular model (BV-2 cells) results in neither augmented NALP3 expression nor increase of apoptosis. On the contrary, statin treatment of BV-2 cells produces an increase both in Mevalonate Kinase and NALP3 expression.

CONCLUSIONS: MKD deficiency could be due or affected by protein accumulation leading to NALP3 activation, opening novel questions about strategies to tackle this disease.

%B J Inflamm (Lond) %V 12 %P 7 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25663823?dopt=Abstract %R 10.1186/s12950-015-0048-5 %0 Journal Article %J Mem Inst Oswaldo Cruz %D 2015 %T Lactotransferrin gene functional polymorphisms do not influence susceptibility to human immunodeficiency virus-1 mother-to-child transmission in different ethnic groups. %A Zupin, Luisa %A Polesello, Vania %A Coelho, Antônio Victor Campos %A Boniotto, Michele %A Arraes, Luiz Claudio %A Segat, Ludovica %A Crovella, Sergio %K Acquired Immunodeficiency Syndrome %K Adolescent %K Brazil %K Child %K Cohort Studies %K Ethnic Groups %K Female %K Gene Frequency %K Genetic Predisposition to Disease %K Genotyping Techniques %K HIV-1 %K Humans %K India %K Infant, Newborn %K Infectious Disease Transmission, Vertical %K Italy %K Lactoferrin %K Male %K Polymorphism, Single Nucleotide %K Real-Time Polymerase Chain Reaction %K Retrospective Studies %K Zimbabwe %X

Lactotransferrin, also known as lactoferrin, is an iron binding glycoprotein that displays antiviral activity against many different infectious agents, including human immunodeficiency virus (HIV)-1. Lactotransferrin is present in the breast milk and in the female genitourinary mucosa and it has been hypothesised as a possible candidate to prevent mother-to-child HIV-1 transmission. To verify if two functional polymorphisms, Thr29Ala and Arg47Lys, in the lactotransferrin encoding gene (LTF) could affect HIV-1 infection and vertical transmission, a preliminary association study was performed in 238 HIV-1 positive and 99 HIV-1 negative children from Brazil, Italy, Africa and India. No statistically significant association for the Thr29Ala and Arg47Lys LTF polymorphisms and HIV-1 susceptibility in the studied populations was found. Additionally LTF polymorphisms frequencies were compared between the four different ethnic groups.

%B Mem Inst Oswaldo Cruz %V 110 %P 222-9 %8 2015 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25946246?dopt=Abstract %R 10.1590/0074-02760140447 %0 Journal Article %J Minerva Pediatr %D 2015 %T Laparoscopic orchiopexy: short term outcomes. Experience of a single centre. %A Pederiva, F %A Guida, E %A Codrich, D %A Scarpa, M G %A Olenik, D %A Schleef, J %X

BACKGROUND: Increased infertility and smaller volume accompany undescended testis. Timing of orchiopexy is still a matter of debate. We evaluated the growth of nonpalpable testes after laparoscopic orchiopexy according to age at surgery, intraoperative findings and type of procedure.

METHODS: Forty-one boys undergoing laparoscopy for nonpalpable testes were retrospectively reviewed and divided into two groups, ≤ 18 months and > 18 months, according to their age at surgery.

RESULTS: At follow-up, 14 testes in the younger group had normal size, while 3 atrophied either after single (2) or two stage procedure (1). Similarly, in older boys 11 testes grew normally, while 5 atrophied after both procedures.

CONCLUSION: Most of the nonpalpable testes grew normally after laparoscopic orchiopexy and the postoperative volume seemed independent from the surgical strategy. Both techniques led to a few cases of testicular hypotrophy In our experience, the age at surgery did not affect the outcome in terms of testicular growth.

%B Minerva Pediatr %8 2015 Oct 27 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26505958?dopt=Abstract %0 Journal Article %J Nat Genet %D 2015 %T Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. %A Day, Felix R %A Ruth, Katherine S %A Thompson, Deborah J %A Lunetta, Kathryn L %A Pervjakova, Natalia %A Chasman, Daniel I %A Stolk, Lisette %A Finucane, Hilary K %A Sulem, Patrick %A Bulik-Sullivan, Brendan %A Esko, Tõnu %A Johnson, Andrew D %A Elks, Cathy E %A Franceschini, Nora %A He, Chunyan %A Altmaier, Elisabeth %A Brody, Jennifer A %A Franke, Lude L %A Huffman, Jennifer E %A Keller, Margaux F %A McArdle, Patrick F %A Nutile, Teresa %A Porcu, Eleonora %A Robino, Antonietta %A Rose, Lynda M %A Schick, Ursula M %A Smith, Jennifer A %A Teumer, Alexander %A Traglia, Michela %A Vuckovic, Dragana %A Yao, Jie %A Zhao, Wei %A Albrecht, Eva %A Amin, Najaf %A Corre, Tanguy %A Hottenga, Jouke-Jan %A Mangino, Massimo %A Smith, Albert V %A Tanaka, Toshiko %A Abecasis, Goncalo R %A Andrulis, Irene L %A Anton-Culver, Hoda %A Antoniou, Antonis C %A Arndt, Volker %A Arnold, Alice M %A Barbieri, Caterina %A Beckmann, Matthias W %A Beeghly-Fadiel, Alicia %A Benitez, Javier %A Bernstein, Leslie %A Bielinski, Suzette J %A Blomqvist, Carl %A Boerwinkle, Eric %A Bogdanova, Natalia V %A Bojesen, Stig E %A Bolla, Manjeet K %A Borresen-Dale, Anne-Lise %A Boutin, Thibaud S %A Brauch, Hiltrud %A Brenner, Hermann %A Brüning, Thomas %A Burwinkel, Barbara %A Campbell, Archie %A Campbell, Harry %A Chanock, Stephen J %A Chapman, J Ross %A Chen, Yii-Der Ida %A Chenevix-Trench, Georgia %A Couch, Fergus J %A Coviello, Andrea D %A Cox, Angela %A Czene, Kamila %A Darabi, Hatef %A De Vivo, Immaculata %A Demerath, Ellen W %A Dennis, Joe %A Devilee, Peter %A Dörk, Thilo %A Dos-Santos-Silva, Isabel %A Dunning, Alison M %A Eicher, John D %A Fasching, Peter A %A Faul, Jessica D %A Figueroa, Jonine %A Flesch-Janys, Dieter %A Gandin, Ilaria %A Garcia, Melissa E %A García-Closas, Montserrat %A Giles, Graham G %A Girotto, Giorgia G %A Goldberg, Mark S %A González-Neira, Anna %A Goodarzi, Mark O %A Grove, Megan L %A Gudbjartsson, Daniel F %A Guenel, Pascal %A Guo, Xiuqing %A Haiman, Christopher A %A Hall, Per %A Hamann, Ute %A Henderson, Brian E %A Hocking, Lynne J %A Hofman, Albert %A Homuth, Georg %A Hooning, Maartje J %A Hopper, John L %A Hu, Frank B %A Huang, Jinyan %A Humphreys, Keith %A Hunter, David J %A Jakubowska, Anna %A Jones, Samuel E %A Kabisch, Maria %A Karasik, David %A Knight, Julia A %A Kolcic, Ivana %A Kooperberg, Charles %A Kosma, Veli-Matti %A Kriebel, Jennifer %A Kristensen, Vessela %A Lambrechts, Diether %A Langenberg, Claudia %A Li, Jingmei %A Li, Xin %A Lindström, Sara %A Liu, Yongmei %A Luan, Jian'an %A Lubinski, Jan %A Mägi, Reedik %A Mannermaa, Arto %A Manz, Judith %A Margolin, Sara %A Marten, Jonathan %A Martin, Nicholas G %A Masciullo, Corrado %A Meindl, Alfons %A Michailidou, Kyriaki %A Mihailov, Evelin %A Milani, Lili %A Milne, Roger L %A Müller-Nurasyid, Martina %A Nalls, Michael %A Neale, Benjamin M %A Nevanlinna, Heli %A Neven, Patrick %A Newman, Anne B %A Nordestgaard, Børge G %A Olson, Janet E %A Padmanabhan, Sandosh %A Peterlongo, Paolo %A Peters, Ulrike %A Petersmann, Astrid %A Peto, Julian %A Pharoah, Paul D P %A Pirastu, Nicola N %A Pirie, Ailith %A Pistis, Giorgio %A Polasek, Ozren %A Porteous, David %A Psaty, Bruce M %A Pylkäs, Katri %A Radice, Paolo %A Raffel, Leslie J %A Rivadeneira, Fernando %A Rudan, Igor %A Rudolph, Anja %A Ruggiero, Daniela %A Sala, Cinzia F %A Sanna, Serena %A Sawyer, Elinor J %A Schlessinger, David %A Schmidt, Marjanka K %A Schmidt, Frank %A Schmutzler, Rita K %A Schoemaker, Minouk J %A Scott, Robert A %A Seynaeve, Caroline M %A Simard, Jacques %A Sorice, Rossella %A Southey, Melissa C %A Stöckl, Doris %A Strauch, Konstantin %A Swerdlow, Anthony %A Taylor, Kent D %A Thorsteinsdottir, Unnur %A Toland, Amanda E %A Tomlinson, Ian %A Truong, Therese %A Tryggvadottir, Laufey %A Turner, Stephen T %A Vozzi, Diego %A Wang, Qin %A Wellons, Melissa %A Willemsen, Gonneke %A Wilson, James F %A Winqvist, Robert %A Wolffenbuttel, Bruce B H R %A Wright, Alan F %A Yannoukakos, Drakoulis %A Zemunik, Tatijana %A Zheng, Wei %A Zygmunt, Marek %A Bergmann, Sven %A Boomsma, Dorret I %A Buring, Julie E %A Ferrucci, Luigi %A Montgomery, Grant W %A Gudnason, Vilmundur %A Spector, Tim D %A van Duijn, Cornelia M %A Alizadeh, Behrooz Z %A Ciullo, Marina %A Crisponi, Laura %A Easton, Douglas F %A Gasparini, Paolo P %A Gieger, Christian %A Harris, Tamara B %A Hayward, Caroline %A Kardia, Sharon L R %A Kraft, Peter %A McKnight, Barbara %A Metspalu, Andres %A Morrison, Alanna C %A Reiner, Alex P %A Ridker, Paul M %A Rotter, Jerome I %A Toniolo, Daniela %A Uitterlinden, André G %A Ulivi, Sheila %A Völzke, Henry %A Wareham, Nicholas J %A Weir, David R %A Yerges-Armstrong, Laura M %A Price, Alkes L %A Stefansson, Kari %A Visser, Jenny A %A Ong, Ken K %A Chang-Claude, Jenny %A Murabito, Joanne M %A Perry, John R B %A Murray, Anna %X

Menopause timing has a substantial impact on infertility and risk of disease, including breast cancer, but the underlying mechanisms are poorly understood. We report a dual strategy in ∼70,000 women to identify common and low-frequency protein-coding variation associated with age at natural menopause (ANM). We identified 44 regions with common variants, including two regions harboring additional rare missense alleles of large effect. We found enrichment of signals in or near genes involved in delayed puberty, highlighting the first molecular links between the onset and end of reproductive lifespan. Pathway analyses identified major association with DNA damage response (DDR) genes, including the first common coding variant in BRCA1 associated with any complex trait. Mendelian randomization analyses supported a causal effect of later ANM on breast cancer risk (∼6% increase in risk per year; P = 3 × 10(-14)), likely mediated by prolonged sex hormone exposure rather than DDR mechanisms.

%B Nat Genet %V 47 %P 1294-303 %8 2015 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/26414677?dopt=Abstract %R 10.1038/ng.3412 %0 Journal Article %J Eur J Clin Invest %D 2015 %T Leptin/adiponectin ratio predicts poststroke neurological outcome. %A Carbone, Federico %A Burger, Fabienne %A Roversi, Gloria %A Tamborino, Carmine %A Casetta, Ilaria %A Seraceni, Silva %A Trentini, Alessandro %A Padroni, Marina %A Bertolotto, Maria %A Dallegri, Franco %A Mach, François %A Fainardi, Enrico %A Montecucco, Fabrizio %X

BACKGROUND AND AIMS: Different adipokines have been associated with atherosclerotic plaque rupture and cardiovascular events, such as acute ischaemic stroke (AIS). However, the potential role of these molecules in postischaemic brain injury remains largely unknown.

METHODS AND METHODS: We performed a substudy analysis on nonobese patients with first atherothrombotic stroke (n = 35) from a recently published prospective cohort. Primary endpoint was to investigate the predictive value of serum leptin/adiponectin ratio on neurological recovery at 90 days after AIS. The secondary endpoint was the predictive value of serum adipokine levels of clinical and radiological outcomes at a shorter follow-up (at days 1 and 7 after AIS). The radiological evaluation included ischaemic lesion volume and haemorrhagic transformation (HT). The clinical examination was based on National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS).

RESULTS: At day 1 after AIS, serum leptin and leptin/adiponectin ratio were increased and inversely correlated with both radiological and clinical parameters at all follow-up time points. Once identified the best cut-off points by receiver operating characteristic (ROC) analysis, risk analysis showed that higher circulating leptin improved neurological recovery at day 90. In addition, leptin/adiponectin ratio maintained statistical significance after adjustment for age, gender and thrombolysis, also predicting the occurrence of HT in the first 7 days after AIS (adjusted OR 0·15 [95% CI 0·03-0·83); P = 0·030]).

CONCLUSIONS: Higher leptin/adiponectin ratio at day 1 predicted better neurological outcomes in patients with atherothrombotic AIS and might be potentially useful as a prognostic biomarker of the disease.

%B Eur J Clin Invest %V 45 %P 1184-91 %8 2015 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/26381386?dopt=Abstract %R 10.1111/eci.12538 %0 Journal Article %J Curr Mol Med %D 2015 %T Long noncoding RNA GAS5: a novel marker involved in glucocorticoid response. %A Lucafo, M %A De Iudicibus, S %A Di Silvestre, A %A Pelin, M %A Candussio, L %A Martelossi, S %A Tommasini, A %A Piscianz, E %A Ventura, A %A Decorti, G %K Adult %K Cell Proliferation %K Female %K Gene Expression Regulation %K Glucocorticoids %K Humans %K Leukocytes, Mononuclear %K Male %K Methylprednisolone %K Middle Aged %K Receptors, Glucocorticoid %K RNA, Long Noncoding %K Transcription, Genetic %X

Glucocorticoids (GCs) exert their effects through regulation of gene expression after activation in the cytoplasm of the glucocorticoid receptor (GR) encoded by NR3C1 gene. A negative feedback mechanism resulting in GR autoregulation has been demonstrated through the binding of the activated receptor to intragenic sequences called GRE-like elements, contained in GR gene. The long noncoding RNA growth arrest-specific transcript 5 (GAS5) interacts with the activated GR suppressing its transcriptional activity. The aim of this study was to evaluate the possible role of GAS5 and NR3C1 gene expression in the antiproliferative effect of methylprednisolone in peripheral blood mononuclear cells and to correlate the expression with individual sensitivity to GCs. Subjects being poor responders to GCs presented higher levels of GAS5 and NR3C1 in comparison with good responders. We suggest that abnormal levels of GAS5 may alter GC effectiveness, probably interfering with the mechanism of GR autoregulation.

%B Curr Mol Med %V 15 %P 94-9 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25601472?dopt=Abstract %0 Journal Article %J BMC Health Serv Res %D 2015 %T Making patient centered care a reality: a survey of patient educational programs in Italian Cancer Research and Care Institutes. %A Cipolat Mis, C %A Truccolo, I %A Ravaioli, V %A Cocchi, S %A Gangeri, L %A Mosconi, P %A Drace, C %A Pomicino, L %A Paradiso, A %A De Paoli, P %X

BACKGROUND: Educational intervention represents an essential element of care for cancer patients; while several single institutions develop their own patient education (PE) programs on cancer, little information is available on the effective existence of PE programs at the level of research and care institutes. In Italy such institutes--Istituti di Ricovero e Cura a Carattere Scientifico--are appointed by the Ministry of Health, and 11 (Cancer Research & Care Istitute-CRCI) of the 48 are specific for cancer on the basis of specific requirements regarding cancer care, research and education. Therefore, they represent an ideal and homogeneous model through which to investigate PE policies and activities throughout the country. The objective of this study was to assess PE activities in Italian CRCI.

METHODS: We carried out a survey on PE strategies and services through a questionnaire. Four key points were investigated: a) PE as a cancer care priority, b) activities that are routinely part of PE, c) real involvement of the patients, and d) involvement of healthcare workers in PE activities.

RESULTS: Most CRCI (85%) completed the survey. All reported having ongoing PE activities, and 4 of the 11 considered PE an institutional activity. More than 90% of CRCI organize classes and prepare PE handouts, while other PE activities (e.g., Cancer Information Services, mutual support groups) are less frequently part of institutional PE programs. Patients are frequently involved in the organization and preparation of educational activities on the basis of their own needs. Various PE activities are carried out for caregivers in 8 (73%) out of 11 institutes. Finally, health care workers have an active role in the organization of PE programs, although nurses take part in these activities in only half of CRCI and pharmacists are seldom included.

CONCLUSIONS: The information arising from our research constitutes a necessary framework to identify areas of development and to design new strategies and standards to disseminate the culture of PE. This may ultimately help and stimulate the establishment of institutional integrated PE programs, including policies and interventions that can benefit a significant proportion of cancer patients.

%B BMC Health Serv Res %V 15 %P 298 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26223861?dopt=Abstract %R 10.1186/s12913-015-0962-5 %0 Journal Article %J J Hum Lact %D 2015 %T Making the first days of life safer: preventing sudden unexpected postnatal collapse while promoting breastfeeding. %A Davanzo, Riccardo %A De Cunto, Angela %A Paviotti, Giulia %A Travan, Laura %A Inglese, Stefania %A Brovedani, Pierpaolo %A Crocetta, Anna %A Calligaris, Chiara %A Corubolo, Elisa %A Dussich, Valentina %A Verardi, Giuseppa %A Causin, Enrica %A Kennedy, Jaquelyn %A Marrazzo, Francesca %A Strajn, Tamara %A Sanesi, Cecilia %A Demarini, Sergio %X

Early and prolonged skin-to-skin contact (SSC) after birth between a mother and her newborn has been shown to generate beneficial effects on the mother-infant relationship and breastfeeding. Close mother-infant body contact immediately after birth positively enhances exclusive breastfeeding during the hospital stay, with a dose-response relationship. Skin-to-skin contact may ease the infant's transition to extra-uterine life and helps regulate the infant's body temperature and nursing behavior. However, reports of sudden unexpected postnatal collapse (SUPC) soon after birth, in healthy term neonates, in association with SSC, have raised concerns about the safety of this practice. Based on available evidence, we developed a surveillance protocol in the delivery room and postnatal ward of the Institute for Maternal and Child Health of Trieste (Italy). The aim of our protocol is (a) to promote safe mother and infant bonding and (b) to establish successful breastfeeding, without increasing the risk of SUPC. As there is no known effective intervention to prevent SUPC, our protocol has been conceived as a potential best practice.

%B J Hum Lact %V 31 %P 47-52 %8 2015 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25339551?dopt=Abstract %R 10.1177/0890334414554927 %0 Journal Article %J JAMA Pediatr %D 2015 %T Maternal holding vs oral glucose administration as nonpharmacologic analgesia in newborns: a functional neuroimaging study. %A Bembich, Stefano %A Cont, Gabriele %A Baldassi, Giulio %A Bua, Jenny %A Demarini, Sergio %K Administration, Oral %K Analgesia %K Blood Specimen Collection %K Female %K Functional Neuroimaging %K Glucose %K Humans %K Infant, Newborn %K Mother-Child Relations %K Pain %K Pain Management %K Spectroscopy, Near-Infrared %B JAMA Pediatr %V 169 %P 284-5 %8 2015 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/25599227?dopt=Abstract %R 10.1001/jamapediatrics.2014.3052 %0 Journal Article %J Pediatr Blood Cancer %D 2015 %T Mature and immature teratoma: A report from the second Italian pediatric study. %A Terenziani, Monica %A D'Angelo, Paolo %A Inserra, Alessandro %A Boldrini, Renata %A Bisogno, Gianni %A Babbo, Gian Luca %A Conte, Massimo %A Dall' Igna, Patrizia %A De Pasquale, Maria Debora %A Indolfi, Paolo %A Piva, Luigi %A Riccipetitoni, Giovanna %A Siracusa, Fortunato %A Spreafico, Filippo %A Tamaro, Paolo %A Cecchetto, Giovanni %K Adolescent %K Adult %K Child %K Child, Preschool %K Female %K Follow-Up Studies %K Humans %K Incidence %K Infant %K Infant, Newborn %K Italy %K Male %K Neoplasm Grading %K Neoplasm Recurrence, Local %K Neoplasm Staging %K Neoplasms, Second Primary %K Neuroblastoma %K Ovarian Neoplasms %K Prognosis %K Prospective Studies %K Survival Rate %K Teratoma %K Testicular Neoplasms %K Young Adult %X

BACKGROUND: Teratomas demonstrate a benign clinical behavior, however they may recur with malignant components or as teratoma, and in a small group of patients prognosis could be fatal. After the first Italian study, we collected cases of teratoma, alongside the protocol for malignant germ cell tumors.

PROCEDURE: Patients with teratoma were collected from 2004 to 2014. Teratomas were classified according to the WHO classifications, as mature and immature. Patients with pathological aFP and/or bHCG, and those with a malignant germ cell component were not included.

RESULTS: The study enrolled 219 patients (150 mature, 69 immature teratomas) with a median age at diagnosis of 42 months. The primary sites involved were: 118 gonadal and 101 extragonadal teratomas. Two females with ovarian teratoma had a positive family history. Complete and incomplete surgeries were performed in 85% and 9% of cases. Seventeen events occurred: six females had a second metachronous tumor (5 contralateral ovarian teratoma, 1 adrenal neuroblastoma) and 11 teratomas relapsed/progressed (3 mature, 8 immature teratomas). Two patients died, one of progressive immature teratoma and one of surgical complications. At a median follow up of 68 months, the event-free, relapse-free, and overall survival rates were 90.6%, 94.3%, 98.6%, respectively.

CONCLUSIONS: Teratomas show a good prognosis, especially the mature ones: surgery and follow-up remain the standard approach. Incomplete surgery in immature teratoma is the group at greatest risk of relapse. Bilateral ovarian tumors are a possibility, and the rare family predisposition to ovarian mature teratoma warrants further analyses.

%B Pediatr Blood Cancer %V 62 %P 1202-8 %8 2015 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/25631333?dopt=Abstract %R 10.1002/pbc.25423 %0 Journal Article %J J Med Virol %D 2015 %T MBL2 polymorphisms in women with atypical squamous cells of undetermined significance. %A Zupin, Luisa %A Polesello, Vania %A Casalicchio, Giorgia %A Freato, Nadia %A Maestri, Iva %A Comar, Manola %A Crovella, Sergio %A Segat, Ludovica %K Adolescent %K Adult %K Atypical Squamous Cells of the Cervix %K Female %K Gene Frequency %K Genetic Predisposition to Disease %K Humans %K Italy %K Mannose-Binding Lectin %K Polymorphism, Single Nucleotide %K Young Adult %X

Infection with high risk Human papillomavirus (HPV) is the main known cause of cervical cancer. HPV induces different grades of lesions: among them, Atypical squamous cells of undetermined significance are abnormal lesions that could evolve in pre-cancer lesions or spontaneously regress. The mannose binding lectin (MBL) is an innate immunity serum protein also found in cervico-vaginal mucosa, whose expression is known to be affected by polymorphisms in exon 1 and promoter of the MBL2 gene. In the present study the possible association between MBL2 functional polymorphisms and susceptibility to develop atypical squamous cells of undetermined significance was investigated in a group of women from North-East of Italy, stratified for HPV infection status. The MBL2 D and O alleles and the deficient producer combined genotypes, responsible for low MBL production, were more represented among atypical squamous cells of undetermined significance positive women than healthy controls and the results were confirmed when only HPV negative samples were considered. These results suggest a possible involvement of MBL2 functional polymorphisms in atypical squamous cells of undetermined significance susceptibility.

%B J Med Virol %V 87 %P 851-9 %8 2015 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/25693844?dopt=Abstract %R 10.1002/jmv.24080 %0 Journal Article %J J Behav Med %D 2015 %T The mediating role of interpersonal conflict at work in the relationship between negative affectivity and biomarkers of stress. %A Girardi, Damiano %A Falco, Alessandra %A De Carlo, Alessandro %A Benevene, Paula %A Comar, Manola %A Tongiorgi, Enrico %A Bartolucci, Giovanni Battista %X

This study examined the association between interpersonal conflict at work (ICW) and serum levels of three possible biomarkers of stress, namely the pro-inflammatory cytokines Interleukin 1 beta (IL-1β), Interleukin 12 (IL-12), and Interleukin 17 (IL-17). Additionally, this study investigated the role of negative affectivity (NA) in the relationship between ICW and the pro-inflammatory cytokines. Data from 121 employees in an Italian healthcare organization were analyzed using structural equation modeling. Results showed that ICW was positively associated with IL-1β, IL-12, and IL-17, after controlling for the effect of gender. Moreover, ICW completely mediated the relationship between NA and the pro-inflammatory cytokines IL-1β, IL-12, and IL-17. This mediating effect was significant after controlling for the effect of gender. Overall, this study suggests that work-related stress may be associated with biomarkers of inflammation, and that negative affectivity may influence the stress process affecting the exposure to psychosocial stressors.

%B J Behav Med %V 38 %P 922-31 %8 2015 Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/26186953?dopt=Abstract %R 10.1007/s10865-015-9658-x %0 Journal Article %J Curr HIV Res %D 2015 %T Meta-analysis and time series modeling allow a systematic review of primary HIV-1 drug-resistant prevalence in Latin America and Caribbean. %A Coelho, Antônio Victor Campos %A De Moura, Ronald Rodrigues %A da Silva, Ronaldo Celerino %A Kamada, Anselmo Jiro %A Guimarães, Rafael Lima %A Brandão, Lucas André Cavalcanti %A Coelho, Hemílio Fernandes Campos %A Crovella, Sergio %X

Here we review the prevalence of HIV-1 primary drug resistance in Latin America and Caribbean using meta-analysis as well as time-series modeling. We also discuss whether there could be a drawback to HIV/AIDS programs due to drug resistance in Latin America and Caribbean in the next years. We observed that, although some studies report low or moderate primary drug resistance prevalence in Caribbean countries, this evidence needs to be updated. In other countries, such as Brazil and Argentina, the prevalence of drug resistance appears to be rising. Mutations conferring resistance against reverse transcriptase inhibitors were the most frequent in the analyzed populations (70% of all mutational events). HIV-1 subtype B was the most prevalent in Latin America and the Caribbean, although subtype C and B/F recombinants have significant contributions in Argentina and Brazil. Thus, we suggest that primary drug resistance in Latin America and the Caribbean could have been underestimated. Clinical monitoring should be improved to offer better therapy, reducing the risk for HIV-1 resistance emergence and spread, principally in vulnerable populations, such as men who have sex with men transmission group, sex workers and intravenous drug users.

%B Curr HIV Res %V 13 %P 125-42 %8 2015 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25777517?dopt=Abstract %0 Journal Article %J Am J Hum Biol %D 2015 %T Meta-analysis of Brazilian genetic admixture and comparison with other Latin America countries. %A Moura, Ronald Rodrigues de %A Coelho, Antônio Victor Campos %A Balbino, Valdir de Queiroz %A Crovella, Sergio %A Brandão, Lucas André Cavalcanti %X

OBJECTIVES: This study aims at performing a systematic review and meta-analysis with the studies of genetic admixture inference of Brazilian population and to compare these results with the genetic admixture levels in other Latin American countries.

METHODS: We searched for articles regarding the estimation of Brazilian genetic admixture published between 1980 and 2014 that used autosomal markers. Then, conducted meta-analyses at the whole-country and regional level. Finally, we compared the results of Brazil with other estimates from other South, Central and North American countries.

RESULTS: We analyzed data from 25 studies in 38 different Brazilian populations. European (EUR) ancestry is the major contributor to the genetic background of Brazilians, followed by African (AFR), and Amerindian (AMR) ancestries. The pooled ancestry contributions were 0.62 EUR, 0.21 AFR, and 0.17AMR. The Southern region had a greater EUR contribution (0.77) than other regions. Individuals from the Northeast (NE) region had the highest AFR contribution (0.27) whereas individuals from the North regions had more AMR contribution (0.32). In the Latin America context, Brazil has the 5th high EUR contribution, the 12th for the AFR component and the 10th for the AMR ancestry.

CONCLUSIONS: Admixture proportions vary greatly among Brazilian populations and also through Latin America. More studies in the Center-West, North and NE regions are needed to capture a more complete picture of the genomic ancestry of Brazil.

%B Am J Hum Biol %V 27 %P 674-80 %8 2015 Sep-Oct %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/25820814?dopt=Abstract %R 10.1002/ajhb.22714 %0 Journal Article %J Int J Mol Sci %D 2015 %T Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link. %A Tricarico, Paola Maura %A Crovella, Sergio %A Celsi, Fulvio %X

The mevalonate pathway, crucial for cholesterol synthesis, plays a key role in multiple cellular processes. Deregulation of this pathway is also correlated with diminished protein prenylation, an important post-translational modification necessary to localize certain proteins, such as small GTPases, to membranes. Mevalonate pathway blockade has been linked to mitochondrial dysfunction: especially involving lower mitochondrial membrane potential and increased release of pro-apoptotic factors in cytosol. Furthermore a severe reduction of protein prenylation has also been associated with defective autophagy, possibly causing inflammasome activation and subsequent cell death. So, it is tempting to hypothesize a mechanism in which defective autophagy fails to remove damaged mitochondria, resulting in increased cell death. This mechanism could play a significant role in Mevalonate Kinase Deficiency, an autoinflammatory disease characterized by a defect in Mevalonate Kinase, a key enzyme of the mevalonate pathway. Patients carrying mutations in the MVK gene, encoding this enzyme, show increased inflammation and lower protein prenylation levels. This review aims at analysing the correlation between mevalonate pathway defects, mitochondrial dysfunction and defective autophagy, as well as inflammation, using Mevalonate Kinase Deficiency as a model to clarify the current pathogenetic hypothesis as the basis of the disease.

%B Int J Mol Sci %V 16 %P 16067-84 %8 2015 %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/26184189?dopt=Abstract %R 10.3390/ijms160716067 %0 Journal Article %J Apoptosis %D 2015 %T Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency. %A Tricarico, Paola Maura %A Piscianz, Elisa %A Monasta, Lorenzo %A Kleiner, Giulio %A Crovella, Sergio %A Marcuzzi, Annalisa %X

Mevalonate kinase deficiency is a rare disease whose worst manifestation, characterised by severe neurologic impairment, is called mevalonic aciduria. The progressive neuronal loss associated to cell death can be studied in vitro with a simplified model based on a biochemical block of the mevalonate pathway and a subsequent inflammatory trigger. The aim of this study was to evaluate the effect of the mevalonate blocking on glial cells (BV-2) and the following effects on neuronal cells (SH-SY5Y) when the two populations were cultured together. To better understand the cross-talk between glial and neuronal cells, as it happens in vivo, BV-2 and SH-SY5Y were co-cultured in different experimental settings (alone, transwell, direct contact); the effect of mevalonate pathway biochemical block by Lovastatin, followed by LPS inflammatory trigger, were evaluated by analysing programmed cell death and mitochondrial membrane potential, cytokines' release and cells' morphology modifications. In this experimental condition, glial cells underwent an evident activation, confirmed by elevated pro-inflammatory cytokines release, typical of these disorders, and a modification in morphology. Moreover, the activation induced an increase in apoptosis. When glial cells were co-cultured with neurons, their activation caused an increase of programmed cell death also in neuronal cells, but only if the two populations were cultured in direct contact. Our findings, being aware of the limitations related to the cell models used, represent a preliminary step towards understanding the pathological and neuroinflammatory mechanisms occurring in mevalonate kinase diseases. Contact co-culture between neuronal and microglial cells seems to be a good model to study mevalonic aciduria in vitro, and to contribute to the identification of potential drugs able to block microglial activation for this orphan disease. In fact, in such a pathological condition, we demonstrated that microglial cells are activated and contribute to neuronal cell death. We can thus hypothesise that the use of microglial activation blockers could prevent this additional neuronal death.

%B Apoptosis %V 20 %P 1048-55 %8 2015 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/26003816?dopt=Abstract %R 10.1007/s10495-015-1139-8 %0 Journal Article %J PLoS One %D 2015 %T Modulation of genetic associations with serum urate levels by body-mass-index in humans. %A Huffman, Jennifer E %A Albrecht, Eva %A Teumer, Alexander %A Mangino, Massimo %A Kapur, Karen %A Johnson, Toby %A Kutalik, Zoltán %A Pirastu, Nicola %A Pistis, Giorgio %A Lopez, Lorna M %A Haller, Toomas %A Salo, Perttu %A Goel, Anuj %A Li, Man %A Tanaka, Toshiko %A Dehghan, Abbas %A Ruggiero, Daniela %A Malerba, Giovanni %A Smith, Albert V %A Nolte, Ilja M %A Portas, Laura %A Phipps-Green, Amanda %A Boteva, Lora %A Navarro, Pau %A Johansson, Åsa %A Hicks, Andrew A %A Polasek, Ozren %A Esko, Tõnu %A Peden, John F %A Harris, Sarah E %A Murgia, Federico %A Wild, Sarah H %A Tenesa, Albert %A Tin, Adrienne %A Mihailov, Evelin %A Grotevendt, Anne %A Gislason, Gauti K %A Coresh, Josef %A d'Adamo, Pio %A Ulivi, Sheila %A Vollenweider, Peter %A Waeber, Gerard %A Campbell, Susan %A Kolcic, Ivana %A Fisher, Krista %A Viigimaa, Margus %A Metter, Jeffrey E %A Masciullo, Corrado %A Trabetti, Elisabetta %A Bombieri, Cristina %A Sorice, Rossella %A Döring, Angela %A Reischl, Eva %A Strauch, Konstantin %A Hofman, Albert %A Uitterlinden, André G %A Waldenberger, Melanie %A Wichmann, H-Erich %A Davies, Gail %A Gow, Alan J %A Dalbeth, Nicola %A Stamp, Lisa %A Smit, Johannes H %A Kirin, Mirna %A Nagaraja, Ramaiah %A Nauck, Matthias %A Schurmann, Claudia %A Budde, Kathrin %A Farrington, Susan M %A Theodoratou, Evropi %A Jula, Antti %A Salomaa, Veikko %A Sala, Cinzia %A Hengstenberg, Christian %A Burnier, Michel %A Mägi, Reedik %A Klopp, Norman %A Kloiber, Stefan %A Schipf, Sabine %A Ripatti, Samuli %A Cabras, Stefano %A Soranzo, Nicole %A Homuth, Georg %A Nutile, Teresa %A Munroe, Patricia B %A Hastie, Nicholas %A Campbell, Harry %A Rudan, Igor %A Cabrera, Claudia %A Haley, Chris %A Franco, Oscar H %A Merriman, Tony R %A Gudnason, Vilmundur %A Pirastu, Mario %A Penninx, Brenda W %A Snieder, Harold %A Metspalu, Andres %A Ciullo, Marina %A Pramstaller, Peter P %A van Duijn, Cornelia M %A Ferrucci, Luigi %A Gambaro, Giovanni %A Deary, Ian J %A Dunlop, Malcolm G %A Wilson, James F %A Gasparini, Paolo %A Gyllensten, Ulf %A Spector, Tim D %A Wright, Alan F %A Hayward, Caroline %A Watkins, Hugh %A Perola, Markus %A Bochud, Murielle %A Kao, W H Linda %A Caulfield, Mark %A Toniolo, Daniela %A Völzke, Henry %A Gieger, Christian %A Köttgen, Anna %A Vitart, Veronique %X

We tested for interactions between body mass index (BMI) and common genetic variants affecting serum urate levels, genome-wide, in up to 42569 participants. Both stratified genome-wide association (GWAS) analyses, in lean, overweight and obese individuals, and regression-type analyses in a non BMI-stratified overall sample were performed. The former did not uncover any novel locus with a major main effect, but supported modulation of effects for some known and potentially new urate loci. The latter highlighted a SNP at RBFOX3 reaching genome-wide significant level (effect size 0.014, 95% CI 0.008-0.02, Pinter= 2.6 x 10-8). Two top loci in interaction term analyses, RBFOX3 and ERO1LB-EDARADD, also displayed suggestive differences in main effect size between the lean and obese strata. All top ranking loci for urate effect differences between BMI categories were novel and most had small magnitude but opposite direction effects between strata. They include the locus RBMS1-TANK (men, Pdifflean-overweight= 4.7 x 10-8), a region that has been associated with several obesity related traits, and TSPYL5 (men, Pdifflean-overweight= 9.1 x 10-8), regulating adipocytes-produced estradiol. The top-ranking known urate loci was ABCG2, the strongest known gout risk locus, with an effect halved in obese compared to lean men (Pdifflean-obese= 2 x 10-4). Finally, pathway analysis suggested a role for N-glycan biosynthesis as a prominent urate-associated pathway in the lean stratum. These results illustrate a potentially powerful way to monitor changes occurring in obesogenic environment.

%B PLoS One %V 10 %P e0119752 %8 2015 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/25811787?dopt=Abstract %R 10.1371/journal.pone.0119752 %0 Journal Article %J J Pediatr %D 2015 %T More than (Double) Bubble. %A Ferrara, Giovanna %A Stampalija, Tamara %A Codrich, Daniela %A Simionato, Cristina %A Taddio, Andrea %A Travan, Laura %K Amniotic Fluid %K Duodenum %K Female %K Humans %K Infant %K Infant, Newborn %K Polyhydramnios %K Pregnancy %K Pregnancy Trimester, Third %K Prenatal Diagnosis %K Ultrasonography, Prenatal %B J Pediatr %V 167 %P 942-942.e1 %8 2015 Oct %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26227438?dopt=Abstract %R 10.1016/j.jpeds.2015.06.066 %0 Journal Article %J Nat Commun %D 2015 %T Multicohort analysis of the maternal age effect on recombination. %A Martin, Hilary C %A Christ, Ryan %A Hussin, Julie G %A O'Connell, Jared %A Gordon, Scott %A Mbarek, Hamdi %A Hottenga, Jouke-Jan %A McAloney, Kerrie %A Willemsen, Gonnecke %A Gasparini, Paolo %A Pirastu, Nicola %A Montgomery, Grant W %A Navarro, Pau %A Soranzo, Nicole %A Toniolo, Daniela %A Vitart, Veronique %A Wilson, James F %A Marchini, Jonathan %A Boomsma, Dorret I %A Martin, Nicholas G %A Donnelly, Peter %X

Several studies have reported that the number of crossovers increases with maternal age in humans, but others have found the opposite. Resolving the true effect has implications for understanding the maternal age effect on aneuploidies. Here, we revisit this question in the largest sample to date using single nucleotide polymorphism (SNP)-chip data, comprising over 6,000 meioses from nine cohorts. We develop and fit a hierarchical model to allow for differences between cohorts and between mothers. We estimate that over 10 years, the expected number of maternal crossovers increases by 2.1% (95% credible interval (0.98%, 3.3%)). Our results are not consistent with the larger positive and negative effects previously reported in smaller cohorts. We see heterogeneity between cohorts that is likely due to chance effects in smaller samples, or possibly to confounders, emphasizing that care should be taken when interpreting results from any specific cohort about the effect of maternal age on recombination.

%B Nat Commun %V 6 %P 7846 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26242864?dopt=Abstract %R 10.1038/ncomms8846 %0 Journal Article %J J Neurol %D 2015 %T A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation. %A Barone, Rita %A Carrozzi, M %A Parini, R %A Battini, R %A Martinelli, D %A Elia, M %A Spada, M %A Lilliu, F %A Ciana, G %A Burlina, A %A Leuzzi, V %A Leoni, M %A Sturiale, L %A Matthijs, G %A Jaeken, J %A Di Rocco, M %A Garozzo, D %A Fiumara, A %X

PMM2-CDG (PMM2 gene mutations) is the most common congenital disorder of N-glycosylation. We conducted a nationwide survey to characterize the frequency, clinical features, glycosylation and genetic correlates in Italian patients with PMM2-CDG. Clinical information was obtained through a questionnaire filled in by the referral physicians including demographics, neurological and systemic features, neuroimaging data and genotype. Glycosylation analyses of serum transferrin were complemented by MALDI-Mass Spectrometry (MALDI-MS). Between 1996 and 2012, data on 37 Italian patients with PMM2-CDG were collected. All the patients with a severe phenotype were unable to walk unaided, 84 % had severe intellectual disability and 81 % microcephaly. Conversely, among 17 mildly affected patients 82 % had independent ambulation, 64 % had borderline to mild intellectual disability and 35 % microcephaly. Epilepsy and stroke-like events did not occur among patients with the mild phenotype. The rate and extent of systemic involvement were more pronounced in severely affected patients. The L32R misfolding mutation of the PMM2 gene occurred in 70 % of the patients with the mild phenotype and was associated with a less severe underglycosylation of serum Tf at MALDI-MS analyses. Despite their different disease severity, all patients had progressive (olivo)ponto-cerebellar atrophy that was the hallmark clinical feature for the diagnosis. A mild neurological phenotype of PMM2-CDG marked by preserved ambulatory ability and autonomy and associated with L32R mutation is particularly frequent in Italy. PMM2-CDG should be considered in patients with even mild developmental disability and/or unexplained progressive cerebellar atrophy.

%B J Neurol %V 262 %P 154-64 %8 2015 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25355454?dopt=Abstract %R 10.1007/s00415-014-7549-7 %0 Journal Article %J Nature %D 2015 %T New genetic loci link adipose and insulin biology to body fat distribution. %A Shungin, Dmitry %A Winkler, Thomas W %A Croteau-Chonka, Damien C %A Ferreira, Teresa %A Locke, Adam E %A Mägi, Reedik %A Strawbridge, Rona J %A Pers, Tune H %A Fischer, Krista %A Justice, Anne E %A Workalemahu, Tsegaselassie %A Wu, Joseph M W %A Buchkovich, Martin L %A Heard-Costa, Nancy L %A Roman, Tamara S %A Drong, Alexander W %A Song, Ci %A Gustafsson, Stefan %A Day, Felix R %A Esko, Tõnu %A Fall, Tove %A Kutalik, Zoltán %A Luan, Jian'an %A Randall, Joshua C %A Scherag, André %A Vedantam, Sailaja %A Wood, Andrew R %A Chen, Jin %A Fehrmann, Rudolf %A Karjalainen, Juha %A Kahali, Bratati %A Liu, Ching-Ti %A Schmidt, Ellen M %A Absher, Devin %A Amin, Najaf %A Anderson, Denise %A Beekman, Marian %A Bragg-Gresham, Jennifer L %A Buyske, Steven %A Demirkan, Ayse %A Ehret, Georg B %A Feitosa, Mary F %A Goel, Anuj %A Jackson, Anne U %A Johnson, Toby %A Kleber, Marcus E %A Kristiansson, Kati %A Mangino, Massimo %A Mateo Leach, Irene %A Medina-Gomez, Carolina %A Palmer, Cameron D %A Pasko, Dorota %A Pechlivanis, Sonali %A Peters, Marjolein J %A Prokopenko, Inga %A Stančáková, Alena %A Ju Sung, Yun %A Tanaka, Toshiko %A Teumer, Alexander %A Van Vliet-Ostaptchouk, Jana V %A Yengo, Loic %A Zhang, Weihua %A Albrecht, Eva %A Arnlöv, Johan %A Arscott, Gillian M %A Bandinelli, Stefania %A Barrett, Amy %A Bellis, Claire %A Bennett, Amanda J %A Berne, Christian %A Blüher, Matthias %A Böhringer, Stefan %A Bonnet, Fabrice %A Böttcher, Yvonne %A Bruinenberg, Marcel %A Carba, Delia B %A Caspersen, Ida H %A Clarke, Robert %A Daw, E Warwick %A Deelen, Joris %A Deelman, Ewa %A Delgado, Graciela %A Doney, Alex S F %A Eklund, Niina %A Erdos, Michael R %A Estrada, Karol %A Eury, Elodie %A Friedrich, Nele %A Garcia, Melissa E %A Giedraitis, Vilmantas %A Gigante, Bruna %A Go, Alan S %A Golay, Alain %A Grallert, Harald %A Grammer, Tanja B %A Gräßler, Jürgen %A Grewal, Jagvir %A Groves, Christopher J %A Haller, Toomas %A Hallmans, Goran %A Hartman, Catharina A %A Hassinen, Maija %A Hayward, Caroline %A Heikkilä, Kauko %A Herzig, Karl-Heinz %A Helmer, Quinta %A Hillege, Hans L %A Holmen, Oddgeir %A Hunt, Steven C %A Isaacs, Aaron %A Ittermann, Till %A James, Alan L %A Johansson, Ingegerd %A Juliusdottir, Thorhildur %A Kalafati, Ioanna-Panagiota %A Kinnunen, Leena %A Koenig, Wolfgang %A Kooner, Ishminder K %A Kratzer, Wolfgang %A Lamina, Claudia %A Leander, Karin %A Lee, Nanette R %A Lichtner, Peter %A Lind, Lars %A Lindström, Jaana %A Lobbens, Stéphane %A Lorentzon, Mattias %A Mach, François %A Magnusson, Patrik K E %A Mahajan, Anubha %A McArdle, Wendy L %A Menni, Cristina %A Merger, Sigrun %A Mihailov, Evelin %A Milani, Lili %A Mills, Rebecca %A Moayyeri, Alireza %A Monda, Keri L %A Mooijaart, Simon P %A Mühleisen, Thomas W %A Mulas, Antonella %A Müller, Gabriele %A Müller-Nurasyid, Martina %A Nagaraja, Ramaiah %A Nalls, Michael A %A Narisu, Narisu %A Glorioso, Nicola %A Nolte, Ilja M %A Olden, Matthias %A Rayner, Nigel W %A Renstrom, Frida %A Ried, Janina S %A Robertson, Neil R %A Rose, Lynda M %A Sanna, Serena %A Scharnagl, Hubert %A Scholtens, Salome %A Sennblad, Bengt %A Seufferlein, Thomas %A Sitlani, Colleen M %A Vernon Smith, Albert %A Stirrups, Kathleen %A Stringham, Heather M %A Sundström, Johan %A Swertz, Morris A %A Swift, Amy J %A Syvänen, Ann-Christine %A Tayo, Bamidele O %A Thorand, Barbara %A Thorleifsson, Gudmar %A Tomaschitz, Andreas %A Troffa, Chiara %A van Oort, Floor V A %A Verweij, Niek %A Vonk, Judith M %A Waite, Lindsay L %A Wennauer, Roman %A Wilsgaard, Tom %A Wojczynski, Mary K %A Wong, Andrew %A Zhang, Qunyuan %A Hua Zhao, Jing %A Brennan, Eoin P %A Choi, Murim %A Eriksson, Per %A Folkersen, Lasse %A Franco-Cereceda, Anders %A Gharavi, Ali G %A Hedman, Åsa K %A Hivert, Marie-France %A Huang, Jinyan %A Kanoni, Stavroula %A Karpe, Fredrik %A Keildson, Sarah %A Kiryluk, Krzysztof %A Liang, Liming %A Lifton, Richard P %A Ma, Baoshan %A McKnight, Amy J %A McPherson, Ruth %A Metspalu, Andres %A Min, Josine L %A Moffatt, Miriam F %A Montgomery, Grant W %A Murabito, Joanne M %A Nicholson, George %A Nyholt, Dale R %A Olsson, Christian %A Perry, John R B %A Reinmaa, Eva %A Salem, Rany M %A Sandholm, Niina %A Schadt, Eric E %A Scott, Robert A %A Stolk, Lisette %A Vallejo, Edgar E %A Westra, Harm-Jan %A Zondervan, Krina T %A Amouyel, Philippe %A Arveiler, Dominique %A Bakker, Stephan J L %A Beilby, John %A Bergman, Richard N %A Blangero, John %A Brown, Morris J %A Burnier, Michel %A Campbell, Harry %A Chakravarti, Aravinda %A Chines, Peter S %A Claudi-Boehm, Simone %A Collins, Francis S %A Crawford, Dana C %A Danesh, John %A de Faire, Ulf %A de Geus, Eco J C %A Dörr, Marcus %A Erbel, Raimund %A Eriksson, Johan G %A Farrall, Martin %A Ferrannini, Ele %A Ferrières, Jean %A Forouhi, Nita G %A Forrester, Terrence %A Franco, Oscar H %A Gansevoort, Ron T %A Gieger, Christian %A Gudnason, Vilmundur %A Haiman, Christopher A %A Harris, Tamara B %A Hattersley, Andrew T %A Heliövaara, Markku %A Hicks, Andrew A %A Hingorani, Aroon D %A Hoffmann, Wolfgang %A Hofman, Albert %A Homuth, Georg %A Humphries, Steve E %A Hyppönen, Elina %A Illig, Thomas %A Järvelin, Marjo-Riitta %A Johansen, Berit %A Jousilahti, Pekka %A Jula, Antti M %A Kaprio, Jaakko %A Kee, Frank %A Keinanen-Kiukaanniemi, Sirkka M %A Kooner, Jaspal S %A Kooperberg, Charles %A Kovacs, Peter %A Kraja, Aldi T %A Kumari, Meena %A Kuulasmaa, Kari %A Kuusisto, Johanna %A Lakka, Timo A %A Langenberg, Claudia %A Le Marchand, Loic %A Lehtimäki, Terho %A Lyssenko, Valeriya %A Männistö, Satu %A Marette, André %A Matise, Tara C %A McKenzie, Colin A %A McKnight, Barbara %A Musk, Arthur W %A Möhlenkamp, Stefan %A Morris, Andrew D %A Nelis, Mari %A Ohlsson, Claes %A Oldehinkel, Albertine J %A Ong, Ken K %A Palmer, Lyle J %A Penninx, Brenda W %A Peters, Annette %A Pramstaller, Peter P %A Raitakari, Olli T %A Rankinen, Tuomo %A Rao, D C %A Rice, Treva K %A Ridker, Paul M %A Ritchie, Marylyn D %A Rudan, Igor %A Salomaa, Veikko %A Samani, Nilesh J %A Saramies, Jouko %A Sarzynski, Mark A %A Schwarz, Peter E H %A Shuldiner, Alan R %A Staessen, Jan A %A Steinthorsdottir, Valgerdur %A Stolk, Ronald P %A Strauch, Konstantin %A Tönjes, Anke %A Tremblay, Angelo %A Tremoli, Elena %A Vohl, Marie-Claude %A Völker, Uwe %A Vollenweider, Peter %A Wilson, James F %A Witteman, Jacqueline C %A Adair, Linda S %A Bochud, Murielle %A Boehm, Bernhard O %A Bornstein, Stefan R %A Bouchard, Claude %A Cauchi, Stéphane %A Caulfield, Mark J %A Chambers, John C %A Chasman, Daniel I %A Cooper, Richard S %A Dedoussis, George %A Ferrucci, Luigi %A Froguel, Philippe %A Grabe, Hans-Jörgen %A Hamsten, Anders %A Hui, Jennie %A Hveem, Kristian %A Jöckel, Karl-Heinz %A Kivimaki, Mika %A Kuh, Diana %A Laakso, Markku %A Liu, Yongmei %A März, Winfried %A Munroe, Patricia B %A Njølstad, Inger %A Oostra, Ben A %A Palmer, Colin N A %A Pedersen, Nancy L %A Perola, Markus %A Pérusse, Louis %A Peters, Ulrike %A Power, Chris %A Quertermous, Thomas %A Rauramaa, Rainer %A Rivadeneira, Fernando %A Saaristo, Timo E %A Saleheen, Danish %A Sinisalo, Juha %A Slagboom, P Eline %A Snieder, Harold %A Spector, Tim D %A Thorsteinsdottir, Unnur %A Stumvoll, Michael %A Tuomilehto, Jaakko %A Uitterlinden, André G %A Uusitupa, Matti %A van der Harst, Pim %A Veronesi, Giovanni %A Walker, Mark %A Wareham, Nicholas J %A Watkins, Hugh %A Wichmann, H-Erich %A Abecasis, Goncalo R %A Assimes, Themistocles L %A Berndt, Sonja I %A Boehnke, Michael %A Borecki, Ingrid B %A Deloukas, Panos %A Franke, Lude %A Frayling, Timothy M %A Groop, Leif C %A Hunter, David J %A Kaplan, Robert C %A O'Connell, Jeffrey R %A Qi, Lu %A Schlessinger, David %A Strachan, David P %A Stefansson, Kari %A van Duijn, Cornelia M %A Willer, Cristen J %A Visscher, Peter M %A Yang, Jian %A Hirschhorn, Joel N %A Zillikens, M Carola %A McCarthy, Mark I %A Speliotes, Elizabeth K %A North, Kari E %A Fox, Caroline S %A Barroso, Inês %A Franks, Paul W %A Ingelsson, Erik %A Heid, Iris M %A Loos, Ruth J F %A Cupples, L Adrienne %A Morris, Andrew P %A Lindgren, Cecilia M %A Mohlke, Karen L %K Adipocytes %K Adipogenesis %K Adipose Tissue %K Age Factors %K Body Fat Distribution %K Body Mass Index %K Continental Population Groups %K Epigenesis, Genetic %K Europe %K Female %K Genome, Human %K Genome-Wide Association Study %K Humans %K Insulin %K Insulin Resistance %K Male %K Models, Biological %K Neovascularization, Physiologic %K Obesity %K Polymorphism, Single Nucleotide %K Quantitative Trait Loci %K Sex Characteristics %K Transcription, Genetic %K Waist-Hip Ratio %X

Body fat distribution is a heritable trait and a well-established predictor of adverse metabolic outcomes, independent of overall adiposity. To increase our understanding of the genetic basis of body fat distribution and its molecular links to cardiometabolic traits, here we conduct genome-wide association meta-analyses of traits related to waist and hip circumferences in up to 224,459 individuals. We identify 49 loci (33 new) associated with waist-to-hip ratio adjusted for body mass index (BMI), and an additional 19 loci newly associated with related waist and hip circumference measures (P < 5 × 10(-8)). In total, 20 of the 49 waist-to-hip ratio adjusted for BMI loci show significant sexual dimorphism, 19 of which display a stronger effect in women. The identified loci were enriched for genes expressed in adipose tissue and for putative regulatory elements in adipocytes. Pathway analyses implicated adipogenesis, angiogenesis, transcriptional regulation and insulin resistance as processes affecting fat distribution, providing insight into potential pathophysiological mechanisms.

%B Nature %V 518 %P 187-96 %8 2015 Feb 12 %G eng %N 7538 %1 http://www.ncbi.nlm.nih.gov/pubmed/25673412?dopt=Abstract %R 10.1038/nature14132 %0 Journal Article %J Ann Rheum Dis %D 2015 %T Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. %A Rusmini, Marta %A Federici, Silvia %A Caroli, Francesco %A Grossi, Alice %A Baldi, Maurizia %A Obici, Laura %A Insalaco, Antonella %A Tommasini, Alberto %A Caorsi, Roberta %A Gallo, Eleonora %A Olivieri, Alma Nunzia %A Marzano, AngeloValerio %A Coviello, Domenico %A Ravazzolo, Roberto %A Martini, Alberto %A Gattorno, Marco %A Ceccherini, Isabella %X

OBJECTIVES: Systemic auto-inflammatory disorders (SAIDs) are a heterogeneous group of monogenic diseases sharing a primary dysfunction of the innate immune system. More than 50% of patients with SAID does not show any mutation at gene(s) tested because of lack of precise clinical classification criteria and/or incomplete gene screening. To improve the molecular diagnosis and genotype interpretation of SAIDs, we undertook the development of a next-generation sequencing (NGS)-based protocol designed to simultaneous screening of 10 genes.

METHODS: Fifty patients with SAID, already genotyped for the respective causative gene(s), were massively sequenced for the coding portions of MEFV, MVK, TNFRSF1A, NLRP3, NLRP12, NOD2, PSTPIP1, IL1RN, LPIN2 and PSMB8. Three different bioinformatic pipelines (Ion Reporter, CLC Bio Genomics Workbench, GATK-based in-house workflow) were compared.

RESULTS: Once resulting variants were compared with the expected mutation list, no workflow turned out to be able to detect all the 79 variants known in the 50 DNAs. Additional variants were also detected, validated by Sanger sequencing and compared to assess true and false positive detection rates of the three workflows. Finally, the overall clinical picture of 34 patients was re-evaluated in the light of the new mutations found.

CONCLUSIONS: The present gene panel has resulted suitable for molecular diagnosis of SAIDs. Moreover, genotype-phenotype correlation has confirmed that the interpretation of NGS data in patients with an undefined inflammatory phenotype is remarkably difficult, thus supporting the need of evidence-based and validated clinical criteria to be used concurrently with the genetic analysis for the final diagnosis and classification of patients with SAIDs.

%B Ann Rheum Dis %8 2015 Sep 17 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26386126?dopt=Abstract %R 10.1136/annrheumdis-2015-207701 %0 Journal Article %J Infect Agent Cancer %D 2015 %T NLRP1 and NLRP3 polymorphisms in mesothelioma patients and asbestos exposed individuals a population-based autopsy study from North East Italy. %A Borelli, Violetta %A Moura, Ronal R %A Trevisan, Elisa %A Crovella, Sergio %X

NRLP1 (rs12150220, rs9889625, rs9900356, rs6502867, rs2670660) and NLRP3 (rs35829419, rs10754558) polymorphisms have been analyzed in 69 subjects with documented asbestos exposure and death for malignant pleural mesothelioma and 59 patients with documented asbestos exposure but death for other causes, all from a North East Italy. No association was found between NLRP1 and NLRP3 polymorphisms and susceptibility to develop mesothelioma using the general, dominant or recessive models. Also haplotype analysis did not reveal any significant association with mesothelioma. Our findings, being controversial with respect to another study on Italian patients, do suggest the need of further studies to unravel the contribution of NLRP1 and NLRP3 in susceptibility to mesothelioma.

%B Infect Agent Cancer %V 10 %P 26 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26236392?dopt=Abstract %R 10.1186/s13027-015-0022-0 %0 Journal Article %J Arch Dis Child %D 2015 %T Normal saline flushes performed once daily maintain peripheral intravenous catheter patency: a randomised controlled trial. %A Schreiber, Silvana %A Zanchi, Chiara %A Ronfani, Luca %A Delise, Anna %A Corbelli, Alessandra %A Bortoluzzi, Rosamaria %A Taddio, Andrea %A Barbi, Egidio %K Adolescent %K Catheterization, Peripheral %K Catheters, Indwelling %K Child %K Child, Preschool %K Equipment Failure %K Female %K Humans %K Infant %K Male %K Outcome Assessment (Health Care) %K Risk Assessment %K Sodium Chloride %K Therapeutic Irrigation %X

OBJECTIVE: Recent evidence supports the use of normal saline flushes in place of heparin to maintain the patency of peripheral intravenous locks (IVLs); however, there are no data regarding the recommended flush frequency.

STUDY DESIGN: This was an open, non-inferiority, randomised controlled trial. Children with IVLs, aged 1-17 years, were randomly assigned to receive saline flushing every 12 h (group A) or every 24 h (group B). The main outcome was the maintenance of catheter patency.

RESULTS: Four hundred patients were randomised; 198 subjects were analysed in the 12 h group and 199 in the 24 h group (three patients were lost at follow-up). Occlusion occurred in 15 children (7.6%) in group A versus 9 (4.5%) in group B (p=0.21). The difference in catheter patency was +3.1% in favour of the 24 h group (95% CI -1.6% to 7.7%), showing the non-inferiority of the 24 h procedure (the non-inferiority margin was set at -4%). Catheter-related complications were not different between the two groups (12.1% in group A vs 9.5% in group B; p=0.42).

CONCLUSIONS: A flushing procedure with one flush per day allows maintenance of catheter patency without an increase in catheter-related complications. We propose a simplification of the flushing procedure with only one flush per day, thereby reducing costs (materials use and nursing time), labour and unnecessary manipulation of the catheters which can cause distress in younger children and their parents.

TRIAL REGISTRATION NUMBER: The study is registered in the international database ClinicalTrial.gov under registration number NCT02221024.

%B Arch Dis Child %V 100 %P 700-3 %8 2015 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/25589559?dopt=Abstract %R 10.1136/archdischild-2014-307478 %0 Journal Article %J Oncotarget %D 2015 %T The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells. %A Simioni, Carolina %A Cani, Alice %A Martelli, Alberto M %A Zauli, Giorgio %A Alameen, Ayman A M %A Ultimo, Simona %A Tabellini, Giovanna %A McCubrey, James A %A Capitani, Silvano %A Neri, Luca M %X

Hepatocellular carcinoma (HCC) is one of the most common lethal human malignancies worldwide and its advanced status is frequently resistant to conventional chemotherapeutic agents and radiation. We evaluated the cytotoxic effect of the orally bioavailable dual PI3K/mTOR inhibitor, NVP-BGT226, on a panel of HCC cell lines, since hyperactivated PI3K/Akt/mTOR signaling pathway could represent a biomolecular target for Small Inhibitor Molecules in this neoplasia. We analyzed the drug activity in both normoxia and hypoxia conditions, the latter playing often a relevant role in the induction of chemoresistance and angiogenesis.In normoxia NVP-BGT226 caused cell cycle arrest in the G0/G1 phase of the cell cycle, induced apoptosis and autophagy at low concentrations. Interestingly the drug inactivated p-Akt and p-S6 at < 10 nM concentration.In hypoxia NVP-BGT226 maintained its cytotoxic efficacy at the same concentration as documented by MTT assays and Western blot analysis. Moreover, the drug showed in hypoxia inhibitory properties against angiogenesis by lowering the expression of the transcription factor HIF-1α and of VEGF.Our results indicate that NVP-BGT226 has a potent cytotoxic effect on HCC cell lines also in hypoxia condition, thus emerging as a potential candidate for cancer treatment in HCC targeted therapy.

%B Oncotarget %V 6 %P 17147-60 %8 2015 Jul 10 %G eng %N 19 %1 http://www.ncbi.nlm.nih.gov/pubmed/26003166?dopt=Abstract %R 10.18632/oncotarget.3940 %0 Journal Article %J Dig Liver Dis %D 2015 %T Orofacial granulomatosis in children: think about Crohn's disease. %A Lazzerini, Marzia %A Martelossi, Stefano %A Cont, Gabriele %A Bersanini, Chiara %A Ventura, Giovanna %A Fontana, Massimo %A Zuin, Giovanna %A Ventura, Alessandro %A Taddio, Andrea %K Adolescent %K Biopsy %K Child %K Colonoscopy %K Crohn Disease %K Diagnosis, Differential %K Female %K Granulomatosis, Orofacial %K Humans %K Immunosuppressive Agents %K Male %K Thalidomide %X

BACKGROUND: The term orofacial granulomatosis is conventionally used to describe patients with granulomatous lesions affecting the orofacial tissues, in absence of intestinal lesions. Lip swelling and facial swelling are the most common clinical signs. Despite the fact that histologically it is not distinguishable from Crohn's disease, and that both diseases have a chronic/recurrent course, the relationship between orofacial granulomatosis and Crohn's disease is still debated.

METHODS: Herein we present five cases of orofacial granulomatosis.

RESULTS: All patients presented concomitant Crohn's disease, supporting the hypothesis that orofacial granulomatosis and Crohn's disease may be one single disease. Thalidomide was effective in inducing remission of oral and intestinal symptoms in all five cases and could be considered a valid treatment opportunity for these patients.

CONCLUSIONS: Orofacial granulomatosis and Crohn's disease may be part of the same disease; both may respond to thalidomide.

%B Dig Liver Dis %V 47 %P 338-41 %8 2015 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25618553?dopt=Abstract %R 10.1016/j.dld.2014.12.012 %0 Journal Article %J Acta Paediatr %D 2015 %T Pain activates a defined area of the somatosensory and motor cortex in newborn infants. %A Bembich, Stefano %A Brovedani, Pierpaolo %A Cont, Gabriele %A Travan, Laura %A Grassi, Veronica %A Demarini, Sergio %B Acta Paediatr %V 104 %P e530-3 %8 2015 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/26174848?dopt=Abstract %R 10.1111/apa.13122 %0 Journal Article %J Hum Mol Genet %D 2015 %T The p.Cys169Tyr variant of connexin 26 is not a polymorphism. %A Zonta, Francesco %A Girotto, Giorgia %A Buratto, Damiano %A Crispino, Giulia %A Morgan, Anna %A Abdulhadi, Khalid %A Alkowari, Moza %A Badii, Ramin %A Gasparini, Paolo %A Mammano, Fabio %K Alleles %K Amino Acid Substitution %K Cell Line %K Connexins %K Female %K Gap Junctions %K Gene Expression %K Genotype %K Hearing Loss %K Humans %K Immunohistochemistry %K Male %K Models, Molecular %K Mutation, Missense %K Pedigree %K Polymorphism, Genetic %K Protein Conformation %K Protein Interaction Domains and Motifs %K Transfection %X

Mutations in the GJB2 gene, which encodes the gap junction protein connexin 26 (Cx26), are the primary cause of hereditary prelingual hearing impairment. Here, the p.Cys169Tyr missense mutation of Cx26 (Cx26C169Y), previously classified as a polymorphism, has been identified as causative of severe hearing loss in two Qatari families. We have analyzed the effect of this mutation using a combination of confocal immunofluorescence microscopy and molecular dynamics simulations. At the cellular level, our results show that the mutant protein fails to form junctional channels in HeLa transfectants despite being correctly targeted to the plasma membrane. At the molecular level, this effect can be accounted for by disruption of the disulfide bridge that Cys169 forms with Cys64 in the wild-type structure (Cx26WT). The lack of the disulfide bridge in the Cx26C169Y protein causes a spatial rearrangement of two important residues, Asn176 and Thr177. In the Cx26WT protein, these residues play a crucial role in the intra-molecular interactions that permit the formation of an intercellular channel by the head-to-head docking of two opposing hemichannels resident in the plasma membrane of adjacent cells. Our results elucidate the molecular pathogenesis of hereditary hearing loss due to the connexin mutation and facilitate the understanding of its role in both healthy and affected individuals.

%B Hum Mol Genet %V 24 %P 2641-8 %8 2015 May 1 %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/25628337?dopt=Abstract %R 10.1093/hmg/ddv026 %0 Journal Article %J Exp Ther Med %D 2015 %T Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17. %A Kleiner, Giulio %A Zanin, Valentina %A Monasta, Lorenzo %A Crovella, Sergio %A Caruso, Lorenzo %A Milani, Daniela %A Marcuzzi, Annalisa %X

Inflammatory bowel disease (IBD) is a chronic and progressive inflammatory condition of the gastrointestinal tract. Although the causative events that lead to the onset of IBD are yet to be fully elucidated, deregulation of immune and inflammatory mechanisms are hypothesized to significantly contribute to this disorder. Since the onset of IBD is often during infancy, in the present study, the serum values of a large panel of cytokines and chemokines in pediatric patients (<18 years; n=26) were compared with age-matched controls (n=37). While elevations in the serum level of several proinflammatory and immune regulating cytokines were confirmed, such as interleukin (IL)-1β, IL-5, IL-7, interferon (IFN)-γ-inducible protein-10, IL-16, cutaneous T-cell-attracting chemokine, leukemia inhibitory factor, monokine induced by γ-IFN, IFN-α2 and IFN-γ, notably decreased levels of IL-2, IL-17 and macrophage inhibitory protein-1β were also observed. Therefore, while a number of proinflammatory cytokines exhibit increased levels in IBD patients, pediatric IBD patients may also exhibit certain aspects of a reduced immunological response.

%B Exp Ther Med %V 9 %P 2047-2052 %8 2015 Jun %G ENG %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/26136934?dopt=Abstract %R 10.3892/etm.2015.2370 %0 Journal Article %J J Clin Virol %D 2015 %T Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy. %A Caracciolo, Ilaria %A Bassetti, Matteo %A Paladini, Giorgio %A Luzzati, Roberto %A Santon, Daniela %A Merelli, Maria %A Sabbata, Giovanni De %A Carletti, Tea %A Marcello, Alessandro %A D'Agaro, Pierlanfranco %X

A persistent tick-borne encephalitis virus infection in an immune-suppressed patient is presented. Such an unusual clinical case offers the unique chance of detecting persistent viremia associated to the erythrocyte fraction and shedding of the virus in the urine for more than six weeks. The infection occurred in a new area of the Friuli Venezia-Giulia region (North Eastern Italy) where two additional cases are also being reported.

%B J Clin Virol %V 69 %P 48-51 %8 2015 Aug %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26209378?dopt=Abstract %R 10.1016/j.jcv.2015.05.019 %0 Journal Article %J J Antimicrob Chemother %D 2015 %T Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation. %A Cojutti, Piergiorgio %A Maximova, Natalia %A Crichiutti, Giovanni %A Isola, Miriam %A Pea, Federico %K Acetamides %K Anti-Bacterial Agents %K Area Under Curve %K Child %K Child, Preschool %K Drug Monitoring %K Female %K Gram-Positive Bacterial Infections %K Hospitalization %K Humans %K Infant %K Inpatients %K Linezolid %K Male %K Monte Carlo Method %K Oxazolidinones %K Plasma %K Retrospective Studies %K Tertiary Care Centers %X

OBJECTIVES: To report on linezolid exposure in a paediatric population who routinely underwent therapeutic drug monitoring (TDM) for dosage optimization and to assess the factors affecting interpatient variability.

METHODS: We performed a retrospective study of patients whose plasma C(min) and Cmax levels were measured during linezolid treatment. Adequate exposure was defined as a C(min) of 2-7 mg/L and/or an estimated AUC24 of 160-300 mg · h/L. Patients were divided into two subgroups (Group 1, 2-11 years; Group 2, 12-18 years). Monte Carlo simulation was performed to investigate whether or not the currently recommended dosages might enable a high probability of target attainment (PTA) of two thresholds for linezolid efficacy (AUC24/MIC ≥ 80 or ≥ 100). Data on demographic characteristics, disease, microbiology and haematochemical parameters and outcomes were collected.

RESULTS: A total of 23 patients were included. Standard dosages were suboptimal in 50.0% and 44.4% of patients in Group 1 and Group 2, respectively. Among those who underwent multiple instances of TDM, the dosages were increased in 33.3% of cases in both groups, and decreased in 6.6% and 9.5% of cases in Group 1 and Group 2, respectively. Co-treatment with phenobarbital, proton pump inhibitors and amiodarone accounted for most of the variability in C(min) (adjusted R(2) of 0.692). Simulations showed a PTA of ≥ 90% with the current dosing regimens in both groups only for pathogens with an MIC ≤ 1 mg/L.

CONCLUSIONS: Higher dosages of linezolid may be needed, especially in Group 1 when in the presence of pathogens with an MIC >1 mg/L. The role of TDM should be encouraged for optimization of linezolid exposure in the paediatric setting in the presence of infections caused by pathogens with borderline susceptibility and/or for patients co-treated with drugs that may alter linezolid exposure.

%B J Antimicrob Chemother %V 70 %P 198-206 %8 2015 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25182066?dopt=Abstract %R 10.1093/jac/dku337 %0 Journal Article %J Antimicrob Agents Chemother %D 2015 %T Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients. %A Cojutti, Piergiorgio %A Maximova, Natalia %A Pea, Federico %X

This study explored the pharmacokinetics and the pharmacodynamics of continuous-infusion meropenem in a population of pediatric hematopoietic stem cell transplant (HSCT) patients who underwent therapeutic drug monitoring. The relationship between meropenem clearance (CLM) and estimated creatinine clearance (CLCR) was assessed by nonlinear regression. A Monte Carlo simulation was performed to investigate the predictive performance of five dosing regimens (15 to 90 mg/kg of body weight/day) for the empirical treatment of severe Gram-negative-related infections in relation to four different categories of renal function. The optimal target was defined as a probability of target attainment (PTA) of ≥90% at steady-state concentration-to-MIC ratios (C SS/MIC) of ≥1 and ≥4 for MICs of up to 8 mg/liter. A total of 21 patients with 44 meropenem C SS were included. A good relationship between CLM and estimated CLCR was observed (r (2) = 0.733). Simulations showed that at an MIC of 2 mg/liter, the administration of continuous-infusion meropenem at doses of 15, 30, 45, and 60 mg/kg/day may achieve a PTA of ≥90% at a C SS/MIC ratio of ≥4 in the CLCR categories of 40 to <80, 80 to <120, 120 to <200, and 200 to <300 ml/min/1.73 m(2), respectively. At an MIC of 8 mg/liter, doses of up to 90 mg/kg/day by continuous infusion may achieve optimal PTA only in the CLCR categories of 40 to <80 and 80 to <120 ml/min/1.73 m(2). Continuous-infusion meropenem at dosages up to 90 mg/kg/day might be effective for optimal treatment of severe Gram-negative-related infections in pediatric HSCT patients, even when caused by carbapenem-resistant pathogens with an MIC of up to 8 mg/liter.

%B Antimicrob Agents Chemother %V 59 %P 5535-41 %8 2015 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/26124157?dopt=Abstract %R 10.1128/AAC.00787-15 %0 Journal Article %J Mol Cytogenet %D 2015 %T Phenotypic and genetic characterization of a family carrying two Xq21.1-21.3 interstitial deletions associated with syndromic hearing loss. %A Iossa, Sandra %A Costa, Valerio %A Corvino, Virginia %A Auletta, Gennaro %A Barruffo, Luigi %A Cappellani, Stefania %A Ceglia, Carlo %A Cennamo, Giovanni %A d'Adamo, Adamo Pio %A D'Amico, Alessandra %A Di Paolo, Nilde %A Forte, Raimondo %A Gasparini, Paolo %A Laria, Carla %A Lombardo, Barbara %A Malesci, Rita %A Vitale, Andrea %A Marciano, Elio %A Franzè, Annamaria %X

BACKGROUND: Sensorineural hearing impairment is a common pathological manifestation in patients affected by X-linked intellectual disability. A few cases of interstitial deletions at Xq21 with several different phenotypic characteristics have been described, but to date, a complete molecular characterization of the deletions harboring disease-causing genes is still missing. Thus, the aim of this study is to realize a detailed clinical and molecular analysis of a family affected by syndromic X-linked hearing loss with intellectual disability.

RESULTS: Clinical analyses revealed a very complex phenotype that included inner ear malformations, vestibular problems, choroideremia and hypotonia with a peculiar pattern of phenotypic variability. Genomic analysis revealed, for the first time, the presence of two close interstitial deletions in the Xq21.1-21.3, harboring 11 protein coding, 9 non-coding genes and 19 pseudogenes. Among these, 3 protein coding genes have already been associated with X-linked hearing loss, intellectual disability and choroideremia.

CONCLUSIONS: In this study we highlighted the presence of peculiar genotypic and phenotypic details in a family affected by syndromic X-linked hearing loss with intellectual disability. We identified two, previously unreported, Xq21.1-21.3 interstitial deletions. The two rearrangements, containing several genes, segregate with the clinical features, suggesting their role in the pathogenicity. However, not all the observed phenotypic features can be clearly associated with the known genes thus, further study is necessary to determine regions involved.

%B Mol Cytogenet %V 8 %P 18 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25821518?dopt=Abstract %R 10.1186/s13039-015-0120-0 %0 Journal Article %J Arch Dis Child %D 2015 %T Phleboliths as a marker of slow-flow venous malformation. %A Calligaris, Lorenzo %A Berti, Irene %A Barbi, Egidio %B Arch Dis Child %V 100 %P 1012 %8 2015 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/26242634?dopt=Abstract %R 10.1136/archdischild-2015-308935 %0 Journal Article %J Arch Dis Child Educ Pract Ed %D 2015 %T A pneumonia that does not improve. %A Naviglio, Samuele %A Chinello, Matteo %A Ventura, Alessandro %K Airway Obstruction %K Bronchoscopy %K Child, Preschool %K Foreign Bodies %K Humans %K Pneumonia %K Radiography, Thoracic %B Arch Dis Child Educ Pract Ed %V 100 %P 18, 55 %8 2015 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24821991?dopt=Abstract %R 10.1136/archdischild-2014-306343 %0 Journal Article %J Nat Genet %D 2015 %T Population genetic differentiation of height and body mass index across Europe. %A Robinson, Matthew R %A Hemani, Gibran %A Medina-Gomez, Carolina %A Mezzavilla, Massimo %A Esko, Tõnu %A Shakhbazov, Konstantin %A Powell, Joseph E %A Vinkhuyzen, Anna %A Berndt, Sonja I %A Gustafsson, Stefan %A Justice, Anne E %A Kahali, Bratati %A Locke, Adam E %A Pers, Tune H %A Vedantam, Sailaja %A Wood, Andrew R %A van Rheenen, Wouter %A Andreassen, Ole A %A Gasparini, Paolo %A Metspalu, Andres %A Berg, Leonard H van den %A Veldink, Jan H %A Rivadeneira, Fernando %A Werge, Thomas M %A Abecasis, Goncalo R %A Boomsma, Dorret I %A Chasman, Daniel I %A de Geus, Eco J C %A Frayling, Timothy M %A Hirschhorn, Joel N %A Hottenga, Jouke Jan %A Ingelsson, Erik %A Loos, Ruth J F %A Magnusson, Patrik K E %A Martin, Nicholas G %A Montgomery, Grant W %A North, Kari E %A Pedersen, Nancy L %A Spector, Timothy D %A Speliotes, Elizabeth K %A Goddard, Michael E %A Yang, Jian %A Visscher, Peter M %X

Across-nation differences in the mean values for complex traits are common, but the reasons for these differences are unknown. Here we find that many independent loci contribute to population genetic differences in height and body mass index (BMI) in 9,416 individuals across 14 European countries. Using discovery data on over 250,000 individuals and unbiased effect size estimates from 17,500 sibling pairs, we estimate that 24% (95% credible interval (CI) = 9%, 41%) and 8% (95% CI = 4%, 16%) of the captured additive genetic variance for height and BMI, respectively, reflect population genetic differences. Population genetic divergence differed significantly from that in a null model (height, P < 3.94 × 10(-8); BMI, P < 5.95 × 10(-4)), and we find an among-population genetic correlation for tall and slender individuals (r = -0.80, 95% CI = -0.95, -0.60), consistent with correlated selection for both phenotypes. Observed differences in height among populations reflected the predicted genetic means (r = 0.51; P < 0.001), but environmental differences across Europe masked genetic differentiation for BMI (P < 0.58).

%B Nat Genet %V 47 %P 1357-62 %8 2015 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/26366552?dopt=Abstract %R 10.1038/ng.3401 %0 Journal Article %J Ital J Pediatr %D 2015 %T Position Statement on Breastfeeding from the Italian Pediatric Societies. %A Davanzo, Riccardo %A Romagnoli, Costantino %A Corsello, Giovanni %X

The 2015 Position Statement on Breastfeeding of The Italian Pediatric Societies (SIP, SIN, SICupp, SIGENP) recognizes breastfeeding as an healthy behaviour with many short and long term benefits for both mother and infant.While protecting, promoting and supporting breastfeeding, neonatologists and pediatricians need specific knowledge, skills and a positive attitude toward breastfeeding. In Maternity Hospitals and in Neonatal Units, appropriate organizative interventions should be applied in order to facilitate the beginning of breastfeeding and the use of mother's/human milk.The Italian Pediatric Societies indicate the desiderable goal of around 6 months exclusive breastfeeding if the infant grows properly according to WHO Growth Charts. In principle, complementary feeding should not be anticipated before 6 months as a nutritional strategy pretending to prevent allergy and/or celiac disease. Eventually, long term breastfeeding should be supported meeting mother's desire.

%B Ital J Pediatr %V 41 %P 80 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26498033?dopt=Abstract %R 10.1186/s13052-015-0191-x %0 Journal Article %J Ann Surg Oncol %D 2015 %T Positron emission tomography-laparoscopy based method in the prediction of complete cytoreduction in platinum-sensitive recurrent ovarian cancer. %A Fanfani, Francesco %A Monterossi, Giorgia %A Fagotti, Anna %A Gallotta, Valerio %A Costantini, Barbara %A Vizzielli, Giuseppe %A Petrillo, Marco %A Carbone, Maria Vittoria %A Scambia, Giovanni %K Adult %K Aged %K Algorithms %K Cytoreduction Surgical Procedures %K Female %K Humans %K Laparoscopy %K Middle Aged %K Neoplasm Recurrence, Local %K Neoplasm Staging %K Neoplasms, Glandular and Epithelial %K Ovarian Neoplasms %K Positron-Emission Tomography %K Tomography, X-Ray Computed %X

BACKGROUND: This study was designed to evaluate the positron emission tomography-laparoscopy-based method in the prediction of complete/optimal cytoreduction in platinum sensitive recurrent epithelial ovarian cancer patients.

METHODS: We analysed 223 consecutive recurrent epithelial ovarian cancer patients. Inclusion criteria were absence of extra-abdominal disease and Eastern Cooperative Oncology Group Performance Status ≤2. Complete and optimal secondary cytoreduction are defined as macroscopic absence or less than 1 cm of residual tumor at the end of surgery.

RESULTS: Laparoscopy was feasible in 210 of 223 patients (94.2 %). Laparoscopy stated 127 (60.5 %) possible cytoreductions and 83 (39.5 %) systemic chemotherapies. In the same population, AGO score evaluation avowed 150 possible cytoreduction (71.5 %) and 60 unresectable women (28.5 %). Overall, 115 of 210 patients (54.7 %) underwent successful secondary cytoreduction: complete and optimal cytoreduction was obtained in 103 (89.5 %) and 12 (10.5 %) patients, respectively. Laparoscopy obtained a positive predictive value of 91.3 %. Laparoscopy recovered to secondary cytoreduction 13 of 60 patients (21.7 %) deemed as not resectable according to AGO score. Forty-eight of 150 AGO score positive patients (32 %) were judged nonresectable by laparoscopy.

CONCLUSIONS: This study confirmed that laparoscopy could be effective for the selection of platinum-sensitive recurrent epithelial ovarian cancer patients suitable for complete cytoreduction.

%B Ann Surg Oncol %V 22 %P 649-54 %8 2015 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25155399?dopt=Abstract %R 10.1245/s10434-014-4011-0 %0 Journal Article %J Infant Ment Health J %D 2015 %T PRE- AND POSTNATAL MODIFICATIONS IN PARENTAL MENTAL REPRESENTATIONS IN THREE CASES OF FETAL GASTROSCHISIS DIAGNOSED DURING PREGNANCY. %A Tripani, Antonella %A Pellizzoni, Sandra %A Giuliani, Rosella %A Bembich, Stefano %A Clarici, Andrea %A Lonciari, Isabella %A Ammaniti, Massimo %X

The aim of this study was to identify possible effects of gastroschisis on parents' intrapsychic dynamics by applying an observational clinical approach. More specifically, we intend to (a) evaluate the representational style of parents informed about the diagnosis of fetal gastroschisis during pregnancy using the Interview of Maternal Representations During Pregnancy and the Interview of Paternal Representations During Pregnancy (M. Ammaniti, C. Candelori, M. Pola, & R. Tambelli, ) and (b) observe whether the baby's birth influences the parents' representational styles through the application of the same tools (the Interview of Maternal Representations After the Birth, M. Ammaniti & R. Tambelli, , and the Interview of Paternal Representations After the Birth, M. Ammaniti & R. Tambelli, ), adapted to the postnatal period. During the prenatal period, all parents showed a restricted/disinvested style. Three parents-one mother and two fathers-changed their styles from restricted/disinvested to integrated between pregnancy and Month 6 after the birth of their child. Clinical data from the interviews and observations are discussed in an attempt at better defining intrapsychic dynamics of parents after a diagnosis of gastroschisis.

%B Infant Ment Health J %8 2015 Nov 10 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26554534?dopt=Abstract %R 10.1002/imhj.21534 %0 Journal Article %J Sci Rep %D 2015 %T PSIP1/LEDGF: a new gene likely involved in sensorineural progressive hearing loss. %A Girotto, Giorgia %A Scheffer, Deborah I %A Morgan, Anna %A Vozzi, Diego %A Rubinato, Elisa %A Di Stazio, Mariateresa %A Muzzi, Enrico %A Pensiero, Stefano %A Giersch, Anne B %A Corey, David P %A Gasparini, Paolo %X

Hereditary Hearing Loss (HHL) is an extremely heterogeneous disorder. Approximately 30 out of 80 known HHL genes are associated with autosomal dominant forms. Here, we identified PSIP1/LEDGF (isoform p75) as a novel strong candidate gene involved in dominant HHL. Using exome sequencing we found a frameshift deletion (c.1554_1555del leading to p.E518Dfs*2) in an Italian pedigree affected by sensorineural mild-to-moderate HHL but also showing a variable eye phenotype (i.e. uveitis, optic neuropathy). This deletion led to a premature stop codon (p.T519X) with truncation of the last 12 amino acids. PSIP1 was recently described as a transcriptional co-activator regulated by miR-135b in vestibular hair cells of the mouse inner ear as well as a possible protector against photoreceptor degeneration. Here, we demonstrate that it is ubiquitously expressed in the mouse inner ear. The PSIP1 mutation is associated with a peculiar audiometric slope toward the high frequencies. These findings indicate that PSIP1 likely plays an important role in HHL.

%B Sci Rep %V 5 %P 18568 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26689366?dopt=Abstract %R 10.1038/srep18568 %0 Journal Article %J Genet Mol Res %D 2015 %T A rapid screening of ancestry for genetic association studies in an admixed population from Pernambuco, Brazil. %A Coelho, A V C %A Moura, R R %A Cavalcanti, C A J %A Guimarães, R L %A Sandrin-Garcia, P %A Crovella, S %A Brandão, L A C %X

Genetic association studies determine how genes influence traits. However, non-detected population substructure may bias the analysis, resulting in spurious results. One method to detect substructure is to genotype ancestry informative markers (AIMs) besides the candidate variants, quantifying how much ancestral populations contribute to the samples' genetic background. The present study aimed to use a minimum quantity of markers, while retaining full potential to estimate ancestries. We tested the feasibility of a subset of the 12 most informative markers from a previously established study to estimate influence from three ancestral populations: European, African and Amerindian. The results showed that in a sample with a diverse ethnicity (N = 822) derived from 1000 Genomes database, the 12 AIMs had the same capacity to estimate ancestries when compared to the original set of 128 AIMs, since estimates from the two panels were closely correlated. Thus, these 12 SNPs were used to estimate ancestry in a new sample (N = 192) from an admixed population in Recife, Northeast Brazil. The ancestry estimates from Recife subjects were in accordance with previous studies, showing that Northeastern Brazilian populations show great influence from European ancestry (59.7%), followed by African (23.0%) and Amerindian (17.3%) ancestries. Ethnicity self-classification according to skin-color was confirmed to be a poor indicator of population substructure in Brazilians, since ancestry estimates overlapped between classifications. Thus, our streamlined panel of 12 markers may substitute panels with more markers, while retaining the capacity to control for population substructure and admixture, thereby reducing sample processing time.

%B Genet Mol Res %V 14 %P 2876-84 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25867437?dopt=Abstract %R 10.4238/2015.March.31.18 %0 Journal Article %J Nat Commun %D 2015 %T Rare coding variants and X-linked loci associated with age at menarche. %A Lunetta, Kathryn L %A Day, Felix R %A Sulem, Patrick %A Ruth, Katherine S %A Tung, Joyce Y %A Hinds, David A %A Esko, Tõnu %A Elks, Cathy E %A Altmaier, Elisabeth %A He, Chunyan %A Huffman, Jennifer E %A Mihailov, Evelin %A Porcu, Eleonora %A Robino, Antonietta %A Rose, Lynda M %A Schick, Ursula M %A Stolk, Lisette %A Teumer, Alexander %A Thompson, Deborah J %A Traglia, Michela %A Wang, Carol A %A Yerges-Armstrong, Laura M %A Antoniou, Antonis C %A Barbieri, Caterina %A Coviello, Andrea D %A Cucca, Francesco %A Demerath, Ellen W %A Dunning, Alison M %A Gandin, Ilaria %A Grove, Megan L %A Gudbjartsson, Daniel F %A Hocking, Lynne J %A Hofman, Albert %A Huang, Jinyan %A Jackson, Rebecca D %A Karasik, David %A Kriebel, Jennifer %A Lange, Ethan M %A Lange, Leslie A %A Langenberg, Claudia %A Li, Xin %A Luan, Jian'an %A Mägi, Reedik %A Morrison, Alanna C %A Padmanabhan, Sandosh %A Pirie, Ailith %A Polasek, Ozren %A Porteous, David %A Reiner, Alex P %A Rivadeneira, Fernando %A Rudan, Igor %A Sala, Cinzia F %A Schlessinger, David %A Scott, Robert A %A Stöckl, Doris %A Visser, Jenny A %A Völker, Uwe %A Vozzi, Diego %A Wilson, James G %A Zygmunt, Marek %A Boerwinkle, Eric %A Buring, Julie E %A Crisponi, Laura %A Easton, Douglas F %A Hayward, Caroline %A Hu, Frank B %A Liu, Simin %A Metspalu, Andres %A Pennell, Craig E %A Ridker, Paul M %A Strauch, Konstantin %A Streeten, Elizabeth A %A Toniolo, Daniela %A Uitterlinden, André G %A Ulivi, Sheila %A Völzke, Henry %A Wareham, Nicholas J %A Wellons, Melissa %A Franceschini, Nora %A Chasman, Daniel I %A Thorsteinsdottir, Unnur %A Murray, Anna %A Stefansson, Kari %A Murabito, Joanne M %A Ong, Ken K %A Perry, John R B %X

More than 100 loci have been identified for age at menarche by genome-wide association studies; however, collectively these explain only ∼3% of the trait variance. Here we test two overlooked sources of variation in 192,974 European ancestry women: low-frequency protein-coding variants and X-chromosome variants. Five missense/nonsense variants (in ALMS1/LAMB2/TNRC6A/TACR3/PRKAG1) are associated with age at menarche (minor allele frequencies 0.08-4.6%; effect sizes 0.08-1.25 years per allele; P<5 × 10(-8)). In addition, we identify common X-chromosome loci at IGSF1 (rs762080, P=9.4 × 10(-13)) and FAAH2 (rs5914101, P=4.9 × 10(-10)). Highlighted genes implicate cellular energy homeostasis, post-transcriptional gene silencing and fatty-acid amide signalling. A frequently reported mutation in TACR3 for idiopathic hypogonatrophic hypogonadism (p.W275X) is associated with 1.25-year-later menarche (P=2.8 × 10(-11)), illustrating the utility of population studies to estimate the penetrance of reportedly pathogenic mutations. Collectively, these novel variants explain ∼0.5% variance, indicating that these overlooked sources of variation do not substantially explain the 'missing heritability' of this complex trait.

%B Nat Commun %V 6 %P 7756 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26239645?dopt=Abstract %R 10.1038/ncomms8756 %0 Journal Article %J Ann Hematol %D 2015 %T Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive the %A Giordano, Paola %A Saracco, Paola %A Grassi, Massimo %A Luciani, Matteo %A Banov, Laura %A Carraro, Francesca %A Crocoli, Alessandro %A Cesaro, Simone %A Zanazzo, Giulio Andrea %A Molinari, Angelo Claudio %K Adult %K Blood Coagulation Disorders %K Catheter Obstruction %K Catheterization, Central Venous %K Central Venous Catheters %K Child %K Hematologic Neoplasms %K Humans %K Risk Factors %K Thrombosis %X

Central venous catheters (CVC), used for the management of children with hemato-oncological disorders, are burdened by a significant incidence of mechanical, infective, or thrombotic complications. These complications favor an increasing risk in prolongation of hospitalization, extra costs of care, and sometimes severe life-threatening events. No guidelines for the management of CVC-related occlusion and CVC-related thrombosis are available for children. To this aim, members of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP) reviewed the pediatric and adult literature to propose the first recommendations for the management of CVC-related occlusion and CVC-related thrombosis in children with hemato-oncological disorders.

%B Ann Hematol %V 94 %P 1765-76 %8 2015 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/26300457?dopt=Abstract %R 10.1007/s00277-015-2481-1 %0 Journal Article %J Sci Rep %D 2015 %T RelB activation in anti-inflammatory decidual endothelial cells: a master plan to avoid pregnancy failure? %A Masat, Elisa %A Gasparini, Chiara %A Agostinis, Chiara %A Bossi, Fleur %A Radillo, Oriano %A De Seta, Francesco %A Tamassia, Nicola %A Cassatella, Marco A %A Bulla, Roberta %X

It is known that excessive inflammation at fetal-maternal interface is a key contributor in a compromised pregnancy. Female genital tract is constantly in contact with microorganisms and several strategies must be adopted to avoid pregnancy failure. Decidual endothelial cells (DECs) lining decidual microvascular vessels are the first cells that interact with pro-inflammatory stimuli released into the environment by microorganisms derived from gestational tissues or systemic circulation. Here, we show that DECs are hypo-responsive to LPS stimulation in terms of IL-6, CXCL8 and CCL2 production. Our results demonstrate that DECs express low levels of TLR4 and are characterized by a strong constitutive activation of the non-canonical NF-κB pathway and a low responsiveness of the canonical pathway to LPS. In conclusion, DECs show a unique hypo-responsive phenotype to the pro-inflammatory stimulus LPS in order to control the inflammatory response at feto-maternal interface.

%B Sci Rep %V 5 %P 14847 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26463648?dopt=Abstract %R 10.1038/srep14847 %0 Journal Article %J J Matern Fetal Neonatal Med %D 2015 %T Sensorineural hearing loss in very low birth weight infants with histological chorioamnionitis. %A Vedovato, Stefania %A Lo Iacono, Angela %A Morando, Carla %A Suppiej, Agnese %A Orzan, Eva %A Trevisanuto, Daniele %A Visentin, Silvia %A Cavallin, Francesco %A Chiarelli, Silvia %A Zanardo, Vincenzo %X

OBJECTIVE: Histological chorioamnionitis (HCAM) has been associated with inflammatory diseases of preterm infants. Recently we have observed that it increased the risk of speech delay and hearing loss. So the aim of this study was to evaluate the relationship between sensorineural hearing loss (SNHL) of VLBW infants and HCAM.

METHODS: We performed an observational study on VLBW infants admitted to the NICU of Padua. Each patient with HCAM was matched with one control without HCAM. All infants underwent hearing screening before discharge by means of automated transient-evoked otoacustic emissions and automated auditory brainstem responses, which were repeated at 3 and 6 months of age with tympanometry measurement. Incidence of SNHL at 6 months of age was compared in the 2 groups and risk factors for hearing loss were studied.

RESULTS: Two of 77 (2.6%) newborns with HCAM e 6/73 (8.2%) without it presented SNHL at 6 months of corrected age (p = 0.16). Multivariable logistic regression analysis identified surgical ligation of patent ductus arteriosus (PDA) as independent predictors of SNHL (OR: 5.75, 95% CI 1.34-24.84, p = 0.02), whereas the effect of HCAM on SNHL was only near to statistical significance level.

CONCLUSIONS: Surgical ligation of PDA is associated with an increased risk of SNHL in VLBW infants, regardless of HCAM.

%B J Matern Fetal Neonatal Med %V 28 %P 895-9 %8 2015 May %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24949929?dopt=Abstract %R 10.3109/14767058.2014.936375 %0 Journal Article %J J Pediatr %D 2015 %T A Shining Scrotal Fountain. %A Copertino, Marco %A Benelli, Elisa %A Gregori, Massimo %A Barbi, Egidio %A Ventura, Alessandro %K Child %K Edema %K Humans %K Male %K Penile Diseases %K Scrotum %B J Pediatr %V 167 %P 205.e1 %8 2015 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25934069?dopt=Abstract %R 10.1016/j.jpeds.2015.04.011 %0 Journal Article %J Genet Mol Res %D 2015 %T Short Communication FYB polymorphisms in Brazilian patients with type I diabetes mellitus and autoimmune polyglandular syndrome type III. %A Addobbati, C J C %A de Azevêdo Silva, J %A Tavares, N A C %A Araujo, J %A Guimarães, R L %A Brandão, L %A Crovella, S %A Sandrin-Garcia, P %X

The aim of this study was to perform an association study between seven Fyn-binding protein gene (FYB)-tag single nucleotide polymorphisms (SNPs) and type I diabetes mellitus (T1DM), as well as with disease age of onset. We also assessed the role of FYB SNPs in the insurgence of autoimmune polyglandular syndrome type III (APSIII), characterized by the simultaneous presence of autoimmune thyroid disease and celiac disease, in patients with T1DM from a Northeastern Brazilian population. One hundred and seventy-seven patients with T1DM and 190 healthy individuals were genotyped for seven tag SNPs, covering most of the FYB locus, using real-time polymerase chain reaction amplification. There was no significant difference in the distribution of allele and genotype frequencies among patients and healthy individuals. Moreover, none of the tag SNPs were associated either to T1DM age of onset or to the insurgence of APSIII. However, since the FYB protein is a key component in T cell response, its gene variants might play a role in protein function, which might be testable in a population with different genetic backgrounds or by using functional assays.

%B Genet Mol Res %V 14 %P 29-33 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25729932?dopt=Abstract %R 10.4238/2015.January.15.4 %0 Journal Article %J J Emerg Med %D 2015 %T Splenic Infarction in Acute Infectious Mononucleosis. %A Naviglio, Samuele %A Abate, Maria Valentina %A Chinello, Matteo %A Ventura, Alessandro %X

BACKGROUND: The evaluation of a febrile patient with acute abdominal pain represents a frequent yet possibly challenging situation in the emergency department (ED). Splenic infarction is an uncommon complication of infectious mononucleosis, and may have a wide range of clinical presentations, from dramatic to more subtle. Its pathogenesis is still incompletely understood, yet it may be associated with the occurrence of transient prothrombotic factors.

CASE REPORT: We report the case of a 14-year-old boy who presented with fever, sore throat, left upper quadrant abdominal pain, and splenomegaly, with no history of recent trauma. Laboratory tests revealed a markedly prolonged activated partial thromboplastin time and positive lupus anticoagulant. Abdominal ultrasonography showed several hypoechoic areas in the spleen consistent with multiple infarctions. Magnetic resonance imaging eventually confirmed the diagnosis. He was admitted for observation and supportive treatment, and was discharged in good condition after 7 days. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Spontaneous splenic infarction should be considered in the differential list of patients presenting with left upper quadrant abdominal pain and features of infectious mononucleosis; the diagnosis, however, may not be straightforward, as clinical presentation may also be subtle, and abdominal ultrasonography, which is often used as a first-line imaging modality in pediatric EDs, has low sensitivity in this scenario and may easily miss it. Furthermore, although treatment is mainly supportive, close observation for possible complications is necessary.

%B J Emerg Med %8 2015 Oct 22 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26602427?dopt=Abstract %R 10.1016/j.jemermed.2015.09.019 %0 Journal Article %J J Pediatr Hematol Oncol %D 2015 %T Subcutaneous panniculitis-like T-cell lymphoma presenting with diffuse cutaneous edema in a 2-year-old child. %A Chinello, Matteo %A Naviglio, Samuele %A Remotti, Daniele %A Locasciulli, Anna %A Ventura, Alessandro %K Child, Preschool %K Edema %K Humans %K Lymphoma, T-Cell %K Male %K Panniculitis %K Skin Diseases %B J Pediatr Hematol Oncol %V 37 %P 329-30 %8 2015 May %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25739026?dopt=Abstract %R 10.1097/MPH.0000000000000312 %0 Journal Article %J Mutat Res %D 2015 %T Target sequencing approach intended to discover new mutations in non-syndromic intellectual disability. %A Morgan, Anna %A Gandin, Ilaria %A Belcaro, Chiara %A Palumbo, Pietro %A Palumbo, Orazio %A Biamino, Elisa %A Dal Col, Valentina %A Laurini, Erik %A Pricl, Sabrina %A Bosco, Paolo %A Carella, Massimo %A Ferrero, Giovanni Battista %A Romano, Corrado %A d'Adamo, Adamo Pio %A Faletra, Flavio %A Vozzi, Diego %X

The technological improvements over the last years made considerable progresses in the knowledge of the etiology of intellectual Disability (ID). However, at present very little is known about the genetic heterogeneity underlying the non-syndromic form of ID (NS-ID). To investigate the genetic basis of NS-ID we analyzed 43 trios and 22 isolated NS-ID patients using a targeted sequencing (TS) approach. 71 NS-ID genes have been selected and sequenced in all subjects. We found putative pathogenic mutations in 7 out of 65 patients. The pathogenic role of mutations was evaluated through sequence comparison and structural analysis was performed to predict the effect of alterations in a 3D computational model through molecular dynamics simulations. Additionally, a deep patient clinical re-evaluation has been performed after the molecular results. This approach allowed us to find novel pathogenic mutations with a detection rate close to 11% in our cohort of patients. This result supports the hypothesis that many NS-ID related genes still remain to be discovered and that NS-ID is a more complex phenotype compared to syndromic form, likely caused by a complex and broad interaction between genes alterations and environment factors.

%B Mutat Res %V 781 %P 32-6 %8 2015 Nov %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26411299?dopt=Abstract %R 10.1016/j.mrfmmm.2015.09.002 %0 Journal Article %J Int J Nanomedicine %D 2015 %T Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies. %A Capolla, Sara %A Garrovo, Chiara %A Zorzet, Sonia %A Lorenzon, Andrea %A Rampazzo, Enrico %A Spretz, Ruben %A Pozzato, Gabriele %A Núñez, Luis %A Tripodo, Claudio %A Macor, Paolo %A Biffi, Stefania %X

The expectations of nanoparticle (NP)-based targeted drug delivery systems in cancer, when compared with convectional therapeutic methods, are greater efficacy and reduced drug side effects due to specific cellular-level interactions. However, there are conflicting literature reports on enhanced tumor accumulation of targeted NPs, which is essential for translating their applications as improved drug-delivery systems and contrast agents in cancer imaging. In this study, we characterized biodegradable NPs conjugated with an anti-CD20 antibody for in vivo imaging and drug delivery onto tumor cells. NPs' binding specificity mediated by anti-CD20 antibody was evaluated on MEC1 cells and chronic lymphocytic leukemia patients' cells. The whole-body distribution of untargeted NPs and anti-CD20 NPs were compared by time-domain optical imaging in a localized human/mouse model of B-cell malignancy. These studies provided evidence that NPs' functionalization by an anti-CD20 antibody improves tumor pharmacokinetic profiles in vivo after systemic administration and increases in vivo imaging of tumor mass compared to non-targeted NPs. Together, drug delivery and imaging probe represents a promising theranostics tool for targeting B-cell malignancies.

%B Int J Nanomedicine %V 10 %P 4099-109 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/26124662?dopt=Abstract %R 10.2147/IJN.S78995 %0 Journal Article %J J Pediatr %D 2015 %T Tinea Incognito. %A Paloni, Giulia %A Valerio, Enrico %A Berti, Irene %A Cutrone, Mario %B J Pediatr %V 167 %P 1450-1450.e2 %8 2015 Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/26423793?dopt=Abstract %R 10.1016/j.jpeds.2015.08.062 %0 Journal Article %J Biomed Res Int %D 2015 %T TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications. %A Perri, Paolo %A Zauli, Giorgio %A Gonelli, Arianna %A Milani, Daniela %A Celeghini, Claudio %A Lamberti, Giuseppe %A Secchiero, Paola %K Apoptosis %K Diabetes Complications %K Diabetes Mellitus %K Eye Neoplasms %K Humans %K Receptors, TNF-Related Apoptosis-Inducing Ligand %K TNF-Related Apoptosis-Inducing Ligand %X

TNF-related apoptosis inducing ligand (TRAIL) is an intensively studied cytokine, in particular for its anticancer activity. The discovery that conjunctival sac fluid contains extremely high levels of soluble TRAIL as compared to other body fluids suggested important implications in the context of the immunological surveillance of the eye, in particular of the anterior surface. In this review, we discuss the potential physiopathologic and therapeutic role of the TRAIL/TRAIL receptor system in a variety of ocular cancers. Moreover, since an increasing amount of data has indicated the important biological activities of the TRAIL/TRAIL receptor systems also in a completely different pathologic context such as diabetes mellitus, in the second part of this review we summarize the currently available data on the involvement of TRAIL in the ocular complications of diabetes mellitus as modulator of the inflammatory and angiogenic response in the eye.

%B Biomed Res Int %V 2015 %P 424019 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25834817?dopt=Abstract %R 10.1155/2015/424019 %0 Journal Article %J Genet Mol Res %D 2015 %T Trace samples of human blood in mosquitoes as a forensic investigation tool. %A Rabelo, K C N %A Albuquerque, C M R %A Tavares, V B %A Santos, S M %A Souza, C A %A Oliveira, T C %A Oliveira, N C L %A Crovella, S %X

Investigations of any type of crime invariably starts at the crime scene by collecting evidence. Thus, the purpose of this research was to collect and analyze an entomological trace from an environment that is similar to those of indoor crime scenes. Hematophagous mosquitoes were collected from two residential units; saliva of volunteers that were residents in the units was also collected for genetic analysis as reference samples. We examined the allele frequencies of 15 short tandem repeat loci (D8S1179, D21S11, D7S820, CSF1PO, D3S1358, TH01, D13S317, D16S539, D2S1338, D19S433, vWA, TPOX, D18S51, D5S818, and FGA) and amelogenin. A total of 26 female hematophagous mosquitoes were identified as Aedes aegypti, Aedes albopictus, and Culex quinquefasciatus; we were able to obtain 11 forensically valid genetic profiles, with a minimum of 0.028203 ng/μL of human DNA. Thus, the results of this study showed that it was possible to correlate human genetic information from mosquitoes with the volunteer reference samples, which validates the use of this information as forensic evidence. Furthermore, we observed mixed genetic profiles from one mosquito. Therefore, it is clearly important to collect these insects indoors where crimes were committed, because it may be possible to find intact genetic profiles of suspects in the blood found in the digestive tract of hematophagous mosquitoes for later comparison to identify an offender and/or exclude suspects.

%B Genet Mol Res %V 14 %P 14847-56 %8 2015 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26600546?dopt=Abstract %R 10.4238/2015.November.18.50 %0 Journal Article %J Oncotarget %D 2015 %T Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia. %A Cani, Alice %A Simioni, Carolina %A Martelli, Alberto M %A Zauli, Giorgio %A Tabellini, Giovanna %A Ultimo, Simona %A McCubrey, James A %A Capitani, Silvano %A Neri, Luca M %X

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive neoplastic disorder in which chemotherapy resistance and refractory relapses occur, with a poorer prognostic outcome.Constitutively active PI3K/Akt/mTOR pathway is a common feature of T-ALL upregulating cell proliferation, survival and drug resistance. This pathway is currently under clinical trials with small molecules inhibitors (SMI).To verify whether a multi-inhibition treatment against Akt protein could enhance the efficacy of individual drug administration and overcome drug resistance as well as to obtain a decrease in single drug concentration, we tested on T-ALL cell lines the effects of combined treatments with three Akt inhibitors with different mode of action, GSK690693, MK-2206 and Perifosine.In cells with hyperactivated Akt, combined administration of the drugs displayed a significant synergistic and cytotoxic effect and affected PI3K/Akt/mTOR pathway at much lower concentration than single drug use. Highest synergistic effect for full inhibition of Akt was also related to the timing of every drug administration. Furthermore the triple treatment had greater efficacy in inducing cell cycle arrest in G0/G1 phase and both apoptosis and autophagy.Targeting Akt as a key protein of PI3K/Akt/mTOR pathway with multiple drugs might represent a new and promising pharmacological strategy for treatment of T-ALL patients.

%B Oncotarget %V 6 %P 6597-610 %8 2015 Mar 30 %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/25788264?dopt=Abstract %R 10.18632/oncotarget.3260 %0 Journal Article %J Ann Hum Biol %D 2015 %T Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion. %A Tavares, Mayara C Mansur %A de Lima Júnior, Sérgio F %A Coelho, Antonio V C %A Marques, Trícia Ruschelle N M %A de Araújo, Diêgo Henrique T %A Heráclio, Sandra de A %A Amorim, Melânia M Ramos %A de Souza, Paulo Roberto E %A Crovella, Sergio %X

BACKGROUND: The Human Papillomavirus (HPV) predisposes 500 000 women to cervical cancer. Host genetic background may facilitate virus persistence in the uterine cervix. Polymorphisms in regulatory and coding regions of cytokine genes have been associated with susceptibility to some human diseases.

AIM: This study aims at investigating whether TNFA -308 G/A and IL18 -137 G/C and -607 C/A polymorphisms are associated with susceptibility to HPV infection/progression to high-grade squamous intraepithelial lesion (HSIL).

SUBJECTS AND METHODS: One hundred and twenty-two HPV infected and 132 HPV negative women (the latter used as healthy controls) were analysed. TNFA -308 G/A and IL18 (-137G/C and -607 C/A) polymorphisms were analysed using specific sequence polymorphism PCR (SSP-PCR). Univariate statistical analysis and a logistic regression were performed.

RESULTS: The TNFA -308A allele was associated with susceptibility to HPV infection (p = 0.0008), while the IL18 -607A allele conferred protection against HPV infection (p = 0.0043). TNFA -308 G/A and IL18 (-137G/C and -607 C/A) polymorphisms were not associated with development of cervical lesions (p > 0.05). An association was also observed between smoking and susceptibility to the development of HSIL.

CONCLUSION: The findings suggest an association between two TNFA SNPs and susceptibility to HPV infection in women from Northeast Brazil. The results need to be functionally validated and replicated in other populations with different ethnic backgrounds.

%B Ann Hum Biol %P 1-8 %8 2015 Jun 16 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26079218?dopt=Abstract %R 10.3109/03014460.2014.1001436 %0 Journal Article %J Genet Mol Res %D 2015 %T Tumor necrosis factor-α and interleukin-6 gene polymorphism association with susceptibility to celiac disease in Italian patients. %A de Albuquerque Maranhão, R M %A Martins Esteves, F A %A Crovella, S %A Segat, L %A Eleutério Souza, P R %X

The aim of this research was to study polymorphisms in the genes encoding cytokines interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in patients with celiac disease (CD) antigens DQ2 (DQ2-positive) or DQ8 (DQ8-positive). We compared the results with healthy controls to determine whether any of the polymorphisms have a role in susceptibility to CD. A case-control of 192 patients with CD (96 DQ2-positive and 96 DQ8-positive) and 96 healthy controls from northeast Italy were included in the study. Analysis of single nucleotide polymorphisms (SNPs) was carried out using the polymerase chain reaction-restriction fragment length polymorphism method. Significant differences for the TNF-α(-308 G>A) polymorphism were observed when we compared the flowing groups: DQ2-positive with controls [odds ratio (OR) = 0.45, P = 0.0002]; DQ8-positive with controls (OR = 3.55, P < 0.0001); and DQ2-positive with DQ8-positive (OR = 0.12, P < 0.0001). We did not observe a statistically significant association between IL-6 (-174 G>C) polymorphism and CD (P > 0.05). Our results suggest that TNF-α(-308 G>A) polymorphism may play a role in susceptibility to CD in Italian patients.

%B Genet Mol Res %V 14 %P 16343-52 %8 2015 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26662429?dopt=Abstract %R 10.4238/2015.December.9.2 %0 Journal Article %J Pediatr Rheumatol Online J %D 2015 %T Unusual onset of a case of chronic recurrent multifocal osteomyelitis. %A Barrani, M %A Massei, F %A Scaglione, M %A Paolicchi, A %A Vitali, S %A Ciancia, E M %A Crovella, S %A Caparello, M C %A Consolini, R %X

BACKGROUND: Chronic recurrent multifocal osteomyelitis (CRMO) is a rare condition that commonly affects the clavicle and pelvis.

CASE PRESENTATION: We report here a case a 12 years old girl with CRMO arising with recurrent episodes of left supraorbital headache, followed by the appearance of a periorbital dyschromia. Magnetic resonance imaging (MRI) of the skull and orbits revealed an important subacute inflammatory process. Few months after, the child presented a painful swelling of the left clavicle; the histological examination of the related biopsy allowed to establish the diagnosis of CRMO.

CONCLUSION: CRMO presenting as acute headache involving neurocranium is rare; to our knowledge this is the first recognized case in the world literature. This pathological condition is frequently misdiagnosed as infection or neoplasm and needs a deep investigation for the differential diagnosis. The physical, laboratoristic and instrumental diagnostic investigations of the patient and the treatment employed are described in detail.

%B Pediatr Rheumatol Online J %V 13 %P 60 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/26653878?dopt=Abstract %R 10.1186/s12969-015-0058-0 %0 Journal Article %J Eur J Hum Genet %D 2015 %T On the use of Chinese population as a proxy of Amerindian ancestors in genetic admixture studies with Latin American populations. %A de Moura, Ronald R %A de Queiroz Balbino, Valdir %A Crovella, Sergio %A Brandão, Lucas A C %B Eur J Hum Genet %8 2015 Sep 2 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26328507?dopt=Abstract %R 10.1038/ejhg.2015.184 %0 Journal Article %J Hear Res %D 2015 %T Usher syndrome: an effective sequencing approach to establish a genetic and clinical diagnosis. %A Lenarduzzi, S %A Vozzi, D %A Morgan, A %A Rubinato, E %A D'Eustacchio, A %A Osland, T M %A Rossi, C %A Graziano, C %A Castorina, P %A Ambrosetti, U %A Morgutti, M %A Girotto, G %K Adult %K Alleles %K Cadherins %K Extracellular Matrix Proteins %K Female %K Genetic Counseling %K High-Throughput Nucleotide Sequencing %K Humans %K Male %K Middle Aged %K Mutation %K Myosins %K Nerve Tissue Proteins %K Usher Syndromes %X

Usher syndrome is an autosomal recessive disorder characterized by retinitis pigmentosa, sensorineural hearing loss and, in some cases, vestibular dysfunction. The disorder is clinically and genetically heterogeneous and, to date, mutations in 11 genes have been described. This finding makes difficult to get a precise molecular diagnosis and offer patients accurate genetic counselling. To overcome this problem and to increase our knowledge of the molecular basis of Usher syndrome, we designed a targeted resequencing custom panel. In a first validation step a series of 16 Italian patients with known molecular diagnosis were analysed and 31 out of 32 alleles were detected (97% of accuracy). After this step, 31 patients without a molecular diagnosis were enrolled in the study. Three out of them with an uncertain Usher diagnosis were excluded. One causative allele was detected in 24 out 28 patients (86%) while the presence of both causative alleles characterized 19 patients out 28 (68%). Sixteen novel and 27 known alleles were found in the following genes: USH2A (50%), MYO7A (7%), CDH23 (11%), PCDH15 (7%) and USH1G (2%). Overall, on the 44 patients the protocol was able to characterize 74 alleles out of 88 (84%). These results suggest that our panel is an effective approach for the genetic diagnosis of Usher syndrome leading to: 1) an accurate molecular diagnosis, 2) better genetic counselling, 3) more precise molecular epidemiology data fundamental for future interventional plans.

%B Hear Res %V 320 %P 18-23 %8 2015 Feb %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25575603?dopt=Abstract %R 10.1016/j.heares.2014.12.006 %0 Journal Article %J Psychol Rep %D 2015 %T Validation of the Italian translation of the affective neuroscience personality scales. %A Pascazio, Lorenzo %A Bembich, Stefano %A Nardone, Ilaria B %A Vecchiet, Cristina %A Guarino, Giuseppina %A Clarici, Andrea %K Adolescent %K Adult %K Affect %K Aged %K Aged, 80 and over %K Female %K Humans %K Italy %K Male %K Middle Aged %K Neurosciences %K Personality %K Personality Inventory %K Psychometrics %K Young Adult %X

The theoretical perspective on affective neuroscience advanced by Panksepp, identified six basic innate affective systems: the SEEK, FEAR, ANGER, SADNESS, PLAY, and CARE systems. (3) It has been proposed that the fundamental elements of human personality and its variants may be based on the different expressions of these basic emotional systems and their combinations. A self-report inventory, the Affective Neuroscience Personality Scales (ANPS), has been devised with the aim of studying and evaluating personality from this perspective. This study reports data on the initial validation of ANPS Italian translation on a sample of 418 adult participants. Descriptive statistics for each scale were calculated, assessing also their internal consistency, as a measure of reliability and factorial validity. Acceptable internal consistency was found in all but one scale (SADNESS), and a second-order factor analysis identified a more general affective feature of personality hinging on relational characteristics, independent of the dimensions of general positive and negative affect.

%B Psychol Rep %V 116 %P 97-115 %8 2015 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25621669?dopt=Abstract %R 10.2466/08.09.PR0.116k13w4 %0 Journal Article %J Mol Biol Rep %D 2015 %T Vitamin D receptor polymorphisms and expression profile in rheumatoid arthritis brazilian patients. %A Cavalcanti, Catarina Addobbati Jordão %A De Azevêdo Silva, Jaqueline %A de Barros Pita, Will %A Veit, Tiago Degani %A Monticielo, Odirlei Andre %A Xavier, Ricardo Machado %A Brenol, João Carlos Tavares %A Brenol, Cleiton Viegas %A Fragoso, Thiago Sotero %A Barbosa, Alexandre Domingues %A Duarte, Ângela Luiza Branco Pinto %A Oliveira, Renê Donizeti Ribeiro %A Louzada-Júnior, Paulo %A Donadi, Eduardo Antônio %A Crovella, Sergio %A Chies, José Artur Bogo %A Sandrin-Garcia, Paula %X

Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation and important joint commitment, being the most common systemic autoimmune disease worldwide. RA displays important genetic background with a variety of genes contributing to the immune balance breakdown. Recent studies have demonstrated that vitamin D, through its receptor (VDR), is able to regulate the immune balance and suppress the autoimmunity process, being a potential target in autoimmune diseases. In the present genetic association study, we assessed 5 Tag single nucleotide polymorphisms (SNPs) (rs11168268, rs2248098, rs1540339, rs4760648 and rs3890733), which cover most of the VDR gene, in three different Brazilian populations (from Northeast, Southeast and South Brazil). We also evaluated the VDR expression profile in whole blood and monocytes from RA patients. For genotyping study, 428 RA patients and 616 healthy controls were genotyped with fluorogenic allele specific probes on an ABI7500 platform. For gene expression study, VDR mRNA levels of 15 RA patients and 26 healthy individuals were assessed by RT-PCR. Our results showed that SNPs rs4760648 and rs3890733 are associated to RA susceptibility (p value = 0.0026, OR 1.31 and p value = 0.0091, OR 1.28 with statistical power = 0.999 and 0.993, respectively). Regarding RA clinical features, the studied SNPs did not show significant associations. The gene expression assays showed that VDR mRNA levels were down regulated in both whole blood (-3.3 fold) and monocytes (-3.2 fold) of RA patients when compared to healthy controls. Our results, the first reported for distinct Brazilian populations, support a role of the VDR gene in the susceptibility to RA.

%B Mol Biol Rep %8 2015 Dec 19 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26686848?dopt=Abstract %R 10.1007/s11033-015-3937-z %0 Journal Article %J J Investig Med High Impact Case Rep %D 2015 %T When Feeding Difficulties Are due to Genetics: The Case of Familial Partial 9q Duplication. %A Travan, Laura %A Rocca, Maria Santa %A Buonomo, Francesca %A Cleva, Lisa %A Pecile, Vanna %A De Cunto, Angela %X

Chromosomal abnormalities may cause growth failure before or since birth. 9q duplication is reported as a cause of intrauterine growth restriction, mild dysmporphism, and intellectual disabilities. We report a case of a maternally inherited 9q21.31q21.33 duplication causing prenatal and postnatal growth restriction with feeding refusal and mild facial dysmorphisms, prenatally diagnosed by single-nucleotide polymorphism array analysis. Hypothesis of the possible pathogenic mechanisms are discussed.

%B J Investig Med High Impact Case Rep %V 3 %P 2324709615574949 %8 2015 Jan-Mar %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/26425634?dopt=Abstract %R 10.1177/2324709615574949 %0 Journal Article %J Haematologica %D 2014 %T Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. %A Noris, Patrizia %A Schlegel, Nicole %A Klersy, Catherine %A Heller, Paula G %A Civaschi, Elisa %A Pujol-Moix, Núria %A Fabris, Fabrizio %A Favier, Rémi %A Gresele, Paolo %A Latger-Cannard, Véronique %A Cuker, Adam %A Nurden, Paquita %A Greinacher, Andreas %A Cattaneo, Marco %A De Candia, Erica %A Pecci, Alessandro %A Hurtaud-Roux, Marie-Françoise %A Glembotsky, Ana C %A Muñiz-Diaz, Eduardo %A Randi, Maria Luigia %A Trillot, Nathalie %A Bury, Loredana %A Lecompte, Thomas %A Marconi, Caterina %A Savoia, Anna %A Balduini, Carlo L %A Bayart, Sophie %A Bauters, Anne %A Benabdallah-Guedira, Schéhérazade %A Boehlen, Françoise %A Borg, Jeanne-Yvonne %A Bottega, Roberta %A Bussel, James %A De Rocco, Daniela %A de Maistre, Emmanuel %A Faleschini, Michela %A Falcinelli, Emanuela %A Ferrari, Silvia %A Ferster, Alina %A Fierro, Tiziana %A Fleury, Dominique %A Fontana, Pierre %A James, Chloé %A Lanza, Francois %A Le Cam Duchez, Véronique %A Loffredo, Giuseppe %A Magini, Pamela %A Martin-Coignard, Dominique %A Menard, Fanny %A Mercier, Sandra %A Mezzasoma, Annamaria %A Minuz, Pietro %A Nichele, Ilaria %A Notarangelo, Lucia D %A Pippucci, Tommaso %A Podda, Gian Marco %A Pouymayou, Catherine %A Rigouzzo, Agnes %A Royer, Bruno %A Sie, Pierre %A Siguret, Virginie %A Trichet, Catherine %A Tucci, Alessandra %A Saposnik, Béatrice %A Veneri, Dino %K Adult %K Female %K Humans %K Infant, Newborn %K Pregnancy %K Pregnancy Complications, Hematologic %K Retrospective Studies %K Thrombocytopenia %K Young Adult %X

Pregnancy in women with inherited thrombocytopenias is a major matter of concern as both the mothers and the newborns are potentially at risk of bleeding. However, medical management of this condition cannot be based on evidence because of the lack of consistent information in the literature. To advance knowledge on this matter, we performed a multicentric, retrospective study evaluating 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. Neither the degree of thrombocytopenia nor the severity of bleeding tendency worsened during pregnancy and the course of pregnancy did not differ from that of healthy subjects in terms of miscarriages, fetal bleeding and pre-term births. The degree of thrombocytopenia in the babies was similar to that in the mother. Only 7 of 156 affected newborns had delivery-related bleeding, but 2 of them died of cerebral hemorrhage. The frequency of delivery-related maternal bleeding ranged from 6.8% to 14.2% depending on the definition of abnormal blood loss, suggesting that the risk of abnormal blood loss was increased with respect to the general population. However, no mother died or had to undergo hysterectomy to arrest bleeding. The search for parameters predicting delivery-related bleeding in the mother suggested that hemorrhages requiring blood transfusion were more frequent in women with history of severe bleedings before pregnancy and with platelet count at delivery below 50 × 10(9)/L.

%B Haematologica %V 99 %P 1387-94 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24763399?dopt=Abstract %R 10.3324/haematol.2014.105924 %0 Journal Article %J PLoS One %D 2014 %T Assessment of coupling between trans-abdominally acquired fetal ECG and uterine activity by bivariate phase-rectified signal averaging analysis. %A Casati, Daniela %A Stampalija, Tamara %A Rizas, Konstantinos %A Ferrazzi, Enrico %A Mastroianni, Cristina %A Rosti, Eleonora %A Quadrifoglio, Mariachiara %A Bauer, Axel %K Electrocardiography %K Female %K Heart Rate, Fetal %K Humans %K Labor, Obstetric %K Pregnancy %K Uterine Contraction %X

UNLABELLED: Couplings between uterine contractions (UC) and fetal heart rate (fHR) provide important information on fetal condition during labor. At present, couplings between UC and fHR are assessed by visual analysis and interpretation of cardiotocography. The application of computerized approaches is restricted due to the non-stationarity of the signal, missing data and noise, typical for fHR. Herein, we propose a novel approach to assess couplings between UC and fHR, based on a signal-processing algorithm termed bivariate phase-rectified signal averaging (BPRSA).

METHODS: Electrohysterogram (EHG) and fetal electrocardiogram (fECG) were recorded non-invasively by a trans-abdominal device in 73 women at term with uneventful singleton pregnancy during the first stage of labor. Coupling between UC and fHR was analyzed by BPRSA and by conventional cross power spectral density analysis (CPSD). For both methods, degree of coupling was assessed by the maximum coefficient of coherence (CPRSA and CRAW, respectively) in the UC frequency domain. Coherence values greater than 0.50 were consider significant. CPRSA and CRAW were compared by Wilcoxon test.

RESULTS: At visual inspection BPRSA analysis identified coupled periodicities in 86.3% (63/73) of the cases. 11/73 (15%) cases were excluded from further analysis because no 30 minutes of fECG recording without signal loss was available for spectral analysis. Significant coupling was found in 90.3% (56/62) of the cases analyzed by BPRSA, and in 24.2% (15/62) of the cases analyzed by CPSD, respectively. The difference between median value of CPRSA and CRAW was highly significant (0.79 [IQR 0.69-0.90] and 0.29 [IQR 0.17-0.47], respectively; p<0.0001).

CONCLUSION: BPRSA is a novel computer-based approach that can be reliably applied to trans-abdominally acquired EHG-fECG. It allows the assessment of correlations between UC and fHR patterns in the majority of labors, overcoming the limitations of non-stationarity and artifacts. Compared to standard techniques of cross-correlations, such as CPSD, BPRSA is significantly superior.

%B PLoS One %V 9 %P e94557 %8 2014 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/24759939?dopt=Abstract %R 10.1371/journal.pone.0094557 %0 Journal Article %J Mol Biol Rep %D 2014 %T Association of CD209 and CD209L polymorphisms with tuberculosis infection in a Northeastern Brazilian population. %A da Silva, Ronaldo Celerino %A Segat, Ludovica %A da Cruz, Heidi Lacerda Alves %A Schindler, Haiana Charifker %A Montenegro, Lilian Maria Lapa %A Crovella, Sergio %A Guimarães, Rafael Lima %K Adult %K Alleles %K Brazil %K Case-Control Studies %K Cell Adhesion Molecules %K Dendritic Cells %K Female %K Genetic Predisposition to Disease %K Haplotypes %K Humans %K Lectins, C-Type %K Male %K Mycobacterium tuberculosis %K Polymorphism, Single Nucleotide %K Promoter Regions, Genetic %K Receptors, Cell Surface %K Tuberculosis %K Young Adult %X

Tuberculosis (TB) caused by Mycobacterium tuberculosis, is major cause of morbidity and mortality worldwide. So far, many candidate genes have been investigated for their possible association with TB. Dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3) grabbing non-integrin (DC-SIGN) and Liver/lymph node-specific intercellular adhesion molecule-grabbing non-integrin (L-SIGN), encoded by CD209 and CD209L genes respectively, are known for binding to M. tuberculosis on human dendritic cells and macrophages. We screened 4 single nucleotide polymorphisms (SNPs) in the promoter region of CD209, namely -939G>A (rs735240), -871A>G (rs735239), -336A>G (rs4804803) and -139G>A (rs2287886) and tandem repeat polymorphisms in exon 4 of CD209 and CD209L genes looking for association with TB in a Northeastern Brazilian population (295 subjects, 131 TB patients and 164 healthy controls). The -139G>A and -939G>A SNPs were associated with susceptibility to TB, and in particular with pulmonary and extra-pulmonary forms respectively. The -871A>G and -336A>G SNPs were associated, the first with protection to both pulmonary and extra-pulmonary TB, the latter only with the pulmonary form. An association between GGAG haplotype and protection to TB infection was also found. Also tandem repeat polymorphism in CD209L exon 4 was associated with TB infection. This study provides evidence of an association between CD209 and CD209L polymorphisms and TB development in a Brazilian population, suggesting that variations in these genes may influence the protection and susceptibility to infection caused by M. tuberculosis.

%B Mol Biol Rep %V 41 %P 5449-57 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24874302?dopt=Abstract %R 10.1007/s11033-014-3416-y %0 Journal Article %J Mediators Inflamm %D 2014 %T Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry. %A Cervellati, Carlo %A Secchiero, Paola %A Bonaccorsi, Gloria %A Celeghini, Claudio %A Zauli, Giorgio %K Absorptiometry, Photon %K Adipose Tissue %K Adiposity %K Adult %K Anthropometry %K Female %K Gene Expression Regulation %K Humans %K Inflammation %K Linear Models %K Menopause %K Middle Aged %K Overweight %K TNF-Related Apoptosis-Inducing Ligand %X

A low chronic inflammation mediated by cytokine release is considered a major pathogenic mechanism accounting for the higher risk of cardiovascular disease in the overweight/obese population. In this context, although the existence of a possible interaction between soluble tumor necrosis factor- (TNF-) related apoptosis inducing ligand (TRAIL) and quantity and localization, of adiposity in the body has been hypothesized, no studies have yet investigated this link by radiologic techniques able to assess directly fat mass (FM) in different body regions. To address this issue, we assessed body fat distribution by dual X-rays absorptiometry (DXA) in a sample of 103 women and investigated the possible association between the derived adiposity measures and serum TRAIL concentration. The level of TRAIL showed a positive and independent correlation with arms FM (P < 0.05), trunk FM (P < 0.001) and trunk FM% (P < 0.05), total FM and total FM% (P < 0.001 for both), and an inverse association with legs FM% (P < 0.05). Only trunk FM retained a significant correlation (P < 0.05) with TRAIL after adjusting for all the other indices of regional adiposity. In conclusion, from our study it emerged a significant and independent association of serum TRAIL levels with overall, and, mainly, central adiposity. Further studies are needed to longitudinally investigate the cause-effect relationship between change in body fat distribution and TRAIL.

%B Mediators Inflamm %V 2014 %P 306848 %8 2014 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/24966465?dopt=Abstract %R 10.1155/2014/306848 %0 Journal Article %J J Med Virol %D 2014 %T Beta defensin-1 gene polymorphisms and susceptibility to atypical squamous cells of undetermined significance lesions in Italian gynecological patients. %A Casalicchio, Giorgia %A Freato, Nadia %A Maestri, Iva %A Comar, Manola %A Crovella, Sergio %A Segat, Ludovica %K 5' Untranslated Regions %K Adolescent %K Adult %K Atypical Squamous Cells of the Cervix %K beta-Defensins %K Female %K Genotype %K Humans %K Italy %K Papillomavirus Infections %K Polymorphism, Single Nucleotide %K Sequence Analysis, DNA %K Uterine Cervical Neoplasms %K Young Adult %X

The role of the human beta-defensin 1 (hBD-1) in the susceptibility to the onset of the Atypical Squamous Cells of Undetermined Significance (ASCUS) lesion, in the presence or not of HPV infection, is still unknown. In the current study, the three functional single nucleotide polymorphisms (SNPs) -52G > A, -44C > G, and -20G > A at the 5' un-translated region (UTR) of DEFB1 gene, encoding hBD-1, were analyzed in ASCUS lesion gynecological patients and healthy women from the north-east of Italy (Trieste). Cervical samples from 249 European-Caucasian women were collected, screened for HPV and cytologically evaluated; DEFB1 genotyping has been performed by direct sequencing. No significant differences were found for -52G > A, -44C > G, and -20G > A SNPs allele and genotype frequencies between women with and without ASCUS lesions. DEFB1 minor haplotypes were significantly more frequent in ASCUS lesion positive than negative women, associating with an increased risk of this type of lesion. When women were stratified according to HPV infection status, significant differences in the distribution of -52G > A SNP genotype frequencies were found: the presence of the A allele in the homozygous genotype A/A associated with a lower risk of developing ASCUS lesions in HPV negative women. DEFB1 minor haplotypes were also associated with an increased risk of developing ASCUS lesions, being significantly more frequent in HPV negative women with lesions, than without lesions. Although these results highlight the possible involvement of DEFB1, further studies are needed to support the role of DEFB1 in the modulation of the susceptibility to ASCUS lesions.

%B J Med Virol %V 86 %P 1999-2004 %8 2014 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/24435641?dopt=Abstract %R 10.1002/jmv.23878 %0 Journal Article %J Int J Mol Sci %D 2014 %T Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds. %A Tricarico, Paola Maura %A Kleiner, Giulio %A Valencic, Erica %A Campisciano, Giuseppina %A Girardelli, Martina %A Crovella, Sergio %A Knowles, Alessandra %A Marcuzzi, Annalisa %K Animals %K Apoptosis %K Carotenoids %K Carrier Proteins %K Cell Line %K Cytokines %K Diterpenes %K Humans %K Mevalonate Kinase Deficiency %K Mevalonic Acid %K Mice %K Mitochondria %K Nitric Oxide %K Phytol %K Terpenes %X

Deregulation of the mevalonate pathway is known to be involved in a number of diseases that exhibit a systemic inflammatory phenotype and often neurological involvements, as seen in patients suffering from a rare disease called mevalonate kinase deficiency (MKD). One of the molecular mechanisms underlying this pathology could depend on the shortage of isoprenoid compounds and the subsequent mitochondrial damage, leading to oxidative stress and pro-inflammatory cytokines' release. Moreover, it has been demonstrated that cellular death results from the balance between apoptosis and pyroptosis, both driven by mitochondrial damage and the molecular platform inflammasome. In order to rescue the deregulated pathway and decrease inflammatory markers, exogenous isoprenoid compounds were administered to a biochemical model of MKD obtained treating a murine monocytic cell line with a compound able to block the mevalonate pathway, plus an inflammatory stimulus. Our results show that isoprenoids acted in different ways, mainly increasing the expression of the evaluated markers [apoptosis, mitochondrial dysfunction, nucleotide-binding oligomerization-domain protein-like receptors 3 (NALP3), cytokines and nitric oxide (NO)]. Our findings confirm the hypothesis that inflammation is triggered, at least partially, by the shortage of isoprenoids. Moreover, although further studies are necessary, the achieved results suggest a possible role for exogenous isoprenoids in the treatment of MKD.

%B Int J Mol Sci %V 15 %P 6843-56 %8 2014 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/24758928?dopt=Abstract %R 10.3390/ijms15046843 %0 Journal Article %J Pediatr Emerg Care %D 2014 %T A boy with sudden headache. %A Norbedo, Stefania %A Naviglio, Samuele %A Murru, Flora Maria %A Cavallin, Roberta %A Giurici, Nagua %A Rabusin, Marco %A Barbi, Egidio %K Abdominal Neoplasms %K Adolescent %K Emergencies %K Headache %K Humans %K Male %K Paraganglioma %X

Headache is a common presenting complaint in pediatric emergency departments. The goal of emergent evaluation is to identify those children with potentially life-threatening conditions. We present the case of an adolescent boy presenting with headache and hypertension who was diagnosed with a catecholamine-secreting abdominal paraganglioma. Genetic testing eventually led to the diagnosis of SDHB-related hereditary paraganglioma-pheochromocytoma syndrome. Alarm features ("red flags") in children presenting with headache are reviewed, as well as the main features of paragangliomas and the indications for genetic testing.

%B Pediatr Emerg Care %V 30 %P 182-4 %8 2014 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/24589807?dopt=Abstract %R 10.1097/PEC.0000000000000090 %0 Journal Article %J Breastfeed Med %D 2014 %T Breastfeeding during pregnancy: safety and socioeconomic status. %A Monasta, Lorenzo %A Cetin, Irene %A Davanzo, Riccardo %K Breast Feeding %K Female %K Humans %K Lactation %K Male %K Pregnancy %K Pregnancy Complications %K Weaning %B Breastfeed Med %V 9 %P 322 %8 2014 Jul-Aug %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/24892360?dopt=Abstract %R 10.1089/bfm.2014.0045 %0 Journal Article %J Arch Dis Child Fetal Neonatal Ed %D 2014 %T Can body mass index accurately predict adiposity in newborns? %A De Cunto, Angela %A Paviotti, Giulia %A Ronfani, Luca %A Travan, Laura %A Bua, Jenny %A Cont, Gabriele %A Demarini, Sergio %K Adiposity %K Adult %K Anthropometry %K Body Composition %K Body Mass Index %K Cross-Sectional Studies %K Female %K Gestational Age %K Humans %K Infant, Newborn %K Male %K Mothers %K Plethysmography %K Predictive Value of Tests %K Regression Analysis %K Reproducibility of Results %K Sex Factors %X

Body mass index (BMI) is correlated with body fatness and risk of related diseases in children and adults. Proportionality indexes such as BMI and ponderal index (PI) have been suggested as complementary measures in neonatal growth assessment. Yet, they are still not used in neonates and their correlation with fatness is unknown. The aim of the study was to test the hypothesis that BMI z-score would predict neonatal adiposity. Body composition measurements (ie, fat mass, fat-free mass) by air displacement plethysmography (PEA POD, LMI, Concord-USA), weight and length were obtained in 200 infants ≥36 weeks' gestational age (GA) at birth. Linear regression analysis showed a direct association between BMI z-score and %fat mass (r(2)=0.43, p<0.0001). This association was confirmed independently from sex, GA and maternal prepregnancy BMI. BMI z-score predicted adiposity better than PI. However, both BMI z-score and PI were poor predictors of adiposity at birth.

%B Arch Dis Child Fetal Neonatal Ed %V 99 %P F238-9 %8 2014 May %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/24302686?dopt=Abstract %R 10.1136/archdischild-2013-305386 %0 Journal Article %J Blood %D 2014 %T Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. %A Conter, Valentino %A Valsecchi, Maria Grazia %A Parasole, Rosanna %A Putti, Maria Caterina %A Locatelli, Franco %A Barisone, Elena %A Lo Nigro, Luca %A Santoro, Nicola %A Aricò, Maurizio %A Ziino, Ottavio %A Pession, Andrea %A Testi, Anna Maria %A Micalizzi, Concetta %A Casale, Fiorina %A Zecca, Marco %A Casazza, Gabriella %A Tamaro, Paolo %A La Barba, Gaetano %A Notarangelo, Lucia Dora %A Silvestri, Daniela %A Colombini, Antonella %A Rizzari, Carmelo %A Biondi, Andrea %A Masera, Giuseppe %A Basso, Giuseppe %K Adolescent %K Antineoplastic Combined Chemotherapy Protocols %K Child %K Child, Preschool %K Combined Modality Therapy %K Female %K Hematopoietic Stem Cell Transplantation %K Humans %K Infant %K Male %K Neoplasm, Residual %K Precursor Cell Lymphoblastic Leukemia-Lymphoma %K Radiotherapy %K Remission Induction %K Treatment Outcome %X

The outcome of high-risk (HR) acute lymphoblastic leukemia patients enrolled in the AIEOP-BFM ALL 2000 study in Italy is described. HR criteria were minimal residual disease (MRD) levels ≥10(-3) at day 78 (MRD-HR), no complete remission (CR) at day 33, t(4;11) translocation, and prednisone poor response (PPR). Treatment (2 years) included protocol I, 3 polychemotherapy blocks, delayed intensification (protocol IIx2 or IIIx3), cranial radiotherapy, and maintenance. A total of 312 HR patients had a 5-year event-free survival (EFS) of 58.9% (standard error [SE] = 2.8) and an overall survival of 68.9% (SE = 2.6). In hierarchical order, EFS was 45.9% (4.4) in 132 MRD-HR patients, 41.2% (11.9) in 17 patients with no CR at day 33, 36.4% (14.5) in 11 patients with t(4;11), and 74.0% (3.6) in 152 HR patients only for PPR. No statistically significant difference was found for disease-free survival in patients with very HR features [MRD-HR, no CR at day 33, t(4;11) translocation], given hematopoietic stem cell transplantation (HSCT) (n = 66) or chemotherapy only (n = 88), after adjusting for waiting time to HSCT (5.7 months). Patients at HR only for PPR have a favorable outcome. MRD-HR is associated with poor outcome despite intensive treatment and/or HSCT and may qualify for innovative therapies. The study was registered at www.clinicaltrials.gov as #NCT00613457.

%B Blood %V 123 %P 1470-8 %8 2014 Mar 6 %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/24415536?dopt=Abstract %R 10.1182/blood-2013-10-532598 %0 Journal Article %J Int J Paediatr Dent %D 2014 %T Class IV laser therapy as treatment for chemotherapy-induced oral mucositis in onco-haematological paediatric patients: a prospective study. %A Chermetz, Maddalena %A Gobbo, Margherita %A Ronfani, Luca %A Ottaviani, Giulia %A Zanazzo, Giulio A %A Verzegnassi, Federico %A Treister, Nathaniel S %A Di Lenarda, Roberto %A Biasotto, Matteo %A Zacchigna, Serena %X

BACKGROUND: Oral mucositis is a debilitating side effect of chemotherapy. Laser therapy has recently demonstrated efficacy in the management of oral mucositis (OM).

AIM: This prospective study was conducted to evaluate the efficacy of class IV laser therapy in patients affected by OM.

DESIGN: Eighteen onco-haematological paediatric patients receiving chemotherapy and/or haematopoietic stem cell transplantation, prior to total body irradiation, affected by OM, were enrolled in this study. Patients were treated with class IV laser therapy for four consecutive days; the assessment of OM was performed through WHO Oral Mucositis Grading Objective Scale, and pain was evaluated through visual analogue scale. Patients completed a validated questionnaire, and photographs of lesions were taken during each session. Patients were re-evaluated 11 days after the first day of laser therapy.

RESULTS: All patients demonstrated improvement in pain sensation, and all mucositis was fully resolved at the 11-day follow-up visit, with no apparent side effects. Laser therapy was well tolerated with remarkable reduction in pain associated with oral mucositis after 1-2 days of laser therapy.

CONCLUSIONS: Given class IV laser therapy appears to be safe, non-invasive, and potentially effective, prospective, randomized, controlled trials are necessary to further assess efficacy and to determine optimal treatment parameters.

%B Int J Paediatr Dent %V 24 %P 441-9 %8 2014 Nov %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/24372909?dopt=Abstract %R 10.1111/ipd.12090 %0 Journal Article %J J Pediatr %D 2014 %T Clinical features and follow-up in patients with 22q11.2 deletion syndrome. %A Cancrini, Caterina %A Puliafito, Pamela %A Digilio, Maria Cristina %A Soresina, Annarosa %A Martino, Silvana %A Rondelli, Roberto %A Consolini, Rita %A Ruga, Ezia Maria %A Cardinale, Fabio %A Finocchi, Andrea %A Romiti, Maria Luisa %A Martire, Baldassarre %A Bacchetta, Rosa %A Albano, Veronica %A Carotti, Adriano %A Specchia, Fernando %A Montin, Davide %A Cirillo, Emilia %A Cocchi, Guido %A Trizzino, Antonino %A Bossi, Grazia %A Milanesi, Ornella %A Azzari, Chiara %A Corsello, Giovanni %A Pignata, Claudio %A Aiuti, Alessandro %A Pietrogrande, Maria Cristina %A Marino, Bruno %A Ugazio, Alberto Giovanni %A Plebani, Alessandro %A Rossi, Paolo %K Abnormalities, Multiple %K Adolescent %K Adult %K Age Factors %K Child %K Child, Preschool %K Chromosomes, Human, Pair 22 %K Delayed Diagnosis %K Developmental Disabilities %K DiGeorge Syndrome %K Disease Progression %K Early Diagnosis %K Female %K Follow-Up Studies %K Genetic Testing %K Humans %K Infant %K Infant, Newborn %K Male %K Monitoring, Physiologic %K Prospective Studies %K Retrospective Studies %K Risk Assessment %K Severity of Illness Index %K Sex Factors %K Time Factors %K Young Adult %X

OBJECTIVE: To investigate the clinical manifestations at diagnosis and during follow-up in patients with 22q11.2 deletion syndrome to better define the natural history of the disease.

STUDY DESIGN: A retrospective and prospective multicenter study was conducted with 228 patients in the context of the Italian Network for Primary Immunodeficiencies. Clinical diagnosis was confirmed by cytogenetic or molecular analysis.

RESULTS: The cohort consisted of 112 males and 116 females; median age at diagnosis was 4 months (range 0 to 36 years 10 months). The diagnosis was made before 2 years of age in 71% of patients, predominantly related to the presence of heart anomalies and neonatal hypocalcemia. In patients diagnosed after 2 years of age, clinical features such as speech and language impairment, developmental delay, minor cardiac defects, recurrent infections, and facial features were the main elements leading to diagnosis. During follow-up (available for 172 patients), the frequency of autoimmune manifestations (P = .015) and speech disorders (P = .002) increased. After a median follow-up of 43 months, the survival probability was 0.92 at 15 years from diagnosis.

CONCLUSIONS: Our data show a delay in the diagnosis of 22q11.2 deletion syndrome with noncardiac symptoms. This study provides guidelines for pediatricians and specialists for early identification of cases that can be confirmed by genetic testing, which would permit the provision of appropriate clinical management.

%B J Pediatr %V 164 %P 1475-80.e2 %8 2014 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/24657119?dopt=Abstract %R 10.1016/j.jpeds.2014.01.056 %0 Journal Article %J Arch Dis Child %D 2014 %T Clinical significance of hyper-IgA in a paediatric laboratory series. %A Copetti, Valentina %A Pastore, Serena %A De Pieri, Carlo %A Radillo, Oriano %A Taddio, Andrea %A Ventura, Alessandro %A Tommasini, Alberto %K Adolescent %K Child %K Child, Preschool %K Female %K Hospitals, Pediatric %K Humans %K Hypergammaglobulinemia %K Immunoglobulin A %K Infant %K Italy %K Male %K Tertiary Care Centers %X

The causes of extremely elevated IgA, whether isolated or associated with an increase in other classes of immunoglobulin, are poorly defined in paediatrics. We reviewed the diagnostic significance of very high IgA levels (greater than 3 SD above the mean for age) in a cohort of patients referred to a tertiary care children's hospital. Hyper-IgA was found in 91 of 6364 subjects (1.4%) and in 68 cases was not associated with an increased IgG and/or IgM level. Most subjects with hyper-IgA (73.5%) had a severe immune defect, a chronic rheumatic disease or inflammatory bowel disease, while these conditions were very rare in a control group with normal IgA values (8%). Although our results may in part reflect the experience of a tertiary care centre, we suggest that hyper-IgA in children should always arouse suspicion of a serious disease.

%B Arch Dis Child %V 99 %P 1114-6 %8 2014 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/25053738?dopt=Abstract %R 10.1136/archdischild-2014-306607 %0 Journal Article %J J Am Soc Nephrol %D 2014 %T Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis. %A Olden, Matthias %A Corre, Tanguy %A Hayward, Caroline %A Toniolo, Daniela %A Ulivi, Sheila %A Gasparini, Paolo %A Pistis, Giorgio %A Hwang, Shih-Jen %A Bergmann, Sven %A Campbell, Harry %A Cocca, Massimiliano %A Gandin, Ilaria %A Girotto, Giorgia %A Glaudemans, Bob %A Hastie, Nicholas D %A Loffing, Johannes %A Polasek, Ozren %A Rampoldi, Luca %A Rudan, Igor %A Sala, Cinzia %A Traglia, Michela %A Vollenweider, Peter %A Vuckovic, Dragana %A Youhanna, Sonia %A Weber, Julien %A Wright, Alan F %A Kutalik, Zoltán %A Bochud, Murielle %A Fox, Caroline S %A Devuyst, Olivier %K Creatinine %K European Continental Ancestry Group %K Genetic Variation %K Humans %K Polymorphism, Single Nucleotide %K Uromodulin %X

Uromodulin is expressed exclusively in the thick ascending limb and is the most abundant protein excreted in normal urine. Variants in UMOD, which encodes uromodulin, are associated with renal function, and urinary uromodulin levels may be a biomarker for kidney disease. However, the genetic factors regulating uromodulin excretion are unknown. We conducted a meta-analysis of urinary uromodulin levels to identify associated common genetic variants in the general population. We included 10,884 individuals of European descent from three genetic isolates and three urban cohorts. Each study measured uromodulin indexed to creatinine and conducted linear regression analysis of approximately 2.5 million single nucleotide polymorphisms using an additive model. We also tested whether variants in genes expressed in the thick ascending limb associate with uromodulin levels. rs12917707, located near UMOD and previously associated with renal function and CKD, had the strongest association with urinary uromodulin levels (P<0.001). In all cohorts, carriers of a G allele of this variant had higher uromodulin levels than noncarriers did (geometric means 10.24, 14.05, and 17.67 μg/g creatinine for zero, one, or two copies of the G allele). rs12446492 in the adjacent gene PDILT (protein disulfide isomerase-like, testis expressed) also reached genome-wide significance (P<0.001). Regarding genes expressed in the thick ascending limb, variants in KCNJ1, SORL1, and CAB39 associated with urinary uromodulin levels. These data indicate that common variants in the UMOD promoter region may influence urinary uromodulin levels. They also provide insights into uromodulin biology and the association of UMOD variants with renal function.

%B J Am Soc Nephrol %V 25 %P 1869-82 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24578125?dopt=Abstract %R 10.1681/ASN.2013070781 %0 Journal Article %J Endocr Metab Immune Disord Drug Targets %D 2014 %T Cow's milk allergy in children, from avoidance to tolerance. %A Calligaris, Lorenzo %A Longo, Giorgio %A Badina, Laura %A Berti, Irene %A Barbi, Egidio %K Animals %K Cattle %K Child %K Child, Preschool %K Desensitization, Immunologic %K Humans %K Immune Tolerance %K Milk Hypersensitivity %K Milk Substitutes %K Retrospective Studies %X

Food allergy is the primary cause of anaphylaxis in paediatric age affecting roughly 4% of children and their families worldwide, and requiring changes in dietary habits. The prognosis for food allergy in children has traditionally been regarded as good for the most frequent allergens, however the prognosis for cow's milk allergy in the pediatric age is currently considered to be worse than previously believed. There is now enough evidence that measures of avoidance for children at risk did not have any preventive effect whatsoever, but they still came to be counterproductive by avoiding the physiological interaction between food allergens and gastrointestinal mucosal immune system. Programs of specific oral tolerance induction (SOTI) have obtained interesting results in the treatment of food allergy supporting the idea that antigen exposure through gastrointestinal section is important to allow the development of tolerance. Nevertheless this approach is not yet considered "ready" for community recommendations. In this paper we describe our experience in the field of SOTI in children with cow's milk allergy.

%B Endocr Metab Immune Disord Drug Targets %V 14 %P 47-53 %8 2014 Mar %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24450451?dopt=Abstract %0 Journal Article %J Immunobiology %D 2014 %T DC-SIGN polymorphisms are associated to type 1 diabetes mellitus. %A da Silva, Ronaldo Celerino %A Cunha Tavares, Nathália de Alencar %A Moura, Ronald %A Coelho, Antônio %A Guimarães, Rafael Lima %A Araújo, Jacqueline %A Crovella, Sergio %A Brandão, Lucas André Cavalcanti %A Silva, Jaqueline de Azevêdo %K Adolescent %K Alleles %K Case-Control Studies %K Cell Adhesion Molecules %K Child %K Child, Preschool %K Diabetes Mellitus, Type 1 %K Female %K Gene Frequency %K Genetic Association Studies %K Genetic Predisposition to Disease %K Genotype %K Humans %K Infant %K Infant, Newborn %K Lectins, C-Type %K Male %K Odds Ratio %K Polymorphism, Genetic %K Polymorphism, Single Nucleotide %K Promoter Regions, Genetic %K Receptors, Cell Surface %X

Type I diabetes mellitus (T1DM) is an autoimmune disorder featured by raised glucoses levels. It has been hypothesised that raised glucose levels in T1DM might be recognised as PAMPs, leading to immune response by overloading the cell receptors for pathogens recognition. DC-SIGN is a transmembrane protein, present in dendritic cells (DC) and macrophages: it has an important role in inflammatory response and T cells activation. Notably, DC-SIGN activation and triggering of the immune response depend on the type of ligand, which may lead to a pro or anti-inflammatory pathway. In our association study, we analysed the SNPs rs4804803 (-336 A>G) and rs735239 (-871 A>G), both at DC-SIGN promoter region, in 210 T1DM patients and 157 healthy controls, also looking for a correlation with the age of onset of the disease. We found that the allele G and genotypes G/G and A/G of SNP-871 (rs735239), as well as the alleles G-G (rs735239-rs4804803) and genotypes combined AA-GG (rs735239-rs4804803) were associated with protection of T1DM development. We did not find association between these variations with the age of onset of the disease and the presence of other autoimmune disorders. Our results suggest that SNPs in DC-SIGN promoter region can be associated to protection for T1DM in the Northeast Brazilian population.

%B Immunobiology %V 219 %P 859-65 %8 2014 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/25092567?dopt=Abstract %R 10.1016/j.imbio.2014.07.011 %0 Journal Article %J Mem Inst Oswaldo Cruz %D 2014 %T DEFB1 polymorphisms are involved in susceptibility to human papillomavirus infection in Brazilian gynaecological patients. %A Segat, Ludovica %A Zupin, Luisa %A Moura, Ronald Rodrigues %A Coelho, Antônio Victor Campos %A Chagas, Bárbara Simas %A de Freitas, Antonio Carlos %A Crovella, Sergio %K Adolescent %K Adult %K Aged %K beta-Defensins %K Brazil %K Case-Control Studies %K Female %K Genetic Predisposition to Disease %K Haplotypes %K Humans %K Middle Aged %K Papillomavirus Infections %K Polymorphism, Single Nucleotide %K Reproductive Tract Infections %K Young Adult %X

The human beta defensin 1 (hBD-1) antimicrobial peptide is a member of the innate immune system known to act in the first line of defence against microorganisms, including viruses such as human papillomavirus (HPV). In this study, five functional polymorphisms (namely g-52G>A, g-44C>G and g-20G>A in the 5'UTR and c.*5G>A and c.*87A>G in the 3'UTR) in the DEFB1 gene encoding for hBD-1 were analysed to investigate the possible involvement of these genetic variants in susceptibility to HPV infection and in the development of HPV-associated lesions in a population of Brazilian women. The DEFB1 g-52G>A and c.*5G>A single-nucleotide polymorphisms (SNPs) and the GCAAA haplotype showed associations with HPV-negative status; in particular, the c.*5G>A SNP was significantly associated after multiple test corrections. These findings suggest a possible role for the constitutively expressed beta defensin-1 peptide as a natural defence against HPV in the genital tract mucosa.

%B Mem Inst Oswaldo Cruz %V 109 %P 918-22 %8 2014 Nov %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/25410996?dopt=Abstract %0 Journal Article %J Front Hum Neurosci %D 2014 %T Differences in time course activation of dorsolateral prefrontal cortex associated with low or high risk choices in a gambling task. %A Bembich, Stefano %A Clarici, Andrea %A Vecchiet, Cristina %A Baldassi, Giulio %A Cont, Gabriele %A Demarini, Sergio %X

Prefrontal cortex plays an important role in decision making (DM), supporting choices in the ordinary uncertainty of everyday life. To assess DM in an unpredictable situation, a playing card task, such as the Iowa Gambling Task (IGT), has been proposed. This task is supposed to specifically test emotion-based learning, linked to the integrity of the ventromedial prefrontal cortex (VMPFC). However, the dorsolateral prefrontal cortex (DLPFC) has demonstrated a role in IGT performance too. Our aim was to study, by multichannel near-infrared spectroscopy, the contribution of DLPFC to the IGT execution over time. We tested the hypothesis that low and high risk choices would differentially activate DLPFC, as IGT execution progressed. We enrolled 11 healthy adults. To identify DLPFC activation associated with IGT choices, we compared regional differences in oxy-hemoglobin variation, from baseline to the event. The time course of task execution was divided in four periods, each one consisting of 25 choices, and DLPFC activation was distinctly analyzed for low and high risk choices in each period. We found different time courses in DLPFC activation, associated with low or high risk choices. During the first period, a significant DLPFC activation emerged with low risk choices, whereas, during the second period, we found a cortical activation with high risk choices. Then, DLPFC activation decreased to non-significant levels during the third and fourth period. This study shows that DLPFC involvement in IGT execution is differentiated over time and according to choice risk level. DLPFC is activated only in the first half of the task, earlier by low risk and later by high risk choices. We speculate that DLPFC may sustain initial and more cognitive functions, such as attention shifting and response inhibition. The lack of DLPFC activation, as the task progresses, may be due to VMPFC activation, not detectable by fNIRS, which takes over the IGT execution in its second half.

%B Front Hum Neurosci %V 8 %P 464 %8 2014 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25009486?dopt=Abstract %R 10.3389/fnhum.2014.00464 %0 Journal Article %J Hum Mol Genet %D 2014 %T DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. %A Perry, John R B %A Hsu, Yi-Hsiang %A Chasman, Daniel I %A Johnson, Andrew D %A Elks, Cathy %A Albrecht, Eva %A Andrulis, Irene L %A Beesley, Jonathan %A Berenson, Gerald S %A Bergmann, Sven %A Bojesen, Stig E %A Bolla, Manjeet K %A Brown, Judith %A Buring, Julie E %A Campbell, Harry %A Chang-Claude, Jenny %A Chenevix-Trench, Georgia %A Corre, Tanguy %A Couch, Fergus J %A Cox, Angela %A Czene, Kamila %A d'Adamo, Adamo Pio %A Davies, Gail %A Deary, Ian J %A Dennis, Joe %A Easton, Douglas F %A Engelhardt, Ellen G %A Eriksson, Johan G %A Esko, Tõnu %A Fasching, Peter A %A Figueroa, Jonine D %A Flyger, Henrik %A Fraser, Abigail %A Garcia-Closas, Montse %A Gasparini, Paolo %A Gieger, Christian %A Giles, Graham %A Guenel, Pascal %A Hägg, Sara %A Hall, Per %A Hayward, Caroline %A Hopper, John %A Ingelsson, Erik %A Kardia, Sharon L R %A Kasiman, Katherine %A Knight, Julia A %A Lahti, Jari %A Lawlor, Debbie A %A Magnusson, Patrik K E %A Margolin, Sara %A Marsh, Julie A %A Metspalu, Andres %A Olson, Janet E %A Pennell, Craig E %A Polasek, Ozren %A Rahman, Iffat %A Ridker, Paul M %A Robino, Antonietta %A Rudan, Igor %A Rudolph, Anja %A Salumets, Andres %A Schmidt, Marjanka K %A Schoemaker, Minouk J %A Smith, Erin N %A Smith, Jennifer A %A Southey, Melissa %A Stöckl, Doris %A Swerdlow, Anthony J %A Thompson, Deborah J %A Truong, Therese %A Ulivi, Sheila %A Waldenberger, Melanie %A Wang, Qin %A Wild, Sarah %A Wilson, James F %A Wright, Alan F %A Zgaga, Lina %A Ong, Ken K %A Murabito, Joanne M %A Karasik, David %A Murray, Anna %K Age Factors %K DNA-Binding Proteins %K Female %K Genome-Wide Association Study %K Humans %K Menopause %K Polymorphism, Single Nucleotide %X

The length of female reproductive lifespan is associated with multiple adverse outcomes, including breast cancer, cardiovascular disease and infertility. The biological processes that govern the timing of the beginning and end of reproductive life are not well understood. Genetic variants are known to contribute to ∼50% of the variation in both age at menarche and menopause, but to date the known genes explain <15% of the genetic component. We have used genome-wide association in a bivariate meta-analysis of both traits to identify genes involved in determining reproductive lifespan. We observed significant genetic correlation between the two traits using genome-wide complex trait analysis. However, we found no robust statistical evidence for individual variants with an effect on both traits. A novel association with age at menopause was detected for a variant rs1800932 in the mismatch repair gene MSH6 (P = 1.9 × 10(-9)), which was also associated with altered expression levels of MSH6 mRNA in multiple tissues. This study contributes to the growing evidence that DNA repair processes play a key role in ovarian ageing and could be an important therapeutic target for infertility.

%B Hum Mol Genet %V 23 %P 2490-7 %8 2014 May 1 %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/24357391?dopt=Abstract %R 10.1093/hmg/ddt620 %0 Journal Article %J Gynecol Endocrinol %D 2014 %T Effects of estroprogestins containing natural estrogen on vaginal flora. %A De Seta, Francesco %A Restaino, Stefano %A Banco, Rubina %A Conversano, Ester %A De Leo, Rossella %A Tonon, Maddalena %A Maso, Gianpaolo %A Barbati, Giulia %A Lello, Stefano %K Adolescent %K Adult %K Drug Combinations %K Estradiol %K Female %K Humans %K Megestrol %K Middle Aged %K Nandrolone %K Norpregnadienes %K Prospective Studies %K Vagina %K Young Adult %X

Estroprogestins with "natural oestrogen" has represented a new option in terms of combined hormonal contraception. So, the aim of this study is to investigate how estroprogestins with natural estrogen may modify the vaginal niche. In literature, very few studies focused on the interaction between hormonal contraception and vaginal milieu. This is a prospective comparative study. We enrolled 60 women from January 2013 to September 2013, 30 of them were administered estradiol valerate dienogest (E2V+DNG - Klaira®) in a quadriphasic regimen, while the other 30 women were administered 17-β estradiol with nomestrol acetate (EV+NOMAC - Zoely®) in a monophasic regimen. After a baseline study of vaginal milieu at recruitment of patients (Gram stain with Nugent score, vaginal pH, vaginal wet mount for the quantification of leukocytes, Lactobacilli and/or presence of Candida), we performed the same follow-up after six months of estroprogestin therapy. Our results showed that the women treated with E2V+DNG had a trend of an improvement of vaginal health in terms of increase of lactobacillar flora and reduction of vaginal pH in place of women treated with EV+NOMAC that showed a reduction of cervical mucus. Finally, our data about the effects on vaginal flora exerted by two estroprogestin pills (EPs) containing a natural estrogen suggest slight, but interesting differences in terms of vaginal ecology. These differences could be related to the type of estrogen, type of progestin, regimen of administration and, after all, to the net balance between estrogenic and progestin component of the EPs.

%B Gynecol Endocrinol %V 30 %P 830-5 %8 2014 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/24993504?dopt=Abstract %R 10.3109/09513590.2014.936847 %0 Journal Article %J J Int AIDS Soc %D 2014 %T Exome analysis of HIV patients submitted to dendritic cells therapeutic vaccine reveals an association of CNOT1 gene with response to the treatment. %A Moura, Ronald %A Pontillo, Alessandra %A d'Adamo, Pio %A Pirastu, Nicola %A Campos Coelho, Antonio %A Crovella, Sergio %K AIDS Vaccines %K Dendritic Cells %K Exome %K HIV Infections %K Humans %K Immunity, Humoral %K Oligonucleotide Array Sequence Analysis %K Polymorphism, Single Nucleotide %K Transcription Factors %K Treatment Outcome %X

INTRODUCTION: With the aim of searching genetic factors associated with the response to an immune treatment based on autologous monocyte-derived dendritic cells pulsed with autologous inactivated HIV, we performed exome analysis by screening more than 240,000 putative functional exonic variants in 18 HIV-positive Brazilian patients that underwent the immune treatment.

METHODS: Exome analysis has been performed using the ILLUMINA Infinium HumanExome BeadChip. zCall algorithm allowed us to recall rare variants. Quality control and SNP-centred analysis were done with GenABEL R package. An in-house implementation of the Wang method permitted gene-centred analysis.

RESULTS: CCR4-NOT transcription complex, subunit 1 (CNOT1) gene (16q21), showed the strongest association with the modification of the response to the therapeutic vaccine (p=0.00075). CNOT1 SNP rs7188697 A/G was significantly associated with DC treatment response. The presence of a G allele indicated poor response to the therapeutic vaccine (p=0.0031; OR=33.00; CI=1.74-624.66), and the SNP behaved in a dominant model (A/A vs. A/G+G/G p=0.0009; OR=107.66; 95% CI=3.85-3013.31), being the A/G genotype present only in weak/transient responders, conferring susceptibility to poor response to the immune treatment.

DISCUSSION: CNOT1 is known to be involved in the control of mRNA deadenylation and mRNA decay. Moreover, CNOT1 has been recently described as being involved in the regulation of inflammatory processes mediated by tristetraprolin (TTP). The TTP-CCR4-NOT complex (CNOT1 in the CCR4-NOT complex is the binding site for TTP) has been reported as interfering with HIV replication, through post-transcriptional control. Therefore, we can hypothesize that genetic variation occurring in the CNOT1 gene could impair the TTP-CCR4-NOT complex, thus interfering with HIV replication and/or host immune response.

CONCLUSIONS: Being aware that our findings are exclusive to the 18 patients studied with a need for replication, and that the genetic variant of CNOT1 gene, localized at intron 3, has no known functional effect, we propose a novel potential candidate locus for the modulation of the response to the immune treatment, and open a discussion on the necessity to consider the host genome as another potential variant to be evaluated when designing an immune therapy study.

%B J Int AIDS Soc %V 17 %P 18938 %8 2014 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/24433985?dopt=Abstract %R 10.7448/IAS.17.1.18938 %0 Journal Article %J Clin Exp Rheumatol %D 2014 %T F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls. %A De Pieri, Carlo %A Vuch, Josef %A Athanasakis, Emmanouil %A Severini, Giovanni Maria %A Crovella, Sergio %A Bianco, Anna Monica %A Tommasini, Alberto %K Cryopyrin-Associated Periodic Syndromes %K Female %K Humans %K Intracellular Signaling Peptides and Proteins %K Male %K Mutation %B Clin Exp Rheumatol %V 32 %P 993-4 %8 2014 Nov-Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/25327218?dopt=Abstract %0 Journal Article %J PLoS One %D 2014 %T Fate of lymphocytes after withdrawal of tofacitinib treatment. %A Piscianz, Elisa %A Valencic, Erica %A Cuzzoni, Eva %A De Iudicibus, Sara %A De Lorenzo, Elisa %A Decorti, Giuliana %A Tommasini, Alberto %K Antigens, CD %K B-Lymphocytes %K CD4-Positive T-Lymphocytes %K CD8-Positive T-Lymphocytes %K Cell Proliferation %K Drug Administration Schedule %K Humans %K Janus Kinase 3 %K Killer Cells, Natural %K Lymphocyte Activation %K Lymphocyte Count %K Phytohemagglutinins %K Piperidines %K Primary Cell Culture %K Protein Kinase Inhibitors %K Pyrimidines %K Pyrroles %X

Tofacitinib (Tofa) is an inhibitor of Janus Kinase 3, developed for the treatment of autoimmune diseases and for the prevention of transplant rejection. Due to its selective action on proliferating cells, Tofa can offer a way to block T cell activation, without toxic effects on resting cells. However, few studies have investigated the effects of Tofa on lymphocyte activation in vitro. Our aim was to study the action of Tofa on different lymphocyte subsets after in vitro stimulation and to track the behaviour of treated cells after interruption of the treatment. Peripheral blood lymphocytes were stimulated in vitro with mitogen and treated with two concentrations of Tofa. After a first period in culture, cells were washed and further incubated for an additional time. Lymphocyte subsets, activation phenotype and proliferation were assessed at the different time frames. As expected, Tofa was able to reduce the activation and proliferation of lymphocytes in the first four days of treatment. In addition the drug led to a relative decrease of Natural Killer, B cells and CD8 T cells compared to CD4 T cells. However, treated cells were still viable after the first period in culture and begun to proliferate, strikingly, in a dose dependent manner when the drug was removed from the environment by replacing the culture medium. This novel data does not necessarily predict a similar behaviour in vivo, but can warn about the clinical use of this drug when a discontinuation of treatment with Tofa is considered for any reason.

%B PLoS One %V 9 %P e85463 %8 2014 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24416411?dopt=Abstract %R 10.1371/journal.pone.0085463 %0 Journal Article %J J Hum Lact %D 2014 %T From tube to breast: the bridging role of semi-demand breastfeeding. %A Davanzo, Riccardo %A Strajn, Tamara %A Kennedy, Jacqueline %A Crocetta, Anna %A De Cunto, Angela %X

Determination of the optimal timing of breastfeeding initiation for preterm infants is still a challenge for health professionals. Often unjustified delays and restrictions of breastfeeding occur due to non-evidence-based current opinions about preterm infants' feeding capacity. Semi-demand feeding has been proposed for preterm infants during the transition from scheduled to full demand feeding, to promote the establishment of self-regulated oral feeding. Although semi-demand feeding has been shown to be safe and effective in reducing time to reaching oral feeding, the implementation of this feeding pattern for preterm infants in the neonatal intensive care unit (NICU) is still limited. We developed a protocol for the application of semi-demand feeding in preterm infants based on the existing knowledge of preterm infant neurodevelopment and NICU organization and staff experience. The protocol's aim is to attain successful transition from tube feeding to breastfeeding. In this article, we describe the protocol used in the neonatal unit of the Maternal and Child Health Institute of Trieste, a third level care center in northeastern Italy.

%B J Hum Lact %V 30 %P 405-9 %8 2014 Nov %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25172892?dopt=Abstract %R 10.1177/0890334414548697 %0 Journal Article %J PLoS Genet %D 2014 %T A general approach for haplotype phasing across the full spectrum of relatedness. %A O'Connell, Jared %A Gurdasani, Deepti %A Delaneau, Olivier %A Pirastu, Nicola %A Ulivi, Sheila %A Cocca, Massimiliano %A Traglia, Michela %A Huang, Jie %A Huffman, Jennifer E %A Rudan, Igor %A McQuillan, Ruth %A Fraser, Ross M %A Campbell, Harry %A Polasek, Ozren %A Asiki, Gershim %A Ekoru, Kenneth %A Hayward, Caroline %A Wright, Alan F %A Vitart, Veronique %A Navarro, Pau %A Zagury, Jean-Francois %A Wilson, James F %A Toniolo, Daniela %A Gasparini, Paolo %A Soranzo, Nicole %A Sandhu, Manjinder S %A Marchini, Jonathan %K Chromosome Mapping %K Cohort Effect %K Family %K Genotype %K Haplotypes %K Humans %K Models, Genetic %K Pedigree %K Phenotype %K Recombination, Genetic %X

Many existing cohorts contain a range of relatedness between genotyped individuals, either by design or by chance. Haplotype estimation in such cohorts is a central step in many downstream analyses. Using genotypes from six cohorts from isolated populations and two cohorts from non-isolated populations, we have investigated the performance of different phasing methods designed for nominally 'unrelated' individuals. We find that SHAPEIT2 produces much lower switch error rates in all cohorts compared to other methods, including those designed specifically for isolated populations. In particular, when large amounts of IBD sharing is present, SHAPEIT2 infers close to perfect haplotypes. Based on these results we have developed a general strategy for phasing cohorts with any level of implicit or explicit relatedness between individuals. First SHAPEIT2 is run ignoring all explicit family information. We then apply a novel HMM method (duoHMM) to combine the SHAPEIT2 haplotypes with any family information to infer the inheritance pattern of each meiosis at all sites across each chromosome. This allows the correction of switch errors, detection of recombination events and genotyping errors. We show that the method detects numbers of recombination events that align very well with expectations based on genetic maps, and that it infers far fewer spurious recombination events than Merlin. The method can also detect genotyping errors and infer recombination events in otherwise uninformative families, such as trios and duos. The detected recombination events can be used in association scans for recombination phenotypes. The method provides a simple and unified approach to haplotype estimation, that will be of interest to researchers in the fields of human, animal and plant genetics.

%B PLoS Genet %V 10 %P e1004234 %8 2014 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/24743097?dopt=Abstract %R 10.1371/journal.pgen.1004234 %0 Journal Article %J Nat Genet %D 2014 %T Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. %A Arking, Dan E %A Pulit, Sara L %A Crotti, Lia %A van der Harst, Pim %A Munroe, Patricia B %A Koopmann, Tamara T %A Sotoodehnia, Nona %A Rossin, Elizabeth J %A Morley, Michael %A Wang, Xinchen %A Johnson, Andrew D %A Lundby, Alicia %A Gudbjartsson, Daniel F %A Noseworthy, Peter A %A Eijgelsheim, Mark %A Bradford, Yuki %A Tarasov, Kirill V %A Dörr, Marcus %A Müller-Nurasyid, Martina %A Lahtinen, Annukka M %A Nolte, Ilja M %A Smith, Albert Vernon %A Bis, Joshua C %A Isaacs, Aaron %A Newhouse, Stephen J %A Evans, Daniel S %A Post, Wendy S %A Waggott, Daryl %A Lyytikäinen, Leo-Pekka %A Hicks, Andrew A %A Eisele, Lewin %A Ellinghaus, David %A Hayward, Caroline %A Navarro, Pau %A Ulivi, Sheila %A Tanaka, Toshiko %A Tester, David J %A Chatel, Stéphanie %A Gustafsson, Stefan %A Kumari, Meena %A Morris, Richard W %A Naluai, Åsa T %A Padmanabhan, Sandosh %A Kluttig, Alexander %A Strohmer, Bernhard %A Panayiotou, Andrie G %A Torres, Maria %A Knoflach, Michael %A Hubacek, Jaroslav A %A Slowikowski, Kamil %A Raychaudhuri, Soumya %A Kumar, Runjun D %A Harris, Tamara B %A Launer, Lenore J %A Shuldiner, Alan R %A Alonso, Alvaro %A Bader, Joel S %A Ehret, Georg %A Huang, Hailiang %A Kao, W H Linda %A Strait, James B %A Macfarlane, Peter W %A Brown, Morris %A Caulfield, Mark J %A Samani, Nilesh J %A Kronenberg, Florian %A Willeit, Johann %A Smith, J Gustav %A Greiser, Karin H %A Meyer Zu Schwabedissen, Henriette %A Werdan, Karl %A Carella, Massimo %A Zelante, Leopoldo %A Heckbert, Susan R %A Psaty, Bruce M %A Rotter, Jerome I %A Kolcic, Ivana %A Polasek, Ozren %A Wright, Alan F %A Griffin, Maura %A Daly, Mark J %A Arnar, David O %A Holm, Hilma %A Thorsteinsdottir, Unnur %A Denny, Joshua C %A Roden, Dan M %A Zuvich, Rebecca L %A Emilsson, Valur %A Plump, Andrew S %A Larson, Martin G %A O'Donnell, Christopher J %A Yin, Xiaoyan %A Bobbo, Marco %A d'Adamo, Adamo P %A Iorio, Annamaria %A Sinagra, Gianfranco %A Carracedo, Angel %A Cummings, Steven R %A Nalls, Michael A %A Jula, Antti %A Kontula, Kimmo K %A Marjamaa, Annukka %A Oikarinen, Lasse %A Perola, Markus %A Porthan, Kimmo %A Erbel, Raimund %A Hoffmann, Per %A Jöckel, Karl-Heinz %A Kälsch, Hagen %A Nöthen, Markus M %A den Hoed, Marcel %A Loos, Ruth J F %A Thelle, Dag S %A Gieger, Christian %A Meitinger, Thomas %A Perz, Siegfried %A Peters, Annette %A Prucha, Hanna %A Sinner, Moritz F %A Waldenberger, Melanie %A de Boer, Rudolf A %A Franke, Lude %A van der Vleuten, Pieter A %A Beckmann, Britt Maria %A Martens, Eimo %A Bardai, Abdennasser %A Hofman, Nynke %A Wilde, Arthur A M %A Behr, Elijah R %A Dalageorgou, Chrysoula %A Giudicessi, John R %A Medeiros-Domingo, Argelia %A Barc, Julien %A Kyndt, Florence %A Probst, Vincent %A Ghidoni, Alice %A Insolia, Roberto %A Hamilton, Robert M %A Scherer, Stephen W %A Brandimarto, Jeffrey %A Margulies, Kenneth %A Moravec, Christine E %A del Greco M, Fabiola %A Fuchsberger, Christian %A O'Connell, Jeffrey R %A Lee, Wai K %A Watt, Graham C M %A Campbell, Harry %A Wild, Sarah H %A El Mokhtari, Nour E %A Frey, Norbert %A Asselbergs, Folkert W %A Mateo Leach, Irene %A Navis, Gerjan %A van den Berg, Maarten P %A van Veldhuisen, Dirk J %A Kellis, Manolis %A Krijthe, Bouwe P %A Franco, Oscar H %A Hofman, Albert %A Kors, Jan A %A Uitterlinden, André G %A Witteman, Jacqueline C M %A Kedenko, Lyudmyla %A Lamina, Claudia %A Oostra, Ben A %A Abecasis, Goncalo R %A Lakatta, Edward G %A Mulas, Antonella %A Orru, Marco %A Schlessinger, David %A Uda, Manuela %A Markus, Marcello R P %A Völker, Uwe %A Snieder, Harold %A Spector, Timothy D %A Arnlöv, Johan %A Lind, Lars %A Sundström, Johan %A Syvänen, Ann-Christine %A Kivimaki, Mika %A Kähönen, Mika %A Mononen, Nina %A Raitakari, Olli T %A Viikari, Jorma S %A Adamkova, Vera %A Kiechl, Stefan %A Brion, Maria %A Nicolaides, Andrew N %A Paulweber, Bernhard %A Haerting, Johannes %A Dominiczak, Anna F %A Nyberg, Fredrik %A Whincup, Peter H %A Hingorani, Aroon D %A Schott, Jean-Jacques %A Bezzina, Connie R %A Ingelsson, Erik %A Ferrucci, Luigi %A Gasparini, Paolo %A Wilson, James F %A Rudan, Igor %A Franke, Andre %A Mühleisen, Thomas W %A Pramstaller, Peter P %A Lehtimäki, Terho J %A Paterson, Andrew D %A Parsa, Afshin %A Liu, Yongmei %A van Duijn, Cornelia M %A Siscovick, David S %A Gudnason, Vilmundur %A Jamshidi, Yalda %A Salomaa, Veikko %A Felix, Stephan B %A Sanna, Serena %A Ritchie, Marylyn D %A Stricker, Bruno H %A Stefansson, Kari %A Boyer, Laurie A %A Cappola, Thomas P %A Olsen, Jesper V %A Lage, Kasper %A Schwartz, Peter J %A Kääb, Stefan %A Chakravarti, Aravinda %A Ackerman, Michael J %A Pfeufer, Arne %A de Bakker, Paul I W %A Newton-Cheh, Christopher %K Adult %K Aged %K Arrhythmias, Cardiac %K Calcium Signaling %K Death, Sudden, Cardiac %K Electrocardiography %K Female %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Genotype %K Heart Ventricles %K Humans %K Long QT Syndrome %K Male %K Middle Aged %K Myocardium %K Polymorphism, Single Nucleotide %X

The QT interval, an electrocardiographic measure reflecting myocardial repolarization, is a heritable trait. QT prolongation is a risk factor for ventricular arrhythmias and sudden cardiac death (SCD) and could indicate the presence of the potentially lethal mendelian long-QT syndrome (LQTS). Using a genome-wide association and replication study in up to 100,000 individuals, we identified 35 common variant loci associated with QT interval that collectively explain ∼8-10% of QT-interval variation and highlight the importance of calcium regulation in myocardial repolarization. Rare variant analysis of 6 new QT interval-associated loci in 298 unrelated probands with LQTS identified coding variants not found in controls but of uncertain causality and therefore requiring validation. Several newly identified loci encode proteins that physically interact with other recognized repolarization proteins. Our integration of common variant association, expression and orthogonal protein-protein interaction screens provides new insights into cardiac electrophysiology and identifies new candidate genes for ventricular arrhythmias, LQTS and SCD.

%B Nat Genet %V 46 %P 826-36 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24952745?dopt=Abstract %R 10.1038/ng.3014 %0 Journal Article %J BMC Genet %D 2014 %T Genetic landscape of populations along the Silk Road: admixture and migration patterns. %A Mezzavilla, Massimo %A Vozzi, Diego %A Pirastu, Nicola %A Girotto, Giorgia %A d'Adamo, Pio %A Gasparini, Paolo %A Colonna, Vincenza %K Asian Continental Ancestry Group %K Commonwealth of Independent States %K European Continental Ancestry Group %K Gene Flow %K Homozygote %K Human Migration %K Humans %K Phenotype %K Polymorphism, Single Nucleotide %K Principal Component Analysis %K Sequence Analysis, DNA %X

BACKGROUND: The ancient Silk Road has been a trading route between Europe and Central Asia from the 2(nd) century BCE to the 15(th) century CE. While most populations on this route have been characterized, the genetic background of others remains poorly understood, and little is known about past migration patterns. The scientific expedition "Marco Polo" has recently collected genetic and phenotypic data in six regions (Georgia, Armenia, Azerbaijan, Uzbekistan, Kazakhstan, Tajikistan) along the Silk Road to study the genetics of a number of phenotypes.

RESULTS: We characterized the genetic structure of these populations within a worldwide context. We observed a West-East subdivision albeit the existence of a genetic component shared within Central Asia and nearby populations from Europe and Near East. We observed a contribution of up to 50% from Europe and Asia to most of the populations that have been analyzed. The contribution from Asia dates back to ~25 generations and is limited to the Eastern Silk Road. Time and direction of this contribution are consistent with the Mongolian expansion era.

CONCLUSIONS: We clarified the genetic structure of six populations from Central Asia and suggested a complex pattern of gene flow among them. We provided a map of migration events in time and space and we quantified exchanges among populations. Altogether these novel findings will support the future studies aimed at understanding the genetics of the phenotypes that have been collected during the Marco Polo campaign, they will provide insights into the history of these populations, and they will be useful to reconstruct the developments and events that have shaped modern Eurasians genomes.

%B BMC Genet %V 15 %P 131 %8 2014 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25476266?dopt=Abstract %R 10.1186/s12863-014-0131-6 %0 Journal Article %J Hum Mol Genet %D 2014 %T Genome-wide association study of sexual maturation in males and females highlights a role for body mass and menarche loci in male puberty. %A Cousminer, Diana L %A Stergiakouli, Evangelia %A Berry, Diane J %A Ang, Wei %A Groen-Blokhuis, Maria M %A Körner, Antje %A Siitonen, Niina %A Ntalla, Ioanna %A Marinelli, Marcella %A Perry, John R B %A Kettunen, Johannes %A Jansen, Rick %A Surakka, Ida %A Timpson, Nicholas J %A Ring, Susan %A McMahon, George %A Power, Chris %A Wang, Carol %A Kähönen, Mika %A Viikari, Jorma %A Lehtimäki, Terho %A Middeldorp, Christel M %A Hulshoff Pol, Hilleke E %A Neef, Madlen %A Weise, Sebastian %A Pahkala, Katja %A Niinikoski, Harri %A Zeggini, Eleftheria %A Panoutsopoulou, Kalliope %A Bustamante, Mariona %A Penninx, Brenda W J H %A Murabito, Joanne %A Torrent, Maties %A Dedoussis, George V %A Kiess, Wieland %A Boomsma, Dorret I %A Pennell, Craig E %A Raitakari, Olli T %A Hyppönen, Elina %A Davey Smith, George %A Ripatti, Samuli %A McCarthy, Mark I %A Widen, Elisabeth %X

Little is known about genes regulating male puberty. Further, while many identified pubertal timing variants associate with age at menarche, a late manifestation of puberty, and body mass, little is known about these variants' relationship to pubertal initiation or tempo. To address these questions, we performed genome-wide association meta-analysis in over 11 000 European samples with data on early pubertal traits, male genital and female breast development, measured by the Tanner scale. We report the first genome-wide significant locus for male sexual development upstream of myocardin-like 2 (MKL2) (P = 8.9 × 10(-9)), a menarche locus tagging a developmental pathway linking earlier puberty with reduced pubertal growth (P = 4.6 × 10(-5)) and short adult stature (p = 7.5 × 10(-6)) in both males and females. Furthermore, our results indicate that a proportion of menarche loci are important for pubertal initiation in both sexes. Consistent with epidemiological correlations between increased prepubertal body mass and earlier pubertal timing in girls, body mass index (BMI)-increasing alleles correlated with earlier breast development. In boys, some BMI-increasing alleles associated with earlier, and others with delayed, sexual development; these genetic results mimic the controversy in epidemiological studies, some of which show opposing correlations between prepubertal BMI and male puberty. Our results contribute to our understanding of the pubertal initiation program in both sexes and indicate that although mechanisms regulating pubertal onset in males and females may largely be shared, the relationship between body mass and pubertal timing in boys may be complex and requires further genetic studies.

%B Hum Mol Genet %V 23 %P 4452-64 %8 2014 Aug 15 %G eng %N 16 %1 http://www.ncbi.nlm.nih.gov/pubmed/24770850?dopt=Abstract %R 10.1093/hmg/ddu150 %0 Journal Article %J Lancet %D 2014 %T Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. %A Murray, Christopher J L %A Ortblad, Katrina F %A Guinovart, Caterina %A Lim, Stephen S %A Wolock, Timothy M %A Roberts, D Allen %A Dansereau, Emily A %A Graetz, Nicholas %A Barber, Ryan M %A Brown, Jonathan C %A Wang, Haidong %A Duber, Herbert C %A Naghavi, Mohsen %A Dicker, Daniel %A Dandona, Lalit %A Salomon, Joshua A %A Heuton, Kyle R %A Foreman, Kyle %A Phillips, David E %A Fleming, Thomas D %A Flaxman, Abraham D %A Phillips, Bryan K %A Johnson, Elizabeth K %A Coggeshall, Megan S %A Abd-Allah, Foad %A Abera, Semaw Ferede %A Abraham, Jerry P %A Abubakar, Ibrahim %A Abu-Raddad, Laith J %A Abu-Rmeileh, Niveen Me %A Achoki, Tom %A Adeyemo, Austine Olufemi %A Adou, Arsène Kouablan %A Adsuar, José C %A Agardh, Emilie Elisabet %A Akena, Dickens %A Al Kahbouri, Mazin J %A Alasfoor, Deena %A Albittar, Mohammed I %A Alcalá-Cerra, Gabriel %A Alegretti, Miguel Angel %A Alemu, Zewdie Aderaw %A Alfonso-Cristancho, Rafael %A Alhabib, Samia %A Ali, Raghib %A Alla, François %A Allen, Peter J %A Alsharif, Ubai %A Alvarez, Elena %A Alvis-Guzmán, Nelson %A Amankwaa, Adansi A %A Amare, Azmeraw T %A Amini, Hassan %A Ammar, Walid %A Anderson, Benjamin O %A Antonio, Carl Abelardo T %A Anwari, Palwasha %A Arnlöv, Johan %A Arsenijevic, Valentina S Arsic %A Artaman, Ali %A Asghar, Rana J %A Assadi, Reza %A Atkins, Lydia S %A Badawi, Alaa %A Balakrishnan, Kalpana %A Banerjee, Amitava %A Basu, Sanjay %A Beardsley, Justin %A Bekele, Tolesa %A Bell, Michelle L %A Bernabe, Eduardo %A Beyene, Tariku Jibat %A Bhala, Neeraj %A Bhalla, Ashish %A Bhutta, Zulfiqar A %A Abdulhak, Aref Bin %A Binagwaho, Agnes %A Blore, Jed D %A Basara, Berrak Bora %A Bose, Dipan %A Brainin, Michael %A Breitborde, Nicholas %A Castañeda-Orjuela, Carlos A %A Catalá-López, Ferrán %A Chadha, Vineet K %A Chang, Jung-Chen %A Chiang, Peggy Pei-Chia %A Chuang, Ting-Wu %A Colomar, Mercedes %A Cooper, Leslie Trumbull %A Cooper, Cyrus %A Courville, Karen J %A Cowie, Benjamin C %A Criqui, Michael H %A Dandona, Rakhi %A Dayama, Anand %A De Leo, Diego %A Degenhardt, Louisa %A del Pozo-Cruz, Borja %A Deribe, Kebede %A Des Jarlais, Don C %A Dessalegn, Muluken %A Dharmaratne, Samath D %A Dilmen, Uğur %A Ding, Eric L %A Driscoll, Tim R %A Durrani, Adnan M %A Ellenbogen, Richard G %A Ermakov, Sergey Petrovich %A Esteghamati, Alireza %A Faraon, Emerito Jose A %A Farzadfar, Farshad %A Fereshtehnejad, Seyed-Mohammad %A Fijabi, Daniel Obadare %A Forouzanfar, Mohammad H %A Fra Paleo, Urbano %A Gaffikin, Lynne %A Gamkrelidze, Amiran %A Gankpé, Fortuné Gbètoho %A Geleijnse, Johanna M %A Gessner, Bradford D %A Gibney, Katherine B %A Ginawi, Ibrahim Abdelmageem Mohamed %A Glaser, Elizabeth L %A Gona, Philimon %A Goto, Atsushi %A Gouda, Hebe N %A Gugnani, Harish Chander %A Gupta, Rajeev %A Gupta, Rahul %A Hafezi-Nejad, Nima %A Hamadeh, Randah Ribhi %A Hammami, Mouhanad %A Hankey, Graeme J %A Harb, Hilda L %A Haro, Josep Maria %A Havmoeller, Rasmus %A Hay, Simon I %A Hedayati, Mohammad T %A Pi, Ileana B Heredia %A Hoek, Hans W %A Hornberger, John C %A Hosgood, H Dean %A Hotez, Peter J %A Hoy, Damian G %A Huang, John J %A Iburg, Kim M %A Idrisov, Bulat T %A Innos, Kaire %A Jacobsen, Kathryn H %A Jeemon, Panniyammakal %A Jensen, Paul N %A Jha, Vivekanand %A Jiang, Guohong %A Jonas, Jost B %A Juel, Knud %A Kan, Haidong %A Kankindi, Ida %A Karam, Nadim E %A Karch, André %A Karema, Corine Kakizi %A Kaul, Anil %A Kawakami, Norito %A Kazi, Dhruv S %A Kemp, Andrew H %A Kengne, Andre Pascal %A Keren, Andre %A Kereselidze, Maia %A Khader, Yousef Saleh %A Khalifa, Shams Eldin Ali Hassan %A Khan, Ejaz Ahmed %A Khang, Young-Ho %A Khonelidze, Irma %A Kinfu, Yohannes %A Kinge, Jonas M %A Knibbs, Luke %A Kokubo, Yoshihiro %A Kosen, S %A Defo, Barthelemy Kuate %A Kulkarni, Veena S %A Kulkarni, Chanda %A Kumar, Kaushalendra %A Kumar, Ravi B %A Kumar, G Anil %A Kwan, Gene F %A Lai, Taavi %A Balaji, Arjun Lakshmana %A Lam, Hilton %A Lan, Qing %A Lansingh, Van C %A Larson, Heidi J %A Larsson, Anders %A Lee, Jong-Tae %A Leigh, James %A Leinsalu, Mall %A Leung, Ricky %A Li, Yichong %A Li, Yongmei %A de Lima, Graça Maria Ferreira %A Lin, Hsien-Ho %A Lipshultz, Steven E %A Liu, Shiwei %A Liu, Yang %A Lloyd, Belinda K %A Lotufo, Paulo A %A Machado, Vasco Manuel Pedro %A Maclachlan, Jennifer H %A Magis-Rodriguez, Carlos %A Majdan, Marek %A Mapoma, Christopher Chabila %A Marcenes, Wagner %A Marzan, Melvin Barrientos %A Masci, Joseph R %A Mashal, Mohammad Taufiq %A Mason-Jones, Amanda J %A Mayosi, Bongani M %A Mazorodze, Tasara T %A Mckay, Abigail Cecilia %A Meaney, Peter A %A Mehndiratta, Man Mohan %A Mejia-Rodriguez, Fabiola %A Melaku, Yohannes Adama %A Memish, Ziad A %A Mendoza, Walter %A Miller, Ted R %A Mills, Edward J %A Mohammad, Karzan Abdulmuhsin %A Mokdad, Ali H %A Mola, Glen Liddell %A Monasta, Lorenzo %A Montico, Marcella %A Moore, Ami R %A Mori, Rintaro %A Moturi, Wilkister Nyaora %A Mukaigawara, Mitsuru %A Murthy, Kinnari S %A Naheed, Aliya %A Naidoo, Kovin S %A Naldi, Luigi %A Nangia, Vinay %A Narayan, K M Venkat %A Nash, Denis %A Nejjari, Chakib %A Nelson, Robert G %A Neupane, Sudan Prasad %A Newton, Charles R %A Ng, Marie %A Nisar, Muhammad Imran %A Nolte, Sandra %A Norheim, Ole F %A Nowaseb, Vincent %A Nyakarahuka, Luke %A Oh, In-Hwan %A Ohkubo, Takayoshi %A Olusanya, Bolajoko O %A Omer, Saad B %A Opio, John Nelson %A Orisakwe, Orish Ebere %A Pandian, Jeyaraj D %A Papachristou, Christina %A Caicedo, Angel J Paternina %A Patten, Scott B %A Paul, Vinod K %A Pavlin, Boris Igor %A Pearce, Neil %A Pereira, David M %A Pervaiz, Aslam %A Pesudovs, Konrad %A Petzold, Max %A Pourmalek, Farshad %A Qato, Dima %A Quezada, Amado D %A Quistberg, D Alex %A Rafay, Anwar %A Rahimi, Kazem %A Rahimi-Movaghar, Vafa %A ur Rahman, Sajjad %A Raju, Murugesan %A Rana, Saleem M %A Razavi, Homie %A Reilly, Robert Quentin %A Remuzzi, Giuseppe %A Richardus, Jan Hendrik %A Ronfani, Luca %A Roy, Nobhojit %A Sabin, Nsanzimana %A Saeedi, Mohammad Yahya %A Sahraian, Mohammad Ali %A Samonte, Genesis May J %A Sawhney, Monika %A Schneider, Ione J C %A Schwebel, David C %A Seedat, Soraya %A Sepanlou, Sadaf G %A Servan-Mori, Edson E %A Sheikhbahaei, Sara %A Shibuya, Kenji %A Shin, Hwashin Hyun %A Shiue, Ivy %A Shivakoti, Rupak %A Sigfusdottir, Inga Dora %A Silberberg, Donald H %A Silva, Andrea P %A Simard, Edgar P %A Singh, Jasvinder A %A Skirbekk, Vegard %A Sliwa, Karen %A Soneji, Samir %A Soshnikov, Sergey S %A Sreeramareddy, Chandrashekhar T %A Stathopoulou, Vasiliki Kalliopi %A Stroumpoulis, Konstantinos %A Swaminathan, Soumya %A Sykes, Bryan L %A Tabb, Karen M %A Talongwa, Roberto Tchio %A Tenkorang, Eric Yeboah %A Terkawi, Abdullah Sulieman %A Thomson, Alan J %A Thorne-Lyman, Andrew L %A Towbin, Jeffrey A %A Traebert, Jefferson %A Tran, Bach X %A Dimbuene, Zacharie Tsala %A Tsilimbaris, Miltiadis %A Uchendu, Uche S %A Ukwaja, Kingsley N %A Uzun, Selen Begüm %A Vallely, Andrew J %A Vasankari, Tommi J %A Venketasubramanian, N %A Violante, Francesco S %A Vlassov, Vasiliy Victorovich %A Vollset, Stein Emil %A Waller, Stephen %A Wallin, Mitchell T %A Wang, Linhong %A Wang, XiaoRong %A Wang, Yanping %A Weichenthal, Scott %A Weiderpass, Elisabete %A Weintraub, Robert G %A Westerman, Ronny %A White, Richard A %A Wilkinson, James D %A Williams, Thomas Neil %A Woldeyohannes, Solomon Meseret %A Wong, John Q %A Xu, Gelin %A Yang, Yang C %A Yano, Yuichiro %A Yentur, Gokalp Kadri %A Yip, Paul %A Yonemoto, Naohiro %A Yoon, Seok-Jun %A Younis, Mustafa %A Yu, Chuanhua %A Jin, Kim Yun %A El Sayed Zaki, Maysaa %A Zhao, Yong %A Zheng, Yingfeng %A Zhou, Maigeng %A Zhu, Jun %A Zou, Xiao Nong %A Lopez, Alan D %A Vos, Theo %K Age Distribution %K Epidemics %K Female %K Global Health %K HIV Infections %K Humans %K Incidence %K Malaria %K Male %K Mortality %K Organizational Objectives %K Sex Distribution %K Tuberculosis %X

BACKGROUND: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration.

METHODS: To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets.

FINDINGS: Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990.

INTERPRETATION: Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action.

FUNDING: Bill & Melinda Gates Foundation.

%B Lancet %V 384 %P 1005-70 %8 2014 Sep 13 %G eng %N 9947 %1 http://www.ncbi.nlm.nih.gov/pubmed/25059949?dopt=Abstract %R 10.1016/S0140-6736(14)60844-8 %0 Journal Article %J Lancet %D 2014 %T Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. %A Kassebaum, Nicholas J %A Bertozzi-Villa, Amelia %A Coggeshall, Megan S %A Shackelford, Katya A %A Steiner, Caitlyn %A Heuton, Kyle R %A Gonzalez-Medina, Diego %A Barber, Ryan %A Huynh, Chantal %A Dicker, Daniel %A Templin, Tara %A Wolock, Timothy M %A Ozgoren, Ayse Abbasoglu %A Abd-Allah, Foad %A Abera, Semaw Ferede %A Abubakar, Ibrahim %A Achoki, Tom %A Adelekan, Ademola %A Ademi, Zanfina %A Adou, Arsène Kouablan %A Adsuar, José C %A Agardh, Emilie E %A Akena, Dickens %A Alasfoor, Deena %A Alemu, Zewdie Aderaw %A Alfonso-Cristancho, Rafael %A Alhabib, Samia %A Ali, Raghib %A Al Kahbouri, Mazin J %A Alla, François %A Allen, Peter J %A AlMazroa, Mohammad A %A Alsharif, Ubai %A Alvarez, Elena %A Alvis-Guzmán, Nelson %A Amankwaa, Adansi A %A Amare, Azmeraw T %A Amini, Hassan %A Ammar, Walid %A Antonio, Carl A T %A Anwari, Palwasha %A Arnlöv, Johan %A Arsenijevic, Valentina S Arsic %A Artaman, Ali %A Asad, Majed Masoud %A Asghar, Rana J %A Assadi, Reza %A Atkins, Lydia S %A Badawi, Alaa %A Balakrishnan, Kalpana %A Basu, Arindam %A Basu, Sanjay %A Beardsley, Justin %A Bedi, Neeraj %A Bekele, Tolesa %A Bell, Michelle L %A Bernabe, Eduardo %A Beyene, Tariku J %A Bhutta, Zulfiqar %A Bin Abdulhak, Aref %A Blore, Jed D %A Basara, Berrak Bora %A Bose, Dipan %A Breitborde, Nicholas %A Cárdenas, Rosario %A Castañeda-Orjuela, Carlos A %A Castro, Ruben Estanislao %A Catalá-López, Ferrán %A Cavlin, Alanur %A Chang, Jung-Chen %A Che, Xuan %A Christophi, Costas A %A Chugh, Sumeet S %A Cirillo, Massimo %A Colquhoun, Samantha M %A Cooper, Leslie Trumbull %A Cooper, Cyrus %A da Costa Leite, Iuri %A Dandona, Lalit %A Dandona, Rakhi %A Davis, Adrian %A Dayama, Anand %A Degenhardt, Louisa %A De Leo, Diego %A del Pozo-Cruz, Borja %A Deribe, Kebede %A Dessalegn, Muluken %A deVeber, Gabrielle A %A Dharmaratne, Samath D %A Dilmen, Uğur %A Ding, Eric L %A Dorrington, Rob E %A Driscoll, Tim R %A Ermakov, Sergei Petrovich %A Esteghamati, Alireza %A Faraon, Emerito Jose A %A Farzadfar, Farshad %A Felicio, Manuela Mendonca %A Fereshtehnejad, Seyed-Mohammad %A de Lima, Graça Maria Ferreira %A Forouzanfar, Mohammad H %A França, Elisabeth B %A Gaffikin, Lynne %A Gambashidze, Ketevan %A Gankpé, Fortuné Gbètoho %A Garcia, Ana C %A Geleijnse, Johanna M %A Gibney, Katherine B %A Giroud, Maurice %A Glaser, Elizabeth L %A Goginashvili, Ketevan %A Gona, Philimon %A González-Castell, Dinorah %A Goto, Atsushi %A Gouda, Hebe N %A Gugnani, Harish Chander %A Gupta, Rahul %A Gupta, Rajeev %A Hafezi-Nejad, Nima %A Hamadeh, Randah Ribhi %A Hammami, Mouhanad %A Hankey, Graeme J %A Harb, Hilda L %A Havmoeller, Rasmus %A Hay, Simon I %A Pi, Ileana B Heredia %A Hoek, Hans W %A Hosgood, H Dean %A Hoy, Damian G %A Husseini, Abdullatif %A Idrisov, Bulat T %A Innos, Kaire %A Inoue, Manami %A Jacobsen, Kathryn H %A Jahangir, Eiman %A Jee, Sun Ha %A Jensen, Paul N %A Jha, Vivekanand %A Jiang, Guohong %A Jonas, Jost B %A Juel, Knud %A Kabagambe, Edmond Kato %A Kan, Haidong %A Karam, Nadim E %A Karch, André %A Karema, Corine Kakizi %A Kaul, Anil %A Kawakami, Norito %A Kazanjan, Konstantin %A Kazi, Dhruv S %A Kemp, Andrew H %A Kengne, Andre Pascal %A Kereselidze, Maia %A Khader, Yousef Saleh %A Khalifa, Shams Eldin Ali Hassan %A Khan, Ejaz Ahmed %A Khang, Young-Ho %A Knibbs, Luke %A Kokubo, Yoshihiro %A Kosen, Soewarta %A Defo, Barthelemy Kuate %A Kulkarni, Chanda %A Kulkarni, Veena S %A Kumar, G Anil %A Kumar, Kaushalendra %A Kumar, Ravi B %A Kwan, Gene %A Lai, Taavi %A Lalloo, Ratilal %A Lam, Hilton %A Lansingh, Van C %A Larsson, Anders %A Lee, Jong-Tae %A Leigh, James %A Leinsalu, Mall %A Leung, Ricky %A Li, Xiaohong %A Li, Yichong %A Li, Yongmei %A Liang, Juan %A Liang, Xiaofeng %A Lim, Stephen S %A Lin, Hsien-Ho %A Lipshultz, Steven E %A Liu, Shiwei %A Liu, Yang %A Lloyd, Belinda K %A London, Stephanie J %A Lotufo, Paulo A %A Ma, Jixiang %A Ma, Stefan %A Machado, Vasco Manuel Pedro %A Mainoo, Nana Kwaku %A Majdan, Marek %A Mapoma, Christopher Chabila %A Marcenes, Wagner %A Marzan, Melvin Barrientos %A Mason-Jones, Amanda J %A Mehndiratta, Man Mohan %A Mejia-Rodriguez, Fabiola %A Memish, Ziad A %A Mendoza, Walter %A Miller, Ted R %A Mills, Edward J %A Mokdad, Ali H %A Mola, Glen Liddell %A Monasta, Lorenzo %A de la Cruz Monis, Jonathan %A Hernandez, Julio Cesar Montañez %A Moore, Ami R %A Moradi-Lakeh, Maziar %A Mori, Rintaro %A Mueller, Ulrich O %A Mukaigawara, Mitsuru %A Naheed, Aliya %A Naidoo, Kovin S %A Nand, Devina %A Nangia, Vinay %A Nash, Denis %A Nejjari, Chakib %A Nelson, Robert G %A Neupane, Sudan Prasad %A Newton, Charles R %A Ng, Marie %A Nieuwenhuijsen, Mark J %A Nisar, Muhammad Imran %A Nolte, Sandra %A Norheim, Ole F %A Nyakarahuka, Luke %A Oh, In-Hwan %A Ohkubo, Takayoshi %A Olusanya, Bolajoko O %A Omer, Saad B %A Opio, John Nelson %A Orisakwe, Orish Ebere %A Pandian, Jeyaraj D %A Papachristou, Christina %A Park, Jae-Hyun %A Caicedo, Angel J Paternina %A Patten, Scott B %A Paul, Vinod K %A Pavlin, Boris Igor %A Pearce, Neil %A Pereira, David M %A Pesudovs, Konrad %A Petzold, Max %A Poenaru, Dan %A Polanczyk, Guilherme V %A Polinder, Suzanne %A Pope, Dan %A Pourmalek, Farshad %A Qato, Dima %A Quistberg, D Alex %A Rafay, Anwar %A Rahimi, Kazem %A Rahimi-Movaghar, Vafa %A ur Rahman, Sajjad %A Raju, Murugesan %A Rana, Saleem M %A Refaat, Amany %A Ronfani, Luca %A Roy, Nobhojit %A Pimienta, Tania Georgina Sánchez %A Sahraian, Mohammad Ali %A Salomon, Joshua A %A Sampson, Uchechukwu %A Santos, Itamar S %A Sawhney, Monika %A Sayinzoga, Felix %A Schneider, Ione J C %A Schumacher, Austin %A Schwebel, David C %A Seedat, Soraya %A Sepanlou, Sadaf G %A Servan-Mori, Edson E %A Shakh-Nazarova, Marina %A Sheikhbahaei, Sara %A Shibuya, Kenji %A Shin, Hwashin Hyun %A Shiue, Ivy %A Sigfusdottir, Inga Dora %A Silberberg, Donald H %A Silva, Andrea P %A Singh, Jasvinder A %A Skirbekk, Vegard %A Sliwa, Karen %A Soshnikov, Sergey S %A Sposato, Luciano A %A Sreeramareddy, Chandrashekhar T %A Stroumpoulis, Konstantinos %A Sturua, Lela %A Sykes, Bryan L %A Tabb, Karen M %A Talongwa, Roberto Tchio %A Tan, Feng %A Teixeira, Carolina Maria %A Tenkorang, Eric Yeboah %A Terkawi, Abdullah Sulieman %A Thorne-Lyman, Andrew L %A Tirschwell, David L %A Towbin, Jeffrey A %A Tran, Bach X %A Tsilimbaris, Miltiadis %A Uchendu, Uche S %A Ukwaja, Kingsley N %A Undurraga, Eduardo A %A Uzun, Selen Begüm %A Vallely, Andrew J %A van Gool, Coen H %A Vasankari, Tommi J %A Vavilala, Monica S %A Venketasubramanian, N %A Villalpando, Salvador %A Violante, Francesco S %A Vlassov, Vasiliy Victorovich %A Vos, Theo %A Waller, Stephen %A Wang, Haidong %A Wang, Linhong %A Wang, XiaoRong %A Wang, Yanping %A Weichenthal, Scott %A Weiderpass, Elisabete %A Weintraub, Robert G %A Westerman, Ronny %A Wilkinson, James D %A Woldeyohannes, Solomon Meseret %A Wong, John Q %A Wordofa, Muluemebet Abera %A Xu, Gelin %A Yang, Yang C %A Yano, Yuichiro %A Yentur, Gokalp Kadri %A Yip, Paul %A Yonemoto, Naohiro %A Yoon, Seok-Jun %A Younis, Mustafa Z %A Yu, Chuanhua %A Jin, Kim Yun %A El Sayed Zaki, Maysaa %A Zhao, Yong %A Zheng, Yingfeng %A Zhou, Maigeng %A Zhu, Jun %A Zou, Xiao Nong %A Lopez, Alan D %A Naghavi, Mohsen %A Murray, Christopher J L %A Lozano, Rafael %K Age Distribution %K Cause of Death %K Female %K Global Health %K HIV Infections %K Humans %K Maternal Mortality %K Models, Statistical %K Organizational Objectives %K Pregnancy %K Pregnancy Complications, Infectious %K Risk Factors %K Socioeconomic Factors %K Time Factors %X

BACKGROUND: The fifth Millennium Development Goal (MDG 5) established the goal of a 75% reduction in the maternal mortality ratio (MMR; number of maternal deaths per 100,000 livebirths) between 1990 and 2015. We aimed to measure levels and track trends in maternal mortality, the key causes contributing to maternal death, and timing of maternal death with respect to delivery.

METHODS: We used robust statistical methods including the Cause of Death Ensemble model (CODEm) to analyse a database of data for 7065 site-years and estimate the number of maternal deaths from all causes in 188 countries between 1990 and 2013. We estimated the number of pregnancy-related deaths caused by HIV on the basis of a systematic review of the relative risk of dying during pregnancy for HIV-positive women compared with HIV-negative women. We also estimated the fraction of these deaths aggravated by pregnancy on the basis of a systematic review. To estimate the numbers of maternal deaths due to nine different causes, we identified 61 sources from a systematic review and 943 site-years of vital registration data. We also did a systematic review of reports about the timing of maternal death, identifying 142 sources to use in our analysis. We developed estimates for each country for 1990-2013 using Bayesian meta-regression. We estimated 95% uncertainty intervals (UIs) for all values.

FINDINGS: 292,982 (95% UI 261,017-327,792) maternal deaths occurred in 2013, compared with 376,034 (343,483-407,574) in 1990. The global annual rate of change in the MMR was -0·3% (-1·1 to 0·6) from 1990 to 2003, and -2·7% (-3·9 to -1·5) from 2003 to 2013, with evidence of continued acceleration. MMRs reduced consistently in south, east, and southeast Asia between 1990 and 2013, but maternal deaths increased in much of sub-Saharan Africa during the 1990s. 2070 (1290-2866) maternal deaths were related to HIV in 2013, 0·4% (0·2-0·6) of the global total. MMR was highest in the oldest age groups in both 1990 and 2013. In 2013, most deaths occurred intrapartum or postpartum. Causes varied by region and between 1990 and 2013. We recorded substantial variation in the MMR by country in 2013, from 956·8 (685·1-1262·8) in South Sudan to 2·4 (1·6-3·6) in Iceland.

INTERPRETATION: Global rates of change suggest that only 16 countries will achieve the MDG 5 target by 2015. Accelerated reductions since the Millennium Declaration in 2000 coincide with increased development assistance for maternal, newborn, and child health. Setting of targets and associated interventions for after 2015 will need careful consideration of regions that are making slow progress, such as west and central Africa.

FUNDING: Bill & Melinda Gates Foundation.

%B Lancet %V 384 %P 980-1004 %8 2014 Sep 13 %G eng %N 9947 %1 http://www.ncbi.nlm.nih.gov/pubmed/24797575?dopt=Abstract %R 10.1016/S0140-6736(14)60696-6 %0 Journal Article %J Lancet %D 2014 %T Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. %A Wang, Haidong %A Liddell, Chelsea A %A Coates, Matthew M %A Mooney, Meghan D %A Levitz, Carly E %A Schumacher, Austin E %A Apfel, Henry %A Iannarone, Marissa %A Phillips, Bryan %A Lofgren, Katherine T %A Sandar, Logan %A Dorrington, Rob E %A Rakovac, Ivo %A Jacobs, Troy A %A Liang, Xiaofeng %A Zhou, Maigeng %A Zhu, Jun %A Yang, Gonghuan %A Wang, Yanping %A Liu, Shiwei %A Li, Yichong %A Ozgoren, Ayse Abbasoglu %A Abera, Semaw Ferede %A Abubakar, Ibrahim %A Achoki, Tom %A Adelekan, Ademola %A Ademi, Zanfina %A Alemu, Zewdie Aderaw %A Allen, Peter J %A AlMazroa, Mohammad AbdulAziz %A Alvarez, Elena %A Amankwaa, Adansi A %A Amare, Azmeraw T %A Ammar, Walid %A Anwari, Palwasha %A Cunningham, Solveig Argeseanu %A Asad, Majed Masoud %A Assadi, Reza %A Banerjee, Amitava %A Basu, Sanjay %A Bedi, Neeraj %A Bekele, Tolesa %A Bell, Michelle L %A Bhutta, Zulfiqar %A Blore, Jed D %A Basara, Berrak Bora %A Boufous, Soufiane %A Breitborde, Nicholas %A Bruce, Nigel G %A Bui, Linh Ngoc %A Carapetis, Jonathan R %A Cárdenas, Rosario %A Carpenter, David O %A Caso, Valeria %A Castro, Ruben Estanislao %A Catalá-López, Ferrán %A Cavlin, Alanur %A Che, Xuan %A Chiang, Peggy Pei-Chia %A Chowdhury, Rajiv %A Christophi, Costas A %A Chuang, Ting-Wu %A Cirillo, Massimo %A da Costa Leite, Iuri %A Courville, Karen J %A Dandona, Lalit %A Dandona, Rakhi %A Davis, Adrian %A Dayama, Anand %A Deribe, Kebede %A Dharmaratne, Samath D %A Dherani, Mukesh K %A Dilmen, Uğur %A Ding, Eric L %A Edmond, Karen M %A Ermakov, Sergei Petrovich %A Farzadfar, Farshad %A Fereshtehnejad, Seyed-Mohammad %A Fijabi, Daniel Obadare %A Foigt, Nataliya %A Forouzanfar, Mohammad H %A Garcia, Ana C %A Geleijnse, Johanna M %A Gessner, Bradford D %A Goginashvili, Ketevan %A Gona, Philimon %A Goto, Atsushi %A Gouda, Hebe N %A Green, Mark A %A Greenwell, Karen Fern %A Gugnani, Harish Chander %A Gupta, Rahul %A Hamadeh, Randah Ribhi %A Hammami, Mouhanad %A Harb, Hilda L %A Hay, Simon %A Hedayati, Mohammad T %A Hosgood, H Dean %A Hoy, Damian G %A Idrisov, Bulat T %A Islami, Farhad %A Ismayilova, Samaya %A Jha, Vivekanand %A Jiang, Guohong %A Jonas, Jost B %A Juel, Knud %A Kabagambe, Edmond Kato %A Kazi, Dhruv S %A Kengne, Andre Pascal %A Kereselidze, Maia %A Khader, Yousef Saleh %A Khalifa, Shams Eldin Ali Hassan %A Khang, Young-Ho %A Kim, Daniel %A Kinfu, Yohannes %A Kinge, Jonas M %A Kokubo, Yoshihiro %A Kosen, Soewarta %A Defo, Barthelemy Kuate %A Kumar, G Anil %A Kumar, Kaushalendra %A Kumar, Ravi B %A Lai, Taavi %A Lan, Qing %A Larsson, Anders %A Lee, Jong-Tae %A Leinsalu, Mall %A Lim, Stephen S %A Lipshultz, Steven E %A Logroscino, Giancarlo %A Lotufo, Paulo A %A Lunevicius, Raimundas %A Lyons, Ronan Anthony %A Ma, Stefan %A Mahdi, Abbas Ali %A Marzan, Melvin Barrientos %A Mashal, Mohammad Taufiq %A Mazorodze, Tasara T %A McGrath, John J %A Memish, Ziad A %A Mendoza, Walter %A Mensah, George A %A Meretoja, Atte %A Miller, Ted R %A Mills, Edward J %A Mohammad, Karzan Abdulmuhsin %A Mokdad, Ali H %A Monasta, Lorenzo %A Montico, Marcella %A Moore, Ami R %A Moschandreas, Joanna %A Msemburi, William T %A Mueller, Ulrich O %A Muszynska, Magdalena M %A Naghavi, Mohsen %A Naidoo, Kovin S %A Narayan, K M Venkat %A Nejjari, Chakib %A Ng, Marie %A de Dieu Ngirabega, Jean %A Nieuwenhuijsen, Mark J %A Nyakarahuka, Luke %A Ohkubo, Takayoshi %A Omer, Saad B %A Caicedo, Angel J Paternina %A Pillay-van Wyk, Victoria %A Pope, Dan %A Pourmalek, Farshad %A Prabhakaran, Dorairaj %A Rahman, Sajjad U R %A Rana, Saleem M %A Reilly, Robert Quentin %A Rojas-Rueda, David %A Ronfani, Luca %A Rushton, Lesley %A Saeedi, Mohammad Yahya %A Salomon, Joshua A %A Sampson, Uchechukwu %A Santos, Itamar S %A Sawhney, Monika %A Schmidt, Jürgen C %A Shakh-Nazarova, Marina %A She, Jun %A Sheikhbahaei, Sara %A Shibuya, Kenji %A Shin, Hwashin Hyun %A Shishani, Kawkab %A Shiue, Ivy %A Sigfusdottir, Inga Dora %A Singh, Jasvinder A %A Skirbekk, Vegard %A Sliwa, Karen %A Soshnikov, Sergey S %A Sposato, Luciano A %A Stathopoulou, Vasiliki Kalliopi %A Stroumpoulis, Konstantinos %A Tabb, Karen M %A Talongwa, Roberto Tchio %A Teixeira, Carolina Maria %A Terkawi, Abdullah Sulieman %A Thomson, Alan J %A Thorne-Lyman, Andrew L %A Toyoshima, Hideaki %A Dimbuene, Zacharie Tsala %A Uwaliraye, Parfait %A Uzun, Selen Begüm %A Vasankari, Tommi J %A Vasconcelos, Ana Maria Nogales %A Vlassov, Vasiliy Victorovich %A Vollset, Stein Emil %A Waller, Stephen %A Wan, Xia %A Weichenthal, Scott %A Weiderpass, Elisabete %A Weintraub, Robert G %A Westerman, Ronny %A Wilkinson, James D %A Williams, Hywel C %A Yang, Yang C %A Yentur, Gokalp Kadri %A Yip, Paul %A Yonemoto, Naohiro %A Younis, Mustafa %A Yu, Chuanhua %A Jin, Kim Yun %A El Sayed Zaki, Maysaa %A Zhu, Shankuan %A Vos, Theo %A Lopez, Alan D %A Murray, Christopher J L %K Child Mortality %K Child, Preschool %K Global Health %K Humans %K Infant %K Infant Mortality %K Infant, Newborn %K Organizational Objectives %K Risk Factors %K Socioeconomic Factors %X

BACKGROUND: Remarkable financial and political efforts have been focused on the reduction of child mortality during the past few decades. Timely measurements of levels and trends in under-5 mortality are important to assess progress towards the Millennium Development Goal 4 (MDG 4) target of reduction of child mortality by two thirds from 1990 to 2015, and to identify models of success.

METHODS: We generated updated estimates of child mortality in early neonatal (age 0-6 days), late neonatal (7-28 days), postneonatal (29-364 days), childhood (1-4 years), and under-5 (0-4 years) age groups for 188 countries from 1970 to 2013, with more than 29,000 survey, census, vital registration, and sample registration datapoints. We used Gaussian process regression with adjustments for bias and non-sampling error to synthesise the data for under-5 mortality for each country, and a separate model to estimate mortality for more detailed age groups. We used explanatory mixed effects regression models to assess the association between under-5 mortality and income per person, maternal education, HIV child death rates, secular shifts, and other factors. To quantify the contribution of these different factors and birth numbers to the change in numbers of deaths in under-5 age groups from 1990 to 2013, we used Shapley decomposition. We used estimated rates of change between 2000 and 2013 to construct under-5 mortality rate scenarios out to 2030.

FINDINGS: We estimated that 6·3 million (95% UI 6·0-6·6) children under-5 died in 2013, a 64% reduction from 17·6 million (17·1-18·1) in 1970. In 2013, child mortality rates ranged from 152·5 per 1000 livebirths (130·6-177·4) in Guinea-Bissau to 2·3 (1·8-2·9) per 1000 in Singapore. The annualised rates of change from 1990 to 2013 ranged from -6·8% to 0·1%. 99 of 188 countries, including 43 of 48 countries in sub-Saharan Africa, had faster decreases in child mortality during 2000-13 than during 1990-2000. In 2013, neonatal deaths accounted for 41·6% of under-5 deaths compared with 37·4% in 1990. Compared with 1990, in 2013, rising numbers of births, especially in sub-Saharan Africa, led to 1·4 million more child deaths, and rising income per person and maternal education led to 0·9 million and 2·2 million fewer deaths, respectively. Changes in secular trends led to 4·2 million fewer deaths. Unexplained factors accounted for only -1% of the change in child deaths. In 30 developing countries, decreases since 2000 have been faster than predicted attributable to income, education, and secular shift alone.

INTERPRETATION: Only 27 developing countries are expected to achieve MDG 4. Decreases since 2000 in under-5 mortality rates are accelerating in many developing countries, especially in sub-Saharan Africa. The Millennium Declaration and increased development assistance for health might have been a factor in faster decreases in some developing countries. Without further accelerated progress, many countries in west and central Africa will still have high levels of under-5 mortality in 2030.

FUNDING: Bill & Melinda Gates Foundation, US Agency for International Development.

%B Lancet %V 384 %P 957-79 %8 2014 Sep 13 %G eng %N 9947 %1 http://www.ncbi.nlm.nih.gov/pubmed/24797572?dopt=Abstract %R 10.1016/S0140-6736(14)60497-9 %0 Journal Article %J Front Biosci (Landmark Ed) %D 2014 %T Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders. %A Campioni, Diana %A Voltan, Rebecca %A Tisato, Veronica %A Zauli, Giorgio %K Humans %K Immunophenotyping %K Karyotyping %K Lymphoproliferative Disorders %K Mesenchymal Stromal Cells %X

Accumulating evidence indicates that bone marrow microenvironment plays an important role in the pathogenesis of some myeloid and lymphoid hematological malignancies (HM). Among different environmental associated parameters, those related to functional, cytogenetic and immunological integrity of mesenchymal stromal cells (MSC) are particularly relevant. Functional alterations and immunophenotypic abnormalities have been described in MSC obtained from HM patients. These data seem to confirm the defective biological pattern of MSC especially in myeloid diseases, while MSC cytogenetic profile in HM is still an open question, because it is not clear whether BM stromal cells are "culprit or bystander" displaying or not an abnormal karyotype. Contradictory findings were reported in different HM but the functional implications of altered MSC karyotype need to be further addressed also in light of a clinical use of MSC. A "pathological" in vivo supportive function of endogenous MSC, which provide important survival and drug resistance signals to leukemic cells especially in lymphoproliferative disorders, is suggested. Thus, the mechanisms underlying these protective versus cytotoxic effects exerted by MSC on leukemic cells need further investigations.

%B Front Biosci (Landmark Ed) %V 19 %P 139-51 %8 2014 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/24389177?dopt=Abstract %0 Journal Article %J Genet Mol Res %D 2014 %T HLA-B35, a common genetic trait, in a familial case of Henoch-Schoenlein purpura and Berger's disease. %A Pellegrin, M C %A Matarazzo, L %A Neri, E %A Pennesi, M %A Crovella, S %K Adolescent %K Child %K Female %K Genotype %K Glomerulonephritis, IGA %K HLA-B35 Antigen %K Humans %K Male %K Middle Aged %K Nephritis %K Phenotype %K Purpura, Schoenlein-Henoch %X

Nephritis characterized by IgA mesangial depositions has been described both in Henoch-Schoenlein purpura (HSP) and in Berger's disease (BD), but common genetic traits are still uncertain. We report here the case of two brothers, the first affected by HSP with persistent nephritis and the second by BD, accidentally discovered as silent microhematuria 1 year after HSP onset in the first brother. HLA genotyping demonstrated the presence of HLA-B35 in both patients. Our findings reinforce the need to screen for urinary abnormalities in family members of patients affected by HSP nephritis to identify a silent IgA nephropathy.

%B Genet Mol Res %V 13 %P 2669-73 %8 2014 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/24782055?dopt=Abstract %R 10.4238/2014.April.8.9 %0 Journal Article %J Tissue Antigens %D 2014 %T HLA-G 14 bp deletion/insertion polymorphism and mother-to-child transmission of HIV. %A Segat, L %A Zupin, L %A Kim, H-Y %A Catamo, E %A Thea, D M %A Kankasa, C %A Aldrovandi, G M %A Kuhn, L %A Crovella, S %K Adult %K Alleles %K Base Pairing %K Child %K Genotype %K HIV Infections %K HLA-G Antigens %K Humans %K INDEL Mutation %K Infant %K Infectious Disease Transmission, Vertical %K Mothers %K Polymorphism, Genetic %K Young Adult %X

The human leukocyte antigen HLA-G, highly expressed at the maternal-fetal interface, has a pivotal role in mediating immune tolerance. In this study we investigated the influence of HLA-G 14 bp insertion polymorphism in human immunodeficiency virus (HIV)-1 mother-to-child HIV-1 transmission. The 14 bp insertion polymorphism was analyzed among 99 HIV-1 positive mothers and 329 infants born to HIV-positive mothers in Zambia, among whom vertical transmission status and timing had been determined. HLA-G 14 bp insertion polymorphism was detected using a custom TaqMan single nucleotide polymorphisms (SNPs) genotyping assay. Logistic regression was conducted to examine the associations between HLA-G alleles and the risk of HIV transmission. The 14 bp insertion allele was more frequent in HIV exposed-uninfected (EU) infants than in infected infants, and was associated with reduced risk of both in utero (IU) and intrapartum (IP) HIV transmission, after adjusting for maternal cluster of differentiation 4 (CD4) cell count and plasma viral load. Maternal HLA-G 14 bp insertion genotype and HLA-G concordance between mother and child were not associated with the risk of perinatal HIV transmission. The presence of the 14 bp insertion associates with protection toward IU and IP HIV infection in children from Zambia, suggesting that HLA-G could be involved in the vertical transmission of HIV.

%B Tissue Antigens %V 83 %P 161-7 %8 2014 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/24571474?dopt=Abstract %R 10.1111/tan.12296 %0 Journal Article %J Tissue Antigens %D 2014 %T HLA-G gene polymorphisms associated with susceptibility to rheumatoid arthritis disease and its severity in Brazilian patients. %A Catamo, E %A Addobbati, C %A Segat, L %A Sotero Fragoso, T %A Domingues Barbosa, A %A Tavares Dantas, A %A de Ataíde Mariz, H %A F da Rocha, L %A Branco Pinto Duarte, A L %A Monasta, L %A Sandrin-Garcia, P %A Crovella, S %K 3' Untranslated Regions %K 5' Flanking Region %K Aged %K Arthritis, Rheumatoid %K Brazil %K Disease Progression %K DNA Mutational Analysis %K Female %K Gene Frequency %K Genetic Association Studies %K Genetic Predisposition to Disease %K Genotype %K Haplotypes %K HLA-G Antigens %K Humans %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Risk %X

We analyzed the possible association between human leukocyte antigen-G (HLA-G) genetic variants, supposed to regulate HLA-G expression, and the susceptibility to develop rheumatoid arthritis (RA) as well as its clinical manifestations. The 5'upstream regulatory region (5'URR) and 3'untranslated region (3'UTR) regions of the HLA-G gene were screened in 127 RA patients and 128 controls: 10 5'URR and 3 3'UTR HLA-G polymorphisms as well as two haplotypes were associated with risk for RA development, while a polymorphism in the 5'URR showed an association with the degree of disease activity. These findings, although the number of cases analyzed is limited and the P-values are modest, indicate a possible association between HLA-G gene polymorphisms and susceptibility to develop RA disease and its severity.

%B Tissue Antigens %V 84 %P 308-15 %8 2014 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/24957665?dopt=Abstract %R 10.1111/tan.12396 %0 Journal Article %J J Med Virol %D 2014 %T HPV and Chlamydia trachomatis co-detection in young asymptomatic women from high incidence area for cervical cancer. %A Bellaminutti, Serena %A Seraceni, Silva %A De Seta, Francesco %A Gheit, Tarik %A Tommasino, Massimo %A Comar, Manola %K Adolescent %K Adult %K Age Factors %K Cervix Uteri %K Chlamydia Infections %K Chlamydia trachomatis %K Coinfection %K Female %K Genotype %K Humans %K Incidence %K Italy %K Middle Aged %K Papillomaviridae %K Papillomavirus Infections %K Prevalence %K Young Adult %X

Chlamydia trachomatis causing chronic inflammatory diseases has investigated as possible human papillomavirus (HPV) cofactor in cervical cancer. The aim of this study is to evaluate the prevalence of Chlamydia trachomatis and HPV co-infection in different cohorts of asymptomatic women from a Northern Italy area at high incidence for cervical cancer. Cervical samples from 441 females were collected from Cervical Cancer Screening Program, Sexually Transmitted Infectious and Assisted Reproductive Technology centres. HPV and Chlamydia trachomatis were detected simultaneously and genotyped using a highly sensitive bead based assay. The overall prevalence of Chlamydia trachomatis was estimated 9.7%, in contrast with the reported national data of 2.3%, and co-infection with HPV was diagnosed in the 17% of the samples. In females ≤ 25 years of age, the infection reached a peak of 22% and co-infection with HPV of 45.8% (P < 0.001). Of note, in young females diagnosed with low grade cervical lesions, no significant difference between Chlamydia trachomatis and HPV distribution was observed, while differently, HPV co-infection was found significantly associated to the presence of intraepithelial lesions when compared to older females (20% vs. 1%; P < 0.001). In this study, the use of a high sensitive molecular technique exhibited higher analytical sensitivity than the referred assays for the diagnosis of Chlamydia trachomatis and HPV co-infection in asymptomatic females, leading to reduction of the potential to identify incorrectly the infection status. An active screening for timely treatment of Chlamydia trachomatis infection is suggested in young females to evaluate a possible decrease in incidence of pre-cancer intraepithelial lesions.

%B J Med Virol %V 86 %P 1920-5 %8 2014 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/25132162?dopt=Abstract %R 10.1002/jmv.24041 %0 Journal Article %J Exp Biol Med (Maywood) %D 2014 %T Human recombinant lysozyme downregulates advanced glycation endproduct-induced interleukin-6 production and release in an in-vitro model of human proximal tubular epithelial cells. %A Gallo, Davide %A Cocchietto, Moreno %A Masat, Elisa %A Agostinis, Chiara %A Harei, Elisa %A Veronesi, Paolo %A Sava, Gianni %K Cell Line %K Cell Movement %K Cell Survival %K Chemokine CX3CL1 %K Diabetic Nephropathies %K Down-Regulation %K Epithelial Cells %K Glycosylation End Products, Advanced %K Humans %K Inflammation Mediators %K Interleukin-18 %K Interleukin-6 %K Kidney Tubules, Proximal %K Macrophage Activation %K Macrophages %K Muramidase %K Recombinant Proteins %K RNA, Messenger %K Tumor Necrosis Factor-alpha %K U937 Cells %X

Diabetic nephropathy is the leading cause of chronic renal disease and one of the major causes of cardiovascular mortality. Evidence suggests that its progression is due to the chronic hyperglycemia consequent to the production and accumulation of advanced glycation endproducts (AGEs). Lysozyme was shown to posses AGE-sequestering properties and the capacity to reduce the severity of the early stage manifestations of the diabetic nephropathy. This study was aimed to contribute to the understanding the molecular mechanisms of lysozyme effectiveness in the diabetic nephropathy, using an in-vitro cellular model, represented by the HK-2 cells, human proximal tubular epithelial cells. Lysozyme significantly reduced the AGE-induced IL-6 mRNA and an ELISA assay showed also a decreased release of the functional protein with a dose-dependent trend. In addition, lysozyme prevented macrophage recruitment, suggesting its capacity to elicit an anti-inflammatory action. We may conclude that the protective action of lysozyme on the nephrotoxic effects of AGE may depend, at least in part, on its ability to prevent the production and release of inflammatory mediators, such as IL-6 and to reduce macrophage recruitment in the inflammatory sites.

%B Exp Biol Med (Maywood) %V 239 %P 337-46 %8 2014 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/24495950?dopt=Abstract %R 10.1177/1535370213518281 %0 Journal Article %J Pediatr Blood Cancer %D 2014 %T In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords. %A Comar, Manola %A Delbue, Serena %A Zanotta, Nunzia %A Valencic, Erica %A Piscianz, Elisa %A Del Savio, Rossella %A Tesser, Alessandra %A Tommasini, Alberto %A Ferrante, Pasquale %K DNA, Viral %K Female %K Fetal Blood %K Humans %K JC Virus %K Male %K Mesenchymal Stromal Cells %K Polyomavirus Infections %K Simian virus 40 %K Tumor Virus Infections %X

BACKGROUND: Multipotent stromal cells are present in the Wharton's jelly matrix (WJSC) of the umbilical cord and can be used as an allogeneic source of cells to treat immunological disorders. Recently it was demonstrated that adult bone marrow (BM)-derived mesenchimal stromal cells (MSC) are susceptible to infection with viruses showing potential oncogenic properties, such as the polyomavirus JC (JCV). The aim of this study was to investigate the presence of human polyomaviruses (JCV, BK Virus-BKV, SV40, and Merkel cell polyomavirus-MCPyV) in WJSC, and explore the risk of infection.

PROCEDURE: MSC samples from 35 umbilical cords were investigated by quantitative Real Time PCRs for the presence of DNA sequences of JCV, BKV, SV40, and MCPyV.

RESULTS: JCV DNA was detected in 1/35 (2.8%) of MSC samples, while SV40 DNA was found in 3/35 (8.6%) of the examined samples. None of the samples showed sequences of BKV and MCPyV.

CONCLUSIONS: The present study demonstrates the in vivo ability of polyomaviruses to infect WJSC. Since the therapeutic approach with the WJSC has high potentiality and a more intensive use can be easily hypothesized, the need to develop consensus guidelines to detect rare viral infections in MSC is pressing.

%B Pediatr Blood Cancer %V 61 %P 1347-9 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24623583?dopt=Abstract %R 10.1002/pbc.24943 %0 Journal Article %J PLoS One %D 2014 %T Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area. %A Comar, Manola %A Zanotta, Nunzia %A Bonotti, Alessandra %A Tognon, Mauro %A Negro, Corrado %A Cristaudo, Alfonso %A Bovenzi, Massimo %K Aged %K Aged, 80 and over %K Asbestos %K Biomarkers, Tumor %K Case-Control Studies %K Chemokine CCL5 %K Cytokines %K Endemic Diseases %K Gene Expression %K Gene Expression Profiling %K Humans %K Lung Neoplasms %K Mesothelioma %K Middle Aged %K Occupational Exposure %K Simian virus 40 %K Viral Proteins %X

BACKGROUND: Asbestos-induced mesothelial inflammatory processes are thought to be the basic mechanisms underlying Malignant Mesothelioma (MM) development. Detection of MM often occurs at late stage due to the long and unpredictable latent period and the low incidence in asbestos exposed individuals. The aim of this study was to investigate early immunological biomarkers to characterize the prognostic profile of a possible asbestos-induced disease, in subjects from a MM hyperendemic area.

METHODS: The Luminex Multiplex Panel Technology was used for the simultaneous measurement of serum levels of a large panel of 47 analytes, including cytokines and growth factors, from workers previously exposed to asbestos (Asb-workers), asbestos-induced MM patients and healthy subjects. In addition, to explore the influence on serum cytokines profile exerted by SV40 infection, a cofactor in MM development, a quantitative real time PCR was performed for sequences detection in the N-terminal and intronic regions of the SV40 Tag gene. Statistical analysis was done by means of the Mann-Whitney test and the Kruskall-Wallis test for variance analysis.

RESULTS: A variety of 25 cytokines linked to pulmonary inflammation and tumor development were found significantly associated with Asb-workers and MM patients compared with healthy controls. A specific pattern of cytokines were found highly expressed in Asb-workers: IFN-alpha (p<0.05), EOTAXIN (p<0.01), RANTES (p<0.001), and in MM patients: IL-12(p40), IL-3, IL-1 alpha, MCP-3, beta-NGF, TNF-beta, RANTES (p<0.001). Notably, the chemokine RANTES measured the highest serum level showing an increased gradient of concentration from healthy subjects to Asb-workers and MM patients (p<0.001), independently of SV40 infection.

CONCLUSION: This study shows that, in subjects from an hyperendemic area for MM, the C-C chemokine RANTES is associated with the exposure to asbestos fibres. If validated in larger samples, this factor could have the potential to be a critical biomarker for MM prognosis as recently reported for breast tumor.

%B PLoS One %V 9 %P e104848 %8 2014 %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/25162674?dopt=Abstract %R 10.1371/journal.pone.0104848 %0 Journal Article %J Infect Genet Evol %D 2014 %T Influence of HLA-G polymorphisms in human immunodeficiency virus infection and hepatitis C virus co-infection in Brazilian and Italian individuals. %A da Silva, G K %A Vianna, Priscila %A Veit, Tiago Degani %A Crovella, Sergio %A Catamo, Eulalia %A Cordero, Elvira Alicia Aparicio %A Mattevi, Vanessa Suñé %A Lazzaretti, Rosmeri Kuhmmer %A Sprinz, Eduardo %A Kuhmmer, Regina %A Chies, José Artur Bogo %K 3' Untranslated Regions %K Adolescent %K Adult %K African Continental Ancestry Group %K Aged %K Brazil %K Coinfection %K Gene Frequency %K Genetic Variation %K Haplotypes %K Hepatitis C %K HIV Infections %K HLA-G Antigens %K Humans %K Italy %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Young Adult %X

OBJECTIVE: This study aimed to investigate the role of Human Leukocyte Antigen (HLA)-G in the susceptibility to HIV-1 infection through the analysis of the HLA-G 3' untranslated region (UTR) polymorphisms 14 bp insertion/deletion (rs66554220) and +3142C>G (rs1063320).

DESIGN: We analyzed 582 HIV-1 infected patients and 626 uninfected individuals from Brazil and Italy in a case-control study.

METHODS: HLA-G polymorphisms were genotyped using PCR, PCR-RFLP assays or direct sequencing. All analyses were stratified by ethnicity. Genotypic, allelic and diplotypic frequencies were compared between HIV-1 infected subjects and controls using Chi-square or Fischer exact tests. Also, haplotypic frequencies were estimated using MLocus software.

RESULTS: African-derived HIV-infected individuals presented a higher frequency of the 14 bp insertion allele as compared to non-infected individuals (0.468 versus 0.373, respectively; p(Bonf) = 0.010). A higher frequency of the 14 bp insertion +3142G (insG) haplotype (0.456 versus 0.346, p<0.001) and the insG/insG diplotype (OR=1.88, 95%CI = 1.08-3.23, p=0.021) was observed among African-derived patients as compared to uninfected controls. Also, we observed a higher frequency of the ins/ins genotype among African-derived HIV patients co-infected with HCV (OR=2.78, 95%CI = 1.20-6.49, p = 0.008).

CONCLUSIONS: Our data point out to an increased frequency of alleles and genotypes associated with low HLA-G expression among African-derived patients, suggesting a potential role for HLA-G in the susceptibility to HIV-1 infection and HCV co-infection in those individuals.

%B Infect Genet Evol %V 21 %P 418-23 %8 2014 Jan %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/24389119?dopt=Abstract %R 10.1016/j.meegid.2013.12.013 %0 Journal Article %J Stem Cell Res Ther %D 2014 %T Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. %A Valencic, Erica %A Loganes, Claudia %A Cesana, Stefania %A Piscianz, Elisa %A Gaipa, Giuseppe %A Biagi, Ettore %A Tommasini, Alberto %K CD4-Positive T-Lymphocytes %K CD8-Positive T-Lymphocytes %K Cell Proliferation %K Cell Survival %K Cells, Cultured %K Coculture Techniques %K Culture Media, Conditioned %K Cytokines %K Humans %K Killer Cells, Natural %K Lymphocyte Activation %K Mesenchymal Stromal Cells %X

INTRODUCTION: Despite having a proven immunosuppressive potential in vitro, human mesenchymal stromal cells (MSCs) are reported to display variable efficacy in vivo and, in fact, their proven benefit in the clinical practice is still limited and controversial.

METHODS: The interplay between clinical grade MSCs and pre-activated donor lymphocytes or selected lymphocyte subsets was studied in vitro. The kinetics of MSC growth and viability was evaluated by adhesion-dependent changes of culture plate impedance and biochemically by a colorimetric assay. Activation of natural killer (NK) cells was assessed as well, using a flow cytometry assay.

RESULTS: A strong inhibition of MSC growth was rapidly induced by the addition of pre-activated lymphocytes but not of resting lymphocytes. Inhibition seems not to be attributable to a single cell population, as similar results can be obtained by depleting NK cells or by using either selected CD4+ or CD8+ lymphocytes. In addition, conditioned medium (CM) from activated lymphocytes was able to inhibit MSC growth in a dose-dependent manner. Furthermore, licensing with IFN-γ partially protected MSCs from pre-activated lymphocytes but not from their CM. These results suggest an inhibitory role of lymphocyte-activation-derived substances. However, the identification of a single molecule responsible for MSC inhibition remained elusive, even if preliminary experiments showed that ATP and, to a lesser extent, TNF-α might play a role.

CONCLUSIONS: These results suggest that survival of MSCs can be affected by soluble mediators released by activated lymphocytes. Thus it can be hypothesized that MSC immunosuppressive action in vivo could be impaired by ongoing immune activation through the release of inflammatory mediators.

%B Stem Cell Res Ther %V 5 %P 3 %8 2014 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24405828?dopt=Abstract %R 10.1186/scrt392 %0 Journal Article %J Hum Immunol %D 2014 %T Interleukin-10 gene promoter polymorphisms in celiac patients from north-eastern Italy. %A Zupin, Luisa %A Polesello, Vania %A Catamo, Eulalia %A Crovella, Sergio %A Segat, Ludovica %K Adolescent %K Adult %K Aged %K Aged, 80 and over %K Alleles %K Case-Control Studies %K Celiac Disease %K Child %K Child, Preschool %K European Continental Ancestry Group %K Female %K Gene Frequency %K HLA-DQ Antigens %K Humans %K Interleukin-10 %K Italy %K Male %K Middle Aged %K Models, Genetic %K Polymorphism, Single Nucleotide %K Promoter Regions, Genetic %K Risk Factors %K Sex Factors %X

Celiac disease is a complex chronic intestinal disorder driven by an immune response against the gliadin fraction of gluten: many factors are involved in the pathogenesis of the disease, and among these Interleukin-10 could play an important role. In the present study, the -1082A>G, -819T>C and -592A>C IL10 functional polymorphisms were analyzed in 565 celiac patients and 576 healthy controls from north-eastern Italy, stratified for HLA class II celiac disease risk haplotypes. No significant differences were observed for the three IL10 polymorphisms distribution between celiac patients and controls with the exception of a slightly increased risk for the -1082A allele in HLA-DQ8 male individuals. Although our findings suggest that the IL10 genetic variants analyzed do not have a major role in the susceptibility to the development of celiac disease in north-eastern Italian patients, we think that the possible involvement of IL10 gene in CD should deserve further investigation and that large-scale studies are recommended to confirm our findings.

%B Hum Immunol %V 75 %P 656-61 %8 2014 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/24768947?dopt=Abstract %R 10.1016/j.humimm.2014.04.011 %0 Journal Article %J J Clin Endocrinol Metab %D 2014 %T Inverse correlation between circulating levels of TNF-related apoptosis-inducing ligand and 17β-estradiol. %A Zauli, Giorgio %A Tisato, Veronica %A Melloni, Elisabetta %A Volpato, Stefano %A Cervellati, Carlo %A Bonaccorsi, Gloria %A Radillo, Oriano %A Marci, Roberto %A Secchiero, Paola %K Adult %K Aged %K Case-Control Studies %K Child %K Child, Preschool %K Estradiol %K Female %K Humans %K Infant %K Male %K Middle Aged %K Pregnancy %K Sex Factors %K TNF-Related Apoptosis-Inducing Ligand %K Young Adult %X

CONTEXT: The regulation of the circulating levels of TNF-related apoptosis-inducing ligand (TRAIL), a cytokine of the TNF family, playing a key role in the immune surveillance against cancer, is incompletely understood.

OBJECTIVE: The objective of the study was to investigate the potential link between TRAIL and 17β-estradiol.

DESIGN, SETTING, AND PARTICIPANTS: Circulating TRAIL levels were measured by an ELISA in plasma samples (n = 246) of healthy, age-matched (range 30-70 y) men and women and in the sera (n = 180) of females belonging to different physiopathological conditions (childhood, pregnancy, under gonadotropin treatment, menopause) characterized by different levels of circulating 17β-estradiol.

RESULTS: TRAIL plasma levels in women with aged younger than 50 years were significantly lower compared with age-matched men, whereas in woman 50 years old or older, TRAIL levels were significantly higher compared with the age-matched men and with the younger women. Moreover, an analysis of women with different conditions revealed a significant inverse correlation between the serum levels of TRAIL and 17β-estradiol, with the lowest levels of TRAIL being observed during pregnancy and the highest in childhood and in postmenopausal women. Moreover, gonadotropin treatment in women undergoing assisted reproduction was accompanied by an acute decrease of serum TRAIL levels. Finally, in vitro treatment with 17β-estradiol decreased the TRAIL expression levels in peripheral blood mononuclear cells.

CONCLUSIONS: Our data suggest that 17β-estradiol plays a role in regulating TRAIL circulating levels. The demonstration that postmenopausal women exhibit the highest TRAIL levels is of particular interest in light of a previous large study population showing that TRAIL is positively correlated to the overall survival.

%B J Clin Endocrinol Metab %V 99 %P E659-64 %8 2014 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/24446659?dopt=Abstract %R 10.1210/jc.2013-4193 %0 Journal Article %J Exp Ther Med %D 2014 %T Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease. %A Celeghini, Claudio %A Not, Tarcisio %A Norcio, Alessia %A Monasta, Lorenzo %A Secchiero, Paola %X

It has previously been demonstrated that the circulating levels of TNF-related apoptosis-inducing ligand (TRAIL) are significantly lower in patients with type 1 diabetes (T1D) than in normal age- and gender-matched controls. Since celiac disease (CD) is often associated with T1D, a retrospective study was performed to analyze the sera of a cohort of pediatric subjects: i) patients with CD at onset (n=100); ii) patients with potential CD (n=45); iii) patients with CD associated with other auto-immune diseases (n=17); and iv) patients with eosinophilic esophagitis (n=15). Among the patients with CD, 49 were also analyzed after six months on a gluten-free diet, while data were also available for 13 patients after one year on a gluten-free diet. No significant differences were found in the circulating levels of TRAIL between the patients with CD and the patients with either eosinophilic esophagitis or potential CD. Patients with CD associated with other auto-immune diseases showed significantly lower levels of TRAIL when compared with patients with CD alone. The gluten-free diet did not significantly modify the levels of circulating TRAIL at 6 or 12 months. Thus, although T1D and CD share common immunological features, the circulating levels of TRAIL show a significant difference between the two pathologies, and do not appear to be modulated in CD.

%B Exp Ther Med %V 8 %P 1906-1908 %8 2014 Dec %G ENG %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/25371753?dopt=Abstract %R 10.3892/etm.2014.2026 %0 Journal Article %J Mol Biol Rep %D 2014 %T LIG4 and RAD52 DNA repair genes polymorphisms and systemic lupus erythematosus. %A De Azevêdo Silva, Jaqueline %A Pancotto, João Alexandre Trés %A Donadi, Eduardo Antônio %A Crovella, Sergio %A Sandrin-Garcia, Paula %K Adult %K Alleles %K Brazil %K Case-Control Studies %K DNA Ligases %K DNA Repair %K Ethnic Groups %K Female %K Genetic Linkage %K Genetic Predisposition to Disease %K Genotype %K Haplotypes %K Humans %K Lupus Erythematosus, Systemic %K Male %K Middle Aged %K Odds Ratio %K Polymorphism, Single Nucleotide %K Rad52 DNA Repair and Recombination Protein %X

Systemic lupus erythematosus (SLE) is a complex autoimmune disorder with a strong genetic background. Nevertheless, SLE might also be triggered due to environmental factors, such as UV light exposure. DNA double strand breaks (DSBs) may be induced secondarily by UV radiation, increasing DNA immunogenicity and in SLE patients DNA repair is diminished, allowing the accumulation of DSBs and genomic instability. LIG4 and RAD52 genes play important roles in DNA repair mechanisms and a recent microarray analysis showed their differential expression in active SLE patients. In this study we investigated a potential association between LIG4 and RAD52 single nucleotide polymorphisms (SNPs) and SLE predisposition in a Southeast Brazilian population. We assessed four Tag SNPs in LIG4 and three in RAD52 gene region, encompassing most of the gene sequence, in 158 SLE patients and 212 healthy controls. We also performed SNPs analysis considering clinical manifestation, gender and ethnicity in SLE patients. Our data did not show association between LIG4 and RAD52 SNPs and SLE, its clinical manifestations or ethnicity in the tested population. The analysis regarding ethnicity and SLE clinical manifestations indicated Caucasian-derived patients as more susceptible to cutaneous and hematological alterations than the African-derived. To our knowledge, this is the first association study involving LIG4 and RAD52 genes and SLE predisposition.

%B Mol Biol Rep %V 41 %P 2249-56 %8 2014 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/24415301?dopt=Abstract %R 10.1007/s11033-014-3076-y %0 Journal Article %J Eur J Paediatr Neurol %D 2014 %T Long-term follow-up in children with benign convulsions associated with gastroenteritis. %A Verrotti, Alberto %A Moavero, Romina %A Vigevano, Federico %A Cantonetti, Laura %A Guerra, Azzurra %A Spezia, Elisabetta %A Tricarico, Antonella %A Nanni, Giuliana %A Agostinelli, Sergio %A Chiarelli, Francesco %A Parisi, Pasquale %A Capovilla, Giuseppe %A Beccaria, Francesca %A Spalice, Alberto %A Coppola, Giangennaro %A Franzoni, Emilio %A Gentile, Valentina %A Casellato, Susanna %A Veggiotti, Pierangelo %A Malgesini, Sara %A Crichiutti, Giovanni %A Balestri, Paolo %A Grosso, Salvatore %A Zamponi, Nelia %A Incorpora, Gemma %A Savasta, Salvatore %A Costa, Paola %A Pruna, Dario %A Cusmai, Raffaella %K Adolescent %K Anticonvulsants %K Attention Deficit Disorder with Hyperactivity %K Child %K Child, Preschool %K Electroencephalography %K Epilepsy %K Female %K Gastroenteritis %K Humans %K Longitudinal Studies %K Male %K Neurologic Examination %K Retrospective Studies %X

BACKGROUND: The outcome of benign convulsions associated with gastroenteritis (CwG) has generally been reported as being excellent. However, these data need to be confirmed in studies with longer follow-up evaluations.

AIM: To assess the long-term neurological outcome of a large sample of children presenting with CwG.

METHODS: We reviewed clinical features of 81 subjects presenting with CwG (1994-2010) from three different Italian centers with a follow-up period of at least 3 years.

RESULTS: Follow-up period ranged from 39 months to 15 years (mean 9.8 years). Neurological examination and cognitive level at the last evaluation were normal in all the patients. A mild attention deficit was detected in three cases (3.7%). Fourteen children (17.3%) received chronic anti-epileptic therapy. Interictal EEG abnormalities detected at onset in 20 patients (24.7%) reverted to normal. Transient EEG epileptiform abnormalities were detected in other three cases (3.7%), and a transient photosensitivity in one (1.2%). No recurrence of CwG was observed. Three patients (3.7%) presented with a febrile seizure and two (2.5%) with an unprovoked seizure, but none developed epilepsy.

CONCLUSIONS: The long-term evaluation of children with CwG confirms the excellent prognosis of this condition, with normal psychomotor development and low risk of relapse and of subsequent epilepsy.

%B Eur J Paediatr Neurol %V 18 %P 572-7 %8 2014 Sep %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/24780603?dopt=Abstract %R 10.1016/j.ejpn.2014.04.006 %0 Journal Article %J Gut %D 2014 %T Mevalonate kinase deficiency and IBD: shared genetic background. %A Bianco, Anna Monica %A Girardelli, Martina %A Vozzi, Diego %A Crovella, Sergio %A Kleiner, Giulio %A Marcuzzi, Annalisa %K Genetic Predisposition to Disease %K Humans %K Inflammatory Bowel Diseases %B Gut %V 63 %P 1367-8 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24531851?dopt=Abstract %R 10.1136/gutjnl-2013-306555 %0 Journal Article %J Haematologica %D 2014 %T Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology. %A De Rocco, Daniela %A Bottega, Roberta %A Cappelli, Enrico %A Cavani, Simona %A Criscuolo, Maria %A Nicchia, Elena %A Corsolini, Fabio %A Greco, Chiara %A Borriello, Adriana %A Svahn, Johanna %A Pillon, Marta %A Mecucci, Cristina %A Casazza, Gabriella %A Verzegnassi, Federico %A Cugno, Chiara %A Locasciulli, Anna %A Farruggia, Piero %A Longoni, Daniela %A Ramenghi, Ugo %A Barberi, Walter %A Tucci, Fabio %A Perrotta, Silverio %A Grammatico, Paola %A Hanenberg, Helmut %A Della Ragione, Fulvio %A Dufour, Carlo %A Savoia, Anna %K Amino Acid Substitution %K Cell Line %K Cohort Studies %K Computational Biology %K Databases, Nucleic Acid %K Fanconi Anemia %K Fanconi Anemia Complementation Group Proteins %K Founder Effect %K Genotype %K Humans %K Italy %K Mosaicism %K Mutation %K Polymorphism, Single Nucleotide %X

Fanconi anemia is an inherited disease characterized by congenital malformations, pancytopenia, cancer predisposition, and sensitivity to cross-linking agents. The molecular diagnosis of Fanconi anemia is relatively complex for several aspects including genetic heterogeneity with mutations in at least 16 different genes. In this paper, we report the mutations identified in 100 unrelated probands enrolled into the National Network of the Italian Association of Pediatric Hematoly and Oncology. In approximately half of these cases, mutational screening was carried out after retroviral complementation analyses or protein analysis. In the other half, the analysis was performed on the most frequently mutated genes or using a next generation sequencing approach. We identified 108 distinct variants of the FANCA, FANCG, FANCC, FANCD2, and FANCB genes in 85, 9, 3, 2, and 1 families, respectively. Despite the relatively high number of private mutations, 45 of which are novel Fanconi anemia alleles, 26% of the FANCA alleles are due to 5 distinct mutations. Most of the mutations are large genomic deletions and nonsense or frameshift mutations, although we identified a series of missense mutations, whose pathogenetic role was not always certain. The molecular diagnosis of Fanconi anemia is still a tiered procedure that requires identifying candidate genes to avoid useless sequencing. Introduction of next generation sequencing strategies will greatly improve the diagnostic process, allowing a rapid analysis of all the genes.

%B Haematologica %V 99 %P 1022-31 %8 2014 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/24584348?dopt=Abstract %R 10.3324/haematol.2014.104224 %0 Journal Article %J J Pediatr Gastroenterol Nutr %D 2014 %T Multiple Ileo-Ileal Intussusceptions Caused by Eosinophilic Enteropathy. %A Bramuzzo, Matteo %A Martelossi, Stefano %A Villanacci, Vincenzo %A Maschio, Massimo %A Costa, Stefano %A Ventura, Alessandro %B J Pediatr Gastroenterol Nutr %8 2014 Jul 2 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/25000350?dopt=Abstract %R 10.1097/MPG.0000000000000479 %0 Journal Article %J Biochim Biophys Acta %D 2014 %T Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics. %A De Rocco, Daniela %A Cerqua, Cristina %A Goffrini, Paola %A Russo, Giovanna %A Pastore, Annalisa %A Meloni, Francesca %A Nicchia, Elena %A Moraes, Carlos T %A Pecci, Alessandro %A Salviati, Leonardo %A Savoia, Anna %K Amino Acid Sequence %K Animals %K Apoptosis %K Base Sequence %K Cells, Cultured %K Child, Preschool %K Cytochromes c %K DNA Mutational Analysis %K Embryo, Mammalian %K Energy Metabolism %K Family Health %K Female %K Fibroblasts %K Humans %K Lung %K Male %K Mice %K Molecular Sequence Data %K Mutation, Missense %K Oxygen Consumption %K Pedigree %K Saccharomyces cerevisiae %K Sequence Homology, Amino Acid %K Thrombocytopenia %X

Inherited thrombocytopenias are heterogeneous diseases caused by at least 20 genes playing different role in the processes of megakaryopoiesis and platelet production. Some forms, such as thrombocytopenia 4 (THC4), are very rare and not well characterized. THC4 is an autosomal dominant mild thrombocytopenia described in only one large family from New Zealand and due to a mutation (G41S) of the somatic isoform of the cytochrome c (CYCS) gene. We report a novel CYCS mutation (Y48H) in patients from an Italian family. Similar to individuals carrying G41S, they have platelets of normal size and morphology, which are only partially reduced in number, but no prolonged bleeding episodes. In order to determine the pathogenetic consequences of Y48H, we studied the effects of the two CYCS mutations in yeast and mouse cellular models. In both cases, we found reduction of respiratory level and increased apoptotic rate, supporting the pathogenetic role of CYCS in thrombocytopenia.

%B Biochim Biophys Acta %V 1842 %P 269-74 %8 2014 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/24326104?dopt=Abstract %R 10.1016/j.bbadis.2013.12.002 %0 Journal Article %J Arch Dis Child Fetal Neonatal Ed %D 2014 %T A neonate with a 'milky' blood. What can it be? %A Bordugo, Andrea %A Carlin, Eva %A Demarini, Sergio %A Faletra, Flavio %A Colonna, Franco %K Female %K Humans %K Hyperlipoproteinemia Type IV %K Infant, Newborn %K Lipoprotein Lipase %K Milk Proteins %K Mutation %B Arch Dis Child Fetal Neonatal Ed %V 99 %P F514 %8 2014 Nov %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/24747307?dopt=Abstract %R 10.1136/archdischild-2014-305940 %0 Journal Article %J PLoS One %D 2014 %T Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in Italy. %A Comar, Manola %A Wong, Connie %A Tognon, Mauro %A Butel, Janet S %X

OBJECTIVE: Polyomavirus simian virus 40 (SV40) sequences have been detected in various human specimens and SV40 antibodies have been found in human sera from both healthy individuals and cancer patients. This study analyzed serum samples from healthy pregnant women as well as cord blood samples to determine the prevalence of SV40 antibodies in pregnancy.

METHODS: Serum samples were collected at the time of delivery from two groups of pregnant women as well as cord bloods from one group. The women were born between 1967 and 1993. Samples were assayed by two different serological methods, one group by neutralization of viral infectivity and the other by indirect ELISA employing specific SV40 mimotopes as antigens. Viral DNA assays by real-time polymerase chain reaction were carried out on blood samples.

RESULTS: Neutralization and ELISA tests indicated that the pregnant women were SV40 antibody-positive with overall prevalences of 10.6% (13/123) and 12.7% (14/110), respectively. SV40 neutralizing antibodies were detected in a low number of cord blood samples. Antibody titers were generally low. No viral DNA was detected in either maternal or cord bloods.

CONCLUSIONS: SV40-specific serum antibodies were detected in pregnant women at the time of delivery and in cord bloods. There was no evidence of transplacental transmission of SV40. These data indicate that SV40 is circulating at a low prevalence in the northern Italian population long after the use of contaminated vaccines.

%B PLoS One %V 9 %P e110700 %8 2014 %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/25335106?dopt=Abstract %R 10.1371/journal.pone.0110700 %0 Journal Article %J Cell Mol Life Sci %D 2014 %T NF-κB pathways in hematological malignancies. %A Gasparini, Chiara %A Celeghini, Claudio %A Monasta, Lorenzo %A Zauli, Giorgio %K Antineoplastic Agents %K B-Lymphocytes %K Carcinogenesis %K Dendritic Cells %K Gene Expression Regulation, Neoplastic %K Hematologic Neoplasms %K Humans %K Imidazoles %K Macrophages %K NF-kappa B %K Piperazines %K Signal Transduction %K T-Lymphocytes %K TNF-Related Apoptosis-Inducing Ligand %K Transcription Factor RelA %K Transcription Factor RelB %K Tumor Suppressor Protein p53 %X

The nuclear factor κB or NF-κB transcription factor family plays a key role in several cellular functions, i.e. inflammation, apoptosis, cell survival, proliferation, angiogenesis, and innate and acquired immunity. The constitutive activation of NF-κB is typical of most malignancies and plays a major role in tumorigenesis. In this review, we describe NF-κB and its two pathways: the canonical pathway (RelA/p50) and the non-canonical pathway (RelB/p50 or RelB/p52). We then consider the role of the NF-κB subunits in the development and functional activity of B cells, T cells, macrophages and dendritic cells, which are the targets of hematological malignancies. The relevance of the two pathways is described in normal B and T cells and in hematological malignancies, acute and chronic leukemias (ALL, AML, CLL, CML), B lymphomas (DLBCLs, Hodgkin's lymphoma), T lymphomas (ATLL, ALCL) and multiple myeloma. We describe the interaction of NF-κB with the apoptotic pathways induced by TRAIL and the transcription factor p53. Finally, we discuss therapeutic anti-tumoral approaches as mono-therapies or combination therapies aimed to block NF-κB activity and to induce apoptosis (PARAs and Nutlin-3).

%B Cell Mol Life Sci %V 71 %P 2083-102 %8 2014 Jun %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/24419302?dopt=Abstract %R 10.1007/s00018-013-1545-4 %0 Journal Article %J Mem Inst Oswaldo Cruz %D 2014 %T NLRP3 polymorphism is associated with protection against human T-lymphotropic virus 1 infection. %A Kamada, Anselmo Jiro %A Pontillo, Alessandra %A Guimarães, Rafael Lima %A Loureiro, Paula %A Crovella, Sergio %A Brandão, Lucas André Cavalcanti %K Adult %K Brazil %K Carrier Proteins %K Female %K Genetic Predisposition to Disease %K HTLV-I Infections %K Human T-lymphotropic virus 1 %K Humans %K Inflammasomes %K Interleukin-1 %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Protective Factors %X

Inter-individual heterogeneity in the response to human T-lymphotropic virus 1 (HTLV-1) infection has been partially attributed to host genetic background. The antiviral activity of the inflammasome cytoplasmic complex recognises viral molecular patterns and regulates immune responses via the activation of interleukin (IL)-1 family (IL-1, IL-18 and IL-33) members. The association between polymorphisms in the inflammasome receptors NLRP1 and NLRP3 and HTLV-1 infection was evaluated in a northeastern Brazilian population (84 HTLV-1 carriers and 155 healthy controls). NLRP3 rs10754558 G/G was associated with protection against HTLV-1 infection (p = 0.012; odds ratio = 0.37). rs10754558 affects NLRP3 mRNA stability; therefore, our results suggest that higher NLRP3 expression may augment first-line defences, leading to the effective protection against HTLV-1 infection.

%B Mem Inst Oswaldo Cruz %V 109 %P 960-3 %8 2014 Nov %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/25411003?dopt=Abstract %0 Journal Article %J J Med Virol %D 2014 %T No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV. %A Comar, Manola %A Zanotta, Nunzia %A Del Savio, Rossella %A Vascotto, Fulvia %A Calabrese, Nadia %A Zorat, Francesca %A Pozzato, Gabriele %K Adult %K Base Sequence %K Cryoglobulinemia %K DNA, Viral %K Epstein-Barr Virus Infections %K Female %K Hepacivirus %K Hepatitis C, Chronic %K Herpesvirus 4, Human %K Humans %K Italy %K Leukemia, B-Cell %K Male %K Middle Aged %K Polyomavirus %K Polyomavirus Infections %K Sequence Analysis, DNA %K Vaginal Smears %K Young Adult %X

Mixed cryoglobulinemia is a lymphoproliferative disorder associated with hepatitis C virus (HCV). In patients chronically affected by HCV the prevalence of mixed cryoglobulinemia is variable ranging from 0% to 56%. To verify whether polyomaviruses (PyV) play a role in this disorder a total of 222 blood samples from 63 HCV chronic patients, 43 with mixed cryoglobulinemia, 59 chronic lymphocytic leukemia, 50 polytransfused patients, and 50 blood donors were evaluated for Merkel (MCPyV), BKV, JCV, and SV40. EBV was additionally included in the analysis since association with this disorder has been reported. Mixed cryoglobulinemia patients infected chronically with HCV resulted negative for both PyV and EBV. MCPyV was found in 1 subject with Merkel Cell Carcinoma, in 10% of polytransfused and in 10% of blood donors while EBV was detected in 22% of polytransfused, 10% of B-cell lymphatic leukemia patients and 4% of blood donors (P < 0.01). Taken together, the absence of PyV and EBV in HCV-mixed cryoglobulinemia patients seems to exclude a direct involvement of these viruses in the pathogenesis of this disease while the presence of MCPyV in healthy individuals, at the same rate as in polytransfused patients, may reinforce data on a minimal role of this virus in other human pathologies.

%B J Med Virol %V 86 %P 666-71 %8 2014 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/24374940?dopt=Abstract %R 10.1002/jmv.23867 %0 Journal Article %J Hum Immunol %D 2014 %T Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic viral infections and in hepatocellular carcinoma. %A Catamo, Eulalia %A Zupin, Luisa %A Crovella, Sergio %A Celsi, Fulvio %A Segat, Ludovica %K Carcinoma, Hepatocellular %K Female %K Genetic Predisposition to Disease %K Hepatitis B %K Hepatitis C %K HLA-G Antigens %K Humans %K Immune Tolerance %K Liver Neoplasms %K Polymorphism, Genetic %K Pregnancy %X

The human leukocyte antigen (HLA)-G is a "nonclassical" major histocompatibility complex (MHC) class Ib gene, located at chromosome 6, in the 6p21.3 region. The HLA-G presents immunomodulatory functions essential in pregnancy for the tolerance of the semi-allogenic fetus, but an abnormal expression of HLA-G has been observed in numerous pathological conditions, such as tumors, autoimmune diseases and viral infections. In recent years, numerous studies have assessed the clinical relevance of HLA-G expression in different types of cancer: in general, a higher HLA-G expression correlates with a lower survival rate or a shorter disease-free survival. Altered expression of HLA-G has been found in both HCV and HBV infection, and some genetic polymorphisms have been associated with altered susceptibility/disease development for these infections, however, whether the biologic role of HLA-G in HCV and HBV infection is beneficial or hazardous, it is not completely clear. In the context of hepatocellular carcinoma, HLA-G has shown a potential diagnostic role, moreover a prognostic value in HCC patients has been also attributed to HLA-G molecules. We revise here the role of HLA-G in hepatotropic HBV/HCV infections and in hepatocellular carcinoma (HCC).

%B Hum Immunol %V 75 %P 1225-31 %8 2014 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/25318079?dopt=Abstract %R 10.1016/j.humimm.2014.09.019 %0 Journal Article %J Int J Mol Sci %D 2014 %T Novel missense mutation in the NOD2 gene in a patient with early onset ulcerative colitis: causal or chance association? %A Girardelli, Martina %A Vuch, Josef %A Tommasini, Alberto %A Crovella, Sergio %A Bianco, Anna Monica %K Age of Onset %K Amino Acid Sequence %K Base Sequence %K Child %K Colitis, Ulcerative %K Crohn Disease %K DNA Mutational Analysis %K Genetic Predisposition to Disease %K Genotype %K Humans %K Interleukin-10 Receptor alpha Subunit %K Interleukin-10 Receptor beta Subunit %K Molecular Sequence Data %K Mutation, Missense %K Nod2 Signaling Adaptor Protein %K Polymorphism, Single Nucleotide %K Risk Factors %K Sequence Homology, Amino Acid %X

Deregulated immune response to gut microflora in genetically predisposed individuals is typical for inflammatory bowel diseases. It is reasonable to assume that genetic association with the disease will be more pronounced in subjects with early onset than adult onset. The nucleotide-binding oligomerization domain containing-2 gene, commonly involved in multifactorial risk of Crohn's disease, and interleukin 10 receptor genes, associated with rare forms of early onset inflammatory bowel diseases, were sequenced in an early onset patient. We identified a novel variant in the NOD2 gene (c.2857A > G p.K953E) and two already described missense variants in the IL10RA gene (S159G and G351R). The new NOD2 missense variant was examined in silico with two online bioinformatics tools to predict the potentially deleterious effects of the mutation. Although cumulative effect of these variations in the early onset of the disease can be only hypothesized, we demonstrated that family information and in silico studies can be used to predict association with the disease.

%B Int J Mol Sci %V 15 %P 3834-41 %8 2014 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/24595243?dopt=Abstract %R 10.3390/ijms15033834 %0 Journal Article %J Mol Cell Endocrinol %D 2014 %T Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes. %A Bernardi, Stella %A Fabris, Bruno %A Thomas, Merlin %A Toffoli, Barbara %A Tikellis, Christos %A Candido, Riccardo %A Catena, Cristiana %A Mulatero, Paolo %A Barbone, Fabio %A Radillo, Oriano %A Zauli, Giorgio %A Secchiero, Paola %K Adipose Tissue %K Adult %K Animals %K Blood Glucose %K Body Mass Index %K C-Reactive Protein %K Case-Control Studies %K Cholesterol, HDL %K Cholesterol, LDL %K Diet, High-Fat %K Female %K Humans %K Inflammation %K Insulin %K Insulin Resistance %K Male %K Metabolic Syndrome X %K Mice %K Mice, Inbred C57BL %K Middle Aged %K Obesity %K Osteoprotegerin %K Triglycerides %X

BACKGROUND: Inflammation is believed to link obesity to insulin resistance, as in the setting of metabolic syndrome (MetS). Osteoprotegerin (OPG) is a soluble protein that seems to exert proatherogenic and prodiabetogenic effects. This study aims at determining OPG levels in MetS and whether OPG might contribute to MetS development and progression.

METHODOLOGY/PRINCIPAL FINDINGS: Circulating OPG was measured in 46 patients with MetS and 63 controls, and was found significantly elevated in those with MetS. In addition, circulating and tissue OPG was significantly increased in high-fat diet (HFD) fed C57BL6 mice, which is one of the animal models for the study of MetS. To evaluate the consequences of OPG elevation, we delivered this protein to C57BL6 mice, finding that it promoted systemic and adipose tissue proinflammatory changes in association with metabolic abnormalities.

CONCLUSIONS/SIGNIFICANCE: These data suggest that OPG may trigger adipose tissue proinflammatory changes in MetS/HFD-induced obesity.

%B Mol Cell Endocrinol %V 394 %P 13-20 %8 2014 Aug 25 %G eng %N 1-2 %1 http://www.ncbi.nlm.nih.gov/pubmed/24998520?dopt=Abstract %R 10.1016/j.mce.2014.06.004 %0 Journal Article %J Oncotarget %D 2014 %T The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias. %A Athanasakis, Emmanouil %A Melloni, Elisabetta %A Rigolin, Gian Matteo %A Agnoletto, Chiara %A Voltan, Rebecca %A Vozzi, Diego %A Piscianz, Elisa %A Segat, Ludovica %A dal Monego, Simeone %A Cuneo, Antonio %A Secchiero, Paola %A Zauli, Giorgio %K Aged %K Aged, 80 and over %K Ataxia Telangiectasia Mutated Proteins %K Base Sequence %K Female %K Genes, p53 %K Humans %K Leukemia, Lymphocytic, Chronic, B-Cell %K Male %K Models, Molecular %K Molecular Sequence Data %K Mutation %K Receptor, Notch1 %K Signal Transduction %K Tumor Suppressor Protein p53 %X

By using next generation sequencing, we have analyzed 108 B chronic lymphocytic leukemia (B-CLL) patients. Among genes involved in the TP53 pathway, we found frequent mutations in ATM (n=18), TP53 (n=10) and NOTCH1 (n=10) genes, rare mutations of NOTCH2 (n=2) and CDKN1A/p21 (n=1) and no mutations in BAX, MDM2, TNFRSF10A and TNFRSF10B genes. The in vitro treatment of primary B-CLL cells with the activator of p53 Nutlin-3 induced the transcription of p53 target genes, without significant differences between the B-CLL without mutations and those harboring either ATM or NOTCH1mutations. On the other hand, the subgroup of TP53mutated B-CLL exhibited a significantly lower induction of the p53 target genes in response to Nutlin-3 as compared to the other B-CLL samples. However, among the TP53mutated B-CLL, those showing mutations in the high hot spot region of the DNA binding domain [273-280 aa] maintained a significantly higher p53-dependent transcriptional activity as compared to the other TP53mutated B-CLL samples. Since the ability to elicit a p53-dependent transcriptional activity in vitro has a positive prognostic significance, our data suggest that ATMmutated, NOTCH1mutated and surprisingly, also a subset of TP53mutated B-CLL patients might benefit from therapeutic combinations including small molecule activator of the p53 pathway.

%B Oncotarget %V 5 %P 12635-45 %8 2014 Dec 30 %G eng %N 24 %1 http://www.ncbi.nlm.nih.gov/pubmed/25587027?dopt=Abstract %R 10.18632/oncotarget.2211 %0 Journal Article %J Nature %D 2014 %T Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. %A Perry, John R B %A Day, Felix %A Elks, Cathy E %A Sulem, Patrick %A Thompson, Deborah J %A Ferreira, Teresa %A He, Chunyan %A Chasman, Daniel I %A Esko, Tõnu %A Thorleifsson, Gudmar %A Albrecht, Eva %A Ang, Wei Q %A Corre, Tanguy %A Cousminer, Diana L %A Feenstra, Bjarke %A Franceschini, Nora %A Ganna, Andrea %A Johnson, Andrew D %A Kjellqvist, Sanela %A Lunetta, Kathryn L %A McMahon, George %A Nolte, Ilja M %A Paternoster, Lavinia %A Porcu, Eleonora %A Smith, Albert V %A Stolk, Lisette %A Teumer, Alexander %A Tšernikova, Natalia %A Tikkanen, Emmi %A Ulivi, Sheila %A Wagner, Erin K %A Amin, Najaf %A Bierut, Laura J %A Byrne, Enda M %A Hottenga, Jouke-Jan %A Koller, Daniel L %A Mangino, Massimo %A Pers, Tune H %A Yerges-Armstrong, Laura M %A Hua Zhao, Jing %A Andrulis, Irene L %A Anton-Culver, Hoda %A Atsma, Femke %A Bandinelli, Stefania %A Beckmann, Matthias W %A Benitez, Javier %A Blomqvist, Carl %A Bojesen, Stig E %A Bolla, Manjeet K %A Bonanni, Bernardo %A Brauch, Hiltrud %A Brenner, Hermann %A Buring, Julie E %A Chang-Claude, Jenny %A Chanock, Stephen %A Chen, Jinhui %A Chenevix-Trench, Georgia %A Collée, J Margriet %A Couch, Fergus J %A Couper, David %A Coviello, Andrea D %A Cox, Angela %A Czene, Kamila %A d'Adamo, Adamo Pio %A Davey Smith, George %A De Vivo, Immaculata %A Demerath, Ellen W %A Dennis, Joe %A Devilee, Peter %A Dieffenbach, Aida K %A Dunning, Alison M %A Eiriksdottir, Gudny %A Eriksson, Johan G %A Fasching, Peter A %A Ferrucci, Luigi %A Flesch-Janys, Dieter %A Flyger, Henrik %A Foroud, Tatiana %A Franke, Lude %A Garcia, Melissa E %A García-Closas, Montserrat %A Geller, Frank %A de Geus, Eco E J %A Giles, Graham G %A Gudbjartsson, Daniel F %A Gudnason, Vilmundur %A Guenel, Pascal %A Guo, Suiqun %A Hall, Per %A Hamann, Ute %A Haring, Robin %A Hartman, Catharina A %A Heath, Andrew C %A Hofman, Albert %A Hooning, Maartje J %A Hopper, John L %A Hu, Frank B %A Hunter, David J %A Karasik, David %A Kiel, Douglas P %A Knight, Julia A %A Kosma, Veli-Matti %A Kutalik, Zoltán %A Lai, Sandra %A Lambrechts, Diether %A Lindblom, Annika %A Mägi, Reedik %A Magnusson, Patrik K %A Mannermaa, Arto %A Martin, Nicholas G %A Masson, Gisli %A McArdle, Patrick F %A McArdle, Wendy L %A Melbye, Mads %A Michailidou, Kyriaki %A Mihailov, Evelin %A Milani, Lili %A Milne, Roger L %A Nevanlinna, Heli %A Neven, Patrick %A Nohr, Ellen A %A Oldehinkel, Albertine J %A Oostra, Ben A %A Palotie, Aarno %A Peacock, Munro %A Pedersen, Nancy L %A Peterlongo, Paolo %A Peto, Julian %A Pharoah, Paul D P %A Postma, Dirkje S %A Pouta, Anneli %A Pylkäs, Katri %A Radice, Paolo %A Ring, Susan %A Rivadeneira, Fernando %A Robino, Antonietta %A Rose, Lynda M %A Rudolph, Anja %A Salomaa, Veikko %A Sanna, Serena %A Schlessinger, David %A Schmidt, Marjanka K %A Southey, Mellissa C %A Sovio, Ulla %A Stampfer, Meir J %A Stöckl, Doris %A Storniolo, Anna M %A Timpson, Nicholas J %A Tyrer, Jonathan %A Visser, Jenny A %A Vollenweider, Peter %A Völzke, Henry %A Waeber, Gerard %A Waldenberger, Melanie %A Wallaschofski, Henri %A Wang, Qin %A Willemsen, Gonneke %A Winqvist, Robert %A Wolffenbuttel, Bruce H R %A Wright, Margaret J %A Boomsma, Dorret I %A Econs, Michael J %A Khaw, Kay-Tee %A Loos, Ruth J F %A McCarthy, Mark I %A Montgomery, Grant W %A Rice, John P %A Streeten, Elizabeth A %A Thorsteinsdottir, Unnur %A van Duijn, Cornelia M %A Alizadeh, Behrooz Z %A Bergmann, Sven %A Boerwinkle, Eric %A Boyd, Heather A %A Crisponi, Laura %A Gasparini, Paolo %A Gieger, Christian %A Harris, Tamara B %A Ingelsson, Erik %A Järvelin, Marjo-Riitta %A Kraft, Peter %A Lawlor, Debbie %A Metspalu, Andres %A Pennell, Craig E %A Ridker, Paul M %A Snieder, Harold %A Sørensen, Thorkild I A %A Spector, Tim D %A Strachan, David P %A Uitterlinden, André G %A Wareham, Nicholas J %A Widen, Elisabeth %A Zygmunt, Marek %A Murray, Anna %A Easton, Douglas F %A Stefansson, Kari %A Murabito, Joanne M %A Ong, Ken K %K Adolescent %K Age Factors %K Alleles %K Body Mass Index %K Breast Neoplasms %K Cardiovascular Diseases %K Child %K Diabetes Mellitus, Type 2 %K Europe %K Female %K Genetic Loci %K Genome-Wide Association Study %K Genomic Imprinting %K Humans %K Hypothalamo-Hypophyseal System %K Intercellular Signaling Peptides and Proteins %K Male %K Membrane Proteins %K Menarche %K Obesity %K Ovary %K Parents %K Polymorphism, Single Nucleotide %K Potassium Channels, Tandem Pore Domain %K Proteins %K Quantitative Trait Loci %K Receptors, GABA-B %K Receptors, Retinoic Acid %K Ribonucleoproteins %X

Age at menarche is a marker of timing of puberty in females. It varies widely between individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-cause mortality. Studies of rare human disorders of puberty and animal models point to a complex hypothalamic-pituitary-hormonal regulation, but the mechanisms that determine pubertal timing and underlie its links to disease risk remain unclear. Here, using genome-wide and custom-genotyping arrays in up to 182,416 women of European descent from 57 studies, we found robust evidence (P < 5 × 10(-8)) for 123 signals at 106 genomic loci associated with age at menarche. Many loci were associated with other pubertal traits in both sexes, and there was substantial overlap with genes implicated in body mass index and various diseases, including rare disorders of puberty. Menarche signals were enriched in imprinted regions, with three loci (DLK1-WDR25, MKRN3-MAGEL2 and KCNK9) demonstrating parent-of-origin-specific associations concordant with known parental expression patterns. Pathway analyses implicated nuclear hormone receptors, particularly retinoic acid and γ-aminobutyric acid-B2 receptor signalling, among novel mechanisms that regulate pubertal timing in humans. Our findings suggest a genetic architecture involving at least hundreds of common variants in the coordinated timing of the pubertal transition.

%B Nature %V 514 %P 92-7 %8 2014 Oct 2 %G eng %N 7520 %1 http://www.ncbi.nlm.nih.gov/pubmed/25231870?dopt=Abstract %R 10.1038/nature13545 %0 Journal Article %J World J Gastroenterol %D 2014 %T Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase? %A Stocco, Gabriele %A Pelin, Marco %A Franca, Raffaella %A De Iudicibus, Sara %A Cuzzoni, Eva %A Favretto, Diego %A Martelossi, Stefano %A Ventura, Alessandro %A Decorti, Giuliana %K 6-Mercaptopurine %K Animals %K Apoptosis %K Azathioprine %K Glutathione %K Glutathione Transferase %K Humans %K Immunosuppressive Agents %K Inflammatory Bowel Diseases %K Oxidative Stress %K Pharmacogenetics %K Polymorphism, Genetic %X

Azathioprine is a purine antimetabolite drug commonly used to treat inflammatory bowel disease (IBD). In vivo it is active after reaction with reduced glutathione (GSH) and conversion to mercaptopurine. Although this reaction may occur spontaneously, the presence of isoforms M and A of the enzyme glutathione-S-transferase (GST) may increase its speed. Indeed, in pediatric patients with IBD, deletion of GST-M1, which determines reduced enzymatic activity, was recently associated with reduced sensitivity to azathioprine and reduced production of azathioprine active metabolites. In addition to increase the activation of azathioprine to mercaptopurine, GSTs may contribute to azathioprine effects even by modulating GSH consumption, oxidative stress and apoptosis. Therefore, genetic polymorphisms in genes for GSTs may be useful to predict response to azathioprine even if more in vitro and clinical validation studies are needed.

%B World J Gastroenterol %V 20 %P 3534-41 %8 2014 Apr 7 %G eng %N 13 %1 http://www.ncbi.nlm.nih.gov/pubmed/24707136?dopt=Abstract %R 10.3748/wjg.v20.i13.3534 %0 Journal Article %J BMC Pediatr %D 2014 %T Piccolipiù, a multicenter birth cohort in Italy: protocol of the study. %A Farchi, Sara %A Forastiere, Francesco %A Vecchi Brumatti, Liza %A Alviti, Sabrina %A Arnofi, Antonio %A Bernardini, Tommaso %A Bin, Maura %A Brescianini, Sonia %A Colelli, Valentina %A Cotichini, Rodolfo %A Culasso, Martina %A De Bartolo, Paolo %A Felice, Laura %A Fiano, Valentina %A Fioritto, Alessandra %A Frizzi, Alfio %A Gagliardi, Luigi %A Giorgi, Giulia %A Grasso, Chiara %A La Rosa, Francesca %A Loganes, Claudia %A Lorusso, Paola %A Martini, Valentina %A Merletti, Franco %A Medda, Emanuela %A Montelatici, Veronica %A Mugelli, Isabella %A Narduzzi, Silvia %A Nisticò, Lorenza %A Penna, Luana %A Piscianz, Elisa %A Piscicelli, Carlo %A Poggesi, Giulia %A Porta, Daniela %A Ranieli, Antonella %A Rapisardi, Gherardo %A Rasulo, Assunta %A Richiardi, Lorenzo %A Rusconi, Franca %A Serino, Laura %A Stazi, Maria Antonietta %A Toccaceli, Virgilia %A Todros, Tullia %A Tognin, Veronica %A Trevisan, Morena %A Valencic, Erica %A Volpi, Patrizia %A Ziroli, Valentina %A Ronfani, Luca %A Di Lallo, Domenico %K Adolescent %K Child %K Child Development %K Child Welfare %K Child, Preschool %K Cohort Studies %K Environmental Exposure %K Humans %K Infant %K Infant, Newborn %K Italy %K Prospective Studies %K Socioeconomic Factors %X

BACKGROUND: The fetal and infant life are periods of rapid development, characterized by high susceptibility to exposures. Birth cohorts provide unique opportunities to study early-life exposures in association with child development and health, as well as, with longer follow-up, the early life origin of adult diseases. Piccolipiù is an Italian birth cohort recently set up to investigate the effects of environmental exposures, parental conditions and social factors acting during pre-natal and early post-natal life on infant and child health and development. We describe here its main characteristics.

METHODS/DESIGN: Piccolipiù is a prospective cohort of expected 3000 newborns, who will be recruiting in six maternity units of five Italian cities (Florence, Rome, Trieste, Turin and Viareggio) since October 2011. Mothers are contacted during pregnancy or at delivery and are offered to participate in the study. Upon acceptance, their newborns are recruited at birth and followed up until at least 18 years of age. At recruitment, the mothers donate a blood sample and complete a baseline questionnaire. Umbilical cord blood, pieces of umbilical cord and heel blood spots are also collected. Postnatal follow-up currently occurs at 6, 12, and 24 months of age using on-line or postal self administered questionnaire; further questionnaires and medical examinations are envisaged. Questionnaires collect information on several factors, including mother's and/or child's environmental exposures, anthropometric measures, reproductive factors, diet, supplements, medical history, cognitive development, mental health and socioeconomic factors. Health promotion materials are also offered to parents.

DISCUSSION: Piccolipiù will broaden our understanding of the contribution of early-life factors to infant and child health and development. Several hypotheses on the developmental origins of health can be tested or piloted using the data collected from the Piccolipiù cohort. By pooling these data with those collected by other existing birth cohorts it will be possible to validate previous findings and to study rare exposures and outcomes.

%B BMC Pediatr %V 14 %P 36 %8 2014 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/24506846?dopt=Abstract %R 10.1186/1471-2431-14-36 %0 Journal Article %J Blood %D 2014 %T Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. %A Noris, Patrizia %A Biino, Ginevra %A Pecci, Alessandro %A Civaschi, Elisa %A Savoia, Anna %A Seri, Marco %A Melazzini, Federica %A Loffredo, Giuseppe %A Russo, Giovanna %A Bozzi, Valeria %A Notarangelo, Lucia Dora %A Gresele, Paolo %A Heller, Paula G %A Pujol-Moix, Núria %A Kunishima, Shinji %A Cattaneo, Marco %A Bussel, James %A De Candia, Erica %A Cagioni, Claudia %A Ramenghi, Ugo %A Barozzi, Serena %A Fabris, Fabrizio %A Balduini, Carlo L %K Adolescent %K Adult %K Blood Platelets %K Case-Control Studies %K Cell Size %K Child %K Child, Preschool %K Diagnosis, Differential %K Female %K Hearing Loss, Sensorineural %K Humans %K Infant %K Male %K Middle Aged %K Molecular Motor Proteins %K Mutation %K Myosin Heavy Chains %K Purpura, Thrombocytopenic, Idiopathic %K Thrombocytopenia %K Young Adult %X

Abnormalities of platelet size are one of the distinguishing features of inherited thrombocytopenias (ITs), and evaluation of blood films is recommended as an essential step for differential diagnosis of these disorders. Nevertheless, what we presently know about this subject is derived mainly from anecdotal evidence. To improve knowledge in this field, we evaluated platelet size on blood films obtained from 376 patients with all 19 forms of IT identified so far and found that these conditions differ not only in mean platelet diameter, but also in platelet diameter distribution width and the percentage of platelets with increased or reduced diameters. On the basis of these findings, we propose a new classification of ITs according to platelet size. It distinguishes forms with giant platelets, with large platelets, with normal or slightly increased platelet size, and with normal or slightly decreased platelet size. We also measured platelet diameters in 87 patients with immune thrombocytopenia and identified cutoff values for mean platelet diameter and the percentage of platelets with increased or reduced size that have good diagnostic accuracy in differentiating ITs with giant platelets and with normal or slightly decreased platelet size from immune thrombocytopenia and all other forms of IT.

%B Blood %V 124 %P e4-e10 %8 2014 Aug 7 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/24990887?dopt=Abstract %R 10.1182/blood-2014-03-564328 %0 Journal Article %J Taiwan J Obstet Gynecol %D 2014 %T Potential role of circulating microRNAs as early markers of preeclampsia. %A Ura, Blendi %A Feriotto, Giordana %A Monasta, Lorenzo %A Bilel, Sabrine %A Zweyer, Marina %A Celeghini, Claudio %K Adult %K Biomarkers %K Female %K Gestational Age %K Humans %K MicroRNAs %K Oligonucleotide Array Sequence Analysis %K Pilot Projects %K Pre-Eclampsia %K Pregnancy %K Retrospective Studies %X

OBJECTIVE: To identify microRNAs (miRNAs) differentially expressed at early stages of gestation (12-14 weeks) in the serum of pregnant women, who later developed severe preeclampsia (sPE) in the third trimester of pregnancy (n = 24) compared to women with normal pregnancy (n = 24).

MATERIALS AND METHODS: Sera from 12-14-week-gestation whole blood were subjected to microarray analysis with TaqMan Low Density Array chips (human microRNA panel V3.0), and to quantitative real-time polymerase chain reaction.

RESULTS: By using the TaqMan Low Density Array chip technology, 19 mature miRNAs appeared differentially expressed in the group of women who later developed sPE as compared to normal women. The expression of four miRNAs (miR-1233, miR-520, miR-210, miR-144) was validated by quantitative real-time polymerase chain reaction analysis. MiR-1233 was the most overexpressed in the serum of women who later developed sPE.

CONCLUSION: Circulating miRNAs deserve further investigation in order to explore their potential role in the pathogenesis of preeclampsia. In particular, miR-1233 might represent a potential marker of early sPE.

%B Taiwan J Obstet Gynecol %V 53 %P 232-4 %8 2014 Jun %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/25017274?dopt=Abstract %R 10.1016/j.tjog.2014.03.001 %0 Journal Article %J J Pediatr Surg %D 2014 %T Pregnancy and postpartum following a prenatal diagnosis of fetal thoracoabdominal malformation: the parental perspective. %A Giuliani, Rosella %A Tripani, Antonella %A Pellizzoni, Sandra %A Clarici, Andrea %A Lonciari, Isabella %A D'Ottavio, Giuseppina %A Schleef, Jurgen %K Adult %K Case-Control Studies %K Counseling %K Cystic Adenomatoid Malformation of Lung, Congenital %K Female %K Hernia, Diaphragmatic %K Hernias, Diaphragmatic, Congenital %K Humans %K Hydronephrosis %K Kidney Diseases %K Longitudinal Studies %K Male %K Musculoskeletal Abnormalities %K Parents %K Pregnancy %K Psychological Tests %K Stress, Psychological %K Ultrasonography, Prenatal %K Urogenital Abnormalities %X

PURPOSE: The study's aim was to evaluate how information related to a prenatal diagnosis of fetal malformation could modify parenthood experience descriptions during pregnancy and after the child's birth.

METHODS: A longitudinal case-control clinical study was conducted. Data on parenthood experience descriptions collected using a validated semantic differential technique during pregnancy and after the child's birth were compared between seven couples of parents receiving a prenatal diagnosis of fetal malformation and seven couples without any fetal diagnosis.

RESULTS: Our results show that during pregnancy parents in the clinical group describe themselves as more fragile, passive, and timid [p=0.007] than those in the control group. On the other hand, after the child's birth, there are no significant differences between groups.

CONCLUSIONS: Data are discussed with reference to better knowledge of the psychological dynamics involved in becoming a parent and to rational planning of support for parents receiving a diagnosis of fetal malformation.

%B J Pediatr Surg %V 49 %P 353-8 %8 2014 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/24528985?dopt=Abstract %R 10.1016/j.jpedsurg.2013.07.025 %0 Journal Article %J Eur Radiol %D 2014 %T Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health %A Cova, Maria Assunta %A Stacul, Fulvio %A Quaranta, Roberto %A Guastalla, Pierpaolo %A Salvatori, Guglielmo %A Banderali, Giuseppe %A Fonda, Claudio %A David, Vincenzo %A Gregori, Massimo %A Zuppa, Antonio Alberto %A Davanzo, Riccardo %K Adult %K Breast Feeding %K Contrast Media %K Female %K Humans %K Infant %K Italy %K Neonatology %K Practice Guidelines as Topic %K Radiology %K Societies, Medical %X

OBJECTIVES: Breastfeeding is a well-recognised investment in the health of the mother-infant dyad. Nevertheless, many professionals still advise breastfeeding mothers to temporarily discontinue breastfeeding after contrast media imaging. Therefore, we performed this review to provide health professionals with basic knowledge and skills for appropriate use of contrast media.

METHODS: A joint working group of the Italian Society of Radiology (SIRM), Italian Society of Paediatrics (SIP), Italian Society of Neonatology (SIN) and Task Force on Breastfeeding, Ministry of Health, Italy prepared a review of the relevant medical literature on the safety profile of contrast media for the nursing infant/child.

RESULTS: Breastfeeding is safe for the nursing infant of any post-conceptional age after administration of the majority of radiological contrast media to the mother; only gadolinium-based agents considered at high risk of nephrogenic systemic fibrosis (gadopentetate dimeglumine, gadodiamide, gadoversetamide) should be avoided in the breastfeeding woman as a precaution; there is no need to temporarily discontinue breastfeeding or to express and discard breast milk following the administration of contrast media assessed as compatible with breastfeeding.

CONCLUSIONS: Breastfeeding women should receive unambiguous professional advice and clear encouragement to continue breastfeeding after imaging with the compatible contrast media.

KEY POINTS: • Breastfeeding is a well-known investment in the health of the mother-infant dyad. • Breastfeeding is safe after administration of contrast media to the mother. • There is no need to temporarily discontinue breastfeeding following administration of contrast media.

%B Eur Radiol %V 24 %P 2012-22 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24838733?dopt=Abstract %R 10.1007/s00330-014-3198-6 %0 Journal Article %J N Engl J Med %D 2014 %T A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. %A Revello, Maria Grazia %A Lazzarotto, Tiziana %A Guerra, Brunella %A Spinillo, Arsenio %A Ferrazzi, Enrico %A Kustermann, Alessandra %A Guaschino, Secondo %A Vergani, Patrizia %A Todros, Tullia %A Frusca, Tiziana %A Arossa, Alessia %A Furione, Milena %A Rognoni, Vanina %A Rizzo, Nicola %A Gabrielli, Liliana %A Klersy, Catherine %A Gerna, Giuseppe %K Adult %K Amniocentesis %K Cytomegalovirus %K Cytomegalovirus Infections %K Female %K Fetal Diseases %K Humans %K Immunoglobulins %K Infectious Disease Transmission, Vertical %K Pregnancy %K Pregnancy Complications, Infectious %X

BACKGROUND: Congenital infection with human cytomegalovirus (CMV) is a major cause of morbidity and mortality. In an uncontrolled study published in 2005, administration of CMV-specific hyperimmune globulin to pregnant women with primary CMV infection significantly reduced the rate of intrauterine transmission, from 40% to 16%.

METHODS: We evaluated the efficacy of hyperimmune globulin in a phase 2, randomized, placebo-controlled, double-blind study. A total of 124 pregnant women with primary CMV infection at 5 to 26 weeks of gestation were randomly assigned within 6 weeks after the presumed onset of infection to receive hyperimmune globulin or placebo every 4 weeks until 36 weeks of gestation or until detection of CMV in amniotic fluid. The primary end point was congenital infection diagnosed at birth or by means of amniocentesis.

RESULTS: A total of 123 women could be evaluated in the efficacy analysis (1 woman in the placebo group withdrew). The rate of congenital infection was 30% (18 fetuses or infants of 61 women) in the hyperimmune globulin group and 44% (27 fetuses or infants of 62 women) in the placebo group (a difference of 14 percentage points; 95% confidence interval, -3 to 31; P=0.13). There was no significant difference between the two groups or, within each group, between the women who transmitted the virus and those who did not, with respect to levels of virus-specific antibodies, T-cell-mediated immune response, or viral DNA in the blood. The clinical outcome of congenital infection at birth was similar in the two groups. The number of obstetrical adverse events was higher in the hyperimmune globulin group than in the placebo group (13% vs. 2%).

CONCLUSIONS: In this study involving 123 women who could be evaluated, treatment with hyperimmune globulin did not significantly modify the course of primary CMV infection during pregnancy. (Funded by Agenzia Italiana del Farmaco; CHIP ClinicalTrials.gov number, NCT00881517; EudraCT no. 2008-006560-11.).

%B N Engl J Med %V 370 %P 1316-26 %8 2014 Apr 3 %G eng %N 14 %1 http://www.ncbi.nlm.nih.gov/pubmed/24693891?dopt=Abstract %R 10.1056/NEJMoa1310214 %0 Journal Article %J Acta Paediatr %D 2014 %T Re: Tramadol can selectively manage moderate pain in children following European advice limiting codeine use. %A Calligaris, Lorenzo %A Marzuillo, Pierluigi %A Barbi, Egidio %B Acta Paediatr %V 103 %P e466 %8 2014 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/25069539?dopt=Abstract %R 10.1111/apa.12763 %0 Journal Article %J Acta Diabetol %D 2014 %T Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. %A Scaramuzza, Andrea %A Cherubini, Valentino %A Tumini, Stefano %A Bonfanti, Riccardo %A Buono, Pietro %A Cardella, Francesca %A d'Annunzio, Giuseppe %A Frongia, Anna Paola %A Lombardo, Fortunato %A Monciotti, Anna Carla Maria %A Rabbone, Ivana %A Schiaffini, Riccardo %A Toni, Sonia %A Zucchini, Stefano %A Frontino, Giulio %A Iafusco, Dario %X

A panel of experts of the Italian Society of Pediatric Endocrinology and Diabetology comprehensively discussed and approved the Italian recommendations regarding self-monitoring of blood glucose, continuous glucose monitoring and other measures of glycemic control in children and adolescents with type 1 diabetes. After an extensive review of the literature, we took these issues into account: self-monitoring blood glucose, continuous glucose monitoring, glycemic variability, glycosuria, ketonuria, ketonemia, glycated hemoglobin, fructosamine and glycated albumin, logbook, data downloading, lancing devices, carbohydrate counting, and glycemic measurements at school. We concluded that clinical guidelines on self-management should be developed in every country with faithful adaptation to local languages and taking into account specific contexts and local peculiarities, without any substantial modifications to the international recommendations. We believe that the National Health Service should provide all necessary resources to ensure self-monitoring of blood glucose and possibly continuous glucose monitoring of all children and adolescents with type 1 diabetes, according to the standards of care provided by these recommendations and internationally.

%B Acta Diabetol %V 51 %P 173-84 %8 2014 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/24162715?dopt=Abstract %R 10.1007/s00592-013-0521-7 %0 Journal Article %J J Am Soc Nephrol %D 2014 %T Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. %A Ruggenenti, Piero %A Ruggiero, Barbara %A Cravedi, Paolo %A Vivarelli, Marina %A Massella, Laura %A Marasà, Maddalena %A Chianca, Antonietta %A Rubis, Nadia %A Ene-Iordache, Bogdan %A Rudnicki, Michael %A Pollastro, Rosa Maria %A Capasso, Giovambattista %A Pisani, Antonio %A Pennesi, Marco %A Emma, Francesco %A Remuzzi, Giuseppe %K Adolescent %K Adrenal Cortex Hormones %K Adult %K Antibodies, Monoclonal, Murine-Derived %K Child %K Female %K Glomerulonephritis, Membranoproliferative %K Glomerulosclerosis, Focal Segmental %K Humans %K Male %K Middle Aged %K Nephrosis, Lipoid %K Nephrotic Syndrome %K Recurrence %K Rituximab %X

The outcome of steroid-dependent or frequently relapsing nephrotic syndrome of minimal change disease (MCD), mesangial proliferative GN (MesGN), or FSGS may be poor and with major treatment toxicity. This academic, multicenter, off-on trial (ClinicalTrials.gov #NCT00981838) primarily evaluated the effects of rituximab therapy followed by immunosuppression withdrawal on disease recurrence in 10 children and 20 adults with MCD/MesGN (n=22) or FSGS who had suffered ≥2 recurrences over the previous year and were in steroid-induced remission for ≥1 month. Participants received one dose (n=28) or two doses of rituximab (375 mg/m(2) intravenously). At 1 year, all patients were in remission: 18 were treatment-free and 15 never relapsed. Compared with the year before rituximab treatment, total relapses decreased from 88 to 22 and the per-patient median number of relapses decreased from 2.5 (interquartile range [IQR], 2-4) to 0.5 (IQR, 0-1; P<0.001) during 1 year of follow-up. Reduction was significant across subgroups (children, adults, MCD/MesGN, and FSGS; P<0.01). After rituximab, the per-patient steroid maintenance median dose decreased from 0.27 mg/kg (IQR, 0.19-0.60) to 0 mg/kg (IQR, 0-0.23) (P<0.001), and the median cumulative dose to achieve relapse remission decreased from 19.5 mg/kg (IQR, 13.0-29.2) to 0.5 mg/kg (IQR, 0-9.4) (P<0.001). Furthermore, the mean estimated GFR increased from 111.3±25.7 to 121.8±29.2 ml/min per 1.73 m(2) (P=0.01), with the largest increases in children and in FSGS subgroups. The mean height z score slope stabilized in children (P<0.01). Treatment was well tolerated. Rituximab effectively and safely prevented recurrences and reduced the need for immunosuppression in steroid-dependent or frequently relapsing nephrotic syndrome, and halted disease-associated growth deficit in children.

%B J Am Soc Nephrol %V 25 %P 850-63 %8 2014 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/24480824?dopt=Abstract %R 10.1681/ASN.2013030251 %0 Journal Article %J Hum Mol Genet %D 2014 %T Salt-inducible kinase 3, SIK3, is a new gene associated with hearing. %A Wolber, Lisa E %A Girotto, Giorgia %A Buniello, Annalisa %A Vuckovic, Dragana %A Pirastu, Nicola %A Lorente-Cánovas, Beatriz %A Rudan, Igor %A Hayward, Caroline %A Polasek, Ozren %A Ciullo, Marina %A Mangino, Massimo %A Steves, Claire %A Concas, Maria Pina %A Cocca, Massilimiliano %A Spector, Tim D %A Gasparini, Paolo %A Steel, Karen P %A Williams, Frances M K %K Age Factors %K Animals %K Cochlea %K European Continental Ancestry Group %K Genome-Wide Association Study %K Hearing %K Humans %K Mice, Inbred C57BL %K Polymorphism, Single Nucleotide %K Protein Kinases %X

Hearing function is known to be heritable, but few significant and reproducible associations of genetic variants have been identified to date in the adult population. In this study, genome-wide association results of hearing function from the G-EAR consortium and TwinsUK were used for meta-analysis. Hearing ability in eight population samples of Northern and Southern European ancestry (n = 4591) and the Silk Road (n = 348) was measured using pure-tone audiometry and summarized using principal component (PC) analysis. Genome-wide association analyses for PC1-3 were conducted separately in each sample assuming an additive model adjusted for age, sex and relatedness of subjects. Meta-analysis was performed using 2.3 million single-nucleotide polymorphisms (SNPs) tested against each of the three PCs of hearing ability in 4939 individuals. A single SNP lying in intron 6 of the salt-inducible kinase 3 (SIK3) gene was found to be associated with hearing PC2 (P = 3.7×10(-8)) and further supported by whole-genome sequence in a subset. To determine the relevance of this gene in the ear, expression of the Sik3 protein was studied in mouse cochlea of different ages. Sik3 was expressed in murine hair cells during early development and in cells of the spiral ganglion during early development and adulthood. Our results suggest a developmental role of Sik3 in hearing and may be required for the maintenance of adult auditory function.

%B Hum Mol Genet %V 23 %P 6407-18 %8 2014 Dec 1 %G eng %N 23 %1 http://www.ncbi.nlm.nih.gov/pubmed/25060954?dopt=Abstract %R 10.1093/hmg/ddu346 %0 Journal Article %J BMC Infect Dis %D 2014 %T The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection. %A Calitri, Carmelina %A Gabiano, Clara %A Galli, Luisa %A Chiappini, Elena %A Giaquinto, Carlo %A Buffolano, Wilma %A Genovese, Orazio %A Esposito, Susanna %A Bernardi, Stefania %A de Martino, Maurizio %A Tovo, Pier-Angelo %K Adult %K Anti-HIV Agents %K Antiretroviral Therapy, Highly Active %K Birth Weight %K Cesarean Section %K Child %K Female %K HIV Infections %K HIV-1 %K Humans %K Infant %K Infectious Disease Transmission, Vertical %K Italy %K Male %K Pediatrics %K Pregnancy %K Pregnancy Complications, Infectious %K Pregnancy Outcome %K Prospective Studies %K Viral Load %K Young Adult %K Zidovudine %X

BACKGROUND: In the Highly Active Antiretroviral Therapy (HAART) era, the prognosis of children perinatally infected with HIV-1 has significantly improved, so the number of perinatally-infected females entering child-bearing age and experiencing motherhood is increasing.

METHODS: A description of the medical history and pregnancy outcomes of women with perinatal acquired HIV-1 infection enrolled in the Italian Register for HIV infection in Children.

RESULTS: Twenty-three women had 29 pregnancies. They had started an antiretroviral therapy at a median of 7.7 years (interquartile range, IQR 2.3 - 11.4), and had experienced a median of 4 therapeutic regimens (IQR 2-6). Twenty women (87%) had taken zidovudine (AZT) before pregnancy, in 14 cases as a starting monotherapy. In 21 pregnancies a protease inhibitor-based regimen was used. At delivery, the median of CD4+ T lymphocytes was 450/μL (IQR 275-522), and no viral load was detectable in 15 cases (reported in 21 pregnancies). Twenty-eight children were delivered through caesarean section (median gestational age: 38 weeks, IQR 36-38, median birth weight: 2550 grams, IQR 2270 - 3000). Intravenous AZT was administered during delivery in 26 cases. All children received oral AZT (median: 42 days, IQR 31 - 42), with no adverse events reported. No child acquired HIV-1 infection.

CONCLUSIONS: Despite a long history of maternal infection, multiple antiretroviral regimens and, perhaps, the development of drug-resistant viruses, the risk of mother-to-child transmission does not seem to have increased among the second-generation of HIV-1 exposed infants.

%B BMC Infect Dis %V 14 %P 277 %8 2014 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/24885649?dopt=Abstract %R 10.1186/1471-2334-14-277 %0 Journal Article %J Clin Exp Rheumatol %D 2014 %T Serum amyloid protein A concentration in cryopyrin-associated periodic syndromes patients treated with interleukin-1 beta antagonist. %A Pastore, Serena %A Paloni, Giulia %A Caorsi, Roberta %A Ronfani, Luca %A Taddio, Andrea %A Lepore, Loredana %K Adolescent %K Adult %K Amyloidosis %K Child %K Child, Preschool %K Cryopyrin-Associated Periodic Syndromes %K Drug Monitoring %K Female %K Humans %K Immunosuppressive Agents %K Interleukin-1beta %K Male %K Middle Aged %K Serum Amyloid A Protein %K Treatment Outcome %K Young Adult %X

OBJECTIVES: Cryopyrin-associated periodic syndromes (CAPS) are a group of chronic, relapsing autoinflammatory disorders which may be complicated by systemic AA amyloidosis. The aim of our study was to evaluate serum amyloid protein A (SAA) level in CAPS patients treated with Interleukin-1beta (IL-1β) antagonist and to correlate its level with treatment response.

METHODS: All patients of CAPS Italian Register treated with IL-1β inhibitor were enrolled. SAA levels before starting therapy, and at last visit were evaluated. Patients were then divided in complete responders and partial responders.

RESULTS: Twenty-five patients were enrolled. SAA level before starting therapy was increased (median 118.5 mg/L, IQR 96.4-252.8; normal value <6.4 mg/L), while at last visit SAA was significantly reduced (median 4.3 mg/L, IQR 2.3-12.7) (p<0.001). However 12 patients still presented SAA levels beyond normal range, 10/25 patients (40%) showed a complete response to treatment. Conversely, 15 patients presented only a partial response, of which 12 for increased SAA value and 3 for increased CRP value. Patients with partial response had SAA values significantly higher than patients with complete response (median 12.6 mg/L; IQR 8.3-20.0 vs. 2.7 mg/L; IQR 1.6-4.1, p<0.001).

CONCLUSIONS: Our results confirm the long term efficacy of anti IL-1β treatment in CAPS and the decrease of SAA levels; however 48% of patients still presented SAA elevation despite treatment. The real risk of these patients in developing amyloidosis is not clear but the persistent increase of SAA needs a close follow-up.

%B Clin Exp Rheumatol %V 32 %P S63-6 %8 2014 Jul-Aug %G eng %N 4 Suppl 84 %1 http://www.ncbi.nlm.nih.gov/pubmed/25069027?dopt=Abstract %0 Journal Article %J J Pediatr %D 2014 %T Severe neonatal hyperbilirubinemia and UGT1A1 promoter polymorphism. %A Travan, Laura %A Lega, Sara %A Crovella, Sergio %A Montico, Marcella %A Panontin, Elisa %A Demarini, Sergio %K Case-Control Studies %K Female %K Genotype %K Gilbert Disease %K Glucuronosyltransferase %K Humans %K Hyperbilirubinemia, Neonatal %K Infant, Newborn %K Male %K Polymerase Chain Reaction %K Polymorphism, Genetic %K Prevalence %K Promoter Regions, Genetic %X

OBJECTIVE: To assess whether UGT1A1 promoter polymorphisms associated with Gilbert Syndrome (GS) occur with a greater frequency in neonates with severe hyperbilirubinemia.

STUDY DESIGN: In a case-control study performed at a single hospital center in Italy, 70 case subjects with severe hyperbilirubinemia (defined as bilirubin level ≥20 mg/dL or 340 μmol/L) and 70 controls (bilirubin level <12 mg/dL or 210 μmol/L) were enrolled. Both case and control subjects were full term newborns. Polymerase chain reaction analysis on blood spot was performed to determine the frequency of UGTA1A1 promoter polymorphisms in cases and controls.

RESULTS: No statistical difference in the prevalence of UGTA1A1 gene variants was found between cases and controls (P = 1). Thirteen infants homozygous for (TA)7 polymorphism associated with GS were in the case group (18.6%) and 14 in the control group (20.0%). A heterozygous group was also equally distributed between cases (44.3%) and controls (42.9%). No (TA)8 repeat was found in the 2 groups.

CONCLUSIONS: In our study population, GS polymorphism alone does not appear to play a major role in severe neonatal hyperbilirubinemia in neonates without signs of hemolysis.

%B J Pediatr %V 165 %P 42-5 %8 2014 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24726540?dopt=Abstract %R 10.1016/j.jpeds.2014.03.013 %0 Journal Article %J Genet Mol Res %D 2014 %T Short communication: novel truncating mutations in the CFTR gene causing a severe form of cystic fibrosis in Italian patients. %A Lenarduzzi, S %A Morgutti, M %A Crovella, S %A Coiana, A %A Rosatelli, M C %K Alleles %K Base Sequence %K Cystic Fibrosis %K Cystic Fibrosis Transmembrane Conductance Regulator %K DNA Mutational Analysis %K Exons %K Female %K Heterozygote %K Humans %K Infant %K Infant, Newborn %K Italy %K Molecular Sequence Data %K Mutation %K Open Reading Frames %K Severity of Illness Index %X

Cystic fibrosis (CF) is a common recessive genetic disease caused by mutations in the gene encoding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. More than 1800 different mutations have been described to date. Here, we report 3 novel mutations in CFTR in 3 Italian CF patients. To detect and identify 36 frequent mutations in Caucasians, we used the INNO-LiPA CFTR19 and INNO-LiPA CFTR17+Tn Update kits (Innogenetics; Ghent, Belgium). Our first analysis did not reveal both of the responsible mutations; thus, direct sequencing of the CFTR gene coding region was performed. The 3 patients were compound heterozygous. In one allele, the F508del (c.1521_1523delCTT, p.PHE508del) mutation in exon 11 was observed in each case. For the second allele, in patient No.1, direct sequencing revealed an 11-base pair deletion (GAGGCGATACT) in exon 14 (c.2236_2246del; pGlu746Alafs*29). In patient No. 2, direct sequencing revealed a nonsense mutation at nucleotide 3892 (c.3892G>T) in exon 24. In patient No. 3, direct sequencing revealed a deletion of cytosine in exon 27 (c.4296delC; p.Asn1432Lysfs*16). These 3 novel mutations indicate the production of a truncated protein, which consequently results in a non-functional polypeptide.

%B Genet Mol Res %V 13 %P 9636-41 %8 2014 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/25501174?dopt=Abstract %R 10.4238/2014.November.14.8 %0 Journal Article %J J Pediatr %D 2014 %T Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer. %A Caselli, Désirée %A Petris, Maria Grazia %A Rondelli, Roberto %A Carraro, Francesca %A Colombini, Antonella %A Muggeo, Paola %A Ziino, Ottavio %A Melchionda, Fraia %A Russo, Giovanna %A Pierani, Paolo %A Soncini, Elena %A DeSantis, Raffaella %A Zanazzo, Giulio %A Barone, Angelica %A Cesaro, Simone %A Cellini, Monica %A Mura, Rossella %A Milano, Giuseppe M %A Meazza, Cristina %A Cicalese, Maria P %A Tropia, Serena %A De Masi, Salvatore %A Castagnola, Elio %A Aricò, Maurizio %K Anti-Infective Agents %K Child %K Dose-Response Relationship, Drug %K Drug Administration Schedule %K Follow-Up Studies %K Hematologic Neoplasms %K Humans %K Incidence %K Italy %K Pneumocystis carinii %K Pneumonia, Pneumocystis %K Prospective Studies %K Treatment Outcome %K Trimethoprim, Sulfamethoxazole Drug Combination %X

OBJECTIVE: To determine whether a simplified, 1-day/week regimen of trimethoprim/sulfamethoxazole is sufficient to prevent Pneumocystis (jirovecii [carinii]) pneumonia (PCP). Current recommended regimens for prophylaxis against PCP range from daily administration to 3 consecutive days per week dosing.

STUDY DESIGN: A prospective survey of the regimens adopted for the PCP prophylaxis in all patients treated for childhood cancer at pediatric hematology-oncology centers of the Associazione Italiana Ematologia Oncologia Pediatrica.

RESULTS: The 20 centers participating in the study reported a total of 2466 patients, including 1093 with solid tumor and 1373 with leukemia/lymphoma (or primary immunodeficiency; n = 2). Of these patients, 1371 (55.6%) received the 3-day/week prophylaxis regimen, 406 (16.5%) received the 2-day/week regimen, and 689 (27.9%), including 439 with leukemia/lymphoma, received the 1-day/week regimen. Overall, only 2 cases of PCP (0.08%) were reported, both in the 2-day/week group. By intention to treat, the cumulative incidence of PCP at 3 years was 0.09% overall (95% CI, 0.00-0.40%) and 0.51% for the 2-day/week group (95% CI, 0.10%-2.00%). Remarkably, both patients who failed had withdrawn from prophylaxis.

CONCLUSION: A single-day course of prophylaxis with trimethoprim/sulfamethoxazole may be sufficient to prevent PCP in children with cancer undergoing intensive chemotherapy regimens. This simplified strategy might have implications for the emerging need for PCP prophylaxis in other patients subjected to the increased use of biological and nonbiological agents that induce higher levels of immune suppression, such as those with rheumatic diseases.

%B J Pediatr %V 164 %P 389-92.e1 %8 2014 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/24252793?dopt=Abstract %R 10.1016/j.jpeds.2013.10.021 %0 Journal Article %J Oncotarget %D 2014 %T Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3. %A Agnoletto, Chiara %A Melloni, Elisabetta %A Casciano, Fabio %A Rigolin, Gian Matteo %A Rimondi, Erika %A Celeghini, Claudio %A Brunelli, Laura %A Cuneo, Antonio %A Secchiero, Paola %A Zauli, Giorgio %K Aged %K Aged, 80 and over %K Dichloroacetic Acid %K Drug Synergism %K Female %K Humans %K Imidazoles %K Leukemia, Lymphocytic, Chronic, B-Cell %K Male %K Middle Aged %K Piperazines %K Tumor Suppressor Protein p53 %X

The anti-leukemic activity of the mitochondria-targeting small molecule sodium dichloroacetate (DCA), used alone and in association with the small molecule inhibitor of the p53/MDM2 interaction Nutlin-3, was analyzed in primary B-chronic lymphocytic leukemia (B-CLL) samples (n=22), normal peripheral blood cells (n=10) and in p53wild-type EHEB, JVM-2, JVM-3 B lymphoblastoid cell lines. DCA exhibited a dose-dependent anti-leukemic activity in both primary B-CLL and B leukemic cell lines with a functional p53 status and showed a synergistic cytotoxic activity when used in combination with Nutlin-3. At the molecular level, DCA positively regulated p53 activity, as documented by post-transcriptional modifications of p53 protein and synergized with Nutlin-3 in increasing the expression of the p53-target genes MDM2, PUMA, TIGAR and in particular p21. The potential role of p21 in mediating the DCA+Nutlin-3 anti-leukemic activity was underscored in knocking-down experiments. Indeed, transfection of leukemic cells with p21 siRNAs significantly decreased the DCA+Nutlin-3-induced cytotoxicity. Taken together, our data emphasize that DCA is a molecule that merits to be further evaluated as a chemotherapeutic agent for B-CLL, likely in combination with other therapeutic compounds.

%B Oncotarget %V 5 %P 4347-60 %8 2014 Jun 30 %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/24962518?dopt=Abstract %0 Journal Article %J Reproduction %D 2014 %T Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. %A Zauli, Giorgio %A Celeghini, Claudio %A Monasta, Lorenzo %A Martinelli, Monica %A Luppi, Stefania %A Gonelli, Arianna %A Grill, Vittorio %A Ricci, Giuseppe %A Secchiero, Paola %K Adult %K Apoptosis %K Enzyme-Linked Immunosorbent Assay %K Flow Cytometry %K Humans %K Infertility, Male %K Male %K Receptors, TNF-Related Apoptosis-Inducing Ligand %K Semen %K Sperm Capacitation %K Sperm Motility %K Spermatozoa %K TNF-Related Apoptosis-Inducing Ligand %X

The expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL(TNFSF10)) and of its receptors (TRAILR1, TRAILR2, TRAILR3, and TRAILR4) have been documented in testis, but the presence of soluble TRAIL in seminal fluid, as well as the potential physiopathological role of the TRAIL/TRAILR system in spermatozoa, has not been previously investigated. Male donors (n=123) among couples presenting for infertility evaluation were consecutively enrolled in this study. The presence of soluble TRAIL was analyzed in seminal samples by ELISA, while the surface expression of TRAIL receptors was investigated by flow cytometry. High levels of soluble TRAIL were detected in seminal plasma (median, 11 621 pg/ml and mean±s.d., 13 371±8367 pg/ml) and flow cytometric analysis revealed a variable expression of TRAIL receptors in the sperm cellular fraction among different subjects. In addition, the effect of physiologically relevant concentrations of recombinant TRAIL was investigated on survival and motility of spermatozoa. Of interest, the in vitro exposure of capacitated spermatozoa to recombinant TRAIL (10 ng/ml) significantly preserved their overall survival. Therefore, the present study demonstrates for the first time the presence of elevated levels of the anti-inflammatory cytokine TRAIL in seminal fluids. Moreover, the demonstration that recombinant TRAIL promotes spermatozoa survival after capacitation suggests potential therapeutic implications.

%B Reproduction %V 148 %P 191-8 %8 2014 Aug %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/24825910?dopt=Abstract %R 10.1530/REP-14-0144 %0 Journal Article %J Hum Mutat %D 2014 %T Spectrum of the mutations in Bernard-Soulier syndrome. %A Savoia, Anna %A Kunishima, Shinji %A De Rocco, Daniela %A Zieger, Barbara %A Rand, Margaret L %A Pujol-Moix, Núria %A Caliskan, Umran %A Tokgoz, Huseyin %A Pecci, Alessandro %A Noris, Patrizia %A Srivastava, Alok %A Ward, Christopher %A Morel-Kopp, Marie-Christine %A Alessi, Marie-Christine %A Bellucci, Sylvia %A Beurrier, Philippe %A de Maistre, Emmanuel %A Favier, Rémi %A Hézard, Nathalie %A Hurtaud-Roux, Marie-Françoise %A Latger-Cannard, Véronique %A Lavenu-Bombled, Cécile %A Proulle, Valérie %A Meunier, Sandrine %A Négrier, Claude %A Nurden, Alan %A Randrianaivo, Hanitra %A Fabris, Fabrizio %A Platokouki, Helen %A Rosenberg, Nurit %A HadjKacem, Basma %A Heller, Paula G %A Karimi, Mehran %A Balduini, Carlo L %A Pastore, Annalisa %A Lanza, Francois %K Alleles %K Bernard-Soulier Syndrome %K Databases, Nucleic Acid %K Founder Effect %K Genetic Variation %K Humans %K Mutation %K Platelet Glycoprotein GPIb-IX Complex %K Polymorphism, Single Nucleotide %K von Willebrand Diseases %K Web Browser %X

Bernard-Soulier syndrome (BSS) is a rare autosomal recessive bleeding disorder characterized by defects of the GPIb-IX-V complex, a platelet receptor for von Willebrand factor (VWF). Most of the mutations identified in the genes encoding for the GP1BA (GPIbα), GP1BB (GPIbβ), and GP9 (GPIX) subunits prevent expression of the complex at the platelet membrane or more rarely its interaction with VWF. As a consequence, platelets are unable to adhere to the vascular subendothelium and agglutinate in response to ristocetin. In order to collect information on BSS patients, we established an International Consortium for the study of BSS, allowing us to enrol and genotype 132 families (56 previously unreported). With 79 additional families for which molecular data were gleaned from the literature, the 211 families characterized so far have mutations in the GP1BA (28%), GP1BB (28%), or GP9 (44%) genes. There is a wide spectrum of mutations with 112 different variants, including 22 novel alterations. Consistent with the rarity of the disease, 85% of the probands carry homozygous mutations with evidence of founder effects in some geographical areas. This overview provides the first global picture of the molecular basis of BSS and will lead to improve patient diagnosis and management.

%B Hum Mutat %V 35 %P 1033-45 %8 2014 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/24934643?dopt=Abstract %R 10.1002/humu.22607 %0 Journal Article %J Curr Genomics %D 2014 %T Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations. %A J, De Azevêdo Silva %A C, Addobbati %A P, Sandrin-Garcia %A S, Crovella %X

Systemic Lupus Erythematosus (SLE) is one of the most relevant world-wide autoimmune disorders. The formation of autoantibodies and the deposition of antibody-containing immune complexes in blood vessels throughout the body is the main pathogenic mechanism of SLE leading to heterogeneous clinical manifestations and target tissue damage. The complexity of etiology and pathogenesis in SLE, enclosing genetic and environmental factors, apparently is one of the greatest challenges for both researchers and clinicians. Strong indications for a genetic background in SLE come from studies in families as well as in monozygotic and dizygotic twins, discovering several SLE-associated loci and genes (e.g. IRF5, PTPN22, CTLA4, STAT4 and BANK1). As SLE has a complex genetic background, none of these genes is likely to be entirely responsible for triggering autoimmune response in SLE even if they disclosure a potentially novel molecular mechanisms in the pathogenesis' disease. The clinical manifestations and disease severity varies greatly among patients, thus several studies try to associate clinical heterogeneity and prognosis with specific genetic polymorphisms in SLE associated genes. The continue effort to describe new predisposing or modulating genes in SLE is justified by the limited knowledge about the pathogenesis, assorted clinical manifestation and the possible prevention strategies. In this review we describe newly discovered, as well as the most studied genes associated to SLE susceptibility, and relate them to clinical manifestations of the disease.

%B Curr Genomics %V 15 %P 52-65 %8 2014 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24653663?dopt=Abstract %R 10.2174/138920291501140306113715 %0 Journal Article %J Acta Paediatr %D 2014 %T Tramadol can selectively manage moderate pain in children following European advice limiting codeine use. %A Marzuillo, Pierluigi %A Calligaris, Lorenzo %A Barbi, Egidio %X

UNLABELLED: The European Medicine Agency recommendations limiting codeine use in children have created a void in managing moderate pain. We review the evidence on the pharmacokinetic, pharmacodynamic and safety profile of tramadol, a possible substitute for codeine.

CONCLUSION: Tramadol appears to be safe in both paediatric inpatients and outpatients. It may be appropriate to limit the current use of tramadol to monitored settings in children with risk factors for respiratory depression, subject to further safety evidence.

%B Acta Paediatr %V 103 %P 1110-6 %8 2014 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/25041277?dopt=Abstract %R 10.1111/apa.12738 %0 Journal Article %J Hum Mol Genet %D 2014 %T Trans-ethnic meta-analysis of white blood cell phenotypes. %A Keller, Margaux F %A Reiner, Alexander P %A Okada, Yukinori %A van Rooij, Frank J A %A Johnson, Andrew D %A Chen, Ming-Huei %A Smith, Albert V %A Morris, Andrew P %A Tanaka, Toshiko %A Ferrucci, Luigi %A Zonderman, Alan B %A Lettre, Guillaume %A Harris, Tamara %A Garcia, Melissa %A Bandinelli, Stefania %A Qayyum, Rehan %A Yanek, Lisa R %A Becker, Diane M %A Becker, Lewis C %A Kooperberg, Charles %A Keating, Brendan %A Reis, Jared %A Tang, Hua %A Boerwinkle, Eric %A Kamatani, Yoichiro %A Matsuda, Koichi %A Kamatani, Naoyuki %A Nakamura, Yusuke %A Kubo, Michiaki %A Liu, Simin %A Dehghan, Abbas %A Felix, Janine F %A Hofman, Albert %A Uitterlinden, André G %A van Duijn, Cornelia M %A Franco, Oscar H %A Longo, Dan L %A Singleton, Andrew B %A Psaty, Bruce M %A Evans, Michelle K %A Cupples, L Adrienne %A Rotter, Jerome I %A O'Donnell, Christopher J %A Takahashi, Atsushi %A Wilson, James G %A Ganesh, Santhi K %A Nalls, Mike A %K African Americans %K Asian Continental Ancestry Group %K Bayes Theorem %K European Continental Ancestry Group %K Genome, Human %K Genome-Wide Association Study %K Genotype %K Humans %K Leukocyte Count %K Leukocytes %K Linkage Disequilibrium %K Phenotype %K Polymorphism, Single Nucleotide %K Quantitative Trait Loci %X

White blood cell (WBC) count is a common clinical measure used as a predictor of certain aspects of human health, including immunity and infection status. WBC count is also a complex trait that varies among individuals and ancestry groups. Differences in linkage disequilibrium structure and heterogeneity in allelic effects are expected to play a role in the associations observed between populations. Prior genome-wide association study (GWAS) meta-analyses have identified genomic loci associated with WBC and its subtypes, but much of the heritability of these phenotypes remains unexplained. Using GWAS summary statistics for over 50 000 individuals from three diverse populations (Japanese, African-American and European ancestry), a Bayesian model methodology was employed to account for heterogeneity between ancestry groups. This approach was used to perform a trans-ethnic meta-analysis of total WBC, neutrophil and monocyte counts. Ten previously known associations were replicated and six new loci were identified, including several regions harboring genes related to inflammation and immune cell function. Ninety-five percent credible interval regions were calculated to narrow the association signals and fine-map the putatively causal variants within loci. Finally, a conditional analysis was performed on the most significant SNPs identified by the trans-ethnic meta-analysis (MA), and nine secondary signals within loci previously associated with WBC or its subtypes were identified. This work illustrates the potential of trans-ethnic analysis and ascribes a critical role to multi-ethnic cohorts and consortia in exploring complex phenotypes with respect to variants that lie outside the European-biased GWAS pool.

%B Hum Mol Genet %V 23 %P 6944-60 %8 2014 Dec 20 %G eng %N 25 %1 http://www.ncbi.nlm.nih.gov/pubmed/25096241?dopt=Abstract %R 10.1093/hmg/ddu401 %0 Journal Article %J Biochim Biophys Acta %D 2014 %T Unusual splice site mutations disrupt FANCA exon 8 definition. %A Mattioli, Chiara %A Pianigiani, Giulia %A De Rocco, Daniela %A Bianco, Anna Monica Rosaria %A Cappelli, Enrico %A Savoia, Anna %A Pagani, Franco %K Base Sequence %K Cell Line, Tumor %K Codon, Nonsense %K Exons %K Fanconi Anemia Complementation Group A Protein %K HeLa Cells %K Humans %K Introns %K Molecular Sequence Data %K Mutagenesis, Site-Directed %K Ribonucleoproteins, Small Nuclear %K RNA Splice Sites %K RNA Splicing %X

The pathological role of mutations that affect not conserved splicing regulatory sequences can be difficult to determine. In a patient with Fanconi anemia, we identified two unpredictable splicing mutations that act on either sides of FANCA exon 8. In patients-derived cells and in minigene splicing assay, we showed that both an apparently benign intronic c.710-5T>C transition and the nonsense c.790C>T substitution induce almost complete exon 8 skipping. Site-directed mutagenesis experiments indicated that the c.710-5T>C transition affects a polypyrimidine tract where most of the thymidines cannot be compensated by cytidines. The c.790C>T mutation located in position -3 relative to the donor site induce exon 8 skipping in an NMD-independent manner and complementation experiments with modified U1 snRNAs showed that U1 snRNP is only partially involved in the splicing defect. Our results highlight the importance of performing splicing functional assay for correct identification of disease-causing mechanism of genomic variants and provide mechanistic insights on how these two FANCA mutations affect exon 8 definition.

%B Biochim Biophys Acta %V 1842 %P 1052-8 %8 2014 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/24704046?dopt=Abstract %R 10.1016/j.bbadis.2014.03.014 %0 Journal Article %J Arch Dis Child %D 2014 %T Validation of point-of-care testing for coeliac disease in children in a tertiary hospital in north India. %A Singh, Prashant %A Wadhwa, Nitya %A Chaturvedi, Mona K %A Bhatia, Vidyut %A Saini, Savita %A Tandon, Nikhil %A Makharia, Govind K %A Maki, Markku %A Not, Tarcisio %A Phillips, Alan %A Bhatnagar, Shinjini %K Adolescent %K Celiac Disease %K Child %K Child, Preschool %K Cross-Sectional Studies %K Female %K Humans %K India %K Male %K Point-of-Care Systems %K Sensitivity and Specificity %K Serologic Tests %K Tertiary Care Centers %X

OBJECTIVE: Some of the conventional serological tests for coeliac disease (CD) are expensive, time-consuming and not readily available in developing countries, leading to a delay in diagnosis. Recently, point-of-care tests (POCT) have been manufactured and tested in Europe but have not been validated in our setting. We therefore aimed to study the diagnostic accuracy of the POCT 'Biocard' test in diagnosing CD in Indian children.

DESIGN: Cross-sectional study.

SETTING: Tertiary care centre in north India.

PATIENTS: Children, aged 2-18 years, with chronic diarrhoea, short stature or refractory anaemia underwent serological testing for CD with antiendomysial antibodies (AEA), antitissue transglutaminase (tTG) antibodies and Biocard test followed by duodenal biopsy irrespective of serological results. CD was diagnosed with positive AEA and duodenal biopsy showing >grade 2 changes using modified Marsh criteria. Those who were both AEA negative and had normal histology were considered CD negative.

RESULTS: Of 319 children who underwent the serological testing, 170 agreed for biopsy. Of these, 110 were diagnosed with CD and 30 were found to be CD negative. Remaining 30 had discordant AEA and histology results and were not included in analysis. Biocard test agreed with 92/110 positive and 27/30 negative diagnoses based on reference tests (83.6% sensitivity and 90% specificity). tTG was found to be 93.8% sensitive and 96.4% specific.

CONCLUSIONS: We successfully validated the POCT for CD in our setting. It could be used to increase case detection rates in developing countries with a large undiagnosed CD burden.

%B Arch Dis Child %V 99 %P 1004-8 %8 2014 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/24942708?dopt=Abstract %R 10.1136/archdischild-2013-305567 %0 Journal Article %J Arch Dis Child Fetal Neonatal Ed %D 2013 %T Acropustulosis of infancy. %A Paloni, Giulia %A Berti, Irene %A Cutrone, Mario %K Acrodermatitis %K Diagnosis, Differential %K Female %K Foot Dermatoses %K Hand Dermatoses %K Humans %K Infant, Newborn %B Arch Dis Child Fetal Neonatal Ed %V 98 %P F340 %8 2013 Jul %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22990133?dopt=Abstract %R 10.1136/archdischild-2012-302685 %0 Journal Article %J J Hum Lact %D 2013 %T Breastfeeding and neonatal weight loss in healthy term infants. %A Davanzo, Riccardo %A Cannioto, Zemira %A Ronfani, Luca %A Monasta, Lorenzo %A Demarini, Sergio %K Apgar Score %K Breast Feeding %K Delivery, Obstetric %K Gestational Age %K Humans %K Infant, Newborn %K Length of Stay %K Patient Readmission %K Retrospective Studies %K Seasons %K Weight Loss %X

BACKGROUND: Neonatal weight loss is universally recognized, yet poorly understood. Limited professional consensus exists on the definition of lower limit of safe weight loss.

OBJECTIVE: Our aim was to assess the extent of neonatal weight loss and its association with selected clinical variables in a population of healthy term infants cared for using a specific protocol on weight loss.

METHODS: We retrospectively considered 1003 infants consecutively admitted to the regular nursery of the Institute for Maternal and Child Health "Burlo Garofolo" (Trieste, Italy). We studied the relationship of selected variables with neonatal weight loss recorded during the hospital stay. We also analyzed all readmissions in the first month of life as a result of weight loss and its complications.

RESULTS: We observed a mean absolute weight loss of 228 g ± 83g, and a mean percent weight loss of 6.7% ± 2.2%. Weight loss ≥ 10% and > 12% were 6% and 0.3%, respectively. In multivariate logistic regression, cesarean section, hot season, any formula feeding, and jaundice not requiring phototherapy were independently associated with neonatal weight loss ≥ 8%. Conversely, low gestational age status was associated with lower weight loss. Readmission within the first month of life because of dehydration occurred in 0.3% of infants.

CONCLUSIONS: Breastfeeding, compared to formula feeding, may not be a risk factor for greater early neonatal weight loss, at least in contexts in which weight is routinely monitored, breastfeeding is repeatedly assessed and appropriately supported, and careful supplementation is prescribed to limit and promptly treat excess weight loss and its related complications.

%B J Hum Lact %V 29 %P 45-53 %8 2013 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22554678?dopt=Abstract %R 10.1177/0890334412444005 %0 Journal Article %J Rheumatol Int %D 2013 %T A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues. %A Girardelli, M %A Bianco, A M %A Marcuzzi, A %A Crovella, S %K Arthritis, Rheumatoid %K Female %K Humans %K Inflammation Mediators %K Lipids %K Male %K Osteoarthritis %K Oxidative Stress %X

In chronic diseases such as rheumatoid arthritis and osteoarthritis, the progression of the disease is characterized by stress oxidative, inflammation, and elevated levels of cholesterol. In mevalonate kinase deficiency, an auto-inflammatory disease, the correlation between inflammation and cholesterol levels is opposite. The metabolic pathway that underlies the production of cholesterol is the mevalonate pathway; it is also essential for the biosynthesis of isoprenoids involved in the control of several cell functions. This divergence of cholesterol levels, associated with these two inflammatory disorders, is probably due to a different etiology, pathogenesis, and progression.

%B Rheumatol Int %V 33 %P 2445-6 %8 2013 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/22562750?dopt=Abstract %R 10.1007/s00296-012-2436-y %0 Journal Article %J Eur J Pediatr %D 2013 %T Does EMLA cream application interfere with the success of venipuncture or venous cannulation? A prospective multicenter observational study. %A Schreiber, S %A Ronfani, L %A Chiaffoni, G P %A Matarazzo, L %A Minute, M %A Panontin, E %A Poropat, F %A Germani, C %A Barbi, E %K Anesthetics, Local %K Catheterization, Peripheral %K Child %K Child, Preschool %K Female %K Humans %K Lidocaine %K Logistic Models %K Male %K Ointments %K Phlebotomy %K Prilocaine %K Prospective Studies %K Vasoconstriction %X

UNLABELLED: Venipuncture and intravenous cannulation are the most common painful procedures performed on children. The most widely used topical anesthetic is eutectic mixture of local anesthetics (EMLA). EMLA use is associated with a transient cutaneous vasoconstriction which can make it difficult to identify veins. We assessed with a prospective, multicenter, observational study whether EMLA interferes with venipuncture and intravenous cannulation. The primary study outcome was a success at first attempt in the course of venipuncture or venous cannulation. The study enrolled 388 children; 255 of them received EMLA and 133 did not. Eighty-six percent of procedures were successful at the first attempt in the EMLA group and 76.7 % in the no EMLA group.

CONCLUSION: In this study, EMLA use did not interfere with the success of venipuncture or venous cannulation in children.

%B Eur J Pediatr %V 172 %P 265-8 %8 2013 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/23093138?dopt=Abstract %R 10.1007/s00431-012-1866-6 %0 Journal Article %J J Gastroenterol %D 2013 %T Family history in early-onset inflammatory bowel disease. %A Bianco, Anna Monica %A Zanin, Valentina %A Monasta, Lorenzo %A Martelossi, Stefano %A Marcuzzi, Annalisa %A Crovella, Sergio %K Colitis, Ulcerative %K Crohn Disease %K Female %K Humans %K Male %B J Gastroenterol %V 48 %P 144 %8 2013 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22886482?dopt=Abstract %R 10.1007/s00535-012-0654-4 %0 Journal Article %J Nat Genet %D 2013 %T Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. %A Köttgen, Anna %A Albrecht, Eva %A Teumer, Alexander %A Vitart, Veronique %A Krumsiek, Jan %A Hundertmark, Claudia %A Pistis, Giorgio %A Ruggiero, Daniela %A O'Seaghdha, Conall M %A Haller, Toomas %A Yang, Qiong %A Tanaka, Toshiko %A Johnson, Andrew D %A Kutalik, Zoltán %A Smith, Albert V %A Shi, Julia %A Struchalin, Maksim %A Middelberg, Rita P S %A Brown, Morris J %A Gaffo, Angelo L %A Pirastu, Nicola %A Li, Guo %A Hayward, Caroline %A Zemunik, Tatijana %A Huffman, Jennifer %A Yengo, Loic %A Zhao, Jing Hua %A Demirkan, Ayse %A Feitosa, Mary F %A Liu, Xuan %A Malerba, Giovanni %A Lopez, Lorna M %A van der Harst, Pim %A Li, Xinzhong %A Kleber, Marcus E %A Hicks, Andrew A %A Nolte, Ilja M %A Johansson, Åsa %A Murgia, Federico %A Wild, Sarah H %A Bakker, Stephan J L %A Peden, John F %A Dehghan, Abbas %A Steri, Maristella %A Tenesa, Albert %A Lagou, Vasiliki %A Salo, Perttu %A Mangino, Massimo %A Rose, Lynda M %A Lehtimäki, Terho %A Woodward, Owen M %A Okada, Yukinori %A Tin, Adrienne %A Müller, Christian %A Oldmeadow, Christopher %A Putku, Margus %A Czamara, Darina %A Kraft, Peter %A Frogheri, Laura %A Thun, Gian Andri %A Grotevendt, Anne %A Gislason, Gauti Kjartan %A Harris, Tamara B %A Launer, Lenore J %A McArdle, Patrick %A Shuldiner, Alan R %A Boerwinkle, Eric %A Coresh, Josef %A Schmidt, Helena %A Schallert, Michael %A Martin, Nicholas G %A Montgomery, Grant W %A Kubo, Michiaki %A Nakamura, Yusuke %A Tanaka, Toshihiro %A Munroe, Patricia B %A Samani, Nilesh J %A Jacobs, David R %A Liu, Kiang %A d'Adamo, Pio %A Ulivi, Sheila %A Rotter, Jerome I %A Psaty, Bruce M %A Vollenweider, Peter %A Waeber, Gerard %A Campbell, Susan %A Devuyst, Olivier %A Navarro, Pau %A Kolcic, Ivana %A Hastie, Nicholas %A Balkau, Beverley %A Froguel, Philippe %A Esko, Tõnu %A Salumets, Andres %A Khaw, Kay Tee %A Langenberg, Claudia %A Wareham, Nicholas J %A Isaacs, Aaron %A Kraja, Aldi %A Zhang, Qunyuan %A Wild, Philipp S %A Scott, Rodney J %A Holliday, Elizabeth G %A Org, Elin %A Viigimaa, Margus %A Bandinelli, Stefania %A Metter, Jeffrey E %A Lupo, Antonio %A Trabetti, Elisabetta %A Sorice, Rossella %A Döring, Angela %A Lattka, Eva %A Strauch, Konstantin %A Theis, Fabian %A Waldenberger, Melanie %A Wichmann, H-Erich %A Davies, Gail %A Gow, Alan J %A Bruinenberg, Marcel %A Stolk, Ronald P %A Kooner, Jaspal S %A Zhang, Weihua %A Winkelmann, Bernhard R %A Boehm, Bernhard O %A Lucae, Susanne %A Penninx, Brenda W %A Smit, Johannes H %A Curhan, Gary %A Mudgal, Poorva %A Plenge, Robert M %A Portas, Laura %A Persico, Ivana %A Kirin, Mirna %A Wilson, James F %A Mateo Leach, Irene %A van Gilst, Wiek H %A Goel, Anuj %A Ongen, Halit %A Hofman, Albert %A Rivadeneira, Fernando %A Uitterlinden, André G %A Imboden, Medea %A von Eckardstein, Arnold %A Cucca, Francesco %A Nagaraja, Ramaiah %A Piras, Maria Grazia %A Nauck, Matthias %A Schurmann, Claudia %A Budde, Kathrin %A Ernst, Florian %A Farrington, Susan M %A Theodoratou, Evropi %A Prokopenko, Inga %A Stumvoll, Michael %A Jula, Antti %A Perola, Markus %A Salomaa, Veikko %A Shin, So-Youn %A Spector, Tim D %A Sala, Cinzia %A Ridker, Paul M %A Kähönen, Mika %A Viikari, Jorma %A Hengstenberg, Christian %A Nelson, Christopher P %A Meschia, James F %A Nalls, Michael A %A Sharma, Pankaj %A Singleton, Andrew B %A Kamatani, Naoyuki %A Zeller, Tanja %A Burnier, Michel %A Attia, John %A Laan, Maris %A Klopp, Norman %A Hillege, Hans L %A Kloiber, Stefan %A Choi, Hyon %A Pirastu, Mario %A Tore, Silvia %A Probst-Hensch, Nicole M %A Völzke, Henry %A Gudnason, Vilmundur %A Parsa, Afshin %A Schmidt, Reinhold %A Whitfield, John B %A Fornage, Myriam %A Gasparini, Paolo %A Siscovick, David S %A Polasek, Ozren %A Campbell, Harry %A Rudan, Igor %A Bouatia-Naji, Nabila %A Metspalu, Andres %A Loos, Ruth J F %A van Duijn, Cornelia M %A Borecki, Ingrid B %A Ferrucci, Luigi %A Gambaro, Giovanni %A Deary, Ian J %A Wolffenbuttel, Bruce H R %A Chambers, John C %A März, Winfried %A Pramstaller, Peter P %A Snieder, Harold %A Gyllensten, Ulf %A Wright, Alan F %A Navis, Gerjan %A Watkins, Hugh %A Witteman, Jacqueline C M %A Sanna, Serena %A Schipf, Sabine %A Dunlop, Malcolm G %A Tönjes, Anke %A Ripatti, Samuli %A Soranzo, Nicole %A Toniolo, Daniela %A Chasman, Daniel I %A Raitakari, Olli %A Kao, W H Linda %A Ciullo, Marina %A Fox, Caroline S %A Caulfield, Mark %A Bochud, Murielle %A Gieger, Christian %K Analysis of Variance %K European Continental Ancestry Group %K Gene Frequency %K Genetic Loci %K Genome-Wide Association Study %K Glucose %K Gout %K Humans %K Inhibins %K Polymorphism, Single Nucleotide %K Signal Transduction %K Uric Acid %X

Elevated serum urate concentrations can cause gout, a prevalent and painful inflammatory arthritis. By combining data from >140,000 individuals of European ancestry within the Global Urate Genetics Consortium (GUGC), we identified and replicated 28 genome-wide significant loci in association with serum urate concentrations (18 new regions in or near TRIM46, INHBB, SFMBT1, TMEM171, VEGFA, BAZ1B, PRKAG2, STC1, HNF4G, A1CF, ATXN2, UBE2Q2, IGF1R, NFAT5, MAF, HLF, ACVR1B-ACVRL1 and B3GNT4). Associations for many of the loci were of similar magnitude in individuals of non-European ancestry. We further characterized these loci for associations with gout, transcript expression and the fractional excretion of urate. Network analyses implicate the inhibins-activins signaling pathways and glucose metabolism in systemic urate control. New candidate genes for serum urate concentration highlight the importance of metabolic control of urate production and excretion, which may have implications for the treatment and prevention of gout.

%B Nat Genet %V 45 %P 145-54 %8 2013 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/23263486?dopt=Abstract %R 10.1038/ng.2500 %0 Journal Article %J Ophthalmic Genet %D 2013 %T Infantile bilateral glaucoma in a child with ectodermal dysplasia. %A Callea, Michele %A Vinciguerra, Agatino %A Willoughby, Colin E %A Deroma, Laura %A Clarich, Gabriella %K Antihypertensive Agents %K Child %K Ectodermal Dysplasia %K Ectodysplasins %K Humans %K Hydrophthalmos %K Intraocular Pressure %K Male %K Mutation %K Polymorphism, Single Nucleotide %K Tonometry, Ocular %X

Ectodermal dysplasia is a rare disease which affects at least two ectodermal-derived structures such as hair, nails, skin, sweat glands and teeth. Approximately 200 different conditions have been classified as an ectodermal dysplasia and X-linked hypohidrotic ectodermal dysplasia (XHED) represents the commonest form. Clinically, XHED is characterized by hypotrichosis, hypohidrosis and hypodontia. A variety of ocular manifestations have been reported in XHED, the most common being dryness of eyes due to tear deficiency and instability of the film secondary to the absence of meibomian gland function. Here we report a child with the distinctive clinical features of XHED confirmed with molecular diagnosis who presented with infantile bilateral glaucoma, in addition to the classical ocular involvement in XHED.

%B Ophthalmic Genet %V 34 %P 58-60 %8 2013 Mar-Jun %G eng %N 1-2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22428923?dopt=Abstract %R 10.3109/13816810.2012.666707 %0 Journal Article %J Ophthalmic Genet %D 2013 %T A novel CRYBB2 missense mutation causing congenital autosomal dominant cataract in an Italian family. %A Faletra, Flavio %A d'Adamo, Adamo Pio %A Pensiero, Stefano %A Athanasakis, Emmanouil %A Catalano, Dario %A Bruno, Irene %A Gasparini, Paolo %K Amino Acid Sequence %K beta-Crystallin B Chain %K Cataract %K DNA Mutational Analysis %K Female %K Genes, Dominant %K Genetic Linkage %K Genotype %K Humans %K Italy %K Male %K Molecular Sequence Data %K Mutation, Missense %K Pedigree %K Phenotype %X

Congenital cataract is a leading cause of visual impairment in children and brings approximately 10% of childhood blindness worldwide. Molecular analysis revealed ~60 loci to be associated with several phenotypes of childhood cataracts. Until now, more than 30 loci and 18 genes on different chromosomes have been associated with autosomal dominant congenital cataract (ADCC). Here, we present a three-generation Italian family with a non syndromic ADCC. A linkage analysis carried out using HumanCytoSNP-12 DNA Analysis BeadChip led us to identify ten genomic regions virtually involved in the disease. All the genes located in these regions were scored for possible relationship with ADCC and, according to a strict clinical and genetic selection, 4 genes have been analyzed. A novel sequence variant was found in the CRYBB2 gene (p.Ser143Phe). This variant affects a conserved aminoacid in the third Greek key motif of the protein, cosegregates with the disease phenotype in all affected individuals and is not present both in the unaffected family members and 100 healthy control subjects. Finally, we identified the first CRYBB2 mutation in an Italian family causing a clinical picture of ADCC.

%B Ophthalmic Genet %V 34 %P 115-7 %8 2013 Mar-Jun %G eng %N 1-2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22846113?dopt=Abstract %R 10.3109/13816810.2012.707273 %0 Journal Article %J Orphanet J Rare Dis %D 2013 %T Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood. %A Colombatti, Raffaella %A Perrotta, Silverio %A Samperi, Piera %A Casale, Maddalena %A Masera, Nicoletta %A Palazzi, Giovanni %A Sainati, Laura %A Russo, Giovanna %K Adolescent %K Anemia, Sickle Cell %K Child %K Child, Preschool %K Disease Management %K Female %K Hematologic Diseases %K Humans %K Infant %K Infant, Newborn %K Italy %K Male %K Neonatal Screening %K Rare Diseases %X

BACKGROUND: Sickle cell disease (SCD) is the most frequent hemoglobinopathy worldwide but remains a rare blood disorder in most western countries. Recommendations for standard of care have been produced in the United States, the United Kingdom and France, where this disease is relatively frequent because of earlier immigration from Africa. These recommendations have changed the clinical course of SCD but can be difficult to apply in other contexts. The Italian Association of Pediatric Hematology Oncology (AIEOP) decided to develop a common national response to the rising number of SCD patients in Italy with the following objectives: 1) to create a national working group focused on pediatric SCD, and 2) to develop tailored guidelines for the management of SCD that could be accessed and practiced by those involved in the care of children with SCD in Italy.

METHODS: Guidelines, adapted to the Italian social context and health system, were developed by 22 pediatric hematologists representing 54 AIEOP centers across Italy. The group met five times for a total of 128 hours in 22 months; documents and opinions were circulated via web.

RESULTS: Recommendations regarding the prevention and treatment of the most relevant complications of SCD in childhood adapted to the Italian context and health system were produced.

CONCLUSIONS: Creating a network of physicians involved in the day-to-day care of children with SCD is feasible in a country where it remains rare. Providing hematologists, primary and secondary care physicians, and caregivers across the country with web-based guidelines for the management of SCD tailored to the Italian context is the first step in building a sustainable response to a rare but emerging childhood blood disorder and in implementing the World Health Organization's suggestion "to design (and) implement … comprehensive national integrated programs for the prevention and management of SCD".

%B Orphanet J Rare Dis %V 8 %P 169 %8 2013 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/24139596?dopt=Abstract %R 10.1186/1750-1172-8-169 %0 Journal Article %J Clin Nutr %D 2013 %T Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB. %A Tisato, Veronica %A Toffoli, Barbara %A Monasta, Lorenzo %A Bernardi, Stella %A Candido, Riccardo %A Zauli, Giorgio %A Secchiero, Paola %K Adolescent %K Adult %K Aged %K Case-Control Studies %K Cell Line, Tumor %K Chemokine CXCL10 %K Endothelial Cells %K Female %K Humans %K Interleukin-6 %K Linear Models %K Male %K Metabolic Syndrome X %K Middle Aged %K Obesity %K Pilot Projects %K Proto-Oncogene Proteins c-sis %K RNA, Messenger %K Young Adult %X

BACKGROUND & AIMS: The development and/or progression of metabolic syndrome (MetS) in overweight and obese individuals have been associated to low-grade inflammation, but few studies have simultaneously analyzed the circulating levels of several cytokines.

METHODS: In this pilot study, a group of 27 cytokines and growth factors was analyzed in the serum of obese patients (n=40) diagnosed for MetS in comparison with sex- and age-matched control subjects without MetS (n=53) by using a multiplex immunoassay. Release of cytokines was measured in culture supernatants of human primary endothelial cells, THP-1 macrophagic cells and HuH-7 hepatoma cells upon exposure to a high fat mixture.

RESULTS: While the majority of cytokines did not show significant differences between the investigated groups, the circulating levels of CXCL10/IP-10 and IL-6 were higher in the MetS group versus overweight control group. In contrast, PDGF-BB serum levels were significantly decreased in MetS patients. The in vitro addition of a high fat mixture increased the release of IL-6 and/or CXCL10/IP-10 in the culture supernatant of human primary endothelial cells and THP-1 macrophagic cells, while the same mixture significantly decreased the release of PDGF-BB by human THP-1 macrophagic and HuH-7 hepatoma cells.

CONCLUSIONS: The current demonstration that MetS is associated with decrease of the pro-fibrotic PDGF cytokine is a completely novel finding, which adds complexity to the interplay between inflammation and fibrosis in patients affected by MetS.

%B Clin Nutr %V 32 %P 259-64 %8 2013 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22840561?dopt=Abstract %R 10.1016/j.clnu.2012.07.003 %0 Journal Article %J J Rheumatol %D 2013 %T Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. %A Zannin, Maria E %A Birolo, Carolina %A Gerloni, Valeria M %A Miserocchi, Elisabetta %A Pontikaki, Irene %A Paroli, Maria P %A Bracaglia, Claudia %A Shardlow, Alison %A Parentin, Fulvio %A Cimaz, Rolando %A Simonini, Gabriele %A Falcini, Fernanda %A Corona, Fabrizia %A Viola, Stefania %A De Marco, Riccardo %A Breda, Luciana %A La Torre, Francesco %A Vittadello, Fabio %A Martini, Giorgia %A Zulian, Francesco %K Adolescent %K Antibodies, Monoclonal %K Antibodies, Monoclonal, Humanized %K Antirheumatic Agents %K Arthritis, Juvenile %K Child %K Child, Preschool %K Female %K Follow-Up Studies %K Humans %K Infant %K Italy %K Male %K Registries %K Treatment Outcome %K Tumor Necrosis Factor-alpha %K Uveitis %X

OBJECTIVE: To evaluate safety and efficacy of adalimumab (ADA) and infliximab (IFX) for the treatment of juvenile idiopathic arthritis-related anterior uveitis (JIA-AU).

METHODS: Starting January 2007, patients with JIA-AU treated with IFX and ADA were managed by a standard protocol and data were entered into the National Italian Registry (NIR). At baseline, all patients were refractory to standard immunosuppressive treatment and/or were corticosteroid-dependent. Data recorded every 3 months included uveitis course, number/type of ocular complications, drug-related adverse events (AE), treatment change or withdrawal, and laboratory measures. Data of patients treated for at least 1 year were retrieved from the NIR and analyzed using descriptive statistics. Treatment efficacy was based on change in uveitis course and in number of ocular complications.

RESULTS: Up to December 2009, data for 108 patients with JIA-AU treated with anti-tumor necrosis factor-α agents were recorded in the NIR and data from 91, with at least 12 months' followup, were included in the study. Forty-eight patients were treated with IFX, 43 with ADA. Forty-seven patients (55.3%) achieved remission of AU, 28 (32.9%) had recurrent AU, and 10 (11.8%) maintained a chronic course. A higher remission rate was observed with ADA (67.4% vs 42.8% with IFX; p = 0.025). Ocular complications decreased from 0.47 to 0.32 per subject. Five patients experienced resolution of structural complications. No patient reported serious AE; 8 (8.8%) experienced 11 minor AE (9 with IFX, 2 with ADA).

CONCLUSION: IFX and ADA appear to be effective and safe for treatment of refractory JIA-related uveitis, with a better performance of ADA in the medium-term period.

%B J Rheumatol %V 40 %P 74-9 %8 2013 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/23118110?dopt=Abstract %R 10.3899/jrheum.120583 %0 Journal Article %J Eur J Obstet Gynecol Reprod Biol %D 2013 %T Third trimester abdominal circumference, estimated fetal weight and uterine artery doppler for the identification of newborns small and large for gestational age. %A Di Lorenzo, Giovanni %A Monasta, Lorenzo %A Ceccarello, Matteo %A Cecotti, Vera %A D'Ottavio, Giuseppina %K Adult %K Anthropometry %K Birth Weight %K Diabetes, Gestational %K Female %K Fetal Growth Retardation %K Fetal Weight %K Gestational Age %K Humans %K Hypertension, Pregnancy-Induced %K Infant, Newborn %K Infant, Small for Gestational Age %K Pregnancy %K Pregnancy Trimester, Third %K Prospective Studies %K Sensitivity and Specificity %K Ultrasonography, Prenatal %K Uterine Artery %X

OBJECTIVE: To understand if ultrasound biometric evaluation at 30-32 weeks of gestation is a valuable screening tool for the detection of small-for-gestational-age (SGA) and large-for-gestational-age (LGA) infants at birth in a low risk population.

STUDY DESIGN: We enrolled 1848 pregnant women with singleton pregnancy undergoing routine fetal biometry. We divided the infants into four groups: moderate SGA, severe SGA, moderate LGA and severe LGA. We considered third-trimester estimated fetal weight (EFW), abdominal circumference (AC), EFW centile (EFWc), AC centile (ACc) and compared their prediction toward SGA and LGA to determine which of these parameters was the best estimator for fetal size. Then we took the strongest predictive value and added all history-related and ultrasound factors to run a stepdown multivariate logistic regression. All the variables were then dichotomized and sensitivity models only for statistically significant parameters were calculated.

RESULTS: We identified the following predictive factors for each outcome: for severe SGA: EFWc with p<0.001, uterine artery pulsatility index (UtA PI) with p<0.002. For moderate SGA: EFWc with p<0.001, UtA PI with p<0.004, maternal preeclampsia p<0.002. For moderate and severe LGA: EFWc with p<0.001.

CONCLUSION: We can detect in a low-risk population a group at risk of growth deviations. Adding Doppler velocimetry to 30-32 weeks EFWc improves the specificity (84%) regarding SGA newborns, maintaining a good sensitivity (71%), and reducing the population to be re-screened from 27 to 17%. An ultrasound examination at 34-36 weeks or the clinical assessment of maternal risk factors remain the best tools for LGA newborns.

%B Eur J Obstet Gynecol Reprod Biol %V 166 %P 133-8 %8 2013 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/23122032?dopt=Abstract %R 10.1016/j.ejogrb.2012.10.010 %0 Journal Article %J Breastfeed Med %D 2012 %T Academy of breastfeeding medicine founder's lecture 2011: inequalities and inequities in breastfeeding: an international perspective. %A Cattaneo, Adriano %K Breast Feeding %K Cross-Cultural Comparison %K Female %K Health Policy %K Health Promotion %K Healthcare Disparities %K Humans %K Infant Food %K Infant, Newborn %K Internationality %K Maternal Health Services %K Mothers %K Pregnancy %K Socioeconomic Factors %X

Breastfeeding is the biological norm for infant feeding but is also a social construct. As such, its rates and practices are determined by the same social determinants that shape health inequalities and inequities. In the past 30 years, several reports have drawn attention to the changing pattern of breastfeeding inequalities across countries and population groups. Breastfeeding rates tend to fall and rise following a similar pattern everywhere, although at different times and speed. The role of women within families and societies, the routines of maternity hospitals and other healthcare services, and the pressure exerted by the baby food industry are among the factors that influence the time and speed of changes in breastfeeding rates and practices across countries and population groups. Inequities (i.e., inequalities considered unfair and avoidable by reasonable action) can be redressed by interventions for the protection, promotion, and support of breastfeeding. Evidence-based and quality-implemented support and promotion activities, if applied without an equity lens, may increase inequities. Activities for the protection of breastfeeding (e.g., implementation and enforcement of the International Code of Marketing of Breastmilk Substitutes; legislations, regulations, and policies to remove obstacles and barriers to good-quality breastfeeding support and to protect women and mothers in the workforce; elimination of obstacles and barriers to breastfeeding anywhere, anyhow, and anytime mothers want) apply to all women and are less dependent on take up by the target population. If well designed and enforced, protective interventions contribute to reducing inequalities and inequities and to delivering promotion and support activities more effectively.

%B Breastfeed Med %V 7 %P 3-9 %8 2012 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22168906?dopt=Abstract %R 10.1089/bfm.2012.9999 %0 Journal Article %J J Pediatr Gastroenterol Nutr %D 2012 %T Acute febrile cholestatic jaundice in children: keep in mind Kawasaki disease. %A Taddio, Andrea %A Pellegrin, Maria Chiara %A Centenari, Chiara %A Filippeschi, Irene Pellegrini %A Ventura, Alessandro %A Maggiore, Giuseppe %K Child %K Child, Preschool %K Diagnosis, Differential %K Female %K Fever %K Humans %K Infant %K Jaundice, Obstructive %K Male %K Mucocutaneous Lymph Node Syndrome %K Virus Diseases %X

Kawasaki disease (KD) is characterized by persistent fever in addition to 4 of 5 signs of mucocutaneous inflammation. Although gastrointestinal involvement does not belong to the classic diagnostic criteria, it has been often associated with KD onset. We reviewed patients who were admitted for febrile cholestatic jaundice between 2003 and 2010 in 2 tertiary pediatric care centers. KD was the second most frequent cause (21%) after viral infections. Considering the relative high frequency of this condition, a high index of suspicion of KD should be maintained in patients presenting with febrile cholestatic jaundice.

%B J Pediatr Gastroenterol Nutr %V 55 %P 380-3 %8 2012 Oct %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22437475?dopt=Abstract %R 10.1097/MPG.0b013e31825513de %0 Journal Article %J Invest New Drugs %D 2012 %T Anti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. %A Bosco, Raffaella %A Rabusin, Marco %A Voltan, Rebecca %A Celeghini, Claudio %A Corallini, Federica %A Capitani, Silvano %A Secchiero, Paola %K Antineoplastic Agents %K Apoptosis %K B-Lymphocytes %K Cell Line, Tumor %K Cell Survival %K G1 Phase Cell Cycle Checkpoints %K Granulocyte Precursor Cells %K Humans %K Leukemia, Prolymphocytic, B-Cell %K Mitogen-Activated Protein Kinase 1 %K Mitogen-Activated Protein Kinase 3 %K Mutation %K p38 Mitogen-Activated Protein Kinases %K Phosphorylation %K Protein Kinase Inhibitors %K Pyrimidines %K STAT3 Transcription Factor %K Thiazoles %K Time Factors %K Tumor Suppressor Protein p53 %X

The multi-kinase inhibitor dasatinib induced a variable but significant decrease of viability in both p53(wild-type) (EHEB, JVM-2, JVM-3) and p53(mutated) (MEC-1, MEC-2, BJAB) prolymphocytic B leukemic cells, due to a combination of cell cycle block in G1 and apoptosis. Antibody phospho-kinase array analysis revealed that dasatinib inhibited the phosphorylation of various kinases, including ERK1/2 and p38/MAPK as well as of STAT3 transcription factors, in both p53(wild-type) and p53(mutated) cells. Therefore, dasatinib might offer a novel therapeutic strategy not only for p53(wild-type), but also for p53(mutated) B malignancies that have the worst prognosis and urgently need innovative therapeutic approaches.

%B Invest New Drugs %V 30 %P 417-22 %8 2012 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/20953816?dopt=Abstract %R 10.1007/s10637-010-9564-6 %0 Journal Article %J Tumori %D 2012 %T Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy. %A Comar, Manola %A Zanotta, Nunzia %A Pesel, Giuliano %A Visconti, Patrizia %A Maestri, Iva %A Rinaldi, Rosa %A Crovella, Sergio %A Cortale, Maurizio %A De Zotti, Renata %A Bovenzi, Massimo %K Adult %K Aged %K Asbestos %K Carcinogens %K Disease Susceptibility %K DNA, Viral %K Endemic Diseases %K Female %K Humans %K Italy %K Male %K Mesothelioma %K Middle Aged %K Pleural Neoplasms %K Polyomavirus Infections %K Real-Time Polymerase Chain Reaction %K Risk Factors %K Simian virus 40 %K Tumor Virus Infections %K Viral Load %X

AIMS AND BACKGROUND: Malignant mesothelioma is a fatal cancer of increasing incidence in north-eastern Italy. Together with asbestos, the polyomavirus SV40 was hypothesized to contribute to the onset of malignant mesothelioma. To investigate the putative role of SV40 in the individual susceptibility to asbestos-induced malignant mesothelioma, we conducted a molecular epidemiological study on a series of malignant mesothelioma patients from an area in north-eastern Italy hyperendemic for malignant pleural mesothelioma.

METHODS AND STUDY DESIGN: We collected 63 mesothelioma samples from incidence cases of patients diagnosed with malignant pleural mesothelioma in the period 2009-2010. DNA was extracted from patients' tissue biopsies using the BioRobot EZ1 Qiagen workstation. SV40 sequence detection and quantification was performed by specific real time PCR. The 74.6% of the 63 enrolled patients had a history of asbestos exposure. The epithelioid histotype was more prevalent in males (64.0%) and the mixed in females (61.5%) who showed significantly higher cancer co-morbidity (46.1% vs 12%, P = 0.005). SV40 was detected in 22% of MM tumors, with a low viral load. In SV40-positive patients, a threefold increased risk of asbestos exposure was observed, more evident in females (OR 4.32) than in males (OR 1.20).

CONCLUSIONS: Our findings indicate that a high prevalence of SV40 was present in malignant mesothelioma incident cases from an area hyperendemic for malignant mesothelioma in north-eastern Italy. Although asbestos is considered the main risk factor in malignant mesothelioma onset, a role for SV40 could be hypothesized.

%B Tumori %V 98 %P 210-4 %8 2012 Mar-Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22677986?dopt=Abstract %R 10.1700/1088.11931 %0 Journal Article %J Br J Clin Pharmacol %D 2012 %T Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. %A Cuzzoni, Eva %A De Iudicibus, Sara %A Bartoli, Fiora %A Ventura, Alessandro %A Decorti, Giuliana %K Adaptor Proteins, Signal Transducing %K Adolescent %K Adult %K Apoptosis Regulatory Proteins %K Cyclin D1 %K Dose-Response Relationship, Drug %K Female %K Genotype %K Glucocorticoids %K Humans %K Lymphocytes %K Male %K Methylprednisolone %K Middle Aged %K Polymorphism, Single Nucleotide %K Receptors, Glucocorticoid %K Young Adult %X

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: In vitro lymphocyte steroid sensitivity has been suggested as a useful tool to predict in vivo response to glucocorticoid treatment in different inflammatory chronic diseases. A correlation between genetic polymorphisms and clinical response to glucocorticoids has been demonstrated in these patients.

WHAT THIS STUDY ADDS: The BclI polymorphism in the glucocorticoid receptor (NR3C1) gene is associated with higher methylprednisolone potency in vitro. The combined evaluation of the in vitro sensitivity to methylprednisolone and BclI polymorphism could represent an aid for physicians to adjust therapy a priori. AIM To evaluate the association between the in vitro sensitivity of peripheral blood mononuclear cells (PBMCs) to methylprednisolone (MP) and the presence of genetic polymorphisms involved in glucocorticoid (GC) response.

METHODS: In vitro MP inhibition of the proliferation of lymphocytes stimulated with concanavalin A was determined. Non linear regression of dose-response data was performed computing the MP concentration required to reduce proliferation to 50% (IC(50) ). The maximum inhibition achievable at the highest MP concentration (I(max) ) was also calculated. Moreover, the Taqman technique was used to analyze the BclI polymorphism in the NR3C1 gene and the Leu155His polymorphism in the NALP1 gene.

RESULTS: A significant association between the BclI mutated genotype and an increased in vitro sensitivity to GCs was observed.

CONCLUSIONS: The a priori evaluation of the BclI polymorphism, associated with a lymphocyte proliferation assay, could represent a useful diagnostic tool for the optimization of steroid treatment.

%B Br J Clin Pharmacol %V 73 %P 651-5 %8 2012 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22008062?dopt=Abstract %R 10.1111/j.1365-2125.2011.04130.x %0 Journal Article %J PLoS One %D 2012 %T Association between the JC polyomavirus infection and male infertility. %A Comar, Manola %A Zanotta, Nunzia %A Croci, Eleonora %A Murru, Immacolata %A Marci, Roberto %A Pancaldi, Cecilia %A Dolcet, Ornella %A Luppi, Stefania %A Martinelli, Monica %A Giolo, Elena %A Ricci, Giuseppe %A Tognon, Mauro %K Adult %K Amino Acid Sequence %K Amino Acid Substitution %K Base Sequence %K BK Virus %K Capsid Proteins %K DNA, Viral %K Humans %K Infertility, Male %K JC Virus %K Male %K Molecular Sequence Data %K Polyomavirus Infections %K Semen %K Sequence Analysis, DNA %K Tumor Virus Infections %X

In recent years the incidence of male infertility has increased. Many risk factors have been taken into consideration, including viral infections. Investigations into viral agents and male infertility have mainly been focused on human papillomaviruses, while no reports have been published on polyomaviruses and male infertility. The aim of this study was to verify whether JC virus and BK virus are associated with male infertility. Matched semen and urine samples from 106 infertile males and 100 fertile males, as controls, were analyzed. Specific PCR analyses were carried out to detect and quantify large T (Tag) coding sequences of JCV and BKV. DNA sequencing, carried out in Tag JCV-positive samples, was addressed to viral protein 1 (VP1) coding sequences. The prevalence of JCV Tag sequences in semen and urine samples from infertile males was 34% (72/212), whereas the BKV prevalence was 0.94% (2/212). Specifically, JCV Tag sequences were detected in 24.5% (26/106) of semen and 43.4% (46/106) of urine samples from infertile men. In semen and urine samples from controls the prevalence was 11% and 28%, respectively. A statistically significant difference (p<0.05) in JCV prevalence was disclosed in semen and urine samples of cases vs. controls. A higher JC viral DNA load was detected in samples from infertile males than in controls. In samples from infertile males the JC virus type 2 strain, subtype 2b, was more prevalent than ubiquitous type 1. JCV type 2 strain infection has been found to be associated with male infertility. These data suggest that the JC virus should be taken into consideration as an infectious agent which is responsible for male infertility.

%B PLoS One %V 7 %P e42880 %8 2012 %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/22912758?dopt=Abstract %R 10.1371/journal.pone.0042880 %0 Journal Article %J Int J Immunogenet %D 2012 %T Association of MBL2 gene exon 1 variants with autoimmune thyroid disease in Brazilian patients. %A Filho, C B %A Rodrigues, F F %A Segat, L %A Fonseca, A M %A Araujo, J %A Arahata, C %A Pontes, L %A Vilar, L %A de Lima Filho, J L %A Crovella, S %K Adolescent %K Adult %K Brazil %K Case-Control Studies %K Child %K Child, Preschool %K Exons %K Female %K Genetic Association Studies %K Genetic Predisposition to Disease %K Genetic Testing %K Graves Disease %K Hashimoto Disease %K Humans %K Infant %K Male %K Mannose-Binding Lectin %K Middle Aged %K Polymorphism, Single Nucleotide %K Young Adult %X

We investigated the association between MBL2 gene exon 1 functional polymorphisms and autoimmune thyroid disease (AITD) in 163 Brazilian patients (87 with Hashimoto thyroiditis, HT; 76 with Graves' disease) and 214 healthy controls. Individuals carrying MBL2 O allele are at higher risk of developing AITD (OR = 1.58, 95% CI: 1.11-2.26; P-value = 0.009) and HT (OR = 1.67, 95% CI: 1.09-2.55; P-value = 0.013) as suggesting a possible role for mannose-binding lectin in influencing disease susceptibility.

%B Int J Immunogenet %V 39 %P 357-61 %8 2012 Aug %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22360648?dopt=Abstract %R 10.1111/j.1744-313X.2012.01102.x %0 Journal Article %J J Endocrinol Invest %D 2012 %T Autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy in Calabria: clinical, immunological and genetic patterns. %A Betterle, C %A Ghizzoni, L %A Cassio, A %A Baronio, F %A Cervato, S %A Garelli, S %A Barbi, E %A Tonini, G %K Adolescent %K Adult %K Autoantibodies %K Child %K Female %K Genetic Association Studies %K Heterozygote %K Homozygote %K Humans %K Italy %K Male %K Mutation %K Polyendocrinopathies, Autoimmune %K Prognosis %K Sicily %K Transcription Factors %K Young Adult %X

UNLABELLED: Autoimmune polyendocrinopathy-candidiasis-ectodermal- dystrophy (APECED), also known as autoimmune polyendocrine syndrome type 1 (APS-1), is a very rare disease. Diagnosis requires the presence of at least two of three major clinical features: chronic mucocutaneous candidiasis, chronic hypoparathyroidism, and Addison's disease.

DESIGN: In this study, we analyzed Autoimmune Regulator (AIRE) gene mutations and genotype-phenotype correlation in APECED patients originating from Calabria, a region in the south of Italy.

PATIENTS AND METHODS: Four patients and their first-degree relatives were evaluated for clinical manifestations, autoantibody presence and AIRE gene mutations.

RESULTS: Three patients carried a homozygous W78R mutation on exon 2, typical of patients with APECED from Apulia; the fourth patient had a homozygous R203X mutation on exon 5, typical of APECED patients from Sicily. Clinical disease expression showed wide variability. Analysis of relatives allowed the identification of 6 heterozygotes, none of whom showed major findings of APECED.

CONCLUSIONS: No AIRE gene mutations specific to Calabria were found in patients with APS-1, but mutations similar to those in patients from Apulia and Sicily. Heterozygosity for AIRE gene mutation is not associated with major findings of APECED.

%B J Endocrinol Invest %V 35 %P 877-81 %8 2012 Nov %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/22104652?dopt=Abstract %R 10.3275/8109 %0 Journal Article %J Genes Immun %D 2012 %T CD14 polymorphisms correlate with an augmented risk for celiac disease in Italian patients. %A Catamo, E %A Segat, L %A Lenarduzzi, S %A Petix, V %A Morgutti, M %A Crovella, S %K Adolescent %K Adult %K Aged %K Antigens, CD14 %K Case-Control Studies %K Celiac Disease %K Child %K Child, Preschool %K European Continental Ancestry Group %K Female %K Gene Frequency %K Genetic Predisposition to Disease %K Haplotypes %K HLA Antigens %K Humans %K Infant %K Italy %K Linkage Disequilibrium %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Risk Factors %K Young Adult %X

Celiac disease (CD) is a T-cell-mediated chronic inflammatory disease characterized by autoimmune, immunological and environmental components, where genetic factors in addition to the main known risk factors (gliadin and human leukocyte antigen (HLA)-DQ haplotypes) are supposed to be involved. CD14 is a multifunctional receptor involved in the bacterial lipopolysaccharides-dependent signal transduction. The CD14 gene maps on the long arm of chromosome 5 (5q22-q32), a 'hotbed' region for CD; promoter polymorphisms are known to influence its expression. In this study we analyzed three CD14 promoter polymorphisms (c.-1359G>T, c.-1145A>G and c.-159C>T, ) in 938 CD Italian patients and 533 healthy controls, with known HLA-DQ haplotypes, with the aim of evaluating their possible association with the disease. The c.-1145A>G G and c.-159C>T T alleles (as well as the combination of the two alleles in the GT haplotype), were identified as susceptibility factors for CD development, being significantly more frequent in CD patients than in healthy controls. This association was also confirmed when the analysis was restricted to only those subjects characterized by HLA-DQ risk haplotypes. Our results indicate the involvement of CD14 gene polymorphisms in the susceptibility to CD.

%B Genes Immun %V 13 %P 489-95 %8 2012 Sep %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22648004?dopt=Abstract %R 10.1038/gene.2012.23 %0 Journal Article %J J Clin Endocrinol Metab %D 2012 %T Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy. %A Carlino, Claudia %A Trotta, Eleonora %A Stabile, Helena %A Morrone, Stefania %A Bulla, Roberta %A Soriani, Alessandra %A Iannitto, Maria Luisa %A Agostinis, Chiara %A Mocci, Carlo %A Minozzi, Massimo %A Aragona, Cesare %A Perniola, Giorgia %A Tedesco, Francesco %A Sozzani, Silvano %A Santoni, Angela %A Gismondi, Angela %K Capillaries %K Cell Movement %K Chemokines %K Decidua %K Endothelial Cells %K Female %K Humans %K Killer Cells, Natural %K MAP Kinase Signaling System %K Neovascularization, Physiologic %K Pregnancy %K Pregnancy Trimester, First %K Receptors, Chemokine %K RNA, Messenger %K Stromal Cells %K Trophoblasts %X

CONTEXT: Although decidual natural killer (NK) cell accumulation and vascular remodeling are critical steps to ensure successful pregnancy, the molecular mechanisms controlling these events are poorly defined.

OBJECTIVE: Herein we analyzed whether chemerin, a recently identified chemoattractant involved in many pathophysiological processes, could be expressed in the uterine compartment and could regulate events relevant for the good outcome of pregnancy.

DESIGN: Chemerin expression in human primary culture of stromal (ST) cells, extravillous trophoblast cells, and decidual endothelial cells (DEC) was analyzed by RT-PCR, ELISA, and Western blot. Migration through ST or DEC of peripheral blood and decidual (d) NK cells from pregnant women was performed using a transwell assay. A DEC capillary-like tube formation assay was used to evaluate endothelial morphogenesis.

RESULTS: Chemerin is differentially expressed by decidual cells during early pregnancy being present at high levels in ST and extravillous trophoblast cells but not in DEC. Notably, ST cells from pregnant women exhibit and release higher levels of chemerin as compared with ST cells from menopausal or fertile nonpregnant women. Chemerin can support peripheral blood NK cell migration through both DEC and ST cells. Although dNK cells exhibit lower chemerin receptor (CMKLR1) expression than their blood counterpart, CMKLR1 engagement on dNK cells resulted in both ERK activation and migration through decidual ST cells. Interestingly, DEC also express CMKLR1 and undergo ERK activation and capillary-like tube structure formation upon exposure to chemerin.

CONCLUSIONS: Our data indicate that chemerin is up-regulated during decidualization and might contribute to NK cell accumulation and vascular remodeling during early pregnancy.

%B J Clin Endocrinol Metab %V 97 %P 3603-12 %8 2012 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/22791765?dopt=Abstract %R 10.1210/jc.2012-1102 %0 Journal Article %J Arch Bronconeumol %D 2012 %T A child with severe pneumomediastinum and ABCA3 gene mutation: a puzzling connection. %A Copertino, Marco %A Barbi, Egidio %A Poli, Furio %A Zennaro, Floriana %A Ferrari, Maurizio %A Carrera, Paola %A Ventura, Alessandro %K Anemia %K ATP-Binding Cassette Transporters %K Child, Preschool %K Dyspnea %K Genetic Predisposition to Disease %K Heterozygote %K Humans %K Intensive Care %K Leukocytosis %K Male %K Mediastinal Emphysema %K Mutation, Missense %K Point Mutation %K Pulmonary Emphysema %K Respiratory Tract Infections %K Subcutaneous Emphysema %K Tomography, X-Ray Computed %B Arch Bronconeumol %V 48 %P 139-40 %8 2012 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22304854?dopt=Abstract %R 10.1016/j.arbres.2011.11.008 %0 Journal Article %J Cell Biochem Funct %D 2012 %T Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation. %A Bianco, Anna Monica %A Zanin, Valentina %A Marcuzzi, Annalisa %A Crovella, Sergio %K Carcinoma, Hepatocellular %K Enzyme Inhibitors %K Humans %K Hydroxymethylglutaryl-CoA Reductase Inhibitors %K Liver Neoplasms %K Simvastatin %K Terpenes %B Cell Biochem Funct %V 30 %P 176 %8 2012 Mar %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22275121?dopt=Abstract %R 10.1002/cbf.2798 %0 Journal Article %J Haematologica %D 2012 %T Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation). %A Noris, Patrizia %A Perrotta, Silverio %A Bottega, Roberta %A Pecci, Alessandro %A Melazzini, Federica %A Civaschi, Elisa %A Russo, Sabina %A Magrin, Silvana %A Loffredo, Giuseppe %A Di Salvo, Veronica %A Russo, Giovanna %A Casale, Maddalena %A De Rocco, Daniela %A Grignani, Claudio %A Cattaneo, Marco %A Baronci, Carlo %A Dragani, Alfredo %A Albano, Veronica %A Jankovic, Momcilo %A Scianguetta, Saverio %A Savoia, Anna %A Balduini, Carlo L %K Adolescent %K Adult %K Aged %K Aged, 80 and over %K Bernard-Soulier Syndrome %K Child %K Child, Preschool %K Family Health %K Female %K Heterozygote %K Humans %K Infant %K Italy %K Male %K Membrane Glycoproteins %K Middle Aged %K Mutation, Missense %K Platelet Aggregation %K Platelet Count %K Platelet Glycoprotein GPIb-IX Complex %K Polymorphism, Genetic %K Thrombocytopenia %K Thrombopoietin %K Tubulin %K Young Adult %X

BACKGROUND: Bernard-Soulier syndrome is a very rare form of inherited thrombocytopenia that derives from mutations in GPIbα, GPIbβ, or GPIX and is typically inherited as a recessive disease. However, some years ago it was shown that the monoallelic c.515C>T transition in the GPIBA gene (Bolzano mutation) was responsible for macrothrombocytopenia in a few Italian patients.

DESIGN AND METHODS: Over the past 10 years, we have searched for the Bolzano mutation in all subjects referred to our institutions because of an autosomal, dominant form of thrombocytopenia of unknown origin.

RESULTS: We identified 42 new Italian families (103 cases) with a thrombocytopenia induced by monoallelic Bolzano mutation. Analyses of the geographic origin of affected pedigrees and haplotypes indicated that this mutation originated in southern Italy. Although the clinical expression was variable, patients with this mutation typically had a mild form of Bernard-Soulier syndrome with mild thrombocytopenia and bleeding tendency. The most indicative laboratory findings were enlarged platelets and reduced GPIb/IX/V platelet expression; in vitro platelet aggregation was normal in nearly all of the cases.

CONCLUSIONS: Our study indicates that monoallelic Bolzano mutation is the most frequent cause of inherited thrombocytopenia in Italy, affecting 20% of patients recruited at our institutions during the last 10 years. Because many people from southern Italy have emigrated during the last century, this mutation may have spread to other countries.

%B Haematologica %V 97 %P 82-8 %8 2012 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21933849?dopt=Abstract %R 10.3324/haematol.2011.050682 %0 Journal Article %J J Pediatr Gastroenterol Nutr %D 2012 %T Coeliac disease diagnosis: ESPGHAN 1990 criteria or need for a change? Results of a questionnaire. %A Ribes-Koninckx, C %A Mearin, M L %A Korponay-Szabó, I R %A Shamir, R %A Husby, S %A Ventura, A %A Branski, D %A Catassi, C %A Koletzko, S %A Mäki, M %A Troncone, R %A Zimmer, K P %K Adolescent %K Adult %K Biopsy %K Celiac Disease %K Child %K Child, Preschool %K Glutens %K Guideline Adherence %K Guidelines as Topic %K Health Care Surveys %K Humans %K Immunoglobulin A %K Intestine, Small %K Physician's Practice Patterns %K Questionnaires %K Societies, Medical %K Transglutaminases %K Young Adult %X

BACKGROUND AND OBJECTIVES: A revision of criteria for diagnosing coeliac disease (CD) is being conducted by The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). In parallel, we have performed a survey aimed to evaluate present practices for CD among paediatric gastroenterologists and to learn their views on the need for modification of present criteria for CD diagnosis.

PATIENTS AND METHODS: Questionnaires were distributed to experienced paediatric gastroenterologists (ESPGHAN members) via the Internet.

RESULTS: Overall, 95 valid questionnaires were available for analysis, pertaining to 28 different countries, with the majority of responders treating patients with CD for >15 years. Only about 12% of the responders comply with present criteria, noncompliance being related mainly to the challenge policy. Approximately 90% request a revision and modification of the present criteria. Forty-four percent want to omit the small bowel biopsy in symptomatic children with positive anti-tissue transglutaminase immunoglobulin (Ig) A or endomysial IgA antibodies, especially if they are DQ2/DQ8 positive. For silent cases detected by screening with convincingly positive anti-tissue transglutaminase IgA or EMA IgA, about 30% consider that no small bowel biopsy should be required in selected cases. Adding human leukocyte antigen typing in the diagnostic workup was asked for by 42% of the responders. As for gluten challenge, a new policy is advocated restricting its obligation to cases whenever the diagnosis is doubtful or unclear.

CONCLUSIONS: Based on these opinions, revision of the ESPGHAN criteria for diagnosing CD is urgently needed.

%B J Pediatr Gastroenterol Nutr %V 54 %P 15-9 %8 2012 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21716133?dopt=Abstract %R 10.1097/MPG.0b013e31822a00bb %0 Journal Article %J Early Hum Dev %D 2012 %T Cognitive assessment of very preterm infants at 2-year corrected age: performance of the Italian version of the PARCA-R parent questionnaire. %A Cuttini, Marina %A Ferrante, Pierpaolo %A Mirante, Nadia %A Chiandotto, Valeria %A Fertz, Mariacristina %A Dall'Oglio, Anna Maria %A Coletti, Maria Franca %A Johnson, Samantha %K Cognition %K Female %K Humans %K Infant %K Infant, Newborn %K Infant, Premature %K Italy %K Male %K Parents %K Questionnaires %K ROC Curve %X

BACKGROUND: Serial assessments of cognitive and language development are recommended for very preterm children, but standardized neuropsychological testing is time-consuming and expensive, as well as tiring for the child.

AIMS: To validate the Italian version of the PARCA-R parent questionnaire and test its clinical effectiveness in assessing cognitive development of very preterm children at 2 years of corrected age.

METHODS: 120 consecutive Italian very preterm children (mean gestational age 28.8 weeks, standard deviation 2.1) were assessed in four hospitals through the Mental Development Index (MDI) of the Bayley Scales of Infant Development (BSID-II). Parents completed the PARCA-R questionnaire, designed to measure children's non-verbal and verbal (vocabulary and sentence complexity) cognitive level. The correlation between the MDI and the PARCA-R Parent Report Composite (PRC) was tested through the Pearson correlation coefficient, and the receiver operating characteristic (ROC) curve was used to identify optimal PRC cut-offs.

RESULTS: Significant correlation between the PRC score and MDI (r=0.60, p<0.001) indicated good concurrent validity. The area under the ROC curve was 0.83, and the cut-off of 46 lead to 72.7% sensitivity and 77.1% specificity in identifying children with moderate/severe cognitive delay (MDI<70). Negative predictive value was 96.6 (90.3-99.3). Screening through PARCA-R would reduce the number of children with MDI≥70 undergoing BSID-II or equivalent standardized tool from 109 to 25.

CONCLUSIONS: The Italian version of PARCA-R retains good discriminative power for identifying cognitive delay in 2-year very preterm children. It is well accepted by parents, and represents a valid and efficient alternative for developmental screening and outcome measurement.

%B Early Hum Dev %V 88 %P 159-63 %8 2012 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21862246?dopt=Abstract %R 10.1016/j.earlhumdev.2011.07.022 %0 Journal Article %J Toxicology %D 2012 %T Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al. %A Vuch, Josef %A Marcuzzi, Annalisa %A Zanin, Valentina %A Crovella, Sergio %K Animals %K Antineoplastic Agents %K Kidney Neoplasms %K Male %K Signal Transduction %K Terpenes %B Toxicology %V 293 %P 123-4 %8 2012 Mar 11 %G eng %N 1-3 %1 http://www.ncbi.nlm.nih.gov/pubmed/22210290?dopt=Abstract %R 10.1016/j.tox.2011.12.008 %0 Journal Article %J Med Hypotheses %D 2012 %T A common genetic background could explain early-onset Crohn's disease. %A Bianco, Anna Monica %A Zanin, Valentina %A Girardelli, Martina %A Magnolato, Andrea %A Martelossi, Stefano %A Martellossi, Stefano %A Tommasini, Alberto %A Marcuzzi, Annalisa %A Crovella, Sergio %K Crohn Disease %K Genetic Linkage %K Genetic Predisposition to Disease %K Humans %K Models, Biological %X

Crohn's disease (CD) is a multifactorial disease, in which environmental, microbial and genetic factors play important roles. CD is characterized by a chronic granulomatous inflammation by necrotic scarring with aspects of full-thickness wall. In spite of affecting mainly young adults, sometimes, CD can be present in the first year of life (early onset Crohn disease, EOCD) showing an unpredictable course and being often more severe than at older ages. In this paper we propose the hypothesis that EOCD patients should be analyzed using a Mendelian approach with family studies aimed to identify new loci directly involved in the early onset Crohn's disease. So we will leave the classic association study approach used until now for the identification of genes responsible for susceptibility to CD and propose linkage family analysis as alternative and powerful tool for the identification of new genetic variants associated with familiar cases of EOCD.

%B Med Hypotheses %V 78 %P 520-2 %8 2012 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22309886?dopt=Abstract %R 10.1016/j.mehy.2012.01.023 %0 Journal Article %J J Clin Microbiol %D 2012 %T Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance. %A Comar, Manola %A Iannacone, Michelle R %A Casalicchio, Giorgia %A McKay-Chopin, Sandrine %A Tommasino, Massimo %A Gheit, Tarik %K Adult %K DNA, Viral %K Female %K Humans %K Molecular Diagnostic Techniques %K Papillomavirus Infections %K Sensitivity and Specificity %K Uterine Cervical Neoplasms %K Virology %X

Many methods with different levels of analytical sensitivity and clinical specificity have been developed to detect the presence of high-risk (HR) types of the human papillomavirus (HPV) in cervical samples. The Hybrid Capture II (HC-II) assay is broadly used for primary screening. In addition, several HPV genotyping assays, based on PCR methods, display higher sensitivity than the HC-II and are also used in screening programs. We evaluated the performance of three HPV DNA tests, namely, the HC-II, the Linear Array (LA) HPV genotyping assay, and an HPV type-specific E7 PCR bead-based multiplex genotyping assay (TS-MPG) that is a laboratory-developed method for the detection of HPV, in 94 women with atypical squamous cells of undetermined significance (ASC-US) and in cytological samples from 86 women with a negative Pap test. The HPV prevalence with the TS-MPG assay was increased compared to the prevalence with the LA and HC-II assays. The HPV DNA prevalence in women with ASC-US was greater with the TS-MPG assay (46.2%) than with the LA (36.3%) and HC-II (29.7%) assays. The HPV DNA prevalence in the control group was greater with the TS-MPG assay (32.1%) than with the LA assay (10.7%). Two women with ASC-US who were HPV DNA negative by the HC-II and positive by the TS-MPG or/and LA assays had lesions that progressed to low-grade squamous intraepithelial and high-grade squamous intraepithelial lesions. This study shows that the TS-MPG assay exhibited higher analytical sensitivity than the LA and HC-II assays for the detection of HPV DNA, which reduces the potential to incorrectly identify a woman's HPV infection status.

%B J Clin Microbiol %V 50 %P 4041-6 %8 2012 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/23035194?dopt=Abstract %R 10.1128/JCM.02105-12 %0 Journal Article %J Gene %D 2012 %T Contribution of SNP arrays in diagnosis of deletion 2p11.2-p12. %A Rocca, Maria Santa %A Fabretto, Antonella %A Faletra, Flavio %A Carlet, Ombretta %A Skabar, Aldo %A Gasparini, Paolo %A Pecile, Vanna %K Abnormalities, Multiple %K Child %K Chromosomes, Human, Pair 2 %K Female %K Humans %K Intellectual Disability %K Oligonucleotide Array Sequence Analysis %K Polymorphism, Single Nucleotide %K Sequence Deletion %X

Deletions of the short arm of chromosome 2 are exceedingly rare, having been reported in few patients. Furthermore most cases with deletion in 2p11.2-p12 have been studied using standard karyotype and so it is not possible to delineate the precise size of deletions. Here, we describe a 9-year-old girl with a 9.4 Mb de novo interstitial deletion of region 2p11.2-p12 identified by SNP array analysis. The deleted region encompasses over 40 known genes, including LRRTM1, CTNNA2 and REEP1, haploinsufficiency of which could explain some clinical features of this patient such as mental retardation, speech delay and gait abnormalities. A comparison of our case with previously reported patients who present deletions in 2p11.2-p12 was carried out. Our case adds new information to the deletion of 2p11.2-p12, improving the knowledge on this rearrangement.

%B Gene %V 492 %P 315-8 %8 2012 Jan 15 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22062632?dopt=Abstract %R 10.1016/j.gene.2011.10.035 %0 Journal Article %J Clinics (Sao Paulo) %D 2012 %T DEFB1 gene 5' untranslated region (UTR) polymorphisms in inflammatory bowel diseases. %A Zanin, Valentina %A Segat, Ludovica %A Bianco, Anna Monica %A Padovan, Lara %A Tavares, Nathalia de Alencar Cunha %A Crovella, Sergio %K 5' Untranslated Regions %K Adult %K Antimicrobial Cationic Peptides %K beta-Defensins %K Case-Control Studies %K Colitis, Ulcerative %K Crohn Disease %K Female %K Genetic Predisposition to Disease %K Haplotypes %K Humans %K Inflammatory Bowel Diseases %K Male %K Polymorphism, Genetic %K Polymorphism, Single Nucleotide %B Clinics (Sao Paulo) %V 67 %P 395-8 %8 2012 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22522766?dopt=Abstract %0 Journal Article %J J Pediatr Gastroenterol Nutr %D 2012 %T Delayed diagnosis of glycogen storage disease type III. %A Minen, Federico %A Cont, Gabriele %A De Cunto, Angela %A Martelossi, Stefano %A Ventura, Alessandro %A Maggiore, Giuseppe %A Faletra, Flavio %A Gasparini, Paolo %A Cassandrini, Denise %K Delayed Diagnosis %K Diagnostic Errors %K Glycogen Storage Disease Type I %K Glycogen Storage Disease Type III %K Humans %K Infant %K Liver %K Male %B J Pediatr Gastroenterol Nutr %V 54 %P 122-4 %8 2012 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21691223?dopt=Abstract %R 10.1097/MPG.0b013e318228d806 %0 Journal Article %J Eur Ann Allergy Clin Immunol %D 2012 %T Diagnosed child, treated child: food challenge as the first step toward tolerance induction in cow's milk protein allergy. %A Longo, G %A Berti, I %A Barbi, E %A Calligaris, L %A Matarazzo, L %A Radillo, O %A Ronfani, L %A Ventura, A %K Administration, Oral %K Adolescent %K Animals %K Cattle %K Child %K Child, Preschool %K Humans %K Immune Tolerance %K Infant %K Milk Hypersensitivity %K Milk Proteins %K Self Administration %X

BACKGROUND: Food challenge is required to assess tolerance in cow milk (CM) allergy. A positive challenge contraindicates the reintroduction of CM. Specific oral tolerance induction (SOTI) is a promising treatment.

METHODS: All children admitted for a challenge were prospectively enrolled. To those tolerating between 2 and 150 ml a SOTI protocol was offered. Outcome, adverse reactions, parents' satisfaction were recorded.

RESULTS: Out of 245 challenged patients, 175 reacted 122 out of 125, able to tolerate a minimum dose of 2 ml, underwent SOTI. After one year 75.4% were in an unrestricted diet, 16.1% tolerated between 5 and 150 ml, 8.5% stopped SOTI. Side effects were mild, parents' satisfaction was very high.

CONCLUSIONS: The majority of children tolerating limited amounts of CM at the challenge acquires tolerance with SOTI without relevant side effects. Maintaining on an exclusion diet partially tolerant children should be considered debatable.

%B Eur Ann Allergy Clin Immunol %V 44 %P 54-60 %8 2012 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22768724?dopt=Abstract %0 Journal Article %J Am J Med Genet A %D 2012 %T Does the 1.5 Mb microduplication in chromosome band Xp22.31 have a pathogenetic role? New contribution and a review of the literature. %A Faletra, Flavio %A d'Adamo, Adamo Pio %A Santa Rocca, Maria %A Carrozzi, Marco %A Perrone, Maria Dolores %A Pecile, Vanna %A Gasparini, Paolo %K Chromosome Breakpoints %K Chromosome Duplication %K Chromosomes, Human, X %K Hand Deformities, Congenital %K Humans %K Intellectual Disability %K Karyotyping %K Muscle Hypotonia %K Polymorphism, Single Nucleotide %K Protein Tyrosine Phosphatases %B Am J Med Genet A %V 158A %P 461-4 %8 2012 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22140086?dopt=Abstract %R 10.1002/ajmg.a.34398 %0 Journal Article %J Inflamm Res %D 2012 %T The effect of clodronate on a mevalonate kinase deficiency cellular model. %A Zanin, Valentina %A Marcuzzi, Annalisa %A Piscianz, Elisa %A Vuch, Josef %A Bianco, Anna Monica %A Monasta, Lorenzo %A Decorti, Giuliana %A Crovella, Sergio %K Adolescent %K Adult %K Alendronate %K Animals %K Anti-Inflammatory Agents %K Apoptosis %K Cell Line %K Cells, Cultured %K Child %K Clodronic Acid %K Female %K Humans %K Inflammation %K Lipopolysaccharides %K Male %K Mevalonate Kinase Deficiency %K Mice %K Models, Biological %K Monocytes %K Nitric Oxide %K Young Adult %X

BACKGROUND: A potential anti-inflammatory effect of clodronate--an aminobisphosphonate--was described to antagonize the pro-inflammatory effects of the block in the mevalonate pathway, the main feature of a rare auto-inflammatory disease called mevalonate kinase deficiency (MKD).

OBJECTIVE: In this study we evaluated the potential anti-inflammatory effect of clodronate in MKD--a still orphan drug pediatric disease.

METHODS: We studied some biological parameters, nitric oxide production using Griess reagents and programmed cell death by flow cytometry, as common inflammatory parameters in MKD, in the presence of different doses of clodronate (1, 10 and 100 μM).

RESULTS: In our cellular model and in monocytes from patients with MKD, clodronate induced an increase in programed cell death and nitric oxide production in comparison with non-treated cells.

CONCLUSION: Our findings suggest that clodronate does not have an anti-inflammatory effect as previously reported but that it increases the epiphenomena of this pediatric disease.

%B Inflamm Res %V 61 %P 1363-7 %8 2012 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/22851203?dopt=Abstract %R 10.1007/s00011-012-0537-4 %0 Journal Article %J J Pediatr %D 2012 %T Effects of prone and supine position on cerebral blood flow in preterm infants. %A Bembich, Stefano %A Oretti, Chiara %A Travan, Laura %A Clarici, Andrea %A Massaccesi, Stefano %A Demarini, Sergio %K Cerebrovascular Circulation %K Female %K Humans %K Infant, Newborn %K Infant, Premature %K Male %K Prone Position %K Regional Blood Flow %K Supine Position %X

We evaluated the effect of prone and supine position on cerebral blood flow (CBF) in stable preterm infants. CBF, PO(2), and PCO(2) were measured in the two positions. Peripheral oxygenation increased and CBF decreased in prone position. We speculate that CBF autoregulation may compensate for increased peripheral oxygenation, by decreasing CBF.

%B J Pediatr %V 160 %P 162-4 %8 2012 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22000305?dopt=Abstract %R 10.1016/j.jpeds.2011.08.056 %0 Journal Article %J Antimicrob Agents Chemother %D 2012 %T Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota. %A Cruciani, Federica %A Brigidi, Patrizia %A Calanni, Fiorella %A Lauro, Vittoria %A Tacchi, Raffaella %A Donders, Gilbert %A Peters, Klaus %A Guaschino, Secondo %A Vitali, Beatrice %K Adolescent %K Adult %K Anti-Bacterial Agents %K Double-Blind Method %K Female %K Humans %K Lactobacillus %K Metagenome %K Middle Aged %K Rifamycins %K RNA, Ribosomal, 16S %K Vagina %K Vaginal Creams, Foams, and Jellies %K Vaginosis, Bacterial %K Young Adult %X

Bacterial vaginosis (BV) is a common vaginal disorder characterized by an alteration of the vaginal bacterial morphotypes, associated with sexually transmitted infections and adverse pregnancy outcomes. The purpose of the present study was to evaluate the impact of different doses of rifaximin vaginal tablets (100 mg/day for 5 days, 25 mg/day for 5 days, and 100 mg/day for 2 days) on the vaginal microbiota of 102 European patients with BV enrolled in a multicenter, double-blind, randomized, placebo-controlled study. An integrated molecular approach based on quantitative PCR (qPCR) and PCR-denaturing gradient gel electrophoresis (PCR-DGGE) was used to investigate the effects of vaginal tablets containing the antibiotic. An increase in members of the genus Lactobacillus and a decrease in the BV-related bacterial groups after the antibiotic treatment were demonstrated by qPCR. PCR-DGGE profiles confirmed the capability of rifaximin to modulate the composition of the vaginal microbial communities and to reduce their complexity. This molecular analysis supported the clinical observation that rifaximin at 25 mg/day for 5 days represents an effective treatment to be used in future pivotal studies for the treatment of BV.

%B Antimicrob Agents Chemother %V 56 %P 4062-70 %8 2012 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/22585228?dopt=Abstract %R 10.1128/AAC.00061-12 %0 Journal Article %J J Hum Lact %D 2012 %T Establishing the Baby-Friendly Community Initiative in Italy: development, strategy, and implementation. %A Bettinelli, Maria Enrica %A Chapin, Elise M %A Cattaneo, Adriano %K Breast Feeding %K Continuity of Patient Care %K Delivery Rooms %K Female %K Health Policy %K Humans %K Infant %K Infant Care %K Infant Welfare %K Infant, Newborn %K Italy %K Maternal Health Services %K Organizational Policy %K Outcome and Process Assessment (Health Care) %K Practice Guidelines as Topic %K Pregnancy %K Program Development %K Program Evaluation %K United Nations %K World Health Organization %X

BACKGROUND: The Baby-Friendly Hospital Initiative (BFHI), developed by the World Health Organization and the United Nations Children's Fund (UNICEF) to promote breastfeeding in maternity facilities worldwide, has had a global impact on breastfeeding outcomes, but other interventions are needed both before and after hospital discharge to meet the recommended targets at 6 months. The Baby-Friendly Community Initiative (BFCI), a multifaceted program for community-based breastfeeding promotion that is complementary to the BFHI, addresses this challenge.

OBJECTIVE: To describe the development, strategy, and implementation of the BFCI in Italy.

METHODS: In 2006, UNICEF Italy created a working group to develop the BFCI for the Italian health system. A review of the different BFCI models worldwide was conducted. A preliminary adaptation of tools to Italian community health care settings was developed in 2007, when the Italian BFCI Seven Steps were published. Two years later, UNICEF Italy launched the Standards for Best Practice for both hospitals and communities, based on 2009 BFHI and UNICEF UK BFCI materials.

OUTCOMES: The main outcome was to promote this process in Italian regional health systems and develop tools to assess compliance with the BFCI criteria. There is now one fully accredited Baby-Friendly Community in Italy, and 17 other communities are working on the various stages.

CONCLUSIONS: The BFCI, a complex program that involves participation, training, audits, a continuous flow of feedback, and provision of resources for health workers and families, is now a reality in Italy.

%B J Hum Lact %V 28 %P 297-303 %8 2012 Aug %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/22674964?dopt=Abstract %R 10.1177/0890334412447994 %0 Journal Article %J J Pediatr Gastroenterol Nutr %D 2012 %T European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. %A Husby, S %A Koletzko, S %A Korponay-Szabó, I R %A Mearin, M L %A Phillips, A %A Shamir, R %A Troncone, R %A Giersiepen, K %A Branski, D %A Catassi, C %A Lelgeman, M %A Mäki, M %A Ribes-Koninckx, C %A Ventura, A %A Zimmer, K P %K Adolescent %K Celiac Disease %K Child %K Duodenum %K HLA-DQ Antigens %K Humans %K Immunoglobulin A %K Transglutaminases %X

OBJECTIVE: Diagnostic criteria for coeliac disease (CD) from the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) were published in 1990. Since then, the autoantigen in CD, tissue transglutaminase, has been identified; the perception of CD has changed from that of a rather uncommon enteropathy to a common multiorgan disease strongly dependent on the haplotypes human leukocyte antigen (HLA)-DQ2 and HLA-DQ8; and CD-specific antibody tests have improved.

METHODS: A panel of 17 experts defined CD and developed new diagnostic criteria based on the Delphi process. Two groups of patients were defined with different diagnostic approaches to diagnose CD: children with symptoms suggestive of CD (group 1) and asymptomatic children at increased risk for CD (group 2). The 2004 National Institutes of Health/Agency for Healthcare Research and Quality report and a systematic literature search on antibody tests for CD in paediatric patients covering the years 2004 to 2009 was the basis for the evidence-based recommendations on CD-specific antibody testing.

RESULTS: In group 1, the diagnosis of CD is based on symptoms, positive serology, and histology that is consistent with CD. If immunoglobulin A anti-tissue transglutaminase type 2 antibody titers are high (>10 times the upper limit of normal), then the option is to diagnose CD without duodenal biopsies by applying a strict protocol with further laboratory tests. In group 2, the diagnosis of CD is based on positive serology and histology. HLA-DQ2 and HLA-DQ8 testing is valuable because CD is unlikely if both haplotypes are negative.

CONCLUSIONS: The aim of the new guidelines was to achieve a high diagnostic accuracy and to reduce the burden for patients and their families. The performance of these guidelines in clinical practice should be evaluated prospectively.

%B J Pediatr Gastroenterol Nutr %V 54 %P 136-60 %8 2012 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22197856?dopt=Abstract %R 10.1097/MPG.0b013e31821a23d0 %0 Journal Article %J PLoS Genet %D 2012 %T Evidence of inbreeding depression on human height. %A McQuillan, Ruth %A Eklund, Niina %A Pirastu, Nicola %A Kuningas, Maris %A McEvoy, Brian P %A Esko, Tõnu %A Corre, Tanguy %A Davies, Gail %A Kaakinen, Marika %A Lyytikäinen, Leo-Pekka %A Kristiansson, Kati %A Havulinna, Aki S %A Gögele, Martin %A Vitart, Veronique %A Tenesa, Albert %A Aulchenko, Yurii %A Hayward, Caroline %A Johansson, Åsa %A Boban, Mladen %A Ulivi, Sheila %A Robino, Antonietta %A Boraska, Vesna %A Igl, Wilmar %A Wild, Sarah H %A Zgaga, Lina %A Amin, Najaf %A Theodoratou, Evropi %A Polasek, Ozren %A Girotto, Giorgia %A Lopez, Lorna M %A Sala, Cinzia %A Lahti, Jari %A Laatikainen, Tiina %A Prokopenko, Inga %A Kals, Mart %A Viikari, Jorma %A Yang, Jian %A Pouta, Anneli %A Estrada, Karol %A Hofman, Albert %A Freimer, Nelson %A Martin, Nicholas G %A Kähönen, Mika %A Milani, Lili %A Heliövaara, Markku %A Vartiainen, Erkki %A Räikkönen, Katri %A Masciullo, Corrado %A Starr, John M %A Hicks, Andrew A %A Esposito, Laura %A Kolcic, Ivana %A Farrington, Susan M %A Oostra, Ben %A Zemunik, Tatijana %A Campbell, Harry %A Kirin, Mirna %A Pehlic, Marina %A Faletra, Flavio %A Porteous, David %A Pistis, Giorgio %A Widen, Elisabeth %A Salomaa, Veikko %A Koskinen, Seppo %A Fischer, Krista %A Lehtimäki, Terho %A Heath, Andrew %A McCarthy, Mark I %A Rivadeneira, Fernando %A Montgomery, Grant W %A Tiemeier, Henning %A Hartikainen, Anna-Liisa %A Madden, Pamela A F %A d'Adamo, Pio %A Hastie, Nicholas D %A Gyllensten, Ulf %A Wright, Alan F %A van Duijn, Cornelia M %A Dunlop, Malcolm %A Rudan, Igor %A Gasparini, Paolo %A Pramstaller, Peter P %A Deary, Ian J %A Toniolo, Daniela %A Eriksson, Johan G %A Jula, Antti %A Raitakari, Olli T %A Metspalu, Andres %A Perola, Markus %A Järvelin, Marjo-Riitta %A Uitterlinden, André %A Visscher, Peter M %A Wilson, James F %K Adult %K Aged %K Body Height %K Consanguinity %K Databases, Genetic %K Family %K Female %K Genes, Recessive %K Genetic Heterogeneity %K Genome-Wide Association Study %K Homozygote %K Humans %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Quantitative Trait, Heritable %X

Stature is a classical and highly heritable complex trait, with 80%-90% of variation explained by genetic factors. In recent years, genome-wide association studies (GWAS) have successfully identified many common additive variants influencing human height; however, little attention has been given to the potential role of recessive genetic effects. Here, we investigated genome-wide recessive effects by an analysis of inbreeding depression on adult height in over 35,000 people from 21 different population samples. We found a highly significant inverse association between height and genome-wide homozygosity, equivalent to a height reduction of up to 3 cm in the offspring of first cousins compared with the offspring of unrelated individuals, an effect which remained after controlling for the effects of socio-economic status, an important confounder (χ(2) = 83.89, df = 1; p = 5.2 × 10(-20)). There was, however, a high degree of heterogeneity among populations: whereas the direction of the effect was consistent across most population samples, the effect size differed significantly among populations. It is likely that this reflects true biological heterogeneity: whether or not an effect can be observed will depend on both the variance in homozygosity in the population and the chance inheritance of individual recessive genotypes. These results predict that multiple, rare, recessive variants influence human height. Although this exploratory work focuses on height alone, the methodology developed is generally applicable to heritable quantitative traits (QT), paving the way for an investigation into inbreeding effects, and therefore genetic architecture, on a range of QT of biomedical importance.

%B PLoS Genet %V 8 %P e1002655 %8 2012 %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/22829771?dopt=Abstract %R 10.1371/journal.pgen.1002655 %0 Journal Article %J Proc Natl Acad Sci U S A %D 2012 %T Extra-large letter spacing improves reading in dyslexia. %A Zorzi, Marco %A Barbiero, Chiara %A Facoetti, Andrea %A Lonciari, Isabella %A Carrozzi, Marco %A Montico, Marcella %A Bravar, Laura %A George, Florence %A Pech-Georgel, Catherine %A Ziegler, Johannes C %K Attention %K Awareness %K Child %K Dyslexia %K Form Perception %K France %K Humans %K Italy %K Language %K Pattern Recognition, Visual %K Phonetics %K Reading %K Vision, Ocular %K Visual Fields %X

Although the causes of dyslexia are still debated, all researchers agree that the main challenge is to find ways that allow a child with dyslexia to read more words in less time, because reading more is undisputedly the most efficient intervention for dyslexia. Sophisticated training programs exist, but they typically target the component skills of reading, such as phonological awareness. After the component skills have improved, the main challenge remains (that is, reading deficits must be treated by reading more--a vicious circle for a dyslexic child). Here, we show that a simple manipulation of letter spacing substantially improved text reading performance on the fly (without any training) in a large, unselected sample of Italian and French dyslexic children. Extra-large letter spacing helps reading, because dyslexics are abnormally affected by crowding, a perceptual phenomenon with detrimental effects on letter recognition that is modulated by the spacing between letters. Extra-large letter spacing may help to break the vicious circle by rendering the reading material more easily accessible.

%B Proc Natl Acad Sci U S A %V 109 %P 11455-9 %8 2012 Jul 10 %G eng %N 28 %1 http://www.ncbi.nlm.nih.gov/pubmed/22665803?dopt=Abstract %R 10.1073/pnas.1205566109 %0 Journal Article %J Acta Paediatr %D 2012 %T Febrile urinary tract infections in young children: recommendations for the diagnosis, treatment and follow-up. %A Ammenti, Anita %A Cataldi, Luigi %A Chimenz, Roberto %A Fanos, Vassilios %A La Manna, Angela %A Marra, Giuseppina %A Materassi, Marco %A Pecile, Paolo %A Pennesi, Marco %A Pisanello, Lorena %A Sica, Felice %A Toffolo, Antonella %A Montini, Giovanni %K Anti-Bacterial Agents %K Child, Preschool %K Female %K Fever %K Follow-Up Studies %K Humans %K Infant %K Male %K Urinary Tract Infections %X

UNLABELLED: We report the recommendations for the diagnosis, treatment, imaging evaluation and use of antibiotic prophylaxis in children with the first febrile urinary tract infection, aged 2 months to 3 years. They were prepared by a working group of the Italian Society of Pediatric Nephrology after careful review of the available literature and a consensus decision, when clear evidence was not available.

CONCLUSION: These recommendations are endorsed by the Italian Society of Pediatric Nephrology. They can also be a tool of comparison with other existing guidelines in issues in which much controversy still exists.

%B Acta Paediatr %V 101 %P 451-7 %8 2012 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/22122295?dopt=Abstract %R 10.1111/j.1651-2227.2011.02549.x %0 Journal Article %J Placenta %D 2012 %T First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. %A Di Lorenzo, G %A Ceccarello, M %A Cecotti, V %A Ronfani, L %A Monasta, L %A Vecchi Brumatti, L %A Montico, M %A D'Ottavio, G %K Adult %K Biological Markers %K Chorionic Gonadotropin, beta Subunit, Human %K Cohort Studies %K Female %K Galectins %K Humans %K Hypertension, Pregnancy-Induced %K Pre-Eclampsia %K Pregnancy %K Pregnancy Complications %K Pregnancy Proteins %K Pregnancy Trimester, First %K Pregnancy-Associated Plasma Protein-A %K Prospective Studies %K Ultrasonography, Prenatal %K Uterine Artery %K Uterus %X

OBJECTIVE: To evaluate the detection of pregnancy hypertensive disorders by integrating maternal history, serum biomarkers and uterine artery Doppler in the first trimester.

METHODS: We prospectively recruited 2118 women that underwent an 11-13 weeks aneuploidy screening. We gathered information on maternal history, uterine artery Doppler and serum biomarkers (PAPP-A, PlGF, PP-13 and free β-hCG). Models were developed for the prediction of overall preeclampsia (PE), early-onset PE, late-onset PE and gestational hypertension (GH). For each outcome, we performed a multivariate logistic regression starting from the saturated model: adopting a step-down procedure we excluded all factors not statistically significant (p > 0.05). Sensitivity models only for statistically significant parameters were calculated from the ROC curves for fixed false-positive rates (FPR).

RESULTS: Among 2118 women, 46 (2.17%) developed GH and 25 (1.18%) were diagnosed with PE, including 12 (0.57%) early-onset PE and 13 (0.61%) late-onset PE. For a fixed FPR of 10 and 5%, serum PlGF, free β-hCG and chronic hypertension identified respectively 67 and 75% of women who developed early-onset PE. In the model for the prediction of overall PE the combination of the uterine artery Doppler pulsatility index (UtA PI) with PlGF and chronic hypertension reached a sensitivity of 60% for a 20% of FPR.

CONCLUSION: An integration of maternal characteristics and first trimester maternal serum biomarkers (free β-hCG and PlGF) provided a possible screening for early-onset PE. In the overall PE model, UtA PI turned out to be statistically significant but did not improve the detection rate.

%B Placenta %V 33 %P 495-501 %8 2012 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22459245?dopt=Abstract %R 10.1016/j.placenta.2012.03.003 %0 Journal Article %J Genet Mol Res %D 2012 %T Frequency of human papillomavirus types 16, 18, 31, and 33 and sites of cervical lesions in gynecological patients from Recife, Brazil. %A Baldez da Silva, M F P T %A Guimarães, V %A Silva, M A R %A Medeiros do Amaral, C M %A Beçak, W %A Stocco, R C %A Freitas, A C %A Crovella, S %K Adolescent %K Adult %K Brazil %K Cervix Uteri %K DNA, Viral %K Female %K Human papillomavirus 16 %K Human papillomavirus 18 %K Human papillomavirus 31 %K Humans %K Papillomavirus Infections %K Uterine Cervical Diseases %K Young Adult %X

Human papilloma virus (HPV) is a well-established cause of cervical cancer. While many studies have been performed so far on HPV viral biology, mode of infection and prevention measures, scanty information is available on lesion sites of infected women and the incidence of viral types at specific locations. We looked for a possible relationship between the most common viral types (HPVs 16, 18, 31, 33) found in Recife, PE, Brazil, and lesion sites. We examined 396 HPV-positive women at the Gynecological Unit of the IMIP at Recife; 288 women were positive for HPV 16, 18, 31, or 33, present as a single-virus type or as co-infection. HPV 16 was the most frequent virus type found in the vulva, vagina, uterine cervix-vagina, and uterine cervix. HPV 31 was the second prevalent virus type in vulva, vagina, uterine cervix-vagina, uterine cervix, and mole. HPVs 18 and 33 were present with similar frequencies in the mole-vulva region. Among the co-infections, HPV 16/18 and HPV16/31 were the most frequent in our study group, followed by HPV 16/33.

%B Genet Mol Res %V 11 %P 462-6 %8 2012 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22427039?dopt=Abstract %R 10.4238/2012.March.1.3 %0 Journal Article %J Lupus %D 2012 %T Functional single-nucleotide polymorphisms in the DEFB1 gene are associated with systemic lupus erythematosus in Southern Brazilians. %A Sandrin-Garcia, P %A Brandão, L A C %A Guimarães, R L %A Pancoto, J A T %A Donadi, E A %A Lima-Filho, J L de %A Segat, L %A Crovella, S %K Adolescent %K Adult %K Aged %K beta-Defensins %K Brazil %K Case-Control Studies %K Female %K Genetic Predisposition to Disease %K Genotype %K Haplotypes %K Humans %K Lupus Erythematosus, Systemic %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Risk Factors %K Young Adult %X

Systemic lupus erythematosus (SLE) is an autoimmune disease that results in inflammation and tissue damage. The etiology of SLE remains unknown, but recent studies have shown that the innate immune system may have a role in SLE pathogenesis through the secretion of small cationic peptides named defensins. The aim of the study was to determine the possible involvement in SLE of three functional single nucleotide polymorphisms (SNPs) (c.-52G>A, c.-44C>G and c.-20G>A) in the 5'UTR region of DEFB1 gene, by analyzing them in a population of 139 SLE patients and 288 healthy controls. The c.-52G>A SNP showed significant differences in allele and genotype frequency distribution between SLE patients and controls (p = 0.01 and p = 0.02 respectively) indicating protection against SLE (A allele, OR = 0.68, AA genotype OR = 0.51). Significant differences were also observed for c.-44C>G SNP, the C/G genotype being associated with susceptibility to SLE (OR = 1.60, p = 0.04). Moreover, statistically significant differences between patients and controls were found for two DEFB1 haplotypes (GCA and GGG, p = 0.01 and p = 0.02 respectively). When considering DEFB1 SNPs and SLE clinical and laboratory manifestations, significant association was found with neuropsychiatric disorders, immunological alterations and anti-DNA antibodies. In conclusion, our results evidence a possible role for the c.-52G>A and c.-44C>G DEFB1 polymorphisms in SLE pathogenesis, that can be considered as possible risk factors for development of disease and disease-related clinical manifestations. Additional studies are needed, to corroborate these results as well as functional studies to understand the biological role of these SNPs in the pathogenesis of SLE.

%B Lupus %V 21 %P 625-31 %8 2012 May %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22323338?dopt=Abstract %R 10.1177/0961203312436858 %0 Journal Article %J PLoS Genet %D 2012 %T Genome-wide association and functional follow-up reveals new loci for kidney function. %A Pattaro, Cristian %A Köttgen, Anna %A Teumer, Alexander %A Garnaas, Maija %A Böger, Carsten A %A Fuchsberger, Christian %A Olden, Matthias %A Chen, Ming-Huei %A Tin, Adrienne %A Taliun, Daniel %A Li, Man %A Gao, Xiaoyi %A Gorski, Mathias %A Yang, Qiong %A Hundertmark, Claudia %A Foster, Meredith C %A O'Seaghdha, Conall M %A Glazer, Nicole %A Isaacs, Aaron %A Liu, Ching-Ti %A Smith, Albert V %A O'Connell, Jeffrey R %A Struchalin, Maksim %A Tanaka, Toshiko %A Li, Guo %A Johnson, Andrew D %A Gierman, Hinco J %A Feitosa, Mary %A Hwang, Shih-Jen %A Atkinson, Elizabeth J %A Lohman, Kurt %A Cornelis, Marilyn C %A Johansson, Åsa %A Tönjes, Anke %A Dehghan, Abbas %A Chouraki, Vincent %A Holliday, Elizabeth G %A Sorice, Rossella %A Kutalik, Zoltán %A Lehtimäki, Terho %A Esko, Tõnu %A Deshmukh, Harshal %A Ulivi, Sheila %A Chu, Audrey Y %A Murgia, Federico %A Trompet, Stella %A Imboden, Medea %A Kollerits, Barbara %A Pistis, Giorgio %A Harris, Tamara B %A Launer, Lenore J %A Aspelund, Thor %A Eiriksdottir, Gudny %A Mitchell, Braxton D %A Boerwinkle, Eric %A Schmidt, Helena %A Cavalieri, Margherita %A Rao, Madhumathi %A Hu, Frank B %A Demirkan, Ayse %A Oostra, Ben A %A de Andrade, Mariza %A Turner, Stephen T %A Ding, Jingzhong %A Andrews, Jeanette S %A Freedman, Barry I %A Koenig, Wolfgang %A Illig, Thomas %A Döring, Angela %A Wichmann, H-Erich %A Kolcic, Ivana %A Zemunik, Tatijana %A Boban, Mladen %A Minelli, Cosetta %A Wheeler, Heather E %A Igl, Wilmar %A Zaboli, Ghazal %A Wild, Sarah H %A Wright, Alan F %A Campbell, Harry %A Ellinghaus, David %A Nöthlings, Ute %A Jacobs, Gunnar %A Biffar, Reiner %A Endlich, Karlhans %A Ernst, Florian %A Homuth, Georg %A Kroemer, Heyo K %A Nauck, Matthias %A Stracke, Sylvia %A Völker, Uwe %A Völzke, Henry %A Kovacs, Peter %A Stumvoll, Michael %A Mägi, Reedik %A Hofman, Albert %A Uitterlinden, André G %A Rivadeneira, Fernando %A Aulchenko, Yurii S %A Polasek, Ozren %A Hastie, Nick %A Vitart, Veronique %A Helmer, Catherine %A Wang, Jie Jin %A Ruggiero, Daniela %A Bergmann, Sven %A Kähönen, Mika %A Viikari, Jorma %A Nikopensius, Tiit %A Province, Michael %A Ketkar, Shamika %A Colhoun, Helen %A Doney, Alex %A Robino, Antonietta %A Giulianini, Franco %A Krämer, Bernhard K %A Portas, Laura %A Ford, Ian %A Buckley, Brendan M %A Adam, Martin %A Thun, Gian-Andri %A Paulweber, Bernhard %A Haun, Margot %A Sala, Cinzia %A Metzger, Marie %A Mitchell, Paul %A Ciullo, Marina %A Kim, Stuart K %A Vollenweider, Peter %A Raitakari, Olli %A Metspalu, Andres %A Palmer, Colin %A Gasparini, Paolo %A Pirastu, Mario %A Jukema, J Wouter %A Probst-Hensch, Nicole M %A Kronenberg, Florian %A Toniolo, Daniela %A Gudnason, Vilmundur %A Shuldiner, Alan R %A Coresh, Josef %A Schmidt, Reinhold %A Ferrucci, Luigi %A Siscovick, David S %A van Duijn, Cornelia M %A Borecki, Ingrid %A Kardia, Sharon L R %A Liu, Yongmei %A Curhan, Gary C %A Rudan, Igor %A Gyllensten, Ulf %A Wilson, James F %A Franke, Andre %A Pramstaller, Peter P %A Rettig, Rainer %A Prokopenko, Inga %A Witteman, Jacqueline C M %A Hayward, Caroline %A Ridker, Paul %A Parsa, Afshin %A Bochud, Murielle %A Heid, Iris M %A Goessling, Wolfram %A Chasman, Daniel I %A Kao, W H Linda %A Fox, Caroline S %K African Americans %K Aged %K Animals %K Caspase 9 %K Cyclin-Dependent Kinases %K DEAD-box RNA Helicases %K DNA Helicases %K European Continental Ancestry Group %K Female %K Follow-Up Studies %K Gene Knockdown Techniques %K Genome-Wide Association Study %K Glomerular Filtration Rate %K Humans %K Kidney %K Kidney Failure, Chronic %K Male %K Middle Aged %K Phosphoric Diester Hydrolases %K Zebrafish %X

Chronic kidney disease (CKD) is an important public health problem with a genetic component. We performed genome-wide association studies in up to 130,600 European ancestry participants overall, and stratified for key CKD risk factors. We uncovered 6 new loci in association with estimated glomerular filtration rate (eGFR), the primary clinical measure of CKD, in or near MPPED2, DDX1, SLC47A1, CDK12, CASP9, and INO80. Morpholino knockdown of mpped2 and casp9 in zebrafish embryos revealed podocyte and tubular abnormalities with altered dextran clearance, suggesting a role for these genes in renal function. By providing new insights into genes that regulate renal function, these results could further our understanding of the pathogenesis of CKD.

%B PLoS Genet %V 8 %P e1002584 %8 2012 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/22479191?dopt=Abstract %R 10.1371/journal.pgen.1002584 %0 Journal Article %J Genes Chromosomes Cancer %D 2012 %T Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse. %A Perotti, Daniela %A Spreafico, Filippo %A Torri, Federica %A Gamba, Beatrice %A d'Adamo, Pio %A Pizzamiglio, Sara %A Terenziani, Monica %A Catania, Serena %A Collini, Paola %A Nantron, Marilina %A Pession, Andrea %A Bianchi, Maurizio %A Indolfi, Paolo %A D'Angelo, Paolo %A Fossati-Bellani, Franca %A Verderio, Paolo %A Macciardi, Fabio %A Radice, Paolo %K Adolescent %K Allelic Imbalance %K Child %K Child, Preschool %K Chromosome Aberrations %K DNA Copy Number Variations %K Female %K Genetic Markers %K Genetic Predisposition to Disease %K Genome, Human %K Genome-Wide Association Study %K Humans %K Infant %K Kaplan-Meier Estimate %K Male %K Polymorphism, Single Nucleotide %K Prospective Studies %K Recurrence %K Wilms Tumor %X

Despite the excellent survival rate of Wilms tumor (WT) patients, only approximately one-half of children who suffer tumor recurrence reach second durable remission. This underlines the need for novel markers to optimize initial treatment. We investigated 77 tumors using Illumina 370CNV-QUAD genotyping BeadChip arrays and compared their genomic profiles to detect copy number (CN) abnormalities and allelic ratio anomalies associated with the following clinicopathological variables: relapse (yes vs. no), age at diagnosis (≤ 24 months vs. >24 months), and disease stage (low stage, I and II, vs. high stage, III and IV). We found that CN gains at chromosome region 1q21.1-q31.3 were significantly associated with relapse. Additional genetic events, including allelic imbalances at chromosome arms 1p, 1q, 3p, 3q, and 14q were also found to occur at higher frequency in relapsing tumors. Interestingly, allelic imbalances at 1p and 14q also showed a borderline association with higher tumor stages. No genetic events were found to be associated with age at diagnosis. This is the first genome wide analysis with single nucleotide polymorphism (SNP) arrays specifically investigating the role of genetic anomalies in predicting WT relapse on cases prospectively enrolled in the same clinical trial. Our study, besides confirming the role of 1q gains, identified a number of additional candidate genetic markers, warranting further molecular investigations.

%B Genes Chromosomes Cancer %V 51 %P 644-53 %8 2012 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/22407497?dopt=Abstract %R 10.1002/gcc.21951 %0 Journal Article %J Bone Marrow Transplant %D 2012 %T Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. %A Snowden, J A %A Saccardi, R %A Allez, M %A Ardizzone, S %A Arnold, R %A Cervera, R %A Denton, C %A Hawkey, C %A Labopin, M %A Mancardi, G %A Martin, R %A Moore, J J %A Passweg, J %A Peters, C %A Rabusin, M %A Rovira, M %A van Laar, J M %A Farge, D %K Autoimmune Diseases %K Clinical Trials, Phase I as Topic %K Clinical Trials, Phase II as Topic %K European Union %K Female %K Hematopoietic Stem Cell Transplantation %K Humans %K Male %K Risk Factors %K Safety %K Severity of Illness Index %X

In 1997, the first consensus guidelines for haematopoietic SCT (HSCT) in autoimmune diseases (ADs) were published, while an international coordinated clinical programme was launched. These guidelines provided broad principles for the field over the following decade and were accompanied by comprehensive data collection in the European Group for Blood and Marrow Transplantation (EBMT) AD Registry. Subsequently, retrospective analyses and prospective phase I/II studies generated evidence to support the feasibility, safety and efficacy of HSCT in several types of severe, treatment-resistant ADs, which became the basis for larger-scale phase II and III studies. In parallel, there has also been an era of immense progress in biological therapy in ADs. The aim of this document is to provide revised and updated guidelines for both the current application and future development of HSCT in ADs in relation to the benefits, risks and health economic considerations of other modern treatments. Patient safety considerations are central to guidance on patient selection and HSCT procedural aspects within appropriately experienced and Joint Accreditation Committee of International Society for Cellular Therapy and EBMT accredited centres. A need for prospective interventional and non-interventional studies, where feasible, along with systematic data reporting, in accordance with EBMT policies and procedures, is emphasized.

%B Bone Marrow Transplant %V 47 %P 770-90 %8 2012 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22002489?dopt=Abstract %R 10.1038/bmt.2011.185 %0 Journal Article %J Proc Natl Acad Sci U S A %D 2012 %T High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma. %A Mazzoni, Elisa %A Corallini, Alfredo %A Cristaudo, Alfonso %A Taronna, Angelo %A Tassi, Gianfranco %A Manfrini, Marco %A Comar, Manola %A Bovenzi, Massimo %A Guaschino, Roberto %A Vaniglia, Francesca %A Magnani, Corrado %A Casali, Ferruccio %A Rezza, Giovanni %A Barbanti-Brodano, Giuseppe %A Martini, Fernanda %A Tognon, Mauro G %K Amino Acid Sequence %K Antibodies, Viral %K Capsid Proteins %K Enzyme-Linked Immunosorbent Assay %K Female %K Humans %K Male %K Mesothelioma %K Molecular Sequence Data %K Pleural Neoplasms %K Pregnancy %K Simian virus 40 %X

Human malignant pleural mesothelioma (MPM) is considered a rare tumor, but recent estimations indicate that one-quarter million people will die of this neoplasm in Europe in the next three decades. The mineral asbestos is considered the main causative agent of this neoplasm. MPM is largely unresponsive to conventional chemotherapy/radiotherapy. In addition to asbestos exposure, genetic predisposition to asbestos carcinogenesis and to simian virus (SV)40 infection has also been suggested. SV40 is a DNA tumor virus found in some studies to be associated at high prevalence with MPM. SV40 sequences have also been detected, although at a lower prevalence than in MPM, in blood specimens from healthy donors. However, some studies have failed to reveal SV40 footprints in MPM and its association with this neoplasm. These conflicting results indicate the need for further investigations with new approaches. We report on the presence of antibodies in serum samples from patients affected by MPM that specifically react with two different SV40 mimotopes. The two SV40 peptides used in indirect ELISAs correspond to viral capsid proteins. ELISA with the two SV40 mimotopes gave overlapping results. Our data indicate that in serum samples from MPM-affected patients (n = 97), the prevalence of antibodies against SV40 viral capsid protein antigens is significantly higher (26%, P = 0.043) than in the control group (15%) represented by healthy subjects (n = 168) with the same median age (66 y) and sex. Our results suggest that SV40 is associated with a subset of MPM and circulates in humans.

%B Proc Natl Acad Sci U S A %V 109 %P 18066-71 %8 2012 Oct 30 %G eng %N 44 %1 http://www.ncbi.nlm.nih.gov/pubmed/23071320?dopt=Abstract %R 10.1073/pnas.1213238109 %0 Journal Article %J AIDS %D 2012 %T HIV-1 induces NALP3-inflammasome expression and interleukin-1β secretion in dendritic cells from healthy individuals but not from HIV-positive patients. %A Pontillo, Alessandra %A Silva, Lais T %A Oshiro, Telma M %A Finazzo, Claudia %A Crovella, Sergio %A Duarte, Alberto J S %K Acquired Immunodeficiency Syndrome %K Adult %K Brazil %K Carrier Proteins %K Caspase 1 %K Cells, Cultured %K Dendritic Cells %K DNA, Viral %K Female %K HIV-1 %K Humans %K Immunity, Innate %K Inflammasomes %K Interleukin-1beta %K Male %K Tumor Necrosis Factor-alpha %X

OBJECTIVE: NALP3-inflammasome is an innate mechanism, alternative to type-1 interferon, which is able to recognize nucleic acids and viruses in the cytoplasm and to induce pro-inflammatory response. Here, we hypothesized the involvement of inflammasome in the early defense against HIV-1 and in the full maturation of dendritic cells: for this, we evaluated the response of dendritic cells pulsed with HIV-1 in terms of inflammasome activation in healthy donors. Moreover, inflammasome response to HIV was evaluated in HIV-infected individuals.

DESIGN AND METHODS: Monocyte-derived dendritic cells isolated from 20 healthy individuals (HC-DC) and 20 HIV-1-infected patients (HIV-DC) were pulsed with alditrithiol-2-inactivated HIV-1. We then analyzed inflammasome genes expression and interleukin-1β (IL-1β) secretion.

RESULTS: In HC-DC, HIV-1 induced higher NLRP3/NALP3 mRNA expression compared with other inflammasome genes such as NALP1/NLRP1 or IPAF/NLRC4 (P < 0.001). This augmented expression was accompanied by CASP1-increased and IL1B-increased mRNA levels and by a significant increment of IL-1β secretion (P < 0.05). Otherwise, HIV-1 failed to activate inflammasome and cytokine production in HIV-DC. HIV-DC showed an increased NLRP3/NALP3 basal expression, suggesting a chronic inflammatory profile of patients' immune cells.

CONCLUSION: HIV-1 was able to induce a NALP3-inflammasome response in healthy individuals, indicating that this inflammasome could play a role in the first steps of HIV-1 infection; the consequent inflammatory process may be important for directing host immune response against the virus and/or disease progression. HIV-DC seemed to be chronically activated, but unresponsive against pathogens. Our findings could be of interest considering the ongoing research about dendritic cell manipulation and therapeutic strategies for AIDS involving dendritic cell-based immune-vaccines.

%B AIDS %V 26 %P 11-8 %8 2012 Jan 2 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21971358?dopt=Abstract %R 10.1097/QAD.0b013e32834d697f %0 Journal Article %J Tissue Antigens %D 2012 %T HLA-G 14bp del/ins genetic variation: association with susceptibility to human immunodeficiency virus-1 vertical transmission but not with human immunodeficiency virus-1 infection through horizontal transmission. %A Segat, L %A Crovella, S %K Ethnic Groups %K Genetic Association Studies %K Genetic Predisposition to Disease %K HIV Infections %K HIV-1 %K HLA-G Antigens %K Humans %K INDEL Mutation %K Infectious Disease Transmission, Vertical %K Polymorphism, Genetic %B Tissue Antigens %V 80 %P 12-3 %8 2012 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22512775?dopt=Abstract %R 10.1111/j.1399-0039.2012.01874.x %0 Journal Article %J Invest New Drugs %D 2012 %T Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. %A Rimondi, Erika %A di Iasio, Maria Grazia %A Gonelli, Arianna %A Celeghini, Claudio %A Secchiero, Paola %A Zauli, Giorgio %K Cell Death %K Cytostatic Agents %K Down-Regulation %K Human Umbilical Vein Endothelial Cells %K Humans %K Hydrogen Sulfide %K Osteoprotegerin %K Tumor Necrosis Factor-alpha %B Invest New Drugs %V 30 %P 1731-5 %8 2012 Aug %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21541705?dopt=Abstract %R 10.1007/s10637-011-9675-8 %0 Journal Article %J Invest New Drugs %D 2012 %T In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. %A Zauli, Giorgio %A Corallini, Federica %A Zorzet, Sonia %A Grill, Vittorio %A Marzari, Roberto %A Secchiero, Paola %K Animals %K Humans %K Immunotherapy %K Injections, Intraperitoneal %K Lymphoma, B-Cell %K Mice %K Mice, SCID %K Receptors, TNF-Related Apoptosis-Inducing Ligand %K Single-Chain Antibodies %K Time Factors %K Xenograft Model Antitumor Assays %X

A new single-chain fragment variable (scFv) to TRAIL-R2 receptor produced as minibody (MB2.23) was characterized for anti-lymphoma activity in vivo. For this purpose, a disseminated lymphoma model was generated by intraperitoneal inoculation of BJAB cells in severe combined immunodeficiency mice. Two weekly injections with MB2.23 (10 mg/kg) were able to significantly increase the median survival time of lymphoma-bearing animals with respect to the vehicle-treated control mice, providing a rationale for further investigating the use of MB2.23 in anticancer therapy.

%B Invest New Drugs %V 30 %P 405-7 %8 2012 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/20714918?dopt=Abstract %R 10.1007/s10637-010-9519-y %0 Journal Article %J Gene %D 2012 %T Inflammation profile of four early onset Crohn patients. %A Marcuzzi, Annalisa %A Girardelli, Martina %A Bianco, Anna Monica %A Martelossi, Stefano %A Magnolato, Andrea %A Tommasini, Alberto %A Crovella, Sergio %K Crohn Disease %K Cytokines %K Humans %K Inflammation %K Monocytes %K Nod2 Signaling Adaptor Protein %K Polymorphism, Genetic %K Receptors, Interleukin-10 %K Tumor Necrosis Factor-alpha %X

Crohn disease (CD) is a multifactorial disorder affecting mainly young adults. Sometimes, however, it can present in the first year of life (Early onset Crohn disease (EOCD)) showing an unpredictable course and can often be more severe than at older ages. Some cases have been associated to an underlying primary immunodeficiency such as IL10R deficiency. We studied the functional response to IL-10 and the genotype of IL-10 receptor in four patients with early onset crohn-like colitis. We found an IL10R variant, which may be associated with a decreased response to the cytokine in one patient. Further studies to determine its pathogenic effect should be performed. In addition IL-10 mediated inhibition of LPS-induced TNFα expression was measured in patient's monocytes.

%B Gene %V 493 %P 282-5 %8 2012 Feb 10 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22155628?dopt=Abstract %R 10.1016/j.gene.2011.11.043 %0 Journal Article %J Br J Haematol %D 2012 %T Influence of age, sex and ethnicity on platelet count in five Italian geographic isolates: mild thrombocytopenia may be physiological. %A Biino, Ginevra %A Gasparini, Paolo %A d'Adamo, Pio %A Ciullo, Marina %A Nutile, Teresa %A Toniolo, Daniela %A Sala, Cinzia %A Minelli, Cosetta %A Gögele, Martin %A Balduini, Carlo L %K Adolescent %K Adult %K Age Distribution %K Aged %K Aged, 80 and over %K Child %K Child, Preschool %K Female %K Humans %K Infant %K Italy %K Male %K Middle Aged %K Platelet Count %K Reference Values %K Sex Distribution %K Thrombocytopenia %K Young Adult %B Br J Haematol %V 157 %P 384-7 %8 2012 May %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/22171955?dopt=Abstract %R 10.1111/j.1365-2141.2011.08981.x %0 Journal Article %J Hum Mol Genet %D 2012 %T Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. %A Chasman, Daniel I %A Fuchsberger, Christian %A Pattaro, Cristian %A Teumer, Alexander %A Böger, Carsten A %A Endlich, Karlhans %A Olden, Matthias %A Chen, Ming-Huei %A Tin, Adrienne %A Taliun, Daniel %A Li, Man %A Gao, Xiaoyi %A Gorski, Mathias %A Yang, Qiong %A Hundertmark, Claudia %A Foster, Meredith C %A O'Seaghdha, Conall M %A Glazer, Nicole %A Isaacs, Aaron %A Liu, Ching-Ti %A Smith, Albert V %A O'Connell, Jeffrey R %A Struchalin, Maksim %A Tanaka, Toshiko %A Li, Guo %A Johnson, Andrew D %A Gierman, Hinco J %A Feitosa, Mary F %A Hwang, Shih-Jen %A Atkinson, Elizabeth J %A Lohman, Kurt %A Cornelis, Marilyn C %A Johansson, Åsa %A Tönjes, Anke %A Dehghan, Abbas %A Lambert, Jean-Charles %A Holliday, Elizabeth G %A Sorice, Rossella %A Kutalik, Zoltán %A Lehtimäki, Terho %A Esko, Tõnu %A Deshmukh, Harshal %A Ulivi, Sheila %A Chu, Audrey Y %A Murgia, Federico %A Trompet, Stella %A Imboden, Medea %A Coassin, Stefan %A Pistis, Giorgio %A Harris, Tamara B %A Launer, Lenore J %A Aspelund, Thor %A Eiriksdottir, Gudny %A Mitchell, Braxton D %A Boerwinkle, Eric %A Schmidt, Helena %A Cavalieri, Margherita %A Rao, Madhumathi %A Hu, Frank %A Demirkan, Ayse %A Oostra, Ben A %A de Andrade, Mariza %A Turner, Stephen T %A Ding, Jingzhong %A Andrews, Jeanette S %A Freedman, Barry I %A Giulianini, Franco %A Koenig, Wolfgang %A Illig, Thomas %A Meisinger, Christa %A Gieger, Christian %A Zgaga, Lina %A Zemunik, Tatijana %A Boban, Mladen %A Minelli, Cosetta %A Wheeler, Heather E %A Igl, Wilmar %A Zaboli, Ghazal %A Wild, Sarah H %A Wright, Alan F %A Campbell, Harry %A Ellinghaus, David %A Nöthlings, Ute %A Jacobs, Gunnar %A Biffar, Reiner %A Ernst, Florian %A Homuth, Georg %A Kroemer, Heyo K %A Nauck, Matthias %A Stracke, Sylvia %A Völker, Uwe %A Völzke, Henry %A Kovacs, Peter %A Stumvoll, Michael %A Mägi, Reedik %A Hofman, Albert %A Uitterlinden, André G %A Rivadeneira, Fernando %A Aulchenko, Yurii S %A Polasek, Ozren %A Hastie, Nick %A Vitart, Veronique %A Helmer, Catherine %A Wang, Jie Jin %A Stengel, Bénédicte %A Ruggiero, Daniela %A Bergmann, Sven %A Kähönen, Mika %A Viikari, Jorma %A Nikopensius, Tiit %A Province, Michael %A Ketkar, Shamika %A Colhoun, Helen %A Doney, Alex %A Robino, Antonietta %A Krämer, Bernhard K %A Portas, Laura %A Ford, Ian %A Buckley, Brendan M %A Adam, Martin %A Thun, Gian-Andri %A Paulweber, Bernhard %A Haun, Margot %A Sala, Cinzia %A Mitchell, Paul %A Ciullo, Marina %A Kim, Stuart K %A Vollenweider, Peter %A Raitakari, Olli %A Metspalu, Andres %A Palmer, Colin %A Gasparini, Paolo %A Pirastu, Mario %A Jukema, J Wouter %A Probst-Hensch, Nicole M %A Kronenberg, Florian %A Toniolo, Daniela %A Gudnason, Vilmundur %A Shuldiner, Alan R %A Coresh, Josef %A Schmidt, Reinhold %A Ferrucci, Luigi %A Siscovick, David S %A van Duijn, Cornelia M %A Borecki, Ingrid B %A Kardia, Sharon L R %A Liu, Yongmei %A Curhan, Gary C %A Rudan, Igor %A Gyllensten, Ulf %A Wilson, James F %A Franke, Andre %A Pramstaller, Peter P %A Rettig, Rainer %A Prokopenko, Inga %A Witteman, Jacqueline %A Hayward, Caroline %A Ridker, Paul M %A Parsa, Afshin %A Bochud, Murielle %A Heid, Iris M %A Kao, W H Linda %A Fox, Caroline S %A Köttgen, Anna %K Amino Acid Transport Systems, Basic %K Antigens, CD98 Heavy Chain %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Glomerular Filtration Rate %K Humans %K Inhibin-beta Subunits %K Intracellular Signaling Peptides and Proteins %K Low Density Lipoprotein Receptor-Related Protein-2 %K Membrane Proteins %K Polymorphism, Single Nucleotide %X

In conducting genome-wide association studies (GWAS), analytical approaches leveraging biological information may further understanding of the pathophysiology of clinical traits. To discover novel associations with estimated glomerular filtration rate (eGFR), a measure of kidney function, we developed a strategy for integrating prior biological knowledge into the existing GWAS data for eGFR from the CKDGen Consortium. Our strategy focuses on single nucleotide polymorphism (SNPs) in genes that are connected by functional evidence, determined by literature mining and gene ontology (GO) hierarchies, to genes near previously validated eGFR associations. It then requires association thresholds consistent with multiple testing, and finally evaluates novel candidates by independent replication. Among the samples of European ancestry, we identified a genome-wide significant SNP in FBXL20 (P = 5.6 × 10(-9)) in meta-analysis of all available data, and additional SNPs at the INHBC, LRP2, PLEKHA1, SLC3A2 and SLC7A6 genes meeting multiple-testing corrected significance for replication and overall P-values of 4.5 × 10(-4)-2.2 × 10(-7). Neither the novel PLEKHA1 nor FBXL20 associations, both further supported by association with eGFR among African Americans and with transcript abundance, would have been implicated by eGFR candidate gene approaches. LRP2, encoding the megalin receptor, was identified through connection with the previously known eGFR gene DAB2 and extends understanding of the megalin system in kidney function. These findings highlight integration of existing genome-wide association data with independent biological knowledge to uncover novel candidate eGFR associations, including candidates lacking known connections to kidney-specific pathways. The strategy may also be applicable to other clinical phenotypes, although more testing will be needed to assess its potential for discovery in general.

%B Hum Mol Genet %V 21 %P 5329-43 %8 2012 Dec 15 %G eng %N 24 %1 http://www.ncbi.nlm.nih.gov/pubmed/22962313?dopt=Abstract %R 10.1093/hmg/dds369 %0 Journal Article %J Epileptic Disord %D 2012 %T Involuntary movements after correction of vitamin B12 deficiency: a video-case report. %A Zanus, Caterina %A Alberini, Elena %A Costa, Paola %A Colonna, Franco %A Zennaro, Floriana %A Carrozzi, Marco %K Atrophy %K Brain %K Dyskinesias %K Electroencephalography %K Female %K Humans %K Infant %K Magnetic Resonance Imaging %K Myelin Sheath %K Myoclonus %K Tremor %K Video Recording %K Vitamin B 12 %K Vitamin B 12 Deficiency %K Vitamins %X

Involuntary movements can appear before and after initiation of vitamin B12 treatment. The pathogenesis of involuntary movements in vitamin B12 deficiency and their relationship with cobalamin injection remain unclear due to a lack of video-EEG documentation making the electroclinical correlation difficult to ascertain. Here, we report video-EEG and neuroimaging findings of an 11-month-old girl with vitamin B12 deficiency, who acutely developed involuntary movements a few days after initiation of vitamin B12 treatment with normal vitamin plasmatic levels. Abnormal movements were a combination of tremor and myoclonus involving the face, mouth, and left arm, which disappeared after discontinuation of therapy. [Published with video sequences].

%B Epileptic Disord %V 14 %P 174-80 %8 2012 Jun %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22591802?dopt=Abstract %R 10.1684/epd.2012.0507 %0 Journal Article %J Inflamm Bowel Dis %D 2012 %T JCV+ Patients with Inflammatory bowel disease show elevated plasma levels of MIG and SCF. %A Comar, Manola %A Secchiero, Paola %A De Lorenzo, Elisa %A Martelossi, Stefano %A Tommasini, Alberto %A Zauli, Giorgio %K Adolescent %K Adult %K Chemokine CXCL9 %K Child %K DNA, Viral %K Female %K Humans %K Inflammatory Bowel Diseases %K JC Virus %K Leukoencephalopathy, Progressive Multifocal %K Male %K Stem Cell Factor %K Young Adult %B Inflamm Bowel Dis %V 18 %P 1194-6 %8 2012 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22467521?dopt=Abstract %R 10.1002/ibd.22953 %0 Journal Article %J Aliment Pharmacol Ther %D 2012 %T Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics. %A Bianco, A M %A Vuch, J %A Girardelli, M %A Zanin, V %A Marcuzzi, A %A Crovella, S %K Complementary Therapies %K Female %K Humans %K Inflammatory Bowel Diseases %K Male %K Medication Adherence %B Aliment Pharmacol Ther %V 35 %P 1110-1 %8 2012 May %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/25099779?dopt=Abstract %R 10.1111/j.1365-2036.2012.05065.x %0 Journal Article %J Aliment Pharmacol Ther %D 2012 %T Letter: TPMT activity and age in IBD patients. %A Stocco, G %A De Iudicibus, S %A Cuzzoni, E %A Decorti, G %A Martelossi, S %A Ventura, A %K Azathioprine %K Humans %K Immunosuppressive Agents %K Inflammatory Bowel Diseases %K Thioguanine %B Aliment Pharmacol Ther %V 35 %P 966-7; author reply 967-9 %8 2012 Apr %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/22436044?dopt=Abstract %R 10.1111/j.1365-2036.2012.05027.x %0 Journal Article %J Int J Dev Neurosci %D 2012 %T Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. %A Marcuzzi, Annalisa %A Zanin, Valentina %A Piscianz, Elisa %A Tricarico, Paola Maura %A Vuch, Josef %A Girardelli, Martina %A Monasta, Lorenzo %A Bianco, Anna Monica %A Crovella, Sergio %K Analysis of Variance %K Apoptosis %K Caspases %K Cell Line, Tumor %K Diterpenes %K Dose-Response Relationship, Drug %K Drug Interactions %K Humans %K Hydroxymethylglutaryl-CoA Reductase Inhibitors %K Lovastatin %K Neuroblastoma %K Time Factors %X

Mevalonic aciduria (MA), the most severe form of mevalonate kinase deficiency (MKD), is still an orphan drug disease and the pathogenetic mechanisms underlying neuronal dysfunction is still poorly understood. In our study we have investigated the apoptotic mechanism mediated by the exposure of the cultured neuroblastoma cell line, SH-SY5Y, to lovastatin in absence or in presence of the isoprenoid, geranylgeraniol, with the aim of unraveling the pathogenesis of MA. Lovastatin, blocks the mevalonate pathway inhibiting the 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CR), an enzyme of the mevalonate pathway upstream the mevalonate kinase enzyme, reproducing biochemical features similar to those found in MKD. We demonstrate that apoptosis in neuronal lovastatin treated-cells is induced by the mitochondrial pathway, with caspase-9 as the initiator and caspase-3 as the effector caspase. The presence of geranylgeraniol modulates both the caspase-9 and caspase-3 activity in a dose-dependent way, confirming that this isoprenoid enters the mevalonate pathway, is metabolized and finally is able to by-pass the statin biochemical block reconstituting the mevalonate pathway. According to our findings, it should not be the time course adopted that modulates the apoptotic response but rather the isoprenoid itself. Being aware that our results have been obtained using a biochemical model of MKD, and not cells from patients with the disease, we believe our findings increase the knowledge of MA pathogenesis, and may possibly contribute to the development of novel therapeutic strategies.

%B Int J Dev Neurosci %V 30 %P 451-6 %8 2012 Oct %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22759742?dopt=Abstract %R 10.1016/j.ijdevneu.2012.06.002 %0 Journal Article %J Int J Immunogenet %D 2012 %T Mannose-binding lectin and MBL-associated serine protease-2 gene polymorphisms in a Brazilian population from Rio de Janeiro. %A Ferraroni, N R %A Segat, L %A Guimarães, R L %A Brandão, L A C %A Crovella, S %A Constantino-Silva, R N %A Loja, C %A da Silva Duarte, A J %A Grumach, A S %K Adolescent %K Adult %K Brazil %K Ethnic Groups %K Exons %K Female %K Fluorescent Dyes %K Gene Frequency %K Genetics, Population %K Genome, Human %K HapMap Project %K Humans %K Male %K Mannose-Binding Lectin %K Mannose-Binding Protein-Associated Serine Proteases %K Middle Aged %K Polymorphism, Single Nucleotide %K Promoter Regions, Genetic %K Sequence Analysis, DNA %K Young Adult %X

Mannose-binding lectin (MBL) is a protein able to bind to carbohydrate patterns on pathogen membranes; upon MBL binding, its' associated serine protease MBL-associated serine protease type 2 (MASP2) is autoactivated, promoting the activation of complement via the lectin pathway. For both MBL2 and MASP2 genes, the frequencies of polymorphisms are extremely variable between different ethnicities, and this aspect has to be carefully considered when performing genetic studies. While polymorphisms in the MBL-encoding gene (MBL2) have been associated, depending upon ethnicity, with several diseases in different populations, little is known about the distribution of MASP2 gene polymorphisms in human populations. The aim of our study was thus to determine the frequencies of MBL2 (exon 1 and promoter) and MASP2 (p.D371Y) polymorphisms in a Brazilian population from Rio de Janeiro. A total of 294 blood donor samples were genotyped for 27 polymorphisms in the MBL2 gene by direct sequencing of a region spanning from the promoter polymorphism H/L rs11003125 to the rs1800451 polymorphism (at codon 57 in the first exon of the gene). Genotyping for MASP2 p.D371Y was carried out using fluorogenic probes. To our knowledge, this is the first study reporting the prevalence of the MASP2 p.D371Y polymorphism in a Brazilian population. The C allele frequency 39% is something intermediate between the reported 14% in Europeans and 90% in Sub-Saharan Africans. MBL2 polymorphisms frequencies were quite comparable to those previously reported for admixed Brazilians. Both MBL2 and MASP2 polymorphisms frequencies reported in our study for the admixed Brazilian population are somehow intermediate between those reported in Europeans and Africans, reflecting the ethnic composition of the southern Brazilian population, estimated to derive from an admixture of Caucasian (31%), African (34%) and Native American (33%) populations. In conclusion, our population genetic study describes the frequencies of MBL2 and MASP2 functional SNPs in a population from Rio de Janeiro, with the aim of adding new information concerning the distribution of these SNPs in a previously unanalysed Brazilian population, thus providing a new genetic tool for the evaluation of the association of MBL2 and MASP2 functional SNPs with diseases in Brazil, with particular emphasis on the state of Rio de Janeiro.

%B Int J Immunogenet %V 39 %P 32-8 %8 2012 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22035380?dopt=Abstract %R 10.1111/j.1744-313X.2011.01052.x %0 Journal Article %J Br J Haematol %D 2012 %T MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. %A Secchiero, Paola %A Melloni, Elisabetta %A Voltan, Rebecca %A Norcio, Alessia %A Celeghini, Claudio %A Zauli, Giorgio %K Antineoplastic Agents %K Benzenesulfonates %K Cell Line, Tumor %K Down-Regulation %K Humans %K Leukemia, Myeloid, Acute %K Myeloid Cell Leukemia Sequence 1 Protein %K Niacinamide %K Phenylurea Compounds %K Protein Kinase Inhibitors %K Proto-Oncogene Proteins c-bcl-2 %K Pyridines %K Pyrimidines %K Thiazoles %B Br J Haematol %V 157 %P 510-4 %8 2012 May %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22313359?dopt=Abstract %R 10.1111/j.1365-2141.2012.09042.x %0 Journal Article %J J Clin Virol %D 2012 %T Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease. %A Comar, Manola %A Cuneo, Antonio %A Maestri, Iva %A Melloni, Elisabetta %A Pozzato, Gabriele %A Soffritti, Olga %A Secchiero, Paola %A Zauli, Giorgio %K Aged %K Aged, 80 and over %K Blood %K Female %K Humans %K Italy %K Leukemia, Lymphocytic, Chronic, B-Cell %K Male %K Merkel cell polyomavirus %K Middle Aged %K Palatine Tonsil %K Polyomavirus Infections %K Prevalence %K Skin %K Tumor Virus Infections %X

BACKGROUND: Previous studies have reported conflicting results on the frequency and potential pathogenetic role of Merkel-cell polyomavirus (MCPyV) in B-chronic lymphocytic leukemia (B-CLL).

OBJECTIVES: To evaluate the association of MCPyV to B-CLL and to investigate the occurrence of MCPyV infection in relationship to the natural history of B-CLL.

STUDY DESIGN: Samples of primary B-CLL peripheral blood mononuclear cells were obtained from two distinct University Hospitals of Italy from January 2010. For one B-CLL patient, it was possible to retrospectively examine the blood sample at diagnosis of B-CLL (March 2004) and several pathological tissues of cutaneous tumors occurring during the course of the disease.

RESULTS: Only one out of 50 B-CLL blood samples examined was positive for MCPyV DNA. Retrospective analysis revealed that MCPyV DNA was absent in peripheral blood sample at diagnosis, becoming present only in advanced disease stages also in tonsil tissue as well as in a biopsy of differentiated squamous cell carcinoma.

CONCLUSIONS: The association with MCPyV seems to represent a rare and late event during the natural history of B-CLL.

%B J Clin Virol %V 55 %P 367-9 %8 2012 Dec %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22959215?dopt=Abstract %R 10.1016/j.jcv.2012.08.011 %0 Journal Article %J Invest New Drugs %D 2012 %T Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts. %A Secchiero, Paola %A Corallini, Federica %A Zavan, Barbara %A Tripodo, Claudio %A Vindigni, Vincenzo %A Zauli, Giorgio %K Alanine Transaminase %K Animals %K Aspartate Aminotransferases %K Biological Markers %K Cell Communication %K Cell Line, Tumor %K Cell Survival %K Coculture Techniques %K Hepatocyte Growth Factor %K Humans %K Hyaluronic Acid %K Liver %K Liver Neoplasms %K Lymphoma, Non-Hodgkin %K Mesenchymal Stem Cell Transplantation %K Mesenchymal Stromal Cells %K Mice %K Mice, Nude %K Mice, SCID %K Time Factors %K Tissue Scaffolds %K Xenograft Model Antitumor Assays %X

A disseminated model of non-Hodgkin's lymphoma with prevalent liver metastasis was generated by intraperitoneal (i.p.) injection of EBV(+) B lymphoblastoid SKW6.4 in nude-SCID mice. The survival of SKW6.4 xenografts (median survival = 27 days) was significantly improved when hyaluronan scaffolds embedded with mesenchimal stem cells (MSC) were implanted in the abdominal area 4 days after SKW6.4 injection (median survival = 39.5 days). Mice implanted with MSC showed a significant improvement of hepatic functionality in lymphoma xenografts, as demonstrated by measurement of serum ALT/AST levels. Co-culture of MSC with lymphoma cells enhanced the release of hepatocyte growth factor (HGF) by MSC. These data suggest that hyaluronan-embedded MSC exert anti-lymphoma activity by ameliorating hepatic functionality.

%B Invest New Drugs %V 30 %P 803-7 %8 2012 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/20827501?dopt=Abstract %R 10.1007/s10637-010-9534-z %0 Journal Article %J Nat Genet %D 2012 %T Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. %A Stolk, Lisette %A Perry, John R B %A Chasman, Daniel I %A He, Chunyan %A Mangino, Massimo %A Sulem, Patrick %A Barbalic, Maja %A Broer, Linda %A Byrne, Enda M %A Ernst, Florian %A Esko, Tõnu %A Franceschini, Nora %A Gudbjartsson, Daniel F %A Hottenga, Jouke-Jan %A Kraft, Peter %A McArdle, Patrick F %A Porcu, Eleonora %A Shin, So-Youn %A Smith, Albert V %A van Wingerden, Sophie %A Zhai, Guangju %A Zhuang, Wei V %A Albrecht, Eva %A Alizadeh, Behrooz Z %A Aspelund, Thor %A Bandinelli, Stefania %A Lauc, Lovorka Barac %A Beckmann, Jacques S %A Boban, Mladen %A Boerwinkle, Eric %A Broekmans, Frank J %A Burri, Andrea %A Campbell, Harry %A Chanock, Stephen J %A Chen, Constance %A Cornelis, Marilyn C %A Corre, Tanguy %A Coviello, Andrea D %A d'Adamo, Pio %A Davies, Gail %A de Faire, Ulf %A de Geus, Eco J C %A Deary, Ian J %A Dedoussis, George V Z %A Deloukas, Panagiotis %A Ebrahim, Shah %A Eiriksdottir, Gudny %A Emilsson, Valur %A Eriksson, Johan G %A Fauser, Bart C J M %A Ferreli, Liana %A Ferrucci, Luigi %A Fischer, Krista %A Folsom, Aaron R %A Garcia, Melissa E %A Gasparini, Paolo %A Gieger, Christian %A Glazer, Nicole %A Grobbee, Diederick E %A Hall, Per %A Haller, Toomas %A Hankinson, Susan E %A Hass, Merli %A Hayward, Caroline %A Heath, Andrew C %A Hofman, Albert %A Ingelsson, Erik %A Janssens, A Cecile J W %A Johnson, Andrew D %A Karasik, David %A Kardia, Sharon L R %A Keyzer, Jules %A Kiel, Douglas P %A Kolcic, Ivana %A Kutalik, Zoltán %A Lahti, Jari %A Lai, Sandra %A Laisk, Triin %A Laven, Joop S E %A Lawlor, Debbie A %A Liu, Jianjun %A Lopez, Lorna M %A Louwers, Yvonne V %A Magnusson, Patrik K E %A Marongiu, Mara %A Martin, Nicholas G %A Klaric, Irena Martinovic %A Masciullo, Corrado %A McKnight, Barbara %A Medland, Sarah E %A Melzer, David %A Mooser, Vincent %A Navarro, Pau %A Newman, Anne B %A Nyholt, Dale R %A Onland-Moret, N Charlotte %A Palotie, Aarno %A Paré, Guillaume %A Parker, Alex N %A Pedersen, Nancy L %A Peeters, Petra H M %A Pistis, Giorgio %A Plump, Andrew S %A Polasek, Ozren %A Pop, Victor J M %A Psaty, Bruce M %A Räikkönen, Katri %A Rehnberg, Emil %A Rotter, Jerome I %A Rudan, Igor %A Sala, Cinzia %A Salumets, Andres %A Scuteri, Angelo %A Singleton, Andrew %A Smith, Jennifer A %A Snieder, Harold %A Soranzo, Nicole %A Stacey, Simon N %A Starr, John M %A Stathopoulou, Maria G %A Stirrups, Kathleen %A Stolk, Ronald P %A Styrkarsdottir, Unnur %A Sun, Yan V %A Tenesa, Albert %A Thorand, Barbara %A Toniolo, Daniela %A Tryggvadottir, Laufey %A Tsui, Kim %A Ulivi, Sheila %A van Dam, Rob M %A van der Schouw, Yvonne T %A van Gils, Carla H %A van Nierop, Peter %A Vink, Jacqueline M %A Visscher, Peter M %A Voorhuis, Marlies %A Waeber, Gerard %A Wallaschofski, Henri %A Wichmann, H Erich %A Widen, Elisabeth %A Wijnands-van Gent, Colette J M %A Willemsen, Gonneke %A Wilson, James F %A Wolffenbuttel, Bruce H R %A Wright, Alan F %A Yerges-Armstrong, Laura M %A Zemunik, Tatijana %A Zgaga, Lina %A Zillikens, M Carola %A Zygmunt, Marek %A Arnold, Alice M %A Boomsma, Dorret I %A Buring, Julie E %A Crisponi, Laura %A Demerath, Ellen W %A Gudnason, Vilmundur %A Harris, Tamara B %A Hu, Frank B %A Hunter, David J %A Launer, Lenore J %A Metspalu, Andres %A Montgomery, Grant W %A Oostra, Ben A %A Ridker, Paul M %A Sanna, Serena %A Schlessinger, David %A Spector, Tim D %A Stefansson, Kari %A Streeten, Elizabeth A %A Thorsteinsdottir, Unnur %A Uda, Manuela %A Uitterlinden, André G %A van Duijn, Cornelia M %A Völzke, Henry %A Murray, Anna %A Murabito, Joanne M %A Visser, Jenny A %A Lunetta, Kathryn L %K Age Factors %K DNA Helicases %K DNA Primase %K DNA Repair %K DNA Repair Enzymes %K DNA-Directed DNA Polymerase %K European Continental Ancestry Group %K Exodeoxyribonucleases %K Female %K Genetic Loci %K Genome-Wide Association Study %K Humans %K Immunity %K Menopause %K Polymorphism, Single Nucleotide %K Proteins %X

To newly identify loci for age at natural menopause, we carried out a meta-analysis of 22 genome-wide association studies (GWAS) in 38,968 women of European descent, with replication in up to 14,435 women. In addition to four known loci, we identified 13 loci newly associated with age at natural menopause (at P < 5 × 10(-8)). Candidate genes located at these newly associated loci include genes implicated in DNA repair (EXO1, HELQ, UIMC1, FAM175A, FANCI, TLK1, POLG and PRIM1) and immune function (IL11, NLRP11 and PRRC2A (also known as BAT2)). Gene-set enrichment pathway analyses using the full GWAS data set identified exoDNase, NF-κB signaling and mitochondrial dysfunction as biological processes related to timing of menopause.

%B Nat Genet %V 44 %P 260-8 %8 2012 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/22267201?dopt=Abstract %R 10.1038/ng.1051 %0 Journal Article %J Nat Genet %D 2012 %T Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. %A Okada, Yukinori %A Sim, Xueling %A Go, Min Jin %A Wu, Jer-Yuarn %A Gu, Dongfeng %A Takeuchi, Fumihiko %A Takahashi, Atsushi %A Maeda, Shiro %A Tsunoda, Tatsuhiko %A Chen, Peng %A Lim, Su-Chi %A Wong, Tien-Yin %A Liu, Jianjun %A Young, Terri L %A Aung, Tin %A Seielstad, Mark %A Teo, Yik-Ying %A Kim, Young Jin %A Lee, Jong-Young %A Han, Bok-Ghee %A Kang, Daehee %A Chen, Chien-Hsiun %A Tsai, Fuu-Jen %A Chang, Li-Ching %A Fann, S-J Cathy %A Mei, Hao %A Rao, Dabeeru C %A Hixson, James E %A Chen, Shufeng %A Katsuya, Tomohiro %A Isono, Masato %A Ogihara, Toshio %A Chambers, John C %A Zhang, Weihua %A Kooner, Jaspal S %A Albrecht, Eva %A Yamamoto, Kazuhiko %A Kubo, Michiaki %A Nakamura, Yusuke %A Kamatani, Naoyuki %A Kato, Norihiro %A He, Jiang %A Chen, Yuan-Tsong %A Cho, Yoon Shin %A Tai, E-Shyong %A Tanaka, Toshihiro %K Asian Continental Ancestry Group %K Blood Urea Nitrogen %K Cohort Studies %K Creatinine %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Glomerular Filtration Rate %K Humans %K Kidney %K Polymorphism, Single Nucleotide %K Renal Insufficiency, Chronic %K Uric Acid %X

Chronic kidney disease (CKD), impairment of kidney function, is a serious public health problem, and the assessment of genetic factors influencing kidney function has substantial clinical relevance. Here, we report a meta-analysis of genome-wide association studies for kidney function-related traits, including 71,149 east Asian individuals from 18 studies in 11 population-, hospital- or family-based cohorts, conducted as part of the Asian Genetic Epidemiology Network (AGEN). Our meta-analysis identified 17 loci newly associated with kidney function-related traits, including the concentrations of blood urea nitrogen, uric acid and serum creatinine and estimated glomerular filtration rate based on serum creatinine levels (eGFRcrea) (P < 5.0 × 10(-8)). We further examined these loci with in silico replication in individuals of European ancestry from the KidneyGen, CKDGen and GUGC consortia, including a combined total of ∼110,347 individuals. We identify pleiotropic associations among these loci with kidney function-related traits and risk of CKD. These findings provide new insights into the genetics of kidney function.

%B Nat Genet %V 44 %P 904-9 %8 2012 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/22797727?dopt=Abstract %R 10.1038/ng.2352 %0 Journal Article %J Curr Pharm Des %D 2012 %T Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. %A Marcuzzi, Annalisa %A Crovella, Sergio %A Monasta, Lorenzo %A Vecchi Brumatti, Liza %A Gattorno, Marco %A Frenkel, Joost %K Animals %K Anti-Inflammatory Agents %K Apoptosis %K Cytokines %K Drug Design %K Hereditary Autoinflammatory Diseases %K Humans %K Inflammasomes %K Inflammation %K Mevalonate Kinase Deficiency %K Mevalonic Acid %X

Inflammation is a highly regulated process involved both in the response to pathogens as well as in tissue homeostasis. In recent years, a complex network of proteins in charge of inflammation control has been revealed by the study of hereditary periodic fever syndromes. Most of these proteins belong to a few families and share the capability of sensing pathogen-associated and damageassociated molecular patterns. By interacting with each other, these proteins participate in the assembly of molecular platforms, called inflammasomes, which ultimately lead to the activation of cytokines, to the transcription of inflammatory genes or to the induction of cell apoptosis. Among hereditary periodic fever syndromes, mevalonate kinase deficiency (MKD) is the sole in which the phenotype did not directly associate with a deficiency of these proteins, but with a metabolic defect of the mevalonate pathway, highlighting the importance of this metabolic pathway in the inflammation control. Noteworthy, drugs acting on this pathway can greatly influence the inflammatory response. The modulation of inflammation by mevalonate pathway is of interest, since it may involve mechanisms not directly referable to inflammasomes. MKD provides a model to study these mechanisms and possibly to develop new classes of anti-inflammatory drugs.

%B Curr Pharm Des %V 18 %P 5746-52 %8 2012 %G eng %N 35 %1 http://www.ncbi.nlm.nih.gov/pubmed/22726114?dopt=Abstract %0 Journal Article %J Bioinformatics %D 2012 %T miR-EdiTar: a database of predicted A-to-I edited miRNA target sites. %A Laganà, Alessandro %A Paone, Alessio %A Veneziano, Dario %A Cascione, Luciano %A Gasparini, Pierluigi %A Carasi, Stefania %A Russo, Francesco %A Nigita, Giovanni %A Macca, Valentina %A Giugno, Rosalba %A Pulvirenti, Alfredo %A Shasha, Dennis %A Ferro, Alfredo %A Croce, Carlo M %K Adenosine %K Binding Sites %K Databases, Genetic %K Gene Expression Regulation %K Humans %K Inosine %K Internet %K MicroRNAs %K Nucleic Acid Conformation %K RNA Editing %X

MOTIVATION: A-to-I RNA editing is an important mechanism that consists of the conversion of specific adenosines into inosines in RNA molecules. Its dysregulation has been associated to several human diseases including cancer. Recent work has demonstrated a role for A-to-I editing in microRNA (miRNA)-mediated gene expression regulation. In fact, edited forms of mature miRNAs can target sets of genes that differ from the targets of their unedited forms. The specific deamination of mRNAs can generate novel binding sites in addition to potentially altering existing ones.

RESULTS: This work presents miR-EdiTar, a database of predicted A-to-I edited miRNA binding sites. The database contains predicted miRNA binding sites that could be affected by A-to-I editing and sites that could become miRNA binding sites as a result of A-to-I editing.

AVAILABILITY: miR-EdiTar is freely available online at http://microrna.osumc.edu/mireditar.

CONTACT: alessandro.lagana@osumc.edu or carlo.croce@osumc.edu

SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

%B Bioinformatics %V 28 %P 3166-8 %8 2012 Dec 1 %G eng %N 23 %1 http://www.ncbi.nlm.nih.gov/pubmed/23044546?dopt=Abstract %R 10.1093/bioinformatics/bts589 %0 Journal Article %J Alzheimer Dis Assoc Disord %D 2012 %T NALP1/NLRP1 genetic variants are associated with Alzheimer disease. %A Pontillo, Alessandra %A Catamo, Eulalia %A Arosio, Beatrice %A Mari, Daniela %A Crovella, Sergio %K Adaptor Proteins, Signal Transducing %K Aged, 80 and over %K Alzheimer Disease %K Apoptosis Regulatory Proteins %K Female %K Genetic Predisposition to Disease %K Genotype %K Humans %K Italy %K Male %K Polymerase Chain Reaction %K Polymorphism, Single Nucleotide %X

Alzheimer disease (AD) is a complex neurodegenerative disease. Genetic and molecular studies have confirmed that in the human brain, amyloid-β fibrils can induce, through the activation of NALP1 inflammosome, inflammatory and apoptotic responses involved in the pathogenesis of AD. Considering that AD pathogenesis is multifactorial, we hypothesized that NALP1/NLRP1 could be a susceptibility gene involved in the devolvement of the disease. The possible association between 9 selected polymorphisms in the NALP1/NLRP1 gene and AD was evaluated by comparing their frequency distribution in an Italian cohort of AD patients (AD, n = 276) and in a group of Italian sex-matched and age-matched healthy controls without dementia (HC, n = 266). Our study, evidences the association of 4 nonsynonymous polymorphisms in the NLRP1 gene (rs2137722, rs34733791, rs11657747, rs11651595) with AD. The major alleles of all 4 single nucleotide polymorphisms and the corresponding homozygote genotypes were more frequent in AD patients than in healthy controls, suggesting an association of these variants in the predisposition versus the development of the disease. These findings seem to support the previously reported role of NALP1 in neuronal damage, and provide evidence of an association between single nucleotide variations in the NLRP1 gene and AD.

%B Alzheimer Dis Assoc Disord %V 26 %P 277-81 %8 2012 Jul-Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21946017?dopt=Abstract %R 10.1097/WAD.0b013e318231a8ac %0 Journal Article %J Invest New Drugs %D 2012 %T The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. %A Carinci, Francesco %A Monasta, Lorenzo %A Rubini, Corrado %A Stramazzotti, Daniela %A Palmieri, Annalisa %A Melloni, Elisabetta %A Knowles, Alex %A Ronfani, Luca %A Zauli, Giorgio %A Secchiero, Paola %K Adult %K Aged %K Aged, 80 and over %K Antineoplastic Agents %K Apoptosis %K Carcinoma, Squamous Cell %K Female %K Flow Cytometry %K HL-60 Cells %K Humans %K Immunohistochemistry %K Male %K Middle Aged %K Mouth Neoplasms %K Predictive Value of Tests %K Prognosis %K Proportional Hazards Models %K Recombinant Proteins %K Risk Assessment %K Risk Factors %K Survival Analysis %K TNF-Related Apoptosis-Inducing Ligand %K Tumor Markers, Biological %K Up-Regulation %K Young Adult %B Invest New Drugs %V 30 %P 810-8 %8 2012 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21086019?dopt=Abstract %R 10.1007/s10637-010-9586-0 %0 Journal Article %J ScientificWorldJournal %D 2012 %T New insights in the sugarcane transcriptome responding to drought stress as revealed by superSAGE. %A Kido, Éderson Akio %A Ferreira Neto, José Ribamar Costa %A Silva, Roberta Lane de Oliveira %A Pandolfi, Valesca %A Guimarães, Ana Carolina Ribeiro %A Veiga, Daniela Truffi %A Chabregas, Sabrina Moutinho %A Crovella, Sergio %A Benko-Iseppon, Ana Maria %K Droughts %K Gene Expression Profiling %K Heat-Shock Response %K Plant Proteins %K Saccharum %K Transcriptome %X

In the scope of the present work, four SuperSAGE libraries have been generated, using bulked root tissues from four drought-tolerant accessions as compared with four bulked sensitive genotypes, aiming to generate a panel of differentially expressed stress-responsive genes. Both groups were submitted to 24 hours of water deficit stress. The SuperSAGE libraries produced 8,787,315 tags (26 bp) that, after exclusion of singlets, allowed the identification of 205,975 unitags. Most relevant BlastN matches comprised 567,420 tags, regarding 75,404 unitags with 164,860 different ESTs. To optimize the annotation efficiency, the Gene Ontology (GO) categorization was carried out for 186,191 ESTs (BlastN against Uniprot-SwissProt), permitting the categorization of 118,208 ESTs (63.5%). In an attempt to elect a group of the best tags to be validated by RTqPCR, the GO categorization of the tag-related ESTs allowed the in silico identification of 213 upregulated unitags responding basically to abiotic stresses, from which 145 presented no hits after BlastN analysis, probably concerning new genes still uncovered in previous studies. The present report analyzes the sugarcane transcriptome under drought stress, using a combination of high-throughput transcriptome profiling by SuperSAGE with the Solexa sequencing technology, allowing the identification of potential target genes during the stress response.

%B ScientificWorldJournal %V 2012 %P 821062 %8 2012 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/22629208?dopt=Abstract %R 10.1100/2012/821062 %0 Journal Article %J Infect Agent Cancer %D 2012 %T NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. %A Girardelli, Martina %A Maestri, Iva %A Rinaldi, Rosa R %A Tognon, Mauro %A Boldorini, Renzo %A Bovenzi, Massimo %A Crovella, Sergio %A Comar, Manola %X

UNLABELLED:

BACKGROUND: An increasing incidence of malignant mesothelioma (MM) cases in patients with low levels of asbestos exposure suggests the interference of alternative cofactors. SV40 infection was detected, as co-morbidity factor, only in 22% of asbestos-MM patients from a North-Eastern Italy area. An additional mechanism of injury related to asbestos exposure in MM development has been recently associated to inflammatory responses, principally driven by interleukin (IL)-1 beta (ß) activated within the inflammasome complex.NLRP3 inflammosome has been described as the intracellular sensor for asbestos able to induce inflammasome activation and IL-1ß secretion while NLRP1 is expressed in lung epithelial cells and alveolar macrophages and contributes to the immune response and to survival/apoptosis balance. This study proposes to evaluate the impact of known NLRP3 and NLRP1 polymorphisms in the individual susceptibility to asbestos-induced mesothelioma in subjects from a hyperendemic area for MM.

METHODS: 134 Italian patients with diagnosis of mesothelioma due (MMAE, n=69) or not (MMAF, n=65) to asbestos, 256 healthy Italian blood donors and 101 Italian healthy subjects exposed to asbestos (HCAE) were genotyped for NLRP1 (rs2670660 and rs12150220) and NLRP3 (rs35829419 and rs10754558) polymorphisms.

RESULTS: While NLRP3 SNPs were not associated to mesothelioma, the NLRP1 rs12150220 allele T was significantly more frequent in MMAE (0.55) than in HCAE (0.41) (p=0.011; OR=1.79) suggesting a predisponent effect of this allele on the development of mesothelioma. This effect was amplified when the NLRP1 rs2670660 allele was combined with the NLRP1 rs12150220 allele (p=0.004; OR=0.52).

CONCLUSION: Although NLRP3 SNPs was not involved in mesothelioma predisposition, these data proposed NLRP1 as a novel factor possibly involved in the development of mesothelioma.

%B Infect Agent Cancer %V 7 %P 25 %8 2012 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/23031505?dopt=Abstract %R 10.1186/1750-9378-7-25 %0 Journal Article %J BMJ Case Rep %D 2012 %T Oral rehabilitation of children with ectodermal dysplasia. %A Montanari, Marco %A Callea, Michele %A Battelli, Filippo %A Piana, Gabriela %K Child %K Child, Preschool %K Denture, Complete %K Denture, Partial %K Ectodermal Dysplasia 1, Anhidrotic %K Esthetics, Dental %K Humans %K Male %K Mastication %K Speech %X

The aim of this study was to describe the clinical treatment of young patients, affected by ectodermal dysplasia (ED), and to possibly establish clinical guidelines. The study design was case series. ED syndromes (EDs) are a heterogeneous group of inherited diseases characterised by abnormal development of tissues of ectodermal origin. The most common form of EDs is X linked hypohidrotic ED (HED). Characteristic triad of HED is oligo-anodontia, hypotricosis, hypo-anhydrosis. Oligo-anodontia is one of the most severe impairment, since it affects chewing, swallowing, speech, esthetics and social relation. Early prosthetic rehabilitation (at 2-3 years of age), with partial or complete dentures, is essential to improve oral function and reduce the social impairment.

%B BMJ Case Rep %V 2012 %8 2012 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/22729329?dopt=Abstract %R 10.1136/bcr.01.2012.5652 %0 Journal Article %J G Ital Dermatol Venereol %D 2012 %T Pelvic inflammatory disease (PID) from Chlamydia trachomatis versus PID from Neisseria gonorrhea: from clinical suspicion to therapy. %A De Seta, F %A Banco, R %A Turrisi, A %A Airoud, M %A De Leo, R %A Stabile, G %A Ceccarello, M %A Restaino, S %A De Santo, D %K Chlamydia Infections %K Chlamydia trachomatis %K Female %K Gonorrhea %K Humans %K Neisseria gonorrhoeae %K Pelvic Inflammatory Disease %X

Pelvic inflammatory disease (PID) is the most significant complication of sexually transmitted infections in childbearing-age women and it represents an important public health problem because of its long-term sequelae (chronic pelvic pain, tubal infertility, ectopic pregnancy). Prior to the mid 1970s PID was considered a monoetiologic infection, due primarily to Neisseria gonorrhea. Now it is well documented as a polymicrobial process, with a great number of microrganisms involved. In addition to Neisseria gonorrhea and Chlamydia trachomatis, other vaginal microrganisms (anaerobes, Gardnerella vaginalis, Haemophilus influenzae, enteric Gram negative rods, Streptococco agalactie, Mycoplasma genitalium) also have been associated with PID. There is a wide variation in PID clinical features; the type and severity of symptoms vary by microbiologic etiology. Women who have chlamydial PID seem more likely than women who have gonococcal PID to be asymptomatic. Since clinical diagnosis is imprecise, the suspicion of PID should be confirmed by genital assessment for signs of inflammation or infection, blood test and imaging evaluation. Laparoscopic approach is considered the gold standard. According to the polymicrobial etiology of PID, antibiotic treatment must provide broad spectrum coverage of likely pathogens. Early administration of antibiotics is necessary to reduce the risk of long-term sequelae.

%B G Ital Dermatol Venereol %V 147 %P 423-30 %8 2012 Oct %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/23007248?dopt=Abstract %0 Journal Article %J Dermatology %D 2012 %T Phylloid pattern of hypomelanosis closely related to chromosomal abnormalities in the 13q detected by SNP array analysis. %A Faletra, F %A Berti, I %A Tommasini, A %A Pecile, V %A Cleva, L %A Alberini, E %A Bruno, I %A Gasparini, P %K Chromosomes, Human, Pair 13 %K Humans %K Hypopigmentation %K Male %K Mosaicism %K Oligonucleotide Array Sequence Analysis %K Polymorphism, Single Nucleotide %X

Phylloid hypomelanosis is a distinct type of pigmentary mosaicism characterized by congenital hypochromic macules resembling a floral ornament with various elements such as round or oval patches, asymmetrical macules similar to begonia leaves, or oblong lesions. It has been found to be predominantly associated with abnormalities in chromosome 13 and sometimes as-sociated with different extracutaneous abnormalities. Here, we report 2 new cases of phylloid hypomelanosis due to mosaicism involving chromosome 13. The first one is a mosaicism for a supernumerary marker belonging to chromosome 13 and the second one is the first report of phylloid hypomelanosis associated with a mosaic deletion of 13q. Because of the extremely low level of mosaicism in these 2 cases, SNP array analysis on skin fibroblasts was carried out, showing a 13q21.33-q34 duplication (71,024,411-115,103,529) and a 13q13.3-q34 (38,368,012-115,103,529) deletion. Both cases underline on the one hand the strict connection between phylloid hypomelanosis and anomalies of chromosome 13, and on the other hand the relevance of the SNP array analysis on skin fibroblasts in the detection of low-level mosaicism.

%B Dermatology %V 225 %P 294-7 %8 2012 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/23095783?dopt=Abstract %R 10.1159/000342884 %0 Journal Article %J Autoimmunity %D 2012 %T Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. %A Pontillo, Alessandra %A Girardelli, Martina %A Kamada, Anselmo J %A Pancotto, Joao A T %A Donadi, Eduardo A %A Crovella, Sergio %A Sandrin-Garcia, Paula %K Adaptor Proteins, Signal Transducing %K Adult %K Alleles %K Apoptosis Regulatory Proteins %K Brazil %K Female %K Genetic Predisposition to Disease %K Genotype %K Haplotypes %K Humans %K Inflammasomes %K Lupus Erythematosus, Systemic %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %X

Recent findings provide evidence of inflammasome critical role in the predisposition to autoimmune disorders. The involvement of inflammasome in the pathogenesis of systemic lupus erythematosus (SLE) has been hypothesized even if no significant association within inflammasome genes mutations or polymorphisms and lupus has been reported yet. We analyzed 14 single nucleotide polymorphisms (SNPs) within 7 inflammasome genes (NLRP1, NLRP3, NLRC4, AIM2, CARD8, CASP1, IL1B) in 144 patients affected by systemic lupus erythematosus and in 158 healthy controls from Southern Brazilian (state of São Paulo) with the aim of disclosing the possible role of inflammasome genes in the susceptibility of SLE. Our results demonstrated that NLRP1 rs2670660 SNP and the NLRP1 rs12150220-rs2670660 A-G haplotype were associated with SLE in our study population, and in particular with the development of nephritis, rash and arthritis. These findings are concordant with previously reported association of NLRP1 with vitiligo and type-1 diabetes underlining once more the involvement of NALP1 inflammasome in the pathogenesis of autoimmune disorders.

%B Autoimmunity %V 45 %P 271-8 %8 2012 Jun %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22235789?dopt=Abstract %R 10.3109/08916934.2011.637532 %0 Journal Article %J Hum Immunol %D 2012 %T Polymorphisms in DC-SIGN and L-SIGN genes are associated with HIV-1 vertical transmission in a Northeastern Brazilian population. %A da Silva, Ronaldo Celerino %A Segat, Ludovica %A Zanin, Valentina %A Arraes, Luiz Claudio %A Crovella, Sergio %K Alleles %K Brazil %K Cell Adhesion Molecules %K Child %K Child, Preschool %K Exons %K Female %K Gene Frequency %K Genotype %K HIV Infections %K HIV-1 %K Humans %K Infectious Disease Transmission, Vertical %K Lectins, C-Type %K Male %K Polymorphism, Single Nucleotide %K Promoter Regions, Genetic %K Receptors, Cell Surface %K Tandem Repeat Sequences %X

DC-SIGN and L-SIGN are receptors expressed on specialized macrophages in decidua, (Hofbauer and placental capillary endothelial cells), known to interact with several pathogens, including HIV-1. To disclose the possible involvement of these molecules in the susceptibility to HIV vertical transmission, we analyzed DC-SIGN and L-SIGN gene single nucleotide polymorphisms (SNPs) in 192 HIV-1 positive children and 58 HIV-1 negative children all born to HIV-1 positive mothers, as well as 96 healthy uninfected children not exposed to HIV-1, all from Northeast Brazil. The frequency of three SNPs in the DC-SIGN promoter (-139G>A, -201G>T and -336A>G) were significantly different when comparing HIV positive children with HIV-1 exposed uninfected children, indicating an association with susceptibility to HIV-1 vertical transmission. This genetic association suggests that DC-SIGN molecule may play a role in susceptibility to HIV-1 infection through vertical transmission.

%B Hum Immunol %V 73 %P 1159-65 %8 2012 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/22902397?dopt=Abstract %R 10.1016/j.humimm.2012.07.338 %0 Journal Article %J J Acquir Immune Defic Syndr %D 2012 %T Polymorphisms in inflammasome' genes and susceptibility to HIV-1 infection. %A Pontillo, Alessandra %A Oshiro, Telma M %A Girardelli, Martina %A Kamada, Anselmo J %A Crovella, Sergio %A Duarte, Alberto J S %K Adaptor Proteins, Signal Transducing %K Adult %K Apoptosis Regulatory Proteins %K Brazil %K Calcium-Binding Proteins %K CARD Signaling Adaptor Proteins %K Carrier Proteins %K Caspase 1 %K Female %K Gene Frequency %K Genetic Predisposition to Disease %K Genotype %K HIV Infections %K HIV-1 %K Humans %K Inflammasomes %K Interleukin-1beta %K Intracellular Signaling Peptides and Proteins %K Male %K Middle Aged %K Neoplasm Proteins %K Polymorphism, Single Nucleotide %X

The involvement of inflammasome genes in the susceptibility to HIV-1 infection was investigated. Twelve single nucleotide polymorphisms within NLRP1, NLRP3, NLRC4, CARD8, CASP1, and IL1B genes were analyzed in 150 HIV-1-infected Brazilian subjects and 158 healthy controls. The 2 polymorphisms rs10754558 in NLRP3 and rs1143634 in IL1B were significantly associated to the HIV-1 infection. These findings supported the previously hypothesized involvement of NALP3-inflammasome in HIV-1 pathogenesis, underlining once more the key role of inflammation and innate immunity in the susceptibility to HIV-1 infection.

%B J Acquir Immune Defic Syndr %V 59 %P 121-5 %8 2012 Feb 1 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22227487?dopt=Abstract %R 10.1097/QAI.0b013e3182392ebe %0 Journal Article %J Genet Test Mol Biomarkers %D 2012 %T A real-time polymerase chain reaction-based protocol for low/medium-throughput Y-chromosome microdeletions analysis. %A Segat, Ludovica %A Padovan, Lara %A Doc, Darja %A Petix, Vincenzo %A Morgutti, Marcello %A Crovella, Sergio %A Ricci, Giuseppe %K Azoospermia %K Chromosome Deletion %K Chromosomes, Human, Y %K Female %K Humans %K Kruppel-Like Transcription Factors %K Male %K Real-Time Polymerase Chain Reaction %K Sex Chromosome Aberrations %K Sex Chromosome Disorders of Sex Development %X

PURPOSE: We describe a real-time polymerase chain reaction (PCR) protocol based on the fluorescent molecule SYBR Green chemistry, for a low- to medium-throughput analysis of Y-chromosome microdeletions, optimized according to the European guidelines and aimed at making the protocol faster, avoiding post-PCR processing, and simplifying the results interpretation.

METHODS: We screened 156 men from the Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Institute for Maternal and Child Health IRCCS Burlo Garofolo (Trieste, Italy), 150 not presenting Y-chromosome microdeletion, and 6 with microdeletions in different azoospermic factor (AZF) regions. For each sample, the Zinc finger Y-chromosomal protein (ZFY), sex-determining region Y (SRY), sY84, sY86, sY127, sY134, sY254, and sY255 loci were analyzed by performing one reaction for each locus.

RESULTS: AZF microdeletions were successfully detected in six individuals, confirming the results obtained with commercial kits.

CONCLUSION: Our real-time PCR protocol proved to be a rapid, safe, and relatively cheap method that was suitable for a low- to medium-throughput diagnosis of Y-chromosome microdeletion, which allows an analysis of approximately 10 samples (with the addition of positive and negative controls) in a 96-well plate format, or approximately 46 samples in a 384-well plate for all markers simultaneously, in less than 2 h without the need of post-PCR manipulation.

%B Genet Test Mol Biomarkers %V 16 %P 1349-55 %8 2012 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/23101560?dopt=Abstract %R 10.1089/gtmb.2012.0220 %0 Journal Article %J Early Hum Dev %D 2012 %T Relation between maternal thrombophilia and stillbirth according to causes/associated conditions of death. %A Monari, F %A Alberico, S %A Avagliano, L %A Cetin, I %A Cozzolino, S %A Gargano, G %A Marozio, L %A Mecacci, F %A Neri, I %A Tranquilli, A L %A Venturini, P %A Facchinetti, F %K Adult %K Case-Control Studies %K Cause of Death %K Female %K Fetal Diseases %K Fetal Mortality %K Humans %K Infant, Newborn %K Male %K Placenta Diseases %K Pre-Eclampsia %K Pregnancy %K Pregnancy Complications, Hematologic %K Socioeconomic Factors %K Stillbirth %K Thrombophilia %K Young Adult %X

OBJECTIVE: To investigate maternal thrombophilia in cases of Stillbirth (SB), also an uncertain topic because most case series were not characterised for cause/associated conditions of death.

STUDY DESIGN: In a consecutive, prospective, multicentre design, maternal DNA was obtained in 171 cases of antenatal SB and 326 controls (uneventful pregnancy at term, 1:2 ratio). Diagnostic work-up of SB included obstetric history, neonatologist inspection, placenta histology, autopsy, microbiology/chromosome evaluations. Results audited in each centre were classified by two of us by using CoDAC. Cases were subdivided into explained SB where a cause of death was identified and although no defined cause was detected in the remnants, 64 cases found conditions associated with placenta-vascular disorders (including preeclampsia, growth restriction and placenta abruption - PVD). In the remnant 79 cases, no cause of death or associated condition was found. Antithrombin activity, Factor V Leiden, G20210A Prothrombin mutation (FII mutation) and acquired thrombophilia were analysed.

RESULTS: Overall, the presence of a thrombophilic defect was significantly more prevalent in mothers with SBs compared to controls. In particular, SB mothers showed an increased risk of carrying Factor II mutation (OR=3.2, 95% CI: 1.3-8.3, p=0.01), namely in unexplained cases. Such mutation was significantly associated also with previous SB (OR=8.9, 95%CI 1.2-70.5). At multiple logistic regression, Factor II mutation was the only significantly associated variable with SB (adj OR=3.8, 95% CI: 1.3-13.5).

CONCLUSION: These data suggest that Factor II mutation is the only condition specifically associated with unexplained SB and could represents a risk of recurrence. PVD-associated condition is unrelated to thrombophilia.

%B Early Hum Dev %V 88 %P 251-4 %8 2012 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21945103?dopt=Abstract %R 10.1016/j.earlhumdev.2011.08.013 %0 Journal Article %J Acta Paediatr %D 2012 %T Sedation with intranasal midazolam of Angolan children undergoing invasive procedures. %A Kawanda, Lumana %A Capobianco, Ivan %A Starc, Meta %A Felipe, Daniel %A Zanon, Davide %A Barbi, Egidio %A Munkela, Nadine %A Rodrigues, Verónica %A Malundo, Lúis %A Not, Tarcisio %K Administration, Intranasal %K Adolescent %K Ambulatory Surgical Procedures %K Angola %K Child %K Child Behavior %K Child, Preschool %K Conscious Sedation %K Crying %K Female %K Humans %K Hypnotics and Sedatives %K Infant %K Male %K Midazolam %K Prospective Studies %X

AIM: Ambulatory surgery is a daily requirement in poor countries, and limited means and insufficient trained staff lead to the lack of attention to the patient's pain. Midazolam is a rapid-onset, short-acting benzodiazepine which is used safely to reduce pain in children. We evaluated the practicability of intranasal midazolam sedation in a suburban hospital in Luanda (Angola), during the surgical procedures.

METHODS: Intranasal midazolam solution was administered at a dose of 0.5 mg/kg. Using the Ramsay's reactivity score, we gave a score to four different types of children's behaviour: moaning, shouting, crying and struggling, and the surgeon evaluated the ease of completing the surgical procedure using scores from 0 (very easy) to 3 (managing with difficulty).

RESULTS: Eighty children (median age, 3 years) were recruited, and 140 surgical procedures were performed. Fifty-two children were treated with midazolam during 85 procedures, and 28 children were not treated during 55 procedures. We found a significant difference between the two groups on the shouting, crying and struggling parameters (p < 0.001). The mean score of the ease of completing the procedures was significantly different among the two groups (p < 0.0001).

CONCLUSION: These results provide a model of procedural sedation in ambulatory surgical procedures in poor countries, thus abolishing pain and making the surgeon's job easier.

%B Acta Paediatr %V 101 %P e296-8 %8 2012 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/22458936?dopt=Abstract %R 10.1111/j.1651-2227.2012.02691.x %0 Journal Article %J Amyloid %D 2012 %T Serum amyloid A and cholesterol: a pivotal role on inflammation. %A Tricarico, Paola Maura %A Marcuzzi, Annalisa %A Zanin, Valentina %A Kleiner, Giulio %A Bianco, Anna Monica %A Crovella, Sergio %K Animals %K Humans %K Serum Amyloid A Protein %B Amyloid %V 19 %P 163-4; author reply 165-6 %8 2012 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/22624603?dopt=Abstract %R 10.3109/13506129.2012.689266 %0 Journal Article %J Exp Hematol %D 2012 %T Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan. %A Mazzoni, Elisa %A Rigolin, Gian Matteo %A Alaribe, Franca Nneka %A Pancaldi, Cecilia %A Maniero, Stefania %A Comar, Manola %A Martini, Fernanda %A Tognon, Mauro %K Antigens, Polyomavirus Transforming %K Cell Line, Transformed %K Cell Survival %K Humans %K Microscopy, Electron, Transmission %K Simian virus 40 %K T-Lymphocytes %X

The relevance of viral infections to the onset and progression of human hematologic malignancies and other blood diseases is still a matter of active investigation. Purified human T lymphocytes isolated from the peripheral blood mononuclear cells of healthy blood donors were experimentally infected with simian virus 40 (SV40), a small DNA tumor virus. SV40-positive T lymphocytes extended their lifespan up to day 80 postinfection (PI). Expression of viral antigens, such as the large T antigen and the viral capsid protein VP1 from the early and late regions, respectively, was detected up to day 40 PI. SV40 viral progeny were continuously produced from day 10 to 40 PI. SV40 DNA sequences were detected in infected T cells for up to 80 days. Our data indicate that human T lymphocytes can be efficiently infected with SV40. Although T cells infected by SV40 were not immortalized, 30% of these lymphocytes appeared to be morphologically transformed with an enlarged T-cell shape. Our investigation provides a simple model for studying the interactions of human T lymphocytes with this small DNA tumor virus and it might represent an experimental tool for investigating new biomarkers and targets for innovative therapeutic approaches.

%B Exp Hematol %V 40 %P 466-76 %8 2012 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22421183?dopt=Abstract %R 10.1016/j.exphem.2012.02.008 %0 Journal Article %J Haematologica %D 2012 %T The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status. %A Zauli, Giorgio %A Celeghini, Claudio %A Melloni, Elisabetta %A Voltan, Rebecca %A Ongari, Manuele %A Tiribelli, Mario %A di Iasio, Maria Grazia %A Lanza, Francesco %A Secchiero, Paola %K Antineoplastic Agents %K Drug Synergism %K Female %K fms-Like Tyrosine Kinase 3 %K HL-60 Cells %K Humans %K Imidazoles %K Leukemia, Myeloid, Acute %K Male %K Niacinamide %K Phenylurea Compounds %K Piperazines %K Tumor Suppressor Protein p53 %X

BACKGROUND: Both the multi-kinase inhibitor sorafenib and the small molecule inhibitor of the MDM2/p53 interaction, nutlin-3, used alone, have shown promising anti-leukemic activity in acute myeloid leukemia cells. Thus, in this study we investigated the effect of the combination of sorafenib plus nutlin-3 in acute myeloid leukemia.

DESIGN AND METHODS: Primary acute myeloid leukemia blasts (n=13) and FLT3(wild-type)/p53(wild-type) (OCI-AML3), FLT3(mutated)/p53(wild-type) (MOLM), FLT3(mutated)/p53(mutated) (MV4-11), FLT3(wild-type)/p53(deleted) (HL60) or FLT3(wild-type)/p53(mutated) (NB4) acute myeloid cell lines were exposed to sorafenib, used alone or in association with nutlin-3 at a 1:1 ratio, in a range of clinically achievable concentrations (1-10 μM). Induction of apoptosis and autophagy was evaluated by transmission electron microscopy and by specific flow cytometry analyses. The levels of Mcl-1, p53 and Bak proteins were analyzed by western blotting. Knock-down of Bax and Bak gene expression was performed in transfection experiments with specific short interfering RNA.

RESULTS: The sorafenib+nutlin-3 drug combination exhibits synergistic cytotoxicity in primary acute myeloid leukemia blasts and in acute myeloid leukemia cell lines with maximal cytotoxicity in FLT3(mutated) MV4-11 and MOLM, followed by the FLT3(wild-type) OCI-AML3, HL60 and NB4 cell lines. The cytotoxic activity of sorafenib+nutlin-3 was characterized by an increase of both apoptosis and autophagy. Moreover, Bax and Bak showed prominent roles in mediating the decrease of cell viability in response to the drug combination in p53(wild-type) OCI-AML3 and p53(deleted) HL-60 cells, respectively, as demonstrated in transfection experiments performed with specific short interfering RNA.

CONCLUSIONS: Our data demonstrate that acute myeloid leukemia cells show a variable but overall good susceptibility to the innovative therapeutic combination of sorafenib+nutlin-3, which differentially involves the pro-apoptotic Bcl-2 family members Bax and Bak in p53(wild-type) and p53(deleted) cells.

%B Haematologica %V 97 %P 1722-30 %8 2012 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/22689683?dopt=Abstract %R 10.3324/haematol.2012.062083 %0 Journal Article %J J Neurovirol %D 2012 %T Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. %A Zanin, Valentina %A Delbue, Serena %A Marcuzzi, Annalisa %A Tavazzi, Eleonora %A Del Savio, Rossella %A Crovella, Sergio %A Marchioni, Enrico %A Ferrante, Pasquale %A Comar, Manola %K Adult %K Aged %K Anti-HIV Agents %K Cytokines %K Encephalomyelitis, Acute Disseminated %K Female %K HIV Infections %K HIV-1 %K Humans %K Leukoencephalopathy, Progressive Multifocal %K Male %K Middle Aged %K Pilot Projects %X

Cytokines/chemokines are involved in the immune response of infections, including HIV-1. We defined the profile of 48 cytokines/chemokines in cerebrospinal fluid from 18 cART patients with chronic HIV-1 infection by Luminex technology. Nine patients were affected with leukoencephalopathies: five with John Cunningham virus (JCV) + progressive multifocal leukoencephalopathy (PML) and four with JCV-not determined leukoencephalopathy (NDLE). In addition, nine HIV-1-positive patients with no neurological signs (NND) and five HIV-1-negative patients affected with acute disseminated encephalomyelitis (ADEM) were enrolled. Ten cytokines (IL-15, IL-3, IL-16, IL-18, CTACK, GRO1, SCF, MCP-1, MIF, SDF) were highly expressed in HIV-1-positive patients while IL-1Ra and IL-17 were present at a lower level. In addition, the levels of IL-17, IL-9, FGF-basic, MIP-1β, and MCP-1 were significantly higher (p < 0.05) in patients with neurological diseases (PML, NDLE, ADEM) with respect to NND. Focusing the attention to the cytokine profile in JCV + PML patients with respect to JCV-NDLE patients, only TNF-β was significantly downregulated (p < 0.05) in JCV + PML patients. This pilot study emphasized the role of immunoregulation in HIV-1-related neurological disorders during cART treatment.

%B J Neurovirol %V 18 %P 416-22 %8 2012 Oct %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/22581428?dopt=Abstract %R 10.1007/s13365-012-0109-y %0 Journal Article %J Curr Pharm Des %D 2012 %T Stem cell ageing and apoptosis. %A Fulle, Stefania %A Centurione, Lucia %A Mancinelli, Rosa %A Sancilio, Silvia %A Manzoli, Francesco Antonio %A Di Pietro, Roberta %K Adult %K Apoptosis %K Cell Aging %K Humans %K Stem Cells %X

Ageing has been defined as the process of deterioration of many body functions over the lifespan of an individual. In spite of the number of different theories about ageing, there is a general consensus in identifying ageing effects in a reduced capacity to regenerate injured tissues or organs and an increased propensity to infections and cancer. In recent years the stem cell theory of ageing has gained much attention. Adult stem cells residing in mammalian tissues are essential for tissue homeostasis and repair throughout adult life. With advancing age, the highly regulated molecular signalling necessary to ensure proper cellular, tissue, and organ homeostasis loses coordination and leads, as a consequence, to a compromised potential of regeneration and repair of damaged cells and tissues. Although a complete comprehension of the molecular mechanisms involved in stem cell ageing and apoptosis is far to be reached, recent studies are beginning to unravel the processes involved in stem cell ageing, particularly in adult skeletal muscle stem cells, namely satellite cells. Thus, the focus of this review is to analyse the relationship between stem cell ageing and apoptosis with a peculiar attention to human satellite cells as compared to haematopoietic stem cells. Undoubtedly, the knowledge of age-related changes of stem cells will help in understanding the ageing process itself and will provide novel therapeutic challenges for improved tissue regeneration.

%B Curr Pharm Des %V 18 %P 1694-717 %8 2012 %G eng %N 13 %1 http://www.ncbi.nlm.nih.gov/pubmed/22352749?dopt=Abstract %0 Journal Article %J Neuromuscul Disord %D 2012 %T Stem cells in severe infantile spinal muscular atrophy (SMA1). %A Carrozzi, Marco %A Amaddeo, Alessandro %A Biondi, Andrea %A Zanus, Caterina %A Monti, Fabrizio %A Alessandro, Ventura %K Humans %K Spinal Muscular Atrophies of Childhood %K Stem Cell Transplantation %K Stem Cells %K Treatment Outcome %B Neuromuscul Disord %V 22 %P 1032-4 %8 2012 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/23046997?dopt=Abstract %R 10.1016/j.nmd.2012.09.005 %0 Journal Article %J PLoS One %D 2012 %T The submerged dyslexia iceberg: how many school children are not diagnosed? Results from an Italian study. %A Barbiero, Chiara %A Lonciari, Isabella %A Montico, Marcella %A Monasta, Lorenzo %A Penge, Roberta %A Vio, Claudio %A Tressoldi, Patrizio Emanuele %A Ferluga, Valentina %A Bigoni, Anna %A Tullio, Alessia %A Carrozzi, Marco %A Ronfani, Luca %K Area Under Curve %K Child %K Cross-Sectional Studies %K Delayed Diagnosis %K Dyslexia %K Female %K Humans %K Italy %K Male %K Neuropsychological Tests %K Prevalence %K Questionnaires %K ROC Curve %X

BACKGROUND: Although dyslexia is one of the most common neurobehavioral disorders affecting children, prevalence is uncertain and available data are scanty and dated. The objective of this study is to evaluate the prevalence of dyslexia in an unselected school population using clearly defined and rigorous diagnostic criteria and methods.

METHODS: Cross sectional study. We selected a random cluster sample of 94 fourth grade elementary school classes of Friuli Venezia Giulia, a Region of North Eastern Italy. We carried out three consecutive levels of screening: the first two at school and the last at the Neuropsychiatry Unit of a third level Mother and Child Hospital. The main outcome measure was the prevalence of dyslexia, defined as the number of children positive to the third level of screening divided by the total number of children enrolled.

RESULTS: We recruited 1774 children aged 8-10 years, of which 1528 received parents' consent to participate. After applying exclusion criteria, 1357 pupils constituted the final working sample. The prevalence of dyslexia in the enrolled population ranged from 3.1% (95% CI 2.2-4.1%) to 3.2% (95% CI 2.4-4.3%) depending on different criteria adopted. In two out of three children with dyslexia the disorder had not been previously diagnosed.

CONCLUSIONS: This study shows that dyslexia is largely underestimated in Italy and underlines the need for reliable information on prevalence, in order to better allocate resources both to Health Services and Schools.

%B PLoS One %V 7 %P e48082 %8 2012 %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/23118930?dopt=Abstract %R 10.1371/journal.pone.0048082 %0 Journal Article %J Eur J Pediatr Surg %D 2012 %T Thoracoscopic removal of a bulky cystic mediastinal mature teratoma in a 4-year-old child: report of one case and few surgical tricks. %A Codrich, Daniela %A Lembo, Maria Antonietta %A Schleef, Jurgen %K Child, Preschool %K Female %K Humans %K Mediastinal Neoplasms %K Teratoma %K Thoracoscopy %K Tomography, X-Ray Computed %B Eur J Pediatr Surg %V 22 %P 318-20 %8 2012 Aug %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22576302?dopt=Abstract %R 10.1055/s-0032-1308697 %0 Journal Article %J Clin Sci (Lond) %D 2012 %T TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation. %A Bernardi, Stella %A Zauli, Giorgio %A Tikellis, Christos %A Candido, Riccardo %A Fabris, Bruno %A Secchiero, Paola %A Cooper, Mark E %A Thomas, Merlin C %K Adiposity %K Animals %K Apoptosis %K Calorimetry %K Cytokines %K Dietary Fats %K Energy Intake %K Glucose Tolerance Test %K Hyperglycemia %K Hyperinsulinism %K Inflammation %K Inflammation Mediators %K Male %K Mice %K Mice, Inbred C57BL %K Oxidation-Reduction %K Palmitic Acid %K Real-Time Polymerase Chain Reaction %K TNF-Related Apoptosis-Inducing Ligand %X

TRAIL [TNF (tumour necrosis factor)-related apoptosis-inducing ligand] has recently been shown to ameliorate the natural history of DM (diabetes mellitus). It has not been determined yet whether systemic TRAIL delivery would prevent the metabolic abnormalities due to an HFD [HF (high-fat) diet]. For this purpose, 27 male C57bl6 mice aged 8 weeks were randomly fed on a standard diet, HFD or HFD+TRAIL for 12 weeks. TRAIL was delivered weekly by intraperitoneal injection. Body composition was evaluated; indirect calorimetry studies, GTT (glucose tolerance test) and ITT (insulin tolerance test) were performed. Pro-inflammatory cytokines, together with adipose tissue gene expression and apoptosis, were measured. TRAIL treatment reduced significantly the increased adiposity associated with an HFD. Moreover, it reduced significantly hyperglycaemia and hyperinsulinaemia during a GTT and it improved significantly the peripheral response to insulin. TRAIL reversed the changes in substrate utilization induced by the HFD and ameliorated skeletal muscle non-esterified fatty acids oxidation rate. This was associated with a significant reduction of pro-inflammatory cytokines together with a modulation of adipose tissue gene expression and apoptosis. These findings shed light on the possible anti-adipogenic and anti-inflammatory effects of TRAIL and open new therapeutic possibilities against obesity, systemic inflammation and T2DM (Type 2 DM).

%B Clin Sci (Lond) %V 123 %P 547-55 %8 2012 Nov %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/22616837?dopt=Abstract %R 10.1042/CS20120176 %0 Journal Article %J Cytokine %D 2012 %T TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. %A Marcuzzi, Annalisa %A Secchiero, Paola %A Crovella, Sergio %A Zauli, Giorgio %K Acetylmuramyl-Alanyl-Isoglutamine %K Acute Disease %K Animals %K Chemokine CCL2 %K Cytokines %K Disease Models, Animal %K Down-Regulation %K Granulocyte Colony-Stimulating Factor %K Humans %K Immunoassay %K Inflammation %K Inflammation Mediators %K Interleukin-1alpha %K Interleukin-6 %K Lipopolysaccharides %K Male %K Mice %K Mice, Inbred BALB C %K Recombinant Proteins %K Serum Amyloid A Protein %K TNF-Related Apoptosis-Inducing Ligand %X

The potent inducer of apoptosis TRAIL/Apo2 ligand is now under considerations in clinical trials for the treatment of different types of cancer. Since the natural history of cancer is often characterized by microbial infections, we have investigated the effect of recombinant human TRAIL in a mouse model of systemic acute inflammation of microbial origin represented by BALB/c mice treated with either bacterial muramyldipeptide (MDP) or lipopolysaccharide (LPS). When administered intraperitoneally (i.p.), these inflammatory bacterial compounds triggered a severe systemic inflammatory response within 2h, represented by body temperature elevation, increase of circulating serum amyloid-A (SAA) and of the number of leukocytes in the peritoneal cavity. Moreover, both MDP and LPS induced a significant elevation of the circulating levels of several inflammatory cytokines and chemokines. Noteworthy, pre-treatment with recombinant human TRAIL 48 and 72 h before administration of either MDP or LPS, significantly counteracted all acute inflammatory responses, including the elevation of key pro-inflammatory cytokines/chemokines such as IL-1α, IL-6, G-CSF, MCP-1. These data demonstrate for the first time that TRAIL has a potent anti-inflammatory activity, which might be beneficial for the anti-tumoral activity of TRAIL.

%B Cytokine %V 60 %P 43-6 %8 2012 Oct %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22727903?dopt=Abstract %R 10.1016/j.cyto.2012.06.001 %0 Journal Article %J Invest New Drugs %D 2012 %T TRAIL shows potential cardioprotective activity. %A Toffoli, Barbara %A Bernardi, Stella %A Candido, Riccardo %A Zacchigna, Serena %A Fabris, Bruno %A Secchiero, Paola %K Animals %K Apolipoproteins E %K Apoptosis %K Cardiotonic Agents %K Diabetes Mellitus, Experimental %K Diabetes Mellitus, Type 1 %K Diabetic Cardiomyopathies %K Fibrosis %K Male %K Mice %K Mice, Knockout %K Recombinant Proteins %K TNF-Related Apoptosis-Inducing Ligand %X

Recent clinical trials carried out in patients with advanced cancer have shown that recombinant TRAIL administration is usually safe and well tolerated when used either alone or in association with chemotherapeutic drugs. Notably, anticancer chemotherapy can be associated to cardiomiopathy. We have here demonstrated that TRAIL (administrated as either recombinant soluble TRAIL or as AAV-TRAIL expression viral vector) reduced the development of cardiomyopathy in the ApoE(-/-) diabetic mouse model. These data suggest, for the first time, that therapeutically administration of TRAIL might have a cardioprotective effect.

%B Invest New Drugs %V 30 %P 1257-60 %8 2012 Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21197620?dopt=Abstract %R 10.1007/s10637-010-9627-8 %0 Journal Article %J J Crohns Colitis %D 2012 %T Upper gastrointestinal involvement in paediatric onset Crohn's disease: prevalence and clinical implications. %A Crocco, S %A Martelossi, S %A Giurici, N %A Villanacci, V %A Ventura, A %K Adolescent %K Age of Onset %K Child %K Crohn Disease %K Female %K Humans %K Male %K Prospective Studies %K Upper Gastrointestinal Tract %X

BACKGROUND AND AIMS: Our study evaluated the prevalence, the characteristics and implications of the upper gastrointestinal localisation (UGI+) in paediatric Crohn's Disease (CD) patients.

METHODS: This prospective study evaluated 45 newly diagnosed CD patients at diagnosis and follow up with respect to CD localisation.

RESULTS: All patients presented CD at the colon and/or ileum. In 24/45 patients (53.3%, 12 F and 12 M) an UGI+ involvement was also found. UGI+ patients had a younger age of onset (10.9 years versus 12.6 years; P<0.05). PCDAI at diagnosis was significantly higher in the UGI+ (41 vs. 25 P<0.01). UGI+ patients were overall more symptomatic. Pancolitis and extraintestinal manifestations were also more frequent (19/24 (80%) vs. 12/21 (57%) P<0.01). Growth was more impaired at diagnosis in UGI+ patients. By the end of the follow-up (mean 3 years, range 2 to 4) no significant difference was found in PCDAI (17 in UGI+ patients vs. 11 in UGI- P=NS), or the number of relapses. Weight and growth catch-up in UGI+ patients were comparable to UGI- ones. However, UGI+ patients required a more aggressive therapeutic approach.

CONCLUSION: At least half of paediatric onset CD patients have an upper gastrointestinal localisation. UGI+ patients present an earlier onset and a more severe disease. The final outcome does not differ, but UGI+ patients require a more aggressive therapeutic approach.

%B J Crohns Colitis %V 6 %P 51-5 %8 2012 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22261527?dopt=Abstract %R 10.1016/j.crohns.2011.06.013 %0 Journal Article %J Pediatr Med Chir %D 2012 %T Videogame playing as distraction technique in course of venipuncture. %A Minute, M %A Badina, L %A Cont, G %A Montico, M %A Ronfani, L %A Barbi, E %A Ventura, A %K Anesthetics, Local %K Child %K Child, Preschool %K Female %K Humans %K Lidocaine %K Male %K Pain %K Phlebotomy %K Prilocaine %K Prospective Studies %K Video Games %X

BACKGROUND: Needle-related procedures (venipuncture, intravenous cannulation) are the most common source of pain and distress for children. Reducing needle related pain and anxiety could be important in order to prevent further distress, especially for children needing multiple hospital admissions. The aim of the present open randomized controlled trial was to investigate the efficacy of adding an active distraction strategy (videogame) to EMLA premedication in needle-related pain in children.

METHODS: One-hundred and nine children (4 -10 years of age) were prospectively recruited to enter in the study. Ninety-seven were randomized in two groups: CC group (conventional care: EMLA only) as control group and AD group (active distraction: EMLA plus videogame) as intervention group. Outcome measures were: self-reported pain by mean of FPS-R scale (main study outcome), observer-reported pain by FLACC scale, number of attempts for successful procedure.

RESULTS: In both groups FPS-R median rate was 0 (interquartile range: 0-2), with significant pain (FPS-R > 4) reported by 9% of subjects. FLACC median rate was 1 in both groups (interquartile range 0-3 in CC group; 0-2 in AD group). The percentage of children with major pain (FLACC > 4) was 18% in CC group and 9% in AD group (p = 0.2). The median of necessary attempts to succeed in the procedures was 1 (interquartile range 1-2) in both groups..

CONCLUSION: Active distraction doesn't improve EMLA analgesia for iv cannulation and venipuncture. Even though, it resulted in an easily applicable strategy appreciated by children. This technique could be usefully investigated in other painful procedures.

%B Pediatr Med Chir %V 34 %P 77-83 %8 2012 Mar-Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22730632?dopt=Abstract %R 10.4081/pmc.2012.64 %0 Journal Article %J Am J Hematol %D 2011 %T Adam's rib and the origin of stem cells. %A Callea, Francesco %A Callea, Michele %K Humans %K Ribs %K Stem Cell Transplantation %K Stem Cells %B Am J Hematol %V 86 %P 529 %8 2011 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/21520222?dopt=Abstract %R 10.1002/ajh.22005 %0 Journal Article %J Breastfeed Med %D 2011 %T Antidepressant drugs and breastfeeding: a review of the literature. %A Davanzo, Riccardo %A Copertino, Marco %A De Cunto, Angela %A Minen, Federico %A Amaddeo, Alessandro %K Adrenergic Uptake Inhibitors %K Antidepressive Agents %K Antidepressive Agents, Tricyclic %K Biological Availability %K Breast Feeding %K Depression, Postpartum %K Directive Counseling %K Drug Monitoring %K Female %K Humans %K Infant, Newborn %K Lactation %K Lithium Compounds %K Maternal Exposure %K Milk, Human %K Monoamine Oxidase Inhibitors %K Pregnancy %K Serotonin Uptake Inhibitors %X

The use of antidepressants in breastfeeding mothers is controversial: Manufacters often routinely discourage breastfeeding for the nursing mother despite the well-known positive impact that breastfeeding carries on the health of the nursing infant and on his or her family and society. We conducted a systematic review of drugs commonly used in the treatment of postpartum depression. For every single drug two sets of data were provided: (1) selected pharmacokinetic characteristics such as half-life, milk-to-plasma ratio, protein binding, and oral bioavailability and (2) information about lactational risk, according to some authoritative sources of the literature: Drugs in Pregnancy and Lactation edited by Briggs et al. (Lippincott Williams, Philadelphia, 2008), Medications and Mothers' Milk by Hale (Hale Publishing, Amarillo, TX, 2010), and the LactMed database of TOXNET ( www.pubmed.gov ; accessed June 2010). Notwithstanding a certain variability of advice, we found that (1) knowledge of pharmacokinetic characteristics are scarcely useful to assess safety and (2) the majority of antidepressants are not usually contraindicated: (a) Selective serotinin reuptake inhibitors and nortryptiline have a better safety profile during lactation, (b) fluoxetine must be used carefully, (c) the tricyclic doxepine and the atypical nefazodone should better be avoided, and (d) lithium, usually considered as contraindicated, has been recently rehabilitated.

%B Breastfeed Med %V 6 %P 89-98 %8 2011 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/20958101?dopt=Abstract %R 10.1089/bfm.2010.0019 %0 Journal Article %J Int J Rheumatol %D 2011 %T Anti-α-enolase Antibodies in Serum from Pediatric Patients Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights. %A Pontillo, Alessandra %A Di Toro, Nicola %A Edomi, Paolo %A Shadlow, A %A Ammadeo, A %A Gattorno, M %A Not, T %A Lepore, L %A Crovella, S %X

Human glycolytic enzyme α-enolase was associated with human diseases and with inflammation. An ELISA test was developed to measure anti-α-enolase AAE IgG and AAE IgA in the serum from patients affected by inflammatory diseases with the purpose to evaluate it as a novel diagnostic marker. 80 healthy blood donors and 194 paediatric patients affected by Juvenile idiopathic arthritis (JIA), celiac disease (CD), Crohn's Disease (CrD), hereditary periodic fever (HPF), and PFAPA syndrome were included in the study. HPF patients showed high levels of AAE antibodies, whereas JIA, CD, and CrD presented only partial results. Benign fevers such as PFAPA were almost negative for AAE Abs. These findings suggested that the genetic dysfunction of inflammasome associated with HPF could lead to the formation of AAE Abs that could be used for an early and easy diagnosis.

%B Int J Rheumatol %V 2011 %P 870214 %8 2011 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/22007226?dopt=Abstract %R 10.1155/2011/870214 %0 Journal Article %J Eur J Hum Genet %D 2011 %T Association of a variant in the CHRNA5-A3-B4 gene cluster region to heavy smoking in the Italian population. %A Sorice, Rossella %A Bione, Silvia %A Sansanelli, Serena %A Ulivi, Sheila %A Athanasakis, Emmanouil %A Lanzara, Carmela %A Nutile, Teresa %A Sala, Cinzia %A Camaschella, Clara %A d'Adamo, Pio %A Gasparini, Paolo %A Ciullo, Marina %A Toniolo, Daniela %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Humans %K Italy %K Multigene Family %K Nerve Tissue Proteins %K Polymorphism, Single Nucleotide %K Receptors, Nicotinic %K Smoking %K Tobacco Use Disorder %X

Large-scale population studies have established that genetic factors contribute to individual differences in smoking behavior. Linkage and genome-wide association studies have shown many chromosomal regions and genes associated with different smoking behaviors. One study was the association of single-nucleotide polymorphisms (SNPs) in the CHRNA5-A3-B4 gene cluster to nicotine addiction. Here, we report a replication of this association in the Italian population represented by three genetically isolated populations. One, the Val Borbera, is a genetic isolate from North-Western Italy; the Cilento population, is located in South-Western Italy; and the Carlantino village is located in South-Eastern Italy. Owing to their position and their isolation, the three populations have a different environment, different history and genetic structure. The variant A of the rs1051730 SNP was significantly associated with smoking quantity in two populations, Val Borbera and Cilento, no association was found in Carlantino population probably because difference in LD pattern in the variant region.

%B Eur J Hum Genet %V 19 %P 593-6 %8 2011 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/21248747?dopt=Abstract %R 10.1038/ejhg.2010.240 %0 Journal Article %J Atherosclerosis %D 2011 %T Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults. %A Volpato, Stefano %A Ferrucci, Luigi %A Secchiero, Paola %A Corallini, Federica %A Zuliani, Giovanni %A Fellin, Renato %A Guralnik, Jack M %A Bandinelli, Stefania %A Zauli, Giorgio %K Adult %K Aged %K Ankle Brachial Index %K Cardiovascular Diseases %K Female %K Follow-Up Studies %K Humans %K Italy %K Male %K Middle Aged %K TNF-Related Apoptosis-Inducing Ligand %X

OBJECTIVE: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) exhibits biological activity on vascular cells in vitro. Rapid variation of circulating TRAIL levels occurs during acute coronary ischemia, suggesting that biological pathways involving TRAIL may be activated during ischemic heart disease. However, whether differential levels of soluble TRAIL in normal individuals are associated with adverse health outcomes has not been investigated. We tested the hypothesis that TRAIL levels predict mortality in a population based sample of community dwelling men and women.

METHODS: Plasma TRAIL level was measured by ELISA at baseline in 1282 adults (mean age 68 years) enrolled in the InCHIANTI study. Vital status was ascertained over the six-year follow-up.

RESULTS: In multivariable Cox regression analysis adjusted for potential confounders including prevalent cardiovascular diseases (CVD), ankle-brachial index, electrocardiogram abnormalities, and inflammatory markers, baseline TRAIL levels were inversely related to all-cause mortality (p=0.008). In stratified analyses, the prognostic effect of TRAIL level was strong and highly significant in participants with prevalent CVD (N=321), (lowest versus highest quartile: HR 3.1; 95% CI 1.5-6.5) while it was negligible in those free of CVD (p value for the interaction term between CVD status and TRAIL levels=0.038). Similar findings were obtained when CVD mortality was considered as the outcome of interest.

CONCLUSIONS: In older patients with CVD, low levels of TRAIL were associated with increased risk of death over a period of 6 years. Lower concentration of circulating TRAIL may be related to the clinical evolution of older adults with CVD.

%B Atherosclerosis %V 215 %P 452-8 %8 2011 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21122855?dopt=Abstract %R 10.1016/j.atherosclerosis.2010.11.004 %0 Journal Article %J Breastfeed Med %D 2011 %T Breastfeeding to 24 months of age in the northeast of Italy: a cohort study. %A Carletti, Claudia %A Pani, Paola %A Knowles, Alessandra %A Monasta, Lorenzo %A Montico, Marcella %A Cattaneo, Adriano %K Adult %K Age Factors %K Birth Weight %K Breast Feeding %K Cohort Studies %K Family Characteristics %K Female %K Gestational Age %K Guideline Adherence %K Health Promotion %K Humans %K Infant %K Infant, Newborn %K Italy %K Neonatal Screening %K Prevalence %K Socioeconomic Factors %K Time Factors %X

AIM: This study assessed the prevalence and duration of breastfeeding up to 24 months and the associated socioeconomic determinants in a birth cohort of children.

METHODS: Four hundred infants born in a hospital in the north east of Italy were enrolled at birth and followed up for 36 months. Data on infant feeding were gathered through a feeding diary compiled at fixed intervals. Data were also gathered on type of delivery and weight, length, and health status at birth, as well as on selected socioeconomic indicators of the mothers. A multivariate logistic regression analysis was used to determine any association that exclusivity and duration of breastfeeding may have with selected socioeconomic variables and with health conditions of the infants at birth.

RESULTS: Ninety-eight percent of mothers initiated breastfeeding, 69% of them exclusively. This rate, however, had declined to 6% by 6 months. There was a remarkable endurance of breastfeeding at 24 months (12%). The variables significantly associated with exclusive breastfeeding at 3 months and any form of breastfeeding at 12 months are mother's age (p=0.007 at 3 months, p=0.026 at 12 months) and postdischarge hospital admission (p=0.029 at 3 months).

CONCLUSIONS: In this population, breastfeeding rates are higher than previously reported, but lower than recommended, especially as far as exclusivity is concerned. Full implementation of the World Health Organization-UNICEF Baby Friendly Initiatives in hospitals and communities is needed to improve them further. Monitoring systems should include the collection of data on breastfeeding beyond 12 months of age.

%B Breastfeed Med %V 6 %P 177-82 %8 2011 Aug %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21770733?dopt=Abstract %R 10.1089/bfm.2011.0019 %0 Journal Article %J Clin Exp Gastroenterol %D 2011 %T Celiac disease and immigration in Northeastern Italy: the "drawn double nostalgia" of "cozonac" and "panettone" slices. %A Parco, Sergio %A Città, Angelo %A Vascotto, Fulvia %A Tamaro, Giorgio %X

Many investigators consider children's drawings to be an important test in the evaluation of stress and anxiety, but few studies have examined the reliability and validity of indicators of emotional distress in children's projective drawings. In this report, we describe screening tests in children coming to the Friuli Venezia Giulia region in Northeastern Italy from non-European Union regions and suspected to have celiac disease, the problems involved in diagnosis of the disease, and the "drawn double nostalgia" of Romanian children for both Italian food and traditional Romanian foods. Of 3150 Western European cases, we found 712 with positive antibodies for IgA/IgG antitransglutaminase, 174 with a positive antiendomysium antibody confirmation test, and 20 with an IgA deficit. Of the children examined, 93% were children native to Western Europe, 4% were immigrants from Eastern Europe, and 1.6% originated from Africa. Among these, four Romanian children with celiac disease brought in their drawings, as requested in a hospital questionnaire. The prevalence of celiac disease is destined to increase among immigrants. Economic problems are common, and the twin nostalgia of immigrant children for foods and tastes that are "cozonac" (from the native country) and "panettone" (Italian cake flavor) represents a problem that will be difficult to resolve. Only some children's hospitals in Italy, ie, Burlo Garofolo and Gaslini, public and private foundations, or volunteer associations would be able to deal with this problem.

%B Clin Exp Gastroenterol %V 4 %P 121-5 %8 2011 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/21753894?dopt=Abstract %R 10.2147/CEG.S19225 %0 Journal Article %J Pediatr Rheumatol Online J %D 2011 %T Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series. %A Taddio, Andrea %A Cimaz, Rolando %A Caputo, Roberto %A de Libero, Cinzia %A Di Grande, Laura %A Simonini, Gabriele %A Mori, Francesca %A Novembre, Elio %A Pucci, Neri %X

Uveitis treatment involves topical corticosteroids along with cycloplegic-mydriatics. Particularly severe cases may require systemic corticosteroids and immunosuppressive drugs. Vernal keratoconjunctivitis (VKC) treatment consists of a brief period of topical corticosteroids and/or cyclosporine. In patients refractory to traditional treatment, the use of 0.1% topical ophtalmic FK- 506 (tacrolimus) ointment has been occasionally reported.This is the first report of the coexistence of uveitis and VKC. The documented response to topical tacrolimus eyedrop of uveitis and VKC is also of interest, in particular since to our knowledge there are no published reports on its clinical use in uveitis.

%B Pediatr Rheumatol Online J %V 9 %P 34 %8 2011 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/22047067?dopt=Abstract %R 10.1186/1546-0096-9-34 %0 Journal Article %J Haematologica %D 2011 %T Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations. %A Savoia, Anna %A Pastore, Annalisa %A De Rocco, Daniela %A Civaschi, Elisa %A Di Stazio, Mariateresa %A Bottega, Roberta %A Melazzini, Federica %A Bozzi, Valeria %A Pecci, Alessandro %A Magrin, Silvana %A Balduini, Carlo L %A Noris, Patrizia %K Adolescent %K Adult %K Amino Acid Sequence %K Bernard-Soulier Syndrome %K Blood Platelets %K Cell Shape %K Child %K Child, Preschool %K Female %K Genetic Association Studies %K Genetic Markers %K Hemorrhage %K Homozygote %K Humans %K Italy %K Male %K Membrane Glycoproteins %K Middle Aged %K Molecular Sequence Data %K Platelet Aggregation %K Platelet Count %K Platelet Glycoprotein GPIb-IX Complex %K Point Mutation %K Polymerase Chain Reaction %K Ristocetin %K Thrombocytopenia %K von Willebrand Factor %K Young Adult %X

BACKGROUND: Bernard-Soulier syndrome is a severe bleeding disease due to a defect of GPIb/IX/V, a platelet complex that binds the von Willebrand factor. Due to the rarity of the disease, there are reports only on a few cases compromising any attempt to establish correlations between genotype and phenotype. In order to identify any associations, we describe the largest case series ever reported, which was evaluated systematically at the same center.

DESIGN AND METHODS: Thirteen patients with the disease and seven obligate carriers were enrolled. We collected clinical aspects and determined platelet features, including number and size, expression of membrane glycoproteins, and ristocetin induced platelet aggregation. Mutations were identified by direct sequencing of the GP1BA, GP1BB, and GP9 genes and their effect was shown by molecular modeling analyses.

RESULTS: Patients all had a moderate thrombocytopenia with giant platelets and a bleeding tendency whose severity varied among individuals. Consistent with expression levels of GPIbα always lower than 10% of control values, platelet aggregation was absent or severely reduced. Homozygous mutations were identified in the GP1BA, GP1BB and GP9 genes; six were novel alterations expected to destabilize the conformation of the respective protein. Except for obligate carriers of a GP9 mutation with a reduced GPIb/IX/V expression and defective aggregation, all the other carriers had no obvious anomalies.

CONCLUSIONS: Regardless of mutations identified, the patients' bleeding diathesis did not correlate with thrombocytopenia, which was always moderate, and platelet GPIbα expression, which was always severely impaired. Obligate carriers had features similar to controls though their GPIb/IX/V expression showed discrepancies. Aware of the limitations of our cohort, we cannot define any correlations. However, further investigations should be encouraged to better understand the causes of this rare and underestimated disease.

%B Haematologica %V 96 %P 417-23 %8 2011 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21173099?dopt=Abstract %R 10.3324/haematol.2010.032631 %0 Journal Article %J Clin Immunol %D 2011 %T Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. %A Mazza, Cinzia %A Buzi, Fabio %A Ortolani, Federica %A Vitali, Alberto %A Notarangelo, Lucia D %A Weber, Giovanna %A Bacchetta, Rosa %A Soresina, Annarosa %A Lougaris, Vassilios %A Greggio, Nella A %A Taddio, Andrea %A Pasic, Srdjan %A de Vroede, Monique %A Pac, Malgorzata %A Kilic, Sara Sebnem %A Ozden, Sanal %A Rusconi, Roberto %A Martino, Silvana %A Capalbo, Donatella %A Salerno, Mariacarolina %A Pignata, Claudio %A Radetti, Giorgio %A Maggiore, Giuseppe %A Plebani, Alessandro %A Notarangelo, Luigi D %A Badolato, Raffaele %K Adolescent %K Adult %K Child %K Child, Preschool %K Heterozygote %K Homozygote %K Humans %K Middle Aged %K Mutation %K Polyendocrinopathies, Autoimmune %K Time Factors %K Young Adult %X

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive organ-specific autoimmune disorder that is characterized by a variable combination of (i) chronic mucocutaneous candidiasis, (ii) polyendocrinopathy and/or hepatitis and (iii) dystrophy of the dental enamel and nails. We analyzed the AIRE (autoimmune regulator) gene in subjects who presented any symptom that has been associated with APECED, including candidiasis and autoimmune endocrinopathy. We observed that 83.3% of patients presented at least two of the three typical manifestations of APECED, while the remaining 16.7% of patients showed other signs of the disease. Analysis of the genetic diagnosis of these subjects revealed that a considerable delay occurs in the majority of patients between the appearance of symptoms and the diagnosis. Overall, the mean diagnostic delay in our patients was 10.2 years. These results suggest that molecular analysis of AIRE should be performed in patients with relapsing mucocutaneous candidiasis for early identification of APECED.

%B Clin Immunol %V 139 %P 6-11 %8 2011 Apr %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21295522?dopt=Abstract %R 10.1016/j.clim.2010.12.021 %0 Journal Article %J Oral Oncol %D 2011 %T Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). %A Marcuzzi, Annalisa %A Zanin, Valentina %A Crovella, Sergio %A Pontillo, Alessandra %K Bone Density Conservation Agents %K Diphosphonates %K Diterpenes %K Humans %K Jaw Diseases %K Osteonecrosis %B Oral Oncol %V 47 %P 436-7; author reply 438 %8 2011 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/21411362?dopt=Abstract %R 10.1016/j.oraloncology.2011.02.017 %0 Journal Article %J Pediatr Blood Cancer %D 2011 %T Comparison of propofol versus propofol-ketamine combination in pediatric oncologic procedures performed by non-anesthesiologists. %A Chiaretti, Antonio %A Ruggiero, Antonio %A Barbi, Egidio %A Pierri, Filomena %A Maurizi, Palma %A Fantacci, Claudia %A Bersani, Giulia %A Riccardi, Riccardo %K Biopsy, Needle %K Bone Marrow Examination %K Child %K Conscious Sedation %K Female %K Humans %K Hypnotics and Sedatives %K Ketamine %K Male %K Neoplasms %K Pediatrics %K Physicians %K Propofol %K Spinal Puncture %X

BACKGROUND: Limited data are available on the best option (short acting sedatives, opioids, or ketamine) in oncologic procedural sedation performed by non-anesthesiologists. The aim of the present prospective study is to compare the safety and efficacy of propofol-ketamine versus propofol alone, managed by trained pediatricians, in children with cancer undergoing painful procedures.

PROCEDURES: Data on 121 children with acute lymphatic leukemia (ALL) undergoing procedural sedations (lumbar punctures and bone marrow aspirations) were prospectively collected and included drug doses, side effects, pain assessment, and sedation degree. Children were randomly assigned to one of the two groups: P (n = 62) receiving propofol alone and K (n = 59) in whom a ketamine-propofol combination was used.

RESULTS: In group K, the total dose of propofol required was significantly lower than in group P (3.9 ± 3.6 mg/kg vs. 5.1 ± 3.6 mg/kg; P < 0.001). The incidence of hypotension was also significantly lower (11% vs. 39%; P < 0.001). Major O(2) desaturations (defined as SatO(2) < 88%) occurred principally in group P (7 vs. 1; P = 0.05). Both best analgesia and shorter recovery time were obtained with the propofol-ketamine association. No differences were observed in the degree of sedation and in the awakening quality score between the two groups.

CONCLUSIONS: The combination of propofol and ketamine produced statistically significant clinical advantages combined with a higher profile of safety in children with cancer undergoing painful procedures.

%B Pediatr Blood Cancer %V 57 %P 1163-7 %8 2011 Dec 15 %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/21584935?dopt=Abstract %R 10.1002/pbc.23170 %0 Journal Article %J Pediatr Emerg Care %D 2011 %T Concentrated midazolam for intranasal administration: a pilot study. %A Calligaris, Lorenzo %A Davide, Zanon %A Alessandra, Maestro %A De Bortoli, Romina %A Chiaretti, Antonio %A Barbi, Egidio %K Administration, Intranasal %K Child %K Child, Preschool %K Conscious Sedation %K Dose-Response Relationship, Drug %K Female %K Humans %K Hypnotics and Sedatives %K Infant %K Male %K Midazolam %K Pain %K Pilot Projects %K Preoperative Care %B Pediatr Emerg Care %V 27 %P 245-7 %8 2011 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21378534?dopt=Abstract %R 10.1097/PEC.0b013e31820db93b %0 Journal Article %J J Med Case Rep %D 2011 %T Congenital aplasia of the optic chiasm and esophageal atresia: a case report. %A Pensiero, Stefano %A Cecchini, Paolo %A Michieletto, Paola %A Pelizzo, Gloria %A Madonia, Maurizio %A Parentin, Fulvio %X

INTRODUCTION: The complete absence of the chiasm (chiasmal aplasia) is a rare clinical condition. Hypoplasia of the optic nerve and congenital nystagmus are almost invariably associated characteristics. Microphthalmos or anophthalmos are common features in chiasmal aplasia, while central nervous system abnormalities are less frequent. Esophageal atresia can be isolated or syndromic. In syndromic cases, it is frequently associated with cardiac, limb, renal or vertebral malformations and anal atresia. More rarely, esophageal atresia can be part of anophthalmia-esophageal-genital syndrome, which comprises anophthalmia or microphthalmia, genital abnormalities, vertebral defects and cerebral malformations. Here, a previously unreported case of chiasmal aplasia presenting without microphthalmos and associated with esophageal atresia is described.

CASE PRESENTATION: Aplasia of the optic chiasm was identified in a Caucasian Italian 8-month-old boy with esophageal atresia. An ultrasound examination carried out at 21 weeks' gestation revealed polyhydramnios. Intrauterine growth retardation, esophageal atresia and a small atrial-septal defect were subsequently detected at 28 weeks' gestation. Repair of the esophageal atresia was carried out shortly after birth. A jejunostomy was carried out at four months to facilitate enteral feeding. The child was subsequently noted to be visually inattentive and to be neurodevelopmentally delayed. Magnetic resonance imaging revealed chiasmal aplasia. No other midline brain defects were found. His karyotype was normal.

CONCLUSION: If achiasmia is a spectrum, our patient seems to depict the most severe form, since he appears to have an extremely severe visual impairment. This is in contrast to most of the cases described in the literature, where patients maintain good--or at least useful-- visual function. To the best of our knowledge, the association of optic nerve hypoplasia, complete chiasmal aplasia, esophageal atresia and atrial-septal defect, choanal atresia, hypertelorism and psychomotor retardation has never been described before.

%B J Med Case Rep %V 5 %P 335 %8 2011 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/21806818?dopt=Abstract %R 10.1186/1752-1947-5-335 %0 Journal Article %J Pediatr Crit Care Med %D 2011 %T Daily practice of mechanical ventilation in Italian pediatric intensive care units: a prospective survey. %A Wolfler, Andrea %A Calderoni, Edoardo %A Ottonello, Giancarlo %A Conti, Giorgio %A Baroncini, Simonetta %A Santuz, Pierantonio %A Vitale, Pasquale %A Salvo, Ida %K Adolescent %K Child %K Child, Preschool %K Clinical Protocols %K Female %K Humans %K Infant %K Infant, Newborn %K Intensive Care Units, Pediatric %K Intubation, Intratracheal %K Italy %K Male %K Prospective Studies %K Respiration, Artificial %K Respiratory Insufficiency %X

OBJECTIVES: To assess how children requiring endotracheal intubation are mechanically ventilated in Italian pediatric intensive care units (PICUs).

DESIGN: A prospective, national, observational, multicenter, 6-month study.

SETTING: Eighteen medical-surgical PICUs.

PATIENTS: A total of 1943 consecutive children, aged 0-16 yrs, admitted between November 1, 2006 and April 30, 2007.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Data on cause of respiratory failure, length of mechanical ventilation (MV), mode of ventilation, use of specific interventions were recorded for all children requiring endotracheal intubation for >24 hrs. Children were stratified for age, type of patient, and cause of respiratory failure. A total of 956 (49.2%) patients required MV via an endotracheal tube; 673 (34.6%) were ventilated for >24 hrs. The median length of MV was 4.5 days for all patients. If postoperative patients were excluded, the median time was 5 days. Bronchiolitis (6.7%), pneumonia (6.7%), and upper airway obstruction (5.3%) were the most frequent causes of acute respiratory failure, and altered mental status (9.2%) was the most frequent reason for MV. The overall mortality was 6.7% with highest rates for heart disease (nonoperative), sepsis, and acute respiratory distress syndrome (26.1%, 22.2%, and 16.7% respectively). Length of stay, associated chronic disease, severity score on admission, and PICU mortality were significantly higher in children who received MV (p < .05) than in children who did not. Controlled MV and pressure support ventilation + synchronized intermittent mandatory ventilation were the most frequently used modes of ventilatory assistance during PICU stay.

CONCLUSIONS: Mechanical ventilation is frequently used in Italian PICUs with almost one child of two requiring endotracheal intubation. Children treated with MV represent a more severe category of patients than children who are breathing spontaneously. Describing the standard care and how MV is performed in children can be useful for future clinical studies.

%B Pediatr Crit Care Med %V 12 %P 141-6 %8 2011 Mar %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/20351615?dopt=Abstract %R 10.1097/PCC.0b013e3181dbaeb3 %0 Journal Article %J Clin Cancer Res %D 2011 %T Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. %A Zauli, Giorgio %A Voltan, Rebecca %A Bosco, Raffaella %A Melloni, Elisabetta %A Marmiroli, Sandra %A Rigolin, Gian Matteo %A Cuneo, Antonio %A Secchiero, Paola %K Antineoplastic Agents %K Apoptosis %K Cell Line, Tumor %K Cell Survival %K Down-Regulation %K Drug Synergism %K Humans %K Imidazoles %K Leukemia, Lymphocytic, Chronic, B-Cell %K Mutation %K Piperazines %K Protein Kinase Inhibitors %K Protein Kinases %K Proto-Oncogene Proteins c-akt %K Pyrimidines %K Thiazoles %K Transcription, Genetic %K Tumor Suppressor Protein p53 %X

PURPOSE: To analyze the effect of the combination of Dasatinib, a multikinase inhibitor, plus Nutlin-3, a nongenotoxic activator of the p53 pathway, in primary B chronic lymphocytic leukemia (B-CLL) patient samples and B leukemic cell line models.

EXPERIMENTAL DESIGN: The induction of cytotoxicity was evaluated in both primary B-CLL cell samples (n = 20) and in p53(wild-type) (EHEB, JVM-2) and p53(deleted/mutated) (MEC-2, BJAB) B leukemic cell lines. The role of Akt in modulating leukemic cell survival/apoptosis in response to Dasatinib or Dasatinib + Nutlin-3 was documented by functional experiments carried out using specific pharmacological inhibitors and by overexpression of membrane-targeted constitutively active form of Akt.

RESULTS: The combination of Dasatinib + Nutlin-3 exhibited a synergistic cytotoxicity in the majority (19 out of 20) of B-CLL samples, including patients carrying 17p- (n = 4), and in both p53(wild-type) and p53(deleted/mutated) B leukemic cell lines. At the molecular level, Dasatinib significantly counteracted the Nutlin-3-mediated induction of the p53 transcriptional targets MDM2 and p21 observed in p53(wild-type) leukemic cells. Conversely, Nutlin-3 did not interfere with the ability of Dasatinib to decrease the phosphorylation levels of ERK1/2, p38/MAPK, and Akt in both p53(wild-type) and p53(deleted/mutated) B leukemic cell lines. A critical role of Akt downregulation in mediating the antileukemic activity of Dasatinib and Dasatinib + Nutlin-3 was demonstrated in experiments carried out by specifically modulating the Akt pathway.

CONCLUSIONS: These findings suggest that Dasatinib + Nutlin-3 might represent an innovative therapeutic combination for both p53(wild-type) and p53(deleted/mutated) B-CLL.

%B Clin Cancer Res %V 17 %P 762-70 %8 2011 Feb 15 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21106726?dopt=Abstract %R 10.1158/1078-0432.CCR-10-2572 %0 Journal Article %J Musculoskelet Surg %D 2011 %T Diagnosis and treatment of pediatric chronic osteomyelitis in developing countries: prospective study of 96 patients treated in Kenya. %A Mantero, E %A Carbone, M %A Calevo, M G %A Boero, S %K Adolescent %K Algorithms %K Anti-Bacterial Agents %K Child %K Chronic Disease %K Developing Countries %K Female %K Follow-Up Studies %K Humans %K Kenya %K Male %K Methicillin-Resistant Staphylococcus aureus %K Microbial Sensitivity Tests %K Osteomyelitis %K Prospective Studies %K Recurrence %K Reproducibility of Results %K Risk Factors %K Staphylococcal Infections %K Treatment Outcome %X

The authors carried out a prospective study on 96 patients they treated in Kenya for chronic osteomyelitis from 2000 to 2009. All the patients received orthopedic surgery and antibiotic therapy, when possible based on the antibiotic sensitivity test. Among the 90 patients with at least 12 months' follow-up, 11 had osteomyelitis relapse (12.2%) and recovery rate was therefore 87.8% with no resulting disability. Risk factors for osteomyelitis relapse were investigated and previous treatment with beta-lactamines, predisposing to onset of methycillin-resistant Staphylococcus aureus (MRSA) infections (P = 0.03, OR = 5.74), and onset of osteomyelitis in the metaepiphyseal region (P < 0.0001) resulted statistically significant. Aim of the study was to evaluate the validity of our treatment of chronic osteomyelitis in Kenya on the basis of outcome.

%B Musculoskelet Surg %V 95 %P 13-8 %8 2011 Apr %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21373913?dopt=Abstract %R 10.1007/s12306-011-0104-0 %0 Journal Article %J Int Immunopharmacol %D 2011 %T Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. %A Piscianz, Elisa %A Cuzzoni, Eva %A De Iudicibus, Sara %A Valencic, Erica %A Decorti, Giuliana %A Tommasini, Alberto %K 3-Hydroxyanthranilic Acid %K Boronic Acids %K Cell Survival %K Cells, Cultured %K Humans %K Lymphocyte Activation %K Lymphocytes %K Manganese %K Pyrazines %X

Lymphocytes proliferation after antigen-driven activation leads to an increase in cell count, which could last some week, until apoptosis mechanisms allow the homeostatic control of the system. During the first days of this stimulation, activated lymphocytes display high resistance to apoptosis and to most immunosuppressive drugs. According to the literature, few compounds have been described to kill recently activated cells, by inhibiting metabolic processes fundamental to proliferation. The aim of our work was to evaluate comparatively these different compounds, in order to identify the best strategy to kill cells that have undergone proliferation, while sparing the repertoire of resting cells. After preliminary experiments, 3-HAA and bortezomib were selected as the most suitable compounds for our purposes. The possible synergic effect of 3-HAA with bortezomib or with manganese ions was also assessed. 3-HAA was confirmed to be the most reliable pharmacologic approach to inhibit proliferation with acceptable toxicity on resting cells. While in the case of PHA stimulation 3-HAA led to death of most lymphocytes, only a minor percentage of cells were killed after allo-stimulation, suggesting that the effect is proportional to the percentage of stimulated lymphocytes. Manganese ions further enhanced this effect, while results with bortezomib seemed to be less consistent. These results deserve further investigations to develop new procedures for targeting activated cells with pharmacological approaches.

%B Int Immunopharmacol %V 11 %P 2242-5 %8 2011 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/21979495?dopt=Abstract %R 10.1016/j.intimp.2011.09.009 %0 Journal Article %J Early Hum Dev %D 2011 %T Endothelial progenitor cells, bronchopulmonary dysplasia and other short-term outcomes of extremely preterm birth. %A Paviotti, Giulia %A Fadini, Gian Paolo %A Boscaro, Elisa %A Agostini, Carlo %A Avogaro, Angelo %A Chiandetti, Lino %A Baraldi, Eugenio %A Filippone, Marco %K Blood Cell Count %K Bronchopulmonary Dysplasia %K Cohort Studies %K Ductus Arteriosus, Patent %K Endothelial Cells %K Female %K Flow Cytometry %K Humans %K Infant, Newborn %K Infant, Premature %K Italy %K Pregnancy %K Prospective Studies %K Regression Analysis %K Stem Cells %X

AIM: To evaluate the impact of endothelial progenitor cells (EPCs), a subset of committed circulatory stem cells, on the development of bronchopulmonary dysplasia (BPD) and other short term outcomes in a cohort of extremely premature newborns.

METHODS: Progenitor cells were quantified by flow cytometry at birth in 36 neonates born <=28 weeks of gestation and at 36 postmenstrual weeks in 18 of them. Cells expressing the stemness markers CD34, CD133, or both were defined as circulating progenitor cells (CPCs). EPCs were defined as CPCs co-expressing the endothelial marker KDR.

RESULTS: Mean (SD) gestational age and birth weight of the infants studied were 26.2(1.5) weeks and 761.6(171.8) grams, respectively. EPC levels at birth did not differ between infants who subsequently developed BPD (n=9) and those who did not (n=24) [CD34(+)KDR(+) EPCs: 81(34-41) vs 80(56-110), p=0.7] and were not correlated with the duration of mechanical ventilation or O2-dependence, nor with the need of surfactant replacement. Infants with a hemodynamically significant patent ductus arteriosus (PDA) (n=22) had significantly lower EPC levels at birth than those with no PDA (n=11) [CD34(+)KDR(+) cells: 47(34-92) vs 142(84.5-221), p=0.008]. Data from the 18 infants studied both at birth and at 36 postmenstrual weeks showed that, while CPCs sharply decline over time, levels of all EPCs phenotypes are preserved after delivery.

CONCLUSIONS: Levels of EPCs at birth did not affect the risk of developing BPD in our group of extremely premature neonates. However, the association between low EPC counts at birth and PDA may be clinically relevant, and deserves further studies.

%B Early Hum Dev %V 87 %P 461-5 %8 2011 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/21511414?dopt=Abstract %R 10.1016/j.earlhumdev.2011.03.011 %0 Journal Article %J Epidemiol Infect %D 2011 %T Epidemiological and molecular assessment of a measles outbreak in a highly vaccinated population of northeast Italy. %A D'Agaro, P %A Molin, G Dal %A Gallo, T %A Rossi, T %A Santon, D %A Busetti, M %A Comar, M %A Campello, C %K Adolescent %K Adult %K Chi-Square Distribution %K Child %K Child, Preschool %K Community-Acquired Infections %K Disease Outbreaks %K Female %K Humans %K Immunization Schedule %K Infant %K Italy %K Male %K Measles %K Measles Vaccine %K Measles virus %K Middle Aged %K Molecular Epidemiology %K Phylogeny %X

Two distinct measles outbreaks, unrelated from the epidemiological point of view but caused by genetically related strains, occurred in the Friuli Venezia Giulia region of northeastern Italy. Forty-two cases were reported during the period April-May 2008. In the first outbreak the index case was a teacher who introduced the virus into the Pordenone area, involving eight adolescents and young adults. The other concomitant outbreak occurred in the city of Trieste with 33 cases. The containment of the epidemics can be explained by the high MMR vaccine coverage in an area where the first dose was delivered to 93·4% and the second dose to 88·3% of the target children. Phylogenetic analysis of 14 measles virus strains showed that they belonged to a unique D4 genotype indistinguishable from the MVs/Enfield.GBR/14.07 strain, probably introduced from areas (i.e. Piedmont and Germany) where this genotype was present or had recently caused a large epidemic.

%B Epidemiol Infect %V 139 %P 1727-33 %8 2011 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/21396148?dopt=Abstract %R 10.1017/S095026881100032X %0 Journal Article %J Matern Child Nutr %D 2011 %T ESPGHAN's 2008 recommendation for early introduction of complementary foods: how good is the evidence? %A Cattaneo, Adriano %A Williams, Carol %A Pallás-Alonso, Carmen Rosa %A Hernández-Aguilar, Maria Teresa %A Lasarte-Velillas, Juan José %A Landa-Rivera, Leonardo %A Rouw, Elien %A Pina, Mónica %A Volta, Alessandro %A Oudesluys-Murphy, Anne Marie %K Breast Feeding %K Evidence-Based Practice %K Humans %K Infant %K Infant Food %K Infant Nutritional Physiological Phenomena %K Milk, Human %K Nutritional Status %K Public Health %K Reproducibility of Results %K World Health Organization %X

Since 2002, the World Health Organization and many governments and professional associations have recommended exclusive breastfeeding for 6 months followed by complementary feeding (giving solid foods alongside breast milk) as optimal infant feeding practice. Several articles have been published challenging this recommendation. Arguably, the most influential has been the 2008 commentary of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition, which recommended that complementary foods should be introduced to all infants between 17 and 26 weeks. We challenge the validity of ESPGHAN's position, questioning the adequacy of the literature search, the interpretation and evidence used to reach their conclusions and the balance of an approach that focuses on disease prevention, with scant consideration of growth and neuromotor development. We contend that ESPGHAN's position should be understood as an expert opinion that may be influenced by conflicts of interest. In our view, the ESPGHAN position paper is not evidence based and does not justify a change of the current public health recommendation for 6 months of exclusive breastfeeding. At an individual level, health professionals should understand that developmental readiness for starting solid foods has an age range like other developmental milestones; that fewer infants will probably be ready to start complementary feeding before, rather than after, 6 months; and that their role is to equip parents with the confidence and skills to recognise the signs of developmental readiness. This empowerment process for infants and parents should be preferred over the prescriptive ESPGHAN approach.

%B Matern Child Nutr %V 7 %P 335-43 %8 2011 Oct %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21902806?dopt=Abstract %R 10.1111/j.1740-8709.2011.00363.x %0 Journal Article %J Pediatr Res %D 2011 %T The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. %A Marcuzzi, Annalisa %A De Leo, Luigina %A Decorti, Giuliana %A Crovella, Sergio %A Tommasini, Alberto %A Pontillo, Alessandra %K Alendronate %K Animals %K Anti-Inflammatory Agents %K Cell Line %K Child %K Child, Preschool %K Cholesterol %K Cytokines %K Dose-Response Relationship, Drug %K Enzyme Inhibitors %K Farnesyltranstransferase %K Humans %K Inflammation Mediators %K Lovastatin %K Male %K Mevalonate Kinase Deficiency %K Mice %K Monocytes %K Phosphotransferases (Alcohol Group Acceptor) %K Piperidines %K Polyenes %K Polyisoprenyl Phosphates %K Polyunsaturated Alkamides %K Pyridines %K Quinolones %K Terpenes %X

The shortage of geranylgeranyl-pyrophosphate (GGPP) was associated to an increased IL-1β release in the autoinflammatory syndrome mevalonate kinase deficiency (MKD), a rare inherited disease that has no specific therapy. Farnesyltransferase inhibitors (FTIs) act at the end of mevalonate pathway. Two FTIs, tipifarnib (Tip) and lonafarnib (Lon), were therefore evaluated as possible therapeutical choices for the treatment of MKD. FTIs could lead to a redirection of the limited available number of mevalonate intermediates preferentially to GGPP synthesis, eventually preventing the uncontrolled inflammatory response. The effect of Tip and Lon on intracellular cholesterol level (ICL) and on proinflammatory cytokines secretion was evaluated in a cellular model of MKD, chemically obtained treating RAW 264.7 cells with lovastatin (Lova) and alendronate (Ald). The combination of FTIs with the isoprenoid geraniol (GOH) was also tested both in this model and in monocytes isolated from MKD patients. Tip and Lon proved to revert the ICL lowering and to significantly reduce the lipopolysaccharide-induced cytokines secretion in Ald-Lova -RAW 264.7 cells. This anti-inflammatory effect was amplified combining the use of GOH with FTIs. The effect of GOH and Tip was successfully replicated in MKD patients' monocytes. Tip and Lon showed a dramatic anti-inflammatory effect in monocytes where mevalonate pathway was chemically or genetically impaired.

%B Pediatr Res %V 70 %P 78-82 %8 2011 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21430599?dopt=Abstract %R 10.1038/pr.2011.303 %0 Journal Article %J Mini Rev Med Chem %D 2011 %T Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. %A Bosco, R %A Melloni, E %A Celeghini, C %A Rimondi, E %A Vaccarezza, M %A Zauli, G %K Antineoplastic Agents %K Biological Products %K Enzyme Inhibitors %K Humans %K Isoenzymes %K Neoplasms %K Oligonucleotides, Antisense %K Peptides %K Protein Kinase C %X

The serine/threonine protein kinase C (PKC) family was first identified as intracellular receptor(s) for the tumor promoting agents phorbol esters. Thirty years after the discovery of PKC, the role of specific PKC isoforms has been described in relationship with an altered pattern of expression in different types of cancer and a good number of small molecule inhibitors (inhibitory peptides, antisense oligonucleotides or natural compounds) targeting PKC are now available. Despite all these achievements and a huge amount of basic research studies on the biochemical regulation of PKC, there has been a delay in clinical trials with drugs targeting PKC function. This delay is easily explained taking into account the extreme biological complexity of the PKC family of isoforms and the incomplete understanding of the specific role of each PKC isozyme in different types of cancers. Some of the difficulties in developing pharmacological compounds selectively tuning the different PKCs have started to be overcome. In this review, the growing evidences of the role of the PKC isoforms α, βII, δ, ε, ζ and ι is in promoting or counteracting tumor progression will be discussed in relationship with promising therapeutic perspectives.

%B Mini Rev Med Chem %V 11 %P 185-99 %8 2011 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21534929?dopt=Abstract %0 Journal Article %J Ital J Pediatr %D 2011 %T Foreign children with cancer in Italy. %A Rondelli, Roberto %A Dini, Giorgio %A De Rosa, Marisa %A Quarello, Paola %A Bisogno, Gianni %A Aricò, Maurizio %A Vasconcelos, Carivaldo %A Tamaro, Paolo %A Casazza, Gabriella %A Zecca, Marco %A De Laurentis, Clementina %A Porta, Fulvio %A Pession, Andrea %K Adolescent %K Africa %K Asia %K Child %K Child, Preschool %K Databases, Factual %K Emigrants and Immigrants %K Ethnic Groups %K Europe, Eastern %K European Union %K Female %K Humans %K Incidence %K Infant %K Infant, Newborn %K Italy %K Male %K Neoplasms %K North America %K Oceania %K Prevalence %K Retrospective Studies %K South America %K Survival Rate %X

BACKGROUND: There has been a noticeable annual increase in the number of children coming to Italy for medical treatment, just like it has happened in the rest of the European Union. In Italy, the assistance to children suffering from cancer is assured by the current network of 54 centres members of the Italian Association of Paediatric Haematology and Oncology (AIEOP), which has kept records of all demographic and clinical data in the database of Mod.1.01 Registry since 1989.

METHODS: We used the information stored in the already mentioned database to assess the impact of immigration of foreign children with cancer on centres' activity, with the scope of drawing a map of the assistance to these cases.

RESULTS: Out of 14,738 cases recorded by all centres in the period from 1999 to 2008, 92.2% were born and resident in Italy, 4.1% (608) were born abroad and living abroad and 3.7% (538) were born abroad and living in Italy. Foreign children cases have increased over the years from 2.5% in 1999 to. 8.1% in 2008.Most immigrant children came from Europe (65.7%), whereas patients who came from America, Asia and Oceania amounted to 13.2%, 10.1%, 0.2%, respectively. The immigrant survival rate was lower compared to that of children who were born in Italy. This is especially true for acute lymphoblastic leukaemia patients entered an AIEOP protocol, who showed a 10-years survival rate of 71.0% vs. 80.7% (p < 0.001) for immigrants and patients born in Italy, respectively.

CONCLUSIONS: Children and adolescents are an increasingly important part of the immigration phenomenon, which occurs in many parts of the world. In Italy the vast majority of children affected by malignancies are treated in AIEOP centres. Since immigrant children are predominantly treated in northern Italy, these centres have developed a special expertise in treating immigrant patients, which is certainly very useful for the entire AIEOP network.

%B Ital J Pediatr %V 37 %P 44 %8 2011 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/21923939?dopt=Abstract %R 10.1186/1824-7288-37-44 %0 Journal Article %J J Allergy Clin Immunol %D 2011 %T Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. %A Passerini, Laura %A Olek, Sven %A Di Nunzio, Sara %A Barzaghi, Federica %A Hambleton, Sophie %A Abinun, Mario %A Tommasini, Alberto %A Vignola, Silvia %A Cipolli, Marco %A Amendola, Mario %A Naldini, Luigi %A Guidi, Luisa %A Cecconi, Massimiliano %A Roncarolo, Maria G %A Bacchetta, Rosa %K Forkhead Transcription Factors %K Gene Expression Regulation %K Genetic Diseases, X-Linked %K Humans %K Immunologic Deficiency Syndromes %K Intestinal Diseases %K Male %K Mutation %K Polyendocrinopathies, Autoimmune %B J Allergy Clin Immunol %V 128 %P 1376-1379.e1 %8 2011 Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22000569?dopt=Abstract %R 10.1016/j.jaci.2011.09.010 %0 Journal Article %J Clinics (Sao Paulo) %D 2011 %T Frequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil. %A Castro-Antunes, Margarida Maria %A Crovella, Sergio %A Brandão, Lucas André Cavalcanti %A Guimarães, Rafael Lima %A Motta, Maria Eugênia Farias Almeida %A Silva, Giselia Alves Pontes da %K Adolescent %K Adult %K Brazil %K Celiac Disease %K Chi-Square Distribution %K Child %K Child, Preschool %K Cross-Sectional Studies %K Europe %K Family %K Female %K Gene Frequency %K Genetic Predisposition to Disease %K HLA-DQ Antigens %K Humans %K Infant %K Male %K Middle Aged %K Young Adult %X

AIMS: The aim of this study was to evaluate the frequencies of the HLA genotypes DQ2 and DQ8 and the alleles A1*05, A1*0201, B1*0201 and B1*0302 in individuals with celiac disease in Recife, northeastern Brazil.

METHODS: HLA DQ2 and DQ8 genotyping was performed for 73 individuals with celiac disease and 126 first-degree relatives with negative transglutaminase serology. The alleles DQA1*05, DQA1*0201, DQB1*02 and DQB1*0302 were identified by sequencing using specific primers and the EU-DQ kit from the Eurospital Laboratory, Trieste, Italy and double-checked by the All Set SPP kit (Dynal).

RESULTS: Among the 73 cases, 50 (68.5%) had the genotype DQ2, 13 (17.8%) had DQ8, 5 (6.8%) had DQ2 and DQ8, and 5 did not have any of these genotypes. Among the 5 negative individuals, four had the B1*02 allele and one did not have any of the alleles studied. B1*02 was the most frequent allele in both groups (94% in the patients and 89% in the control relatives).

CONCLUSIONS: In this study, celiac disease was associated with the genotypes DQ2 and DQ8. DQ2 predominated, but the distribution of the frequencies was different from what has been found in European populations and was closer to what has been found in the Americas. The high frequencies of the HLA genotypes DQ2 and DQ8 that were found in first-degree relatives would make it difficult to use these HLA genotypes for routine diagnosis of celiac disease in this group.

%B Clinics (Sao Paulo) %V 66 %P 227-31 %8 2011 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21484038?dopt=Abstract %0 Journal Article %J Clinics (Sao Paulo) %D 2011 %T Frequency of HLA B*5701 allele carriers in abacavir treated-HIV infected patients and controls from northeastern Brazil. %A Crovella, Sergio %A Biller, Lara %A Santos, Sergio %A Salustiano, Ana %A Brandão, Lucas %A Guimarães, Rafael %A Segat, Ludovica %A Lima Filho, Jose Luiz de %A Arraes, Luiz Claudio %K Adolescent %K Adult %K Anti-HIV Agents %K Brazil %K Case-Control Studies %K Dideoxynucleosides %K Drug Hypersensitivity %K Female %K Gene Frequency %K Genotype %K HIV Infections %K HLA-B Antigens %K Humans %K Male %K Middle Aged %K Real-Time Polymerase Chain Reaction %K Young Adult %B Clinics (Sao Paulo) %V 66 %P 1485-8 %8 2011 %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/21915505?dopt=Abstract %0 Journal Article %J Eur J Immunol %D 2011 %T Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. %A Passerini, Laura %A Di Nunzio, Sara %A Gregori, Silvia %A Gambineri, Eleonora %A Cecconi, Massimiliano %A Seidel, Markus G %A Cazzola, Giantonio %A Perroni, Lucia %A Tommasini, Alberto %A Vignola, Silvia %A Guidi, Luisa %A Roncarolo, Maria G %A Bacchetta, Rosa %K Cell Differentiation %K Cell Lineage %K Cells, Cultured %K Enteritis %K Forkhead Transcription Factors %K Genetic Diseases, X-Linked %K Humans %K Immunity, Innate %K Interleukin-2 Receptor alpha Subunit %K Mutation %K Polyendocrinopathies, Autoimmune %K Syndrome %K T-Lymphocytes, Regulatory %X

Mutations of forkhead box p3 (FOXP3), the master gene for naturally occurring regulatory T cells (nTregs), are responsible for the impaired function of nTregs, resulting in an autoimmune disease known as the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. The relevance of other peripheral tolerance mechanisms, such as the presence and function of type 1 regulatory T (Tr1) cells, the major adaptive IL-10-producing Treg subset, in patients with IPEX syndrome remains to be clarified. FOXP3(mutated) Tr1-polarized cells, differentiated in vitro from CD4(+) T cells of four IPEX patients, were enriched in IL-10(+) IL-4(-) IFN-γ(+) T cells, a cytokine production profile specific for Tr1 cells, and expressed low levels of FOXP3 and high levels of Granzyme-B. IPEX Tr1 cells were hypoproliferative and suppressive, thus indicating that FOXP3 mutations did not impair their function. Furthermore, we isolated Tr1 cell clones from the peripheral blood of one FOXP3(null) patient, demonstrating that Tr1 cells are present in vivo and they can be expanded in vitro in the absence of WT FOXP3. Overall, our results (i) show that functional Tr1 cells differentiate independently of FOXP3, (ii) confirm that human Tr1 and nTregs are distinct T-cell lineages, and (iii) suggest that under favorable conditions Tr1 cells could exert regulatory functions in IPEX patients.

%B Eur J Immunol %V 41 %P 1120-31 %8 2011 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21400500?dopt=Abstract %R 10.1002/eji.201040909 %0 Journal Article %J Leukemia %D 2011 %T A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. %A Chen, S-H %A Yang, W %A Fan, Y %A Stocco, G %A Crews, K R %A Yang, J J %A Paugh, S W %A Pui, C-H %A Evans, W E %A Relling, M V %K Antineoplastic Agents %K Asparaginase %K Aspartic Acid %K Cell Line %K Genome-Wide Association Study %K Humans %K Multivariate Analysis %K Polymorphism, Single Nucleotide %K Precursor Cell Lymphoblastic Leukemia-Lymphoma %X

Asparaginase is an important component for treatment of childhood acute lymphoblastic leukemia (ALL). The basis for interindividual differences in asparaginase sensitivity remains unclear. To comprehensively identify genetic variants important in the cytotoxicity of asparaginase, we used a genome-wide association approach using the HapMap lymphoblastoid cell lines (87 CEU trio members) and 54 primary ALL leukemic blast samples at diagnosis. Asparaginase sensitivity was assessed as the drug concentration necessary to inhibit 50% of growth (inhibitory concentration (IC)(50)). In CEU lines, we tested 2,390,203 single-nucleotide polymorphism (SNP) genotypes at the individual SNP (P<0.001) and gene level (P<0.05), and identified 329 SNPs representing 94 genes that were associated with asparaginase IC(50). The aspartate metabolism pathway was the most overrepresented among 199 pathways evaluated (P=8.1 × 10(-3)), with primary involvement of adenylosuccinate lyase and aspartyl-tRNA synthetase genes. We validated that SNPs in the aspartate metabolism pathway were also associated with asparaginase sensitivity in primary ALL leukemic blast samples (P=5.5 × 10(-5)). Our genome-wide interrogation of CEU cell lines and primary ALL blasts revealed that inherited genomic interindividual variation in a plausible candidate pathway can contribute to asparaginase sensitivity.

%B Leukemia %V 25 %P 66-74 %8 2011 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21072045?dopt=Abstract %R 10.1038/leu.2010.256 %0 Journal Article %J Nat Genet %D 2011 %T Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. %A Wain, Louise V %A Verwoert, Germaine C %A O'Reilly, Paul F %A Shi, Gang %A Johnson, Toby %A Johnson, Andrew D %A Bochud, Murielle %A Rice, Kenneth M %A Henneman, Peter %A Smith, Albert V %A Ehret, Georg B %A Amin, Najaf %A Larson, Martin G %A Mooser, Vincent %A Hadley, David %A Dörr, Marcus %A Bis, Joshua C %A Aspelund, Thor %A Esko, Tõnu %A Janssens, A Cecile J W %A Zhao, Jing Hua %A Heath, Simon %A Laan, Maris %A Fu, Jingyuan %A Pistis, Giorgio %A Luan, Jian'an %A Arora, Pankaj %A Lucas, Gavin %A Pirastu, Nicola %A Pichler, Irene %A Jackson, Anne U %A Webster, Rebecca J %A Zhang, Feng %A Peden, John F %A Schmidt, Helena %A Tanaka, Toshiko %A Campbell, Harry %A Igl, Wilmar %A Milaneschi, Yuri %A Hottenga, Jouke-Jan %A Vitart, Veronique %A Chasman, Daniel I %A Trompet, Stella %A Bragg-Gresham, Jennifer L %A Alizadeh, Behrooz Z %A Chambers, John C %A Guo, Xiuqing %A Lehtimäki, Terho %A Kuhnel, Brigitte %A Lopez, Lorna M %A Polasek, Ozren %A Boban, Mladen %A Nelson, Christopher P %A Morrison, Alanna C %A Pihur, Vasyl %A Ganesh, Santhi K %A Hofman, Albert %A Kundu, Suman %A Mattace-Raso, Francesco U S %A Rivadeneira, Fernando %A Sijbrands, Eric J G %A Uitterlinden, André G %A Hwang, Shih-Jen %A Vasan, Ramachandran S %A Wang, Thomas J %A Bergmann, Sven %A Vollenweider, Peter %A Waeber, Gerard %A Laitinen, Jaana %A Pouta, Anneli %A Zitting, Paavo %A McArdle, Wendy L %A Kroemer, Heyo K %A Völker, Uwe %A Völzke, Henry %A Glazer, Nicole L %A Taylor, Kent D %A Harris, Tamara B %A Alavere, Helene %A Haller, Toomas %A Keis, Aime %A Tammesoo, Mari-Liis %A Aulchenko, Yurii %A Barroso, Inês %A Khaw, Kay-Tee %A Galan, Pilar %A Hercberg, Serge %A Lathrop, Mark %A Eyheramendy, Susana %A Org, Elin %A Sõber, Siim %A Lu, Xiaowen %A Nolte, Ilja M %A Penninx, Brenda W %A Corre, Tanguy %A Masciullo, Corrado %A Sala, Cinzia %A Groop, Leif %A Voight, Benjamin F %A Melander, Olle %A O'Donnell, Christopher J %A Salomaa, Veikko %A d'Adamo, Adamo Pio %A Fabretto, Antonella %A Faletra, Flavio %A Ulivi, Sheila %A Del Greco, Fabiola M %A Facheris, Maurizio %A Collins, Francis S %A Bergman, Richard N %A Beilby, John P %A Hung, Joseph %A Musk, A William %A Mangino, Massimo %A Shin, So-Youn %A Soranzo, Nicole %A Watkins, Hugh %A Goel, Anuj %A Hamsten, Anders %A Gider, Pierre %A Loitfelder, Marisa %A Zeginigg, Marion %A Hernandez, Dena %A Najjar, Samer S %A Navarro, Pau %A Wild, Sarah H %A Corsi, Anna Maria %A Singleton, Andrew %A de Geus, Eco J C %A Willemsen, Gonneke %A Parker, Alex N %A Rose, Lynda M %A Buckley, Brendan %A Stott, David %A Orru, Marco %A Uda, Manuela %A van der Klauw, Melanie M %A Zhang, Weihua %A Li, Xinzhong %A Scott, James %A Chen, Yii-Der Ida %A Burke, Gregory L %A Kähönen, Mika %A Viikari, Jorma %A Döring, Angela %A Meitinger, Thomas %A Davies, Gail %A Starr, John M %A Emilsson, Valur %A Plump, Andrew %A Lindeman, Jan H %A Hoen, Peter A C 't %A König, Inke R %A Felix, Janine F %A Clarke, Robert %A Hopewell, Jemma C %A Ongen, Halit %A Breteler, Monique %A Debette, Stéphanie %A Destefano, Anita L %A Fornage, Myriam %A Mitchell, Gary F %A Smith, Nicholas L %A Holm, Hilma %A Stefansson, Kari %A Thorleifsson, Gudmar %A Thorsteinsdottir, Unnur %A Samani, Nilesh J %A Preuss, Michael %A Rudan, Igor %A Hayward, Caroline %A Deary, Ian J %A Wichmann, H-Erich %A Raitakari, Olli T %A Palmas, Walter %A Kooner, Jaspal S %A Stolk, Ronald P %A Jukema, J Wouter %A Wright, Alan F %A Boomsma, Dorret I %A Bandinelli, Stefania %A Gyllensten, Ulf B %A Wilson, James F %A Ferrucci, Luigi %A Schmidt, Reinhold %A Farrall, Martin %A Spector, Tim D %A Palmer, Lyle J %A Tuomilehto, Jaakko %A Pfeufer, Arne %A Gasparini, Paolo %A Siscovick, David %A Altshuler, David %A Loos, Ruth J F %A Toniolo, Daniela %A Snieder, Harold %A Gieger, Christian %A Meneton, Pierre %A Wareham, Nicholas J %A Oostra, Ben A %A Metspalu, Andres %A Launer, Lenore %A Rettig, Rainer %A Strachan, David P %A Beckmann, Jacques S %A Witteman, Jacqueline C M %A Erdmann, Jeanette %A van Dijk, Ko Willems %A Boerwinkle, Eric %A Boehnke, Michael %A Ridker, Paul M %A Järvelin, Marjo-Riitta %A Chakravarti, Aravinda %A Abecasis, Goncalo R %A Gudnason, Vilmundur %A Newton-Cheh, Christopher %A Levy, Daniel %A Munroe, Patricia B %A Psaty, Bruce M %A Caulfield, Mark J %A Rao, Dabeeru C %A Tobin, Martin D %A Elliott, Paul %A van Duijn, Cornelia M %K Arteries %K Blood Pressure %K Case-Control Studies %K Follow-Up Studies %K Genetic Loci %K Genome-Wide Association Study %K Humans %K Hypertension %K Linkage Disequilibrium %K Polymorphism, Single Nucleotide %X

Numerous genetic loci have been associated with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Europeans. We now report genome-wide association studies of pulse pressure (PP) and mean arterial pressure (MAP). In discovery (N = 74,064) and follow-up studies (N = 48,607), we identified at genome-wide significance (P = 2.7 × 10(-8) to P = 2.3 × 10(-13)) four new PP loci (at 4q12 near CHIC2, 7q22.3 near PIK3CG, 8q24.12 in NOV and 11q24.3 near ADAMTS8), two new MAP loci (3p21.31 in MAP4 and 10q25.3 near ADRB1) and one locus associated with both of these traits (2q24.3 near FIGN) that has also recently been associated with SBP in east Asians. For three of the new PP loci, the estimated effect for SBP was opposite of that for DBP, in contrast to the majority of common SBP- and DBP-associated variants, which show concordant effects on both traits. These findings suggest new genetic pathways underlying blood pressure variation, some of which may differentially influence SBP and DBP.

%B Nat Genet %V 43 %P 1005-11 %8 2011 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/21909110?dopt=Abstract %R 10.1038/ng.922 %0 Journal Article %J In Vivo %D 2011 %T Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. %A Marcuzzi, Annalisa %A Crovella, Sergio %A Pontillo, Alessandra %K Animals %K Anti-Inflammatory Agents %K Cell Line %K Diphosphonates %K Disease Models, Animal %K Inflammation %K Lipopolysaccharides %K Mevalonate Kinase Deficiency %K Mice %K Mice, Inbred BALB C %K Monocytes %K Nitric Oxide %K Terpenes %X

BACKGROUND/AIM: The inhibition of the mevalonate pathway through genetic defects such as mevalonate kinase deficiency (MKD) or pharmacological drugs such as aminobisphosphonates causes a shortage of intermediate compounds, in particular geranylgeranyl-pyrophosphate (GGPP), which is associated with the consequent augmented IL-1β release in monocytes. Considering that, due to its biochemical structure, isoprenoid geraniol enters the mevalonate pathway and may revert the genetic or pharmacological inhibition, the present study tested isoprenoid geraniol in cellular and animal MKD models obtained through the use of aminobisphosphonate pamidronate.

MATERIALS AND METHODS: The effect of natural isoprenoid geraniol on bacterial induced-inflammation was evaluated in a monocytic cell line (Raw 264.7) and in Balb/c mice treated with pamidronate.

RESULTS: Geraniol diminished the levels of inflammatory markers induced by pamidronate stimuli in vitro and in vivo.

CONCLUSION: Geraniol may be proposed as a novel therapeutic approach for the orphan disease MKD, and may also be considered for the evaluation of possible inflammatory side-effects of aminobisphosphonates.

%B In Vivo %V 25 %P 87-92 %8 2011 Jan-Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21282739?dopt=Abstract %0 Journal Article %J Transplantation %D 2011 %T Glutamine-enriched nutrition does not reduce mucosal morbidity or complications after stem-cell transplantation for childhood malignancies: a prospective randomized study. %A Uderzo, Cornelio %A Rebora, Paola %A Marrocco, Emanuela %A Varotto, Stefania %A Cichello, Francesca %A Bonetti, Maurizio %A Maximova, Natalia %A Zanon, Davide %A Fagioli, Franca %A Nesi, Francesca %A Masetti, Riccardo %A Masetti, Roberto %A Rovelli, Attilio %A Rondelli, Roberto %A Valsecchi, Maria Grazia %A Cesaro, Simone %K Adolescent %K Analgesia %K Child %K Child, Preschool %K Double-Blind Method %K Female %K Glutamine %K Hematopoietic Stem Cell Transplantation %K Humans %K Infant %K Male %K Mucositis %K Mucous Membrane %K Neoplasms %K Odds Ratio %K Parenteral Nutrition %K Prospective Studies %K Recurrence %K Stem Cells %K Treatment Outcome %X

BACKGROUND: Intravenous glutamine-enriched solution seems to be effective in posttransplant period in decreasing the severity and duration of mucositis. The aim of this randomized study was to determine the benefit of glutamine supplementation both on mucosal morbidity and in posttransplant associated complications.

METHODS: Children undergoing allogeneic hematopoietic stem-cell transplantation (HSCT) for malignant hematological diseases were randomly assigned to standard total parenteral nutrition (S-TPN) or glutamine-enriched (GE)-TPN solution consisting of 0.4 g/kg/day of l-alanine-glutamine dipeptide. This treatment started on the day of HSCT and ended when the patients could orally cover more than 50% of their daily energy requirements. The severity and the rate of post-HSCT mucositis were based on World Health Organization criteria. All the analyses were conducted on intention-to-treat principle.

RESULTS: One hundred twenty consecutive patients (83 men; median age, 8.1 years) were enrolled. The mean duration of treatment was 23.5 and 23 days in the two treatment arms. The mean calorie intake was 1538 kcal/d in the S-TPN group and 1512 kcal/d in GE-TPN group. All patients were well nourished before and after HSCT. Mucositis occurred in 91.4% and 91.7% of patients in S-TPN and GE-TPN arm, respectively (P=0.98). Odds ratio adjusted by type of HSCT was 0.98 (95% confidence interval, 0.26-2.63). Type and duration of analgesic treatment, clinical outcome (engraftment, graft versus host disease, early morbidity, and mortality, relapse rate up to 180 days post-HSCT) were not significantly different in the two treatment arms.

CONCLUSION: GE-TPN solution does not affect mucositis and outcome in well-nourished HSCT allogeneic patients.

%B Transplantation %V 91 %P 1321-5 %8 2011 Jun 27 %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/21499196?dopt=Abstract %R 10.1097/TP.0b013e31821ab959 %0 Journal Article %J J Med Genet %D 2011 %T Hearing function and thresholds: a genome-wide association study in European isolated populations identifies new loci and pathways. %A Girotto, Giorgia %A Pirastu, Nicola %A Sorice, Rossella %A Biino, Ginevra %A Campbell, Harry %A d'Adamo, Adamo P %A Hastie, Nicholas D %A Nutile, Teresa %A Polasek, Ozren %A Portas, Laura %A Rudan, Igor %A Ulivi, Sheila %A Zemunik, Tatijana %A Wright, Alan F %A Ciullo, Marina %A Hayward, Caroline %A Pirastu, Mario %A Gasparini, Paolo %K Adaptor Proteins, Signal Transducing %K Animals %K Auditory Threshold %K Carrier Proteins %K Databases, Genetic %K Europe %K European Continental Ancestry Group %K Female %K Founder Effect %K Genetic Linkage %K Genome-Wide Association Study %K Hearing %K Hearing Loss %K Humans %K Intracellular Signaling Peptides and Proteins %K Male %K Mice %K Phenotype %K Polymorphism, Single Nucleotide %K Protein-Serine-Threonine Kinases %K Receptor-Like Protein Tyrosine Phosphatases, Class 2 %K Receptors, Metabotropic Glutamate %X

BACKGROUND: Hearing is a complex trait, but until now only a few genes are known to contribute to variability of this process. In order to discover genes and pathways that underlie auditory function, a genome-wide association study was carried out within the International Consortium G-EAR.

METHODS: Meta-analysis of genome-wide association study's data from six isolated populations of European ancestry for an overall number of 3417 individuals.

RESULTS: Eight suggestive significant loci (p<10(-7)) were detected with a series of genes expressed within the inner ear such as: DCLK1, PTPRD, GRM8, CMIP. Additional biological candidates marked by a single nucleotide polymorphism (SNP) with a suggestive association (p<10(-6)) were identified, as well as loci encompassing 'gene desert regions'-genes of unknown function or genes whose function has not be linked to hearing so far. Some of these new loci map to already known hereditary hearing loss loci whose genes still need to be identified. Data have also been used to construct a highly significant 'in silico' pathway for hearing function characterised by a network of 49 genes, 34 of which are certainly expressed in the ear.

CONCLUSION: These results provide new insights into the molecular basis of hearing function and may suggest new targets for hearing impairment treatment and prevention.

%B J Med Genet %V 48 %P 369-74 %8 2011 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/21493956?dopt=Abstract %R 10.1136/jmg.2010.088310 %0 Journal Article %J J Med Virol %D 2011 %T High prevalence of BK polyomavirus sequences in human papillomavirus-16-positive precancerous cervical lesions. %A Comar, Manola %A Bonifacio, Daniela %A Zanconati, Fabrizio %A Di Napoli, Michela %A Isidoro, Erica %A Martini, Fernanda %A Torelli, Lucio %A Tognon, Mauro %K Adult %K BK Virus %K Cervical Intraepithelial Neoplasia %K Cervix Uteri %K DNA, Viral %K Female %K Human papillomavirus 16 %K Human papillomavirus 18 %K Human papillomavirus 31 %K Humans %K JC Virus %K Middle Aged %K Oncogene Proteins, Viral %K Papillomavirus Infections %K Precancerous Conditions %K Simian virus 40 %K Uterine Cervical Diseases %X

High- and low-grade cervical lesions were analyzed for the presence of polyomavirus (PYV) and human papillomavirus (HPV) sequences. In precancerous cervical lesions, the overall prevalence of PYV sequences was 44% (41/93). Specifically, among the PYV-positive samples, 83% (34/41) tested positive for BK polyomavirus (BKV) sequences, whereas 17% (7/41) were positive for JC-virus. None of the samples were positive for simian virus 40. The presence of BKV DNA in high-grade squamous intraepithelial lesions was confirmed by in situ PCR. BKV sequences were detected more frequently in high-grade squamous intraepithelial lesions, together with the genotype HPV-16. The association of BKV with precancerous cervical lesions suggests that this polyomavirus participates with HPV-16 in the cell transformation process. Alternatively, BKV might multiply better in HPV-16-positive cells from precancerous cervical lesions than in HPV-16-negative cells.

%B J Med Virol %V 83 %P 1770-6 %8 2011 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/21837794?dopt=Abstract %R 10.1002/jmv.22184 %0 Journal Article %J Am J Gastroenterol %D 2011 %T HLA-G 14 bp deletion/insertion polymorphism in celiac disease. %A Fabris, Annalisa %A Segat, Ludovica %A Catamo, Eulalia %A Morgutti, Marcello %A Vendramin, Anna %A Crovella, Sergio %K Adolescent %K Adult %K Aged %K Aged, 80 and over %K Alleles %K Case-Control Studies %K Celiac Disease %K Child %K Child, Preschool %K Confidence Intervals %K Female %K Genetic Predisposition to Disease %K Genotype %K Histocompatibility Antigens Class I %K HLA Antigens %K HLA-DQ Antigens %K HLA-G Antigens %K Humans %K Male %K Middle Aged %K Mutagenesis, Insertional %K Odds Ratio %K Polymerase Chain Reaction %K Polymorphism, Genetic %K Reference Values %K RNA Stability %K Sequence Deletion %K Young Adult %X

OBJECTIVES: Nonclassical major histocompatibility class I HLA-G antigen is a tolerogenic molecule that inhibits lytic activity of natural killer (NK) cells and cytotoxic T lymphocytes. Because of its immunomodulatory and tolerogenic properties, HLA-G molecules may have a role in celiac disease (CD). We analyzed the HLA-G 14 bp deletion/insertion polymorphism, known to have a functional effect on mRNA stability, in a group of 522 CD patients, stratified for the presence of HLA-DQ2 genotype, and 400 healthy individuals to evaluate the possible effect of the polymorphism on the risk to develop the disease.

METHODS: HLA-G 14 bp deletion/insertion polymorphism (rs1704) was detected by polymerase chain reaction and double-checked by direct sequencing.

RESULTS: The 14 bp inserted (I) allele and the homozygous I/I genotype were significantly more frequent in CD patients than in healthy controls. The presence of I allele was associated with an increased risk of CD (OR 1.35) and the effect of I allele was consistent with a recessive genetic model (P<0.001).

CONCLUSIONS: Our results also indicate that the effect of the HLA-G D/I polymorphism is restricted for HLA-DQ2, and not simply due to the presence of linkage disequilibrium with the major known risk factor; moreover we found that the presence of the I allele confers an increased risk of CD in addition to the risk conferred by HLA-DQ2 alone and that subjects that carry both DQ2 and HLA-G I alleles have an increased risk of CD than subjects that carry DQ2 but not the I allele.

%B Am J Gastroenterol %V 106 %P 139-44 %8 2011 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/20823837?dopt=Abstract %R 10.1038/ajg.2010.340 %0 Journal Article %J Ophthalmic Genet %D 2011 %T Horizontal gaze palsy and progressive scoliosis without ROBO3 mutations. %A Abu-Amero, Khaled K %A Faletra, Flavio %A Gasparini, Paolo %A Parentin, Fulvio %A Pensiero, Stefano %A Alorainy, Ibrahim A %A Hellani, Ali M %A Catalano, Dario %A Bosley, Thomas M %K Child %K Humans %K Kyphosis %K Magnetic Resonance Imaging %K Male %K Mutation %K Ocular Motility Disorders %K Oculomotor Nerve Diseases %K Pedigree %K Receptors, Immunologic %K Scoliosis %X

BACKGROUND: To describe clinical and genetic observations in a patient with horizontal gaze palsy and progressive scoliosis (HGPPS) without identified mutations in the ROBO3 gene.

MATERIALS AND METHODS: Neurologic and orthopedic evaluation of the proband; sequencing all exons, exon-intron boundaries, and promoter region of ROBO3 in the proband and his mother. Array CGH was also carried out in the proband and his mother to evaluate possible chromosomal deletion(s) and/or duplication(s).

RESULTS: The proband had complete horizontal gaze restriction with full vertical gaze and small amplitude horizontal pendular nystagmus. He also had severe scoliosis and brainstem hypoplasia pathognomonic of HGPPS. However, complete sequencing of ROBO3 twice in both forward and reverse directions did not reveal any mutations. Array CGH investigation revealed no chromosomal abnormalities.

CONCLUSIONS: This patient had clinical and neuroimaging characteristics considered pathognomonic of HGPPS and yet did not have ROBO3 mutations. A clinical misdiagnosis is unlikely in the absence of facial weakness (typical of Moebius syndrome), deafness (typical of the HOXA1 spectrum), or mental retardation (typical of other central decussation abnormalities). It is perhaps more likely that a phenotype identical to HGPPS can be caused by abnormalities in ROBO3 splice variant expression, by mutations of a gene other than ROBO3, or by some environmental or epigenetic factor(s) inhibiting the action of ROBO3 or its protein product in the developing brainstem.

%B Ophthalmic Genet %V 32 %P 212-6 %8 2011 Nov %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21510772?dopt=Abstract %R 10.3109/13816810.2011.574186 %0 Journal Article %J Obes Rev %D 2011 %T Interventions for the prevention of overweight and obesity in preschool children: a systematic review of randomized controlled trials. %A Monasta, L %A Batty, G D %A Macaluso, A %A Ronfani, L %A Lutje, V %A Bavcar, A %A van Lenthe, F J %A Brug, J %A Cattaneo, A %K Child Nutrition Sciences %K Child Nutritional Physiological Phenomena %K Child, Preschool %K Exercise %K Female %K Health Promotion %K Humans %K Life Style %K Male %K Obesity %K Overweight %K Randomized Controlled Trials as Topic %X

The objective of this study was to analyse interventions for the prevention of overweight and obesity in children under 5 years of age. We carried out a systematic review focusing exclusively on randomized controlled trials (RCTs). Data sources include Medline, Cochrane Library, EMBASE, CINHAL, PsychInfo and Web of Science. Data were extracted from seventeen articles describing seven RCTs identified through electronic search, screening of references in systematic reviews, own files and contact with authors. RCTs were assessed with the Jadad scale. Four trials were carried out in preschool settings, one with an exclusive educational component, two with an exclusive physical activity component and one with both. Two trials were family-based, with education and counselling for parents and children. The remaining trial was carried out in maternity hospitals, with a training intervention on breastfeeding. None of the interventions had an effect in preventing overweight and obesity. The failure to show an effect may be due to the choice of outcomes, the quality of the RCTs, the suboptimal implementation of the interventions, the lack of focus on social and environmental determinants. More rigorous research is needed on interventions and on social and environmental factors that could impact on lifestyle.

%B Obes Rev %V 12 %P e107-18 %8 2011 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/20576004?dopt=Abstract %R 10.1111/j.1467-789X.2010.00774.x %0 Journal Article %J Arch Dis Child %D 2011 %T Intranasal lidocaine and midazolam for procedural sedation in children. %A Chiaretti, Antonio %A Barone, Giuseppe %A Rigante, Donato %A Ruggiero, Antonio %A Pierri, Filomena %A Barbi, Egidio %A Barone, Giovanni %A Riccardi, Riccardo %K Administration, Intranasal %K Anesthetics, Local %K Anxiety %K Child, Preschool %K Conscious Sedation %K Diagnostic Techniques and Procedures %K Female %K Humans %K Hypnotics and Sedatives %K Infant %K Lidocaine %K Male %K Midazolam %K Minimally Invasive Surgical Procedures %K Nebulizers and Vaporizers %K Nose Diseases %K Prospective Studies %X

OBJECTIVE: To evaluate the safety and efficacy of a sedation protocol based on intranasal lidocaine spray and midazolam (INM) in children who are anxious and uncooperative when undergoing minor painful or diagnostic procedures, such as peripheral line insertion, venipuncture, intramuscular injection, echocardiogram, CT scan, audiometry testing and dental examination and extractions.

PATIENTS AND DESIGN: 46 children, aged 5-50 months, received INM (0.5 mg/kg) via a mucosal atomiser device. To avoid any nasal discomfort a puff of lidocaine spray (10 mg/puff) was administered before INM. The child's degree of sedation was scored using a modified Ramsay sedation scale. A questionnaire was designed to evaluate the parents' and doctors' opinions on the efficacy of the sedation. Statistical analysis was used to compare sedation times with children's age and weight.

RESULTS: The degree of sedation achieved by INM enabled all procedures to be completed without additional drugs. Premedication with lidocaine spray prevented any nasal discomfort related to the INM. The mean duration of sedation was 23.1 min. The depth of sedation was 1 on the modified Ramsay scale. The questionnaire revealed high levels of satisfaction by both doctors and parents. Sedation start and end times were significantly correlated with age only. No side effects were recorded in the cohort of children studied.

CONCLUSIONS: This study has shown that the combined use of lidocaine spray and atomised INM appears to be a safe and effective method to achieve short-term sedation in children to facilitate medical care and procedures.

%B Arch Dis Child %V 96 %P 160-3 %8 2011 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21030365?dopt=Abstract %R 10.1136/adc.2010.188433 %0 Journal Article %J J Korean Med Sci %D 2011 %T Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis. %A Marcuzzi, Annalisa %A Zanin, Valentina %A Vuch, Josef %A Pontillo, Alessandra %A Crovella, Sergio %K Anti-Inflammatory Agents %K Cytokines %K Diphosphonates %K Humans %K Injections, Intravenous %K Osteoporosis %B J Korean Med Sci %V 26 %P 848-9; author reply 850 %8 2011 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/21655077?dopt=Abstract %R 10.3346/jkms.2011.26.6.848 %0 Journal Article %J Arthritis Rheum %D 2011 %T Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. %A Pelagatti, M A %A Meini, A %A Caorsi, R %A Cattalini, M %A Federici, S %A Zulian, F %A Calcagno, G %A Tommasini, A %A Bossi, G %A Sormani, M P %A Caroli, F %A Plebani, A %A Ceccherini, I %A Martini, A %A Gattorno, M %K Adolescent %K Antirheumatic Agents %K Biological Therapy %K Child %K Child, Preschool %K Familial Mediterranean Fever %K Female %K Fever %K Follow-Up Studies %K Genotype %K Health Surveys %K Humans %K Infant %K Interleukin 1 Receptor Antagonist Protein %K Longitudinal Studies %K Lymphadenitis %K Male %K Mutation %K Pharyngitis %K Quality of Life %K Receptors, Tumor Necrosis Factor %K Receptors, Tumor Necrosis Factor, Type I %K Recurrence %K Retrospective Studies %K Steroids %K Syndrome %X

OBJECTIVE: To analyze the long-term impact of the R92Q mutation of TNFRSF1A in children with periodic fever, in comparison with children with tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with TNFRSF1A structural mutations and children with periodic fever of unknown origin fulfilling the criteria for periodic fever, aphthosis, pharyngitis, and adenitis syndrome (PFAPA).

METHODS: The extracellular region of TNFRSF1A was analyzed in 720 consecutive children with periodic fever, using denaturing high-performance liquid chromatography and DNA sequencing. Followup data on 11 pediatric patients with TNFRSF1A structural mutations (cysteine or T50M), 23 pediatric patients with an R92Q substitution, and 64 pediatric patients with PFAPA were collected during routine clinic visits. The 50-item Child Health Questionnaire was used to assess health-related quality of life (HRQOL).

RESULTS: The frequency of typical TRAPS-related clinical manifestations was significantly lower and the impact of the disease on HRQOL was significantly reduced in patients with the R92Q mutation compared with TRAPS patients carrying structural mutations of TNFRSF1A. Followup data on 11 TRAPS patients with TNFRSF1A structural mutations (mean followup 7.9 years), 16 patients with theR92Q substitution (mean followup 7.3 years), and 64 patients with PFAPA (mean followup 5.2 years) were available. Patients with R92Q mutations and patients with PFAPA displayed a higher rate of self-resolution or amelioration of the fever episodes than did TRAPS patients with structural mutations.

CONCLUSION: Although some cases may progress to a more chronic disease course, the majority of children with an R92Q mutation of the TNFRSFA1 gene show a milder disease course than that in children with TNFRSFA1 structural mutations and have a high rate of spontaneous resolution and amelioration of the recurrent fever episodes.

%B Arthritis Rheum %V 63 %P 1141-50 %8 2011 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21225694?dopt=Abstract %R 10.1002/art.30237 %0 Journal Article %J Hum Immunol %D 2011 %T Mannose binding lectin gene (MBL2) functional polymorphisms are associated with systemic lupus erythematosus in southern Brazilians. %A Sandrin-Garcia, Paula %A Brandão, Lucas André Cavalcanti %A Coelho, Antônio Victor Campos %A Guimarães, Rafael Lima %A Pancoto, João Alexandre Trés %A Segat, Ludovica %A Donadi, Eduardo Antônio %A de Lima-Filho, José Luiz %A Crovella, Sergio %K Adolescent %K Adult %K Aged %K Brazil %K DNA Mutational Analysis %K Female %K Gene Frequency %K Genetic Association Studies %K Genetic Predisposition to Disease %K Genotype %K Humans %K Lupus Erythematosus, Systemic %K Male %K Mannose-Binding Lectin %K Middle Aged %K Polymorphism, Genetic %K Population Groups %K Promoter Regions, Genetic %X

Susceptibility to systemic lupus erythematosus (SLE) has been associated with immunologic, environmental, and genetic factors. To uncover a possible association between MBL2 gene polymorphisms and SLE, we analyzed functional polymorphisms in the promoter and first exon of the MBL2 gene in 134 Brazilian SLE patients and 101 healthy controls. Genotype and allele frequencies of MBL2 A/O polymorphism were significantly different between patients and controls, and the O allele was associated with an increased risk of SLE. An association between low mannose binding lectin (MBL) producer combined genotypes and increased risk for SLE was also reported. Furthermore, when stratifying SLE patients according to clinical and laboratory data, an association between the A/O genotype and nephritic disorders and between the X/Y genotype and antiphospholipid syndrome was evident. Combined genotypes responsible for low MBL production were more frequently observed in SLE patients with nephritis. Our results indicate MBL2 polymorphisms as possible risk factors for SLE development and disease-related clinical manifestations.

%B Hum Immunol %V 72 %P 516-21 %8 2011 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/21510992?dopt=Abstract %R 10.1016/j.humimm.2011.03.007 %0 Journal Article %J Clin Oral Investig %D 2011 %T Mannose-binding lectin gene (MBL-2) polymorphism in oral lichen planus. %A Barkokebas, Andreza %A de Albuquerque T Carvalho, Alessandra %A de Souza, Paulo Roberto Eleutério %A Gomez, Ricardo Santiago %A Xavier, Guilherme Machado %A Ribeiro, Camila Maria Beder %A Crovella, Sergio %A Porter, Stephen Ross %A Leão, Jair Carneiro %K Adolescent %K Adult %K Aged %K Female %K Gene Expression Regulation %K Gene Frequency %K Genes, Recessive %K Genetic Variation %K Genotype %K Heterozygote %K Homozygote %K Humans %K Lichen Planus, Oral %K Male %K Mannose-Binding Lectin %K Middle Aged %K Mutation %K Polymorphism, Genetic %K Real-Time Polymerase Chain Reaction %K Tumor Necrosis Factor-alpha %K Young Adult %X

TNF-α may be associated with the etiopathogenesis of oral lichen planus (OLP), and it has been suggested that polymorphism of mannose-binding lectin (MBL) increases the in vitro production of TNF- α. The aim of the present study was to assess the relevance of genetic diversity of MBL in OLP. The study sample comprised 90 individuals, 45 OLP patients and 45 healthy volunteers. MBL-2 gene was amplified using real-time PCR. Frequency of A/A genotype was 55.6% in OLP and 53.3% in healthy volunteers. Likewise, A/0 heterozygote genotype was found in 42.2% and 35.6%; 2.2% and 11.1%, had the recessive 0/0 genotype respectively. Frequencies of the "A" and "0" alleles were 77% and 23% in the OLP group and 71.2% in control group. There were no statistically significant differences regarding genotype frequency (p = 0.546) or allele frequency (p = 0.497). In conclusion, no significant association was found between polymorphism of MBL-2 gene and OLP.

%B Clin Oral Investig %V 15 %P 699-704 %8 2011 Oct %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/20499118?dopt=Abstract %R 10.1007/s00784-010-0428-4 %0 Journal Article %J Haematologica %D 2011 %T Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry. %A Pivetta, Emanuele %A Maule, Milena M %A Pisani, Paola %A Zugna, Daniela %A Haupt, Riccardo %A Jankovic, Momcilo %A Aricò, Maurizio %A Casale, Fiorina %A Clerico, Anna %A Cordero di Montezemolo, Luca %A Kiren, Valentina %A Locatelli, Franco %A Palumbo, Giovanna %A Pession, Andrea %A Pillon, Marta %A Santoro, Nicola %A Terenziani, Monica %A Valsecchi, Maria Grazia %A Dama, Elisa %A Magnani, Corrado %A Merletti, Franco %A Pastore, Guido %K Adult %K Child %K Child, Preschool %K Cohort Studies %K Female %K Follow-Up Studies %K Hematologic Neoplasms %K Humans %K Infant %K Infant, Newborn %K Italy %K Male %K Marriage %K Middle Aged %K Parents %K Registries %K Survivors %X

BACKGROUND: The aim of this study was to describe the patterns of marriage and parenthood in a cohort of childhood cancer survivors included in the Off-Therapy Registry maintained by the Italian Association of Pediatric Hematology and Oncology.

DESIGN AND METHODS: We analyzed a cohort of 6,044 patients diagnosed with cancer between 1960 and 1998, while aged 0 to 14 years and who were 18 years old or older by December 2003. They were followed up through the regional vital statistics registers until death or the end of follow up (October 30, 2006), whichever occurred first, and their marital status and date of birth of their children were recorded. The cumulative probabilities of being married and having a first child were computed by gender and compared by tumor type within the cohort. Marriage and fertility rates (the latter defined as the number of live births per woman-year) were compared with those of the Italian population of the same age, gender, area of residence and calendar period by means of the observed to expected (O/E) ratios.

RESULTS: During the follow-up period, 4,633 (77%) subjects had not married. The marriage O/E ratios were 0.56 (95% CI: 0.51-0.61) and 0.70 (95% CI: 0.65-0.76) among men and women, respectively. Overall, 263 men had 367 liveborn children, and 473 women had 697 liveborn children. The female fertility O/E ratio was 0.57 (95% CI: 0.53-0.62) overall, and 1.08 (95% CI: 0.99-1.17) when analyses were restricted to married/cohabiting women

CONCLUSIONS: Childhood cancer survivors are less likely to marry and to have children than the general population, confirming the life-long impact of their previous disease on their social behavior and choices. The inclusion of counseling in the strategies of management and long-term surveillance of childhood cancer patients could be beneficial to survivors as they approach adulthood.

%B Haematologica %V 96 %P 744-51 %8 2011 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/21228031?dopt=Abstract %R 10.3324/haematol.2010.036129 %0 Journal Article %J Allergy %D 2011 %T Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. %A Bossi, F %A Frossi, B %A Radillo, O %A Cugno, M %A Tedeschi, A %A Riboldi, P %A Asero, R %A Tedesco, F %A Pucillo, C %K Adult %K Aged %K Capillary Permeability %K Chronic Disease %K Endothelial Cells %K Female %K Histamine Release %K Humans %K Male %K Mast Cells %K Middle Aged %K Receptors, IgE %K Serum %K Urticaria %K Young Adult %X

BACKGROUND: Chronic urticaria (CU) is one of the most common skin disorders whose pathogenic mechanisms are not fully clarified. Autoimmune aetiology can be ascribed to 45% of patients with CU, and basophil histamine release is positive in 40% of cases. Our aim was to use a novel approach to evaluate the serum permeabilizing effect to identify the mediators of endothelial cell (EC) leakage and to define the role of mast cells (MCs) in the process.

METHODS: Permeabilizing activity of sera from 19 patients with CU and 11 healthy blood donors was evaluated by measuring serum-induced degranulation of two MC lines, expressing (LAD2) or lacking (HMC-1) the IgE receptor. Mast cell supernatant (SN) was then incubated with an EC monolayer, and endothelial permeability was evaluated by Fluorescein isothiocyanate-bovine serum albumin leakage in a transwell system.

RESULTS: All 19 patient sera failed to induce direct EC leakage, but 15/19 and 17/19 promoted degranulation of HMC-1 and LAD2, respectively. Interestingly, 85% of autologous serum skin test-negative sera were able to cause MC degranulation. Also, 17/19 SNs from HMC-1 and all SNs from LAD2 incubated with CU sera increased endothelial permeability. Endothelial cell leakage remained unchanged after Ig depletion and was prevented by antihistamine, platelet-activating factor or leukotriene antagonist.

CONCLUSIONS: Our study shows that CU sera are able to degranulate MCs through an IgE- and IgG-independent mechanism. The nature of histamine-releasing factors involved is still unclear, but our finding opens new ways to the understanding of the pathogenesis of CU, particularly in patients not showing circulating autoantibodies to FcεRI or IgE.

%B Allergy %V 66 %P 1538-45 %8 2011 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/21906078?dopt=Abstract %R 10.1111/j.1398-9995.2011.02704.x %0 Journal Article %J Hum Immunol %D 2011 %T MBL1 gene in nonhuman primates. %A Segat, Ludovica %A Crovella, Sergio %K Animals %K Base Sequence %K Evolution, Molecular %K Gene Silencing %K Genome %K Humans %K Mannose-Binding Lectin %K Molecular Sequence Data %K Multigene Family %K Phylogeny %K Polymorphism, Genetic %K Primates %K Pseudogenes %K Sequence Alignment %K Sequence Analysis, DNA %K Sequence Deletion %K Species Specificity %X

With the aim of investigating the evolution of MBL1P1 (MBL1) gene, we analyzed the MBL1 coding region sequences in several specimens of two species of great apes, two species of Hylobatidae, four species of Cercopithecidae, and one Platyrrhine species, and in human beings. An indication for a progressive silencing of the molecule has been found. We found a ∼300 bp insertion in the first intron of MBL1 in the Cercopithecidae that could explain the different splicing between primates species and possibly why Macaca mulatta is able to produce a complete protein, whereas in human beings the protein product is truncated. Based on our genetic findings, we could speculate that all the Cercopithecidae (presenting the 300-bp insertion) may express MBL1 mature protein like the M mulatta, whereas the lesser and great apes, which lack this insertion as do human beings, may have only the truncated pseudogene.

%B Hum Immunol %V 72 %P 1084-90 %8 2011 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/21889966?dopt=Abstract %R 10.1016/j.humimm.2011.08.009 %0 Journal Article %J Int J Immunogenet %D 2011 %T MBL2 polymorphisms and the choice of controls for association studies: just another story? %A Segat, L %A Crovella, S %K Antibodies %K Brazil %K Control Groups %K Gene Frequency %K Genetic Association Studies %K Genetic Heterogeneity %K Genetic Predisposition to Disease %K Hepatitis C %K Humans %K Mannose-Binding Lectin %K Polymorphism, Genetic %K Thyroid Gland %B Int J Immunogenet %V 38 %P 101-4; author reply 105-8 %8 2011 Apr %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21362144?dopt=Abstract %R 10.1111/j.1744-313X.2010.00981.x %0 Journal Article %J Blood %D 2011 %T Merkel cell polyomavirus DNA sequences in the buffy coats of healthy blood donors. %A Pancaldi, Cecilia %A Corazzari, Valentina %A Maniero, Stefania %A Mazzoni, Elisa %A Comar, Manola %A Martini, Fernanda %A Tognon, Mauro %K Adult %K Aged %K Base Sequence %K Blood Buffy Coat %K Carcinoma, Merkel Cell %K Databases, Nucleic Acid %K DNA, Viral %K Expressed Sequence Tags %K Humans %K Italy %K Middle Aged %K Molecular Sequence Data %K Polymerase Chain Reaction %K Polyomavirus %K Polyomavirus Infections %K Prevalence %K Reverse Transcriptase Polymerase Chain Reaction %K Sequence Alignment %K Sequence Analysis, DNA %K Tumor Virus Infections %K Viral Load %K Young Adult %X

Merkel cell polyomavirus (MCPyV), a DNA tumor virus, has been found to be associated with Merkel cell carcinoma and chronic lymphocytic leukemia. MCPyV sequences have also been detected in various normal tissues in tumor-affected patients. Immunologic studies have detected MCPyV antibodies in as many as 80% of healthy blood donors. This high seroprevalence suggests that MCPyV infection is widespread in humans. In our study, buffy coats, which were examined for MCPyV DNA Tag sequences, showed a prevalence of 22%. Viral DNA load was revealed in blood samples from 10 to 100 molecules/100 000 cells. DNA sequencing confirmed that polymerase chain reaction amplicons belong to the MCPyV strain, MKL-1. To interpret the putative role of MCPyV in chronic lymphocytic leukemia, we may infer that, during a long period of viral persistence in blood cells, this DNA tumor virus may generate mutants, which are able to participate as cofactors in the multistep process of cell transformation.

%B Blood %V 117 %P 7099-101 %8 2011 Jun 30 %G eng %N 26 %1 http://www.ncbi.nlm.nih.gov/pubmed/21464370?dopt=Abstract %R 10.1182/blood-2010-09-310557 %0 Journal Article %J Am J Gastroenterol %D 2011 %T The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. %A Pontillo, Alessandra %A Vendramin, Anna %A Catamo, Eulalia %A Fabris, Annalisa %A Crovella, Sergio %K Adaptor Proteins, Signal Transducing %K Adolescent %K Apoptosis Regulatory Proteins %K Carrier Proteins %K Celiac Disease %K Child %K Child, Preschool %K Female %K Genetic Predisposition to Disease %K Genotype %K Glutamine %K Haplotypes %K Humans %K Inflammasomes %K Italy %K Lysine %K Male %K Mutation, Missense %K Polymorphism, Single Nucleotide %X

OBJECTIVES: Celiac disease (CD) is a multifactorial common disorder with several susceptibility loci. Variations in the NALP1/NLRP1 and NALP3/NLRP3 genes have been reported to confer risk for several autoimmune conditions. We hypothesized that polymorphisms in these genes, due to their role in innate immunity and inflammatory processes, may affect susceptibility to CD.

METHODS: Two single-nucleotide polymorphisms (SNPs) in NLRP1 (rs12150220, rs2670660) and two SNPs (rs10754558, rs35829419) in NLRP3 genes were genotyped in 504 CD Italian patients and 256 healthy controls.

RESULTS: The minor A allele of NLRP3 rs35829419 (Q705K) polymorphism appeared to exert a protective role against the development of CD (P=0.029; odds ratio (OR)=0.56). Moreover, a particular NLRP1 haplotype was associated with predisposition to CD (P=0.003; OR=1.38), even more when present in combination with the rs35829419 major C allele (P=0.002; OR=1.42).

CONCLUSIONS: We hypothesized that the deregulation of CIAS1/NALP3/NLRP3 and NALP1/NLRP1 inflammasomes could have a role in CD pathogenesis.

%B Am J Gastroenterol %V 106 %P 539-44 %8 2011 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21245836?dopt=Abstract %R 10.1038/ajg.2010.474 %0 Journal Article %J J Med Virol %D 2011 %T A molecular case-control study of the Merkel cell polyomavirus in colon cancer. %A Campello, Cesare %A Comar, Manola %A D'Agaro, Pierlanfranco %A Minicozzi, Anna %A Rodella, Luca %A Poli, Albino %K Aged %K Aged, 80 and over %K Case-Control Studies %K Cluster Analysis %K Colonic Neoplasms %K DNA, Viral %K Female %K Genotype %K Humans %K Italy %K Male %K Merkel Cells %K Middle Aged %K Molecular Sequence Data %K Polymerase Chain Reaction %K Polyomavirus %K Polyomavirus Infections %K Prevalence %K Sequence Analysis, DNA %K Tumor Virus Infections %X

To explore the putative role of the Merkel cell polyomavirus in human colon cancer, a prospective molecular case-control study was undertaken in patients and their relatives enrolled during a screening program. Fresh tissue samples from 64 cases of colon cancer (mean age 69.9 ± 11.0 years; 40 males) and fresh biopsies from 80 relatives (mean age 53.7 ± 8.6 years; 43 male; 55 son/daughter, 23 brother/sister, 2 parents) were analyzed by PCR and sequencing. Pre-cancerous lesions, namely adenomas and polyps, were detected in 15 (18.8%) and 9 (11.2%) of the controls, respectively. In addition, 144 blood samples were examined. Merkel cell polyomavirus DNA was detected in 6.3% of cases and 8.8% of controls. This difference was not statistically significant in the logistic regression analysis, after adjustment for age. Whereas blood samples from both cases and controls tested negative, the DNA Merkel cell polyomavirus was identified in 12.5% of adenoma/polyp tissues. No statistically significant difference was found when prevalence rates of Merkel cell polyomavirus in normal, pre-cancerous and cancer tissues were compared. Sequence analysis of the viral LT3 and VP1 regions showed high homology (>99%) with those of strains circulating worldwide, especially with genotypes detected in France. The findings of this survey are consistent with the hypothesis that the Merkel cell polyomavirus, in addition to other human polyomaviruses, can be recovered frequently from the gastrointestinal tract, because it is transmitted throughout the fecal-oral route. Moreover, the study does not indicate a role for Merkel cell polyomavirus in the genesis of colon cancer.

%B J Med Virol %V 83 %P 721-4 %8 2011 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21328389?dopt=Abstract %R 10.1002/jmv.22004 %0 Journal Article %J J Matern Fetal Neonatal Med %D 2011 %T A multicenter, case-control study on risk factors for antepartum stillbirth. %A Facchinetti, Fabio %A Alberico, Salvatore %A Benedetto, Chiara %A Cetin, Irene %A Cozzolino, Sabrina %A Di Renzo, Gian Carlo %A Del Giovane, Cinzia %A Ferrari, Francesca %A Mecacci, Federico %A Menato, Guido %A Tranquilli, Andrea L %A Baronciani, Dante %K Adult %K Case-Control Studies %K Cause of Death %K Congenital Abnormalities %K Female %K Fetal Death %K Fetal Growth Retardation %K Humans %K Infant, Newborn %K Male %K Obstetric Labor Complications %K Pre-Eclampsia %K Pregnancy %K Risk Factors %K Stillbirth %K Young Adult %X

OBJECTIVE: As the influence of socio-demographic variables, lifestyle and medical conditions on the epidemiology of stillbirth (SB) is modified by population features, we aimed at investigating the role played by these factors on the incidence of SB in a developed country.

STUDY DESIGN: Multivariate logistic regression analysis (OR with 95% CI) was utilized in a prospective multicentre nested case-control study to compare in a 1:2 ratio stillborn of >22 weeks gestation with matched for gestational age live-born (LB) infants. Intrapartum SB were excluded.

RESULTS: Two hundred fifty-four consecutive SBs and 497 LBs were enrolled. Socio-demographic variables were equally distributed. Fetal malformations (7.96, 2.69-23.55), severe intrauterine growth restriction (IUGR) (birthweight ≤ 5(th) %ile) (4.32, 2.27?8.24), BMI > 25 (2.87, 1.90-4.33), and preeclampsia (PE, 0.40, 0.21-0.77) were recognized as independent predictors for SB. At term, only BMI > 25 was associated with SB (7.70, 2.9-20.5).

CONCLUSION: Fetal malformations, severe IUGR and maternal BMI > 25 were associated with a significant increase in the risk of SB; PE presented instead a protective role. Maternal BMI > 25 was the only risk factor for SB identified in term pregnancies.

%B J Matern Fetal Neonatal Med %V 24 %P 407-10 %8 2011 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/20586545?dopt=Abstract %R 10.3109/14767058.2010.496880 %0 Journal Article %J Epilepsia %D 2011 %T A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. %A Fattore, Cinzia %A Boniver, Clementina %A Capovilla, Giuseppe %A Cerminara, Caterina %A Citterio, Antonietta %A Coppola, Giangennaro %A Costa, Paola %A Darra, Francesca %A Vecchi, Marilena %A Perucca, Emilio %K Adolescent %K Age Factors %K Anticonvulsants %K Child %K Child, Preschool %K Double-Blind Method %K Drug Resistance %K Epilepsy, Absence %K Female %K Humans %K Male %K Outcome Assessment (Health Care) %K Piracetam %X

PURPOSE: To evaluate the potential efficacy of levetiracetam as an antiabsence agent in children and adolescents with newly diagnosed childhood or juvenile absence epilepsy.

METHODS: Patients were randomized in a 2:1 ratio to receive de novo monotherapy with levetiracetam (up to 30 mg/kg/day) or placebo for 2 weeks under double-blind conditions. Responder status (primary end point) was defined as freedom from clinical seizures on days 13 and 14 and from electroencephalographic (EEG) seizures during a standard EEG recording with hyperventilation and intermittent photic stimulation on day 14. The double-blind phase was followed by an open-label follow-up.

KEY FINDINGS: Nine of 38 patients (23.7%) were responders in the levetiracetam group, compared with one of 21 (4.8%) in the placebo group (p = 0.08). Seven of 38 patients (18.4%) were free from clinical and EEG seizures during the last 4 days of the trial (including 24-h EEG monitoring on day 14) compared with none of the patients treated with placebo (p = 0.04). Seventeen patients remained seizure-free on levetiracetam after 1 year follow-up. Of the 41 patients who discontinued levetiracetam due to lack of efficacy (n = 39) or adverse events (n = 2), 34 became seizure-free on other treatments.

SIGNIFICANCE: Although superiority to placebo just failed to reach statistical significance for the primary end point, the overall findings are consistent with levetiracetam having modest efficacy against absence seizures. Further controlled trials exploring larger doses and an active comparator are required to determine the role of levetiracetam in the treatment of absence epilepsy.

%B Epilepsia %V 52 %P 802-9 %8 2011 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21320119?dopt=Abstract %R 10.1111/j.1528-1167.2010.02976.x %0 Journal Article %J PLoS Genet %D 2011 %T Multiple loci are associated with white blood cell phenotypes. %A Nalls, Michael A %A Couper, David J %A Tanaka, Toshiko %A van Rooij, Frank J A %A Chen, Ming-Huei %A Smith, Albert V %A Toniolo, Daniela %A Zakai, Neil A %A Yang, Qiong %A Greinacher, Andreas %A Wood, Andrew R %A Garcia, Melissa %A Gasparini, Paolo %A Liu, Yongmei %A Lumley, Thomas %A Folsom, Aaron R %A Reiner, Alex P %A Gieger, Christian %A Lagou, Vasiliki %A Felix, Janine F %A Völzke, Henry %A Gouskova, Natalia A %A Biffi, Alessandro %A Döring, Angela %A Völker, Uwe %A Chong, Sean %A Wiggins, Kerri L %A Rendon, Augusto %A Dehghan, Abbas %A Moore, Matt %A Taylor, Kent %A Wilson, James G %A Lettre, Guillaume %A Hofman, Albert %A Bis, Joshua C %A Pirastu, Nicola %A Fox, Caroline S %A Meisinger, Christa %A Sambrook, Jennifer %A Arepalli, Sampath %A Nauck, Matthias %A Prokisch, Holger %A Stephens, Jonathan %A Glazer, Nicole L %A Cupples, L Adrienne %A Okada, Yukinori %A Takahashi, Atsushi %A Kamatani, Yoichiro %A Matsuda, Koichi %A Tsunoda, Tatsuhiko %A Tanaka, Toshihiro %A Kubo, Michiaki %A Nakamura, Yusuke %A Yamamoto, Kazuhiko %A Kamatani, Naoyuki %A Stumvoll, Michael %A Tönjes, Anke %A Prokopenko, Inga %A Illig, Thomas %A Patel, Kushang V %A Garner, Stephen F %A Kuhnel, Brigitte %A Mangino, Massimo %A Oostra, Ben A %A Thein, Swee Lay %A Coresh, Josef %A Wichmann, H-Erich %A Menzel, Stephan %A Lin, JingPing %A Pistis, Giorgio %A Uitterlinden, André G %A Spector, Tim D %A Teumer, Alexander %A Eiriksdottir, Gudny %A Gudnason, Vilmundur %A Bandinelli, Stefania %A Frayling, Timothy M %A Chakravarti, Aravinda %A van Duijn, Cornelia M %A Melzer, David %A Ouwehand, Willem H %A Levy, Daniel %A Boerwinkle, Eric %A Singleton, Andrew B %A Hernandez, Dena G %A Longo, Dan L %A Soranzo, Nicole %A Witteman, Jacqueline C M %A Psaty, Bruce M %A Ferrucci, Luigi %A Harris, Tamara B %A O'Donnell, Christopher J %A Ganesh, Santhi K %K Genetic Loci %K Genome-Wide Association Study %K Humans %K Leukocyte Count %K Leukocytes %K Molecular Epidemiology %K Multigene Family %K Phenotype %K Polymorphism, Single Nucleotide %K Ubiquitin-Protein Ligases %X

White blood cell (WBC) count is a common clinical measure from complete blood count assays, and it varies widely among healthy individuals. Total WBC count and its constituent subtypes have been shown to be moderately heritable, with the heritability estimates varying across cell types. We studied 19,509 subjects from seven cohorts in a discovery analysis, and 11,823 subjects from ten cohorts for replication analyses, to determine genetic factors influencing variability within the normal hematological range for total WBC count and five WBC subtype measures. Cohort specific data was supplied by the CHARGE, HeamGen, and INGI consortia, as well as independent collaborative studies. We identified and replicated ten associations with total WBC count and five WBC subtypes at seven different genomic loci (total WBC count-6p21 in the HLA region, 17q21 near ORMDL3, and CSF3; neutrophil count-17q21; basophil count- 3p21 near RPN1 and C3orf27; lymphocyte count-6p21, 19p13 at EPS15L1; monocyte count-2q31 at ITGA4, 3q21, 8q24 an intergenic region, 9q31 near EDG2), including three previously reported associations and seven novel associations. To investigate functional relationships among variants contributing to variability in the six WBC traits, we utilized gene expression- and pathways-based analyses. We implemented gene-clustering algorithms to evaluate functional connectivity among implicated loci and showed functional relationships across cell types. Gene expression data from whole blood was utilized to show that significant biological consequences can be extracted from our genome-wide analyses, with effect estimates for significant loci from the meta-analyses being highly corellated with the proximal gene expression. In addition, collaborative efforts between the groups contributing to this study and related studies conducted by the COGENT and RIKEN groups allowed for the examination of effect homogeneity for genome-wide significant associations across populations of diverse ancestral backgrounds.

%B PLoS Genet %V 7 %P e1002113 %8 2011 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/21738480?dopt=Abstract %R 10.1371/journal.pgen.1002113 %0 Journal Article %J Blood %D 2011 %T Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. %A Noris, Patrizia %A Perrotta, Silverio %A Seri, Marco %A Pecci, Alessandro %A Gnan, Chiara %A Loffredo, Giuseppe %A Pujol-Moix, Núria %A Zecca, Marco %A Scognamiglio, Francesca %A De Rocco, Daniela %A Punzo, Francesca %A Melazzini, Federica %A Scianguetta, Saverio %A Casale, Maddalena %A Marconi, Caterina %A Pippucci, Tommaso %A Amendola, Giovanni %A Notarangelo, Lucia D %A Klersy, Catherine %A Civaschi, Elisa %A Balduini, Carlo L %A Savoia, Anna %K Adolescent %K Adult %K Aged %K Aged, 80 and over %K Ankyrin Repeat %K Child %K Cohort Studies %K Family %K Female %K Gene Frequency %K Humans %K Inheritance Patterns %K Male %K Middle Aged %K Mutation %K Pedigree %K Thrombocytopenia %K Transcription Factors %K Young Adult %X

Until recently, thrombocytopenia 2 (THC2) was considered an exceedingly rare form of autosomal dominant thrombocytopenia and only 2 families were known. However, we recently identified mutations in the 5'-untranslated region of the ANKRD26 gene in 9 THC2 families. Here we report on 12 additional pedigrees with ANKRD26 mutations, 6 of which are new. Because THC2 affected 21 of the 210 families in our database, it has to be considered one of the less rare forms of inherited thrombocytopenia. Analysis of all 21 families with ANKRD26 mutations identified to date revealed that thrombocytopenia and bleeding tendency were usually mild. Nearly all patients had no platelet macrocytosis, and this characteristic distinguishes THC2 from most other forms of inherited thrombocytopenia. In the majority of cases, platelets were deficient in glycoprotein Ia and α-granules, whereas in vitro platelet aggregation was normal. Bone marrow examination and serum thrombopoietin levels suggested that thrombocytopenia was derived from dysmegakaryopoiesis. Unexplained high values of hemoglobin and leukocytes were observed in a few cases. An unexpected finding that warrants further investigation was a high incidence of acute leukemia. Given the scarcity of distinctive characteristics, the ANKRD26-related thrombocytopenia has to be taken into consideration in the differential diagnosis of isolated thrombocytopenias.

%B Blood %V 117 %P 6673-80 %8 2011 Jun 16 %G eng %N 24 %1 http://www.ncbi.nlm.nih.gov/pubmed/21467542?dopt=Abstract %R 10.1182/blood-2011-02-336537 %0 Journal Article %J Am J Hum Genet %D 2011 %T Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. %A Pippucci, Tommaso %A Savoia, Anna %A Perrotta, Silverio %A Pujol-Moix, Núria %A Noris, Patrizia %A Castegnaro, Giovanni %A Pecci, Alessandro %A Gnan, Chiara %A Punzo, Francesca %A Marconi, Caterina %A Gherardi, Samuele %A Loffredo, Giuseppe %A De Rocco, Daniela %A Scianguetta, Saverio %A Barozzi, Serena %A Magini, Pamela %A Bozzi, Valeria %A Dezzani, Luca %A Di Stazio, Mariateresa %A Ferraro, Marcella %A Perini, Giovanni %A Seri, Marco %A Balduini, Carlo L %K Ankyrin Repeat %K Base Sequence %K Chromosome Breakage %K Chromosome Disorders %K Conserved Sequence %K Female %K Genes, Dominant %K Genetic Loci %K Haploinsufficiency %K Humans %K Male %K Molecular Sequence Data %K Mutation %K Pedigree %K Thrombocytopenia %X

THC2, an autosomal-dominant thrombocytopenia described so far in only two families, has been ascribed to mutations in MASTL or ACBD5. Here, we show that ANKRD26, another gene within the THC2 locus, and neither MASTL nor ACBD5, is mutated in eight unrelated families. ANKRD26 was also found to be mutated in the family previously reported to have an ACBD5 mutation. We identified six different ANKRD26 mutations, which were clustered in a highly conserved 19 bp sequence located in the 5' untranslated region. Mutations were not detected in 500 controls and are absent from the 1000 Genomes database. Available data from an animal model and Dr. Watson's genome give evidence against haploinsufficiency as the pathogenetic mechanism for ANKRD26-mediated thrombocytopenia. The luciferase reporter assay suggests that these 5' UTR mutations might enhance ANKRD26 expression. ANKRD26 is the ancestor of a family of primate-specific genes termed POTE, which have been recently identified as a family of proapoptotic proteins. Dysregulation of apoptosis might therefore be the pathogenetic mechanism, as demonstrated for another thrombocytopenia, THC4. Further investigation is needed to provide evidence supporting this hypothesis.

%B Am J Hum Genet %V 88 %P 115-20 %8 2011 Jan 7 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21211618?dopt=Abstract %R 10.1016/j.ajhg.2010.12.006 %0 Journal Article %J Nat Genet %D 2011 %T Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies. %A Ghezzi, Daniele %A Arzuffi, Paola %A Zordan, Mauro %A Da Re, Caterina %A Lamperti, Costanza %A Benna, Clara %A d'Adamo, Pio %A Diodato, Daria %A Costa, Rodolfo %A Mariotti, Caterina %A Uziel, Graziella %A Smiderle, Cristina %A Zeviani, Massimo %K Adult %K Animals %K Brain %K Codon, Nonsense %K Drosophila melanogaster %K Electron Transport Complex III %K Female %K Gene Knockdown Techniques %K Humans %K Male %K Membrane Proteins %K Mitochondria %K Mitochondrial Proteins %K Nervous System Diseases %X

Although mutations in CYTB (cytochrome b) or BCS1L have been reported in isolated defects of mitochondrial respiratory chain complex III (cIII), most cIII-defective individuals remain genetically undefined. We identified a homozygous nonsense mutation in the gene encoding tetratricopeptide 19 (TTC19) in individuals from two families affected by progressive encephalopathy associated with profound cIII deficiency and accumulation of cIII-specific assembly intermediates. We later found a second homozygous nonsense mutation in a fourth affected individual. We demonstrated that TTC19 is embedded in the inner mitochondrial membrane as part of two high-molecular-weight complexes, one of which coincides with cIII. We then showed a physical interaction between TTC19 and cIII by coimmunoprecipitation. We also investigated a Drosophila melanogaster knockout model for TTC19 that showed low fertility, adult-onset locomotor impairment and bang sensitivity, associated with cIII deficiency. TTC19 is a putative cIII assembly factor whose disruption is associated with severe neurological abnormalities in humans and flies.

%B Nat Genet %V 43 %P 259-63 %8 2011 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21278747?dopt=Abstract %R 10.1038/ng.761 %0 Journal Article %J Res Dev Disabil %D 2011 %T Neuromotor deficits in developmental coordination disorder: evidence from a reach-to-grasp task. %A Biancotto, Marina %A Skabar, Aldo %A Bulgheroni, Maria %A Carrozzi, Marco %A Zoia, Stefania %K Analysis of Variance %K Biomechanical Phenomena %K Child %K Female %K Humans %K Male %K Motor Skills Disorders %K Psychometrics %K Psychomotor Performance %K Reaction Time %K Space Perception %X

Developmental coordination disorder (DCD) has been classified as a specific learning disability, nonetheless the underlying cognitive mechanisms are still a matter of discussion. After a summary of the main hypotheses on the principal neuromotor causes of DCD, this study applies a causal model framework to describe the possible coexistence of more than one deficit in this disorder. For this purpose, kinematic analysis was applied to an ecological task, the reach-to-grasp action, introducing the manipulation of three variables: vision, distance and object size. After a thorough neurological and neuropsychological evaluation, 9 children with DCD (7-9 years old) were selected and compared to 27 age-matched control children. The results suggest that children with DCD have a normal neurological characterization of the reaching and grasping movements, in terms of proximal to distal action, but their grasping aperture (MGA) was always wider with respect to controls, particularly when vision was not allowed. In addition, the performance of children with DCD was always slower, more dependent on vision and more variable than that of controls. The MGA of children with DCD could be explained by a deficit in the internal construction of movement for a forward model, while slowness could be related to a control problem in the neuronal firing of the muscles. The idea of a possible coexistence of these two deficits is discussed in accordance to a causal model framework and also addressed considering recent neurophysiologic evidences.

%B Res Dev Disabil %V 32 %P 1293-300 %8 2011 Jul-Aug %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21377830?dopt=Abstract %R 10.1016/j.ridd.2011.02.007 %0 Journal Article %J J Appl Genet %D 2011 %T A new case of duplication of the MDS region identified by high-density SNP arrays and a review of the literature. %A Faletra, Flavio %A Devescovi, Raffaella %A Pecile, Vanna %A Fabretto, Antonella %A Carrozzi, Marco %A Gasparini, Paolo %K 1-Alkyl-2-acetylglycerophosphocholine Esterase %K Child %K Female %K Gene Duplication %K Humans %K Microtubule-Associated Proteins %K Myelodysplastic Syndromes %K Oligonucleotide Array Sequence Analysis %K Polymorphism, Single Nucleotide %K Prognosis %B J Appl Genet %V 52 %P 77-80 %8 2011 Feb %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21107783?dopt=Abstract %R 10.1007/s13353-010-0004-2 %0 Journal Article %J Med Sci Monit %D 2011 %T Non-invasive assessment of hemispheric language dominance by optical topography during a brief passive listening test: a pilot study. %A Bembich, Stefano %A Demarini, Sergio %A Clarici, Andrea %A Massaccesi, Stefano %A Grasso, Domenico Loenardo %K Acoustic Stimulation %K Adult %K Cerebrum %K Diagnostic Techniques and Procedures %K Dominance, Cerebral %K Female %K Humans %K Language %K Male %K Middle Aged %K Oxyhemoglobins %K Pilot Projects %K Spectroscopy, Near-Infrared %X

BACKGROUND: The Wada test is usually used for pre-surgical assessment of language lateralization. Considering its invasiveness and risk of complications, alternative methods have been proposed but they are not always applicable to non-cooperative patients. In this study we explored the possibility of using optical topography (OT)--a multichannel near-infrared system--for non-invasive assessment of hemispheric language dominance during passive listening.

MATERIAL/METHODS: Cortical activity was monitored in a sample of healthy, adult Italian native speakers, all right-handed. We assessed changes in oxy-haemoglobin concentration in temporal, parietal and posterior frontal lobes during a passive listening of bi-syllabic words and vowel-consonant-vowel syllables lasting less then 3 minutes. Activated channels were identified by t tests.

RESULTS: Left hemisphere showed significant activity only during the passive listening of bi-syllabic words. Specifically, the superior temporal gyrus, the supramarginal gyrus and the posterior inferior parietal lobe were activated.

CONCLUSIONS: During passive listening of bi-syllabic words, right handed healthy adults showed a significant activation in areas already known to be involved in speech comprehension. Although more research is needed, OT proved to be a promising alternative to the Wada test for non-invasive assessment of hemispheric language lateralization, even if using a particularly brief trial, which has been designed for future applications with non-cooperative subjects.

%B Med Sci Monit %V 17 %P CR692-7 %8 2011 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/22129900?dopt=Abstract %0 Journal Article %J Mol Cell Endocrinol %D 2011 %T Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. %A Toffoli, Barbara %A Bernardi, Stella %A Candido, Riccardo %A Sabato, Nicoletta %A Carretta, Renzo %A Corallini, Federica %A Secchiero, Paola %A Zauli, Giorgio %A Fabris, Bruno %K Animals %K Apoptosis %K Blood Glucose %K Blood Pressure %K Body Weight %K Cell Lineage %K Cell Movement %K Chemokine CCL2 %K Connective Tissue Growth Factor %K Fibrosis %K Gene Expression Regulation %K Humans %K Insulin %K Islets of Langerhans %K Macrophages %K Mice %K Monocytes %K Organ Size %K Osteoprotegerin %K Peptidyl-Dipeptidase A %K Receptor, Angiotensin, Type 1 %K Systole %K Transforming Growth Factor beta %K Vascular Cell Adhesion Molecule-1 %X

Although serum osteoprotegerin (OPG) is significantly increased in diabetic subjects, its potential role in beta cell dysfunction has not been investigated. This study aimed to assess the effect of full-length OPG administered in vivo in mice on pancreatic islet structure and function and its interaction with the renin-angiotensin system (RAS). OPG-treated mice showed increased islet monocyte/macrophage infiltration, fibrosis and apoptosis with reduction of islet function. The remodeling of islet architecture was associated with increased pancreatic expression of components of the RAS, growth factor genes (transforming growth factor β and connective tissue growth factor) and inflammatory molecules (monocyte chemotactic protein-1 and vascular adhesion molecule type 1). Prevention of these changes with improvement of insulin secretion was observed in ramipril treated animals. Our data suggest that OPG might play an important role in promoting beta cell dysfunction and that the upregulation of the local RAS represents one possible mechanism responsible for the OPG-induced beta cell dysfunction.

%B Mol Cell Endocrinol %V 331 %P 136-42 %8 2011 Jan 1 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/20832449?dopt=Abstract %R 10.1016/j.mce.2010.08.019 %0 Journal Article %J Transfusion %D 2011 %T A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients. %A Cesaro, Simone %A Zanazzo, Andrea Giulio %A Frenos, Stefano %A Luksch, Roberto %A Pegoraro, Anna %A Tridello, Gloria %A Dallorso, Sandro %K Adolescent %K Adult %K Child %K Child, Preschool %K Female %K Granulocyte Colony-Stimulating Factor %K Hematopoietic Stem Cell Mobilization %K Humans %K Infant %K Male %K Neoplasms %K Peripheral Blood Stem Cell Transplantation %K Prospective Studies %K Recombinant Proteins %K Transplantation, Autologous %X

BACKGROUND: Limited data are available on the use of pegfilgrastim in pediatric patients as a mobilizing agent in association with chemotherapy.

STUDY DESIGN AND METHODS: This was a prospective, multicenter, Phase II study to evaluate the safety and efficacy of a single dose of 100 µg/kg pegfilgrastim in mobilizing peripheral blood stem cells (PBSCs) in pediatric patients. The primary endpoint of the study was the percentage of good mobilizers with pegfilgrastim (blood peak of CD34+ cells ≥ 20 × 10(6) /L). The results were compared with a historical control group.

RESULTS: Thirty of 36 recruited patients were classified as good mobilizers (83%). The median value of circulating CD34+ at leukapheresis was 143 × 10(6) /L (range, 20 × 10(6) -1988 × 10(6) /L). No significant adverse effects were associated with the use of pegfilgrastim and no patient was withdrawn from using the drug. A blood peak of 20 × 10(6) /L or more CD34+ was observed in 33 of 36 control patients (92%) and the median CD34+ count at leukapheresis was 158 × 10(6) /kg (range, 28 × 10(6) -4529 × 10(6) /kg; p = 0.7). No significant differences were found between the two groups in terms of toxicity or other variables of mobilization. As at October 2008, 23 patients of the pegfilgrastim group and 32 patients of the filgrastim group underwent autologous transplant. No significant differences were found in terms of early toxicity, myeloid recovery, and Day 100 survival.

CONCLUSION: A single dose of 100 µg/kg pegfilgrastim was safe and effective for PBSC collection in pediatric patients. We suggest that these results support the use of pegfilgrastim for pediatric patients.

%B Transfusion %V 51 %P 2480-7 %8 2011 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/21542852?dopt=Abstract %R 10.1111/j.1537-2995.2011.03157.x %0 Journal Article %J J Immunol %D 2011 %T Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells. %A Bezzerri, Valentino %A d'Adamo, Pio %A Rimessi, Alessandro %A Lanzara, Carmen %A Crovella, Sergio %A Nicolis, Elena %A Tamanini, Anna %A Athanasakis, Emmanouil %A Tebon, Maela %A Bisoffi, Giulia %A Drumm, Mitchell L %A Knowles, Michael R %A Pinton, Paolo %A Gasparini, Paolo %A Berton, Giorgio %A Cabrini, Giulio %K Adenosine Triphosphate %K Calcium %K Cell Line, Transformed %K Cystic Fibrosis %K Enzyme Activation %K Epithelial Cells %K Gene Expression %K Gene Frequency %K Genotype %K Green Fluorescent Proteins %K Host-Pathogen Interactions %K Humans %K Interleukin-8 %K Isoenzymes %K Lung Diseases %K Microscopy, Fluorescence %K Phospholipase C beta %K Polymorphism, Single Nucleotide %K Protein Kinase C %K Protein Kinase C beta %K Pseudomonas aeruginosa %K RNA Interference %K Toll-Like Receptors %K Transcription Factor RelA %X

Respiratory insufficiency is the major cause of morbidity and mortality in patients affected by cystic fibrosis (CF). An excessive neutrophilic inflammation, mainly orchestrated by the release of IL-8 from bronchial epithelial cells and amplified by chronic bacterial infection with Pseudomonas aeruginosa, leads to progressive tissue destruction. The anti-inflammatory drugs presently used in CF patients have several limitations, indicating the need for identifying novel molecular targets. To address this issue, we preliminarily studied the association of 721 single nucleotide polymorphisms from 135 genes potentially involved in signal transduction implicated in neutrophil recruitment in a cohort of F508del homozygous CF patients with either severe or mild progression of lung disease. The top ranking association was found for a nonsynonymous polymorphism of the phospholipase C-β3 (PLCB3) gene. Studies in bronchial epithelial cells exposed to P. aeruginosa revealed that PLCB3 is implicated in extracellular nucleotide-dependent intracellular calcium signaling, leading to activation of the protein kinase Cα and Cβ and of the nuclear transcription factor NF-κB p65. The proinflammatory pathway regulated by PLCB3 acts by potentiating the Toll-like Receptors' signaling cascade and represents an interesting molecular target to attenuate the excessive recruitment of neutrophils without completely abolishing the inflammatory response.

%B J Immunol %V 186 %P 4946-58 %8 2011 Apr 15 %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/21411730?dopt=Abstract %R 10.4049/jimmunol.1003535 %0 Journal Article %J AIDS %D 2011 %T A polymorphism in PRF1 gene is associated with HIV-1 vertical transmission in Brazilian children. %A Padovan, Lara %A Segat, Ludovica %A Crovella, Sergio %K Brazil %K Female %K HIV Infections %K HIV-1 %K Humans %K Infant, Newborn %K Infectious Disease Transmission, Vertical %K Male %K Polymorphism, Genetic %K Pore Forming Cytotoxic Proteins %K Pregnancy %X

We investigated the possible association between PRF1 gene polymorphisms and HIV-1 vertical transmission in Brazilian children by analyzing PRF1 gene coding and untranslated regions in 173 perinatally infected children (HIV+), 51 exposed uninfected (HIV-), and 171 HIV-unexposed uninfected children. Seven single nucleotide polymorphisms were identified in our samples. The rs885822 C allele and CC genotype were significantly more frequent in HIV-negative than in HIV-positive patients and associated with a protective effect toward HIV vertical transmission.

%B AIDS %V 25 %P 535-7 %8 2011 Feb 20 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21157294?dopt=Abstract %R 10.1097/QAD.0b013e3283428b7c %0 Journal Article %J Clin Chem Lab Med %D 2011 %T A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients. %A Crovella, Sergio %A Segat, Ludovica %A Amato, Annalisa %A Athanasakis, Emmanouil %A Bezzerri, Valentino %A Braggion, Cesare %A Casciaro, Rosaria %A Castaldo, Giuseppe %A Colombo, Carla %A Covone, Angela Elvira %A De Rose, Virginia %A Gagliardini, Rolando %A Lanzara, Carmen %A Minicucci, Laura %A Morgutti, Marcello %A Nicolis, Elena %A Pardo, Francesca %A Quattrucci, Serena %A Raia, Valeria %A Ravazzolo, Roberto %A Seia, Manuela %A Stanzial, Valentino %A Termini, Lisa %A Zazzeron, Laura %A Cabrini, Giulio %A Gasparini, Paolo %K 5' Untranslated Regions %K Adult %K beta-Defensins %K Cystic Fibrosis %K Cystic Fibrosis Transmembrane Conductance Regulator %K Female %K Genotype %K Homozygote %K Humans %K Italy %K Male %K Mutation %K Phenotype %K Polymorphism, Genetic %K Young Adult %X

BACKGROUND: The identification of cystic fibrosis (CF) patients who are at greater risk of lung damage could be clinically valuable. Thus, we attempted to replicate previous findings and verify the possible association between three single nucleotide polymorphisms (SNPs c.-52G>A, c.-44C>G and c.-20G>A) in the 5' untranslated region (5' UTR) of the β defensin 1 (DEFB1) gene and the CF pulmonary phenotype.

METHODS: Genomic DNA from 92 Italian CF patients enrolled in different regional CF centres was extracted from peripheral blood and genotyped for DEFB1 SNPs using TaqMan(®) allele specific probes. In order to avoid genetic confounding causes that can account for CF phenotype variability, all patients were homozygous for the F508del CFTR mutation, and were then classified on the basis of clinical and functional data as mild lung phenotype (Mp, n=50) or severe lung phenotype patients (Sp, n=42).

RESULTS: For the c.-20G>A SNP, the frequency of the A allele, as well as the AA genotype, were significantly more frequent in Mp than in Sp patients, and thus this was associated with a protective effect against severe pulmonary disease (OR=0.48 and 0.28, respectively). The effect of the c.-20G>A A allele is consistent with a recessive model, and the protective effect against Sp is exerted only when it is present in homozygosis. For the other two SNPs, no differences were observed as allelic and genotypic frequency in the two subgroups of CF patients.

CONCLUSIONS: Our results, although necessary to be confirmed in larger and multiethnic populations, reinforce DEFB1 as a candidate modifier gene of the CF pulmonary phenotype.

%B Clin Chem Lab Med %V 49 %P 49-54 %8 2011 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21077791?dopt=Abstract %R 10.1515/CCLM.2011.023 %0 Journal Article %J Arch Dis Child Fetal Neonatal Ed %D 2011 %T Procalcitonin in detecting neonatal nosocomial sepsis. %A Auriti, Cinzia %A Fiscarelli, Ersilia %A Ronchetti, Maria Paola %A Argentieri, Marta %A Marrocco, Gabriella %A Quondamcarlo, Anna %A Seganti, Giulio %A Bagnoli, Francesco %A Buonocore, Giuseppe %A Serra, Giovanni %A Bacolla, Gianfranco %A Mastropasqua, Savino %A Mari, Annibale %A Corchia, Carlo %A Prencipe, Giusi %A Piersigilli, Fiammetta %A Ravà, Lucilla %A Di Ciommo, Vincenzo %X

OBJECTIVE: To investigate the accuracy of procalcitonin (PCT) as a diagnostic marker of nosocomial sepsis (NS) and define the most accurate cut-off to distinguish infected from uninfected neonates. SETTING: Six neonatal intensive care units (NICUs). PATIENTS: 762 neonates admitted to six NICUs during a 28-month observational study for whom at least one serum sample was taken on admission. MAIN OUTCOME MEASURES: Positive and negative predictive values at different PCT cut-off levels. RESULTS: The overall probability of an NS was doubled or more if PCT was >0.5 ng/ml. In very-low-birth-weight (VLBW) infants, a cut-off of >2.4 ng/ml gave a positive predictive value of NS near to 50% with a probability of a false-positive diagnosis of NS in about 10% of the patients. CONCLUSIONS: In VLBW neonates, a serum PCT value >2.4 ng/ml prompts early empirical antibiotic therapy, while in normal-birth-weight infants, a PCT value ≤2.4 ng/ml carries a low risk of missing an NS.

%B Arch Dis Child Fetal Neonatal Ed %8 2011 Mar 15 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/21406453?dopt=Abstract %R 10.1136/adc.2010.194100 %0 Journal Article %J Diagn Mol Pathol %D 2011 %T Quantification of heteroplasmic mitochondrial DNA mutations for DNA samples in the low picogram range by nested real-time ARMS-qPCR. %A Biffi, Stefania %A Bortot, Barbara %A Carrozzi, Marco %A Severini, Giovanni Maria %K Child %K DNA, Mitochondrial %K Humans %K Mitochondrial Diseases %K Mutation %K Polymerase Chain Reaction %K Sensitivity and Specificity %X

In many mitochondrial diseases, different clinical manifestations are related to tissue-specific distribution of mutated mitochondrial DNA (mtDNA). In this study, we describe an assay for the determination of mutated mtDNA copy number in small clinical samples, using standard polymerase chain reaction (PCR) followed by SYBR Green real-time allelic-specific PCR [amplification refractory mutation system-quantitative PCR (ARMS-qPCR)]. To assess the degree of heteroplasmy in a patient harboring 2 cosegregating mtDNA mutations (4415A>G and 9922A>C) starting from picogram amounts of DNA, we first amplified the mutated target sequence by standard PCR, and then analyzed it by real-time ARMS-qPCR. To validate this method, we analyzed by real-time ARMS-qPCR the PCR amplification products derived from different mixtures containing known proportions of mutant and wild-type cloned mtDNA fragments. The correlation coefficient of 0.994 between expected and observed values for the percentage of mutant A4415G confirms that the relative proportion of mutated and wild-type mtDNA was maintained after the first PCR amplification. This method allows the precise quantification of heteroplasmic mutations in DNA samples extracted from hairs, urine, small stomach biopsies, and, more importantly, single-muscle fiber, with a limit of detection close to 0.5%. This nested real-time ARMS-PCR represents a rapid, efficient, and less expensive method for the detection and quantification of heteroplasmic mutant mtDNA, even in very small clinical samples.

%B Diagn Mol Pathol %V 20 %P 117-22 %8 2011 Jun %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21532488?dopt=Abstract %R 10.1097/PDM.0b013e3181efe2c6 %0 Journal Article %J Curr Pharm Des %D 2011 %T Recent advances in the therapeutic perspectives of Nutlin-3. %A Secchiero, Paola %A Bosco, Raffaella %A Celeghini, Claudio %A Zauli, Giorgio %K Antineoplastic Agents %K Antineoplastic Combined Chemotherapy Protocols %K Drug Synergism %K Genes, p53 %K Humans %K Imidazoles %K Neoplasms %K Piperazines %K Proto-Oncogene Proteins c-mdm2 %K Tumor Suppressor Protein p53 %X

Nutlin-3 is a small molecule inhibitor of the MDM2/p53 interaction, which leads to the non-genotoxic p53 stabilization, activation of cell cycle arrest and apoptosis pathways. A series of recent studies have strengthened the concept that selective, non-genotoxic p53 activation by Nutlin-3 might represent an alternative to the current cytotoxic chemotherapy, in particular for pediatric tumors and for hematological malignancies, which retain a high percentage of p53(wild-type) status at diagnosis. Like most other drugs employed in cancer therapy, it will be unlikely that Nutlin-3 will be used as a monotherapy. In this respect, Nutlin-3 shows a synergistic cytotoxic effect when used in combination with innovative drugs, such as TRAIL or bortozemib. Although Nutlin-3 is currently in phase I clinical trial for the treatment of retinoblastoma, its effects on normal tissues and cell types remain largely to be determined and will require further investigation in the future years.

%B Curr Pharm Des %V 17 %P 569-77 %8 2011 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/21391907?dopt=Abstract %0 Journal Article %J Gut %D 2011 %T Refractory iron-deficiency anaemia in a child with portal cavernoma. %A Pastore, Serena %A Londero, Margherita %A Cont, Gabriele %A Di Leo, Grazia %A Ventura, Alessandro %K Anemia, Iron-Deficiency %K Antihypertensive Agents %K Child %K Hemangioma, Cavernous %K Humans %K Hypertension, Portal %K Ileal Diseases %K Male %K Propranolol %K Vascular Neoplasms %B Gut %V 60 %P 317, 377 %8 2011 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21051450?dopt=Abstract %R 10.1136/gut.2009.184697 %0 Journal Article %J Hum Immunol %D 2011 %T Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. %A da Silva, Ronaldo Celerino %A Segat, Ludovica %A Crovella, Sergio %K Cell Adhesion Molecules %K HIV Infections %K HIV-1 %K Humans %K Immunity, Innate %K Infectious Disease Transmission, Vertical %K Lectins, C-Type %K Polymorphism, Genetic %K Receptors, Cell Surface %X

The innate immune system acts in the first line of host defense against pathogens. One of the mechanisms used involves the early recognition and uptake of microbes by host professional phagocytes, through pattern recognition receptors (PRRs). These PRRs bind to conserved microbial ligands expressed by pathogens and initiate both innate and adaptative immune responses. Some PRRs located on the surface of dendritic cells (DCs) and other cells seem to play an important role in human immunodeficiency virus type 1 (HIV-1) transmission. Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin, CD209 (DC-SIGN) and its homolog, DC-SIGN-related (DC-SIGNR or L-SIGN) receptors are PPRs able to bind the HIV-1 gp120 envelope protein and, because alterations in their expression patterns also occur, they might play a role in both horizontal and vertical transmission as well as in disseminating the virus within the host. This review aims to explore the involvement of the DC-SIGN and L-SIGN receptors in HIV-1 transmission from mother to child.

%B Hum Immunol %V 72 %P 305-11 %8 2011 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21277928?dopt=Abstract %R 10.1016/j.humimm.2011.01.012 %0 Journal Article %J AIDS %D 2011 %T The role of mannose-binding lectin gene polymorphisms in susceptibility to HIV-1 infection in Southern Brazilian patients. %A da Silva, Gabriela Kniphoff %A Guimarães, Rafael %A Mattevi, Vanessa Suñé %A Lazzaretti, Rosmeri Kuhmmer %A Sprinz, Eduardo %A Kuhmmer, Regina %A Brandão, Lucas %A Crovella, Sergio %A Chies, José Artur Bogo %K Adult %K Aged %K Brazil %K Female %K Genetic Predisposition to Disease %K HIV Infections %K HIV-1 %K Humans %K Lectins, C-Type %K Male %K Mannose-Binding Lectin %K Mannose-Binding Lectins %K Middle Aged %K Polymorphism, Genetic %K Promoter Regions, Genetic %K Receptors, Cell Surface %K Young Adult %X

OBJECTIVE: This study investigates the role of mannose-binding lectin (MBL) in the susceptibility to HIV-1 infection analyzing polymorphisms located at the MBL2 promoter and exon 1 regions.

MATERIALS AND METHODS: The prevalence of MBL2 variant alleles was investigated in 410 HIV-1-infected patients from the South Brazilian HIV cohort and in 345 unexposed uninfected healthy individuals. The promoter variants were genotyped using polymerase chain reaction with sequence-specific primers (PCR-SSP) and exon 1 variants were analyzed by real-time PCR using a melting temperature assay and were confirmed by PCR-restriction fragment length polymorphism (RFLP). MBL2 genotypic and allelic frequencies were compared between HIV-1-infected patients and controls using the chi-squared tests.

RESULTS: The analyses were performed subdividing the individuals according to their ethnic origin. Among Euro-derived individuals a higher frequency of the LX/LX genotype was observed in patients when compared to controls (P < 0.001). The haplotypic analysis also showed a higher frequency of the haplotypes associated with lower MBL levels among HIV-1-infected patients (P = 0.0001). Among Afro-derived individuals the frequencies of LY/LY and HY/HY genotypes were higher in patients when compared to controls (P = 0.009 and P = 0.02).

CONCLUSIONS: An increased frequency of MBL2 genotypes associated with low MBL levels was observed in Euro-derived patients, suggesting a potential role for MBL in the susceptibility to HIV-1 infection in Euro-derived individuals.

%B AIDS %V 25 %P 411-8 %8 2011 Feb 20 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21192229?dopt=Abstract %R 10.1097/QAD.0b013e328342fef1 %0 Journal Article %J Clin Infect Dis %D 2011 %T Rubella susceptibility profile in pregnant women with HIV. %A Floridia, Marco %A Pinnetti, Carmela %A Ravizza, Marina %A Tibaldi, Cecilia %A Sansone, Matilde %A Fiscon, Marta %A Guaraldi, Giovanni %A Guerra, Brunella %A Alberico, Salvatore %A Spinillo, Arsenio %A Castelli, Paula %A Dalzero, Serena %A Cavaliere, Anna Franca %A Tamburrini, Enrica %K Female %K HIV Infections %K Humans %K Pregnancy %K Pregnancy Complications, Infectious %K Rubella %B Clin Infect Dis %V 52 %P 960-2 %8 2011 Apr 1 %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/21427406?dopt=Abstract %R 10.1093/cid/cir040 %0 Journal Article %J J Med Virol %D 2011 %T Secondary lymphoid tissue as an important site for WU polyomavirus infection in immunocompetent children. %A Comar, Manola %A Zanotta, Nunzia %A Rossi, Tatiana %A Pelos, Giorgio %A D'Agaro, Pierlanfranco %K Adenoids %K Child %K Child, Preschool %K DNA, Viral %K Female %K Humans %K Infant %K Leukocytes, Mononuclear %K Male %K Nasopharynx %K Palatine Tonsil %K Phylogeny %K Polymerase Chain Reaction %K Polyomavirus %K Polyomavirus Infections %K Prevalence %K Sequence Analysis, DNA %K Sequence Homology %X

The polyomaviruses KI and WU (KIPyV and WUPyV) have been identified in respiratory specimens from children with acute respiratory infections, which suggests the respiratory tract as a possible site of infection. However, the persistence of infection in the lymphoid system is unknown. Fresh samples (n = 211) of tonsils, adenoids, and peripheral blood mononuclear cells (PBMCs) from 83 immunocompetent children (mean age 4.8 years) were tested for amplification of the KIPyV VP1 and WUPyV VP2 genes. The known BK and JC polyomaviruses and the lymphotropic human herpesvirus (HHV)-6 were also investigated by quantitative real-time PCR and direct sequencing. In addition, 98 nasopharyngeal swabs collected from children (mean age 6.2 years) affected by seasonal influenza-like illness were tested. Of the lymphoid tissues, 34.9% were positive for WUPyV, 4.8% for BK virus, and 33.8% for HHV-6. KIPyV and JC virus were not detected in these specimens. None of the polyomaviruses were detected in PBMCs. Among the nasopharyngeal samples, the prevalence of WUPyV was 27.5%, although 70% of the positive samples were co-infected with at least one of the following respiratory viruses: influenza virus, adenovirus, and respiratory syncytial virus. Phylogenetic analysis revealed high sequence homology (99%) between lymphoid- and nasopharynx-derived WUPyV strains. These results suggest that the tonsils and adenoids of immunocompetent children are a reservoir for WUPyV infection; probably due to the respiratory route of transmission. In addition, the prevalence of WUPyV was high among the children, and the virus was identified more frequently in older children than during the first years of life.

%B J Med Virol %V 83 %P 1446-50 %8 2011 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/21678449?dopt=Abstract %R 10.1002/jmv.22124 %0 Journal Article %J PLoS Med %D 2011 %T Setting research priorities to reduce global mortality from childhood pneumonia by 2015. %A Rudan, Igor %A El Arifeen, Shams %A Bhutta, Zulfiqar A %A Black, Robert E %A Brooks, Abdullah %A Chan, Kit Yee %A Chopra, Mickey %A Duke, Trevor %A Marsh, David %A Pio, Antonio %A Simoes, Eric A F %A Tamburlini, Giorgio %A Theodoratou, Evropi %A Weber, Martin W %A Whitney, Cynthia G %A Campbell, Harry %A Qazi, Shamim A %K Biomedical Research %K Child, Preschool %K Humans %K Infant %K Infant, Newborn %K Pneumonia %B PLoS Med %V 8 %P e1001099 %8 2011 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/21980266?dopt=Abstract %R 10.1371/journal.pmed.1001099 %0 Journal Article %J Exp Clin Endocrinol Diabetes %D 2011 %T Shwachman-Diamond syndrome and type 1 diabetes mellitus: more than a chance association? %A Gana, S %A Sainati, L %A Frau, M R %A Monciotti, C %A Poli, F %A Cannioto, Z %A Comelli, M %A Danesino, C %A Minelli, A %K Bone Marrow Diseases %K CD4-CD8 Ratio %K Diabetes Mellitus, Type 1 %K Exocrine Pancreatic Insufficiency %K Female %K Heterozygote %K Humans %K Immune System %K Infant %K Italy %K Lipomatosis %K Male %K Mutation %K Prevalence %K Proteins %K Registries %X

Shwachman-Diamond syndrome is a rare clinical condition consisting of exocrine pancreatic dysfunction, various degree of pancytopenia, and metaphyseal dysplasia. The majority of Shwachman-Diamond syndrome cases result from mutations in the Shwachman-Bodian-Diamond Syndrome gene. To date, type 1 diabetes mellitus has only been reported in 4 independent cases presenting with Shwachman-Diamond syndrome, 3 of them with molecular confirmation of the diagnosis. We describe 2 unrelated patients with clinical and molecular features typical of Shwachman-Diamond syndrome and type 1 diabetes mellitus. In addition, we report the occurrence rate of type 1 diabetes mellitus in the Italian registry for Shwachman-Diamond syndrome, which is low (3.23%) but increased at least 30-fold over the type 1 diabetes mellitus occurrence rate in the general population. No evidence of a direct correlation between Shwachman-Diamond syndrome and type 1 diabetes mellitus have been reported, therefore the presence of both diseases in the same patient might be a chance association, however we suggest that the defects in immune regulation of Shwachman-Diamond syndrome might play a role in the development of type 1 diabetes mellitus.

%B Exp Clin Endocrinol Diabetes %V 119 %P 610-2 %8 2011 Nov %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/21553366?dopt=Abstract %R 10.1055/s-0031-1275699 %0 Journal Article %J Hum Immunol %D 2011 %T The significance of mannose-binding lectin gene polymorphisms on the risk of BK virus coinfection in women with human papillomavirus-positive cervical lesions. %A Comar, Manola %A Segat, Ludovica %A Crovella, Sergio %A Bovenzi, Massimo %A Cortini, Enzo %A Tognon, Mauro %K Adult %K Aged %K Alleles %K BK Virus %K Cervical Intraepithelial Neoplasia %K Cervix Uteri %K DNA Fingerprinting %K DNA, Viral %K Female %K Gene Frequency %K Genetic Association Studies %K Genetic Predisposition to Disease %K Genotype %K Human papillomavirus 16 %K Humans %K Italy %K Mannose-Binding Lectin %K Odds Ratio %K Papillomavirus Infections %K Polymorphism, Genetic %K Polyomavirus Infections %K Risk %K Viral Load %X

The simultaneous detection of oncogenic human papillomavirus (HPV) and BK virus (BKV) has been recently reported in cervical cancers, suggesting that these viruses may act together in the process of cell transformation; host genetic polymorphisms may also influence virus persistence/reactivation. To disclose a possible role of the gene encoding for the mannose-binding lectin, MBL2, in susceptibility to BKV infection, we analyzed functional polymorphisms in the first exon of MBL2 in women stratified for the presence/absence of BKV and affected by different grades of HPV-induced cervical precancerous lesions. All BKV-positive samples were also HPV positive (HPV 16), and all presented with high-grade squamous intraepithelial lesions. The MBL2 A allele was significantly more frequent in BKV-negative patients than in BKV-positive patients. These data indicate a possible role for the A allele in conferring protection to BKV infection in high-risk HPV-positive women (odds ratio 0.40, 95% confidence interval 0.20-0.85, p = 0.01).

%B Hum Immunol %V 72 %P 663-6 %8 2011 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/21536088?dopt=Abstract %R 10.1016/j.humimm.2011.04.002 %0 Journal Article %J Nat Genet %D 2011 %T Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. %A Pansuriya, Twinkal C %A van Eijk, Ronald %A d'Adamo, Pio %A van Ruler, Maayke A J H %A Kuijjer, Marieke L %A Oosting, Jan %A Cleton-Jansen, Anne-Marie %A van Oosterwijk, Jolieke G %A Verbeke, Sofie L J %A Meijer, Daniëlle %A van Wezel, Tom %A Nord, Karolin H %A Sangiorgi, Luca %A Toker, Berkin %A Liegl-Atzwanger, Bernadette %A San-Julian, Mikel %A Sciot, Raf %A Limaye, Nisha %A Kindblom, Lars-Gunnar %A Daugaard, Soeren %A Godfraind, Catherine %A Boon, Laurence M %A Vikkula, Miikka %A Kurek, Kyle C %A Szuhai, Karoly %A French, Pim J %A Bovée, Judith V M G %K Adult %K Case-Control Studies %K Cell Line, Tumor %K DNA Methylation %K Enchondromatosis %K Female %K Gene Expression Profiling %K Gene Expression Regulation %K Genome-Wide Association Study %K Humans %K Isocitrate Dehydrogenase %K Male %K Middle Aged %K Mosaicism %K Mutation, Missense %K Sequence Analysis, DNA %K Transcription, Genetic %K Young Adult %X

Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome). We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions). In total, 35 of 43 (81%) subjects with Ollier disease and 10 of 13 (77%) with Maffucci syndrome carried IDH1 (98%) or IDH2 (2%) mutations in their tumors. Fourteen of 16 subjects had identical mutations in separate lesions. Immunohistochemistry to detect mutant IDH1 R132H protein suggested intraneoplastic and somatic mosaicism. IDH1 mutations in cartilage tumors were associated with hypermethylation and downregulated expression of several genes. Mutations were also found in 40% of solitary central cartilaginous tumors and in four chondrosarcoma cell lines, which will enable functional studies to assess the role of IDH1 and IDH2 mutations in tumor formation.

%B Nat Genet %V 43 %P 1256-61 %8 2011 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/22057234?dopt=Abstract %R 10.1038/ng.1004 %0 Journal Article %J Hum Immunol %D 2011 %T Tag-single nucleotide polymorphism-based human leukocyte antigen genotyping in celiac disease patients from northeastern Italy. %A Vatta, Serena %A Fabris, Annalisa %A Segat, Ludovica %A Not, Tarcisio %A Crovella, Sergio %K Adolescent %K Adult %K Aged %K Celiac Disease %K Child %K Child, Preschool %K Female %K Humans %K Infant %K Italy %K Male %K Mass Screening %K Middle Aged %K Polymerase Chain Reaction %K Polymorphism, Single Nucleotide %K Reproducibility of Results %K Reverse Transcriptase Polymerase Chain Reaction %K Sensitivity and Specificity %X

We genotyped celiac disease (CD)-associated haplotypes DQ2.5, DQ8, DQ2.2, and DQ7 in 1005 CD patients from North Eastern Italy using a Tag-single nucleotide polymorphism (SNPs) approach and real time PCR platform, checking the accuracy and reliability of the method and comparing it to traditional PCR-SSP. Only 14 of 2010 chromosomes analyzed (0.7%) showed discrepancies between the Tag-SNPs real-time polymerase chain reaction (PCR) method and the PCR-single-strand polymorphism (SSP) technique, indicating a high sensitivity and specificity (ranging from 0.987 to 1 and from 0.998 to 0.999, respectively) for tagging with respect to corresponding human leukocyte antigen (HLA) alleles identified by PCR-SSP. Moreover, the overall cost of the Tag-SNPs HLA typing method was low (3 to 4 €/sample instead of 35 to 70 €/sample with commercial kits), making it suitable for mass screenings. Hence, we believe that the Tag-SNPs HLA typing could be used to complement or replace classic HLA typing in at high-risk groups, for research purposes and eventually in population screening programs.

%B Hum Immunol %V 72 %P 499-502 %8 2011 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/21513759?dopt=Abstract %R 10.1016/j.humimm.2011.03.008 %0 Journal Article %J Arthritis Rheum %D 2011 %T Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study. %A Hasija, Rachana %A Pistorio, Angela %A Ravelli, Angelo %A Demirkaya, Erkan %A Khubchandani, Raju %A Guseinova, Dinara %A Malattia, Clara %A Canhao, Helena %A Harel, Liora %A Foell, Dirk %A Wouters, Carine %A De Cunto, Carmen %A Huemer, Christian %A Kimura, Yukiko %A Mangge, Harald %A Minetti, Carlo %A Nordal, Ellen Berit %A Philippet, Pierre %A Garozzo, Rosaria %A Martini, Alberto %A Ruperto, Nicolino %K Adolescent %K Adrenal Cortex Hormones %K Child %K Dermatologic Agents %K Dermatomyositis %K Female %K Humans %K Longitudinal Studies %K Male %K Methotrexate %K Prospective Studies %K Treatment Outcome %X

OBJECTIVE: To evaluate response to therapy over a 24-month period in a large prospective international cohort of patients with juvenile dermatomyositis (DM).

METHODS: The study included 145 patients with recent-onset juvenile DM and 130 juvenile DM patients experiencing disease flare, all of whom were <18 years old. Disease activity parameters and therapeutic approaches in 4 geographic areas were analyzed at baseline and at 6, 12, and 24 months. Response was assessed according to the Pediatric Rheumatology International Trials Organization (PRINTO) juvenile DM response criteria, and data were reported "as observed" and in the intent-to-treat (ITT) population.

RESULTS: Patients with recent-onset juvenile DM at baseline had higher baseline disease activity and greater improvement over 24 months when compared to juvenile DM patients experiencing disease flare at baseline. Methotrexate (MTX) or high-dose corticosteroids were administered more frequently to patients with recent-onset juvenile DM, compared to juvenile DM patients experiencing disease flare, who were more likely to receive cyclosporine. Compared to patients from Western and Eastern Europe, a higher proportion of patients from South and Central America and North America received pulse steroids, and the average steroid dosage was higher in the North American and South and Central American patients. The use of MTX was similar in all 4 regions, while cyclosporin A was more frequently used in Western Europe. In the "as observed" analysis, 57.9% of the patients with recent-onset juvenile DM and 36.4% of the patients experiencing disease flare (P<0.001) reached at least a 70% response by PRINTO criteria at 6 months; these proportions had increased at month 24 to 78.4% and 51.2%, respectively (P<0.001). Corresponding results of the ITT analysis were much lower, with only one-third of the patients able to maintain the initial assigned therapy over 24 months.

CONCLUSION: Patients with recent-onset juvenile DM are more likely to achieve significant clinical improvement over 24 months, when compared to patients experiencing flares of juvenile DM. Internationally, various therapeutic approaches are used to treat this disease.

%B Arthritis Rheum %V 63 %P 3142-52 %8 2011 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/21647864?dopt=Abstract %R 10.1002/art.30475 %0 Journal Article %J J Cell Physiol %D 2011 %T Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. %A Corallini, Federica %A Celeghini, Claudio %A Rimondi, Erika %A di Iasio, Maria Grazia %A Gonelli, Arianna %A Secchiero, Paola %A Zauli, Giorgio %K Bone Marrow Cells %K Cell Death %K Cells, Cultured %K Coculture Techniques %K Down-Regulation %K Endothelial Cells %K Enzyme Activation %K Enzyme-Linked Immunosorbent Assay %K Fibroblasts %K Humans %K MAP Kinase Signaling System %K Mesenchymal Stromal Cells %K Osteoprotegerin %K p38 Mitogen-Activated Protein Kinases %K Protein Binding %K Recombinant Proteins %K Stromal Cells %K TNF-Related Apoptosis-Inducing Ligand %K Tumor Necrosis Factor-alpha %X

The soluble member of the TNF-R superfamily osteoprotegerin (OPG) is abundantly released under basal conditions by both mesenchymal stem cells (MSC) and fibroblasts and by endothelial cells upon stimulation with inflammatory cytokines. Since MSC, fibroblasts and endothelial cells represent key elements of the normal and tumor microenvironment and express detectable levels of surface TRAIL receptors, we investigated the effect of TRAIL on OPG release. Unexpectedly, recombinant TRAIL decreased the spontaneous OPG release in all cell types examined. Moreover, TRAIL decreased OPG release also in stromal cells co-cultured with lymphoma cells and counteracted the OPG induction by TN-alpha in HUVEC and MSC. Such down-regulation was not due to a masking effect in the ELISA quantification of the OPG released in the culture supernatants due to binding of OPG to its ligands (TRAIL and RANKL), as demonstrated by competition experiments with recombinant TRAIL and by the lack of RANKL release/induction. In addition, OPG down-regulation was not due to induction of cytotoxic effects by TRAIL, since the degree of apoptosis in response to TRAIL was negligible in all primary cell types. With regards to the possible molecular mechanism accounting for the down-regulation of OPG release by TRAIL, we found that treatment of MSC with TRAIL significantly decreased the phosphorylation levels of p38/MAPK. There is a suggestion that this pathway is involved in the stabilization of OPG mRNA. In this respect, the ability of TRAIL to decrease the release of OPG, in the absence of cell cytotoxicity, was mimicked by the p38/MAPK inhibitor SB203580.

%B J Cell Physiol %V 226 %P 2279-86 %8 2011 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/21660951?dopt=Abstract %R 10.1002/jcp.22564 %0 Journal Article %J J Biol Regul Homeost Agents %D 2011 %T TRAIL promotes a pro-survival signal in erythropoietin-deprived human erythroblasts through the activation of an NF-kB/IkBalpha pathway. %A Sancilio, S %A Di Giacomo, V %A Quaglietta, A M %A Iacone, A %A Angelucci, D %A Tatasciore, U %A Rana, R A %A Cataldi, A %A Zauli, G %A Di Pietro, R %K Cell Survival %K Erythroblasts %K Erythropoietin %K Gene Expression Regulation %K Humans %K I-kappa B Kinase %K Jurkat Cells %K NF-kappa B %K Peptides %K TNF-Related Apoptosis-Inducing Ligand %K Tumor Necrosis Factor Decoy Receptors %X

The biological activity of TNF-related apoptosis inducing ligand (TRAIL) was analyzed in primary human erythroblasts derived from mononuclear cells of blood donors, kept in culture in the presence of 20 percent foetal calf serum, growth factors (EPO, SCF, IL-3) and glucocorticoids (10-6 M dexamethasone, 10-6 M oestradiol) or under growth factor and serum starvation. In the presence of growth factors and serum, primary erythroblasts showed a differential expression of TRAIL-Receptors (Rs) at various degrees of maturation and responded to TRAIL treatment with a mild cytotoxicity. On the other hand, in the absence of serum and growth factors, TRAIL treatment unexpectedly up-regulated TRAIL-R4 decoy receptor and promoted erythroblast survival. The concomitant activation of NF-kB/IkB survival pathway was detected with Western blotting and immunofluorescence procedures and confirmed by experiments performed with SN50, a pharmacological inhibitor of the NF-kB/IkB pathway. Our study indicates that TRAIL has a twofold activity on erythroid lineages: it induces a mild erythroid cell cytotoxicity in the presence of serum and growth factors, while it promotes erythroid cell survival through the activation of the NF-kB/IkB pathway under starvation conditions.

%B J Biol Regul Homeost Agents %V 25 %P 375-86 %8 2011 Jul-Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/22023762?dopt=Abstract %0 Journal Article %J J Acquir Immune Defic Syndr %D 2011 %T Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. %A Tariq, Shema %A Townsend, Claire L %A Cortina-Borja, Mario %A Duong, Trinh %A Elford, Jonathan %A Thorne, Claire %A Tookey, Pat A %K Adult %K Anti-HIV Agents %K Antiretroviral Therapy, Highly Active %K CD4 Lymphocyte Count %K Europe %K Female %K HIV Infections %K Humans %K Infant %K Infectious Disease Transmission, Vertical %K Pregnancy %K Pregnancy Complications, Infectious %K Retrospective Studies %K Time Factors %K Viral Load %K Zidovudine %X

BACKGROUND: Increasing numbers of women in resource-rich settings are prescribed zidovudine (ZDV)-sparing highly active antiretroviral therapy (HAART) in pregnancy. We compare ZDV-sparing with ZDV-containing HAART in relation to maternal viral load at delivery, mother-to-child transmission (MTCT) of HIV, and congenital abnormality.

METHODS: This is an analysis of data from the National Study of HIV in Pregnancy and Childhood and the European Collaborative Study. Data on 7573 singleton births to diagnosed HIV-infected women between January 2000 and June 2009 were analyzed. Logistic regression models were fitted to estimate adjusted odds ratios (AORs).

RESULTS: Overall, 15.8% (1199 of 7573) of women received ZDV-sparing HAART, with increasing use between 2000 and 2009 (P < 0.001). Nearly a fifth (18.4%) of women receiving ZDV-sparing HAART in pregnancy had a detectable viral load at delivery compared with 28.6% of women on ZDV-containing HAART [AOR 0.90; 95% confidence interval (CI): 0.72 to 1.14, P = 0.4]. MTCT rates were 0.8% and 0.9% in the ZDV-sparing and ZDV-containing groups, respectively (AOR 1.81; 95% CI: 0.77 to 4.26, P = 0.2). The congenital abnormality rate was the same in both groups (2.7%, AOR 0.98; 95% CI: 0.66 to 1.45, P = 0.9), with no significant difference between the groups in a subanalysis of pregnancies with first trimester HAART exposure (AOR 0.79; 95% CI: 0.48 to 1.30, P = 0.4).

CONCLUSIONS: We found no difference in risk of detectable viral load at delivery, MTCT, or congenital abnormality when comparing ZDV-sparing with ZDV-containing HAART. With increasing use of ZDV-sparing HAART, continued monitoring of pregnancy outcomes and long-term consequences of in utero exposure to these drugs is required.

%B J Acquir Immune Defic Syndr %V 57 %P 326-33 %8 2011 Aug 1 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21499113?dopt=Abstract %R 10.1097/QAI.0b013e31821d34d0 %0 Journal Article %J Eur J Pediatr %D 2011 %T Usefulness of wireless capsule endoscopy for detecting inflammatory bowel disease in children presenting with arthropathy. %A Taddio, Andrea %A Simonini, Gabriele %A Lionetti, Paolo %A Lepore, Loredana %A Martelossi, Stefano %A Ventura, Alessandro %A Cimaz, Rolando %K Adolescent %K Arthritis, Juvenile %K Capsule Endoscopy %K Child %K Colitis, Ulcerative %K Colon %K Crohn Disease %K Diagnosis, Differential %K Follow-Up Studies %K Humans %K Inflammatory Bowel Diseases %K Intestine, Small %K Male %K Predictive Value of Tests %K Sensitivity and Specificity %K Severity of Illness Index %K Treatment Outcome %X

Inflammatory bowel disease (IBD) is a cause of chronic intestinal inflammation in children. In a subset of patients affected by IBD, arthropathy may be the leading presenting sign. In the past years, remarkable advances in gastrointestinal endoscopy techniques have been achieved; recently, the development of capsule endoscopy (CE) provided a non-invasive method for the complete endoscopic evaluation, including small bowel assessment. We report three children suffering from IBD but presenting with articular complaints in whom CE was a useful tool for detecting gut inflammation. Patients were investigated with the wireless CE: PillCam SB2 (Given Imaging, Yoqneam, Israel) capsule, the second-generation capsule, was used in our paediatric patients. Three patients were initially evaluated for arthropathy. Enteropathic arthritis was suspected for gastrointestinal symptoms and/or persistence of inflammatory markers elevation. In one of these children, conventional endoscopy was refused by parents, while in the other two children, CE was proposed as first-line diagnostic tool. In all patients, CE revealed to be safe and provided information that led to diagnosis. Paediatric rheumatologists should consider CE as a valid, non-invasive tool, eventually first level diagnostic approach in order to evaluate the presence of IBD in children presenting with chronic articular complaints.

%B Eur J Pediatr %V 170 %P 1343-7 %8 2011 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/21643650?dopt=Abstract %R 10.1007/s00431-011-1505-7 %0 Journal Article %J Clin Exp Pharmacol Physiol %D 2011 %T X-ray fluorescence elemental mapping and microscopy to follow hepatic disposition of a Gd-based magnetic resonance imaging contrast agent. %A Delfino, Riccarda %A Altissimo, Matteo %A Menk, Ralf Hendrik %A Alberti, Roberto %A Klatka, Tomasz %A Frizzi, Tommaso %A Longoni, Antonio %A Salomè, Murielle %A Tromba, Giuliana %A Arfelli, Fulvia %A Clai, Milan %A Vaccari, Lisa %A Lorusso, Vito %A Tiribelli, Claudio %A Pascolo, Lorella %K Animals %K Contrast Media %K Fatty Liver %K Female %K Gadolinium %K Hepatitis %K Iron %K Liver %K Magnetic Resonance Imaging %K Mice %K Mice, Inbred CBA %K Organometallic Compounds %K Spectrometry, X-Ray Emission %X

1. Spatially resolved X-ray fluorescence (XRF) spectroscopy with synchrotron radiation is a technique that allows imaging and quantification of chemical elements in biological specimens with high sensitivity. In the present study, we applied XRF techniques at a macro and micro level to carry out drug distribution studies on ex vivo models to confirm the hepatobiliary disposition of the Gd-based magnetic resonance imaging contrast agent B22956/1. 2. Gd presence was selectively quantified allowing the determination of the time dependent disappearance of the drug from blood and its hepatic accumulation in mice after administration. Elemental mapping highlighted the drug distribution differences between healthy and diseased livers. XRF microanalyses showed that in CCl(4) -induced hepatitis, B22956/1 has greatly reduced hepatic accumulation, shown as a 20-fold reduction of Gd presence. Furthermore, a significant increase of Fe presence was found in steatotic compared with healthy livers, in line with the disease features. 3. The present results show that XRF might be useful in preclinical pharmacological studies with drugs containing exogenous elements. Furthermore, quantitative and high-sensitivity elemental mapping allows simultaneous detection of chemical variation, showing pathological conditions. This approach was useful in suggesting reduced B22956/1 accumulation in steatotic livers, thus opening possible new diagnostic perspectives for this drug.

%B Clin Exp Pharmacol Physiol %V 38 %P 834-45 %8 2011 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/21957877?dopt=Abstract %R 10.1111/j.1440-1681.2011.05618.x %0 Journal Article %J J Acquir Immune Defic Syndr %D 2010 %T A 3'UTR SNP in NLRP3 gene is associated with susceptibility to HIV-1 infection. %A Pontillo, Alessandra %A Brandão, Lucas A %A Guimarães, Rafael L %A Segat, Ludovica %A Athanasakis, Emmanouil %A Crovella, Sergio %K Adult %K Brazil %K Carrier Proteins %K Case-Control Studies %K Child %K Child, Preschool %K Female %K Genetic Predisposition to Disease %K Genotype %K HIV Infections %K HIV-1 %K Humans %K Infant %K Infectious Disease Transmission, Vertical %K Male %K Middle Aged %K Polymorphism, Single Nucleotide %K Pregnancy %K Young Adult %X

OBJECTIVES: Innate immunity genes polymorphisms are known to be involved in the multifactorial susceptibility to HIV-1 infection. Recently it has been hypothesized that inflammasomes could play an important role in the host response to viruses. The aim of our study is to verify if single-nucleotide polymorphisms (SNPs) in genes encoding for NALPs-innate immune receptors that form molecular complexes leading to the production of IL-1beta and the activation of immune response-could influence the individual susceptibility to HIV-1.

DESIGN: We performed an association study analyzing 2 NLRP1 and NLRP3 SNPs in HIV-1 vertically infected Brazilian children (n = 135), HIV-1-infected Brazilain adults (n = 192) and HIV-1-positive Italian seropositive subjects (n = 192).

RESULTS: The 3'UTR NLRP3 rs10754558 SNP was associated with HIV-1 infection in all the studied groups. The frequency of rs10754558 G allele was differently distributed within seropositive subjects (HIV+) and controls, and in particular the GG genotype was less frequent in HIV+.

CONCLUSIONS: susceptibility to HIV-1 infection is associated with a 3'UTR NLRP3 polymorphism. This is the first report linking SNPs in the NALPs with HIV-1 infection, and further epidemiologic and functional studies are needed to deeper investigate the role of inflammasome in the susceptibility to HIV-1 infection.

%B J Acquir Immune Defic Syndr %V 54 %P 236-40 %8 2010 Jul %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/20502346?dopt=Abstract %R 10.1097/QAI.0b013e3181dd17d4 %0 Journal Article %J Arthritis Care Res (Hoboken) %D 2010 %T Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. %A Ruperto, Nicolino %A Lovell, Daniel J %A Li, Tracy %A Sztajnbok, Flavio %A Goldenstein-Schainberg, Claudia %A Scheinberg, Morton %A Penades, Inmaculada Calvo %A Fischbach, Michael %A Alcala, Javier Orozco %A Hashkes, Philip J %A Hom, Christine %A Jung, Lawrence %A Lepore, Loredana %A Oliveira, Sheila %A Wallace, Carol %A Alessio, Maria %A Quartier, Pierre %A Cortis, Elisabetta %A Eberhard, Anne %A Simonini, Gabriele %A Lemelle, Irene %A Chalom, Elizabeth Candell %A Sigal, Leonard H %A Block, Alan %A Covucci, Allison %A Nys, Marleen %A Martini, Alberto %A Giannini, Edward H %K Adolescent %K Arthritis, Juvenile %K Child %K Double-Blind Method %K Female %K Health Status %K Humans %K Immunoconjugates %K Male %K Pain %K Quality of Life %K Questionnaires %K Sleep Stages %X

OBJECTIVE: To assess health-related quality of life (HRQOL) in abatacept-treated children/adolescents with juvenile idiopathic arthritis (JIA).

METHODS: In this phase III, double-blind, placebo-controlled trial, subjects with active polyarticular course JIA and an inadequate response/intolerance to ≥1 disease-modifying antirheumatic drug (including biologics) received abatacept 10 mg/kg plus methotrexate (MTX) during the 4-month open-label period (period A). Subjects achieving the American College of Rheumatology Pediatric 30 criteria for improvement (defined "responders") were randomized to abatacept or placebo (plus MTX) in the 6-month double-blind withdrawal period (period B). HRQOL assessments included 15 Child Health Questionnaire (CHQ) health concepts plus the physical (PhS) and psychosocial summary scores (PsS), pain (100-mm visual analog scale), the Children's Sleep Habits Questionnaire, and a daily activity participation questionnaire.

RESULTS: A total of 190 subjects from period A and 122 from period B were eligible for analysis. In period A, there were substantial improvements across all of the CHQ domains (greatest improvement was in pain/discomfort) and the PhS (8.3 units) and PsS (4.3 units) with abatacept. At the end of period B, abatacept-treated subjects had greater improvements versus placebo in all domains (except behavior) and both summary scores. Similar improvement patterns were seen with pain and sleep. For participation in daily activities, an additional 2.6 school days/month and 2.3 parents' usual activity days/month were gained in period A responders with abatacept, and further gains were made in period B (1.9 versus 0.9 [P = 0.033] and 0.2 versus -1.3 [P = 0.109] school days/month and parents' usual activity days/month, respectively, in abatacept- versus placebo-treated subjects).

CONCLUSION: Improvements in HRQOL were observed with abatacept, providing real-life tangible benefits to children with JIA and their parents/caregivers.

%B Arthritis Care Res (Hoboken) %V 62 %P 1542-51 %8 2010 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/20597110?dopt=Abstract %R 10.1002/acr.20283 %0 Journal Article %J Int J Immunogenet %D 2010 %T Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy. %A Segat, L %A Morgutti, M %A Athanasakis, E %A Trevisiol, C %A Amaddeo, A %A Poli, F %A Crovella, S %K 5' Untranslated Regions %K Adolescent %K Alleles %K beta-Defensins %K Case-Control Studies %K Child %K Child, Preschool %K Chronic Disease %K Cystic Fibrosis %K Cystic Fibrosis Transmembrane Conductance Regulator %K Female %K Gene Frequency %K Genotype %K Haplotypes %K Humans %K Immunity, Innate %K Infant %K Infant, Newborn %K Italy %K Male %K Polymorphism, Single Nucleotide %K Pseudomonas Infections %X

Cystic fibrosis (CF) transmembrane regulator protein (CFTR) gene is undoubtedly the main genetic factor involved in the modulation of CF phenotype. However, other factors such as human defensins and the genes encoding for these antimicrobial peptides have been hypothesized as possible modifiers influencing airways infection in CF patients, but their role in the pathogenesis of lung disease is still debated. Since DEFB1 gene encoding for human beta-defensin 1 displays features such as antimicrobial or chemotactic activity playing a role in inflammation, it has been considered as a possible candidate CF modifier gene. We analysed three single nucleotide polymorphisms (SNPs) in the 5'-untranslated region of the DEFB1 gene (namely g-52G>A, g-44C>G and g-20G>A) in a group of 62 CF patients from North Eastern Italy, and in 130 healthy controls, with the aim of verifying the possible association of these functional SNPs with the pulmonary phenotype of CF patients. DEFB1 SNPs have been genotyped by using Taqman allele-specific fluorescent probes and a real-time PCR platform. No significant differences were found for allele, genotype and haplotype frequencies of DEFB1 g-52G>A, g-44C>G and g-20G>A SNPs in CF patients stratified for Pseudomonas aeruginosa infection, as well as in patients with a severe and mild clinical phenotype or in patients stratified for CFTR genotypes. DEFB1 allele, genotype and haplotype frequencies of CF patients globally considered were similar to those of healthy controls. Our findings are discordant with respect to another recent study performed on CF patients coming from Southern Italy, probably due to different ethnicity of the patients.

%B Int J Immunogenet %V 37 %P 169-75 %8 2010 Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/20193032?dopt=Abstract %R 10.1111/j.1744-313X.2010.00907.x %0 Journal Article %J Curr Protein Pept Sci %D 2010 %T Antimicrobial plant peptides isolated from native and crop species in Brazil: development of new drugs. %A Crovella, Sergio %K Antimicrobial Cationic Peptides %K Biodiversity %K Brazil %K Crops, Agricultural %K Drug Discovery %K Genomics %K Plants %B Curr Protein Pept Sci %V 11 %P 180 %8 2010 May %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/20408807?dopt=Abstract %0 Journal Article %J Int J Dermatol %D 2010 %T Beta defensin-1 gene (DEFB1) polymorphisms are not associated with atopic dermatitis in children and adolescents from northeast Brazil (Recife, Pernambuco). %A Segat, Ludovica %A Guimarães, Rafael L %A Brandão, Lucas A C %A Rocha, Cintia R C %A Zanin, Valentina %A Trevisiol, Chiara %A de Lima Filho, José Luiz %A Crovella, Sergio %K Adolescent %K beta-Defensins %K Brazil %K Child %K Child, Preschool %K Dermatitis, Atopic %K Female %K Gene Frequency %K Genetic Predisposition to Disease %K Haplotypes %K Humans %K Infant %K Male %K Polymorphism, Single Nucleotide %K Risk Factors %X

BACKGROUND: Atopic dermatitis (AD) is a common inflammatory skin disease resulting from the interplay between environmental, immunological and genetic factors. In our study, we investigated the role of three single nucleotide polymorphisms (SNPs) at 5'-UTR of DEFB1 gene, encoding for the human beta defensin-1, on the susceptibility to develop AD in a group of Brazilian children and adolescents.

METHODS: Three SNPs, -20 G/A (rs11362), -44 C/G (rs1800972), and -52 G/A (rs1799946) at 5'-UTR of DEFB1 gene were genotyped in two groups of children and adolescents, one affected by AD (96 subjects), the other healthy (191 individuals), from northeast Brazil.

RESULTS: -44 C/G frequencies were comparable between the two groups. The -20 GG genotype was more frequent in AD subjects than in healthy controls; the -52 GG, conversely, was more frequent in healthy controls than in AD. However, both these differences did not reach statistical significance. Also, association between SNPs and AD severity has been shown. The analysis of DEFB1 haplotypes did not highlight any association of the three SNPs with AD development or disease severity.

CONCLUSIONS: Our results seem to exclude a role for the -44 C/G DEFB1 SNPs on the pathogenesis and severity of AD, while for the -20 C/G and -52 G/A, even if not statistically significant, we evidenced a slight trend for susceptibility (-20 GG) and protection (-52 GG) for the development of AD. However, as controversial findings have been reported in the literature, the role of DEFB1 in the development of AD and in the severity of the phenotype deserves further investigation.

%B Int J Dermatol %V 49 %P 653-7 %8 2010 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20618470?dopt=Abstract %R 10.1111/j.1365-4632.2009.04343.x %0 Journal Article %J Ann Rheum Dis %D 2010 %T Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. %A Corallini, Federica %A Secchiero, Paola %A Castellino, Gabriella %A Montecucco, Maurizio %A Trotta, Francesco %A Zauli, Giorgio %K Antirheumatic Agents %K Arthritis, Rheumatoid %K Biological Markers %K Glycoproteins %K Humans %B Ann Rheum Dis %V 69 %P 1733-4 %8 2010 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/20447952?dopt=Abstract %R 10.1136/ard.2009.125732 %0 Journal Article %J Intensive Care Med %D 2010 %T Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. %A Confalonieri, Marco %A D'Agaro, Pierlanfranco %A Campello, Cesare %K Adult %K Antiviral Agents %K Bronchoalveolar Lavage Fluid %K Extracorporeal Membrane Oxygenation %K Glucocorticoids %K Humans %K Influenza A Virus, H1N1 Subtype %K Influenza, Human %K Male %K Methylprednisolone %K Oseltamivir %K Respiration, Artificial %K Severity of Illness Index %K Viral Load %K World Health Organization %B Intensive Care Med %V 36 %P 1780-1 %8 2010 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/20631982?dopt=Abstract %R 10.1007/s00134-010-1964-8 %0 Journal Article %J Clin Exp Rheumatol %D 2010 %T Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy. %A Olivito, Biagio %A Taddio, Andrea %A Simonini, Gabriele %A Massai, Cristina %A Ciullini, Sara %A Gambineri, Eleonora %A de Martino, Maurizio %A Azzari, Chiara %A Cimaz, Rolando %K Acute Disease %K Child %K Child, Preschool %K Female %K Flow Cytometry %K Forkhead Transcription Factors %K Genotype %K Humans %K Immunoglobulins, Intravenous %K Infant %K Italy %K Male %K Mucocutaneous Lymph Node Syndrome %K Polymorphism, Single Nucleotide %K Reverse Transcriptase Polymerase Chain Reaction %K RNA, Messenger %K T-Lymphocytes, Regulatory %X

OBJECTIVES: The aims of this study were: 1) to investigate forkhead box P3 (FOXP3) expression in patients with Kawasaki disease (KD), exploring possible differences during the acute phase and after defervescence; 2) to evaluate a possible association of the FOXP3 single nucleotide polymorphism (SNP) 543 (SNP ID: rs2232367) with KD.

METHODS: FOXP3 expression was evaluated on 8 children with KD and 15 healthy children by flow cytometry and Real-Time polymerase chain reaction (RT-PCR). FOXP3 SNP 543 was genotyped by denaturing high-performance liquid chromatography (DHPLC) and sequencing on DNA samples from 58 additional children with KD and 114 healthy donors.

RESULTS: The frequencies of CD4+CD25 +FOXP3+ regulatory T cells were significantly (p=0.0002) lower during the acute phase of KD than in sex- and age-matched healthy donors (median % + SD: 4.8+/-1.3 vs. 7.7+/-1.7) and a similar tendency was revealed for FOXP3 mRNA transcripts (p<0.0001). FOXP3 expression increased significantly, at both protein and mRNA levels, after intravenous immunoglobulin (IVIG) therapy treatment and achieving complete remission of disease (at least 48 hrs; median 9.5 days, range 2-30). Of the 58 patients screened, only one female subject (1.7%) carried the presence of 543 SNP in heterozygosis (C>T; for a total of 1 allele out of 88), with no difference between KD patients and controls (0.0%, 0/203 alleles).

CONCLUSIONS: Our data reinforce the notion of an impaired immunoregulation in KD, suggesting also a role of IVIG treatment in modifying the Treg compartment. FOXP3 SNP 543 does not seem to be involved in susceptibility to KD in Italian children.

%B Clin Exp Rheumatol %V 28 %P 93-7 %8 2010 Jan-Feb %G eng %N 1 Suppl 57 %1 http://www.ncbi.nlm.nih.gov/pubmed/20412712?dopt=Abstract %0 Journal Article %J J Med Virol %D 2010 %T Detection of SV40 in colon cancer: a molecular case-control study from northeast Italy. %A Campello, Cesare %A Comar, Manola %A Zanotta, Nunzia %A Minicozzi, Anna %A Rodella, Luca %A Poli, Albino %K Adenocarcinoma %K Adult %K Aged %K Aged, 80 and over %K BK Virus %K Case-Control Studies %K Colonic Neoplasms %K DNA, Viral %K Female %K Humans %K Italy %K JC Virus %K Male %K Middle Aged %K Polymerase Chain Reaction %K Polyomavirus Infections %K Simian virus 40 %K Tumor Virus Infections %X

To explore the involvement of the simian polyomavirus SV40 in human colon cancer, a molecular case-control study was undertaken in patients and in their relatives living in an area where the spread of SV40 has already been documented. From 2006 to 2008, 94 colon cancer patients (age: 37-90 years) and 91 subjects (age: 32-70 years) relatives of each index case were enrolled. A blood sample and a specimen of cancer tissue or biopsy were collected, from each patient or control, respectively. Samples were analyzed twice for Polyomavirus (i.e., SV40, JCV, and BKV) by PCR and by quantitative real-time PCR (RT-qPCR) with reproducible results. No BKV/JCV was detected either in normal or pathological tissues. SV40 was not present in control subjects, either normal tissue or in biopsies from adenomas or polyps. All blood samples were negative. Conversely, six adenocarcinoma specimens were positive for SV40 sequences (overall prevalence 6.4%, P = 0.03 in comparison with controls). Nevertheless, the SV40-associated colon cancer risk proved statistically not significant (OR = 3.91; P = 0.115) when adjusted for age. Quantitation of SV40 DNA performed by RT-qPCR showed a low viral load ranging from 6.2 x 10(1) to 9 x 10(3) copies per reaction. This molecular case-control survey showed, for the first time in fresh samples and by RT-qPCR, that SV40 can be detected in colon cancer tissue. However, the finding was not statistically significant when compared with a well-structured community control group. Thus, the role of SV40 and other polyomavirus in colon cancer genesis deserves further investigation.

%B J Med Virol %V 82 %P 1197-200 %8 2010 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/20513084?dopt=Abstract %R 10.1002/jmv.21798 %0 Journal Article %J Infect Control Hosp Epidemiol %D 2010 %T Determinants of nosocomial infection in 6 neonatal intensive care units: an Italian multicenter prospective cohort study. %A Auriti, Cinzia %A Ronchetti, Maria Paola %A Pezzotti, Patrizio %A Marrocco, Gabriella %A Quondamcarlo, Anna %A Seganti, Giulio %A Bagnoli, Francesco %A De Felice, Claudio %A Buonocore, Giuseppe %A Arioni, Cesare %A Serra, Giovanni %A Bacolla, Gianfranco %A Corso, Giovanna %A Mastropasqua, Savino %A Mari, Annibale %A Corchia, Carlo %A Di Lallo, Domenico %A Ravà, Lucilla %A Orzalesi, Marcello %A Di Ciommo, Vincenzo %K Bacteremia %K Birth Weight %K Cross Infection %K Gestational Age %K Hospitals, University %K Humans %K Incidence %K Infant, Newborn %K Infant, Very Low Birth Weight %K Intensive Care Units, Neonatal %K Italy %K Length of Stay %K Proportional Hazards Models %K Prospective Studies %K Risk Factors %K Sepsis %K Time Factors %X

BACKGROUND: Nosocomial infections are still a major cause of morbidity and mortality among neonates admitted to neonatal intensive care units (NICUs).

OBJECTIVE: To describe the epidemiology of nosocomial infections in NICUs and to assess the risk of nosocomial infection related to the therapeutic procedures performed and to the clinical characteristics of the neonates at birth and at admission to the NICU, taking into account the time between the exposure and the onset of infection.

DESIGN: A multicenter, prospective cohort study.

PATIENTS AND SETTING: A total of 1,692 neonates admitted to 6 NICUs in Italy were observed and monitored for the development of nosocomial infection during their hospital stay.

METHODS: Data were collected on the clinical characteristics of the neonates admitted to the NICUs, their therapeutic interventions and treatments, their infections, and their mortality rate. The cumulative probability of having at least 1 infection and the cumulative probability of having at least 1 infection or dying were estimated. The hazard ratio (HR) for the first infection and the HR for the first infection or death were also estimated.

RESULTS: A total of 255 episodes of nosocomial infection were diagnosed in 217 neonates, yielding an incidence density of 6.9 episodes per 1,000 patient-days. The risk factors related to nosocomial infection in very-low-birth-weight neonates were receipt of continuous positive airway pressure (HR, 3.8 [95% confidence interval {CI}, 1.7-8.1]), a Clinical Risk Index for Babies score of 4 or greater (HR, 2.2 [95% CI, 1.4-3.4]), and a gestational age of less than 28 weeks (HR, 2.1 [95% CI, 1.2-3.8]). Among heavier neonates, the risk factors for nosocomial infection were receipt of parenteral nutrition (HR, 8.1 [95% CI, 3.2-20.5]) and presence of malformations (HR, 2.3 [95% CI, 1.5-3.5]).

CONCLUSIONS: Patterns of risk factors for nosocomial infection differ between very-low-birth-weight neonates and heavier neonates. Therapeutic procedures appear to be strong determinants of nosocomial infection in both groups of neonates, after controlling for clinical characteristics.

%B Infect Control Hosp Epidemiol %V 31 %P 926-33 %8 2010 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/20645863?dopt=Abstract %R 10.1086/655461 %0 Journal Article %J BMC Pediatr %D 2010 %T Development of paediatric quality of inpatient care indicators for low-income countries - A Delphi study. %A Ntoburi, Stephen %A Hutchings, Andrew %A Sanderson, Colin %A Carpenter, James %A Weber, Martin %A English, Mike %K Child %K Child, Hospitalized %K Delphi Technique %K Developing Countries %K Expert Testimony %K Female %K Humans %K Inpatients %K Male %K Pediatrics %K Quality Indicators, Health Care %K World Health Organization %X

BACKGROUND: Indicators of quality of care for children in hospitals in low-income countries have been proposed, but information on their perceived validity and acceptability is lacking.

METHODS: Potential indicators representing structural and process aspects of care for six common conditions were selected from existing, largely qualitative WHO assessment tools and guidelines. We employed the Delphi technique, which combines expert opinion and existing scientific information, to assess their perceived validity and acceptability. Panels of experts, one representing an international panel and one a national (Kenyan) panel, were asked to rate the indicators over 3 rounds and 2 rounds respectively according to a variety of attributes.

RESULTS: Based on a pre-specified consensus criteria most of the indicators presented to the experts were accepted: 112/137(82%) and 94/133(71%) for the international and local panels respectively. For the other indicators there was no consensus; none were rejected. Most indicators were rated highly on link to outcomes, reliability, relevance, actionability and priority but rated more poorly on feasibility of data collection under routine conditions. There was moderate to substantial agreement between the two panels of experts.

CONCLUSIONS: This Delphi study provided evidence for the perceived usefulness of most of a set of measures of quality of hospital care for children proposed for use in low-income countries. However, both international and local experts expressed concerns that data for many process-based indicators may not currently be available. The feasibility of widespread quality assessment and responsiveness of indicators to intervention should be examined as part of continued efforts to improve approaches to informative hospital quality assessment.

%B BMC Pediatr %V 10 %P 90 %8 2010 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/21144065?dopt=Abstract %R 10.1186/1471-2431-10-90 %0 Journal Article %J J Med Virol %D 2010 %T Epidemiological and molecular assessment of a rubella outbreak in North-Eastern Italy. %A D'Agaro, Pierlanfranco %A Dal Molin, Gianna %A Zamparo, Emanuela %A Rossi, Tatiana %A Micuzzo, Michele %A Busetti, Marina %A Santon, Daniela %A Campello, Cesare %K Adolescent %K Adult %K Antibodies, Viral %K Disease Outbreaks %K Epidemics %K Female %K Genotype %K Humans %K Immunoglobulin G %K Italy %K Male %K Pregnancy %K Pregnancy Complications, Infectious %K Rubella %K Rubella virus %K Young Adult %X

From January to June 2008, a rubella outbreak involving 111 laboratory confirmed cases occurred in the Friuli Venezia Giulia (FVG) region of North-Eastern Italy. The outbreak occurred initially in two residential homes for young adults disabled mentally and physically. Subsequently, the epidemic spread to the general population. Young adult cohorts were mostly affected and the mean age of the patients was 26.8 years; the majority of cases were male (73.8%), with a mean age of 26.6 years in males and 27.4 in females. Three pregnant women had a primary infection and two had their pregnancies terminated. Genotyping of 16 isolates showed the circulation of RUBV 2B, a genotype originating from Asia and South Africa and now present in Europe. In addition, molecular analysis revealed a well defined space-temporal spread of two viruses showing distinct sequences. A seroepidemiological survey carried out in a city within the same geographical area showed that the proportion of women of childbearing age still susceptible to rubella virus was 5.5%, fairly close to the figure (<5%) expected by 2010.

%B J Med Virol %V 82 %P 1976-82 %8 2010 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/20872726?dopt=Abstract %R 10.1002/jmv.21874 %0 Journal Article %J Curr Protein Pept Sci %D 2010 %T Ethnobotanical bioprospection of candidates for potential antimicrobial drugs from Brazilian plants: state of art and perspectives. %A Benko-Iseppon, Ana Maria %A Crovella, Sergio %K Anti-Infective Agents %K Biodiversity %K Brazil %K Ethnobotany %K Plants %X

Despite of the high biological diversity and traditional use of medicinal plants in Brazil, no comprehensive ethnobotanic review of plants with potential antimicrobial effects is available. In the present work own field information is aggregated with a literature review, identifying 433 Brazilian plant species potentially useful for identification of antimicrobial peptides. They included mainly woody species, distributed on 100 plant families (93 angiosperms and 7 pteridophytes) and 266 genera, covering all Brazilian regions and ecosystems. Main plant parts and indications for their use are presented and discussed, revealing the high potential that these plants present for the future planning strategies regarding the future development of antimicrobial drugs.

%B Curr Protein Pept Sci %V 11 %P 189-94 %8 2010 May %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/20353382?dopt=Abstract %0 Journal Article %J Ann Rheum Dis %D 2010 %T EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. %A Ruperto, Nicolino %A Ozen, Seza %A Pistorio, Angela %A Dolezalova, Pavla %A Brogan, Paul %A Cabral, David A %A Cuttica, Ruben %A Khubchandani, Raju %A Lovell, Daniel J %A O'Neil, Kathleen M %A Quartier, Pierre %A Ravelli, Angelo %A Iusan, Silvia M %A Filocamo, Giovanni %A Magalhães, Claudia Saad %A Unsal, Erbil %A Oliveira, Sheila %A Bracaglia, Claudia %A Bagga, Arvind %A Stanevicha, Valda %A Manzoni, Silvia Magni %A Pratsidou, Polyxeni %A Lepore, Loredana %A Espada, Graciela %A Kone-Paut, Isabella %A Paut, Isabelle Kone %A Zulian, Francesco %A Barone, Patrizia %A Bircan, Zelal %A Maldonado, Maria del Rocio %A Russo, Ricardo %A Vilca, Iris %A Tullus, Kjell %A Cimaz, Rolando %A Horneff, Gerd %A Anton, Jordi %A Garay, Stella %A Nielsen, Susan %A Barbano, Giancarlo %A Martini, Alberto %K Adolescent %K Biopsy %K Child %K Delphi Technique %K Granulomatosis with Polyangiitis %K Humans %K International Cooperation %K Internet %K Polyarteritis Nodosa %K Purpura, Schoenlein-Henoch %K Reproducibility of Results %K Takayasu Arteritis %X

OBJECTIVES: To report methodology and overall clinical, laboratory and radiographic characteristics for Henoch-Schönlein purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG) and c-Takayasu arteritis (c-TA) classification criteria.

METHODS: The preliminary Vienna 2005 consensus conference, which proposed preliminary criteria for paediatric vasculitides, was followed by a EULAR/PRINTO/PRES - supported validation project divided into three main steps. Step 1: retrospective/prospective web-data collection for HSP, c-PAN, c-WG and c-TA, with age at diagnosis

RESULTS: A total of 1183/1398 (85%) samples collected were available for analysis: 827 HSP, 150 c-PAN, 60 c-WG, 87 c-TA and 59 c-other. Prevalence, signs/symptoms, laboratory, biopsy and imaging reports were consistent with the clinical picture of the four c-vasculitides. A representative subgroup of 280 patients was blinded to the treating physician diagnosis and classified by a consensus panel, with a kappa-agreement of 0.96 for HSP (95% CI 0.84 to 1), 0.88 for c-WG (95% CI 0.76 to 0.99), 0.84 for c-TA (95% CI 0.73 to 0.96) and 0.73 for c-PAN (95% CI 0.62 to 0.84), with an overall kappa of 0.79 (95% CI 0.73 to 0.84).

CONCLUSION: EULAR/PRINTO/PRES propose validated classification criteria for HSP, c-PAN, c-WG and c-TA, with substantial/almost perfect agreement with the final consensus classification or original treating physician diagnosis.

%B Ann Rheum Dis %V 69 %P 790-7 %8 2010 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/20388738?dopt=Abstract %R 10.1136/ard.2009.116624 %0 Journal Article %J Lancet %D 2010 %T Exenatide in type 2 diabetes. %A Verzegnassi, Federico %A Chinello, Matteo %K Biological Markers %K Diabetes Mellitus, Type 2 %K Energy Intake %K Humans %K Hypoglycemic Agents %K Insulin %K Insulin, Long-Acting %K Peptides %K Quality of Life %K Venoms %B Lancet %V 376 %P 1052-3; author reply 1053 %8 2010 Sep 25 %G eng %N 9746 %1 http://www.ncbi.nlm.nih.gov/pubmed/20870094?dopt=Abstract %R 10.1016/S0140-6736(10)61485-7 %0 Journal Article %J Hum Mutat %D 2010 %T Expression and association data strongly support JARID2 involvement in nonsyndromic cleft lip with or without cleft palate. %A Scapoli, Luca %A Martinelli, Marcella %A Pezzetti, Furio %A Palmieri, Annalisa %A Girardi, Ambra %A Savoia, Anna %A Bianco, Anna Monica %A Carinci, Francesco %K Animals %K Cleft Lip %K Cleft Palate %K DNA Mutational Analysis %K Family Health %K Female %K Gene Expression %K Gene Expression Regulation, Developmental %K Genetic Predisposition to Disease %K Haplotypes %K Humans %K In Situ Hybridization %K Linkage Disequilibrium %K Male %K Mice %K Mice, Inbred C57BL %K Mutation %K Nerve Tissue Proteins %K Palate %K Polycomb Repressive Complex 2 %K Polymorphism, Single Nucleotide %K Pregnancy %K Reverse Transcriptase Polymerase Chain Reaction %X

Nonsyndromic cleft lip with or without cleft palate (CL/P) affects approximately 1 in 1,000 births. Genetic studies have provided evidence for the role of several genes and candidate loci in clefting; however, conflicting results have frequently been obtained and much have to be done to unravel the complex genetics of CL/P. In the present investigation we have focused on the candidate region in 6p23, a region that have been found linked to CL/P in several investigations, in the attempt to find out the susceptibility gene provisionally named OFC1. Gene expression experiments in mice embryo of positional candidate genes revealed that JARID2 was highly and specifically expressed in epithelial cells in merging palatal shelves. A family-based linkage disequilibrium study confirmed the pivotal role of JARID2 in orofacial development and strongly supports a role for this gene in CL/P etiology (multiallelic haplotype test P=6 x 10(-5)). Understanding the molecular role of JARID2 within facial development may offer additional information to further unravel the complex genetics of CL/P.

%B Hum Mutat %V 31 %P 794-800 %8 2010 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/20506229?dopt=Abstract %R 10.1002/humu.21266 %0 Journal Article %J Neurol Res Int %D 2010 %T Eye movement impairment recovery in a Gaucher patient treated with miglustat. %A Accardo, Agostino %A Pensiero, Stefano %A Ciana, Giovanni %A Parentin, Fulvio %A Bembi, Bruno %X

In Gaucher Disease (GD) the enzyme (imiglucerase) replacement therapy (ERT) is not able to stop the progression of the neurological involvement, while the substrate reduction therapy (SRT), performed by N-Butyldeoxynojirimycin (miglustat), is an alternative that should be evaluated. Two sisters, presenting the same genotype (R353G/R353G), were diagnosed as suffering from GD; one of them later developed neurological alterations identified by quantitative saccadic eye movements analysis. The aim of the study was to quantitatively measure the miglustat effects in this GD neurological patient. Eye movement analysis during subsequent controls was performed by estimating the characteristic parameters of saccadic main sequence. The study demonstrates that the SRT alone can be effective in GD3. Moreover, it confirms that quantitative eye movement analysis is able to precociously identify also slight neurological alterations, permitting more accurate GD classification.

%B Neurol Res Int %V 2010 %P 358534 %8 2010 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/21152212?dopt=Abstract %R 10.1155/2010/358534 %0 Journal Article %J J Clin Virol %D 2010 %T First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection. %A Campanini, Giulia %A Piralla, Antonio %A Rovida, Francesca %A Puzelli, Simona %A Facchini, Marzia %A Locatelli, Franco %A Minoli, Lorenzo %A Percivalle, Elena %A Donatelli, Isabella %A Baldanti, Fausto %K Amino Acid Substitution %K Antiviral Agents %K Bodily Secretions %K Child, Preschool %K Drug Resistance, Viral %K Female %K Humans %K Immunocompromised Host %K Influenza A Virus, H1N1 Subtype %K Influenza, Human %K Italy %K Molecular Sequence Data %K Mutation, Missense %K Neuraminidase %K Nose %K Oseltamivir %K RNA, Viral %K Sequence Analysis, DNA %K Treatment Outcome %K Viral Load %K Viral Proteins %K Withholding Treatment %X

A pandemic influenza A/H1N1v strain with the neuraminidase H274Y mutation was detected in nasal secretions of a 2-year-old leukemic patient with influenza-like illness after 18 days of treatment with oseltamivir. At baseline, no drug-resistant virus was found, while 4 days after treatment initiation a mixture of wild-type and mutated virus was detected. After treatment interruption, the wild type influenza virus re-emerged and became prevalent in nasal secretions after a few days, suggesting the lower fitness of the mutated virus strain. The patient slowly improved concurrently with a decrease in virus load, which resulted negative 42 days after diagnosis. No other drug-resistant influenza A/H1N1v virus strains have been detected in Italy (up to the end of November 2009) since the first case of the novel A/H1N1v virus was identified in the country (May 2009).

%B J Clin Virol %V 48 %P 220-2 %8 2010 Jul %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/20447860?dopt=Abstract %R 10.1016/j.jcv.2010.03.027 %0 Journal Article %J Int J Pediatr Otorhinolaryngol %D 2010 %T Five new OTOF gene mutations and auditory neuropathy. %A Zadro, Cristina %A Ciorba, Andrea %A Fabris, Annalisa %A Morgutti, Marcello %A Trevisi, Patrizia %A Gasparini, Paolo %A Martini, Alessandro %K Auditory Diseases, Central %K Deafness %K Evoked Potentials, Auditory, Brain Stem %K Female %K Humans %K Male %K Membrane Proteins %K Mutation %K Otoacoustic Emissions, Spontaneous %K Polymerase Chain Reaction %X

OBJECTIVE: Purpose of this paper is to analyse OTOF gene in a series of subjects affected by auditory neuropathy.

METHODS: Four children showing mild to profound prelingual deafness, confirmed by the absence of a clear and detectable responses at auditory brainstem responses (ABR), associated with the presence of bilateral OAE, were enrolled in the study.

RESULTS AND CONCLUSIONS: Genetic analysis identified five new mutations (a nonsense, a small and a large deletion and two splicing site mutations), and one missense mutation (F1795C) previously described. These results further confirm the role of OTOF gene in auditory neuropathy. In the absence of a context of neurological syndrome, the combination of absent ABR and positive OAE responses should lead to an auditory neuropathy diagnosis and to a mutational screening in OTOF.

%B Int J Pediatr Otorhinolaryngol %V 74 %P 494-8 %8 2010 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/20211493?dopt=Abstract %R 10.1016/j.ijporl.2010.02.004 %0 Journal Article %J J Pediatr %D 2010 %T Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra. %A Lepore, Loredana %A Paloni, Giulia %A Caorsi, Roberta %A Alessio, Maria %A Rigante, Donato %A Ruperto, Nicola %A Cattalini, Marco %A Tommasini, Alberto %A Zulian, Francesco %A Ventura, Alessando %A Martini, Alberto %A Gattorno, Marco %K Adolescent %K Adult %K Case-Control Studies %K Child %K Child, Preschool %K Cryopyrin-Associated Periodic Syndromes %K Female %K Follow-Up Studies %K Humans %K Inflammation %K Interleukin 1 Receptor Antagonist Protein %K Interleukin-1 %K Male %K Phenotype %K Quality of Health Care %K Quality of Life %K Questionnaires %K Syndrome %K Treatment Outcome %X

OBJECTIVE: To evaluate the quality of life and long-term follow-up of patients enrolled in the Italian registry of cryopyrin-associated periodic syndromes (CAPS).

STUDY DESIGN: Since 2004, 20 patients with CAPS were enrolled in a common registry from different Italian Centers of Pediatric Rheumatology; 14 patients were treated with Anakinra in an open fashion. Both treated and untreated patients were routinely followed according to standard of care. The Child Health Questionnaire (CHQ-PF 50) was used to assess the health-related quality of life.

RESULTS: The mean duration of follow-up was 37.5 months. In all treated patients, a complete and persistent control of the inflammatory manifestations was observed with no further progression of the disease. At enrollment in the registry, patients showed a poorer health-related quality of life than healthy children in both physical and the psychosocial summary scores. Treatment was associated with a dramatic and sustained amelioration of a variety of measures of poor quality of life, particularly in those concerning the global health perception, bodily pain-discomfort, and other physical domains.

CONCLUSIONS: Long-term IL-1 blockade produces a significant and persistent improvement in the clinical manifestations associated with the disease and on the overall quality of life.

%B J Pediatr %V 157 %P 310-315.e1 %8 2010 Aug %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/20472245?dopt=Abstract %R 10.1016/j.jpeds.2010.02.040 %0 Journal Article %J Expert Opin Drug Saf %D 2010 %T Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. %A Stocco, Gabriele %A Crews, Kristine R %A Evans, William E %K 6-Mercaptopurine %K Antineoplastic Combined Chemotherapy Protocols %K Child %K Humans %K Individualized Medicine %K Methyltransferases %K Models, Biological %K Neutropenia %K Nucleotide Transport Proteins %K Polymorphism, Genetic %K Precursor Cell Lymphoblastic Leukemia-Lymphoma %K Pyrophosphatases %X

IMPORTANCE OF THE FIELD: Although genetic polymorphisms in the gene encoding human thiopurine methyltransferase (TPMT) are known to have a marked effect on mercaptopurine metabolism and toxicity, there are many patients with wild-type TPMT who develop toxicity. Furthermore, when mercaptopurine dosages are adjusted in patients who are heterozygous at the TPMT locus, there are still some patients who develop toxicity for reasons that are not fully understood. Therefore, we recently studied the effects of a common polymorphism in another gene encoding an enzyme involved in mercaptopurine metabolism (SNP rs1127354 in inosine-triphospate-pyrophosphatase, ITPA), showing that genetic polymorphism of ITPA is a significant determinant of mercaptopurine metabolism and of febrile neutropenia following combination chemotherapy of acute lymphoblastic leukemia (ALL) in which mercaptopurine doses are individualized based on TPMT genotype.

AREA COVERED IN THIS REVIEW: In this review, we summarize the knowledge available about the effect and clinical relevance of TPMT and ITPA on mercaptopurine pharmacogenomics, with a particular focus on the use of this medication in pediatric patients with ALL.

WHAT THE READER WILL GAIN: Reader will gain insights into: i) the effects of pharmacogenomic traits on mercaptopurine toxicity and efficacy for the treatment of ALL and ii) individualization strategies that can be used to mitigate toxicity without compromising efficacy in pediatric patients with ALL.

TAKE HOME MESSAGE: Mercaptopurine dose can be adjusted on the basis of TPMT genotype to mitigate toxicity in pediatric patients with ALL. As treatment is individualized in this way for the most relevant genetic determinant of drug response (i.e., for mercaptopurine, TPMT), the importance of other genetic polymorphisms emerges (e.g., ITPA).

%B Expert Opin Drug Saf %V 9 %P 23-37 %8 2010 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/20021291?dopt=Abstract %R 10.1517/14740330903426151 %0 Journal Article %J Ann Allergy Asthma Immunol %D 2010 %T High polymorphism of the MBL2 gene in patients with atopic dermatitis. %A Carréra, Matilde Campos %A Moura, Patrícia %A Crovella, Sergio %A de Souza, Paulo Roberto Eleutério %A de Alencar, Luiz Cláudio Arraes %A Sarinho, Emanuel %K Adolescent %K Alleles %K Child %K Child, Preschool %K Dermatitis, Atopic %K Disease Progression %K Female %K Genetic Predisposition to Disease %K Genotype %K Humans %K Infant %K Male %K Mannose-Binding Lectin %K Polymorphism, Genetic %K Promoter Regions, Genetic %X

BACKGROUND: Low serum levels of mannose-binding lectin (MBL) are determined mainly by variant alleles of the MBL2 gene and it has been suggested that MBL may play a role in the susceptibility to atopic dermatitis (AD).

OBJECTIVE: The aim was to investigate the difference of the frequency of MBL2 variant alleles in AD patients and in a group of individuals without AD, and associate the MBL2 alleles with AD severity.

METHODS: MBL2 variant allele's frequency was investigated in 131 children with AD and 165 healthy children/adolescents matched by convenience. The severity of disease was graded according to the SCORing Atopic Dermatitis (SCORAD) index. The first exon variants were called "O" and the wild type "A". The variants in the promoter were H/L at -550 and X/Y at -221, determined by Real Time PCR.

RESULTS: Children with AD had higher frequency of allele O and the genotypes related to low or deficient levels of MBL, when compared to the healthy group (p = 0.0012 and p < 0.001, respectively), but not with AD severity.

CONCLUSION: Low or deficient MBL serum levels determined genetically may contribute to the predisposition for AD, but not for disease severity.

%B Ann Allergy Asthma Immunol %V 105 %P 39-42 %8 2010 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/20642202?dopt=Abstract %R 10.1016/j.anai.2010.03.017 %0 Journal Article %J Protein Pept Lett %D 2010 %T Histatins in non-human primates: gene variations and functional effects. %A Padovan, Lara %A Segat, Ludovica %A Pontillo, Alessandra %A Antcheva, Nikolinka %A Tossi, Alessandro %A Crovella, Sergio %K Amino Acid Sequence %K Animals %K Anti-Infective Agents %K Base Sequence %K Candida %K Catarrhini %K Cell Proliferation %K Computational Biology %K Cryptococcus %K Genetic Variation %K Histatins %K Humans %K Molecular Sequence Data %K Phylogeny %K Sequence Alignment %K Sequence Analysis, DNA %X

Human histatins are histidine-rich, low molecular weight salivary proteins that contribute to the immune system of the oral cavity. In this work, nucleotide sequences of the HIS1 (coding for histatin 1) and HIS2 (coding for histatin 3) genes, homologous to the human ones, have been sequenced and analysed in five primates species including Great Ape, Hylobatidae and Cercopithecidae. In HIS1, the region corresponding to the putative mature peptide shows a premature stop codon in Macaca and Cercopithecus, while HIS2 a six codon insertion in the Cercopithecidae. Histatin 5, a 24-residue peptide derived from histatin 3, is the most antimicrobially active among human histatins, thus macaque and nomascus orthologues of histatin 5 were selected for chemical synthesis and functional characterization, in comparison to the human peptide. All synthesized histatins are predicted to be poorly amphipathic, depending on the charged state of His residues and assume partially a-helical conformations only in lipophilic conditions. Antimicrobial assays against Candida and Criptococcus spp. indicate somewhat different spectra of in vitro activity against the tested fungi. We have described HIS1 and HIS2 gene variations in primates and have analysed their functional effects on selected Hst5 orthologues. The human antimicrobial peptide has been proposed to represent an important lead for new generation of antimicrobial compounds for the treatment of oral mycoses, thus the information from the non-human primates histatins studied may aid strategies for drugs design.

%B Protein Pept Lett %V 17 %P 909-18 %8 2010 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/20423320?dopt=Abstract %0 Journal Article %J AIDS %D 2010 %T HLA-G*0105N allele is associated with augmented risk for HIV infection in white female patients. %A Segat, Ludovica %A Catamo, Eulalia %A Fabris, Annalisa %A Morgutti, Marcello %A D'Agaro, Pierlanfranco %A Campello, Cesare %A Crovella, Sergio %K Adolescent %K Adult %K Aged %K Female %K Genetic Predisposition to Disease %K Histocompatibility Antigens Class I %K HIV Infections %K HIV-1 %K Humans %K Middle Aged %K Polymorphism, Genetic %K Young Adult %X

We analyzed HLA-G 3777G > C, HLA-G 14 bp deletion/insertion and HLA-G*0105N polymorphisms in HIV-positive white adult participants, infected through horizontal heterosexual transmission, and unexposed uninfected individuals, all from north eastern Italy. We report a new association between the HLA-G*0105N allele and HIV infection in adult white female participants, being HLA-G*0105N null allele correlated with an augmented risk (odds ratio = 4.35, 95% confidence interval = 1.38-18.07, P = 0.005) for HIV infection.

%B AIDS %V 24 %P 1961-4 %8 2010 Jul 31 %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/20588159?dopt=Abstract %R 10.1097/QAD.0b013e32833c3324 %0 Journal Article %J Rev Bras Ginecol Obstet %D 2010 %T [Human papillomavirus cervical infection: viral genotyping and risk factors for high-grade squamous intraepithelial lesion and cervix cancer]. %A de Mendonça, Vilma Guimarães %A Guimarães, Maria José Bezerra %A de Lima Filho, José Luiz %A de Mendonça, Carolina Guimarães %A Martins, Danyelly Bruneska Gondim %A Crovella, Sergio %A de Alencar, Luiz Cláudio Arraes %K Adult %K Carcinoma in Situ %K Case-Control Studies %K Female %K Genotype %K Humans %K Papillomaviridae %K Papillomavirus Infections %K Risk Factors %K Socioeconomic Factors %K Uterine Cervical Neoplasms %X

PURPOSE: to analyze the characteristics of viral infection and the risk factors for high-grade squamous intraepithelial lesion and cervical carcinoma in women with cervical HPV infection.

METHODS: a case-control study was conducted on women with cervical HPV at a Gynecology reference service enrolled at the Public Health System, located in Recife, Northeastern Brazil. The groups of cases (72 women with high-grade squamous intraepithelial lesion or cervical cancer) and controls (176 women with normal Pap smear or benign alterations) were investigated for six viral genotypes (HPV 16, 18, 31, 33, 6, 11) in ecto- and endocervical material using MY09/MY11 primers. The independent variables were ranked in three levels of determination: distal (sociodemographic), intermediate (behavioral) and proximal (previous Pap smear). The homogeneity of proportions was tested (χ2), unadjusted Odds Ratios (OR) were obtained and hierarchical logistic regression was applied to the final model, with adjustment of the effect of each variable to the outcome based on the variables in the same and previous levels of causality.

RESULTS: the viral genotype of cervical infection was identified in 76.6% of the 248 women participating in the study. High-risk HPV genotypes (83.4% of cases and 67.1% of controls) were predominant, especially HPV 16 and 31. The distal risk factors identified were: living in a rural area (OR=2.71, 95%CI: 1.18-6.23), less than three years of study (OR=3.97, 95%CI: 2.09-7.54) and family income below two minimum wages (OR=3.30, 95%CI: 1.04-10.51); intermediate: four or more pregnancies (OR=2.00, 95%CI: 1.06-3.76); and proximal: absence of a previous Pap smear (OR=9.74, 95%CI: 2.48-38.28).

CONCLUSIONS: genotypes 16 and 31 of cervical HPV infection are predominant among women assisted by the Public Health System in Northeastern Brazil. Socioeconomic and reproductive factors, as well as the absence of cytological screening, represent risk factors for the progression of infection to high-grade squamous intraepithelial lesion and cervical cancer.

%B Rev Bras Ginecol Obstet %V 32 %P 476-85 %8 2010 Oct %G por %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/21271154?dopt=Abstract %0 Journal Article %J Pediatr Blood Cancer %D 2010 %T Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study. %A Castagnola, Elio %A Rossi, Mario R %A Cesaro, Simone %A Livadiotti, Susanna %A Giacchino, Mareva %A Zanazzo, Giulio %A Fioredda, Francesca %A Beretta, Chiara %A Ciocchello, Francesca %A Carli, Modesto %A Putti, Maria Caterina %A Pansini, Valeria %A Berger, Massimo %A Licciardello, Maria %A Farina, Silvia %A Caviglia, Ilaria %A Haupt, Riccardo %K Antineoplastic Combined Chemotherapy Protocols %K Bacteremia %K Child %K Female %K Follow-Up Studies %K Humans %K Incidence %K Italy %K Leukemia, Myeloid, Acute %K Male %K Mycoses %K Neoplasm Recurrence, Local %K Retrospective Studies %X

BACKGROUND: Data on the epidemiology of bacteremias and invasive fungal diseases (IFD) in children with acute myeloid leukemia (AML) are scarce.

DESIGN AND METHODS: In a multi-center, retrospective study, we analyzed proportion, rate per 1,000 person-days at risk, and cumulative risk of bacteremias and IFD in children with AML.

RESULTS: Between January 1998 and December 2005, 240 children were treated for AML at 8 Italian Centers, for a total of 521 treatment courses and 63,232 person-days at risk. Bacteremia was observed in 32% of treatment courses and IFD was seen in 10% (P < 0.0001), with rates of 2.62 and 0.84, respectively (P < 0.001). There was a significantly higher frequency of IFD during relapse treatment: proportion 15% versus 9% (P = 0.05), rate 2.10 versus 0.64 (P = 0.008) and cumulative risk 32% versus 12% (P = 0.007), while there were no differences in the proportion, rate and cumulative risk of bacteremia during front-line or relapse treatment. The epidemiology of bacteremias and IFD was different during front-line therapy for M3 as compared to other types of AML, but the differences were not statistically significant.

CONCLUSIONS: Severe infectious complications are frequent during the treatment of pediatric AML, especially during relapse treatment, and bacteremias are more frequent than IFD.

%B Pediatr Blood Cancer %V 55 %P 1103-7 %8 2010 Dec 1 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20680968?dopt=Abstract %R 10.1002/pbc.22750 %0 Journal Article %J Chem Senses %D 2010 %T Individual differences in prefrontal cortex activity during perception of bitter taste using fNIRS methodology. %A Bembich, Stefano %A Lanzara, Carmela %A Clarici, Andrea %A Demarini, Sergio %A Tepper, Beverly J %A Gasparini, Paolo %A Grasso, Domenico L %K Adult %K Eating %K Female %K Food Preferences %K Humans %K Individuality %K Male %K Perception %K Phenotype %K Prefrontal Cortex %K Propylthiouracil %K Sodium Chloride %K Spectroscopy, Near-Infrared %K Taste %K Taste Threshold %K Young Adult %X

Although bitter taste has a crucial role in nutrition by preventing the ingestion of toxic foods, there are few studies on bitter taste neuroimaging. To identify cortical areas involved in bitter taste perception and to determine if individual differences in taste sensitivity to 6-n-propylthiouracil (PROP) are represented in the brain by different cortical activation patterns, we examined 48 healthy volunteers using functional near-infrared spectroscopy. Participants rated the perceived intensity of filter paper disks impregnated with PROP and NaCl during the imaging procedure and were then classified as PROP tasters and nontasters. We monitored cortical activity in both the anterior and posterior regions of the dorsolateral prefrontal cortex (DLPFC) and in the ventrolateral prefrontal cortex (VLPFC). No activity was detected in the anterior DLPFC in any of the participants. However, during the administration of PROP, significant cortical activation was detected in the more posterior regions of the left DLPFC and in the left and right VLPFC but only in PROP tasters. PROP nontasters showed no cortical activity in these areas. These data suggest that the prefrontal cortex is involved in the conscious perception of the bitter taste of PROP and that the pattern of activity is consistent with individual differences in the ability to taste this compound. Thus, the PROP phenotype is associated with fundamental differences in cortical taste processing.

%B Chem Senses %V 35 %P 801-12 %8 2010 Nov %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/20801896?dopt=Abstract %R 10.1093/chemse/bjq080 %0 Journal Article %J PLoS One %D 2010 %T Insights into the binding of Phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor. %A Biarnés, Xevi %A Marchiori, Alessandro %A Giorgetti, Alejandro %A Lanzara, Carmela %A Gasparini, Paolo %A Carloni, Paolo %A Born, Stephan %A Brockhoff, Anne %A Behrens, Maik %A Meyerhof, Wolfgang %K Amino Acid Sequence %K Calcium %K Cell Line %K Computational Biology %K Dose-Response Relationship, Drug %K Humans %K Intracellular Space %K Ligands %K Models, Molecular %K Molecular Sequence Data %K Mutagenesis, Site-Directed %K Phenylthiourea %K Protein Binding %K Protein Structure, Secondary %K Receptors, G-Protein-Coupled %X

Humans' bitter taste perception is mediated by the hTAS2R subfamily of the G protein-coupled membrane receptors (GPCRs). Structural information on these receptors is currently limited. Here we identify residues involved in the binding of phenylthiocarbamide (PTC) and in receptor activation in one of the most widely studied hTAS2Rs (hTAS2R38) by means of structural bioinformatics and molecular docking. The predictions are validated by site-directed mutagenesis experiments that involve specific residues located in the putative binding site and trans-membrane (TM) helices 6 and 7 putatively involved in receptor activation. Based on our measurements, we suggest that (i) residue N103 participates actively in PTC binding, in line with previous computational studies. (ii) W99, M100 and S259 contribute to define the size and shape of the binding cavity. (iii) W99 and M100, along with F255 and V296, play a key role for receptor activation, providing insights on bitter taste receptor activation not emerging from the previously reported computational models.

%B PLoS One %V 5 %P e12394 %8 2010 %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/20811630?dopt=Abstract %R 10.1371/journal.pone.0012394 %0 Journal Article %J J Med Virol %D 2010 %T JCV/BKV and SV40 viral load in lymphoid tissues of young immunocompetent children from an area of north-east Italy. %A Comar, Manola %A Zanotta, Nunzia %A Bovenzi, Massimo %A Campello, Cesare %K Adenoids %K BK Virus %K Carrier State %K Child %K Child, Preschool %K Female %K Herpesvirus 6, Human %K Humans %K Immunocompetence %K Italy %K JC Virus %K Male %K Neutrophils %K Palatine Tonsil %K Polyomavirus Infections %K Simian virus 40 %K Viral Load %K Virus Latency %X

Polyomavirus infection occurring during childhood is followed by a lifelong latency in immunocompetent subjects. The major site of polyomavirus persistence are the uroepithelial cells which leads to oral transmission. It has recently been hypothesized that tonsils could be a possible reservoir. The role of tonsil, adenoid, and peripheral blood mononuclear cells (PBMCs) as possible sites of JCV, BKV, and SV40 latency in young healthy children was assessed. Two hundred fifteen fresh specimens, including 57 tonsil, 80 adenoid, and 78 PBMC samples from 80 immunocompetent children (mean age 4.8 years) were analyzed to determine the viral load by quantitative real-time PCR. The human herpes virus 6 (HHV-6) was tested as a lymphotropic reference virus. Polyomavirus was detected in 5/80 (6.2%) children while HHV-6 infection affected 27/80 children (33.7%) (P < 0.001). SV40 was detected in one adenoid sample, while footprints of BKV were found in one adenoid and three tonsil samples. JCV was never found in all samples. Polyomavirus sequences were not detected in the 78 blood samples. One adenoid and two tonsils from three children (1.4%) were positive for both polyomavirus and HHV-6. Infections were characterized by low replication rates ranging typically from 1 x 10e(2)/5.5 x 10e(4) to 6.8 x 10e(3)/8.5 x 10e(4) viral copies/number of cells. In conclusion, tonsils and adenoids of children could effectively harbor BKV and SV40, although only very few cells proved to be infected. Nevertheless, the low prevalence of polyomavirus, in comparison with the lymphotropic HHV-6, suggests that these tissues are unlikely to be the preferred site of polyomavirus latency, at least in younger children.

%B J Med Virol %V 82 %P 1236-40 %8 2010 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/20513090?dopt=Abstract %R 10.1002/jmv.21786 %0 Journal Article %J J Inherit Metab Dis %D 2010 %T Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. %A Bembi, Bruno %A Pisa, Federica Edith %A Confalonieri, Marco %A Ciana, Giovanni %A Fiumara, Agata %A Parini, Rossella %A Rigoldi, Miriam %A Moglia, Arrigo %A Costa, Alfredo %A Carlucci, Annalisa %A Danesino, Cesare %A Pittis, Maria Gabriela %A Dardis, Andrea %A Ravaglia, Sabrina %K Adolescent %K Adult %K Age of Onset %K Aged %K alpha-Glucosidases %K Child %K Enzyme Replacement Therapy %K Female %K Follow-Up Studies %K Glycogen Storage Disease Type II %K Humans %K Male %K Middle Aged %K Observation %K Time Factors %K Treatment Outcome %K Young Adult %X

OBJECTIVES: Type II glycogenosis (GSDII) is a lysosomal storage disorder due to acid alpha-glucosidase (GAA) deficiency. Enzyme replacement therapy (ERT) with human recombinant alpha-glucosidase (rhGAA) has been demonstrated to be effective in the treatment of infantile forms of GSDII, but little information is available concerning late-onset phenotypes. Long-term follow-up studies are not available at present. The aim of this study was to evaluate the ERT long-term effects in late-onset GSDII.

METHODS: Twenty-four patients, including 7 juveniles and 17 adults, received bi-weekly infusion of rhGAA (20 mg/kg) for at least 36 months. Clinical conditions, muscular function (6-min walking test, 6MWT; Walton scale, WS), respiratory function (vital capacity, VC; forced expiratory volume, FEV1; arterial pCO(2)), and muscle enzymes were assessed every 6 months.

RESULTS: The 6MWT improved in both juvenile and adult patients (p = 0.01, p = 0.0002, respectively), as well as in patients with moderate to severe muscle function impairment (WS >3.5; p = 0.002). An overall improvement in WS was also observed (p = 0.0003). VC and FEV1 remained unchanged, while pCO(2) decreased (p = 0.017). Muscle enzymes decreased significantly (p < 0.0001). Two patients (8%) showed transient secondary events during ERT.

CONCLUSIONS: Long-term ERT with rhGAA was shown to be safe, well tolerated, and effective in improving motor function and in stabilizing respiratory function in late-onset GSDII. The response pattern showed a progressive clinical improvement during the follow-up period in juvenile patients, while in adults it reached and maintained a plateau after the first year of treatment.

%B J Inherit Metab Dis %V 33 %P 727-35 %8 2010 Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20838899?dopt=Abstract %R 10.1007/s10545-010-9201-8 %0 Journal Article %J Mol Immunol %D 2010 %T Mannose-binding lectin is produced by vaginal epithelial cells and its level in the vaginal fluid is influenced by progesterone. %A Bulla, R %A De Seta, F %A Radillo, O %A Agostinis, C %A Durigutto, P %A Pellis, V %A De Santo, D %A Crovella, S %A Tedesco, F %K Adolescent %K Adult %K Body Fluids %K Enzyme-Linked Immunosorbent Assay %K Epithelial Cells %K Female %K Humans %K Immunohistochemistry %K Mannose-Binding Lectin %K Menstrual Cycle %K Progesterone %K Reverse Transcriptase Polymerase Chain Reaction %K Vagina %K Young Adult %X

Mannose-binding lectin (MBL) is a recognition molecule of the complement (C) system and binds to carbohydrate ligands present on a wide range of pathogenic bacteria, viruses, fungi, and parasites. MBL has been detected in the cervico-vaginal cavity where it can provide a first-line defence against infectious agents colonizing the lower tract of the reproductive system. Analysis of the cervico-vaginal lavage (CVL) obtained from 11 normal cycling women at different phases of the menstrual cycle revealed increased levels of MBL in the secretive phase. Part of this MBL derives from the circulation as indicated by the presence of transferrin in CVL tested as a marker of vascular and tissue permeability. The local synthesis of MBL is suggested by the finding that its level is substantially higher than that of transferrin in the secretive phase. The contribution of endometrium is negligible since the MBL level did not change before and after hysterectomy. RT-PCR and in situ RT-PCR analysis showed that the vaginal tissue, and in particular the basal layer of the epithelium, is a source of MBL which binds to the basal membrane and to cells of the outer layers of the epithelium. In conclusion, we have shown that MBL detected in CVL derives both from plasma as result of transudation and from local synthesis and its level is progesterone dependent increasing in the secretive phase of the menstrual cycle.

%B Mol Immunol %V 48 %P 281-6 %8 2010 Nov-Dec %G eng %N 1-3 %1 http://www.ncbi.nlm.nih.gov/pubmed/20728220?dopt=Abstract %R 10.1016/j.molimm.2010.07.016 %0 Journal Article %J JAMA %D 2010 %T Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. %A Foell, Dirk %A Wulffraat, Nico %A Wedderburn, Lucy R %A Wittkowski, Helmut %A Frosch, Michael %A Gerss, Joachim %A Stanevicha, Valda %A Mihaylova, Dimitrina %A Ferriani, Virginia %A Tsakalidou, Florence Kanakoudi %A Foeldvari, Ivan %A Cuttica, Ruben %A Gonzalez, Benito %A Ravelli, Angelo %A Khubchandani, Raju %A Oliveira, Sheila %A Armbrust, Wineke %A Garay, Stella %A Vojinovic, Jelena %A Norambuena, Ximena %A Gamir, María Luz %A García-Consuegra, Julia %A Lepore, Loredana %A Susic, Gordana %A Corona, Fabrizia %A Dolezalova, Pavla %A Pistorio, Angela %A Martini, Alberto %A Ruperto, Nicolino %A Roth, Johannes %K Adolescent %K Antirheumatic Agents %K Arthritis, Juvenile %K ATP-Binding Cassette Transporters %K Calgranulin B %K Child %K Child, Preschool %K Female %K Humans %K Infant %K Male %K Methotrexate %K Predictive Value of Tests %K Prospective Studies %K Recurrence %K Remission Induction %X

CONTEXT: Novel therapies have improved the remission rate in chronic inflammatory disorders including juvenile idiopathic arthritis (JIA). Therefore, strategies of tapering therapy and reliable parameters for detecting subclinical inflammation have now become challenging questions.

OBJECTIVES: To analyze whether longer methotrexate treatment during remission of JIA prevents flares after withdrawal of medication and whether specific biomarkers identify patients at risk for flares.

DESIGN, SETTING, AND PATIENTS: Prospective, open, multicenter, medication-withdrawal randomized clinical trial including 364 patients (median age, 11.0 years) with JIA recruited in 61 centers from 29 countries between February 2005 and June 2006. Patients were included at first confirmation of clinical remission while continuing medication. At the time of therapy withdrawal, levels of the phagocyte activation marker myeloid-related proteins 8 and 14 heterocomplex (MRP8/14) were determined.

INTERVENTION: Patients were randomly assigned to continue with methotrexate therapy for either 6 months (group 1 [n = 183]) or 12 months (group 2 [n = 181]) after induction of disease remission.

MAIN OUTCOME MEASURES: Primary outcome was relapse rate in the 2 treatment groups; secondary outcome was time to relapse. In a prespecified cohort analysis, the prognostic accuracy of MRP8/14 concentrations for the risk of flares was assessed.

RESULTS: Intention-to-treat analysis of the primary outcome revealed relapse within 24 months after the inclusion into the study in 98 of 183 patients (relapse rate, 56.7%) in group 1 and 94 of 181 (55.6%) in group 2. The odds ratio for group 1 vs group 2 was 1.02 (95% CI, 0.82-1.27; P = .86). The median relapse-free interval after inclusion was 21.0 months in group 1 and 23.0 months in group 2. The hazard ratio for group 1 vs group 2 was 1.07 (95% CI, 0.82-1.41; P = .61). Median follow-up duration after inclusion was 34.2 and 34.3 months in groups 1 and 2, respectively. Levels of MRP8/14 during remission were significantly higher in patients who subsequently developed flares (median, 715 [IQR, 320-1 110] ng/mL) compared with patients maintaining stable remission (400 [IQR, 220-800] ng/mL; P = .003). Low MRP8/14 levels indicated a low risk of flares within the next 3 months following the biomarker test (area under the receiver operating characteristic curve, 0.76; 95% CI, 0.62-0.90).

CONCLUSIONS: In patients with JIA in remission, a 12-month vs 6-month withdrawal of methotrexate did not reduce the relapse rate. Higher MRP8/14 concentrations were associated with risk of relapse after discontinuing methotrexate.

TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN18186313.

%B JAMA %V 303 %P 1266-73 %8 2010 Apr 7 %G eng %N 13 %1 http://www.ncbi.nlm.nih.gov/pubmed/20371785?dopt=Abstract %R 10.1001/jama.2010.375 %0 Journal Article %J Euro Surveill %D 2010 %T Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. %A Puzelli, S %A Facchini, M %A De Marco, M A %A Palmieri, A %A Spagnolo, D %A Boros, S %A Corcioli, F %A Trotta, D %A Bagnarelli, P %A Azzi, A %A Cassone, A %A Rezza, G %A Pompa, M G %A Oleari, F %A Donatelli, I %K Adolescent %K Adult %K Age Distribution %K Aged %K Amino Acid Substitution %K Child %K Child, Preschool %K Female %K Hemagglutinins %K Humans %K Infant %K Influenza A Virus, H1N1 Subtype %K Influenza, Human %K Italy %K Male %K Middle Aged %K Mutation %K Pandemics %K Population Surveillance %K Reverse Transcriptase Polymerase Chain Reaction %K Severity of Illness Index %K Sex Distribution %K Young Adult %X

Haemagglutinin sequences of pandemic influenza A(H1N1) viruses circulating in Italy were examined, focusing on amino acid changes at position 222 because of its suggested pathogenic relevance. Among 169 patients, the D222G substitution was detected in three of 52 (5.8%) severe cases and in one of 117 (0.9%) mild cases, whereas the D222E mutation was more frequent and evenly distributed in mild (31.6%) and severe cases (38.4%). A cluster of D222E viruses among school children confirms reported human-to-human transmission of viruses mutated at amino acid position 222.

%B Euro Surveill %V 15 %8 2010 %G eng %N 43 %1 http://www.ncbi.nlm.nih.gov/pubmed/21087581?dopt=Abstract %0 Journal Article %J Pediatr Blood Cancer %D 2010 %T Morbidity of pandemic H1N1 influenza in children with cancer. %A Caselli, Désirée %A Carraro, Francesca %A Castagnola, Elio %A Ziino, Ottavio %A Frenos, Stefano %A Milano, Giuseppe Maria %A Livadiotti, Susanna %A Cesaro, Simone %A Marra, Nicoletta %A Zanazzo, Giulio %A Meazza, Cristina %A Cellini, Monica %A Aricò, Maurizio %K Adolescent %K Antineoplastic Agents %K Cause of Death %K Child %K Child, Preschool %K Data Collection %K Disease Outbreaks %K Humans %K Influenza A Virus, H1N1 Subtype %K Influenza, Human %K Leukemia %K Lymphoma, Non-Hodgkin %K Morbidity %K Neoplasms %K Treatment Outcome %K Young Adult %X

BACKGROUND: To define the mortality and the current impact of the H1N1 pandemic in pediatric hematology-oncology centers, we performed a specific survey.

PROCEDURE: Pharyngeal swabs from patients with fevers of unknown origin, flu-like symptoms or bronchopneumonia were screened for H1N1 using PCR.

RESULTS: Sixty-two patients with documented H1N1 infection were reported: 16 had recently stopped therapy, 2 were at the diagnosis stage, and 44 were receiving therapy. The clinical course was severe (requiring ICU admission) in only 1 patient, moderate (requiring hospital admission) in 38, and mild in the remaining 23 (37%), treated as outpatients. While none of the patients died of H1N1-related complications, two patients died of progressive cancer; in all of the remaining cases, symptoms resolved within 11 days. The clinical course was complicated by respiratory distress or bronchopneumonia in 10 cases. Oseltamivir was given to 82% of patients. Chemotherapy was temporarily withdrawn in 54% of cases for a median time of 21 days (range, 4-43 days).

CONCLUSION: H1N1 infection in children with cancer was not reported as the cause of death in any case but resulted in reduced intensity of anti-cancer therapy.

%B Pediatr Blood Cancer %V 55 %P 226-8 %8 2010 Aug %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/20582951?dopt=Abstract %R 10.1002/pbc.22619 %0 Journal Article %J Haematologica %D 2010 %T Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation. %A Caselli, Désirée %A Cesaro, Simone %A Ziino, Ottavio %A Zanazzo, Giulio %A Manicone, Rosaria %A Livadiotti, Susanna %A Cellini, Monica %A Frenos, Stefano %A Milano, Giuseppe M %A Cappelli, Barbara %A Licciardello, Maria %A Beretta, Chiara %A Aricò, Maurizio %A Castagnola, Elio %K Adolescent %K Antineoplastic Agents %K Bacteremia %K Child %K Child, Preschool %K Drug Resistance, Multiple %K Female %K Hematopoietic Stem Cell Transplantation %K Humans %K Immunocompromised Host %K Infant %K Infant, Newborn %K Italy %K Male %K Pseudomonas aeruginosa %K Pseudomonas Infections %K Retrospective Studies %K Young Adult %X

Pseudomonas aeruginosa is one leading gram-negative organism associated with nosocomial infections. Bacteremia is life-threatening in the immunocompromised host. Increasing frequency of multi-drug-resistant (MDRPA) strains is concerning. We started a retrospective survey in the pediatric hematology oncology Italian network. Between 2000 and 2008, 127 patients with Pseudomonas aeruginosa bacteremia were reported from 12 centers; 31.4% of isolates were MDRPA. Death within 30 days of a positive blood culture occurred in 19.6% (25/127) of total patients; in patients with MDRPA infection it occurred in 35.8% (14/39). In the multivariate analysis, only MDRPA had significant association with infection-related death. This is the largest series of Pseudomonas aeruginosa bacteremia cases from pediatric hematology oncology centers. Monitoring local bacterial isolates epidemiology is mandatory and will allow empiric antibiotic therapy to be tailored to reduce fatalities.

%B Haematologica %V 95 %P 1612-5 %8 2010 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/20305140?dopt=Abstract %R 10.3324/haematol.2009.020867 %0 Journal Article %J Int Immunopharmacol %D 2010 %T Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. %A Marcuzzi, Annalisa %A Tommasini, Alberto %A Crovella, Sergio %A Pontillo, Alessandra %K Animals %K Cell Line %K Cells, Cultured %K Child %K Child, Preschool %K Cytokines %K Diphosphonates %K Humans %K Inflammation %K Interleukin-1beta %K Lipopolysaccharides %K Male %K Mevalonate Kinase Deficiency %K Mice %K Monocytes %K Nitric Oxide %K Terpenes %X

The inhibition of mevalonate pathway through genetic defects (mevalonate kinase deficiency, MKD) or pharmacologic drugs (aminobisphosphonates) causes a shortage of intermediate compounds and, in particular, of geranylgeranyl-pyrophosphate (GGPP) associated to the activation of caspase-1 and IL-1beta release. Geraniol (GOH), farnesol (FOH), geranylgeraniol (GGOH) and menthol (MOH), due to their isoprenoid structure, are supposed to enter the mevalonate pathway and to by-pass the biochemical block, reconstituting the pathway. Considering the already known side effects of aminobisphosphonates, and the lack of a specific treatment for MKD, we evaluated the impact of these natural isoprenoids compounds in a RAW cell lines chemically treated with the aminobisphosphonate alendronate, and in monocytes isolated from 2 patients affected by MKD. GOH, FOH, GGOH and MOH were all capable to diminish inflammatory marker levels induced by LPS. These natural isoprenoids could be proposed as novel therapeutic approach for the still orphan drug MKD, but also considered for the evaluation of possible inflammatory side effects of aminobisphosphonates.

%B Int Immunopharmacol %V 10 %P 639-42 %8 2010 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20304105?dopt=Abstract %R 10.1016/j.intimp.2010.03.008 %0 Journal Article %J Arch Biochem Biophys %D 2010 %T Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. %A Cvorovic, Jovana %A Tramer, Federica %A Granzotto, Marilena %A Candussio, Luigi %A Decorti, Giuliana %A Passamonti, Sabina %K Anthocyanins %K Antioxidants %K Apoptosis %K Caco-2 Cells %K Camptothecin %K Cell Line, Tumor %K Colonic Neoplasms %K Drug Resistance, Neoplasm %K Glutathione %K Glutathione Reductase %K Humans %K Oxidants %K Oxidative Stress %X

Colorectal cancer is the second most frequent cause of cancer death in the western world. Although the prognosis has improved after the introduction of newer anticancer drugs, the treatment of metastatic colorectal cancer still remains a challenge due to a high percentage of drug-resistant tumor forms. We aimed at testing whether anthocyanidins exerted cytotoxicity in primary (Caco-2) and metastatic (LoVo and LoVo/ADR) colorectal cancer cell lines. Both cyanidin and delphinidin, though neither pelargonidin nor malvidin, were cytotoxic in metastatic cells only. The cell line most sensitive to anthocyanidins was the drug-resistant LoVo/ADR. There, cellular ROS accumulation, inhibition of glutathione reductase, and depletion of glutathione could be observed. This suggests that anthocyanidins may be used as sensitizing agents in metastatic colorectal cancer therapy.

%B Arch Biochem Biophys %V 501 %P 151-7 %8 2010 Sep 1 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/20494645?dopt=Abstract %R 10.1016/j.abb.2010.05.019 %0 Journal Article %J Ann Rheum Dis %D 2010 %T Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. %A Vilca, Iris %A Munitis, Pablo Garcia %A Pistorio, Angela %A Ravelli, Angelo %A Buoncompagni, Antonella %A Bica, Blanca %A Campos, Lucia %A Häfner, Renate %A Hofer, Michael %A Ozen, Seza %A Huemer, Christian %A Bae, Sang Cheol %A Sztajnbok, Flavio %A Arguedas, Olga %A Foeldvari, Ivan %A Huppertz, Hans Iko %A Gamir, María Luz %A Magnusson, Bo %A Dressler, Frank %A Uziel, Yosef %A van Rossum, Marion A J %A Hollingworth, Peter %A Cawkwell, Gail %A Martini, Alberto %A Ruperto, Nicolino %K Adolescent %K Antibodies, Antinuclear %K Antirheumatic Agents %K Arthritis, Juvenile %K Child %K Child, Preschool %K Disability Evaluation %K Female %K Follow-Up Studies %K Humans %K Immunosuppressive Agents %K Male %K Methotrexate %K Prognosis %K Treatment Outcome %X

OBJECTIVES: To determine whether baseline demographic, clinical, articular and laboratory variables predict methotrexate (MTX) poor response in polyarticular-course juvenile idiopathic arthritis.

METHODS: Patients newly treated for 6 months with MTX enrolled in the Paediatric Rheumatology International Trials Organization (PRINTO) MTX trial. Bivariate and logistic regression analyses were used to identify baseline predictors of poor response according to the American College of Rheumatology pediatric (ACR-ped) 30 and 70 criteria.

RESULTS: In all, 405/563 (71.9%) of patients were women; median age at onset and disease duration were 4.3 and 1.4 years, respectively, with anti-nuclear antibody (ANA) detected in 259/537 (48.2%) patients. With multivariate logistic regression analysis, the most important determinants of ACR-ped 70 non-responders were: disease duration > 1.3 years (OR 1.93), ANA negativity (OR 1.77), Childhood Health Assessment Questionnaire (CHAQ) disability index > 1.125 (OR 1.65) and the presence of right and left wrist activity (OR 1.55). Predictors of ACR-ped 30 non-responders were: ANA negativity (OR 1.92), CHAQ disability index > 1.14 (OR 2.18) and a parent's evaluation of child's overall well-being < or = 4.69 (OR 2.2).

CONCLUSION: The subgroup of patients with longer disease duration, ANA negativity, higher disability and presence of wrist activity were significantly associated with a poorer response to a 6-month MTX course.

%B Ann Rheum Dis %V 69 %P 1479-83 %8 2010 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/20525842?dopt=Abstract %R 10.1136/ard.2009.120840 %0 Journal Article %J Health Res Policy Syst %D 2010 %T Progress towards the achievement of MDG4 in the Commonwealth of Independent States: uncertain data, clear priorities. %A Cattaneo, Adriano %A Gafurov, Ilkhom %A Bomestar, Tamara %A Bacci, Marianna %A Kumar, Sanjiv %A Popovic, Dragoslav %A Tamburlini, Giorgio %X

Data on under five mortality in the twelve countries of the Commonwealth of Independent States show important fluctuations over time due to variations in quality of data, definitions of neonatal deaths and methods of mortality estimation. Despite the uncertainties regarding mortality trends, the analysis of health and social information from different sources offers clues to identify priority areas and key strategic directions for accelerating the achievement of the 4th Millennium Development Goal. Neonatal deaths represent from 40% to over 50% of under five deaths in all these countries. Maternal mortality was above 50 per 100,000 in 2005, despite the good coverage with antenatal care and births assisted by skilled birth attendants. The scanty information on quality of perinatal care indicates widespread substandard care at all levels. Stunting in children under five is above 10% in ten out of twelve countries and coexists with emerging overweight. Exclusivity and duration of breastfeeding fall short of what is recommended. There are important inequalities in child and maternal mortality, malnutrition and access and use of health services within countries. Taken as a whole, the available information clearly indicates that priority should be given to improvement of the health of women in reproductive age and of the quality of perinatal care, including the establishment of reliable data collection systems. To achieve this, action will need to focus on strengthening the capacity of the health system to improve the technical content of service provision, and on improving access and appropriate use of services by the most disadvantaged groups. The involvement of other sectors will be necessary to improve reproductive health and nutrition at community level and to tackle inequity. Comparisons between countries with similar socioeconomic background but different health policies seem to indicate that gradual progression towards universal coverage with essential health care through a national health insurance system is associated with larger reduction of child mortality than troubled transition towards a privatized and unregulated health system.

%B Health Res Policy Syst %V 8 %P 5 %8 2010 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/20205914?dopt=Abstract %R 10.1186/1478-4505-8-5 %0 Journal Article %J Lancet %D 2010 %T Rotavirus vaccine efficacy in African and Asian countries. %A Tamburlini, Giorgio %A Cattaneo, Adriano %A Monasta, Lorenzo %K Africa %K Child %K Dysentery %K Gastroenteritis %K Humans %K Rotavirus Infections %K Rotavirus Vaccines %K Treatment Outcome %B Lancet %V 376 %P 1897; author reply 1898 %8 2010 Dec 4 %G eng %N 9756 %1 http://www.ncbi.nlm.nih.gov/pubmed/21130281?dopt=Abstract %R 10.1016/S0140-6736(10)62207-6 %0 Journal Article %J Int J Audiol %D 2010 %T Screening for GJB2 and GJB6 gene mutations in patients from Campania region with sensorineural hearing loss. %A Chinetti, Viviana %A Iossa, Sandra %A Auletta, Gennaro %A Laria, Carla %A De Luca, Maria %A Di Leva, Francesca %A Riccardi, Pasquale %A Giannini, Pasquale %A Gasparini, Paolo %A Ciccodicola, Alfredo %A Marciano, Elio %A Franzè, Annamaria %K Acoustic Stimulation %K Adolescent %K Adult %K Audiometry %K Auditory Perception %K Child %K Child, Preschool %K Connexins %K Genetic Predisposition to Disease %K Genetic Testing %K Hearing Loss, Sensorineural %K Heterozygote %K Homozygote %K Humans %K Italy %K Mass Screening %K Middle Aged %K Mutation %K Phenotype %K Risk Factors %K Severity of Illness Index %K Young Adult %X

The aim of this study was to screen 349 patients affected by sensorineural hearing loss (SNHL), mostly from the Campania region (southern Italy), for GJB2 gene mutations and for two deletions of the GJB6 gene (del GJB6 -D13S1830 and del GJB6 -D13S1854). We identified pathogenetic GJB2 mutations in 51 cases (15% of patients). No GJB6 mutation was found. We also examined the audiologic features of the patients for whom we had an etiologic diagnosis, in order to identify correlations between the severity of hearing loss and the type of mutation.

%B Int J Audiol %V 49 %P 326-31 %8 2010 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/20233142?dopt=Abstract %R 10.3109/14992021003601756 %0 Journal Article %J J Pediatr %D 2010 %T Splenomegaly as presentation of a wandering spleen. %A Maschio, Massimo %A Cozzi, Giorgio %A Sanabor, Daniela %A Zennaro, Floriana %A Gloria, Pelizzo %A Barbi, Egidio %K Child %K Female %K Humans %K Splenomegaly %K Wandering Spleen %B J Pediatr %V 157 %P 859.e1 %8 2010 Nov %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/20591443?dopt=Abstract %R 10.1016/j.jpeds.2010.04.046 %0 Journal Article %J Breastfeed Rev %D 2010 %T State of the art and recommendations. Kangaroo mother care: application in a high-tech environment. %A Nyqvist, K H %A Anderson, G C %A Bergman, N %A Cattaneo, A %A Charpak, N %A Davanzo, R %A Ewald, U %A Ludington-Hoe, S %A Mendoza, S %A Pallás-Allonso, C %A Peláez, J G %A Sizun, J %A Wiström, A M %X

UNLABELLED: Since Kangaroo Mother Care (KMC) was developed in Colombia in the 1970s, two trends in clinical application emerged. In low-income settings, the original KMC modelis implemented. This consists of continuous (24 h/day; 7 days/week) and prolonged mother/parent-infant skin-to-skin contact; early discharge with the infant in the kangaroo position; (ideally) exclusive breastfeeding and, adequate follow up. In affluent settings, intermittent KMC with sessions of one or a few hours skin-to-skin contact for a limited period is common. As a result of the increasing evidence of the benefits of KMC for both infants and families in all intensive care settings, KMC in a high-tech environment was chosen as the topic for the first European Conference on KMC, and the clinical implementation of the KMC modelin all types of settings was discussed at the 7th International Workshop on KMC Kangaroo Mother Care protocols in high-tech Neonatal Intensive Care Units (NICU) should specify criteria for initiation, kangaroo position, transfer to/from KMC, transport in kangaroo position, kangaroo nutrition, parents'role, modification of the NICU environment, performance of care in KMC, and KMCin case of infant instability.

CONCLUSION: Implementation of the original KMC method, with continuous skin-to-skin contact whenever possible, is recommended for application in high-tech environments, although scientific evaluation should continue.

%B Breastfeed Rev %V 18 %P 21-8 %8 2010 Nov %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21226419?dopt=Abstract %0 Journal Article %J Acta Paediatr %D 2010 %T State of the art and recommendations. Kangaroo mother care: application in a high-tech environment. %A Nyqvist, K H %A Anderson, G C %A Bergman, N %A Cattaneo, A %A Charpak, N %A Davanzo, R %A Ewald, U %A Ludington-Hoe, S %A Mendoza, S %A Pallás-Allonso, C %A Peláez, J G %A Sizun, J %A Widström, A-M %K Attitude of Health Personnel %K Female %K Humans %K Infant Care %K Infant, Newborn %K Intensive Care Units, Neonatal %K Male %K Parent-Child Relations %K Practice Guidelines as Topic %K Professional-Patient Relations %K Role %K Skin %K Visitors to Patients %X

UNLABELLED: Since Kangaroo Mother Care (KMC) was developed in Colombia in the 1970s, two trends in clinical application emerged. In low income settings, the original KMC model is implemented. This consists of continuous (24 h/day, 7 days/week) and prolonged mother/parent-infant skin-to-skin contact; early discharge with the infant in the kangaroo position; (ideally) exclusive breastfeeding; and, adequate follow-up. In affluent settings, intermittent KMC with sessions of one or a few hours skin-to-skin contact for a limited period is common. As a result of the increasing evidence of the benefits of KMC for both infants and families in all intensive care settings, KMC in a high-tech environment was chosen as the topic for the first European Conference on KMC, and the clinical implementation of the KMC model in all types of settings was discussed at the 7th International Workshop on KMC. Kangaroo Mother Care protocols in high-tech Neonatal Intensive Care Units (NICU) should specify criteria for initiation, kangaroo position, transfer to/from KMC, transport in kangaroo position, kangaroo nutrition, parents' role, modification of the NICU environment, performance of care in KMC, and KMC in case of infant instability.

CONCLUSION: Implementation of the original KMC method, with continuous skin-to-skin contact whenever possible, is recommended for application in high-tech environments, although scientific evaluation should continue.

%B Acta Paediatr %V 99 %P 812-9 %8 2010 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20219028?dopt=Abstract %R 10.1111/j.1651-2227.2010.01794.x %0 Journal Article %J Pharmacol Res %D 2010 %T Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. %A De Leo, Luigina %A Marcuzzi, Annalisa %A Decorti, Giuliana %A Tommasini, Alberto %A Crovella, Sergio %A Pontillo, Alessandra %K Adult %K Animals %K Anti-Inflammatory Agents %K Cells, Cultured %K Child, Preschool %K Enzyme Inhibitors %K Farnesyltranstransferase %K Female %K Humans %K Male %K Mevalonate Kinase Deficiency %K Mevalonic Acid %K Mice %K Mice, Inbred BALB C %K Monocytes %K Polyenes %K Polyisoprenyl Phosphates %K Polyunsaturated Alkamides %K Young Adult %X

Mevalonate kinase deficiency (MKD) is a rare inborn auto-inflammatory disease due to the impairment of the pathway for the biosynthesis of cholesterol and non-sterol isoprenoids. The shortage of isoprenoids compounds and in particular of geranylgeranylpyrophosphate (GGPP) was recently associated to the MKD characteristic inflammatory attacks. The aim of this study is to demonstrate that the normalization of the mevalonate pathway intermediates levels and in particular of GGPP, through the specific inhibition of farnesyl-transferase (FT) with Manumycin A could ameliorate the inflammatory phenotype of MKD patients. The effect of Manumycin A was first evaluated in MKD mouse and cellular models, chemically obtained using the aminobisphosphonate alendronate (ALD), and then in monocytes isolated from 2 MKD patients. Our findings were compared to those obtained by using natural exogenous isoprenoids (NEIs). Manumycin A was able to significantly reduce the inflammatory marker serum amyloid A in ALD-treated Balb/c mice, as well as IL-1 beta secretion in ALD-monocytes and in MKD patients. These results clearly showed that, through the inhibition of FT, an increased number of mevalonate pathway intermediates could be redirected towards the synthesis of GGPP diminishing the inflammatory response. The importance in limiting the shortage of GGPP was emphasized by the anti-inflammatory effect of NEIs that, due to their biochemical structure, can enter the MKD pathway. In conclusion, manumycin A, as well as NEIs, showed anti-inflammatory effect in MKD models and especially in MKD-monocytes, suggesting novel approaches in the treatment of MKD, an orphan disease without any efficacious treatment currently available.

%B Pharmacol Res %V 61 %P 506-10 %8 2010 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20206266?dopt=Abstract %R 10.1016/j.phrs.2010.02.012 %0 Journal Article %J Nat Genet %D 2010 %T Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. %A Elks, Cathy E %A Perry, John R B %A Sulem, Patrick %A Chasman, Daniel I %A Franceschini, Nora %A He, Chunyan %A Lunetta, Kathryn L %A Visser, Jenny A %A Byrne, Enda M %A Cousminer, Diana L %A Gudbjartsson, Daniel F %A Esko, Tõnu %A Feenstra, Bjarke %A Hottenga, Jouke-Jan %A Koller, Daniel L %A Kutalik, Zoltán %A Lin, Peng %A Mangino, Massimo %A Marongiu, Mara %A McArdle, Patrick F %A Smith, Albert V %A Stolk, Lisette %A van Wingerden, Sophie H %A Zhao, Jing Hua %A Albrecht, Eva %A Corre, Tanguy %A Ingelsson, Erik %A Hayward, Caroline %A Magnusson, Patrik K E %A Smith, Erin N %A Ulivi, Shelia %A Warrington, Nicole M %A Zgaga, Lina %A Alavere, Helen %A Amin, Najaf %A Aspelund, Thor %A Bandinelli, Stefania %A Barroso, Inês %A Berenson, Gerald S %A Bergmann, Sven %A Blackburn, Hannah %A Boerwinkle, Eric %A Buring, Julie E %A Busonero, Fabio %A Campbell, Harry %A Chanock, Stephen J %A Chen, Wei %A Cornelis, Marilyn C %A Couper, David %A Coviello, Andrea D %A d'Adamo, Pio %A de Faire, Ulf %A de Geus, Eco J C %A Deloukas, Panos %A Döring, Angela %A Smith, George Davey %A Easton, Douglas F %A Eiriksdottir, Gudny %A Emilsson, Valur %A Eriksson, Johan %A Ferrucci, Luigi %A Folsom, Aaron R %A Foroud, Tatiana %A Garcia, Melissa %A Gasparini, Paolo %A Geller, Frank %A Gieger, Christian %A Gudnason, Vilmundur %A Hall, Per %A Hankinson, Susan E %A Ferreli, Liana %A Heath, Andrew C %A Hernandez, Dena G %A Hofman, Albert %A Hu, Frank B %A Illig, Thomas %A Järvelin, Marjo-Riitta %A Johnson, Andrew D %A Karasik, David %A Khaw, Kay-Tee %A Kiel, Douglas P %A Kilpeläinen, Tuomas O %A Kolcic, Ivana %A Kraft, Peter %A Launer, Lenore J %A Laven, Joop S E %A Li, Shengxu %A Liu, Jianjun %A Levy, Daniel %A Martin, Nicholas G %A McArdle, Wendy L %A Melbye, Mads %A Mooser, Vincent %A Murray, Jeffrey C %A Murray, Sarah S %A Nalls, Michael A %A Navarro, Pau %A Nelis, Mari %A Ness, Andrew R %A Northstone, Kate %A Oostra, Ben A %A Peacock, Munro %A Palmer, Lyle J %A Palotie, Aarno %A Paré, Guillaume %A Parker, Alex N %A Pedersen, Nancy L %A Peltonen, Leena %A Pennell, Craig E %A Pharoah, Paul %A Polasek, Ozren %A Plump, Andrew S %A Pouta, Anneli %A Porcu, Eleonora %A Rafnar, Thorunn %A Rice, John P %A Ring, Susan M %A Rivadeneira, Fernando %A Rudan, Igor %A Sala, Cinzia %A Salomaa, Veikko %A Sanna, Serena %A Schlessinger, David %A Schork, Nicholas J %A Scuteri, Angelo %A Segrè, Ayellet V %A Shuldiner, Alan R %A Soranzo, Nicole %A Sovio, Ulla %A Srinivasan, Sathanur R %A Strachan, David P %A Tammesoo, Mar-Liis %A Tikkanen, Emmi %A Toniolo, Daniela %A Tsui, Kim %A Tryggvadottir, Laufey %A Tyrer, Jonathon %A Uda, Manuela %A van Dam, Rob M %A van Meurs, Joyce B J %A Vollenweider, Peter %A Waeber, Gerard %A Wareham, Nicholas J %A Waterworth, Dawn M %A Weedon, Michael N %A Wichmann, H Erich %A Willemsen, Gonneke %A Wilson, James F %A Wright, Alan F %A Young, Lauren %A Zhai, Guangju %A Zhuang, Wei Vivian %A Bierut, Laura J %A Boomsma, Dorret I %A Boyd, Heather A %A Crisponi, Laura %A Demerath, Ellen W %A van Duijn, Cornelia M %A Econs, Michael J %A Harris, Tamara B %A Hunter, David J %A Loos, Ruth J F %A Metspalu, Andres %A Montgomery, Grant W %A Ridker, Paul M %A Spector, Tim D %A Streeten, Elizabeth A %A Stefansson, Kari %A Thorsteinsdottir, Unnur %A Uitterlinden, André G %A Widen, Elisabeth %A Murabito, Joanne M %A Ong, Ken K %A Murray, Anna %K Adolescent %K Aging %K Body Height %K Body Size %K Child %K DNA Copy Number Variations %K Female %K Genetic Loci %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Humans %K Inheritance Patterns %K Menarche %K Obesity %K Polymorphism, Single Nucleotide %K Quantitative Trait Loci %K Reproducibility of Results %K Time Factors %X

To identify loci for age at menarche, we performed a meta-analysis of 32 genome-wide association studies in 87,802 women of European descent, with replication in up to 14,731 women. In addition to the known loci at LIN28B (P = 5.4 × 10⁻⁶⁰) and 9q31.2 (P = 2.2 × 10⁻³³), we identified 30 new menarche loci (all P < 5 × 10⁻⁸) and found suggestive evidence for a further 10 loci (P < 1.9 × 10⁻⁶). The new loci included four previously associated with body mass index (in or near FTO, SEC16B, TRA2B and TMEM18), three in or near other genes implicated in energy homeostasis (BSX, CRTC1 and MCHR2) and three in or near genes implicated in hormonal regulation (INHBA, PCSK2 and RXRG). Ingenuity and gene-set enrichment pathway analyses identified coenzyme A and fatty acid biosynthesis as biological processes related to menarche timing.

%B Nat Genet %V 42 %P 1077-85 %8 2010 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/21102462?dopt=Abstract %R 10.1038/ng.714 %0 Journal Article %J Med Vet Entomol %D 2010 %T Ticks and Lyme borreliosis in an alpine area in northeast Italy. %A Nazzi, F %A Martinelli, E %A Del Fabbro, S %A Bernardinelli, I %A Milani, N %A Iob, A %A Pischiutti, P %A Campello, C %A D'Agaro, P %K Animals %K Borrelia burgdorferi %K Climate %K Ecology %K Humans %K Incidence %K Italy %K Ixodes %K Lyme Disease %K Nymph %K Population Density %K Prevalence %K Seasons %K Ticks %X

A 2-year study was conducted in a mountainous area of northeast Italy to evaluate the occurrence and distribution of ticks, as well as to assess the prevalence of the spirochaete Borrelia burgdorferi sensu lato. All ticks collected were Ixodes ricinus L. (Parasitiformes: Ixodidae). In general, most nymphs and adult ticks were collected from April to July. Tick density was highly variable among sites; however, two areas with different infestation levels were recognized. Prevalences of B. burgdorferi s.l. in nymphal stages were rather variable between sites; overall the prevalence of infected nymphs in the whole area was slightly higher than 20%. The prevalence of B. burgdorferi s.l. in nymphs does not seem to be correlated with nymph density. The correlation between the incidence of Lyme borreliosis (reported human cases/1000 inhabitants/year) and Borrelia prevalence in nymphs was not significant, although a significant correlation was found between borreliosis incidence and nymph density.

%B Med Vet Entomol %V 24 %P 220-6 %8 2010 Sep %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/20534008?dopt=Abstract %R 10.1111/j.1365-2915.2010.00877.x %0 Journal Article %J PLoS Med %D 2010 %T Toward a consensus on guiding principles for health systems strengthening. %A Swanson, Robert C %A Bongiovanni, Annette %A Bradley, Elizabeth %A Murugan, Varnee %A Sundewall, Jesper %A Betigeri, Arvind %A Nyonator, Frank %A Cattaneo, Adriano %A Harless, Brandi %A Ostrovsky, Andrey %A Labonté, Ronald %K Global Health %K Humans %K Public Health %B PLoS Med %V 7 %P e1000385 %8 2010 %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/21203584?dopt=Abstract %R 10.1371/journal.pmed.1000385 %0 Journal Article %J Acta Paediatr %D 2010 %T Towards universal Kangaroo Mother Care: recommendations and report from the First European conference and Seventh International Workshop on Kangaroo Mother Care. %A Nyqvist, K H %A Anderson, G C %A Bergman, N %A Cattaneo, A %A Charpak, N %A Davanzo, R %A Ewald, U %A Ibe, O %A Ludington-Hoe, S %A Mendoza, S %A Pallás-Allonso, C %A Ruiz Peláez, J G %A Sizun, J %A Widström, A-M %K Congresses as Topic %K Female %K Global Health %K Humans %K Infant Care %K Infant, Newborn %K Male %K Parent-Child Relations %K Practice Guidelines as Topic %K Randomized Controlled Trials as Topic %K Skin %X

UNLABELLED: The hallmark of Kangaroo Mother Care (KMC) is the kangaroo position: the infant is cared for skin-to-skin vertically between the mother's breasts and below her clothes, 24 h/day, with father/substitute(s) participating as KMC providers. Intermittent KMC (for short periods once or a few times per day, for a variable number of days) is commonly employed in high-tech neonatal intensive care units. These two modalities should be regarded as a progressive adaptation of the mother-infant dyad, ideally towards continuous KMC, starting gradually and progressively with intermittent KMC. The other components in KMC are exclusive breastfeeding (ideally) and early discharge in kangaroo position with strict follow-up. Current evidence allows the following general statements about KMC in affluent and low-income settings: KMC enhances bonding and attachment; reduces maternal postpartum depression symptoms; enhances infant physiologic stability and reduces pain, increases parental sensitivity to infant cues; contributes to the establishment and longer duration of breastfeeding and has positive effects on infant development and infant/parent interaction. Therefore, intrapartum and postnatal care in all types of settings should adhere to a paradigm of nonseparation of infants and their mothers/families. Preterm/low-birth-weight infants should be regarded as extero-gestational foetuses needing skin-to-skin contact to promote maturation.

CONCLUSION: Kangaroo Mother Care should begin as soon as possible after birth, be applied as continuous skin-to-skin contact to the extent that this is possible and appropriate and continue for as long as appropriate.

%B Acta Paediatr %V 99 %P 820-6 %8 2010 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20219044?dopt=Abstract %R 10.1111/j.1651-2227.2010.01787.x %0 Journal Article %J Emerg Infect Dis %D 2010 %T Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. %A Puzelli, Simona %A Facchini, Marzia %A Spagnolo, Domenico %A De Marco, Maria A %A Calzoletti, Laura %A Zanetti, Alessandro %A Fumagalli, Roberto %A Tanzi, Maria L %A Cassone, Antonio %A Rezza, Giovanni %A Donatelli, Isabella %K Adult %K Amino Acid Substitution %K Disease Outbreaks %K Hemagglutinin Glycoproteins, Influenza Virus %K Humans %K Influenza A Virus, H1N1 Subtype %K Influenza, Human %K Male %K Middle Aged %K Mutation, Missense %K Phylogeny %K Retrospective Studies %K RNA, Viral %K Sequence Analysis, RNA %K Severity of Illness Index %X

A pandemic (H1N1) 2009 virus strain carrying the D222G mutation was identified in a severely ill man and was transmitted to a household contact. Only mild illness developed in the contact, despite his obesity and diabetes. The isolated virus reacted fully with an antiserum against the pandemic vaccine strain.

%B Emerg Infect Dis %V 16 %P 863-5 %8 2010 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/20409386?dopt=Abstract %R 10.3201/eid1605.091815 %0 Journal Article %J Diabetes %D 2010 %T Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes. %A Zauli, Giorgio %A Toffoli, Barbara %A di Iasio, Maria Grazia %A Celeghini, Claudio %A Fabris, Bruno %A Secchiero, Paola %K Animals %K Cells, Cultured %K Diabetes Mellitus, Experimental %K Gene Expression %K Humans %K Islets of Langerhans %K Leukocytes, Mononuclear %K Mice %K Recombinant Proteins %K Suppressor of Cytokine Signaling Proteins %K TNF-Related Apoptosis-Inducing Ligand %X

OBJECTIVE: To evaluate the potential therapeutic effect of recombinant human tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) treatment in a model of type 1 diabetes.

RESEARCH DESIGN AND METHODS: Recombinant TRAIL was added in vitro to primary human and mouse peripheral blood mononuclear cells (PBMCs) and isolated human islets to evaluate the expression of the immunoregulatory gene SOCS1. Diabetes was induced by five consecutive daily injections of low-concentration (50 mg/kg) streptozotocin (STZ) in C57 black mice (n = 24). A group of these mice (n = 12) was co-injected with recombinant TRAIL (20 microg/day) for 5 days, and the diabetic status (glycemia and body weight) was followed over time. After 6 weeks, circulating levels of insulin, TNF-alpha, and osteoprotegerin (OPG) were measured, and animals were killed to perform the histological analysis of the pancreas.

RESULTS: The in vitro exposure of both PBMCs and human islets to recombinant TRAIL significantly upregulated the expression of SOCS1. With respect to STZ-treated animals, mice co-injected with STZ+TRAIL were characterized by 1) lower levels of hyperglycemia, 2) higher levels of body weight and insulinemia, 3) a partial preservation of pancreatic islets with normal morphology, and 4) a lower expression of both systemic (TNF-alpha and OPG) and pancreatic (vascular cell adhesion molecule [VCAM]-1) inflammatory markers.

CONCLUSIONS: Overall, these data demonstrate that the administration of recombinant TRAIL ameliorates the severity of STZ-induced type 1 diabetes, and this effect was accompanied by the upregulation of SOCS1 expression.

%B Diabetes %V 59 %P 1261-5 %8 2010 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/20185810?dopt=Abstract %R 10.2337/db09-1771 %0 Journal Article %J Scand J Gastroenterol %D 2010 %T The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease? %A Tommasini, Alberto %A Pirrone, Angela %A Palla, Gabriella %A Taddio, Andrea %A Martelossi, Stefano %A Crovella, Sergio %A Ventura, Alessandro %K Biological Markers %K Crohn Disease %K Cytokines %K Evidence-Based Medicine %K Granulomatous Disease, Chronic %K Hematopoietic Stem Cell Transplantation %K Humans %K Immunosuppressive Agents %K Phagocytes %K Treatment Outcome %K Wiskott-Aldrich Syndrome %X

Crohn's disease (CD) is generally considered a multifactorial disorder, since different genetic and environmental factors are thought to play a role in its pathogenesis. Recently, genome wide linkage studies allowed to identify the association of several loci with the increased risk of CD, although it is still unclear how they interact with environmental factors in causing the disease. The fact that many CD-risk-related genes are involved in the function of phagocytes seems in agreement with the well known role of these cells in CD histopathology. Functional defects in cytokine production or in clearance of bacteria in CD patients have recently been reported. Growing evidence that CD could arise from primary phagocyte immunodeficiency is also coming from the study of cases with early onset in infancy. We review such evidences starting from selected cases and discuss the clinical implications of these findings.

%B Scand J Gastroenterol %V 45 %P 1141-9 %8 2010 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/20497046?dopt=Abstract %R 10.3109/00365521.2010.492529 %0 Journal Article %J J Crohns Colitis %D 2010 %T Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence. %A Stocco, Gabriele %A Londero, Margherita %A Campanozzi, Angelo %A Martelossi, Stefano %A Marino, Sara %A Malusà, Noelia %A Bartoli, Fiora %A Decorti, Giuliana %A Ventura, Alessandro %K 6-Mercaptopurine %K Adolescent %K Azathioprine %K Child %K Child, Preschool %K Female %K Guanine Nucleotides %K Hepatitis, Autoimmune %K Humans %K Immunosuppressive Agents %K Inflammatory Bowel Diseases %K Male %K Medication Adherence %K Thionucleotides %K Young Adult %X

Azathioprine is a thiopurine immunosuppressive antimetabolite used to chronically treat inflammatory bowel disease and autoimmune hepatitis. Azathioprine treatment is a long-term therapy and therefore it is at risk for non-adherence, which is considered an important determinant of treatment inefficacy. Measurement of 6-thioguanine and 6-methylmercaptopurine nucleotides has been recently suggested as a screener for non-adherence detection. We describe four young patients in which non-adherence to azathioprine therapy was detected only through the measurement of drug metabolite concentrations, and the criterion for non-adherence was undetectable metabolite levels. After the identification of non-adherence, patients and their families were approached and the importance of a correct drug administration was thoroughly enlightened and discussed; this allowed obtaining a full remission in all subjects. Our observations support the use of undetectable metabolite levels as indicators of non-adherence to therapy in azathioprine treated patients. The additional level of medical supervision given by this assay allows getting a better adherence to medical treatment, which results in an improvement in the response to therapy; these benefits may justify the costs associated with the assay.

%B J Crohns Colitis %V 4 %P 599-602 %8 2010 Nov %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/21122567?dopt=Abstract %R 10.1016/j.crohns.2010.04.003 %0 Journal Article %J PLoS One %D 2010 %T Wired to be social: the ontogeny of human interaction. %A Castiello, Umberto %A Becchio, Cristina %A Zoia, Stefania %A Nelini, Cristian %A Sartori, Luisa %A Blason, Laura %A D'Ottavio, Giuseppina %A Bulgheroni, Maria %A Gallese, Vittorio %K Female %K Fetus %K Humans %K Pregnancy %K Social Behavior %K Ultrasonography, Prenatal %X

BACKGROUND: Newborns come into the world wired to socially interact. Is a propensity to socially oriented action already present before birth? Twin pregnancies provide a unique opportunity to investigate the social pre-wiring hypothesis. Although various types of inter-twins contact have been demonstrated starting from the 11(th) week of gestation, no study has so far investigated the critical question whether intra-pair contact is the result of motor planning rather then the accidental outcome of spatial proximity.

METHODOLOGY/PRINCIPAL FINDINGS: Kinematic profiles of movements in five pairs of twin foetuses were studied by using four-dimensional ultrasonography during two separate recording sessions carried out at the 14(th) and 18(th) week of gestation. We demonstrate that by the 14th week of gestation twin foetuses do not only display movements directed towards the uterine wall and self-directed movements, but also movements specifically aimed at the co-twin, the proportion of which increases between the 14(th) and 18(th) gestational week. Kinematic analysis revealed that movement duration was longer and deceleration time was prolonged for other-directed movements compared to movements directed towards the uterine wall. Similar kinematic profiles were observed for movements directed towards the co-twin and self-directed movements aimed at the eye-region, i.e. the most delicate region of the body.

CONCLUSIONS/SIGNIFICANCE: We conclude that performance of movements towards the co-twin is not accidental: already starting from the 14th week of gestation twin foetuses execute movements specifically aimed at the co-twin.

%B PLoS One %V 5 %P e13199 %8 2010 %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/20949058?dopt=Abstract %R 10.1371/journal.pone.0013199 %0 Journal Article %J Biochem Biophys Res Commun %D 1975 %T Studies of oxygen binding energy to hemoglobin molecule. %A Chow, Y W %A Pietranico, R %A Mukerji, A %K Binding Sites %K Cobalt %K Hemoglobins %K Humans %K Hydrogen-Ion Concentration %K Iron %K Ligands %K Mathematics %K Oxygen %K Oxyhemoglobins %K Protein Binding %K Spectrum Analysis %B Biochem Biophys Res Commun %V 66 %P 1424-31 %8 1975 Oct 27 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/6?dopt=Abstract